Citrus Sinensis ID: 047892
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 442 | 2.2.26 [Sep-21-2011] | |||||||
| Q3EDL4 | 472 | Probable serine/threonine | no | no | 0.864 | 0.809 | 0.581 | 1e-147 | |
| Q6NKZ9 | 437 | Probable receptor-like se | no | no | 0.891 | 0.901 | 0.525 | 1e-125 | |
| Q9SJG2 | 494 | Probable receptor-like pr | no | no | 0.936 | 0.838 | 0.486 | 1e-116 | |
| Q8LEB6 | 484 | Probable receptor-like pr | no | no | 0.904 | 0.826 | 0.501 | 1e-115 | |
| Q9LRP3 | 467 | Probable receptor-like pr | no | no | 0.866 | 0.820 | 0.474 | 1e-111 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.622 | 0.381 | 0.423 | 8e-63 | |
| Q9C821 | 509 | Proline-rich receptor-lik | no | no | 0.610 | 0.530 | 0.416 | 6e-62 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.606 | 0.411 | 0.411 | 9e-62 | |
| Q3EBR4 | 453 | Putative receptor-like pr | no | no | 0.651 | 0.635 | 0.392 | 2e-61 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.617 | 0.358 | 0.413 | 7e-61 |
| >sp|Q3EDL4|Y1154_ARATH Probable serine/threonine-protein kinase At1g01540 OS=Arabidopsis thaliana GN=At1g01540 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 522 bits (1344), Expect = e-147, Method: Compositional matrix adjust.
Identities = 276/475 (58%), Positives = 320/475 (67%), Gaps = 93/475 (19%)
Query: 8 TSIFGLRIWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNATKSSSLCNNYNSSS 67
TSIFGLR+WVV+GI +G+ IV+ LFL+SL TS+R + + +S
Sbjct: 17 TSIFGLRLWVVIGILLGSLIVIALFLLSLCLTSRRKNRKPRADF--------------AS 62
Query: 68 GNPTIPNISKEIQEIRIDLDSKSISNCKPHSAPNPEPLPEPEPILVEDSPVRGRNRIHIE 127
P ISKEI+EI + S P I ++
Sbjct: 63 AAIATPPISKEIKEI---------VPAQNQSVPA---------------------EIQVD 92
Query: 128 IGK-DHRIAYR----------------------------RVSHLGWGHWYTLRELEVSTN 158
IGK +HR+ + VSHLGWG WYTLRELE +TN
Sbjct: 93 IGKIEHRVVFSDRVSSGESRGTASASETASYSGSGNCGPEVSHLGWGRWYTLRELEAATN 152
Query: 159 GFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 218
G +ENVIGEGGYGIVYRG+L D T VAVKNLLNNRGQAEKEFKVEVE IGRVRHKNLVR
Sbjct: 153 GLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 212
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 278
L+GYC EGA+RMLV ++VDNGNLEQW+HGDVG SPLTW+IRMNIILG AKGL YLHEGL
Sbjct: 213 LLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLTWDIRMNIILGMAKGLAYLHEGL 272
Query: 279 EPK----------------WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 322
EPK WN K+SDFGLAKLLG+E SYVTTRVMGTFGYVAPEYA TGM
Sbjct: 273 EPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESSYVTTRVMGTFGYVAPEYACTGM 332
Query: 323 LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382
LNE SD+YSFGILIME+I+GRNPVDYSRP GE NL +WLK+MV N +E V+DP++
Sbjct: 333 LNEKSDIYSFGILIMEIITGRNPVDYSRPQGE----TNLVDWLKSMVGNRRSEEVVDPKI 388
Query: 383 QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDERRAGREHG 437
E PSS+ALKR LLVALRCVDP+A+KRPKMGH+IHMLEAE+ +RDERR R+HG
Sbjct: 389 PEPPSSKALKRVLLVALRCVDPDANKRPKMGHIIHMLEAEDLLYRDERRTTRDHG 443
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6NKZ9|Y4345_ARATH Probable receptor-like serine/threonine-protein kinase At4g34500 OS=Arabidopsis thaliana GN=At4g34500 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 449 bits (1155), Expect = e-125, Method: Compositional matrix adjust.
Identities = 240/457 (52%), Positives = 302/457 (66%), Gaps = 63/457 (13%)
Query: 9 SIFGLRIWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNATKSSSLCNNYNSSSG 68
S+FGL +++V+ IC + ++L + ++ N + R++ SS
Sbjct: 17 SVFGLNLYLVIAIC---SVFILLISLLIFLFVCLNRVSRARRMRVKHSSG---------- 63
Query: 69 NPTIPNISKEIQEIRI-------DLDSKSISN--CKPHSAPNPEPLPEPEPILVEDSPVR 119
+IP +SKEI EI+ D I N SA + E + + V S
Sbjct: 64 --SIPLVSKEISEIKTVGKFINSDDSKGKIGNEVVVVVSATSKEATSGFDTLSVASSGDV 121
Query: 120 GRNRIHIEIGKDHRIAYRRVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYRGVL 179
G + +GWG WY+L++LE++T GF+D+N+IGEGGYG+VYR
Sbjct: 122 GTSE-----------------AMGWGKWYSLKDLEIATRGFSDDNMIGEGGYGVVYRADF 164
Query: 180 EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAH--RMLVNEYVD 237
D + AVKNLLNN+GQAEKEFKVEVEAIG+VRHKNLV L+GYCA+ A RMLV EY+D
Sbjct: 165 SDGSVAAVKNLLNNKGQAEKEFKVEVEAIGKVRHKNLVGLMGYCADSAQSQRMLVYEYID 224
Query: 238 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK---------------- 281
NGNLEQWLHGDVGP SPLTW+IRM I +GTAKGL YLHEGLEPK
Sbjct: 225 NGNLEQWLHGDVGPVSPLTWDIRMKIAIGTAKGLAYLHEGLEPKVVHRDVKSSNILLDKK 284
Query: 282 WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS 341
WN K+SDFGLAKLLG+E SYVTTRVMGTFGYV+PEYASTGMLNE SDVYSFG+L+ME+I+
Sbjct: 285 WNAKVSDFGLAKLLGSETSYVTTRVMGTFGYVSPEYASTGMLNECSDVYSFGVLLMEIIT 344
Query: 342 GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRC 401
GR+PVDYSRPPGE +NL +W K MV + E V+DP+++ P RALKRALLV LRC
Sbjct: 345 GRSPVDYSRPPGE----MNLVDWFKGMVASRRGEEVIDPKIKTSPPPRALKRALLVCLRC 400
Query: 402 VDPNAHKRPKMGHVIHMLEAEEFPFRDERRAGREHGR 438
+D ++ KRPKMG +IHMLEAE+FPFR E R+ +E +
Sbjct: 401 IDLDSSKRPKMGQIIHMLEAEDFPFRPEHRSNQERSK 437
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SJG2|Y2296_ARATH Probable receptor-like protein kinase At2g42960 OS=Arabidopsis thaliana GN=At2g42960 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 419 bits (1078), Expect = e-116, Method: Compositional matrix adjust.
Identities = 233/479 (48%), Positives = 298/479 (62%), Gaps = 65/479 (13%)
Query: 1 MQEGFPLTSIFGLRIWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNATKSSSLC 60
M + + GL++WV + + VG IV++L ++SLW T +R S S + +
Sbjct: 11 MSKKISFFGLKGLKLWVWVCLVVGVFIVMILCILSLWITFRRKSRRSSSKFPFNQ----- 65
Query: 61 NNYNSSSGNPTIPNISKEI------------QEIRIDLDSKS-----ISNCKPHSAPNPE 103
IP++SK+I + + I+++ KS +S+ + + +
Sbjct: 66 -----------IPHVSKDIRVDRAGFQNPHPESLYIEMNDKSTGKTMMSHLGRTKSSDND 114
Query: 104 PLPEPEPILVEDSPVRGRNRIHIEIGKDHR------------IAYRRVSHLGWGHWYTLR 151
L + + + + G R + +SHLGWGHW+TLR
Sbjct: 115 TLSQCSSVNHHERACSSHSGEEGGFGSAGRQYGGGPVTASPLVGLPEISHLGWGHWFTLR 174
Query: 152 ELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 211
+LE++TN FA NV+GEGGYG+VYRG L + T VAVK LLNN GQAEKEF+VEVEAIG V
Sbjct: 175 DLELATNRFAPVNVLGEGGYGVVYRGKLVNGTEVAVKKLLNNLGQAEKEFRVEVEAIGHV 234
Query: 212 RHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 271
RHKNLVRL+GYC EG HRMLV EYV++GNLEQWLHG + H LTWE RM II GTA+ L
Sbjct: 235 RHKNLVRLLGYCIEGVHRMLVYEYVNSGNLEQWLHGAMRQHGNLTWEARMKIITGTAQAL 294
Query: 272 TYLHEGLEPK----------------WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 315
YLHE +EPK +N KLSDFGLAKLL + S++TTRVMGTFGYVAP
Sbjct: 295 AYLHEAIEPKVVHRDIKASNILIDDEFNAKLSDFGLAKLLDSGESHITTRVMGTFGYVAP 354
Query: 316 EYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375
EYA+TG+LNE SD+YSFG+L++E I+GR+PVDY RP E VNL EWLK MV AE
Sbjct: 355 EYANTGLLNEKSDIYSFGVLLLEAITGRDPVDYGRPANE----VNLVEWLKMMVGTRRAE 410
Query: 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDERRAGR 434
V+DPRL+ +PS ALKRALLV+LRCVDP A KRP+M V MLE++E PF ERR R
Sbjct: 411 EVVDPRLEPRPSKSALKRALLVSLRCVDPEAEKRPRMSQVARMLESDEHPFHKERRNKR 469
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LEB6|Y5185_ARATH Probable receptor-like protein kinase At5g18500 OS=Arabidopsis thaliana GN=At5g18500 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 414 bits (1064), Expect = e-115, Method: Compositional matrix adjust.
Identities = 226/451 (50%), Positives = 290/451 (64%), Gaps = 51/451 (11%)
Query: 12 GLRIWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNATKSSSLCNNYNSSSGNPT 71
GL +W ++ I + A I +V+ ISLW T +R ++ S L S P+
Sbjct: 15 GLELWEIIVIVLSA-IFVVVLAISLWLTFRRKTSRSSSNLIPV----------SRQIPPS 63
Query: 72 IPNISKEIQEIRIDLDSKSISNCKPHSAPNPEPLPEPEPILVEDSPVRGRNRI----HIE 127
+P +EI+EIR+D S S S EPE + +S +R H+E
Sbjct: 64 VP---EEIKEIRVDEVSSSNGGNGYPSISEKFGDKEPEKGIKAESENGDSSRSGSFNHLE 120
Query: 128 IGKDHRIAYR-------------RVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIV 174
++ SHLGWGHW+TLR+L+++TN F+ +N+IG+GGYG+V
Sbjct: 121 KKDGSSVSSANPLTAPSPLSGLPEFSHLGWGHWFTLRDLQMATNQFSRDNIIGDGGYGVV 180
Query: 175 YRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234
YRG L + T VAVK LLNN GQA+K+F+VEVEAIG VRHKNLVRL+GYC EG RMLV E
Sbjct: 181 YRGNLVNGTPVAVKKLLNNLGQADKDFRVEVEAIGHVRHKNLVRLLGYCMEGTQRMLVYE 240
Query: 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP-------------- 280
YV+NGNLEQWL GD H LTWE R+ I++GTAK L YLHE +EP
Sbjct: 241 YVNNGNLEQWLRGDNQNHEYLTWEARVKILIGTAKALAYLHEAIEPKVVHRDIKSSNILI 300
Query: 281 --KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIME 338
K+N K+SDFGLAKLLGA++S++TTRVMGTFGYVAPEYA++G+LNE SDVYSFG++++E
Sbjct: 301 DDKFNSKISDFGLAKLLGADKSFITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLE 360
Query: 339 VISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVA 398
I+GR PVDY+RPP E V+L EWLK MV +E V+DP L+ KPS+ ALKR LL A
Sbjct: 361 AITGRYPVDYARPPPE----VHLVEWLKMMVQQRRSEEVVDPNLETKPSTSALKRTLLTA 416
Query: 399 LRCVDPNAHKRPKMGHVIHMLEAEEFPFRDE 429
LRCVDP + KRP+M V MLE+EE+P E
Sbjct: 417 LRCVDPMSEKRPRMSQVARMLESEEYPIARE 447
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LRP3|Y3174_ARATH Probable receptor-like protein kinase At3g17420 OS=Arabidopsis thaliana GN=At3g17420 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 402 bits (1033), Expect = e-111, Method: Compositional matrix adjust.
Identities = 218/459 (47%), Positives = 289/459 (62%), Gaps = 76/459 (16%)
Query: 7 LTSIFG-LRIWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSK-RQLNATKSSSLCNNYN 64
LT +G L +W ++ I + A +++L L S+W + ++ S S L T+S
Sbjct: 9 LTKRYGVLELWEIIVIALFAAFIVILVL-SVWLSFRKKSKRSNATTLPVTQS-------- 59
Query: 65 SSSGNPTIPNISKEIQEIRID-------------LDSKSISNC----KPHSAPNPEPL-- 105
P ++EI+EI +D LD K + + K + +PL
Sbjct: 60 --------PRFTEEIKEISVDHGSSNNNGTSYQTLDEKFVEDIENGDKFSGSLEKKPLVG 111
Query: 106 ---PEPEPILVEDSPVRGRNRIHIEIGKDHRIAYRRVSHLGWGHWYTLRELEVSTNGFAD 162
P P SP+ G VSH+GWGHW+TLR+L+++TN F+
Sbjct: 112 SHLPPSTPSTTAPSPLLG---------------LPEVSHIGWGHWFTLRDLQLATNHFSK 156
Query: 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGY 222
E++IG+GGYG+VY G L + T VAVK LLNN GQA+K+F+VEVEAIG VRHKNLVRL+GY
Sbjct: 157 ESIIGDGGYGVVYHGTLTNKTPVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY 216
Query: 223 CAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK- 281
C EG HRMLV EY++NGNLEQWLHGD+ LTWE R+ +++GTAK L YLHE +EPK
Sbjct: 217 CVEGTHRMLVYEYMNNGNLEQWLHGDMIHKGHLTWEARIKVLVGTAKALAYLHEAIEPKV 276
Query: 282 ---------------WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNET 326
++ KLSDFGLAKLLGA+ +YV+TRVMGTFGYVAPEYA++G+LNE
Sbjct: 277 VHRDIKSSNILMDDNFDAKLSDFGLAKLLGADSNYVSTRVMGTFGYVAPEYANSGLLNEK 336
Query: 327 SDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKP 386
SDVYS+G++++E I+GR PVDY+RP E V++ EWLK MV E V+D L+ KP
Sbjct: 337 SDVYSYGVVLLEAITGRYPVDYARPKEE----VHMVEWLKLMVQQKQFEEVVDKELEIKP 392
Query: 387 SSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 425
++ LKRALL ALRCVDP+A KRPKM V MLE++E+P
Sbjct: 393 TTSELKRALLTALRCVDPDADKRPKMSQVARMLESDEYP 431
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 241 bits (615), Expect = 8e-63, Method: Compositional matrix adjust.
Identities = 128/302 (42%), Positives = 184/302 (60%), Gaps = 27/302 (8%)
Query: 142 LGWGHW-YTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKE 200
LG G ++ EL T GFA +N++GEGG+G VY+G L+D VAVK L GQ ++E
Sbjct: 352 LGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDRE 411
Query: 201 FKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIR 260
FK EVE I RV H++LV LVGYC HR+L+ EYV N LE LHG P L W R
Sbjct: 412 FKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPV--LEWSKR 469
Query: 261 MNIILGTAKGLTYLHEGLEPK----------------WNPKLSDFGLAKLLGAERSYVTT 304
+ I +G+AKGL YLHE PK + +++DFGLA+L +++V+T
Sbjct: 470 VRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVST 529
Query: 305 RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEW 364
RVMGTFGY+APEYAS+G L + SDV+SFG++++E+++GR PVD ++P GE +L EW
Sbjct: 530 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGE----ESLVEW 585
Query: 365 LKTM----VTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
+ + + G+ ++D RL+++ + R + A CV + KRP+M V+ L+
Sbjct: 586 ARPLLLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALD 645
Query: 421 AE 422
+
Sbjct: 646 CD 647
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 238 bits (608), Expect = 6e-62, Method: Compositional matrix adjust.
Identities = 123/295 (41%), Positives = 180/295 (61%), Gaps = 25/295 (8%)
Query: 146 HWYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEV 205
+ +T +L +T+ F++ N++G+GG+G V+RGVL D T VA+K L + GQ E+EF+ E+
Sbjct: 129 NLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAEI 188
Query: 206 EAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIIL 265
+ I RV H++LV L+GYC GA R+LV E+V N LE LH P + W RM I L
Sbjct: 189 QTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERP--VMEWSKRMKIAL 246
Query: 266 GTAKGLTYLHEGLEPK----------------WNPKLSDFGLAKLLGAERSYVTTRVMGT 309
G AKGL YLHE PK + KL+DFGLA+ ++V+TR+MGT
Sbjct: 247 GAAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVSTRIMGT 306
Query: 310 FGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTM- 368
FGY+APEYAS+G L E SDV+S G++++E+I+GR PVD S+P F ++ +W K +
Sbjct: 307 FGYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQP---FADDDSIVDWAKPLM 363
Query: 369 ---VTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
+ +GN +G++DPRL+ + R + A V +A +RPKM ++ E
Sbjct: 364 IQALNDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFE 418
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 238 bits (606), Expect = 9e-62, Method: Compositional matrix adjust.
Identities = 121/294 (41%), Positives = 178/294 (60%), Gaps = 26/294 (8%)
Query: 148 YTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEA 207
+T EL +TNGF++ N++G+GG+G V++G+L VAVK L GQ E+EF+ EVE
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327
Query: 208 IGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 267
I RV H++LV L+GYC G R+LV E+V N NLE LHG P + W R+ I LG+
Sbjct: 328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRP--TMEWSTRLKIALGS 385
Query: 268 AKGLTYLHEGLEP----------------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 311
AKGL+YLHE P K+ K++DFGLAK+ ++V+TRVMGTFG
Sbjct: 386 AKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFG 445
Query: 312 YVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVT- 370
Y+APEYA++G L E SDV+SFG++++E+I+GR PVD + +L +W + ++
Sbjct: 446 YLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDAN----NVYVDDSLVDWARPLLNR 501
Query: 371 ---NGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421
G+ EG+ D ++ + + R + A CV +A +RP+M ++ LE
Sbjct: 502 ASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEG 555
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3EBR4|Y2394_ARATH Putative receptor-like protein kinase At2g30940 OS=Arabidopsis thaliana GN=At2g30940 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 237 bits (604), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 141/359 (39%), Positives = 189/359 (52%), Gaps = 71/359 (19%)
Query: 117 PVRGRNRI-----HIEIGKDHRIAY---------RRVSHLGWG----------------- 145
P R R+++ HI + +I Y +R+S +GW
Sbjct: 89 PFRLRSKLCLPLSHIPLTNKQQIPYNRCGDDIESQRISQVGWSSARLSYYTRSFSSTGSF 148
Query: 146 ---HWYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLL-NNRGQAEKEF 201
+ +T E++ T+ FAD+NVI +G VYRG+L VAVK L +N +K+F
Sbjct: 149 GSFNVFTFMEIKNVTDSFADDNVITKGDSSTVYRGILMGTVTVAVKRFLPSNSRYEDKDF 208
Query: 202 KVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRM 261
+ E I VRHKN+VRL+GYC EG R+LV EY + G+L +WLHG G + PLTW RM
Sbjct: 209 ITKAEMIANVRHKNVVRLLGYCIEGDERVLVYEYAEKGDLHEWLHGSAGRNRPLTWRKRM 268
Query: 262 NIILGTAKGLTYLHEGLEPK----------------WNPKLSDFGLAKLLGAERSYVTTR 305
II G AKGL Y+HE +EPK WNPK+ D G S + T
Sbjct: 269 KIIQGVAKGLAYIHEDIEPKITHQDIRPSKILLDYQWNPKILDVGFIG-----HSDIPTL 323
Query: 306 VMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWL 365
+ S G ++E DVYSFG +IME++SGR VD S P +V L +W+
Sbjct: 324 I-----------PSPGNMDEKIDVYSFGNMIMELVSGRVSVDQSSP----HVRVYLVDWI 368
Query: 366 KTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 424
K MV N VLDP L E P+ + LKR +L++LRCVDP +RPKMG VIHML+ +
Sbjct: 369 KEMVANHMIVDVLDPSLPEFPTIKELKRIVLISLRCVDPELKERPKMGDVIHMLQPHDL 427
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 234 bits (598), Expect = 7e-61, Method: Compositional matrix adjust.
Identities = 125/302 (41%), Positives = 180/302 (59%), Gaps = 29/302 (9%)
Query: 143 GWGH---WYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEK 199
G+G ++ EL ++TNGF+DEN++GEGG+G VY+GVL D VAVK L GQ ++
Sbjct: 410 GFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDR 469
Query: 200 EFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEI 259
EFK EV+ I RV H+NL+ +VGYC R+L+ +YV N NL LH P L W
Sbjct: 470 EFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPG--LDWAT 527
Query: 260 RMNIILGTAKGLTYLHEGLEPK----------------WNPKLSDFGLAKLLGAERSYVT 303
R+ I G A+GL YLHE P+ ++ +SDFGLAKL +++T
Sbjct: 528 RVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNTHIT 587
Query: 304 TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFE 363
TRVMGTFGY+APEYAS+G L E SDV+SFG++++E+I+GR PVD S+P G+ +L E
Sbjct: 588 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGD----ESLVE 643
Query: 364 WLKTMVTNGNA----EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHML 419
W + +++N + DP+L + R + A C+ +A KRP+M ++
Sbjct: 644 WARPLLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAF 703
Query: 420 EA 421
++
Sbjct: 704 DS 705
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 442 | ||||||
| 225458659 | 519 | PREDICTED: probable serine/threonine-pro | 0.920 | 0.784 | 0.730 | 0.0 | |
| 449482676 | 521 | PREDICTED: probable serine/threonine-pro | 0.932 | 0.790 | 0.728 | 0.0 | |
| 255538254 | 528 | Serine/threonine-protein kinase PBS1, pu | 0.950 | 0.795 | 0.724 | 0.0 | |
| 449450231 | 842 | PREDICTED: uncharacterized protein LOC10 | 0.893 | 0.469 | 0.716 | 1e-174 | |
| 307135852 | 842 | serine/threonine-protein kinase [Cucumis | 0.877 | 0.460 | 0.723 | 1e-174 | |
| 356496904 | 503 | PREDICTED: probable serine/threonine-pro | 0.911 | 0.801 | 0.665 | 1e-171 | |
| 224137574 | 469 | predicted protein [Populus trichocarpa] | 0.880 | 0.829 | 0.702 | 1e-170 | |
| 359480850 | 516 | PREDICTED: probable serine/threonine-pro | 0.929 | 0.796 | 0.689 | 1e-169 | |
| 255565232 | 509 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.918 | 0.797 | 0.659 | 1e-167 | |
| 356541793 | 499 | PREDICTED: probable serine/threonine-pro | 0.904 | 0.801 | 0.667 | 1e-167 |
| >gi|225458659|ref|XP_002282863.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 671 bits (1731), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/486 (73%), Positives = 379/486 (77%), Gaps = 79/486 (16%)
Query: 8 TSIFGLRIWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNATKSSSLCNNYNSSS 67
TSIFGLR+WVV+GICVGAGIVLVLFLISLWFTS+RNS SS
Sbjct: 15 TSIFGLRLWVVVGICVGAGIVLVLFLISLWFTSRRNSA-------------------KSS 55
Query: 68 GNPTIPNISKEIQEIRIDLDSKSISNCKP----HSAPNPEPLPEPEPILV--------ED 115
PTIPN+SKEIQEIRID S++ +N P H PN PLPE +P E+
Sbjct: 56 HKPTIPNVSKEIQEIRID-HSRNPANPNPDPKTHHPPNANPLPESDPFAGAERLLQPGEE 114
Query: 116 SPVRGRNRIHIEIGKDHRIAYRR------------------------VSHLGWGHWYTLR 151
SPV G RIHIEIGKDHRI+Y VSHLGWGHWYTLR
Sbjct: 115 SPV-GLQRIHIEIGKDHRISYPERGGGSSHGSGEARSGDQVTIAVPEVSHLGWGHWYTLR 173
Query: 152 ELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 211
ELE+STNGFADENVIGEGGYGIVYRGVLEDNT VAVKNLLNNRGQAEKEFKVEVEAIGRV
Sbjct: 174 ELELSTNGFADENVIGEGGYGIVYRGVLEDNTQVAVKNLLNNRGQAEKEFKVEVEAIGRV 233
Query: 212 RHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 271
RHKNLVRL+GYCAEGAHRMLV EYVDNGNLEQWLHGDVGPHSPLTW+IRMNII+GTAKGL
Sbjct: 234 RHKNLVRLLGYCAEGAHRMLVYEYVDNGNLEQWLHGDVGPHSPLTWDIRMNIIIGTAKGL 293
Query: 272 TYLHEGLEPK----------------WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 315
TYLHEGLEPK WNPK+SDFGLAKLLG+ERSYVTTRVMGTFGYVAP
Sbjct: 294 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSERSYVTTRVMGTFGYVAP 353
Query: 316 EYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375
EYASTGMLNE SDVYSFGIL+ME+ISGRNPVDYSRPPGE VNL EWLK MVTN NAE
Sbjct: 354 EYASTGMLNERSDVYSFGILLMEIISGRNPVDYSRPPGE----VNLVEWLKAMVTNRNAE 409
Query: 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRD--ERRAG 433
GVLDP++ EKPSSRALKRALLVALRCVDPNA KRPKMGHVIHMLEA++FPFRD +RRAG
Sbjct: 410 GVLDPKIPEKPSSRALKRALLVALRCVDPNAQKRPKMGHVIHMLEADDFPFRDFQDRRAG 469
Query: 434 REHGRS 439
REHGR+
Sbjct: 470 REHGRA 475
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449482676|ref|XP_004156368.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 671 bits (1731), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/478 (72%), Positives = 374/478 (78%), Gaps = 66/478 (13%)
Query: 8 TSIFGLRIWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNATKSSSLCNNYNSSS 67
TSIFGLR+WVVLGICVGA IV+VLFLISLWFTS+RNS+N + S
Sbjct: 15 TSIFGLRLWVVLGICVGAAIVIVLFLISLWFTSRRNSSNKSK----------------PS 58
Query: 68 GNPTIPNISKEIQEIRIDLDSKSI-SNCKPHSAPNPEPLPEPEPILV-----EDSPVRGR 121
NP IPN+SKEIQEIRID + S+ K A NPEPLPE EP+ E SP GR
Sbjct: 59 LNPIIPNVSKEIQEIRIDHSRNTTHSDPKVQLASNPEPLPEAEPLATLLQTEEGSPPSGR 118
Query: 122 NRIHIEIGKDHRIAYRR------------------------VSHLGWGHWYTLRELEVST 157
+RIHIEIGKDHRI+Y VSHLGWGHWYTLRELE ST
Sbjct: 119 HRIHIEIGKDHRISYPERGGGSSHGSGEARSGDQAPMTVPEVSHLGWGHWYTLRELEYST 178
Query: 158 NGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV 217
N FADENVIGEGGYGIVYRGVLEDNT VA+KNLLNNRGQAEKEFKVEVEAIGRVRHKNLV
Sbjct: 179 NSFADENVIGEGGYGIVYRGVLEDNTVVAIKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV 238
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277
RL+GYCAEGAHR+LV EY+DNGNLEQWLHG+VGP SPLTW+IRMNII+GTAKGLTYLHEG
Sbjct: 239 RLLGYCAEGAHRILVYEYIDNGNLEQWLHGEVGPCSPLTWDIRMNIIVGTAKGLTYLHEG 298
Query: 278 LEPK----------------WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 321
LEPK WNPK+SDFGLAKLLG+ERSYVTTRVMGTFGYVAPEYASTG
Sbjct: 299 LEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSERSYVTTRVMGTFGYVAPEYASTG 358
Query: 322 MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381
MLNE SDVYSFGILIME+ISGRNPVDYSRP GE VNL EWLKTMV+N NAEGVLDP+
Sbjct: 359 MLNEKSDVYSFGILIMEIISGRNPVDYSRPSGE----VNLVEWLKTMVSNRNAEGVLDPK 414
Query: 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDERRAGREHGRS 439
L EKPS+RALKRALLVALRCVDPN KRPKMGHVIHMLEA+EFPFRD+RR GRE GRS
Sbjct: 415 LPEKPSTRALKRALLVALRCVDPNVQKRPKMGHVIHMLEADEFPFRDDRRVGREPGRS 472
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255538254|ref|XP_002510192.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223550893|gb|EEF52379.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 660 bits (1704), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/487 (72%), Positives = 379/487 (77%), Gaps = 67/487 (13%)
Query: 8 TSIFGLRIWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNATKSSSLCNNYNSSS 67
TSIFGLR+WVVLGICVGA IVLVLF+IS+WFTS+R+ N ++TK S N N +
Sbjct: 15 TSIFGLRLWVVLGICVGAAIVLVLFIISVWFTSRRSKTNKNSTSHSTKFRSYLYNNNHNH 74
Query: 68 GNPTIPNISKEIQEIRIDLDSKSISNCKPHSAPNPEPLPEPEPILVED--SPVRGRNRIH 125
NPTIPN+SKEIQEIR+D N P A +P+P+PE EP+L+E+ SPV GRNRIH
Sbjct: 75 -NPTIPNVSKEIQEIRLD------PNPNP-KALSPDPVPESEPVLLEEENSPVGGRNRIH 126
Query: 126 IEIGKDHRIAYRR------------------------------VSHLGWGHWYTLRELEV 155
IEIGKDHRI+Y VSHLGWGHWYTLRELEV
Sbjct: 127 IEIGKDHRISYPERAGGSGNGSGETRSSPRSGDQAGGAIVVPEVSHLGWGHWYTLRELEV 186
Query: 156 STNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNR-------GQAEKEFKVEVEAI 208
STN FADENVIGEGGYGIVYRG+L+DNTNVAVK L GQAEKEFKVEVEAI
Sbjct: 187 STNCFADENVIGEGGYGIVYRGILDDNTNVAVKICLTTACTFWWCMGQAEKEFKVEVEAI 246
Query: 209 GRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 268
GRVRHKNLVRL+GYCAEGAHRMLV EYVDNGNLEQWLHGDVGP SPLTWEIRMNIILGTA
Sbjct: 247 GRVRHKNLVRLLGYCAEGAHRMLVYEYVDNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 306
Query: 269 KGLTYLHEGLEPK----------------WNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 312
KGLTYLHEGLEPK WN K+SDFGLAKLLG+ERSYVTTRVMGTFGY
Sbjct: 307 KGLTYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSERSYVTTRVMGTFGY 366
Query: 313 VAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372
VAPEYASTGMLNE SDVYSFGIL+ME+ISGRNPVDYSRPPGE VNL EWLKTMVTN
Sbjct: 367 VAPEYASTGMLNERSDVYSFGILLMEIISGRNPVDYSRPPGE----VNLVEWLKTMVTNR 422
Query: 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDERRA 432
NAEGVLDPRL EKPSSRALKRALLVALRCVDPNA KRPKMGHVIHMLEA+EFPFRD+RR
Sbjct: 423 NAEGVLDPRLPEKPSSRALKRALLVALRCVDPNAQKRPKMGHVIHMLEADEFPFRDDRRT 482
Query: 433 GREHGRS 439
GREH RS
Sbjct: 483 GREHVRS 489
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450231|ref|XP_004142867.1| PREDICTED: uncharacterized protein LOC101203008 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 616 bits (1589), Expect = e-174, Method: Compositional matrix adjust.
Identities = 321/448 (71%), Positives = 348/448 (77%), Gaps = 53/448 (11%)
Query: 38 FTSKRNSNNSKRQLNATKSSSLCNNYNSSSGNPTIPNISKEIQEIRIDLDSKSI-SNCKP 96
+S N+ QL + ++SS N + S NP IPN+SKEIQEIRID + S+ K
Sbjct: 353 LSSDFKVTNNINQLLSRRNSS---NKSKPSLNPIIPNVSKEIQEIRIDHSRNTTHSDPKV 409
Query: 97 HSAPNPEPLPEPEPILV-----EDSPVRGRNRIHIEIGKDHRIAYRR------------- 138
A NPEPLPE EP+ E SP GR+RIHIEIGKDHRI+Y
Sbjct: 410 QLASNPEPLPEAEPLATLLQTEEGSPPSGRHRIHIEIGKDHRISYPERGGGSSHGSGEAR 469
Query: 139 -----------VSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAV 187
VSHLGWGHWYTLRELE STN FADENVIGEGGYGIVYRGVLEDNT VA+
Sbjct: 470 SGDQAPMTVPEVSHLGWGHWYTLRELEYSTNSFADENVIGEGGYGIVYRGVLEDNTVVAI 529
Query: 188 KNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHG 247
KNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL+GYCAEGAHR+LV EY+DNGNLEQWLHG
Sbjct: 530 KNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRILVYEYIDNGNLEQWLHG 589
Query: 248 DVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK----------------WNPKLSDFGL 291
+VGP SPLTW+IRMNII+GTAKGLTYLHEGLEPK WNPK+SDFGL
Sbjct: 590 EVGPCSPLTWDIRMNIIVGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGL 649
Query: 292 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRP 351
AKLLG+ERSYVTTRVMGTFGYVAPEYASTGMLNE SDVYSFGILIME+ISGRNPVDYSRP
Sbjct: 650 AKLLGSERSYVTTRVMGTFGYVAPEYASTGMLNEKSDVYSFGILIMEIISGRNPVDYSRP 709
Query: 352 PGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPK 411
GE VNL EWLKTMV+N NAEGVLDP+L EKPS+RALKRALLVALRCVDPN KRPK
Sbjct: 710 SGE----VNLVEWLKTMVSNRNAEGVLDPKLPEKPSTRALKRALLVALRCVDPNVQKRPK 765
Query: 412 MGHVIHMLEAEEFPFRDERRAGREHGRS 439
MGHVIHMLEA+EFPFRD+RR GRE GRS
Sbjct: 766 MGHVIHMLEADEFPFRDDRRVGREPGRS 793
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|307135852|gb|ADN33721.1| serine/threonine-protein kinase [Cucumis melo subsp. melo] | Back alignment and taxonomy information |
|---|
Score = 616 bits (1588), Expect = e-174, Method: Compositional matrix adjust.
Identities = 320/442 (72%), Positives = 345/442 (78%), Gaps = 54/442 (12%)
Query: 44 SNNSKRQLNATKSSSLCNNYNSSSGNPTIPNISKEIQEIRIDLDSKSI-SNCKPHSAPNP 102
+NN + L+ SS N + S NP IPN+SKEIQEIRID + S+ K A NP
Sbjct: 360 TNNINQLLSGRNSS----NKSKPSLNPIIPNVSKEIQEIRIDHSRNTTHSDPKVQLASNP 415
Query: 103 EPLPEPEPILV-----EDSPVRGRNRIHIEIGKDHRIAYRR------------------- 138
EPLPE EP+ E SP GR+RIHIEIGKDHRI+Y
Sbjct: 416 EPLPEAEPLATLLETEEGSPPSGRHRIHIEIGKDHRISYPERGGGSSHGSGEARSGDQAP 475
Query: 139 -----VSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNN 193
VSHLGWGHWYTLRELE STN FADENVIGEGGYGIVYRGVLEDNT VA+KNLLNN
Sbjct: 476 MTVPEVSHLGWGHWYTLRELEYSTNSFADENVIGEGGYGIVYRGVLEDNTVVAIKNLLNN 535
Query: 194 RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHS 253
RGQAEKEFKVEVEAIGRVRHKNLVRL+GYCAEGAHR+LV EY+DNGNLEQWLHG+VGP S
Sbjct: 536 RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRILVYEYIDNGNLEQWLHGEVGPCS 595
Query: 254 PLTWEIRMNIILGTAKGLTYLHEGLEPK----------------WNPKLSDFGLAKLLGA 297
PLTW+IRMNII+GTAKGLTYLHEGLEPK WNPK+SDFGLAKLLG+
Sbjct: 596 PLTWDIRMNIIVGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGS 655
Query: 298 ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQF 357
ERSYVTTRVMGTFGYVAPEYASTGMLNE SDVYSFGILIME+ISGRNPVDYSRP GE
Sbjct: 656 ERSYVTTRVMGTFGYVAPEYASTGMLNEKSDVYSFGILIMEIISGRNPVDYSRPSGE--- 712
Query: 358 QVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417
VNL EWLKTMV+N NAEGVLDP+L EKPS+RALKRALLVALRCVDPN KRPKMGHVIH
Sbjct: 713 -VNLVEWLKTMVSNRNAEGVLDPKLPEKPSTRALKRALLVALRCVDPNVQKRPKMGHVIH 771
Query: 418 MLEAEEFPFRDERRAGREHGRS 439
MLEA+EFPFRD+RR GRE GRS
Sbjct: 772 MLEADEFPFRDDRRVGREPGRS 793
|
Source: Cucumis melo subsp. melo Species: Cucumis melo Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356496904|ref|XP_003517305.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 608 bits (1568), Expect = e-171, Method: Compositional matrix adjust.
Identities = 317/476 (66%), Positives = 353/476 (74%), Gaps = 73/476 (15%)
Query: 8 TSIFGLRIWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNATKSSSLCNNYNSSS 67
TSIFGLR+WVVLG+CVGA IVL+LFLIS+W KR+ N
Sbjct: 19 TSIFGLRLWVVLGVCVGAAIVLILFLISVWLAFKRSKTNPV------------------- 59
Query: 68 GNPTIPNISKEIQEIRIDLDSKSISNCKPHSAPNPEPLPEPEPI--LVEDSPVRGRNRIH 125
+IP++SKEIQEIR+D N P P P PL EP+P+ E++ G +RI
Sbjct: 60 ---SIPDVSKEIQEIRLD----HAPNLNPTLQPEP-PLSEPDPVPPTEEETTPLGYHRIQ 111
Query: 126 IEIGKDHRIAYRR------------------------VSHLGWGHWYTLRELEVSTNGFA 161
EIGK+HRI+Y VSHLGWGHWYTLRELE STN FA
Sbjct: 112 FEIGKNHRISYPERPLVRSSSNDPSSCEVQVPTVIPEVSHLGWGHWYTLRELEDSTNAFA 171
Query: 162 DENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVG 221
ENVIGEGGYGIVY G+L DNTNVA+KNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL+G
Sbjct: 172 PENVIGEGGYGIVYHGILNDNTNVAIKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 231
Query: 222 YCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 281
YCAEGAHRMLV EYVDNGNLEQWLHGDVGP SPLTWEIRMNIILGTAKGLTYLHEGLEPK
Sbjct: 232 YCAEGAHRMLVYEYVDNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLTYLHEGLEPK 291
Query: 282 ----------------WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 325
WN K+SDFGLAKLLG++ SY+TTRVMGTFGYVAPEYASTGMLNE
Sbjct: 292 VVHRDIKSSNILLSKQWNAKVSDFGLAKLLGSDNSYITTRVMGTFGYVAPEYASTGMLNE 351
Query: 326 TSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEK 385
SDVYSFGILIME+I+GRNPVDYSRPP E VNL +WLK MV+N N EGVLDP+L EK
Sbjct: 352 RSDVYSFGILIMELITGRNPVDYSRPPEE----VNLVDWLKKMVSNRNPEGVLDPKLPEK 407
Query: 386 PSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDERRAGREHGRSPH 441
P+SRALKRALLVALRC DPNA KRPKMGHVIHMLEAE+ P++++RRA R+ G SP+
Sbjct: 408 PTSRALKRALLVALRCTDPNAQKRPKMGHVIHMLEAEDSPYKEDRRAKRDAGHSPN 463
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224137574|ref|XP_002327160.1| predicted protein [Populus trichocarpa] gi|222835475|gb|EEE73910.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 603 bits (1555), Expect = e-170, Method: Compositional matrix adjust.
Identities = 330/470 (70%), Positives = 353/470 (75%), Gaps = 81/470 (17%)
Query: 8 TSIFGLRIWVVLGICVGAGIVLVLFLISLWFTSKRN-SNNSKRQLNATKSSSLCNNYNSS 66
TSIFGLR+WVVLGICVGA IVL+LFLISLW TSKRN ++N + AT S++ +S
Sbjct: 14 TSIFGLRLWVVLGICVGAAIVLLLFLISLWLTSKRNKTSNKANKPMATTSTATTKFVSSL 73
Query: 67 SGNPTIPNISKEIQEIRIDLDSKSISNCKPHSAPNPEPLPEPEPILVEDSPVRGRNRIHI 126
+ NPTIPNISKEIQEIR SPV G NRIHI
Sbjct: 74 NNNPTIPNISKEIQEIRTT------------------------------SPVGGGNRIHI 103
Query: 127 EIGKDHRIAYRR------------------------------VSHLGWGHWYTLRELEVS 156
EIGKDHRI+Y VSHLGWGHWYTLRELE S
Sbjct: 104 EIGKDHRISYPERVGGLGSGSGETRSGPRSGDQAGAVIAVPEVSHLGWGHWYTLRELEES 163
Query: 157 TNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL 216
TN FADENVIGEGGYGIVYRG+LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL
Sbjct: 164 TNYFADENVIGEGGYGIVYRGLLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL 223
Query: 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276
VRL+GYCAEGAHRMLV E+V+NGNLEQWLHGDVGP SPLTWEIR+NII+GTAKGLTYLHE
Sbjct: 224 VRLLGYCAEGAHRMLVYEFVENGNLEQWLHGDVGPCSPLTWEIRINIIIGTAKGLTYLHE 283
Query: 277 GLEPK----------------WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 320
GLEPK WN K+SDFGLAKLLG+E SYVTTRVMGTFGYVAPEYAST
Sbjct: 284 GLEPKVVHRDIKSSNILLDKQWNSKVSDFGLAKLLGSESSYVTTRVMGTFGYVAPEYAST 343
Query: 321 GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380
GMLNE SDVYSFGIL+ME+ISGRNPVDYSRP GE VNL EWLKTMVT NAEGVLDP
Sbjct: 344 GMLNERSDVYSFGILLMEIISGRNPVDYSRPAGE----VNLVEWLKTMVTIRNAEGVLDP 399
Query: 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDER 430
RL +KPS RALKRALLVALRCVDPNA KRPKMGHV+HMLEA+EFPFRD R
Sbjct: 400 RLPKKPSPRALKRALLVALRCVDPNAQKRPKMGHVVHMLEADEFPFRDVR 449
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359480850|ref|XP_002282732.2| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 600 bits (1548), Expect = e-169, Method: Compositional matrix adjust.
Identities = 329/477 (68%), Positives = 361/477 (75%), Gaps = 66/477 (13%)
Query: 8 TSIFGLRIWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNATKSSSLCNNYNSSS 67
TSIFGLR+WVVLG+CVGA VL+LFLISLW TSKRN+++ R S
Sbjct: 17 TSIFGLRLWVVLGVCVGAAFVLLLFLISLWLTSKRNNSSKIR----------------PS 60
Query: 68 GNPTIPNISKEIQEIRIDLDSKSISNCKPHSAPNPEPLPEPEPILV---EDSPVRGRNRI 124
PTIP +SKEIQEIRID +S P + E + +L+ E+SP G +RI
Sbjct: 61 QKPTIPAVSKEIQEIRIDHGHRSQIQADPFPESDQLAGIEGQALLLPPGEESP-GGVHRI 119
Query: 125 HIEIGKDHRIAYRR-------------------VSHLGWGHWYTLRELEVSTNGFADENV 165
HIE+GKDHRI+Y VSHLGWGHWYTLRELE STN FAD++V
Sbjct: 120 HIELGKDHRISYPERVVSGEARAVEQASIVAPEVSHLGWGHWYTLRELEASTNAFADDHV 179
Query: 166 IGEGGYGIVYRGVLEDNTNVAVKNLLNNR-------GQAEKEFKVEVEAIGRVRHKNLVR 218
IGEGGYGIVY GVLEDNT VAVKNLLNNR GQAEKEFKVEVEAIGRVRHKNLVR
Sbjct: 180 IGEGGYGIVYHGVLEDNTQVAVKNLLNNRCFLATTMGQAEKEFKVEVEAIGRVRHKNLVR 239
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 278
L+GYCAEGAHRMLV EYV+NGNLEQWLHGDVGP SPLTWEIRMNIILGTAKGLTYLHEGL
Sbjct: 240 LLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPRSPLTWEIRMNIILGTAKGLTYLHEGL 299
Query: 279 EPK----------------WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 322
EPK WNPK+SDFGLAKLLG+E SYVTTRVMGTFGYVAPEYASTGM
Sbjct: 300 EPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSEHSYVTTRVMGTFGYVAPEYASTGM 359
Query: 323 LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382
LNE SDVYSFGILIME+ISGRNPVDYSRPP E VNL +WLK MVT+ N EGVLDP++
Sbjct: 360 LNERSDVYSFGILIMEIISGRNPVDYSRPPEE----VNLVDWLKRMVTSRNPEGVLDPKI 415
Query: 383 QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDERRAGREHGRS 439
EKP+SRALKRALLVALRCVDPN+ KRPKMGHVIHMLEAEE PFRD+RRAGR+ R+
Sbjct: 416 PEKPTSRALKRALLVALRCVDPNSQKRPKMGHVIHMLEAEESPFRDDRRAGRDSVRA 472
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255565232|ref|XP_002523608.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223537170|gb|EEF38803.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 595 bits (1534), Expect = e-167, Method: Compositional matrix adjust.
Identities = 312/473 (65%), Positives = 350/473 (73%), Gaps = 67/473 (14%)
Query: 8 TSIFGLRIWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNATKSSSLCNNYNSSS 67
TS+FGLR+WVVLG+CVGA VLVLFLI++W SKR+ ++K +
Sbjct: 17 TSVFGLRVWVVLGVCVGAAFVLVLFLITVWLASKRSKKDNK------------------N 58
Query: 68 GNPTIPNISKEIQEIRIDLDSKSISNCKPHSAPNPEPLP--EPEPILV----EDSPV--- 118
P IP +SKEIQEIR++ + + + H P+PE E + +L+ E+SP+
Sbjct: 59 SKPKIPVVSKEIQEIRVEPVKPNRAQIQTHPFPDPEIAAGNERQALLLMPPEEESPMGYH 118
Query: 119 RGRNRIHIEIGKDHRIAYR--------------------RVSHLGWGHWYTLRELEVSTN 158
G I IEIGK H I+Y VSHLGWGHWYTLRELE STN
Sbjct: 119 HGTGNIQIEIGKGHLISYPVSSGEAPRGGGDQLAMVVGPDVSHLGWGHWYTLRELEASTN 178
Query: 159 GFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 218
GFADENVIG+GGYGIVY GVL DNT VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR
Sbjct: 179 GFADENVIGQGGYGIVYYGVLVDNTQVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 238
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 278
L+GYCAEG+HRMLV EYV+NGNLEQWLHGDVG SPLTWEIRMNIILGTAKGLTYLHEGL
Sbjct: 239 LLGYCAEGSHRMLVYEYVNNGNLEQWLHGDVGSCSPLTWEIRMNIILGTAKGLTYLHEGL 298
Query: 279 EPK----------------WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 322
EPK WN K+SDFGLAKLL E SY+TTRVMGTFGYVAPEYASTGM
Sbjct: 299 EPKVVHRDIKSSNILLDKLWNAKVSDFGLAKLLYPESSYITTRVMGTFGYVAPEYASTGM 358
Query: 323 LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382
+NE SDV+ FGILIME+ISGRNPVDYSRPP E VNL EWLK MVTN N EGVLDP+L
Sbjct: 359 VNERSDVFGFGILIMEIISGRNPVDYSRPPDE----VNLVEWLKRMVTNRNPEGVLDPKL 414
Query: 383 QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDERRAGRE 435
E+PSSRALKR LLVALRCVDPNA KRPKMGHV+HMLEA+EFPFRD+RR G++
Sbjct: 415 PERPSSRALKRVLLVALRCVDPNAQKRPKMGHVVHMLEADEFPFRDDRRGGKD 467
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356541793|ref|XP_003539357.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 594 bits (1532), Expect = e-167, Method: Compositional matrix adjust.
Identities = 317/475 (66%), Positives = 354/475 (74%), Gaps = 75/475 (15%)
Query: 8 TSIFGLRIWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNATKSSSLCNNYNSSS 67
TSIFGLR+WVVLG+CVGA IVL+LFLIS+W KR SS
Sbjct: 19 TSIFGLRLWVVLGVCVGAAIVLILFLISVWLAFKR----------------------SSK 56
Query: 68 GNP-TIPNISKEIQEIRIDLDSKSISNCKPHSAPNPEPLPEPEPILVEDSPVRGRNRIHI 126
NP +IP++SKEIQEIR+D + P P P P P+P P E++ G +RI
Sbjct: 57 TNPVSIPDVSKEIQEIRLDTN--------PTLQPEPYPEPDPVPPTEEETNSLGYHRIQF 108
Query: 127 EIGKDHRIAYRR------------------------VSHLGWGHWYTLRELEVSTNGFAD 162
EIGK+HRI+Y VSHLGWGHWYTLR+LE +TNGFA
Sbjct: 109 EIGKNHRISYPERALLRSSSNDPSSGEVQLPTVIPEVSHLGWGHWYTLRDLEDATNGFAP 168
Query: 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGY 222
ENVIGEGGYGIVY G+L DNTNVA+KNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL+GY
Sbjct: 169 ENVIGEGGYGIVYHGILNDNTNVAIKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 228
Query: 223 CAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP-- 280
CAEGAHRMLV EYVDNGNLEQWLHGDVGP SPLTWEIRMNIILGTAKGLTYLHEGLEP
Sbjct: 229 CAEGAHRMLVYEYVDNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 288
Query: 281 --------------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNET 326
KWN K+SDFGLAKLLG++ SY+TTRVMGTFGYVAPEYASTGMLNE
Sbjct: 289 VHRDIKSSNILLSKKWNAKVSDFGLAKLLGSDSSYITTRVMGTFGYVAPEYASTGMLNER 348
Query: 327 SDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKP 386
SDVYSFGILIME+I+GRNPVDYSRPP E VNL +WLK MV+N N EGVLDP+L EKP
Sbjct: 349 SDVYSFGILIMELITGRNPVDYSRPPEE----VNLVDWLKKMVSNRNPEGVLDPKLPEKP 404
Query: 387 SSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDERRAGREHGRSPH 441
+SRALKRALLVALRC DPNA KRPKMGHVIHMLEAE+ P++++RRA R+ G SP+
Sbjct: 405 TSRALKRALLVALRCTDPNAQKRPKMGHVIHMLEAEDSPYKEDRRAKRDAGHSPN 459
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 442 | ||||||
| TAIR|locus:2025396 | 472 | AT1G01540 [Arabidopsis thalian | 0.918 | 0.860 | 0.585 | 2.6e-127 | |
| TAIR|locus:2132353 | 492 | AT4G02630 [Arabidopsis thalian | 0.658 | 0.591 | 0.616 | 1.7e-111 | |
| TAIR|locus:2045620 | 494 | AT2G42960 [Arabidopsis thalian | 0.660 | 0.591 | 0.621 | 2.7e-107 | |
| TAIR|locus:2027559 | 492 | AT1G56720 [Arabidopsis thalian | 0.658 | 0.591 | 0.599 | 1.2e-106 | |
| TAIR|locus:2077730 | 512 | AT3G59110 [Arabidopsis thalian | 0.653 | 0.564 | 0.614 | 1.5e-106 | |
| TAIR|locus:2093591 | 467 | GPK1 "glyoxysomal protein kina | 0.676 | 0.640 | 0.566 | 1.1e-99 | |
| TAIR|locus:2146203 | 484 | AT5G18500 [Arabidopsis thalian | 0.658 | 0.601 | 0.596 | 2.5e-97 | |
| TAIR|locus:2012325 | 466 | AT1G09440 [Arabidopsis thalian | 0.658 | 0.624 | 0.589 | 1.1e-96 | |
| TAIR|locus:2139559 | 437 | AT4G34500 [Arabidopsis thalian | 0.667 | 0.675 | 0.504 | 4.6e-78 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.610 | 0.396 | 0.413 | 6.1e-60 |
| TAIR|locus:2025396 AT1G01540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1250 (445.1 bits), Expect = 2.6e-127, P = 2.6e-127
Identities = 264/451 (58%), Positives = 310/451 (68%)
Query: 8 TSIFGLRIWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNATKXXXXXXXXXXXX 67
TSIFGLR+WVV+GI +G+ IV+ LFL+SL TS+R N K + +
Sbjct: 17 TSIFGLRLWVVIGILLGSLIVIALFLLSLCLTSRRK--NRKPRADFASAAIAT------- 67
Query: 68 XXPTIPNISKEIQEIRIDLDSKSISNCKPHSAXXXXXXXXXXXILVEDSPVRGRNRIHIE 127
P ISKEI+EI + ++S+ P + ++ D G +R
Sbjct: 68 -----PPISKEIKEI-VPAQNQSV----P-AEIQVDIGKIEHRVVFSDRVSSGESRGTAS 116
Query: 128 IGKDHRIAYR-----RVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDN 182
+ + VSHLGWG WYTLRELE +TNG +ENVIGEGGYGIVYRG+L D
Sbjct: 117 ASETASYSGSGNCGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDG 176
Query: 183 TNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLE 242
T VAVKNLLNNRGQAEKEFKVEVE IGRVRHKNLVRL+GYC EGA+RMLV ++VDNGNLE
Sbjct: 177 TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLE 236
Query: 243 QWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK----------------WNPKL 286
QW+HGDVG SPLTW+IRMNIILG AKGL YLHEGLEPK WN K+
Sbjct: 237 QWIHGDVGDVSPLTWDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKV 296
Query: 287 SDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPV 346
SDFGLAKLLG+E SYVTTRVMGTFGYVAPEYA TGMLNE SD+YSFGILIME+I+GRNPV
Sbjct: 297 SDFGLAKLLGSESSYVTTRVMGTFGYVAPEYACTGMLNEKSDIYSFGILIMEIITGRNPV 356
Query: 347 DYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSXXXXXXXXXXXXCVDPNA 406
DYSRP GE NL +WLK+MV N +E V+DP++ E PSS CVDP+A
Sbjct: 357 DYSRPQGE----TNLVDWLKSMVGNRRSEEVVDPKIPEPPSSKALKRVLLVALRCVDPDA 412
Query: 407 HKRPKMGHVIHMLEAEEFPFRDERRAGREHG 437
+KRPKMGH+IHMLEAE+ +RDERR R+HG
Sbjct: 413 NKRPKMGHIIHMLEAEDLLYRDERRTTRDHG 443
|
|
| TAIR|locus:2132353 AT4G02630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 888 (317.7 bits), Expect = 1.7e-111, Sum P(3) = 1.7e-111
Identities = 190/308 (61%), Positives = 223/308 (72%)
Query: 139 VSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAE 198
VSHLGWGHWYTLRELEVSTNGFADENVIG+GGYGIVYRGVLED + VA+KNLLNNRGQAE
Sbjct: 141 VSHLGWGHWYTLRELEVSTNGFADENVIGQGGYGIVYRGVLEDKSMVAIKNLLNNRGQAE 200
Query: 199 KEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGD-VGPHSPLTW 257
KEFKVEVEAIGRVRHKNLVRL+GYC EGAHRMLV EYVDNGNLEQW+HG +G SPLTW
Sbjct: 201 KEFKVEVEAIGRVRHKNLVRLLGYCVEGAHRMLVYEYVDNGNLEQWIHGGGLGFKSPLTW 260
Query: 258 EIRMNIILGTAKGLTYLHEGLEPKW---NPKLSDFGLAKLLGAERS-YVTTRVMGT-FGY 312
EIRMNI+LGTAKGL YLHEGLEPK + K S+ L K ++ S + +++G+ Y
Sbjct: 261 EIRMNIVLGTAKGLMYLHEGLEPKVVHRDIKSSNILLDKQWNSKVSDFGLAKLLGSEMSY 320
Query: 313 VAPEYAST-GMLNETSDVYSFGILI--MEVIS-GRNPVDY--SRPPGEFQF---QVNLFE 363
V T G + + S G+L +V S G ++ R P ++ +VNL E
Sbjct: 321 VTTRVMGTFGYV--APEYASTGMLNERSDVYSFGVLVMEIISGRSPVDYSRAPGEVNLVE 378
Query: 364 WLKTMVTNGNAEGVLDPRLQEKPSSXXXXXXXXXXXXCVDPNAHKRPKMGHVIHMLEAEE 423
WLK +VTN +AEGVLDPR+ +KPS CVDPNA KRPKMGH+IHMLEAE+
Sbjct: 379 WLKRLVTNRDAEGVLDPRMVDKPSLRSLKRTLLVALRCVDPNAQKRPKMGHIIHMLEAED 438
Query: 424 FPFRDERR 431
+D+RR
Sbjct: 439 LVSKDDRR 446
|
|
| TAIR|locus:2045620 AT2G42960 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 993 (354.6 bits), Expect = 2.7e-107, Sum P(2) = 2.7e-107
Identities = 194/312 (62%), Positives = 227/312 (72%)
Query: 139 VSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAE 198
+SHLGWGHW+TLR+LE++TN FA NV+GEGGYG+VYRG L + T VAVK LLNN GQAE
Sbjct: 162 ISHLGWGHWFTLRDLELATNRFAPVNVLGEGGYGVVYRGKLVNGTEVAVKKLLNNLGQAE 221
Query: 199 KEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWE 258
KEF+VEVEAIG VRHKNLVRL+GYC EG HRMLV EYV++GNLEQWLHG + H LTWE
Sbjct: 222 KEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNSGNLEQWLHGAMRQHGNLTWE 281
Query: 259 IRMNIILGTAKGLTYLHEGLEPK----------------WNPKLSDFGLAKLLGAERSYV 302
RM II GTA+ L YLHE +EPK +N KLSDFGLAKLL + S++
Sbjct: 282 ARMKIITGTAQALAYLHEAIEPKVVHRDIKASNILIDDEFNAKLSDFGLAKLLDSGESHI 341
Query: 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF 362
TTRVMGTFGYVAPEYA+TG+LNE SD+YSFG+L++E I+GR+PVDY RP E VNL
Sbjct: 342 TTRVMGTFGYVAPEYANTGLLNEKSDIYSFGVLLLEAITGRDPVDYGRPANE----VNLV 397
Query: 363 EWLKTMVTNGNAEGVLDPRLQEKPSSXXXXXXXXXXXXCVDPNAHKRPKMGHVIHMLEAE 422
EWLK MV AE V+DPRL+ +PS CVDP A KRP+M V MLE++
Sbjct: 398 EWLKMMVGTRRAEEVVDPRLEPRPSKSALKRALLVSLRCVDPEAEKRPRMSQVARMLESD 457
Query: 423 EFPFRDERRAGR 434
E PF ERR R
Sbjct: 458 EHPFHKERRNKR 469
|
|
| TAIR|locus:2027559 AT1G56720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 974 (347.9 bits), Expect = 1.2e-106, Sum P(2) = 1.2e-106
Identities = 187/312 (59%), Positives = 231/312 (74%)
Query: 140 SHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEK 199
SHLGWGHW+TLR+LE +TN F+ ENVIGEGGYG+VYRG L + T VAVK +LN GQAEK
Sbjct: 159 SHLGWGHWFTLRDLETATNRFSKENVIGEGGYGVVYRGELMNGTPVAVKKILNQLGQAEK 218
Query: 200 EFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEI 259
EF+VEV+AIG VRHKNLVRL+GYC EG HR+LV EYV+NGNLEQWLHG + H LTWE
Sbjct: 219 EFRVEVDAIGHVRHKNLVRLLGYCIEGTHRILVYEYVNNGNLEQWLHGAMRQHGYLTWEA 278
Query: 260 RMNIILGTAKGLTYLHEGLEPK----------------WNPKLSDFGLAKLLGAERSYVT 303
RM +++GT+K L YLHE +EPK +N K+SDFGLAKLLGA +S+VT
Sbjct: 279 RMKVLIGTSKALAYLHEAIEPKVVHRDIKSSNILINDEFNAKVSDFGLAKLLGAGKSHVT 338
Query: 304 TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFE 363
TRVMGTFGYVAPEYA++G+LNE SDVYSFG++++E I+GR+PVDY RP E VNL +
Sbjct: 339 TRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRDPVDYGRPAHE----VNLVD 394
Query: 364 WLKTMVTNGNAEGVLDPRLQEKPSSXXXXXXXXXXXXCVDPNAHKRPKMGHVIHMLEAEE 423
WLK MV +E V+DP ++ KP + CVDP++ KRPKM V+ MLE+EE
Sbjct: 395 WLKMMVGTRRSEEVVDPNIEVKPPTRSLKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 454
Query: 424 FPF-RDERRAGR 434
+P R++RR R
Sbjct: 455 YPIPREDRRRSR 466
|
|
| TAIR|locus:2077730 AT3G59110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 985 (351.8 bits), Expect = 1.5e-106, Sum P(2) = 1.5e-106
Identities = 190/309 (61%), Positives = 231/309 (74%)
Query: 139 VSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAE 198
+SHLGWGHW+TLR+L+++TN FA ENVIGEGGYG+VY+G L + +VAVK LLNN GQAE
Sbjct: 169 ISHLGWGHWFTLRDLQLATNRFAAENVIGEGGYGVVYKGRLINGNDVAVKKLLNNLGQAE 228
Query: 199 KEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWE 258
KEF+VEVEAIG VRHKNLVRL+GYC EG +RMLV EYV++GNLEQWLHG +G S LTWE
Sbjct: 229 KEFRVEVEAIGHVRHKNLVRLLGYCIEGVNRMLVYEYVNSGNLEQWLHGAMGKQSTLTWE 288
Query: 259 IRMNIILGTAKGLTYLHEGLEPK----------------WNPKLSDFGLAKLLGAERSYV 302
RM I++GTA+ L YLHE +EPK +N KLSDFGLAKLL + S++
Sbjct: 289 ARMKILVGTAQALAYLHEAIEPKVVHRDIKASNILIDDDFNAKLSDFGLAKLLDSGESHI 348
Query: 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF 362
TTRVMGTFGYVAPEYA+TG+LNE SD+YSFG+L++E I+GR+PVDY RP E VNL
Sbjct: 349 TTRVMGTFGYVAPEYANTGLLNEKSDIYSFGVLLLETITGRDPVDYERPANE----VNLV 404
Query: 363 EWLKTMVTNGNAEGVLDPRLQEKPSSXXXXXXXXXXXXCVDPNAHKRPKMGHVIHMLEAE 422
EWLK MV AE V+D R++ P++ CVDP A KRPKM V+ MLE++
Sbjct: 405 EWLKMMVGTRRAEEVVDSRIEPPPATRALKRALLVALRCVDPEAQKRPKMSQVVRMLESD 464
Query: 423 EFPFRDERR 431
E PFR+ERR
Sbjct: 465 EHPFREERR 473
|
|
| TAIR|locus:2093591 GPK1 "glyoxysomal protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 946 (338.1 bits), Expect = 1.1e-99, Sum P(2) = 1.1e-99
Identities = 182/321 (56%), Positives = 232/321 (72%)
Query: 139 VSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAE 198
VSH+GWGHW+TLR+L+++TN F+ E++IG+GGYG+VY G L + T VAVK LLNN GQA+
Sbjct: 133 VSHIGWGHWFTLRDLQLATNHFSKESIIGDGGYGVVYHGTLTNKTPVAVKKLLNNPGQAD 192
Query: 199 KEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWE 258
K+F+VEVEAIG VRHKNLVRL+GYC EG HRMLV EY++NGNLEQWLHGD+ LTWE
Sbjct: 193 KDFRVEVEAIGHVRHKNLVRLLGYCVEGTHRMLVYEYMNNGNLEQWLHGDMIHKGHLTWE 252
Query: 259 IRMNIILGTAKGLTYLHEGLEPK----------------WNPKLSDFGLAKLLGAERSYV 302
R+ +++GTAK L YLHE +EPK ++ KLSDFGLAKLLGA+ +YV
Sbjct: 253 ARIKVLVGTAKALAYLHEAIEPKVVHRDIKSSNILMDDNFDAKLSDFGLAKLLGADSNYV 312
Query: 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF 362
+TRVMGTFGYVAPEYA++G+LNE SDVYS+G++++E I+GR PVDY+RP E V++
Sbjct: 313 STRVMGTFGYVAPEYANSGLLNEKSDVYSYGVVLLEAITGRYPVDYARPKEE----VHMV 368
Query: 363 EWLKTMVTNGNAEGVLDPRLQEKPSSXXXXXXXXXXXXCVDPNAHKRPKMGHVIHMLEAE 422
EWLK MV E V+D L+ KP++ CVDP+A KRPKM V MLE++
Sbjct: 369 EWLKLMVQQKQFEEVVDKELEIKPTTSELKRALLTALRCVDPDADKRPKMSQVARMLESD 428
Query: 423 EFPF--RDERRAGREHGRSPH 441
E+P R+ERR R H
Sbjct: 429 EYPVMPREERRRRRNQNAETH 449
|
|
| TAIR|locus:2146203 AT5G18500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 967 (345.5 bits), Expect = 2.5e-97, P = 2.5e-97
Identities = 186/312 (59%), Positives = 232/312 (74%)
Query: 140 SHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEK 199
SHLGWGHW+TLR+L+++TN F+ +N+IG+GGYG+VYRG L + T VAVK LLNN GQA+K
Sbjct: 146 SHLGWGHWFTLRDLQMATNQFSRDNIIGDGGYGVVYRGNLVNGTPVAVKKLLNNLGQADK 205
Query: 200 EFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEI 259
+F+VEVEAIG VRHKNLVRL+GYC EG RMLV EYV+NGNLEQWL GD H LTWE
Sbjct: 206 DFRVEVEAIGHVRHKNLVRLLGYCMEGTQRMLVYEYVNNGNLEQWLRGDNQNHEYLTWEA 265
Query: 260 RMNIILGTAKGLTYLHEGLEPK----------------WNPKLSDFGLAKLLGAERSYVT 303
R+ I++GTAK L YLHE +EPK +N K+SDFGLAKLLGA++S++T
Sbjct: 266 RVKILIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDKFNSKISDFGLAKLLGADKSFIT 325
Query: 304 TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFE 363
TRVMGTFGYVAPEYA++G+LNE SDVYSFG++++E I+GR PVDY+RPP E V+L E
Sbjct: 326 TRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYARPPPE----VHLVE 381
Query: 364 WLKTMVTNGNAEGVLDPRLQEKPSSXXXXXXXXXXXXCVDPNAHKRPKMGHVIHMLEAEE 423
WLK MV +E V+DP L+ KPS+ CVDP + KRP+M V MLE+EE
Sbjct: 382 WLKMMVQQRRSEEVVDPNLETKPSTSALKRTLLTALRCVDPMSEKRPRMSQVARMLESEE 441
Query: 424 FPF-RDERRAGR 434
+P R++RR R
Sbjct: 442 YPIAREDRRRRR 453
|
|
| TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 961 (343.3 bits), Expect = 1.1e-96, P = 1.1e-96
Identities = 184/312 (58%), Positives = 232/312 (74%)
Query: 140 SHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEK 199
SHLGWGHW+TLR+LE++TN F+ ENVIGEGGYG+VYRG L + + VAVK +LN+ GQAEK
Sbjct: 137 SHLGWGHWFTLRDLEIATNRFSKENVIGEGGYGVVYRGELVNGSLVAVKKILNHLGQAEK 196
Query: 200 EFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEI 259
EF+VEV+AIG VRHKNLVRL+GYC EG +R+LV EY++NGNLE+WLHG + H LTWE
Sbjct: 197 EFRVEVDAIGHVRHKNLVRLLGYCIEGTNRILVYEYMNNGNLEEWLHGAMKHHGYLTWEA 256
Query: 260 RMNIILGTAKGLTYLHEGLEPK----------------WNPKLSDFGLAKLLGAERSYVT 303
RM ++ GT+K L YLHE +EPK +N K+SDFGLAKLLG +S+VT
Sbjct: 257 RMKVLTGTSKALAYLHEAIEPKVVHRDIKSSNILIDDRFNAKISDFGLAKLLGDGKSHVT 316
Query: 304 TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFE 363
TRVMGTFGYVAPEYA+TG+LNE SDVYSFG+L++E I+GR+PVDY+RP E VNL E
Sbjct: 317 TRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLVLEAITGRDPVDYARPANE----VNLVE 372
Query: 364 WLKTMVTNGNAEGVLDPRLQEKPSSXXXXXXXXXXXXCVDPNAHKRPKMGHVIHMLEAEE 423
WLK MV + E V+DP + +P++ C+DP++ KRPKM V+ MLE+EE
Sbjct: 373 WLKMMVGSKRLEEVIDPNIAVRPATRALKRVLLTALRCIDPDSEKRPKMSQVVRMLESEE 432
Query: 424 FPF-RDERRAGR 434
+P R+ERR R
Sbjct: 433 YPVPREERRVRR 444
|
|
| TAIR|locus:2139559 AT4G34500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 742 (266.3 bits), Expect = 4.6e-78, Sum P(2) = 4.6e-78
Identities = 158/313 (50%), Positives = 206/313 (65%)
Query: 142 LGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEF 201
+GWG WY+L++LE++T GF+D+N+IGEGGYG+VYR D + AVKNLLNN+GQAEKEF
Sbjct: 127 MGWGKWYSLKDLEIATRGFSDDNMIGEGGYGVVYRADFSDGSVAAVKNLLNNKGQAEKEF 186
Query: 202 KVEVEAIGRVRHKNLVRLVGYCAEGAH--RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEI 259
KVEVEAIG+VRHKNLV L+GYCA+ A RMLV EY+DNGNLEQWLHGDVGP SPLTW+I
Sbjct: 187 KVEVEAIGKVRHKNLVGLMGYCADSAQSQRMLVYEYIDNGNLEQWLHGDVGPVSPLTWDI 246
Query: 260 RMNIILGTAKGLTYLHEGLEPKW---NPKLSDFGLAKLLGAERS-YVTTRVMGT-FGYVA 314
RM I +GTAKGL YLHEGLEPK + K S+ L K A+ S + +++G+ YV
Sbjct: 247 RMKIAIGTAKGLAYLHEGLEPKVVHRDVKSSNILLDKKWNAKVSDFGLAKLLGSETSYVT 306
Query: 315 PEYASTGMLNETSDVY-SFGIL--IMEVIS-GRNPVDY--SRPPGEFQF---QVNLFEWL 365
T S Y S G+L +V S G ++ R P ++ ++NL +W
Sbjct: 307 TRVMGT--FGYVSPEYASTGMLNECSDVYSFGVLLMEIITGRSPVDYSRPPGEMNLVDWF 364
Query: 366 KTMVTNGNAEGVLDPRLQEKPSSXXXXXXXXXXXXCVDPNAHKRPKMGHVIHMLEAEEFP 425
K MV + E V+DP+++ P C+D ++ KRPKMG +IHMLEAE+FP
Sbjct: 365 KGMVASRRGEEVIDPKIKTSPPPRALKRALLVCLRCIDLDSSKRPKMGQIIHMLEAEDFP 424
Query: 426 FRDERRAGREHGR 438
FR E R+ +E +
Sbjct: 425 FRPEHRSNQERSK 437
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 570 (205.7 bits), Expect = 6.1e-60, Sum P(2) = 6.1e-60
Identities = 124/300 (41%), Positives = 177/300 (59%)
Query: 147 WYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE 206
W++ EL T+GF+++N++GEGG+G VY+GVL D VAVK L Q E+EFK EVE
Sbjct: 326 WFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVE 385
Query: 207 AIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSP-LTWEIRMNIIL 265
I RV H++LV LVGYC HR+LV +YV N L LH P P +TWE R+ +
Sbjct: 386 IISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHA---PGRPVMTWETRVRVAA 442
Query: 266 GTAKGLTYLHEGLEPK----------------WNPKLSDFGLAKLLGAE--RSYVTTRVM 307
G A+G+ YLHE P+ + ++DFGLAK+ ++V+TRVM
Sbjct: 443 GAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVM 502
Query: 308 GTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKT 367
GTFGY+APEYA++G L+E +DVYS+G++++E+I+GR PVD S+P G+ +L EW +
Sbjct: 503 GTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGD----ESLVEWARP 558
Query: 368 M----VTNGNAEGVLDPRLQEKPSSXXXXXXXXXXXXCVDPNAHKRPKMGHVIHMLEAEE 423
+ + N + ++DPRL + CV +A KRPKM V+ L+ E
Sbjct: 559 LLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLE 618
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 442 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-37 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-34 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-34 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-31 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-19 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-19 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-17 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-16 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-15 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-13 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-13 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-12 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-12 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-12 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-10 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-09 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-09 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-09 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-09 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-08 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-08 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-08 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-07 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-07 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-07 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-07 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-07 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-07 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-07 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-07 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-06 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-06 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-06 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-06 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-06 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-06 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-05 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-05 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-05 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-05 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-05 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-05 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-04 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-04 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-04 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-04 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-04 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-04 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-04 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-04 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-04 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-04 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 0.001 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.001 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 0.001 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 0.001 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 0.001 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 0.001 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.001 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 0.001 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 0.001 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 0.001 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 0.002 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 0.002 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 0.002 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 0.002 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.002 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 0.002 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 0.002 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 0.002 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 0.002 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 0.003 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 0.003 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 0.003 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 0.003 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 0.003 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 0.004 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 0.004 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-37
Identities = 59/190 (31%), Positives = 95/190 (50%), Gaps = 21/190 (11%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYC 223
+GEGG+G VY + VA+K + + +E E+E + ++ H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GL---- 278
+ H LV EY + G+L+ L L+ + + I+L +GL YLH G+
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 279 ---------EPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM-LNETSD 328
KL+DFGL+KLL +++S + T V GT Y+APE +E SD
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKSD 176
Query: 329 VYSFGILIME 338
++S G+++ E
Sbjct: 177 IWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 75/277 (27%), Positives = 119/277 (42%), Gaps = 43/277 (15%)
Query: 163 ENVIGEGGYGIVYRGVLEDN-----TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNL 216
+GEG +G VY+G L+ VAVK L + Q +EF E + ++ H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276
V+L+G C E +V EY++ G+L +L L+ ++ L A+G+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 277 G-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 323
+ K+SDFGL++ L + Y ++APE G
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF 180
Query: 324 NETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382
SDV+SFG+L+ E+ + G P PG +V E+LK NG RL
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEEV--LEYLK----NGY-------RL 222
Query: 383 QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHML 419
+P + + L L+C + RP ++ +L
Sbjct: 223 -PQPPNCPPELYDL-MLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-34
Identities = 74/277 (26%), Positives = 116/277 (41%), Gaps = 42/277 (15%)
Query: 163 ENVIGEGGYGIVYRGVLEDN-----TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNL 216
+GEG +G VY+G L+ VAVK L + Q +EF E + ++ H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276
V+L+G C E M+V EY+ G+L +L L+ ++ L A+G+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 277 G-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 323
+ K+SDFGL++ L + Y ++APE G
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKF 181
Query: 324 NETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382
SDV+SFG+L+ E+ + G P Y + E+LK G RL
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEP--YPGMSNA-----EVLEYLK----KGY-------RL 223
Query: 383 QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHML 419
KP + + L L+C + RP ++ +L
Sbjct: 224 -PKPPNCPPELYKL-MLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 9e-34
Identities = 77/290 (26%), Positives = 119/290 (41%), Gaps = 61/290 (21%)
Query: 164 NVIGEGGYGIVYRGVLEDNTN----VAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVR 218
+GEG +G VY+G L+ VAVK L + + K+F E + ++ H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWL-----HGDVGPHSPLTWEIRMNIILGTAKGLTY 273
L+G C E LV EY++ G+L +L S L+ + ++ + AKG+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 274 LHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTT-------RVMGTFGYV 313
L + K+SDFGL++ + + Y R M
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM------ 174
Query: 314 APEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372
APE G+ SDV+SFG+L+ E+ + G P Y PG ++ E + + G
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATP--Y---PG-----LSNEE-VLEYLRKG 223
Query: 373 NAEGVLDPRLQEKPS--SRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
RL KP L + L C + RP ++ LE
Sbjct: 224 Y-------RL-PKPEYCPDELYE---LMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 7e-33
Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 34/204 (16%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKV---EVEAIGRVRHKNLVRLV 220
+G G +G VY+ VAVK +L R + K+ + E+ + R+ H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVK-ILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-G-- 277
+ H LV EY + G+L +L PL+ + I L +GL YLH G
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLHSNGII 120
Query: 278 ----------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE------YASTG 321
L+ K++DFGLAK L S +TT V GT Y+APE
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGP- 178
Query: 322 MLNETSDVYSFGILIMEVISGRNP 345
DV+S G+++ E+++G+ P
Sbjct: 179 ----KVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 8e-31
Identities = 62/204 (30%), Positives = 94/204 (46%), Gaps = 28/204 (13%)
Query: 165 VIGEGGYGIVYRGVL-----EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVR 218
+GEG +G VY+G L T VAVK L + E+ EF E + ++ H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG- 277
L+G C +G +V EY+ G+L +L LT + + + L AKG+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLESKN 122
Query: 278 ------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFG---YVAPEYASTGM 322
+ K+SDFGL++ + + Y G ++APE G
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWMAPESLKDGK 180
Query: 323 LNETSDVYSFGILIMEVIS-GRNP 345
SDV+SFG+L+ E+ + G P
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 63/267 (23%), Positives = 103/267 (38%), Gaps = 40/267 (14%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLV 217
+ +GEG +G VY + VA+K + + + E++ + +++H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLT-WEIRMNIILGTAKGLTYLHE 276
RL + LV EY + G+L L L+ E R + L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLK----KRGRLSEDEAR-FYLRQILSALEYLHS 115
Query: 277 -G------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 323
G L+ + KL+DFGLA+ L TT V GT Y+APE
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-TTFV-GTPEYMAPEVLLGKGY 173
Query: 324 NETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ 383
+ D++S G+++ E+++G+ P F L E K +
Sbjct: 174 GKAVDIWSLGVILYELLTGKPP---------FPGDDQLLELFKKIGK-----PKPPFPPP 219
Query: 384 EKPSSRALKRALLVALRCVDPNAHKRP 410
E S K + + + + KR
Sbjct: 220 EWDISPEAKDLI---RKLLVKDPEKRL 243
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 65/204 (31%), Positives = 92/204 (45%), Gaps = 30/204 (14%)
Query: 166 IGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE 225
IG+G +G V G VAVK L ++ A+ F E + +RH NLV+L+G +
Sbjct: 14 IGKGEFGDVMLGDYRGQK-VAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 226 GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL------HEGLE 279
G +V EY+ G+L +L G +T ++ L +G+ YL H L
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSR-GRAV-ITLAQQLGFALDVCEGMEYLEEKNFVHRDLA 129
Query: 280 PKWN--------PKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNETSDV 329
+ N K+SDFGLAK + G + APE + SDV
Sbjct: 130 AR-NVLVSEDLVAKVSDFGLAK---EASQGQDS---GKLPVKWTAPEALREKKFSTKSDV 182
Query: 330 YSFGILIMEVIS-GRNPVDYSRPP 352
+SFGIL+ E+ S GR P Y R P
Sbjct: 183 WSFGILLWEIYSFGRVP--YPRIP 204
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 97.5 bits (241), Expect = 3e-22
Identities = 70/280 (25%), Positives = 115/280 (41%), Gaps = 37/280 (13%)
Query: 159 GFADENVIGEGGYGIVYRGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRH-K 214
+ +GEG +G VY D VA+K L L ++ + + F E++ + + H
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 215 NLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 274
N+V+L + + LV EYVD G+LE L +G PL+ + I+ L YL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYL 117
Query: 275 HEG------LEPK--------WNPKLSDFGLAKLLGAERS-----YVTTRVMGTFGYVAP 315
H ++P+ KL DFGLAKLL S + + +GT GY+AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 316 EYA---STGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372
E S + +SD++S GI + E+++G P + + + + + T
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS---QTLKIILELPTP- 233
Query: 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKM 412
L L K A + + + + R
Sbjct: 234 ----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 4e-22
Identities = 77/289 (26%), Positives = 131/289 (45%), Gaps = 46/289 (15%)
Query: 154 EVSTNGFADENVIGEGGYGIVYRGVLE----DNTNVAVKNLLNNRGQAEKE---FKVEVE 206
E+ + + VIG G +G V+RG+L+ VA+K L G EK+ F E
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL--KPGYTEKQRQDFLSEAS 58
Query: 207 AIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 266
+G+ H N++RL G + M++ EY++NG L+++L G S + ++ G
Sbjct: 59 IMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL---VGMLRG 115
Query: 267 TAKGLTYL------HEGLEPK-------WNPKLSDFGLAKLL--GAERSYVTTRVMGTFG 311
A G+ YL H L + K+SDFGL+++L E +Y T+
Sbjct: 116 IAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR 175
Query: 312 YVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTN 371
+ APE + SDV+SFGI++ EV+S RP + E +K +
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFG-----ERPYWDMSNH----EVMKAI--- 223
Query: 372 GNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
+G P + PS+ + L+C + +RP+ ++++L+
Sbjct: 224 --NDGFRLPAPMDCPSA-----VYQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 61/198 (30%), Positives = 107/198 (54%), Gaps = 22/198 (11%)
Query: 160 FADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 219
F E +G G +G V+ G+ ++ VA+K L ++ +++F+ EV+A+ R+RHK+L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 220 VGYCAEGAHRMLVNEYVDNGNLEQWL---HGDVGPHSPLTWEIRMNIILGTAKGLTYL-- 274
C+ G ++ E ++ G+L +L G V P + L +++ A+G+ YL
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL-----IDMACQVAEGMAYLEE 122
Query: 275 ----HEGLEPK-------WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 323
H L + K++DFGLA+L+ E Y+++ + + APE AS G
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDKKIPYKWTAPEAASHGTF 181
Query: 324 NETSDVYSFGILIMEVIS 341
+ SDV+SFGIL+ E+ +
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 5e-21
Identities = 76/280 (27%), Positives = 127/280 (45%), Gaps = 43/280 (15%)
Query: 162 DENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVG 221
+ENVI G G Y+G N ++ ++ E+ +G+++H N+V+L+G
Sbjct: 694 EENVISRGKKGASYKGKSIKN---GMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIG 750
Query: 222 YCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP- 280
C L++EY++ NL + L L+WE R I +G AK L +LH P
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPA 803
Query: 281 ---------------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 325
K P L L LL + T+ + YVAPE T + E
Sbjct: 804 VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITE 857
Query: 326 TSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEK 385
SD+Y FG++++E+++G++P D EF ++ EW + ++ + + +DP ++
Sbjct: 858 KSDIYGFGLILIELLTGKSPAD-----AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912
Query: 386 PSS--RALKRALLVALRC--VDPNAHKRPKMGHVIHMLEA 421
S + + +AL C DP A RP V+ LE+
Sbjct: 913 VSVNQNEIVEVMNLALHCTATDPTA--RPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 3e-20
Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 39/211 (18%)
Query: 163 ENVIGEGGYGIVYRGVL----EDNTNVAVKNLLNNRGQAEKE---FKVEVEAIGRVRHKN 215
E VIG G +G V RG L + +VA+K L G ++K+ F E +G+ H N
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL--KAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL- 274
++RL G + M++ EY++NG+L+++L + G T + ++ G A G+ YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLS 123
Query: 275 -----HEGLEPKWNP--------KLSDFGLAKLLGAERSYVTTRVMGTFG------YVAP 315
H L + N K+SDFGL++ L + TT+ G + AP
Sbjct: 124 EMNYVHRDLAAR-NILVNSNLVCKVSDFGLSRRLEDSEATYTTK-----GGKIPIRWTAP 177
Query: 316 EYASTGMLNETSDVYSFGILIMEVIS-GRNP 345
E + SDV+SFGI++ EV+S G P
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 160 FADENVIGEGGYGIVYRGVLEDNTNV-AVKNL-LNNRGQAEKEFKV-EVEAIGRVRHKNL 216
F N IG+G +G+V++ V + + V A+K + L+ + E+E + E + ++ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLT----WEIRMNIILGTAKGLT 272
+R + +V EY +NG+L + L G PL W + I+LG L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLG----LA 115
Query: 273 YLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 319
+LH L+ N K+ D G+AKLL ++ T ++GT Y++PE
Sbjct: 116 HLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCE 174
Query: 320 TGMLNETSDVYSFGILIMEVISGRNPVD 347
NE SDV++ G+++ E +G++P D
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 67/209 (32%), Positives = 97/209 (46%), Gaps = 23/209 (11%)
Query: 154 EVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVR 212
E+ E +G G +G V+ G T VAVK L G E F E + + ++R
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL--KPGTMSPEAFLQEAQIMKKLR 59
Query: 213 HKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 272
H LV+L C+E +V EY+ G+L +L G L + M + A+G+
Sbjct: 60 HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI--AEGMA 117
Query: 273 YL------HEGLEP-------KWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEY 317
YL H L K++DFGLA+L+ + Y T R F + APE
Sbjct: 118 YLESRNYIHRDLAARNILVGENLVCKIADFGLARLI-EDDEY-TAREGAKFPIKWTAPEA 175
Query: 318 ASTGMLNETSDVYSFGILIMEVIS-GRNP 345
A+ G SDV+SFGIL+ E+++ GR P
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 21/198 (10%)
Query: 164 NVIGEGGYGIVYRGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLV 220
++IG G +G+VY+G+ LE VA+K +L + +A K E++ + ++H N+V+ +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--- 277
G ++ EY +NG+L Q + P + + +GL YLHE
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIK----KFGPFPESLVAVYVYQVLQGLAYLHEQGVI 121
Query: 278 ---------LEPKW-NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETS 327
L K KL+DFG+A L + V+GT ++APE + S
Sbjct: 122 HRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS-VVGTPYWMAPEVIEMSGASTAS 180
Query: 328 DVYSFGILIMEVISGRNP 345
D++S G ++E+++G P
Sbjct: 181 DIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 7e-19
Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 27/203 (13%)
Query: 164 NVIGEGGYGIVYRGVLEDNTN-VAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLV 220
++G G +G VY + +D +AVK L + + + + E+ + ++H N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 221 GYCAEGAHRML--VNEYVDNGNLEQWLHGDVGPHSPLTWEIR--MNIILGTAKGLTYLHE 276
G + L EYV G+L L P+ IR IL +GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IRKYTRQIL---EGLAYLHS 119
Query: 277 G-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVM-GTFGYVAPEYASTGM 322
++ KL+DFG AK LG + T + GT ++APE
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 323 LNETSDVYSFGILIMEVISGRNP 345
+D++S G ++E+ +G+ P
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 165 VIGEGGYGIVYRGV-LEDNTN----VAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVR 218
V+G G +G VY+GV + + VA+K L +A KE E + V H ++VR
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYLH 275
L+G C L+ + + G L ++ ++G L W +++ AKG++YL
Sbjct: 74 LLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLE 126
Query: 276 EG-------------LEPKWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTG 321
E ++ + K++DFGLAKLL E+ Y ++A E
Sbjct: 127 EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR 186
Query: 322 MLNETSDVYSFGILIMEVIS-GRNPVD 347
+ SDV+S+G+ + E+++ G P +
Sbjct: 187 IYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 23/197 (11%)
Query: 166 IGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE 225
+G G +G V+ G+ + T VAVK L + +F E + + ++RH L++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 226 GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL------HEGLE 279
+V E + G+L ++L G G L I M + A G+ YL H L
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV--ASGMAYLEAQNYIHRDLA 130
Query: 280 PKWNP--------KLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNETSDV 329
+ N K++DFGLA+++ E Y R F + APE A + SDV
Sbjct: 131 AR-NVLVGENNICKVADFGLARVIK-EDIY-EAREGAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 330 YSFGILIMEVIS-GRNP 345
+SFGIL+ E+++ GR P
Sbjct: 188 WSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 4e-18
Identities = 63/239 (26%), Positives = 112/239 (46%), Gaps = 20/239 (8%)
Query: 166 IGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE 225
IG G +G+V+ G + VA+K + +E++F E + + ++ H LV+L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 226 GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL------HEGLE 279
+ LV E++++G L +L G S E + + L +G+ YL H L
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQ---ETLLGMCLDVCEGMAYLESSNVIHRDLA 127
Query: 280 PK-------WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSF 332
+ K+SDFG+ + + ++ +T + +PE S + SDV+SF
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSF 187
Query: 333 GILIMEVIS-GRNPVDYSRPPGEFQFQVNL-FEWLKTMVTNGNAEGVLDPRLQEKPSSR 389
G+L+ EV S G+ P + +R E +N F K + + + ++ +E+P R
Sbjct: 188 GVLMWEVFSEGKTPYE-NRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 56/198 (28%), Positives = 85/198 (42%), Gaps = 29/198 (14%)
Query: 166 IGEGGYGIVYRGVLEDNTN----VAVKNLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRLV 220
+G G +G V +GV + VAVK L A +KEF E + ++ H +VRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG- 277
G C +G MLV E G L ++L ++ A G+ YL
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLESKH 115
Query: 278 ------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGML 323
L + K+SDFG+++ LGA Y G + + APE + G
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 324 NETSDVYSFGILIMEVIS 341
+ SDV+S+G+ + E S
Sbjct: 176 SSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 73/278 (26%), Positives = 116/278 (41%), Gaps = 41/278 (14%)
Query: 152 ELEVSTNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR 210
E E + + V+G+G YGIVY L +A+K + + + E+
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 211 VRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGP--HSPLTWEIRMNIILGTA 268
++H+N+V+ +G +E + E V G+L L GP + T IL
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL--- 118
Query: 269 KGLTYLHE---------GLEPKWNP-----KLSDFGLAKLLGAERSYVTTRVMGTFGYVA 314
+GL YLH+ G N K+SDFG +K L A + T GT Y+A
Sbjct: 119 EGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQYMA 177
Query: 315 PEYASTGM--LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372
PE G +D++S G I+E+ +G+ P P F+V +F+
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK--------- 228
Query: 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRP 410
+ P + E S+ A + + LRC +P+ KR
Sbjct: 229 -----IHPEIPESLSAEA--KNFI--LRCFEPDPDKRA 257
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 3e-17
Identities = 66/225 (29%), Positives = 100/225 (44%), Gaps = 48/225 (21%)
Query: 164 NVIGEGGYGIVYRGVLE---DNTN--VAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLV 217
+GEG +G V + DNT VAVK+L ++ Q +F+ E+E + + H+N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 218 RLVGYCAEGAHR---MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT------- 267
+ G E L+ EY+ +G+L +L H I L
Sbjct: 70 KYKG-VCEKPGGRSLRLIMEYLPSGSLRDYLQR----HRD-------QINLKRLLLFSSQ 117
Query: 268 -AKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMG---TF 310
KG+ YL +E + K+SDFGLAK+L ++ Y + G F
Sbjct: 118 ICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177
Query: 311 GYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEF 355
Y APE T + SDV+SFG+ + E+ + +P S PP EF
Sbjct: 178 WY-APECLRTSKFSSASDVWSFGVTLYELFTYGDP-SQS-PPAEF 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 4e-17
Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 41/226 (18%)
Query: 152 ELEVSTNGFADENVIGEGGYGIVYRGVL------EDNTNVAVKNLL-NNRGQAEKEFKVE 204
E+ +S F +E +GEG +G VY+G L T+VA+K L N + ++EF+ E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 205 VEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWL-----HGDVGP-------H 252
E + ++H N+V L+G C + ++ EY+ +G+L ++L H DVG
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 253 SPLTWEIRMNIILGTAKGLTYL------HEGLE-------PKWNPKLSDFGLAKLLGAER 299
S L ++I + A G+ YL H L K+SDFGL++ + +
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD 178
Query: 300 SYVTTRVMGT----FGYVAPEYASTGMLNETSDVYSFGILIMEVIS 341
Y RV ++ PE G SD++SFG+++ E+ S
Sbjct: 179 YY---RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 62/196 (31%), Positives = 92/196 (46%), Gaps = 26/196 (13%)
Query: 166 IGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLVGYCA 224
IG+G +G VY+GVL+ NT VAVK + K F E E + + H N+V+L+G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 225 EGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL------HEGL 278
+ +V E V G+L +L + LT + + + L A G+ YL H L
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLR---KKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDL 119
Query: 279 EPKWN--------PKLSDFGLAKLLGAERSYVTTRVMGT----FGYVAPEYASTGMLNET 326
+ N K+SDFG+++ E + T G + APE + G
Sbjct: 120 AAR-NCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 327 SDVYSFGILIMEVISG 342
SDV+S+GIL+ E S
Sbjct: 176 SDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 6e-17
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 34/214 (15%)
Query: 165 VIGEGGYGIVYRGVL------EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRHKNLV 217
+GEG +G V+ G D VAVK L A K+F+ E E + +H+N+V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWL--HG--------DVGPHSPLTWEIRMNIILGT 267
+ G C EG ++V EY+++G+L ++L HG P LT + I +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 268 AKGLTYL------HEGLEPKWN--------PKLSDFGLAKLLGAERSY-VTTRVMGTFGY 312
A G+ YL H L + N K+ DFG+++ + Y V M +
Sbjct: 132 ASGMVYLASQHFVHRDLATR-NCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRW 190
Query: 313 VAPEYASTGMLNETSDVYSFGILIMEVIS-GRNP 345
+ PE SDV+SFG+++ E+ + G+ P
Sbjct: 191 MPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 19/206 (9%)
Query: 160 FADENVIGEGGYGIVYRG-VLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 218
F IG+GG+G VY+ VA+K + + +++ E++ + + +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG- 277
G + +V E+ G+L+ L LT + KGL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT---LTESQIAYVCKELLKGLEYLHSNG 118
Query: 278 ------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 325
L KL DFGL+ L ++ ++GT ++APE + +
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVINGKPYDY 176
Query: 326 TSDVYSFGILIMEVISGRNPVDYSRP 351
+D++S GI +E+ G+ P P
Sbjct: 177 KADIWSLGITAIELAEGKPPYSELPP 202
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 4e-16
Identities = 71/273 (26%), Positives = 106/273 (38%), Gaps = 53/273 (19%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 218
+ + IGEG G VY+ VA+K + R Q ++ E+ + +H N+V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVD 79
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTW-EIRMN------IILGTAKGL 271
G +V EY+D G+L D+ +T +RMN + +GL
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLT-----DI-----ITQNFVRMNEPQIAYVCREVLQGL 129
Query: 272 TYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 318
YLH L + KL+DFG A L E+S + V GT ++APE
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVI 188
Query: 319 STGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378
D++S GI+ +E+ G P Y R P L + T G
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEGEPP--YLREPPL--------RALFLITTKGI----- 233
Query: 379 DPRLQEKPS-SRALKRALLVALRCVDPNAHKRP 410
P L+ S K L +C+ + KRP
Sbjct: 234 -PPLKNPEKWSPEFKDFL---NKCLVKDPEKRP 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (192), Expect = 4e-16
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVRHKNL 216
+ IG+G +G VY D +K + L+N + E+E + EV+ + ++ H N+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276
++ E +V EY D G+L Q + P E ++ + L YLH
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121
Query: 277 G-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE------Y 317
L KL DFG++K+L + T V GT Y++PE Y
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNKPY 180
Query: 318 ASTGMLNETSDVYSFGILIMEVISGRNP 345
N SD++S G ++ E+ + ++P
Sbjct: 181 ------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 30/208 (14%)
Query: 163 ENVIGEGGYGIVYRGVLE----DNTNVAVKNLLNNRGQAEK---EFKVEVEAIGRVRHKN 215
E VIG G +G V RG L+ VA+K L G EK +F E +G+ H N
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL- 274
++ L G + M++ E+++NG L+ +L + G + + + ++ G A G+ YL
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYLS 123
Query: 275 -----HEGLEPK---WNP----KLSDFGLAKLLGAERSYVT-TRVMG---TFGYVAPEYA 318
H L + N K+SDFGL++ L + S T T +G + APE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 319 STGMLNETSDVYSFGILIMEVIS-GRNP 345
+ SDV+S+GI++ EV+S G P
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 41/218 (18%)
Query: 165 VIGEGGYGIVYRGVL-EDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLVG- 221
V+G+G G+VY+ A+K + ++ + K+ E++ + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 222 YCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSP-----LTWEIRMNIILGTAKGLTYLHE 276
+ EG +V EY+D G+L L VG + +I KGL YLH
Sbjct: 68 FYKEGEIS-IVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQI--------LKGLDYLHT 117
Query: 277 GL-------EP-------KWNPKLSDFGLAKLL----GAERSYVTTRVMGTFGYVAPEYA 318
+P K K++DFG++K+L ++V GT Y++PE
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSPERI 172
Query: 319 STGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQ 356
+ +D++S G+ ++E G+ P P F+
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFE 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 70/245 (28%), Positives = 103/245 (42%), Gaps = 42/245 (17%)
Query: 164 NVIGEGGYGIVY----RGVLEDNT--NVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNL 216
+G G +G VY RG D VAVK L + Q E +F +E + + H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGD---VGPHSPLTWEIRMNIILGTAKGLTY 273
VRL+G E R ++ E + G+L+ +L + S LT + + AKG Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 274 LHEG----------------LEPKWNPKLSDFGLAK-LLGAERSYVTTRVMGTFGYVAPE 316
L E P K++DFG+A+ + A R M ++ PE
Sbjct: 132 LEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPE 191
Query: 317 YASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375
G+ +DV+SFG+L+ E+ S G P PG +V VT G
Sbjct: 192 AFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY-----PGRTNQEV------MEFVTGG--- 237
Query: 376 GVLDP 380
G LDP
Sbjct: 238 GRLDP 242
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 53/205 (25%), Positives = 83/205 (40%), Gaps = 32/205 (15%)
Query: 166 IGEGGYGIVYRG----VLEDNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLV 220
+G+G +G+V RG VAVK L +++ +F E + + H+NL+RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLT--WEIRMNIILGTAKGLTYLHEG- 277
G M+V E G+L L D H ++ + + I A G+ YL
Sbjct: 63 GVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLESKR 117
Query: 278 ------------LEPKWNPKLSDFGLAKLLGAERSYVTT----RVMGTFGYVAPEYASTG 321
L K+ DFGL + L + +V F + APE T
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLRTR 175
Query: 322 MLNETSDVYSFGILIMEVIS-GRNP 345
+ SDV+ FG+ + E+ + G P
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 6e-15
Identities = 71/271 (26%), Positives = 115/271 (42%), Gaps = 46/271 (16%)
Query: 164 NVIGEGGYGIVYRGVLEDNTNVAVKNLL---NNRGQAEKEFKV---EVEAIGRVRHKNLV 217
V+G+G YG VY G+ +AVK + +N AEKE++ EV+ + ++H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277
+ +G C + + E+V G++ L+ GP + IL G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEPVFCKYTKQIL---DGVAYLHNN 121
Query: 278 -------------LEPKWNPKLSDFGLAKLLG-----AERSYVTTRVMGTFGYVAPEYAS 319
L P KL DFG A+ L S + + GT ++APE +
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 320 TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379
SD++S G + E+ +G+ P+ S L M G G++
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPPLA-SMDR------------LAAMFYIGAHRGLM- 227
Query: 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRP 410
PRL + S+ A+ C+ + H+RP
Sbjct: 228 PRLPDSFSAAAID----FVTSCLTRDQHERP 254
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-14
Identities = 63/194 (32%), Positives = 96/194 (49%), Gaps = 18/194 (9%)
Query: 166 IGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE 225
+G+G +G V+ G T VA+K L E F E + + ++RH+ LV+L +E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 226 GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRM--NIILGTA--KGLTYLHEGLEP- 280
+V EY+ G+L +L G++G + L + M I G A + + Y+H L
Sbjct: 73 EP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 131
Query: 281 ------KWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNETSDVYSF 332
K++DFGLA+L+ E + T R F + APE A G SDV+SF
Sbjct: 132 NILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189
Query: 333 GILIMEVIS-GRNP 345
GIL+ E+ + GR P
Sbjct: 190 GILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 64/206 (31%), Positives = 98/206 (47%), Gaps = 28/206 (13%)
Query: 163 ENVIGEGGYGIVYRGVLE----DNTNVAVKNLLNNRGQAEKE---FKVEVEAIGRVRHKN 215
E VIG G +G V G L+ VA+K L G EK+ F E +G+ H N
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL--KAGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL- 274
++ L G + M+V EY++NG+L+ +L G + + + ++ G A G+ YL
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIASGMKYLS 123
Query: 275 -----HEGLEPK---WNP----KLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEYAST 320
H L + N K+SDFGL+++L E +Y T + APE +
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183
Query: 321 GMLNETSDVYSFGILIMEVIS-GRNP 345
SDV+S+GI++ EV+S G P
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 81/294 (27%), Positives = 130/294 (44%), Gaps = 61/294 (20%)
Query: 166 IGEGGYGIVYR---GVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLV 220
+G+G +G V L+DNT VAVK L ++ + ++F+ E+E + ++H N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 221 GYCAEGAHR--MLVNEYVDNGNLEQWL--HGDVGPHSPL---TWEIRMNIILGTAKGLTY 273
G C R LV EY+ G+L +L H + H L +I KG+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI--------CKGMEY 123
Query: 274 L------HEGL-------EPKWNPKLSDFGLAKLLGAERSYVTTRVMG---TFGYVAPEY 317
L H L E + K+ DFGL K+L ++ Y R G F Y APE
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APES 182
Query: 318 ASTGMLNETSDVYSFGILIMEVI--SGRNPVDYSRPPGEF--------QFQVNLFEWLKT 367
+ + SDV+SFG+++ E+ S ++ PP EF Q Q+ ++ ++
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFTYSDKS----CSPPAEFMRMMGNDKQGQMIVYHLIEL 238
Query: 368 MVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421
+ NG RL P A A++ C + + +RP + +EA
Sbjct: 239 LKNNG--------RLPAPPGCPAEIYAIM--KECWNNDPSQRPSFSELALQVEA 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 75/294 (25%), Positives = 119/294 (40%), Gaps = 61/294 (20%)
Query: 164 NVIGEGGYGIVYRGVLED-------NTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRH 213
N +G G +G VY G D VAVK L +G Q +KEF E + H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL--RKGATDQEKKEFLKEAHLMSNFNH 58
Query: 214 KNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHG---DVGPHSPLTWEIRMNIILGTAKG 270
N+V+L+G C + ++ E ++ G+L +L + LT + ++I L AKG
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 271 LTYLHE------------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMG---- 308
YL + G + K+ DFGLA+ + Y R G
Sbjct: 119 CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEGLL 175
Query: 309 TFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKT 367
++APE G SDV+SFG+L+ E+++ G+ P P +N E L+
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY-----PA-----LNNQEVLQH 225
Query: 368 MVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421
+ G RLQ+ + L+ C + +RP + +L+
Sbjct: 226 VTAGG--------RLQKPENCPDKIYQLM--TNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 49/204 (24%), Positives = 89/204 (43%), Gaps = 29/204 (14%)
Query: 166 IGEGGYGIVYRGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVR 218
+G+G +G+VY G+ E T VA+K + N E+ EF E + ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLHG------DVGPHSPLTWEIRMNIILGTAKGLT 272
L+G + G ++V E + G+L+ +L + P T + + + A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 273 YLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPEY 317
YL + K+ DFG+ + + E Y + + ++APE
Sbjct: 134 YLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMAPES 192
Query: 318 ASTGMLNETSDVYSFGILIMEVIS 341
G+ SDV+SFG+++ E+ +
Sbjct: 193 LKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 163 ENVIGEGGYGIVYRGVLE----DNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 217
E ++G G +G + RG L+ VA+ L ++ F E +G+ H N+V
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL--- 274
RL G G M+V EY+ NG L+ +L G L M ++ G A G+ YL
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG---QLVAGQLMGMLPGLASGMKYLSEM 126
Query: 275 ---HEGLEPK-------WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 324
H+GL K+S F + +E Y T + APE +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186
Query: 325 ETSDVYSFGILIMEVIS-GRNP 345
SDV+SFGI++ EV+S G P
Sbjct: 187 SASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 61/195 (31%), Positives = 94/195 (48%), Gaps = 20/195 (10%)
Query: 166 IGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLVGYCA 224
+G G +G V+ G +T VA+K+L +G E F E + +++H LVRL
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSL--KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 225 EGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRM--NIILGTA--KGLTYLHEGLEP 280
+ ++ EY++NG+L +L G + I M I G A + Y+H L
Sbjct: 72 QEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRA 130
Query: 281 -------KWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNETSDVYS 331
K++DFGLA+L+ E + T R F + APE + G SDV+S
Sbjct: 131 ANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 188
Query: 332 FGILIMEVIS-GRNP 345
FGIL+ E+++ GR P
Sbjct: 189 FGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 68/271 (25%), Positives = 109/271 (40%), Gaps = 43/271 (15%)
Query: 165 VIGEGGYGIVYRGVL------EDNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLV 217
+G G +G V+ T V VK L + + + EF+ E++ ++ HKN+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWL-----HGDVGPHSPLTWEIRMNIILGTAKGLT 272
RL+G C E ++ EY D G+L+Q+L + PL+ + ++ + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 273 YL------HEGLEPK-------WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 319
+L H L + K+S L+K + Y + ++APE
Sbjct: 132 HLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQ 191
Query: 320 TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379
+ SDV+SFG+L+ EV + GE F V N G L+
Sbjct: 192 EDDFSTKSDVWSFGVLMWEVFT----------QGELPFY----GLSDEEVLNRLQAGKLE 237
Query: 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRP 410
+ E SR K + RC N RP
Sbjct: 238 LPVPEGCPSRLYK----LMTRCWAVNPKDRP 264
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 32/203 (15%)
Query: 166 IGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE 225
+G G +G+V+ G +VA+K ++ +E +F E + + ++ H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK-MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 226 GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA----KGLTYL------H 275
+V EY+ NG L +L G ++ +L + + YL H
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKG-------KLGTEWLLDMCSDVCEAMEYLESNGFIH 123
Query: 276 EGLEPK-------WNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEYASTGMLNE 325
L + K+SDFGLA+ + + Y ++ GT + PE +
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYV-LDDQYTSS--QGTKFPVKWAPPEVFDYSRFSS 180
Query: 326 TSDVYSFGILIMEVIS-GRNPVD 347
SDV+SFG+L+ EV S G+ P +
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 32/212 (15%)
Query: 166 IGEGGYGIVYRGVL------EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 219
+GEG +G V+ +D VAVK L A ++F+ E E + ++H+++VR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 220 VGYCAEGAHRMLVNEYVDNGNLEQWLH-----------GDVGPHSPLTWEIRMNIILGTA 268
G C EG ++V EY+ +G+L ++L G+ LT + I A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 269 KGLTYL------HEGLEPK-------WNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVA 314
G+ YL H L + K+ DFG+++ + + Y V R M ++
Sbjct: 133 SGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMP 192
Query: 315 PEYASTGMLNETSDVYSFGILIMEVIS-GRNP 345
PE SD++SFG+++ E+ + G+ P
Sbjct: 193 PESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 24/200 (12%)
Query: 166 IGEGGYGIVYRGVLE---DNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLVG 221
+G G +G V +GV + +VA+K L N ++ + E E E + ++ + +VR++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 222 YCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---- 277
C E MLV E G L ++L G +T + ++ + G+ YL
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 278 ---------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNET 326
L + K+SDFGL+K LGA+ SY R G + + APE + +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178
Query: 327 SDVYSFGILIMEVIS-GRNP 345
SDV+S+GI + E S G+ P
Sbjct: 179 SDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 154 EVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 213
E+ +G G +G V+ G NT VAVK L E F E + + ++RH
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRH 60
Query: 214 KNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRM--NIILGTA--K 269
LV+L +E +V EY+ G+L +L G L + M + G A +
Sbjct: 61 DKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119
Query: 270 GLTYLHEGLEPK-------WNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYAST 320
+ Y+H L K++DFGLA+L+ E + T R F + APE A
Sbjct: 120 RMNYIHRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALY 177
Query: 321 GMLNETSDVYSFGILIMEVIS-GRNP 345
G SDV+SFGIL+ E+++ GR P
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 66/223 (29%), Positives = 96/223 (43%), Gaps = 36/223 (16%)
Query: 164 NVIGEGGYGIVYRGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLV 220
N IG G +G VY V L+ +AVK + +N + KE E++ + ++H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY- 64
Query: 221 GYCAEGAHRMLVN---EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277
Y E HR V EY G LE+ L G + L +GL YLH
Sbjct: 65 -YGVE-VHREKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQL--LEGLAYLHSH 118
Query: 278 -------------LEPKWNPKLSDFGLAKLLGAERSYVTTRV---MGTFGYVAPEYASTG 321
L+ KL DFG A L + + V GT Y+APE + G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 322 MLNE---TSDVYSFGILIMEVISGRNPVDYSRPPGEFQ--FQV 359
+D++S G +++E+ +G+ P +S EFQ F V
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRP--WSELDNEFQIMFHV 219
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 62/193 (32%), Positives = 90/193 (46%), Gaps = 21/193 (10%)
Query: 166 IGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLVGYC 223
IG G +G V+ G L DNT VAVK+ K +F E + + H N+VRL+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL------HEG 277
+ +V E V G+ +L + GP + I+M + A G+ YL H
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQM--VENAAAGMEYLESKHCIHRD 119
Query: 278 LEP-------KWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNETSD 328
L K K+SDFG+++ + Y +T M + APE + G + SD
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178
Query: 329 VYSFGILIMEVIS 341
V+SFGIL+ E S
Sbjct: 179 VWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 5e-13
Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 32/199 (16%)
Query: 165 VIGEGGYGIVYRGVLEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYC 223
+IGEG +G V +G VAVKN+ + QA F E + ++ HKNLVRL+G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 224 A-EGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL------HE 276
G + +V E + GNL +L + ++ + L A+G+ YL H
Sbjct: 69 LHNGLY--IVMELMSKGNLVNFLRTRGRALVSVIQLLQFS--LDVAEGMEYLESKKLVHR 124
Query: 277 GLEPK-------WNPKLSDFGLAKL--LGAERSYVTTRVMGTFGYVAPEYASTGMLNETS 327
L + K+SDFGLA++ +G + S + + + APE + S
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSKS 178
Query: 328 DVYSFGILIMEVIS-GRNP 345
DV+S+G+L+ EV S GR P
Sbjct: 179 DVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 9e-13
Identities = 49/192 (25%), Positives = 87/192 (45%), Gaps = 19/192 (9%)
Query: 163 ENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVG 221
++ +G G YG VY GV + + VAVK L + +EF E + ++H NLV+L+G
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 222 YCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL------H 275
C ++ E++ GNL +L + + + + + + YL H
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKNFIH 127
Query: 276 EGLEPKWN--------PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETS 327
L + N K++DFGL++L+ + + APE + + S
Sbjct: 128 RDLAAR-NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 328 DVYSFGILIMEV 339
DV++FG+L+ E+
Sbjct: 187 DVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-13
Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 31/212 (14%)
Query: 165 VIGEGGYGIVYRGVL--EDNT---NVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVR 218
++G G +G V++G+ E ++ VA+K + + G Q +E + A+G + H +VR
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYLH 275
L+G C GA LV + G+L + + P L W +++ AKG+ YL
Sbjct: 74 LLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYLE 126
Query: 276 EG-------------LEPKWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYASTG 321
E L+ +++DFG+A LL + + Y + ++A E G
Sbjct: 127 EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 322 MLNETSDVYSFGILIMEVIS-GRNPVDYSRPP 352
SDV+S+G+ + E++S G P RP
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 9e-13
Identities = 71/294 (24%), Positives = 109/294 (37%), Gaps = 80/294 (27%)
Query: 160 FADENVIGEGGYGIVYRGVL-EDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRV-RHK 214
F +IGEG + V E N A+K L + + K K+E E + R+ H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 215 NLVRLVGYCAEGAHRM-LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 273
+++L Y + + V EY NG L Q++ + L + L Y
Sbjct: 63 GIIKLY-YTFQDEENLYFVLEYAPNGELLQYIR----KYGSLDEKCTRFYAAEILLALEY 117
Query: 274 LHE------GLEP-------KWNPKLSDFGLAKLLGAERSYVTTRVM------------- 307
LH L+P + K++DFG AK+L S + +
Sbjct: 118 LHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 308 ------GTFGYVAPEYASTGMLNET-----SDVYSFGILIMEVISGRNP----------- 345
GT YV+PE +LNE SD+++ G +I ++++G+ P
Sbjct: 178 RFASFVGTAEYVSPE-----LLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQ 232
Query: 346 ----VDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP--RLQEKPSSRALKR 393
++YS PP +L E L VLDP RL LK
Sbjct: 233 KILKLEYSFPPNFPPDAKDLIEKLL----------VLDPQDRLGVNEGYDELKA 276
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 30/210 (14%)
Query: 166 IGEGGYGIVYRGVL------EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 219
+GEG +G V+ +D VAVK L + A K+F E E + ++H+++V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 220 VGYCAEGAHRMLVNEYVDNGNLEQWL--HG-------DVGPHSPLTWEIRMNIILGTAKG 270
G C EG ++V EY+ +G+L ++L HG + + LT ++I A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 271 LTYL------HEGLEPK-------WNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPE 316
+ YL H L + K+ DFG+++ + + Y V M ++ PE
Sbjct: 133 MVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 192
Query: 317 YASTGMLNETSDVYSFGILIMEVIS-GRNP 345
SDV+S G+++ E+ + G+ P
Sbjct: 193 SIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 73/279 (26%), Positives = 111/279 (39%), Gaps = 62/279 (22%)
Query: 164 NVIGEGGYGIVYRGV-LEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVRHKNLVRLV 220
IG+G +G V + D + K + N + EK+ V EV + ++H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR-- 63
Query: 221 GYCAEGAHRM---------LVNEYVDNGNLEQWLHGDVGPHSPLT----WEIRMNIIL-- 265
Y R+ +V EY + G+L Q + + W I ++L
Sbjct: 64 -YY----DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 266 -----GTAKGLTYLHEGLEP-------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 313
+ G T LH L+P N KL DFGLAK+LG + S+ T V GT Y+
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYM 177
Query: 314 APEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373
+PE + +E SD++S G LI E+ + P F L + + G
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPP-----------FTARNQLQLASKIKEGK 226
Query: 374 AEGVLDPRLQEKPS--SRALKRALLVALRCVDPNAHKRP 410
R+ P S L V ++ + KRP
Sbjct: 227 F-----RRI---PYRYSSELNE---VIKSMLNVDPDKRP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 26/200 (13%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVK--NLLNNRGQAE---KEFKVEVEAIGRVRHKNLVRL 219
+G G +G VY G+ L+D AVK +L ++ + K+ + E+ + +++H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 220 VGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-- 277
+G E + + E V G+L + L G + GL YLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAK-LLKKYG---SFPEPVIRLYTRQILLGLEYLHDRNT 123
Query: 278 -----------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY-ASTGMLNE 325
++ KL+DFG+AK + G+ ++APE A G
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIAQQGGYGL 181
Query: 326 TSDVYSFGILIMEVISGRNP 345
+D++S G ++E+ +G+ P
Sbjct: 182 AADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 51/196 (26%), Positives = 86/196 (43%), Gaps = 19/196 (9%)
Query: 166 IGEGGYGIVYR-GVLEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVRHKNLVRLVGY 222
+G+G YG VY+ L DN A+K + L + Q E+E V E+ + V H N++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 223 CAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE------ 276
+G +V EY G+L + + + + I + +GL LHE
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHR 127
Query: 277 GLEPK----WNP---KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDV 329
L+ K+ D G++K+L + + +GT Y+APE + SD+
Sbjct: 128 DLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDI 184
Query: 330 YSFGILIMEVISGRNP 345
+S G L+ E+ + P
Sbjct: 185 WSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 40/213 (18%)
Query: 166 IGEGGYGIVYRGVL------EDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRV-RHKN 215
+GEG +G V + + + VAVK L ++ EK+ E+E + + +HKN
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKN 77
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLH------------GDVGPHSPLTWEIRMNI 263
++ L+G C + +V EY +GNL +L P LT + ++
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 264 ILGTAKGLTYL------HEGLEPKWNP--------KLSDFGLAKLLGAERSY-VTTRVMG 308
A+G+ +L H L + N K++DFGLA+ + Y TT
Sbjct: 138 AYQVARGMEFLASKKCIHRDLAAR-NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 309 TFGYVAPEYASTGMLNETSDVYSFGILIMEVIS 341
++APE + SDV+SFG+L+ E+ +
Sbjct: 197 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 73/285 (25%), Positives = 113/285 (39%), Gaps = 56/285 (19%)
Query: 164 NVIGEGGYGIVYRGVLEDNTN--VAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVR 218
+G G G+V + VL T +AVK + E K E++ + + +V
Sbjct: 7 GELGAGNSGVVSK-VLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNSPYIVG 63
Query: 219 LVGYC-AEGAHRMLVNEYVDNGNLEQWLHGDVG--PHSPLTWEIRMNIILGTAKGLTYLH 275
G G + + EY+D G+L++ L G P L I + KGLTYLH
Sbjct: 64 FYGAFYNNGDISICM-EYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLH 117
Query: 276 EGL-------EP-------KWNPKLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEYAS 319
E +P + KL DFG++ L +++V GT Y+APE
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERIQ 172
Query: 320 TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379
+ SD++S G+ ++E+ +GR P P E +FE L+ +V N
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPY-----PPENDPPDGIFELLQYIV-NEPP----- 221
Query: 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 424
PRL PS + C+ + +RP L F
Sbjct: 222 PRL---PSGKFSPDFQDFVNLCLIKDPRERPS----YKELLEHPF 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 9e-12
Identities = 61/194 (31%), Positives = 92/194 (47%), Gaps = 18/194 (9%)
Query: 166 IGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE 225
+G+G +G V+ G T VA+K L E F E + + ++RH LV L +E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 226 GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRM--NIILGTA--KGLTYLHEGLEP- 280
+V E++ G+L +L G + L + M I G A + + Y+H L
Sbjct: 73 EP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAA 131
Query: 281 ------KWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNETSDVYSF 332
K++DFGLA+L+ E + T R F + APE A G SDV+SF
Sbjct: 132 NILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189
Query: 333 GILIMEVIS-GRNP 345
GIL+ E+++ GR P
Sbjct: 190 GILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 48/198 (24%), Positives = 83/198 (41%), Gaps = 28/198 (14%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKV----EVEAIGRVRHKNLVRLV 220
IGEG YG+VY+ VA+K + + E++ + + H N+++L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIK--LRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--- 277
LV E++D +L + + L + + + +GL + H
Sbjct: 65 DVFRHKGDLYLVFEFMDT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSHGIL 120
Query: 278 ---LEPKWN--------PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNE 325
L+P+ N KL+DFGLA+ G+ T V+ T Y APE +
Sbjct: 121 HRDLKPE-NLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGYST 178
Query: 326 TSDVYSFGILIMEVISGR 343
D++S G + E++S R
Sbjct: 179 PVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 35/223 (15%)
Query: 152 ELEVSTNGFADENVIGEGGYGIVYRGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEV 205
EL +S F +E +GE +G +Y+G L + VA+K L + N Q EF+ E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 206 EAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWL-----HGDVGPHSPLTWEIR 260
+ + H N+V L+G + ++ EY++ G+L ++L H DVG S ++
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 261 --------MNIILGTAKGLTYL------HEGLEPK-------WNPKLSDFGLAKLLGAER 299
++I + A G+ YL H+ L + + K+SD GL++ + +
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178
Query: 300 SY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS 341
Y V + + ++ PE G + SD++SFG+++ E+ S
Sbjct: 179 YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 31/207 (14%)
Query: 165 VIGEGGYGIVYRGVL--EDNT---NVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVR 218
V+G G +G VY+G+ E T VA+K L G +A EF E + + H +LVR
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYLH 275
L+G C + LV + + +G L ++H ++G L W +++ AKG+ YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 276 EG-------------LEPKWNPKLSDFGLAKLL-GAERSYVTTRVMGTFGYVAPEYASTG 321
E ++ + K++DFGLA+LL G E+ Y ++A E
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186
Query: 322 MLNETSDVYSFGILIMEVIS-GRNPVD 347
SDV+S+G+ I E+++ G P D
Sbjct: 187 KFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 65/210 (30%), Positives = 92/210 (43%), Gaps = 36/210 (17%)
Query: 163 ENVIGEGGYGIV----YRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 218
IG+G +G V YRG VAVK + N+ + F E + ++RH NLV+
Sbjct: 11 LQTIGKGEFGDVMLGDYRG-----NKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQ 63
Query: 219 LVGYCAEGAHRM-LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL--- 274
L+G E + +V EY+ G+L +L S L + + L + + YL
Sbjct: 64 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 275 ---HEGLEPKWN--------PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 323
H L + N K+SDFGL K + + V T APE
Sbjct: 122 NFVHRDLAAR-NVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKF 176
Query: 324 NETSDVYSFGILIMEVIS-GRNPVDYSRPP 352
+ SDV+SFGIL+ E+ S GR P Y R P
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVP--YPRIP 204
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 64/226 (28%), Positives = 105/226 (46%), Gaps = 41/226 (18%)
Query: 152 ELEVSTNGFADENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNN-RGQAEKEFKVE 204
E+ +ST F +E +GE +G VY+G L E VA+K L + G +EFK E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 205 VEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWL-----HGDVGP-------H 252
R++H N+V L+G + ++ Y + +L ++L H DVG
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 253 SPLTWEIRMNIILGTAKGLTYL------HEGLEP-------KWNPKLSDFGLAKLLGAER 299
S L ++I+ A G+ +L H+ L K N K+SD GL + + A
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAAD 178
Query: 300 SYVTTRVMGT----FGYVAPEYASTGMLNETSDVYSFGILIMEVIS 341
Y ++MG +++PE G + SD++S+G+++ EV S
Sbjct: 179 YY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 65/245 (26%), Positives = 104/245 (42%), Gaps = 49/245 (20%)
Query: 165 VIGEGGYGIVYRGV------LEDNTNVAVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNLV 217
+GEG +G V + T VAVK L N +E ++ E + +V H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHGD--VGP------------------HSPLTW 257
+L G C++ +L+ EY G+L +L VGP LT
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 258 EIRMNIILGTAKGLTYL------HEGLEPK-------WNPKLSDFGLAKLLGAERSYVT- 303
++ ++G+ YL H L + K+SDFGL++ + E SYV
Sbjct: 127 GDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKR 186
Query: 304 TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLF 362
++ ++A E + SDV+SFG+L+ E+++ G NP Y E LF
Sbjct: 187 SKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--YPGIAPE-----RLF 239
Query: 363 EWLKT 367
LKT
Sbjct: 240 NLLKT 244
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 57/194 (29%), Positives = 89/194 (45%), Gaps = 17/194 (8%)
Query: 166 IGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE 225
+G G +G V+ G ++T VAVK L + F E + ++H LVRL +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 226 GAHRMLVNEYVDNGNLEQWLHGDVGPHS--PLTWEIRMNIILGTA--KGLTYLHEGLEPK 281
++ EY+ G+L +L D G P + I G A + Y+H L
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAA 132
Query: 282 -------WNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNETSDVYSF 332
K++DFGLA+++ E + T R F + APE + G SDV+SF
Sbjct: 133 NVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 190
Query: 333 GILIMEVIS-GRNP 345
GIL+ E+++ G+ P
Sbjct: 191 GILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 23/194 (11%)
Query: 165 VIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLVGYC 223
++G+G +G V++G L+D T VAVK + Q K +F E + + H N+V+L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL------HEG 277
+ +V E V G+ +L L + + L A G+ YL H
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKNCIHRD 118
Query: 278 LEPKWNP--------KLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEYASTGMLNETS 327
L + N K+SDFG+++ G S ++ + APE + G + S
Sbjct: 119 LAAR-NCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSES 175
Query: 328 DVYSFGILIMEVIS 341
DV+S+GIL+ E S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 58/233 (24%), Positives = 94/233 (40%), Gaps = 51/233 (21%)
Query: 154 EVSTNGFADENVIGEGGYGIVYR----GVL--EDNTNVAVKNLLNNRG-QAEKEFKVEVE 206
E N IG+G +G V++ G+L E T VAVK L + +F+ E
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 207 AIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWL------------HGDV----- 249
+ H N+V+L+G CA G L+ EY+ G+L ++L H
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 250 -GPHSPLTWEIRMNIILGTAKGLTYL------HEGLEPK-------WNPKLSDFGLAKLL 295
PL+ ++ I A G+ YL H L + K++DFGL++ +
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 180
Query: 296 -------GAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS 341
+E + R M PE SDV+++G+++ E+ S
Sbjct: 181 YSADYYKASENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 34/205 (16%)
Query: 166 IGEGGYGIVYRGVLE---DNTNVAVKNLLN--NRGQAEKEFKVEVEAIGRVRHKNLVRLV 220
+G G +G V +G+ + VAVK L N N + E E + ++ + +VR++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWL----HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276
G C E MLV E + G L ++L H + L ++ M G+ YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM--------GMKYLEE 113
Query: 277 G-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTG 321
L + K+SDFGL+K LGA+ +Y + G + + APE +
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 322 MLNETSDVYSFGILIMEVIS-GRNP 345
+ SDV+SFG+L+ E S G+ P
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 5e-11
Identities = 62/269 (23%), Positives = 113/269 (42%), Gaps = 40/269 (14%)
Query: 166 IGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE 225
+G G +G+V+ G VA+K + N +E++F E + + ++ H LV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 226 GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL------HEGLE 279
+V E+++NG L +L G S ++ +++ +G+ YL H L
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSK---DMLLSMCQDVCEGMEYLERNSFIHRDLA 127
Query: 280 PKWNPKLSDFGLAKL--LGAERSYVTTRVMGTFG------YVAPEYASTGMLNETSDVYS 331
+ N +S G+ K+ G R + + G + PE + + SDV+S
Sbjct: 128 AR-NCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186
Query: 332 FGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRA 390
FG+L+ EV + G+ P F+ + N + M++ G + P+L A
Sbjct: 187 FGVLMWEVFTEGKMP---------FEKKSNY--EVVEMISRGFR--LYRPKL-------A 226
Query: 391 LKRALLVALRCVDPNAHKRPKMGHVIHML 419
V C RP ++ +
Sbjct: 227 SMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 33/213 (15%)
Query: 166 IGEGGYGIVYRG------VLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 219
+GEG +G V+ +D VAVK L + A K+F+ E E + ++H+++V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 220 VGYCAEGAHRMLVNEYVDNGNLEQWL--HG-------DVGP---HSPLTWEIRMNIILGT 267
G C +G ++V EY+ +G+L ++L HG D P L ++I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 268 AKGLTYL------HEGLEPK-------WNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYV 313
A G+ YL H L + K+ DFG+++ + + Y V M ++
Sbjct: 133 ASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 192
Query: 314 APEYASTGMLNETSDVYSFGILIMEVIS-GRNP 345
PE SDV+SFG+++ E+ + G+ P
Sbjct: 193 PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 51/196 (26%), Positives = 93/196 (47%), Gaps = 18/196 (9%)
Query: 166 IGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE 225
+G G +G+V G +VA+K ++ +E EF E + + ++ H+ LV+L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 226 GAHRMLVNEYVDNGNLEQWLH-GDVGPHSPLTWEIRMNIILGTA--KGLTYLHEGLEPK- 281
+V EY+ NG L +L E+ ++ G A + ++H L +
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARN 130
Query: 282 ------WNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEYASTGMLNETSDVYSF 332
K+SDFGL++ + + Y ++ +G+ + PE + SDV++F
Sbjct: 131 CLVDDQGCVKVSDFGLSRYV-LDDEYTSS--VGSKFPVRWSPPEVLLYSKFSSKSDVWAF 187
Query: 333 GILIMEVIS-GRNPVD 347
G+L+ EV S G+ P +
Sbjct: 188 GVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 52/201 (25%), Positives = 82/201 (40%), Gaps = 32/201 (15%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYC 223
+GEG YG VY+ + E VA+K + + +E E+ + + +V+ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 224 AEGAHRMLVNEYVDNG------NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277
+ +V EY G + LT E I+ T KGL YLH
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITN---------KTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 278 -------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 324
L + KL+DFG++ L + T V+GT ++APE N
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYN 177
Query: 325 ETSDVYSFGILIMEVISGRNP 345
+D++S GI +E+ G+ P
Sbjct: 178 NKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 36/211 (17%)
Query: 163 ENVIGEGGYGIVYRGVLEDN---TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKNLV 217
E+VIGEG +G V R +++ + N A+K L + + ++F E+E + ++ H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHG------------DVGPHSPLTWEIRMNIIL 265
L+G C + + EY GNL +L + G S LT + +
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 266 GTAKGLTYL------HEGLEPK-------WNPKLSDFGLAKLLGAERSYVTTRVMGTFG- 311
A G+ YL H L + K++DFGL++ E YV + MG
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVK-KTMGRLPV 182
Query: 312 -YVAPEYASTGMLNETSDVYSFGILIMEVIS 341
++A E + + SDV+SFG+L+ E++S
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 63/232 (27%), Positives = 97/232 (41%), Gaps = 38/232 (16%)
Query: 165 VIGEGGYG--IVYRGVLEDNTN------VAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKN 215
V+GEG +G +Y D N VAVK L GQ +K E+ + + H+N
Sbjct: 11 VLGEGHFGKVSLYC---YDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 216 LVRLVGYCAEGAHR--MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 273
+V+ G C+E + L+ EYV G+L +L P L + +G+ Y
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAY 122
Query: 274 LHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMG---TFGYVAPEY 317
LH L+ K+ DFGLAK + Y R G F Y A E
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVEC 181
Query: 318 ASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMV 369
+ SDV+SFG+ + E+++ + PP +F+ + + T+V
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDS--KQSPPKKFEEMIGPKQGQMTVV 231
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 34/204 (16%)
Query: 165 VIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEV----------EAI--GRVR 212
V+GEG +G R +L V+++ +++ A KE ++ EA+ +++
Sbjct: 7 VVGEGSFG---RALL-------VQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMK 56
Query: 213 HKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSP----LTWEIRMNIILGTA 268
H N+V H +V EY D G+L Q + G P L W ++M + +
Sbjct: 57 HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116
Query: 269 KGLTYLHEGLEPK-------WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 321
LH ++ K KL DFG A+LL + +Y T V GT YV PE
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENM 175
Query: 322 MLNETSDVYSFGILIMEVISGRNP 345
N SD++S G ++ E+ + ++P
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 42/192 (21%), Positives = 83/192 (43%), Gaps = 17/192 (8%)
Query: 165 VIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKE---FKVEVEAIGRVRHKNLVRLVG 221
V+G G +GIV+ + + + + + + E + E + + + H N++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 222 YCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSP----LTWEIRMNIILGTAKGLTYLHEG 277
E M+V EY G L +++ L + +++ + L LH
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRD 126
Query: 278 LEP--------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDV 329
L+ K K+ DFG++K+L ++ T V+GT Y++PE N+ SD+
Sbjct: 127 LKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGKPYNQKSDI 184
Query: 330 YSFGILIMEVIS 341
++ G ++ E+ S
Sbjct: 185 WALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 50/206 (24%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 165 VIGEGGYG--IVYRGVLEDNTNVAVKNLLNNRGQAEKEFKV---EVEAIGRVRHKNLVRL 219
V+G+G +G +YR ED++ V K + N +EKE + E+ + ++H N++
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEV-NLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 220 VGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-- 277
+ + ++ EY + G L + G E+ + + ++Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL--FEEEMVLWYLFQIVSAVSYIHKAGI 122
Query: 278 -----------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNET 326
L KL DFG++K+LG+E S T V+GT Y++PE N
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYNFK 181
Query: 327 SDVYSFGILIMEVISGRNPVDYSRPP 352
SD+++ G ++ E+++ + D + P
Sbjct: 182 SDIWALGCVLYELLTLKRTFDATNPL 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 6e-10
Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 32/209 (15%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKE---------FKVEVEAIGRVRHK 214
+IG G +G VY G+ +AVK + A + E+ + ++H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 215 NLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 274
N+V+ +G + H + EYV G++ L+ L +R N + KGL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL---VR-NFVRQILKGLNYL 122
Query: 275 HEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTR-----VMGTFGYVAPE 316
H ++ K K+SDFG++K L A T + G+ ++APE
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 317 YASTGMLNETSDVYSFGILIMEVISGRNP 345
+D++S G L++E+++G++P
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 6e-10
Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 22/199 (11%)
Query: 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGY 222
E +G G +G V+ +T VAVK + E F E + ++H LV+L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV 69
Query: 223 CAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL------HE 276
+ ++ E++ G+L +L D G PL I + + A+G+ ++ H
Sbjct: 70 VTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQRNYIHR 126
Query: 277 GLEPK-------WNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNETS 327
L K++DFGLA+++ E + T R F + APE + G S
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 328 DVYSFGILIMEVIS-GRNP 345
DV+SFGIL+ME+++ GR P
Sbjct: 185 DVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 25/197 (12%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGY 222
+GEG Y VY+G VA+K +L G + E+ + ++H+N+VRL
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENIVRLHDV 66
Query: 223 CAEGAHRMLVNEYVDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTY------L 274
MLV EY+D +L++++ HG G P T + +L KG+ + L
Sbjct: 67 IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLL---KGIAFCHENRVL 122
Query: 275 HEGLEP-------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETS 327
H L+P + KL+DFGLA+ G + + V+ T Y AP+ TS
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYSTS 181
Query: 328 -DVYSFGILIMEVISGR 343
D++S G ++ E+I+GR
Sbjct: 182 IDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 9e-10
Identities = 73/270 (27%), Positives = 113/270 (41%), Gaps = 30/270 (11%)
Query: 166 IGEGGYGIVYRGVLEDN-TNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCA 224
IGEG GIV + VAVK + + Q + EV + H+N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 225 EGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------- 277
G +V E+++ G L D+ H+ + E + L + L+YLH
Sbjct: 90 VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDI 144
Query: 278 ------LEPKWNPKLSDFGLAKLLGAERSYVTTR--VMGTFGYVAPEYASTGMLNETSDV 329
L KLSDFG + E V R ++GT ++APE S D+
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKE---VPKRKSLVGTPYWMAPEVISRLPYGTEVDI 201
Query: 330 YSFGILIMEVISGRNPVDYSRPPGEFQFQV--NLFEWLKTM-VTNGNAEGVLDPRLQEKP 386
+S GI+++E+I G P ++ PP + ++ NL +K + G LD L +P
Sbjct: 202 WSLGIMVIEMIDGEPPY-FNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREP 260
Query: 387 SSRALKRALLVA--LRCVDPNAHKRPKMGH 414
S RA + LL L+ P + P M
Sbjct: 261 SQRATAQELLQHPFLKLAGPPSCIVPLMRQ 290
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 65/239 (27%), Positives = 109/239 (45%), Gaps = 46/239 (19%)
Query: 166 IGEGGYGIVYR----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 215
+GEG +G V G+ +D VAVK L ++ + + + E+E + + +HKN
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHG----------DVG--PHSPLTWEIRMNI 263
++ L+G C + ++ EY GNL ++L D+ P +T++ ++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 264 ILGTAKGLTYL------HEGLEPKWNP--------KLSDFGLAKLLGAERSY-VTTRVMG 308
A+G+ YL H L + N K++DFGLA+ + Y TT
Sbjct: 143 TYQVARGMEYLASQKCIHRDLAAR-NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRL 201
Query: 309 TFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLK 366
++APE + SDV+SFG+L+ E+ + G +P Y P E LF+ LK
Sbjct: 202 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIPVE-----ELFKLLK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 24/169 (14%)
Query: 166 IGEGGYGIVYR-GVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGY 222
IGEG +GIV++ E VA+K + R G + E++A+ +H +V+L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 223 CAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIR--MNIILGTAKGLTYLHEG--- 277
G+ +LV EY+ + L + L + P +++ M ++L KG+ Y+H
Sbjct: 68 FPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEA--QVKSYMRMLL---KGVAYMHANGIM 121
Query: 278 ----------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 316
+ K++DFGLA+L E + + + T Y APE
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 36/222 (16%)
Query: 150 LRELEVSTNGFADENVIGEGGYGIVYRGV-LEDNTN----VAVKNLLN-NRGQAEKEFKV 203
L+E E F V+G G +G VY+G+ + + VA+K L +A KE
Sbjct: 4 LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 58
Query: 204 EVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWL--HGD-VGPHSPLTWEIR 260
E + V + ++ RL+G C + L+ + + G L ++ H D +G L W ++
Sbjct: 59 EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 117
Query: 261 MNIILGTAKGLTYL------HEGLEPK----WNP---KLSDFGLAKLLGA-ERSYVTTRV 306
+ AKG+ YL H L + P K++DFGLAKLLGA E+ Y
Sbjct: 118 I------AKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG 171
Query: 307 MGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVD 347
++A E + SDV+S+G+ + E+++ G P D
Sbjct: 172 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 36/211 (17%)
Query: 163 ENVIGEGGYGIVYRGVLEDN---TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKNLV 217
++VIGEG +G V + ++ + + A+K + + + ++F E+E + ++ H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHG----DVGP--------HSPLTWEIRMNIIL 265
L+G C + L EY +GNL +L + P S L+ + ++
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 266 GTAKGLTYL------HEGLEPK-------WNPKLSDFGLAKLLGAERSYVTTRVMGTFG- 311
A+G+ YL H L + + K++DFGL++ + YV + MG
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-KKTMGRLPV 187
Query: 312 -YVAPEYASTGMLNETSDVYSFGILIMEVIS 341
++A E + + SDV+S+G+L+ E++S
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 2e-09
Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 36/202 (17%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKV----EVEAIGRVRHKNLVRLV 220
+GEG YG+VY+ + VA+K + + E+ E+ + ++H N+V+L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--- 277
LV EY D +L+++L I+ +I+ +GL Y H
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYLD-KRPGPLSPN-LIK-SIMYQLLRGLAYCHSHRIL 120
Query: 278 ---LEP-------KWNPKLSDFGLAKLLG-AERSYVTTRVMGTFGYVAPEYASTGMLNET 326
L+P KL+DFGLA+ G R+Y T V+ T Y APE +L
Sbjct: 121 HRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYRAPEI----LLGSK 174
Query: 327 S-----DVYSFGILIMEVISGR 343
D++S G + E+I+G+
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 45/208 (21%)
Query: 165 VIGEGGYGIVYRG-VLEDNTNVAVKNLLNNRGQAE-KEFKV-EVEAIGRVRHKNLVRLVG 221
V+GEG YG+V + VA+K + + K+ + EV+ + ++RH+N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 222 YCAEGAHRMLVNEYVDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYLH--- 275
LV EYV+ L + L G + P +R I + + Y H
Sbjct: 68 AFRRKGRLYLVFEYVER-TLLELLEASPGGLPPD-----AVRS-YIWQLLQAIAYCHSHN 120
Query: 276 --------EGLEPKWNP--KLSDFGLAKLLGAER-----SYVTTRVMGTFGYVAPEYAST 320
E + + KL DFG A+ L A YV TR Y APE
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR-----WYRAPEL--- 172
Query: 321 GMLNETS-----DVYSFGILIMEVISGR 343
++ +T+ DV++ G ++ E++ G
Sbjct: 173 -LVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 66/250 (26%), Positives = 108/250 (43%), Gaps = 28/250 (11%)
Query: 166 IGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLVGYCA 224
IGEG GIV ++ + + ++ R Q +E EV + +H+N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 225 EGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------- 277
G +V E+++ G L D+ H+ + E + L K L+ LH
Sbjct: 88 VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDI 142
Query: 278 ------LEPKWNPKLSDFGLAKLLGAERSYVTTR--VMGTFGYVAPEYASTGMLNETSDV 329
L KLSDFG + E V R ++GT ++APE S D+
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKE---VPRRKSLVGTPYWMAPELISRLPYGPEVDI 199
Query: 330 YSFGILIMEVISGRNPVDYSRPPGEFQFQV--NLFEWLKTM-VTNGNAEGVLDPRLQEKP 386
+S GI+++E++ G P ++ PP + + NL LK + + + +G LD L P
Sbjct: 200 WSLGIMVIEMVDGEPPY-FNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDP 258
Query: 387 SSRALKRALL 396
+ RA LL
Sbjct: 259 AQRATAAELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 64/277 (23%), Positives = 108/277 (38%), Gaps = 41/277 (14%)
Query: 158 NGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAE--KEFKVEVEAIGRVRHKN 215
+ + +GEG G V + L++ + + + K+ E+E +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 216 LVRLVGYCAEGAHRML--VNEYVDNGNLEQWLHGDVGPHSPLTWE-IRMNIILGTAKGLT 272
+V+ G + + + EY + G+L+ ++ V E + I KGL+
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 273 YLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 319
YLH L K KL DFG++ L S T GT Y+APE
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGTFT-GTSFYMAPERIQ 176
Query: 320 TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379
+ TSDV+S G+ ++EV R P P E + + E L +V N
Sbjct: 177 GKPYSITSDVWSLGLTLLEVAQNRFPF-----PPEGEPPLGPIELLSYIVNMPN------ 225
Query: 380 PRLQEKPS-----SRALKRALLVALRCVDPNAHKRPK 411
P L+++P S K + +C++ + +RP
Sbjct: 226 PELKDEPGNGIKWSEEFKDFI---KQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 34/203 (16%)
Query: 166 IGEGGYGIVY------RGVLEDNTN--VAVKNLL-NNRGQAEKEFKVEVEAIGRVRHKNL 216
+GEG +G V G DNT VAVK+L + G + K E+E + + H+N+
Sbjct: 12 LGEGHFGKVELCRYDPEG---DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 217 VRLVGYCAEGAHR--MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 274
V+ G C E L+ E++ +G+L+++L + + + + ++ + KG+ YL
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYL 125
Query: 275 ------HEGL-------EPKWNPKLSDFGLAKLLGAERSYVTT---RVMGTFGYVAPEYA 318
H L E + K+ DFGL K + ++ Y T F Y APE
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECL 184
Query: 319 STGMLNETSDVYSFGILIMEVIS 341
SDV+SFG+ + E+++
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 41/205 (20%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKV------EVEAIGRVRHKNLVR 218
IGEG YG+VY+ VA+K + R + E E V E+ + + H N+VR
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI---RLETEDE-GVPSTAIREISLLKELNHPNIVR 62
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY----- 273
L+ LV E++D +L++++ D P + L + + + +G+ Y
Sbjct: 63 LLDVVHSENKLYLVFEFLDL-DLKKYM--DSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR 119
Query: 274 -LHEGLEP-------KWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE------YA 318
LH L+P + KL+DFGLA+ G R+Y T V+ T Y APE
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY-THEVV-TLWYRAPEILLGSRQY 177
Query: 319 STGMLNETSDVYSFGILIMEVISGR 343
ST + D++S G + E+++ R
Sbjct: 178 STPV-----DIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 16/198 (8%)
Query: 165 VIGEGGYGIVYRGVLE-DNTNVAVKNL-LNNRGQAEKEF-KVEVEAIGRVRHKNLVRLVG 221
IGEG +G +Y + D+ + +K + L EKE K EV + +++H N+V
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 222 YCAEGAHRMLVNEYVDNGNLEQWLHGDVG----PHSPLTWEIRMNIILGTAKGLTYLHEG 277
E +V EY D G+L + ++ G L+W +++++ L LH
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRD 126
Query: 278 LEPK--------WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDV 329
++ + KL DFG+A+ L T +GT Y++PE N +D+
Sbjct: 127 IKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPEICQNRPYNNKTDI 185
Query: 330 YSFGILIMEVISGRNPVD 347
+S G ++ E+ + ++P +
Sbjct: 186 WSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 49/187 (26%), Positives = 89/187 (47%), Gaps = 30/187 (16%)
Query: 185 VAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQ 243
VAVK L + + A +F EV+ + R++ N++RL+G C + ++ EY++NG+L Q
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 244 WL------------HGDVGPHSPL---TWEIRMNIILGTAKGLTYL------HEGLEPK- 281
+L + V P L ++ +++ L A G+ YL H L +
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRN 168
Query: 282 ------WNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGI 334
K++DFG+++ L A Y + R + ++A E G SDV++FG+
Sbjct: 169 CLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGV 228
Query: 335 LIMEVIS 341
+ E++
Sbjct: 229 TLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 51/210 (24%), Positives = 98/210 (46%), Gaps = 36/210 (17%)
Query: 164 NVIGEGGYGIVYRGVLEDN---TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKNLVR 218
+VIGEG +G V + ++ + + A+K + + + ++F E+E + ++ H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLHG------------DVGPHSPLTWEIRMNIILG 266
L+G C + L EY +GNL +L S L+ + ++
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 267 TAKGLTYL------HEGLEPK-------WNPKLSDFGLAKLLGAERSYVTTRVMGTFG-- 311
A+G+ YL H L + + K++DFGL++ + YV + MG
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVK-KTMGRLPVR 176
Query: 312 YVAPEYASTGMLNETSDVYSFGILIMEVIS 341
++A E + + SDV+S+G+L+ E++S
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 48/179 (26%), Positives = 83/179 (46%), Gaps = 22/179 (12%)
Query: 185 VAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQ 243
VAVK L + A ++F EV+ + R+ N+ RL+G C ++ EY++NG+L Q
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 244 WLHGDVGPHS-------PLTWEIRMNIILGTAKGLTYL------HEGLE-------PKWN 283
+L V S L++ + + A G+ YL H L +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT 168
Query: 284 PKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS 341
K++DFG+++ L + Y V R ++A E G SDV++FG+ + E+++
Sbjct: 169 IKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 40/207 (19%)
Query: 164 NVIGEGGYGIVYRGVLEDNTN---VAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKN 215
N IGEG YGIVYR D T+ VA+K + R E++ + E+ + +RH N
Sbjct: 13 NRIGEGTYGIVYRA--RDTTSGEIVALKKV---RMDNERDGIPISSLREITLLLNLRHPN 67
Query: 216 LVRL----VGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 271
+V L VG + LV EY + +L L P S +++ ++L +GL
Sbjct: 68 IVELKEVVVGKHLDSI--FLVMEYCEQ-DLASLLDNMPTPFS--ESQVKC-LMLQLLRGL 121
Query: 272 TYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 318
YLHE L K K++DFGLA+ G +T +V+ T Y APE
Sbjct: 122 QYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELL 180
Query: 319 STGMLNETS--DVYSFGILIMEVISGR 343
G T+ D+++ G ++ E+++ +
Sbjct: 181 -LGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 8e-09
Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 25/200 (12%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRH---KNLVRL 219
+IG G YG VYRG + VA+K + L+ + + EV + ++R N+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 220 VGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-- 277
G +G ++ EY + G++ + P+ + II L Y+H+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVGV 122
Query: 278 -----------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNE 325
+ N KL DFG+A LL S +T V GT ++APE + G +
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYYDT 181
Query: 326 TSDVYSFGILIMEVISGRNP 345
+D++S GI I E+ +G P
Sbjct: 182 KADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 9e-09
Identities = 60/272 (22%), Positives = 113/272 (41%), Gaps = 46/272 (16%)
Query: 165 VIGEGGYGIVY--RGVLEDNTNVAVKNLL---NNRGQAEK---EFKVEVEAIGRVRHKNL 216
+G G + Y R V + T +AVK + N + E+ + E+ + R+ H ++
Sbjct: 7 QLGTGAFSSCYQARDV-KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276
+R++G E +H L E++ G++ L G + +N +GL+YLHE
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLS-KYGAFKE---AVIINYTEQLLRGLSYLHE 121
Query: 277 GLEPKWNPK--------------LSDFGLAKLLGAERS---YVTTRVMGTFGYVAPEYAS 319
+ K ++DFG A L A+ + +++GT ++APE
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 320 TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379
+ DV+S G +I+E+ + + P + + +F+ + + T + L
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFK-IASATTAPSIPEHLS 237
Query: 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPK 411
P L++ V LRC++ RP
Sbjct: 238 PGLRD------------VTLRCLELQPEDRPP 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 35/213 (16%)
Query: 165 VIGEGGYGIVYRGVL--EDNT--NVAVKNL-LNNRGQAE-KEFKVEVEAIGRVRHKNLVR 218
++GEG +G V G L +D + VAVK + L+ +E +EF E + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 219 LVGYCAEGAHR------MLVNEYVDNGNLEQWLH----GDVGPHSPLTWEIRMNIILGTA 268
L+G C E + M++ ++ +G+L +L G + PL + + ++ A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLLKFMVDIA 123
Query: 269 KGLTYL------HEGLEPKWNPKL--------SDFGLAKLLGAERSYVTTRVMGT-FGYV 313
G+ YL H L + N L +DFGL+K + + Y R+ ++
Sbjct: 124 LGMEYLSNRNFIHRDLAAR-NCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 314 APEYASTGMLNETSDVYSFGILIMEVIS-GRNP 345
A E + + SDV++FG+ + E+ + G+ P
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 1e-08
Identities = 74/291 (25%), Positives = 112/291 (38%), Gaps = 77/291 (26%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNLVRL 219
IGEG YG VY+ + VA+K + R + EKE F + E++ + ++RH N+VRL
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 220 ---VGYCAEGAHRMLVNEYVD---NGNLEQWLHGDVGPHSPLTW-EIR--MNIILGTAKG 270
V +G+ M V EY+D G L+ P T +I+ M +L +G
Sbjct: 64 KEIVTSKGKGSIYM-VFEYMDHDLTGLLDS-------PEVKFTESQIKCYMKQLL---EG 112
Query: 271 LTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 317
L YLH + KL+DFGLA+ S T + T Y PE
Sbjct: 113 LQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172
Query: 318 ASTGMLNETS-----DVYSFGILIMEVISGRNPVDYSRPPGE---------FQF------ 357
+L T D++S G ++ E+ G+ G F+
Sbjct: 173 ----LLGATRYGPEVDMWSVGCILAELFLGKPIF-----QGSTELEQLEKIFELCGSPTD 223
Query: 358 ----QVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDP 404
V+ W + + + L + AL LL L +DP
Sbjct: 224 ENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALD--LLDKLLTLDP 272
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 68/288 (23%), Positives = 111/288 (38%), Gaps = 59/288 (20%)
Query: 162 DENVIGEGGYGIVYRGVLED-NTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRH-KNLVR 218
D IG G +G V + + + T +AVK + + +K ++++ + R +V+
Sbjct: 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVK 67
Query: 219 LVG---------YCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 269
G C E L++ +D ++++ + P EI I + T K
Sbjct: 68 FYGALFREGDCWICME-----LMDISLDK--FYKYVYEVLKSVIP--EEILGKIAVATVK 118
Query: 270 GLTYL-------HEGLEP-------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 315
L YL H ++P N KL DFG++ L S TR G Y+AP
Sbjct: 119 ALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAP 176
Query: 316 EYASTGMLNE---TSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372
E + SDV+S GI + EV +G+ P + ++F+ L T V G
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFP---------YPKWNSVFDQL-TQVVKG 226
Query: 373 NAEGVLDPRLQEKPSSRALKRALLVAL--RCVDPNAHKRPKMGHVIHM 418
+ P L S V C+ + KRPK ++
Sbjct: 227 DP-----PIL--SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 51/200 (25%), Positives = 80/200 (40%), Gaps = 23/200 (11%)
Query: 165 VIGEGGYGIVYRGVL----EDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRL 219
IGEG +G VY+GV + VAVK N + +E F E + + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 220 VGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-- 277
+G E +V E G L +L + L + + L YL
Sbjct: 73 IGVITENP-VWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKRF 128
Query: 278 -----------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNET 326
+ KL DFGL++ L E Y ++ ++APE +
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSA 188
Query: 327 SDVYSFGILIMEVIS-GRNP 345
SDV+ FG+ + E++ G P
Sbjct: 189 SDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 55/181 (30%), Positives = 87/181 (48%), Gaps = 25/181 (13%)
Query: 185 VAVKNLLNNRGQAEKE-FKVEVEAIGRV-RHKNLVRLVGYCAEGAHRMLVNEYVDNGNLE 242
VAVK L +E+E E++ + + H+N+V L+G C G +++ EY G+L
Sbjct: 68 VAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLL 127
Query: 243 QWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL------HEGLEPKWN--------PKLSD 288
+L S LT E ++ AKG+ +L H L + N K+ D
Sbjct: 128 NFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR-NVLLTHGKIVKICD 184
Query: 289 FGLAKLLGAERSYV---TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRN 344
FGLA+ + + +YV R+ ++APE + SDV+S+GIL+ E+ S G N
Sbjct: 185 FGLARDIMNDSNYVVKGNARL--PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSN 242
Query: 345 P 345
P
Sbjct: 243 P 243
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 50/192 (26%), Positives = 82/192 (42%), Gaps = 31/192 (16%)
Query: 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL-------HEGLEP------ 280
E++D G+L+ P+ EI I + +GLTYL H ++P
Sbjct: 83 EFMDCGSLD----RIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN 138
Query: 281 -KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEV 339
+ KL DFG++ G + + +GT Y++PE G SDV+S GI I+E+
Sbjct: 139 SRGQIKLCDFGVS---GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIEL 195
Query: 340 ISGRNPVDYSRPPGEFQF-QVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVA 398
G+ P +S + Q + + + L+ +V PRL PSS +
Sbjct: 196 ALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP------PRL---PSSDFPEDLRDFV 246
Query: 399 LRCVDPNAHKRP 410
C+ + +RP
Sbjct: 247 DACLLKDPTERP 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 67/239 (28%), Positives = 108/239 (45%), Gaps = 46/239 (19%)
Query: 166 IGEGGYGIVYR----GVLEDNTN----VAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 215
+GEG +G V G+ +D N VAVK L ++ + + E+E + + +HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHG------DVG------PHSPLTWEIRMNI 263
++ L+G C + ++ EY GNL ++L D P LT++ ++
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 264 ILGTAKGLTYL------HEGLEPKWNP--------KLSDFGLAKLLGAERSY-VTTRVMG 308
A+G+ YL H L + N K++DFGLA+ + Y TT
Sbjct: 140 AYQVARGMEYLASQKCIHRDLAAR-NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRL 198
Query: 309 TFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLK 366
++APE + SDV+SFG+L+ E+ + G +P Y P E LF+ LK
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP--YPGIPVE-----ELFKLLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 29/202 (14%)
Query: 164 NVIGEGGYGIVYRGVLEDN----TNVAVKNL--LNNRGQAEKEFKVEVEAIGRVRHKNLV 217
VIG+G +G VY G L D+ + AVK+L + + + E+ F E + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-FLKEGIIMKDFSHPNVL 59
Query: 218 RLVGYC--AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 275
L+G C +EG+ ++V Y+ +G+L ++ + H+P T + + L AKG+ YL
Sbjct: 60 SLLGICLPSEGS-PLVVLPYMKHGDLRNFIRSE--THNP-TVKDLIGFGLQVAKGMEYLA 115
Query: 276 EG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEYAS 319
L+ + K++DFGLA+ + + Y G ++A E
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 320 TGMLNETSDVYSFGILIMEVIS 341
T SDV+SFG+L+ E+++
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 60/277 (21%), Positives = 116/277 (41%), Gaps = 37/277 (13%)
Query: 157 TNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNL----LNNRGQAEKEFKVEVEAIGRV 211
F E IG+G + +VY+ + L D VA+K + + + + K E++ + ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59
Query: 212 RHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 271
H N+++ + E +V E D G+L + + + + L
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 272 TYLHE------GLEP-------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 318
++H ++P KL D GL + ++ + + V GT Y++PE
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178
Query: 319 STGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378
N SD++S G L+ E+ + ++P + ++NL+ K + +
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPF--------YGDKMNLYSLCKK-IEKCDY---- 225
Query: 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHV 415
P L S L+ LV+ RC++P+ KRP + +V
Sbjct: 226 -PPLPADHYSEELRD--LVS-RCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 46/182 (25%), Positives = 87/182 (47%), Gaps = 27/182 (14%)
Query: 185 VAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQ 243
VAVK L + A +F E++ + R+++ N++RL+G C ++ EY++NG+L Q
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 244 WL----------HGDVGPHSPLTWEIRMNIILGTAKGLTYL------HEGLEPK------ 281
+L H + P + + M + + A G+ YL H L +
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQI--ASGMKYLASLNFVHRDLATRNCLVGN 164
Query: 282 -WNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEV 339
+ K++DFG+++ L + Y + R + ++A E G SDV++FG+ + E+
Sbjct: 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224
Query: 340 IS 341
+
Sbjct: 225 FT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 31/207 (14%)
Query: 165 VIGEGGYGIVYRGV-LEDNTN----VAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVR 218
V+G G +G VY+G+ + D N VA+K L N +A KE E + V + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYL- 274
L+G C + LV + + G L ++ +G L W +++ AKG++YL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 275 -----HEGLEPK----WNP---KLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTG 321
H L + +P K++DFGLA+LL E Y ++A E
Sbjct: 127 EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186
Query: 322 MLNETSDVYSFGILIMEVIS-GRNPVD 347
SDV+S+G+ + E+++ G P D
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 55/215 (25%), Positives = 84/215 (39%), Gaps = 61/215 (28%)
Query: 164 NVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG-------------- 209
IGEG YG VY+ ++L R A K+ +V + G
Sbjct: 5 AEIGEGAYGTVYKA----------RDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQ 54
Query: 210 --RVRHKNLVRLVGYCA-----EGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMN 262
H N+VRL+ C LV E+VD +L +L P L E +
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL--SKCPKPGLPPETIKD 111
Query: 263 IILGTAKGLTYLH------EGLEPK-------WNPKLSDFGLAKLLGAERSYVTTRVMGT 309
++ +G+ +LH L+P+ K++DFGLA++ E + T V+ T
Sbjct: 112 LMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TSVVVT 169
Query: 310 FGYVAPE------YASTGMLNETSDVYSFGILIME 338
Y APE YA+ D++S G + E
Sbjct: 170 LWYRAPEVLLQSSYAT------PVDMWSVGCIFAE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 70/268 (26%), Positives = 116/268 (43%), Gaps = 39/268 (14%)
Query: 164 NVIGEGGYGIVYRGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLVG 221
VIG G +VY + L +N VA+K + L + E + EV+A+ + H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 222 YCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---- 277
G LV Y+ G+L + P L I ++ KGL YLH
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSNGQIH 125
Query: 278 ---------LEPKWNPKLSDFGLAKLL---GAERSYVTTRVMGTFGYVAPEYASTGM-LN 324
L + K++DFG++ L G V +GT ++APE +
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185
Query: 325 ETSDVYSFGILIMEVISGRNPVDYSR-PPGEFQFQVNLFEWLKTMV-TNGNAEGVLDPRL 382
+D++SFGI +E+ +G P YS+ PP +K ++ T N L+
Sbjct: 186 FKADIWSFGITAIELATGAAP--YSKYPP------------MKVLMLTLQNDPPSLETGA 231
Query: 383 QEKPSSRALKRALLVALRCVDPNAHKRP 410
K S++ ++ +++L C+ + KRP
Sbjct: 232 DYKKYSKSFRK--MISL-CLQKDPSKRP 256
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 7e-08
Identities = 57/206 (27%), Positives = 86/206 (41%), Gaps = 31/206 (15%)
Query: 166 IGEGGYGIVYRG-VLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR-VRHKNLVRLVGYC 223
IGEG GIV VAVK + + R Q +E I R +H N+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM-DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------ 277
G +V E+++ G L D+ H+ + E + L K L++LH
Sbjct: 86 LVGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRD 140
Query: 278 -------LEPKWNPKLSDFGLAKLLGAE----RSYVTTRVMGTFGYVAPEYASTGMLNET 326
L KLSDFG + E +S V GT ++APE S
Sbjct: 141 IKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPYWMAPEVISRLPYGTE 195
Query: 327 SDVYSFGILIMEVISGRNPVDYSRPP 352
D++S GI+++E++ G P ++ PP
Sbjct: 196 VDIWSLGIMVIEMVDGEPPY-FNEPP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 7e-08
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 38/213 (17%)
Query: 166 IGEGGYGIVYR----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 215
+GEG +G V R G+ + VAVK L +N + + E+E + + +HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHG----------DVG--PHSPLTWEIRMNI 263
++ L+G C + ++ EY GNL ++L D+ P L+++ ++
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 264 ILGTAKGLTYL------HEGLEPKWNP--------KLSDFGLAKLLGAERSY-VTTRVMG 308
A+G+ YL H L + N K++DFGLA+ + Y T+
Sbjct: 140 AYQVARGMEYLESRRCIHRDLAAR-NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL 198
Query: 309 TFGYVAPEYASTGMLNETSDVYSFGILIMEVIS 341
++APE + SDV+SFGIL+ E+ +
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 48/202 (23%), Positives = 91/202 (45%), Gaps = 29/202 (14%)
Query: 166 IGEGGYGIVYRGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVR 218
+G+G +G+VY G+ E T VA+K + E+ EF E + ++VR
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLHG------DVGPHSPLTWEIRMNIILGTAKGLT 272
L+G ++G +++ E + G+L+ +L + +P + + + + A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 273 YL------HEGLEPK-------WNPKLSDFGLAKLLGAERSYVTTRVMGTFG--YVAPEY 317
YL H L + + K+ DFG+ + + E Y G +++PE
Sbjct: 134 YLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPES 192
Query: 318 ASTGMLNETSDVYSFGILIMEV 339
G+ SDV+SFG+++ E+
Sbjct: 193 LKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 9e-08
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 29/204 (14%)
Query: 166 IGEGGYGIVYRGVLED------NTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVR 218
+G+G +G+VY G D T VAVK + + E+ EF E + ++VR
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLH-----GDVGPHSPL-TWEIRMNIILGTAKGLT 272
L+G ++G ++V E + +G+L+ +L + P P T + + + A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 273 YL------HEGLEPK-------WNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEY 317
YL H L + + K+ DFG+ + + E Y G ++APE
Sbjct: 134 YLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMAPES 192
Query: 318 ASTGMLNETSDVYSFGILIMEVIS 341
G+ +SD++SFG+++ E+ S
Sbjct: 193 LKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 41/179 (22%), Positives = 84/179 (46%), Gaps = 22/179 (12%)
Query: 185 VAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQ 243
VAVK L + + A +F E++ + R++ N++RL+ C ++ EY++NG+L Q
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 244 WLHGDVGPHSPLTWEIR-------MNIILGTAKGLTYL------HEGLEPK-------WN 283
+L + ++ + + A G+ YL H L + +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT 168
Query: 284 PKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS 341
K++DFG+++ L + Y + R + +++ E G SDV++FG+ + E+++
Sbjct: 169 IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (127), Expect = 1e-07
Identities = 37/121 (30%), Positives = 53/121 (43%), Gaps = 20/121 (16%)
Query: 285 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRN 344
KL+DFGLAK L +E S T GT Y+APE + D +S G+L+ E+++G+
Sbjct: 133 KLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKP 191
Query: 345 PVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDP 404
P Y+ E ++E + R E S A R L+ L DP
Sbjct: 192 PF-YAEDRKE------IYEKILKD----------PLRFPEFLSPEA--RDLISGLLQKDP 232
Query: 405 N 405
Sbjct: 233 T 233
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 57/207 (27%), Positives = 86/207 (41%), Gaps = 28/207 (13%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVG- 221
VIGEG YG VY+ + VA+K +++ E+E K E + + H N+ G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 222 YCAEGAHRM-----LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276
+ + LV E G++ + G L E I+ T +GL YLHE
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE 131
Query: 277 G-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY-ASTGM 322
L KL DFG++ L + T + GT ++APE A
Sbjct: 132 NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAPEVIACDEQ 190
Query: 323 LNET----SDVYSFGILIMEVISGRNP 345
+ + SDV+S GI +E+ G+ P
Sbjct: 191 PDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 55/199 (27%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 164 NVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGY 222
IG G YG VY+ + VA+K + G + + E+ + RH N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 223 CAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG----- 277
+V EY G+L+ GP S L +I + T KGL YLHE
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL--QIAY-VCRETLKGLAYLHETGKIHR 125
Query: 278 --------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA---STGMLNET 326
L + KL+DFG++ L A + + + GT ++APE A G +
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGYDGK 184
Query: 327 SDVYSFGILIMEVISGRNP 345
D+++ GI +E+ + P
Sbjct: 185 CDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 53/211 (25%)
Query: 166 IGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG-------------RVR 212
IGEG YG+VY+ +N L A K+ +++ E G +
Sbjct: 8 IGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 57
Query: 213 HKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 272
H N+V+L+ LV E++ + +L++++ D P S + + + + +GL
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASPLSGIPLPLIKSYLFQLLQGLA 114
Query: 273 Y------LHEGLEPK-------WNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE-- 316
+ LH L+P+ KL+DFGLA+ G R+Y T + T Y APE
Sbjct: 115 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEIL 172
Query: 317 ----YASTGMLNETSDVYSFGILIMEVISGR 343
Y ST + D++S G + E+++ R
Sbjct: 173 LGCKYYSTAV-----DIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 63/279 (22%), Positives = 120/279 (43%), Gaps = 41/279 (14%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVK-----NLLNNRGQAEKEFKVEVEAIGRVRH 213
F E IG G + VYR L D VA+K +L++ +A + E++ + ++ H
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD--AKARADCIKEIDLLKQLNH 61
Query: 214 KNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWL-----HGDVGPHSPLTWE--IRMNIILG 266
N+++ E +V E D G+L + + + P + W+ +++ L
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV-WKYFVQLCSALE 120
Query: 267 TAKGLTYLHEGLEP-------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 319
+H ++P KL D GL + + ++ ++GT Y++PE
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPERIH 179
Query: 320 TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379
N SD++S G L+ E+ + ++P + ++NL+ K + E
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF--------YGDKMNLYSLCKKI------EQCDY 225
Query: 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418
P L S L++ LV + C++P+ KRP + +V +
Sbjct: 226 PPLPSDHYSEELRQ--LVNM-CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 62/222 (27%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKV--------EVEAIGRV-RHKN 215
+G+G +G VY E VA+K + +K+F EV+++ ++ H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 275
+V+L E V EY++ GNL Q + G P + + +II +GL ++H
Sbjct: 60 IVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHIH 116
Query: 276 -----------EGL--EPKWNPKLSDFGLAKLLGAERS------YVTTRVMGTFGYVAPE 316
E L K++DFGLA+ + RS YV+TR Y APE
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAREI---RSRPPYTDYVSTR-----WYRAPE 168
Query: 317 YASTGMLNETS-----DVYSFGILIMEVIS------GRNPVD 347
+L TS D+++ G ++ E+ + G + +D
Sbjct: 169 I----LLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID 206
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 58/199 (29%), Positives = 90/199 (45%), Gaps = 24/199 (12%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVRHKNLVRLVGY 222
IGEG YG V++ E + VA+K + L++ + + E+ + ++HKN+VRL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 223 CAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY------LHE 276
LV EY D +L+++ G P + M +L KGL + LH
Sbjct: 68 LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLL---KGLAFCHSHNVLHR 123
Query: 277 GLEPK-------WNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYASTGMLNETS- 327
L+P+ KL+DFGLA+ G R Y V T Y P+ L TS
Sbjct: 124 DLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYSTSI 181
Query: 328 DVYSFGILIMEVISGRNPV 346
D++S G + E+ + P+
Sbjct: 182 DMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 53/203 (26%), Positives = 86/203 (42%), Gaps = 25/203 (12%)
Query: 160 FADENVIGEGGYGIVYRGVLEDNTN---VAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKN 215
F IG+G +G V++G+ DN VA+K + + E E + E+ + +
Sbjct: 6 FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 275
+ + G +G ++ EY+ G+ L GP + IL KGL YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEIL---KGLDYLH 118
Query: 276 EG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 322
L + + KL+DFG+A L + T V GT ++APE
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSA 177
Query: 323 LNETSDVYSFGILIMEVISGRNP 345
+ +D++S GI +E+ G P
Sbjct: 178 YDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 64/239 (26%), Positives = 108/239 (45%), Gaps = 46/239 (19%)
Query: 166 IGEGGYGIVYR----GVLEDNTN----VAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 215
+GEG +G V G+ ++ N VAVK L ++ + + + E+E + + +HKN
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHG------------DVGPHSPLTWEIRMNI 263
++ L+G C + ++ EY GNL ++L P L+++ ++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 264 ILGTAKGLTYL------HEGLEPKWNP--------KLSDFGLAKLLGAERSY-VTTRVMG 308
A+G+ YL H L + N K++DFGLA+ + Y TT
Sbjct: 146 AYQVARGMEYLASKKCIHRDLAAR-NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 204
Query: 309 TFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLK 366
++APE + SDV+SFG+L+ E+ + G +P Y P E LF+ LK
Sbjct: 205 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YPGVPVE-----ELFKLLK 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 23/202 (11%)
Query: 160 FADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEF---KVEVEAIGRVRHKNL 216
F IG+G +G VY+G+ ++ T V + + +AE E + E+ + + +
Sbjct: 6 FTKLERIGKGSFGEVYKGI-DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 64
Query: 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276
R G +G ++ EY+ G+ D+ PL I+ KGL YLH
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGSAL-----DLLKPGPLEETYIATILREILKGLDYLHS 119
Query: 277 G-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 323
L + + KL+DFG+A L + T V GT ++APE
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 178
Query: 324 NETSDVYSFGILIMEVISGRNP 345
+ +D++S GI +E+ G P
Sbjct: 179 DFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 63/277 (22%), Positives = 120/277 (43%), Gaps = 37/277 (13%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNLL---NNRGQAEKEFKVEVEAIGRVRHKN 215
F E IG G + VYR L D VA+K + +A ++ E++ + ++ H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWL-----HGDVGPHSPLTWE--IRMNIILGTA 268
+++ + E +V E D G+L Q + + P + W+ +++ +
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV-WKYFVQLCSAVEHM 122
Query: 269 KGLTYLHEGLEP-------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 321
+H ++P KL D GL + ++ + + V GT Y++PE
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHEN 181
Query: 322 MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381
N SD++S G L+ E+ + ++P + ++NLF + + E P
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPF--------YGDKMNLFSLCQKI------EQCDYPP 227
Query: 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418
L + S L+ LV++ C+ P+ +RP +G+V +
Sbjct: 228 LPTEHYSEKLRE--LVSM-CIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 65/259 (25%), Positives = 105/259 (40%), Gaps = 40/259 (15%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLVGYC 223
IG+G G VY + + VA+K + N + Q +KE + E+ + +H N+V +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------ 277
G +V EY+ G+L DV + + + + L +LH
Sbjct: 86 LVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRD 140
Query: 278 -------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVY 330
L + KL+DFG + E+S +T V GT ++APE + D++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 331 SFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRA 390
S GI+ +E++ G P N L + TNG P LQ A
Sbjct: 200 SLGIMAIEMVEGEPPY----------LNENPLRALYLIATNGT------PELQNPEKLSA 243
Query: 391 LKRALLVALRCVDPNAHKR 409
+ R L RC++ + KR
Sbjct: 244 IFRDFLN--RCLEMDVEKR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 45/209 (21%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAE--KEFKVEVEAIGRVRHKNLVRLVG 221
++GEG YG+V + E VA+K L + K E+ + ++RH+NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 222 YCAEGAHRMLVNEYVDN---GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG- 277
LV E+VD+ +LE++ +G L + +G+ + H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNG-------LDESRVRKYLFQILRGIEFCHSHN 120
Query: 278 ------------LEPKWNPKLSDFGLAKLLGAE----RSYVTTRVMGTFGYVAPEYASTG 321
+ KL DFG A+ L A YV TR Y APE
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPEL---- 171
Query: 322 MLNETS-----DVYSFGILIMEVISGRNP 345
++ +T D+++ G L+ E+++G P
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTG-EP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 6e-07
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 41/209 (19%)
Query: 166 IGEGGYGIVYRGVLEDNTN-------VAVKNLLNNRGQAEKEFKVEVEAIG---RVRHKN 215
+G+G + +Y+GVL ++ V +L G ++ E ++ HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 275
LV+L G C + M V EYV G L+ +LH + + L W ++++ A L YL
Sbjct: 63 LVKLYGVCVRDENIM-VEEYVKFGPLDVFLHRE-KNNVSLHW--KLDVAKQLASALHYLE 118
Query: 276 E------------------GLEPKWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 315
+ GL + P KLSD G+ + + R R+ ++AP
Sbjct: 119 DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-REERVERI----PWIAP 173
Query: 316 EYASTGMLNETS--DVYSFGILIMEVISG 342
E G + T D +SFG ++E+ S
Sbjct: 174 ECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 28/220 (12%)
Query: 166 IGEGGYGIVYRGVLEDNTN-VAVKNL-------LNNRGQAEKEFKVEVEAIGRVRHKNLV 217
+G+GGYG V+ +D VA+K + LN E + + + LV
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT----KSEWLV 64
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLH--GDVGPHSPLTWEIRMNIILGTAKGLTYLH 275
+L+ + + L EYV G+ L+ G + + M + L Y+H
Sbjct: 65 KLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIH 124
Query: 276 EGLEP-------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSD 328
L+P + KL+DFGL+K +Y + V+G+ Y+APE + T D
Sbjct: 125 RDLKPENFLIDASGHIKLTDFGLSK---GIVTYANS-VVGSPDYMAPEVLRGKGYDFTVD 180
Query: 329 VYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTM 368
+S G ++ E + G P S P ++ NL W +T+
Sbjct: 181 YWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYWKETL 217
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 7e-07
Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 25/203 (12%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKV---EVEAIGRVRHKN 215
F IG+G +G VY+ + N VA+K + + +AE E + E++ + + R
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI--DLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 275
+ + G +G+ ++ EY G+ D+ L I+ GL YLH
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCL-----DLLKPGKLDETYIAFILREVLLGLEYLH 115
Query: 276 EG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 322
E L + + KL+DFG++ L + S T V GT ++APE
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSG 174
Query: 323 LNETSDVYSFGILIMEVISGRNP 345
+E +D++S GI +E+ G P
Sbjct: 175 YDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 35/205 (17%)
Query: 166 IGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLV-GYC 223
+G+G +G VY+ ++ A ++ + E E F VE++ + +H N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTW-EIRMNIILGTAKGLTYLHEG----- 277
E +L+ E+ D G L+ + + LT +IR + + L +LH
Sbjct: 73 YENKLWILI-EFCDGGALDSIM---LELERGLTEPQIRY-VCRQMLEALNFLHSHKVIHR 127
Query: 278 --------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNET--- 326
L + KL+DFG++ + T + GT ++APE + ET
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEV----VACETFKD 182
Query: 327 ------SDVYSFGILIMEVISGRNP 345
+D++S GI ++E+ P
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 9e-07
Identities = 54/201 (26%), Positives = 81/201 (40%), Gaps = 31/201 (15%)
Query: 166 IGEGGYGIVYRGVLEDNTNVAV------KNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 219
+G GG+G V V + N K + GQ ++ E E + H +V+L
Sbjct: 1 LGVGGFGRVEL-VKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVKL 58
Query: 220 VGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE--- 276
+ + ++ EY G L L D G + R I YLH
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTILR-DRGLFD--EYTARF-YIACVVLAFEYLHNRGI 114
Query: 277 ---GLEPKWN--------PKLSDFGLAKLLG-AERSYVTTRVMGTFGYVAPEYASTGMLN 324
L+P+ N KL DFG AK L ++++ GT YVAPE +
Sbjct: 115 IYRDLKPE-NLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNKGYD 170
Query: 325 ETSDVYSFGILIMEVISGRNP 345
+ D +S GIL+ E+++GR P
Sbjct: 171 FSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 56/210 (26%), Positives = 85/210 (40%), Gaps = 46/210 (21%)
Query: 185 VAVKNLLNNRGQAEKE---FKVEVEAIGRVRHKNLVRLV--GYCAEGAHRMLVNEYVDNG 239
VA+K L + + E + F+ E R+ H N+V L+ G G V EYV
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG-LLFAVFEYVPGR 64
Query: 240 NLEQWLHGDVGPHSPLTWEIRMNIIL-----GTAKGLTYLHEGLEPK----------WNP 284
L + L D G M +L +G+ H L+P+ +
Sbjct: 65 TLREVLAAD-GALPAGETGRLMLQVLDALACAHNQGIV--HRDLKPQNIMVSQTGVRPHA 121
Query: 285 KLSDFGLAKLL-GAE-----RSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIME 338
K+ DFG+ LL G TT V+GT Y APE + SD+Y++G++ +E
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181
Query: 339 VISGR----------------NPVDYSRPP 352
++G+ +PVD S PP
Sbjct: 182 CLTGQRVVQGASVAEILYQQLSPVDVSLPP 211
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 34/211 (16%)
Query: 166 IGEGGYGIVYRGVLEDNTN---VAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 219
+GEG +G V G L + + VAVK + + R + E +F E + H N++RL
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME-DFLSEAVCMKEFDHPNVMRL 65
Query: 220 VGYCAEGAHR------MLVNEYVDNGNLEQWL----HGDVGPHSPLTWEIRMNIILGTAK 269
+G C + +++ ++ +G+L +L GD + P ++ + + A
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPT--QMLVKFMTDIAS 123
Query: 270 GLTYL------HEGLEPK-------WNPKLSDFGLAKLLGAERSYVTTRVMGT-FGYVAP 315
G+ YL H L + N ++DFGL+K + Y R+ ++A
Sbjct: 124 GMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 316 EYASTGMLNETSDVYSFGILIMEVIS-GRNP 345
E + + SDV+SFG+ + E+ + G+ P
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 46/193 (23%), Positives = 88/193 (45%), Gaps = 21/193 (10%)
Query: 166 IGEGGYGIVYRGVL----EDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 219
IGEG +G + +L ED +K N+ + +E + EV + ++H N+V+
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 220 VGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSP----LTWEIRMNIILGTAKGLTYLH 275
E + +V +Y + G+L + ++ G P L W +++ + L LH
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILH 124
Query: 276 EGLEPK-------WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSD 328
++ + KL DFG+A++L + T +GT Y++PE N SD
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGTPYYLSPEICENRPYNNKSD 183
Query: 329 VYSFGILIMEVIS 341
+++ G ++ E+ +
Sbjct: 184 IWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 63/259 (24%), Positives = 105/259 (40%), Gaps = 40/259 (15%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLVGYC 223
IG+G G VY + + VA++ + N + Q +KE + E+ + ++ N+V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------ 277
G +V EY+ G+L DV + + + + L +LH
Sbjct: 87 LVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 278 -------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVY 330
L + KL+DFG + E+S + ++GT ++APE + D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 331 SFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRA 390
S GI+ +E+I G P P L + TNG P LQ A
Sbjct: 201 SLGIMAIEMIEGEPPYLNENP----------LRALYLIATNGT------PELQNPEKLSA 244
Query: 391 LKRALLVALRCVDPNAHKR 409
+ R L RC+D + KR
Sbjct: 245 IFRDFLN--RCLDMDVEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 36/205 (17%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVKNL-LNNRGQAE--------KEFKVEVEAIGRVRHKN 215
+GEG Y +VY+ E VA+K + L R +A+ +E K+ E ++H N
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQE----LKHPN 63
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 275
++ L+ ++ LV E+++ +LE+ + +P +I+ + +L T +GL YLH
Sbjct: 64 IIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPA--DIK-SYMLMTLRGLEYLH 119
Query: 276 EG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE--YAST 320
+ KL+DFGLA+ G+ +T +V+ T Y APE + +
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFGAR 178
Query: 321 GMLNETSDVYSFGILIMEVISGRNP 345
D++S G + E++ R P
Sbjct: 179 -HYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.0 bits (116), Expect = 2e-06
Identities = 62/259 (23%), Positives = 105/259 (40%), Gaps = 40/259 (15%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLVGYC 223
IG+G G V+ + + VA+K + N + Q +KE + E+ + +++ N+V +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQI-NLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------ 277
G +V EY+ G+L DV + + + + L +LH
Sbjct: 86 LVGDELFVVMEYLAGGSLT-----DVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRD 140
Query: 278 -------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVY 330
L + KL+DFG + E+S +T V GT ++APE + D++
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 331 SFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRA 390
S GI+ +E++ G P P L + TNG P LQ
Sbjct: 200 SLGIMAIEMVEGEPPYLNENP----------LRALYLIATNGT------PELQNPEKLSP 243
Query: 391 LKRALLVALRCVDPNAHKR 409
+ R L RC++ + KR
Sbjct: 244 IFRDFLN--RCLEMDVEKR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 33/209 (15%)
Query: 164 NVIGEGGYGIVYRGVLEDNTN--VAVKNLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRLV 220
N IG G G VY+ V+ T A+K + N ++ E+E + V H N+V+
Sbjct: 80 NRIGSGAGGTVYK-VIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--- 277
++ E++D G+LE D + + +I G+ YLH
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQI--------LSGIAYLHRRHIV 190
Query: 278 ----------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE-- 325
+ N K++DFG++++L + V GT Y++PE +T LN
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTD-LNHGA 248
Query: 326 ----TSDVYSFGILIMEVISGRNPVDYSR 350
D++S G+ I+E GR P R
Sbjct: 249 YDGYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 41/125 (32%), Positives = 58/125 (46%), Gaps = 24/125 (19%)
Query: 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL------HEGLEP------- 280
E++D G+L+ ++ + H + I + KGLTYL H ++P
Sbjct: 79 EFMDGGSLD--VYRKIPEH------VLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNT 130
Query: 281 KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVI 340
+ KL DFG++ L S T V GT Y+APE S SDV+S GI ME+
Sbjct: 131 RGQVKLCDFGVSTQL--VNSIAKTYV-GTNAYMAPERISGEQYGIHSDVWSLGISFMELA 187
Query: 341 SGRNP 345
GR P
Sbjct: 188 LGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 44/208 (21%), Positives = 86/208 (41%), Gaps = 31/208 (14%)
Query: 165 VIGEGGYGIVYRGVLEDNTNV-AVKNLLNNRGQAEKE----------FKVEVEAIGRVRH 213
+IG+G YG VY + + AVK + A + + E+E + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 214 KNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 273
N+V+ +G+ + + EYV G++ L + ++ +GL Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAY 123
Query: 274 LHEG-------------LEPKWNPKLSDFGLAKLL-GAERSYVTTRVMGTFGYVAPEYAS 319
LH ++ K+SDFG++K + + G+ ++APE
Sbjct: 124 LHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIH 183
Query: 320 TGMLNETS--DVYSFGILIMEVISGRNP 345
+ ++ D++S G +++E+ +GR P
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 62/266 (23%), Positives = 112/266 (42%), Gaps = 47/266 (17%)
Query: 166 IGEGGYGIVYRGVLED--------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV 217
+G+G + +++G+ + T V +K L + + F + ++ HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA------KGL 271
G C G ++V EYV G+L+ +L + ++W++ + L A KGL
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDKGL 121
Query: 272 TY----------LHEGLEPKWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 318
T+ + E NP KLSD G++ + + + R+ +V PE
Sbjct: 122 THGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP-KEILLERI----PWVPPECI 176
Query: 319 STGM-LNETSDVYSFGILIMEVISGRN-PVDYSRPPGEFQF-----QVNLFEW--LKTMV 369
L+ +D +SFG + E+ SG + P+ + QF Q+ +W L ++
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELANLI 236
Query: 370 TNGNAEGVLDPRLQEKPSSRALKRAL 395
+D +PS RA+ R L
Sbjct: 237 NQ-----CMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 44/172 (25%), Positives = 77/172 (44%), Gaps = 30/172 (17%)
Query: 208 IGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 267
+ +V H +L + G C G+ ++V E+V++G L+ L + G P+ W+I + L +
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG-RVPVAWKITVAQQLAS 128
Query: 268 AKGLTYLHE------------------GLEPKWNP--KLSDFGLAKLLGAERSYVTTRVM 307
A L+YL + GL +P KLSD G++ R R+
Sbjct: 129 A--LSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSREERVERI- 184
Query: 308 GTFGYVAPE-YASTGMLNETSDVYSFGILIMEV-ISGRNPVDYSRPPGEFQF 357
++APE L+ +D +SFG ++E+ G P+ P + +F
Sbjct: 185 ---PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 47/200 (23%), Positives = 82/200 (41%), Gaps = 26/200 (13%)
Query: 166 IGEGGYGIVYRG---VLEDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLVG 221
IG G +G V G V VK L + E+ F EV+ + H N+++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 222 YCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTW-EIRMNIILGTAKGLTYLHEG--- 277
C E +LV E+ G+L+ +L + G + + ++ + A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFI 122
Query: 278 ----------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGT-FGYVAPEYAS------- 319
L + K+ D+GLA E Y+T ++APE
Sbjct: 123 HSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLL 182
Query: 320 TGMLNETSDVYSFGILIMEV 339
+ S+++S G+ + E+
Sbjct: 183 PKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 46/201 (22%), Positives = 88/201 (43%), Gaps = 25/201 (12%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVK--NLLNNRGQAEKE---FKVEVEAIGRVRHKNLVRL 219
+G+G +G VY ++ +AVK + + +KE + E++ + ++H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 220 VGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL- 278
G + + EY+ G+++ L + LT + +G+ YLH +
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNMI 125
Query: 279 ------------EPKWNPKLSDFGLAKLLGAERSYVT--TRVMGTFGYVAPEYASTGMLN 324
+ N KL DFG +K L S T V GT +++PE S
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG 185
Query: 325 ETSDVYSFGILIMEVISGRNP 345
+DV+S G ++E+++ + P
Sbjct: 186 RKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 4e-06
Identities = 63/259 (24%), Positives = 105/259 (40%), Gaps = 40/259 (15%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLVGYC 223
IG+G G VY + + VA+K + N + Q +KE + E+ + ++ N+V +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------ 277
G +V EY+ G+L DV + + + + L +LH
Sbjct: 86 LVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRD 140
Query: 278 -------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVY 330
L + KL+DFG + E+S +T V GT ++APE + D++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 331 SFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRA 390
S GI+ +E++ G P P L + TNG P LQ A
Sbjct: 200 SLGIMAIEMVEGEPPYLNENP----------LRALYLIATNGT------PELQNPERLSA 243
Query: 391 LKRALLVALRCVDPNAHKR 409
+ R L RC++ + +R
Sbjct: 244 VFRDFLN--RCLEMDVDRR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 57/201 (28%), Positives = 86/201 (42%), Gaps = 32/201 (15%)
Query: 166 IGEGGYGIVYRGVLED---NTNVAVKNLLNNRGQAEKE-----FKVEVEAIGRVRHKNLV 217
IGEG YG+VY+ D N +A+K + R + E E E+ + ++H N+V
Sbjct: 10 IGEGTYGVVYKA--RDRVTNETIALKKI---RLEQEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY---- 273
RL LV EY+D L+ H D P + + +G+ Y
Sbjct: 65 RLQDVVHSEKRLYLVFEYLD---LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121
Query: 274 --LHEGLEP-------KWNP-KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 323
LH L+P + N KL+DFGLA+ G T V+ T Y APE
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSRH 180
Query: 324 NETS-DVYSFGILIMEVISGR 343
T D++S G + E+++ +
Sbjct: 181 YSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 31/208 (14%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKN 215
F+D IG G +G VY + ++ VA+K + + Q+ ++++ EV + ++RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYL 274
++ G LV EY G+ L H E+ + + G +GL YL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC-LGSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 275 HEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY---A 318
H L KL DFG A ++ +V GT ++APE
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAM 186
Query: 319 STGMLNETSDVYSFGILIMEVISGRNPV 346
G + DV+S GI +E+ + P+
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 6e-06
Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 32/203 (15%)
Query: 166 IGEGGYGIVYRGVLEDN---TNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLVG 221
IG G +G V G + V VK L + Q + +F E + ++H NL++ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 222 YCAEGAHRMLVNEYVDNGNLEQWLH----GDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277
C E +LV E+ G+L+ +L ++ P T + RM + A GL +LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-RMACEI--ALGLLHLHKN 119
Query: 278 -------------LEPKWNPKLSDFGLAKLLGAERSYVTT-RVMGTFGYVAPEYASTGML 323
L K+ D+GL+ E YVT ++ ++APE
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 324 N-------ETSDVYSFGILIMEV 339
N + S+V+S G+ I E+
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 9e-06
Identities = 69/281 (24%), Positives = 112/281 (39%), Gaps = 48/281 (17%)
Query: 166 IGEGGYGIVYRGVLEDNT-------NVAVKNLLNNRGQAEKEFKV-----EVEAIG-RVR 212
+G G +G VY+ ++N + V N + + E++ + EV I ++R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 213 HKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 272
H N+VR E +V + ++ L + + T E NI + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 273 YLHE-------GLEP-------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 318
YLH+ L P ++DFGLAK E S +T+ V+GT Y PE
Sbjct: 128 YLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE-SKLTS-VVGTILYSCPEIV 185
Query: 319 STGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378
E +DV++FG ++ ++ + P YS N+ +V E V
Sbjct: 186 KNEPYGEKADVWAFGCILYQMCT-LQPPFYS---------TNMLSLATKIV-----EAVY 230
Query: 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHML 419
+P L E S + V C+ P+A RP + V M+
Sbjct: 231 EP-LPEGMYSEDVT---DVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 53/199 (26%), Positives = 85/199 (42%), Gaps = 30/199 (15%)
Query: 166 IGEGGYGIVYRGVLEDN-TNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLVGYC 223
IGEG GIV + + VAVK +++ R Q +E EV + +H+N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------ 277
G ++ E++ G L D+ + L E + + L YLH
Sbjct: 88 LVGEELWVLMEFLQGGALT-----DIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRD 142
Query: 278 -------LEPKWNPKLSDFG----LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNET 326
L KLSDFG ++K + +S V GT ++APE S
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISRTPYGTE 197
Query: 327 SDVYSFGILIMEVISGRNP 345
D++S GI+++E++ G P
Sbjct: 198 VDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 25/205 (12%)
Query: 166 IGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVG--Y 222
IG+G YG VY+ + + ++A +L+ ++E + E + + H N+V+ G Y
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89
Query: 223 CAE---GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-- 277
A+ G LV E + G++ + + G + L + I+ G GL +LH
Sbjct: 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRI 149
Query: 278 -----------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNET 326
L + KL DFG++ L + R T V GT ++APE + +
Sbjct: 150 IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQQYDY 208
Query: 327 S-----DVYSFGILIMEVISGRNPV 346
S DV+S GI +E+ G P+
Sbjct: 209 SYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 42/206 (20%)
Query: 166 IGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG-------------RVR 212
IGEG YG+VY+G +N + A K+ ++E E G ++
Sbjct: 8 IGEGTYGVVYKG----------RNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ 57
Query: 213 HKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWL-------HGDVGPHSPLTWEIRMNIIL 265
H N+V L + + L+ E++ +L+++L + D ++I I+
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 266 GTAKGLTYLHEGLEP-------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 318
++ + LH L+P K KL+DFGLA+ G T V+ T Y APE
Sbjct: 117 CHSRRV--LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVL 173
Query: 319 STGMLNETS-DVYSFGILIMEVISGR 343
T D++S G + E+ + +
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 2e-05
Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 31/208 (14%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKN 215
F D IG G +G VY + N VA+K + + Q+ ++++ EV+ + R++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYL 274
+ G LV EY G+ L H E+ + I G +GL YL
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC-LGSASDLLE----VHKKPLQEVEIAAITHGALQGLAYL 141
Query: 275 HEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY---A 318
H L KL+DFG A + S+V GT ++APE
Sbjct: 142 HSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAM 196
Query: 319 STGMLNETSDVYSFGILIMEVISGRNPV 346
G + DV+S GI +E+ + P+
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 39/206 (18%)
Query: 166 IGEGGYGIVYRGVLEDNTNVA---VKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLVG 221
IG G +G V + +T VA VK L N E+ EF + + ++H N+++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 222 YCAEGAHRMLVNEYVDNGNL------EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 275
C E +LV EY + G+L EQW + S L RM + A G+T++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRN----SQLLLLQRMACEI--AAGVTHMH 116
Query: 276 EG-------------LEPKWNPKLSDFGLAKLLGAERSYVTT--RVMGTFGYVAPEYAST 320
+ L K+ D+G+ E Y+ T ++APE
Sbjct: 117 KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE-DYIETEDDKCVPLRWLAPELVGE 175
Query: 321 ---GML----NETSDVYSFGILIMEV 339
G++ + S+V++ G+ + E+
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 54/291 (18%), Positives = 109/291 (37%), Gaps = 75/291 (25%)
Query: 165 VIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKV-------EVEAIGRVRHKNLV 217
+I E +Y+G+ +N V ++ + K KV E++ + R+ N++
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIRTF----KKFHKGHKVLIDITENEIKNLRRIDSNNIL 81
Query: 218 RLVGY----CAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 273
++ G+ + L+ EY G L + L + L+++ ++++ + KGL
Sbjct: 82 KIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYN 137
Query: 274 LHEG--------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY-----VA 314
L++ + + K+ GL K+L + + M F Y +
Sbjct: 138 LYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKIL-SSPPFKNVNFMVYFSYKMLNDIF 196
Query: 315 PEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKT-----MV 369
EY D+YS G+++ E+ +G+ P FE L T ++
Sbjct: 197 SEY------TIKDDIYSLGVVLWEIFTGKIP----------------FENLTTKEIYDLI 234
Query: 370 TNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
N N L +K + C ++ KRP + +++ L
Sbjct: 235 INKNNSLKLPLD-----CPLEIKC---IVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 57/198 (28%), Positives = 91/198 (45%), Gaps = 29/198 (14%)
Query: 166 IGEGGYGIV---YRGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 219
IG G GIV + VL NVAVK L N+ A++ ++ E+ + V HKN++ L
Sbjct: 29 IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISL 85
Query: 220 VGY------CAEGAHRMLVNEYVDNGNLEQWLHGDVGPH--SPLTWEIRMNIILGTAKGL 271
+ E LV E +D NL Q +H ++ S L +++ I + G+
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGI 144
Query: 272 TYLHEGLEPK-------WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 324
+H L+P K+ DFGLA+ A +++ T + T Y APE
Sbjct: 145 --IHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTPYVVTRYYRAPEVILGMGYK 200
Query: 325 ETSDVYSFGILIMEVISG 342
E D++S G ++ E++ G
Sbjct: 201 ENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 40/139 (28%), Positives = 72/139 (51%), Gaps = 19/139 (13%)
Query: 223 CAEGAHRM-LVNEYVDNGNLEQWLHGDVG----PHSPL-TWEIRMNIILGTAKGLTYL-- 274
C + R+ V EYV+ G+L + VG PH+ EI + + +KG+ Y
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYQIQ-QVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 275 ---HEGLEPKWNPKLSDFGLAKLLGAERSY--VTTRVM-GTFGYVAPEYASTGMLNETSD 328
+ L+ + + K++DFG+ K E + VTT+ GT Y+APE + ++ D
Sbjct: 128 KLDNVMLDSEGHIKIADFGMCK----ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVD 183
Query: 329 VYSFGILIMEVISGRNPVD 347
++FG+L+ E+++G+ P +
Sbjct: 184 WWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 35/204 (17%)
Query: 166 IGEGGYGIVYRGVLEDNTN--VAVKNLLNNRGQ---AEKEFKVEVEAIGRVRHKNLVRLV 220
+G+GG+G V V NT A K L R + EK +E E + +V +V L
Sbjct: 1 LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWLH--GDVGPHSPLTWEIRMN-IILGTAK---GLTYL 274
H LV ++ G+L+ ++ G+ G + M +I +A+ G+ +L
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERG--------LEMERVIHYSAQITCGILHL 111
Query: 275 HEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 321
H L+ + N +LSD GLA L ++ T+ GT GY+APE
Sbjct: 112 HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEE 169
Query: 322 MLNETSDVYSFGILIMEVISGRNP 345
+ D ++ G I E+++GR P
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 41/209 (19%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVK---NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVG 221
IG G YGIV E N VA+K N +NR A++ + E++ + + H+N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKD 71
Query: 222 YCAEGAHRM------LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY-- 273
HR +V E +D LH + L+ + + +GL Y
Sbjct: 72 -IMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 274 ----LHEGLEP-------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 322
LH L+P + K+ DFGLA+ + ++T V+ T Y APE +
Sbjct: 126 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPEL----L 180
Query: 323 LNETS-----DVYSFGILIMEVISGRNPV 346
LN + DV+S G + E++ GR P+
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 56/205 (27%), Positives = 86/205 (41%), Gaps = 30/205 (14%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKV--EVEAIGRVR---HKNLVRL 219
IG G YG VY+ VA+K++ + EV + R+ H N+VRL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 220 VGYCA-----EGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 274
+ CA LV E+VD +L +L P P E +++ +GL +L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPA--ETIKDLMRQFLRGLDFL 124
Query: 275 H------EGLEPK-------WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 321
H L+P+ KL+DFGLA++ + + T V+ T Y APE
Sbjct: 125 HANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL--TPVVVTLWYRAPEVLLQS 182
Query: 322 MLNETSDVYSFGILIMEVISGRNPV 346
D++S G + E+ R P+
Sbjct: 183 TYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 61/209 (29%), Positives = 90/209 (43%), Gaps = 35/209 (16%)
Query: 160 FADENVIGEGGYGIVY--RGVLEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHK 214
F D IG G +G VY R V + VA+K + + Q+ ++++ EV + ++RH
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 215 NLVRLVGYCAEGAHRM-LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRM-NIILGTAKGLT 272
N + G C H LV EY G+ L +V H E+ + I G +GL
Sbjct: 76 NTIEYKG-CYLREHTAWLVMEYC-LGSASDIL--EV--HKKPLQEVEIAAICHGALQGLA 129
Query: 273 YLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY-- 317
YLH L KL+DFG A L+ S+V GT ++APE
Sbjct: 130 YLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVIL 184
Query: 318 -ASTGMLNETSDVYSFGILIMEVISGRNP 345
G + DV+S GI +E+ + P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 5e-05
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 46/213 (21%)
Query: 166 IGEGGYGIVYRGVLEDNTN--VAVKNL----LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 219
I +G YG V+ + +T A+K + + + Q + + E + + + + +V+L
Sbjct: 1 ISKGAYGRVFL-AKKKSTGDIYAIKVIKKADMIRKNQVD-QVLTERDILSQAQSPYVVKL 58
Query: 220 VGYCAEGAHRM-LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-- 276
Y +G + LV EY+ G+L L +VG L ++ I L YLH
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLASLLE-NVGS---LDEDVARIYIAEIVLALEYLHSNG 113
Query: 277 ----GLEPKWNP--------KLSDFGLAKLLGAERSYV--------TTRVMGTFGYVAPE 316
L+P N KL+DFGL+K+ G R + R++GT Y+APE
Sbjct: 114 IIHRDLKPD-NILIDSNGHLKLTDFGLSKV-GLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 317 YASTGMLNE----TSDVYSFGILIMEVISGRNP 345
+L + T D +S G ++ E + G P
Sbjct: 172 V----ILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 54/222 (24%), Positives = 97/222 (43%), Gaps = 53/222 (23%)
Query: 164 NVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGY 222
N+IG G +G+VY + ++ + VA+K +L + +E + + + H N++ L Y
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLNHINIIFLKDY 127
Query: 223 CAEGAHRM--------LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNII----LGTAKG 270
+ +V E++ Q +H + ++ + + ++ +
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFI-----PQTVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182
Query: 271 LTYLHEG-------------LEPKWNP-KLSDFGLAK-LLGAER--SYVTTRVMGTFGYV 313
L Y+H ++P + KL DFG AK LL +R SY+ +R Y
Sbjct: 183 LAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YR 237
Query: 314 APEYASTGMLNETS--DVYSFGILIMEVI------SGRNPVD 347
APE G N T+ D++S G +I E+I SG++ VD
Sbjct: 238 APELM-LGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD 278
|
Length = 440 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 48/158 (30%), Positives = 65/158 (41%), Gaps = 29/158 (18%)
Query: 206 EAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIIL 265
E RH LV L H V EY G+L +H DV P ++L
Sbjct: 54 ETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-EPRAVFYAACVVL 112
Query: 266 GTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 312
GL YLHE L+ + K++DFGL K G T+ GT +
Sbjct: 113 ----GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEF 167
Query: 313 VAPEYASTGMLNETS-----DVYSFGILIMEVISGRNP 345
+APE +L ETS D + G+LI E++ G +P
Sbjct: 168 LAPE-----VLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (106), Expect = 5e-05
Identities = 50/230 (21%), Positives = 83/230 (36%), Gaps = 77/230 (33%)
Query: 162 DENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEA---------IGRV 211
IG G YG+V V VA+K + N F ++A + +
Sbjct: 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHL 56
Query: 212 RHKNLVRLVGYCAEGAHRMLVNEYVDNGN------------LEQWLHGDVGPHSPLTWEI 259
RH+N++ L +L ++ N L + + PLT +
Sbjct: 57 RHENIIGL--------LDILRPPSPEDFNDVYIVTELMETDLHKVIKS----PQPLTDDH 104
Query: 260 RMNIILGTAKGLTYLHEG------LEPKWN--------PKLSDFGLAKLLGAERS----- 300
+ +GL YLH L+P N K+ DFGLA+ + +
Sbjct: 105 IQYFLYQILRGLKYLHSANVIHRDLKPS-NILVNSNCDLKICDFGLARGVDPDEDEKGFL 163
Query: 301 --YVTTRVMGTFGYVAPEYASTGMLN-----ETSDVYSFGILIMEVISGR 343
YV TR Y APE +L+ + D++S G + E+++ +
Sbjct: 164 TEYVVTRW-----YRAPEL----LLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 22/63 (34%), Positives = 33/63 (52%), Gaps = 2/63 (3%)
Query: 285 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML--NETSDVYSFGILIMEVISG 342
L+DFGL+K AE GT Y+APE G ++ D +S G+L E+++G
Sbjct: 145 VLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
Query: 343 RNP 345
+P
Sbjct: 205 ASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 52/209 (24%)
Query: 166 IGEGGYGIVYRGVLEDNTN-VAVKNLLNNRGQAEKEFKV------EVEAIGRVRHKNLVR 218
IGEG YG+V++ + VA+K + ++E + + E+ + +++H NLV
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFV----ESEDDPVIKKIALREIRMLKQLKHPNLVN 64
Query: 219 LVGYCAEGAHRMLVNEYVDN---GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY-- 273
L+ LV EY D+ LE+ G + + II T + + +
Sbjct: 65 LIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-------VPEHLIKKIIWQTLQAVNFCH 117
Query: 274 ----LHEGLEP------KWNP-KLSDFGLAKLL----GAERSYVTTRVMGTFGYVAPEYA 318
+H ++P K KL DFG A++L YV TR Y APE
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPEL- 171
Query: 319 STGMLNETS-----DVYSFGILIMEVISG 342
++ +T DV++ G + E+++G
Sbjct: 172 ---LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 58/210 (27%), Positives = 87/210 (41%), Gaps = 39/210 (18%)
Query: 166 IGEGGYGIVY--RGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV---------RHK 214
IGEG YG V+ R + VA+K + R Q +E + + I V H
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEE-GMPLSTIREVAVLRHLETFEHP 64
Query: 215 NLVRLVGYCA-----EGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 269
N+VRL C LV E+VD +L +L D P + E +++ +
Sbjct: 65 NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIKDMMFQLLR 121
Query: 270 GLTYL------HEGLEPK-------WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 316
GL +L H L+P+ KL+DFGLA++ + T V+ T Y APE
Sbjct: 122 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPE 179
Query: 317 YASTGMLNETSDVYSFGILIMEVISGRNPV 346
D++S G + E+ R P+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 8e-05
Identities = 73/269 (27%), Positives = 120/269 (44%), Gaps = 47/269 (17%)
Query: 166 IGEGGYGIVYRGVLEDNTNV--AVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNLVRLVG- 221
+G+G YG VY+ VL T V A+K + +++ + +E++ + + +V G
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 222 YCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL------- 274
+ EGA M + EY+D G+L++ L+ + ++ I KGL +L
Sbjct: 68 FFIEGAVYMCM-EYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNII 125
Query: 275 HEGLEP-------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE-- 325
H ++P KL DFG++ L S T + G Y+APE +G N+
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNL--VASLAKTNI-GCQSYMAPERIKSGGPNQNP 182
Query: 326 ----TSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381
SDV+S G+ I+E+ GR Y PP + N+F L +V +G+ P
Sbjct: 183 TYTVQSDVWSLGLSILEMALGR----YPYPPETYA---NIFAQLSAIV-DGDP-----PT 229
Query: 382 LQEKPSSRALKRALLVALRCVDPNAHKRP 410
L S A VA C++ ++RP
Sbjct: 230 LPSGYSDDAQD---FVAK-CLNKIPNRRP 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 8e-05
Identities = 50/200 (25%), Positives = 83/200 (41%), Gaps = 27/200 (13%)
Query: 166 IGEGGYGIVYRGVLEDNTN--VAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLV 220
+G+GG+G V T A K L R + E+ E + + +V + +V L
Sbjct: 1 LGKGGFGEVC-ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-- 276
LV ++ G+L+ + G+ G II G L +LH+
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQRR 115
Query: 277 ----GLEPK-------WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 325
L+P+ N ++SD GLA L + GT GY+APE + +
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEVYDF 173
Query: 326 TSDVYSFGILIMEVISGRNP 345
+ D ++ G + E+I+GR+P
Sbjct: 174 SVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 48/182 (26%), Positives = 72/182 (39%), Gaps = 44/182 (24%)
Query: 263 IILGTAKGLTYLHEGL-------EP-------KWNPKLSDFGLAKLLGAERSYVTTRVMG 308
I + K L YLH L +P KL DFG++ L S T G
Sbjct: 108 IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTIDAG 165
Query: 309 TFGYVAPEYASTGM----LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEW 364
Y+APE + + + SDV+S GI ++E+ +GR P D + P F+
Sbjct: 166 CKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---------FQQ 216
Query: 365 LKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 424
LK +V + P+L + S + V +C+ N +RP E +
Sbjct: 217 LKQVVEEPS------PQLPAEKFSPEFQD--FVN-KCLKKNYKERPN------YPELLQH 261
Query: 425 PF 426
PF
Sbjct: 262 PF 263
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 46/196 (23%), Positives = 80/196 (40%), Gaps = 23/196 (11%)
Query: 166 IGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEF---KVEVEAIGRVRHKNLVRLVGY 222
IG+G +G V++G+ ++ T V + + +AE E + E+ + + + + G
Sbjct: 12 IGKGSFGEVFKGI-DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 223 CAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG----- 277
+ ++ EY+ G+ L PL I+ KGL YLH
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEKKIHR 125
Query: 278 --------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDV 329
L KL+DFG+A L + +GT ++APE + +D+
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 184
Query: 330 YSFGILIMEVISGRNP 345
+S GI +E+ G P
Sbjct: 185 WSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 40/135 (29%), Positives = 62/135 (45%), Gaps = 21/135 (15%)
Query: 285 KLSDFGLAKLLGAERSYVTTRVM-GTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGR 343
KL DFG +K+ A S R GT YVAPE ++ +D++S G+L+ E+++ +
Sbjct: 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242
Query: 344 NPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVD 403
P D GE N+ E V + G DP PS + ++ AL D
Sbjct: 243 RPFD-----GE-----NMEE-----VMHKTLAGRYDPL---PPSISPEMQEIVTALLSSD 284
Query: 404 PNAHKRPKMGHVIHM 418
P +RP +++M
Sbjct: 285 P--KRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 48/213 (22%), Positives = 84/213 (39%), Gaps = 52/213 (24%)
Query: 166 IGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG---------------- 209
+G G +Y G+L + ++ EKE KV ++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDE-----DDGYSYEKEIKVILKVLDPSHRDISLAFFETASM 57
Query: 210 --RVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 267
+V HK++V L G C ++V E+V+ G L+ ++H LT + +
Sbjct: 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQL 114
Query: 268 AKGLTYLH------------------EGLEPKWNP--KLSDFGLAKLLGAERSYVTTRVM 307
A L+YL EG++ + P KLSD G+ + R R+
Sbjct: 115 ASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP-ITVLSRQECVERI- 172
Query: 308 GTFGYVAPE-YASTGMLNETSDVYSFGILIMEV 339
++APE + L+ +D +SFG + E+
Sbjct: 173 ---PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 28/198 (14%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLVG 221
+G G YG V + VA+K L + A++ ++ E+ + ++H+N++ L+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81
Query: 222 -YCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--- 277
+ + + + Y+ ++ L +G PL+ + ++ GL Y+H
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGII 139
Query: 278 ---LEP-------KWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGM-LNE 325
L+P K+ DFGLA+ AE + YV TR Y APE M N+
Sbjct: 140 HRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILNWMHYNQ 194
Query: 326 TSDVYSFGILIMEVISGR 343
T D++S G ++ E+++G+
Sbjct: 195 TVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 27/93 (29%), Positives = 47/93 (50%), Gaps = 18/93 (19%)
Query: 270 GLTYLHEG-------------LEPKWNPKLSDFGLAK--LLGAERSYVTTRVMGTFGYVA 314
GL +LHE L+ + + K++DFG+ K +LG T+ GT Y+A
Sbjct: 108 GLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIA 164
Query: 315 PEYASTGMLNETSDVYSFGILIMEVISGRNPVD 347
PE S D ++ G+L+ E+++G++P +
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 3e-04
Identities = 55/207 (26%), Positives = 83/207 (40%), Gaps = 43/207 (20%)
Query: 165 VIGEGGYGIVYRGVLEDNTNV-AVKNLLNNRGQAEKEFKV-----------EVEAIGRVR 212
+G G +G V + + A+K L K K+ E + +R
Sbjct: 8 TLGTGSFGRVMLVRHKGSGKYYALKIL-------SKA-KIVKLKQVEHVLNEKRILQSIR 59
Query: 213 HKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 272
H LV L G + ++ LV EYV G L L P+ ++L L
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA----LE 115
Query: 273 YLHE------GLEPKWN--------PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 318
YLH L+P+ N K++DFG AK + R+Y GT Y+APE
Sbjct: 116 YLHSLDIVYRDLKPE-NLLLDSDGYIKITDFGFAKRV-KGRTYTLC---GTPEYLAPEII 170
Query: 319 STGMLNETSDVYSFGILIMEVISGRNP 345
+ + D ++ GILI E+++G P
Sbjct: 171 LSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 62/229 (27%), Positives = 99/229 (43%), Gaps = 55/229 (24%)
Query: 154 EVSTNGFADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNRGQAEKE-FKV----EVEA 207
+ + F IGEG YG VY+ +D VA+K + R EKE F + E++
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV---RLDNEKEGFPITAIREIKI 59
Query: 208 IGRVRHKNLVRL----------VGYCAEGAHRMLVNEYVDN---GNLEQWLHGDVGPHSP 254
+ ++ H+N+V L + + + LV EY+D+ G LE L
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-------VH 112
Query: 255 LTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE--R 299
+ + + + +GL Y H+ L K KL+DFGLA+L +E R
Sbjct: 113 FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172
Query: 300 SYVTTRVMGTFGYVAPEYASTGMLNE-----TSDVYSFGILIMEVISGR 343
Y T +V+ T Y PE +L E DV+S G ++ E+ + +
Sbjct: 173 PY-TNKVI-TLWYRPPEL----LLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 23/63 (36%), Positives = 37/63 (58%), Gaps = 5/63 (7%)
Query: 285 KLSDFGLAK--LLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISG 342
K++DFG+ K +LG + T GT Y+APE N + D +SFG+L+ E++ G
Sbjct: 136 KIADFGMCKENMLGDAK---TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIG 192
Query: 343 RNP 345
++P
Sbjct: 193 QSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 61/266 (22%), Positives = 109/266 (40%), Gaps = 56/266 (21%)
Query: 165 VIGEGGYGIV----YRGVLEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 218
V+G+G YG V +R D +K NL N + K + E + + +++H N+V
Sbjct: 7 VVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 219 LV-GYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSP----LTWEIRMNIILGTAKGLTY 273
+ E +V + + G+L L G P + W +++ A L Y
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI------AMALQY 117
Query: 274 LHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 320
LHE L K+ D G+A++L + +T ++GT Y++PE S
Sbjct: 118 LHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFSN 176
Query: 321 GMLNETSDVYSFGILIMEVISGRNP-------------VDYSRPPGEFQFQVNLFEWLKT 367
N SDV++ G + E+ + ++ ++ PP + L E + T
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236
Query: 368 MVTNGNAEGVLDPRLQEKPSSRALKR 393
M L R +++PS +++ R
Sbjct: 237 M---------LSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 23/94 (24%), Positives = 37/94 (39%), Gaps = 15/94 (15%)
Query: 270 GLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 316
L YLH L+ + + ++DF +A + +TT GT GY+APE
Sbjct: 112 ALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLTTSTSGTPGYMAPE 169
Query: 317 YASTGMLNETSDVYSFGILIMEVISGRNPVDYSR 350
+ D +S G+ E + G+ P
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 61/270 (22%), Positives = 111/270 (41%), Gaps = 49/270 (18%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLVR 218
++G+G +G VY ++ +A K + + E +V E++ + ++H+ +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 219 LVGYCAEGAHRMLV--NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276
G + A + L EY+ G+++ L + LT + +G++YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHS 124
Query: 277 GL-------------EPKWNPKLSDFGLAKLLGAERSYVT--TRVMGTFGYVAPEYASTG 321
+ + N KL DFG +K L T V GT +++PE S
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 322 MLNETSDVYSFGILIMEVISGRNPVDYSRPP-GEFQFQVNLFEWLKTMVTNGNAEGVLDP 380
+DV+S G ++E+++ +PP E++ +F+ + T TN P
Sbjct: 185 GYGRKADVWSLGCTVVEMLT-------EKPPWAEYEAMAAIFK-IATQPTN--------P 228
Query: 381 RLQEKPSSRALKRALLVALRCVDPNAHKRP 410
+L S A L C+ A RP
Sbjct: 229 QLPSHISEHARD-----FLGCIFVEARHRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 21/61 (34%), Positives = 34/61 (55%), Gaps = 1/61 (1%)
Query: 285 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRN 344
K++DFG+ K + GT Y+APE NE+ D +SFG+L+ E++ G++
Sbjct: 136 KIADFGMCKE-NMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQS 194
Query: 345 P 345
P
Sbjct: 195 P 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 35/209 (16%)
Query: 166 IGEGGYGIV---YRGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 219
IG G GIV Y VL+ NVA+K L N+ A++ ++ E+ + V HKN++ L
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 220 VGY------CAEGAHRMLVNEYVDNGNLEQWLHGDVGPH--SPLTWEIRMNIILGTAKGL 271
+ E LV E +D NL Q + ++ S L +++ I + G+
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI 140
Query: 272 TYLHEGLEPK-------WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 324
+H L+P K+ DFGLA+ G S++ T + T Y APE
Sbjct: 141 --IHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGMGYK 196
Query: 325 ETSDVYSFGILIMEVIS------GRNPVD 347
E D++S G ++ E++ GR+ +D
Sbjct: 197 ENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 55/208 (26%), Positives = 84/208 (40%), Gaps = 31/208 (14%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKN 215
F + IG G +G VY N VAVK + + Q ++++ EV+ + +++H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYL 274
+ G + LV EY G+ L H E+ + I G +GL YL
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYC-LGSASDLLE----VHKKPLQEVEIAAITHGALQGLAYL 137
Query: 275 HEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY---A 318
H L KL+DFG A S+V GT ++APE
Sbjct: 138 HSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAM 192
Query: 319 STGMLNETSDVYSFGILIMEVISGRNPV 346
G + DV+S GI +E+ + P+
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 44/221 (19%), Positives = 99/221 (44%), Gaps = 39/221 (17%)
Query: 153 LEVSTNGFADENVIGEGGYGIVYRGVLEDNTN-----VAVKNLLNNRGQAEKEFKV-EVE 206
+ +S + +++ EG +G ++ G+L D V VK + ++ + + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 207 AIGRVRHKNLVRLVGYCAE-GAHRMLVNEYVDNGNLEQWL----HGDVGPHSPLTWEIRM 261
+ + H+N++ ++ C E G ++ Y++ GNL+ +L G+ L+ + +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 262 NIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAK--------LLGAERS 300
++ + A G++YLH+ ++ + K++D L++ LG +
Sbjct: 121 HMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG-DNE 179
Query: 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS 341
+ M A E + SDV+SFG+L+ E+++
Sbjct: 180 NRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 39/141 (27%), Positives = 63/141 (44%), Gaps = 22/141 (15%)
Query: 270 GLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 316
L YLHE L+ + + KL+D+G+ K G T+ GT Y+APE
Sbjct: 108 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPE 166
Query: 317 YASTGMLNETSDVYSFGILIMEVISGRNPVDY---SRPPGE----FQFQVNLFEWLKTMV 369
+ D ++ G+L+ E+++GR+P D S P + + FQV L + ++
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 226
Query: 370 TNG-NAEGVLDPRLQEKPSSR 389
+ A VL L + P R
Sbjct: 227 SLSVKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 9e-04
Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 32/207 (15%)
Query: 163 ENVIGEGGYGIVYRGV-LEDNTNVAVK---NLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 218
+ VIG+G YG+V + VA+K ++ + A + + E++ + +RH ++V
Sbjct: 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVE 63
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG- 277
+ + R + YV +E LH + + LT E + + L Y+H
Sbjct: 64 IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN 123
Query: 278 -----LEPK-------WNPKLSDFGLAKLLGAE-------RSYVTTRVMGTFGYVAPEYA 318
L+PK K+ DFGLA++ + YV TR Y APE
Sbjct: 124 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR-----WYRAPELC 178
Query: 319 STGMLNETS--DVYSFGILIMEVISGR 343
+ T D++S G + EV++G+
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 26/72 (36%), Positives = 40/72 (55%), Gaps = 4/72 (5%)
Query: 285 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRN 344
KL+DFG AK L +R++ + GT Y+APE + N+ D ++ GILI E++ G
Sbjct: 141 KLTDFGFAKKL-RDRTWT---LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196
Query: 345 PVDYSRPPGEFQ 356
P P G ++
Sbjct: 197 PFFDDNPFGIYE 208
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 28/96 (29%), Positives = 49/96 (51%), Gaps = 20/96 (20%)
Query: 268 AKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY--VTTRVM-GTFG 311
+ GL +LH L+ + + K++DFG+ K E VTTR GT
Sbjct: 111 SVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK----EHMVDGVTTRTFCGTPD 166
Query: 312 YVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVD 347
Y+APE + ++ D +++G+L+ E+++G+ P D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 56/198 (28%), Positives = 89/198 (44%), Gaps = 29/198 (14%)
Query: 166 IGEGGYGIVYRGVLEDNTN-VAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYC 223
+GEG Y V++G + N VA+K + L + A EV + ++H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY------LHEG 277
LV EY+D+ +L+Q+L S +I M +L +GL+Y LH
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLL---RGLSYCHKRKILHRD 128
Query: 278 LEP-------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETS--- 327
L+P K KL+DFGLA+ + V+ T Y P+ +L T
Sbjct: 129 LKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDV----LLGSTEYST 183
Query: 328 --DVYSFGILIMEVISGR 343
D++ G ++ E+ +GR
Sbjct: 184 PIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 31/206 (15%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKN 215
+ D +G G YG V + VA+K L + A++ ++ E+ + ++H+N
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHEN 75
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGP---HSPLTWEIRMNIILGTAKGLT 272
++ L+ ++ + D + ++ D+G H L+ + ++ KGL
Sbjct: 76 VIGLLDVFTPDLS---LDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 273 YLHEG------LEP-------KWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYA 318
Y+H L+P K+ DFGLA+ +E + YV TR Y APE
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAPEVI 187
Query: 319 STGM-LNETSDVYSFGILIMEVISGR 343
M +T D++S G ++ E+++G+
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 29/96 (30%), Positives = 49/96 (51%), Gaps = 20/96 (20%)
Query: 268 AKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY--VTTRVM-GTFG 311
A GL +LH L+ + + K++DFG+ K E + TTR GT
Sbjct: 111 AIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCK----ENIFGGKTTRTFCGTPD 166
Query: 312 YVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVD 347
Y+APE + ++ D ++FG+L+ E+++G+ P D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 33/126 (26%), Positives = 54/126 (42%), Gaps = 29/126 (23%)
Query: 275 HEGLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGI 334
HEG + KL+DFG+ K G T+ GT Y+APE + + D ++ G+
Sbjct: 131 HEG-----HCKLADFGMCKE-GIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGV 184
Query: 335 LIMEVISGRNPVDYSRPPGEFQFQVNLFE-----------WLKTMVTNGNAEGVLDPRLQ 383
L+ E++ G P E + + +LFE WL +A +L +
Sbjct: 185 LLYEMLCGHAPF-------EAENEDDLFEAILNDEVVYPTWLSQ-----DAVDILKAFMT 232
Query: 384 EKPSSR 389
+ P+ R
Sbjct: 233 KNPTMR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 29/199 (14%)
Query: 166 IGEGGYGIV---YRGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 219
IG G GIV Y +LE NVA+K L N+ A++ ++ E+ + V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 220 VGY------CAEGAHRMLVNEYVDNGNLEQWLHGDVGPH--SPLTWEIRMNIILGTAKGL 271
+ E +V E +D NL Q + ++ S L +++ I + G+
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI 147
Query: 272 TYLHEGLEPK-------WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 324
+H L+P K+ DFGLA+ G S++ T + T Y APE
Sbjct: 148 --IHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 325 ETSDVYSFGILIMEVISGR 343
E D++S G ++ E+I G
Sbjct: 204 ENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 48/199 (24%), Positives = 93/199 (46%), Gaps = 35/199 (17%)
Query: 166 IGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLVG-YC 223
+G+G +G VY+ ++ +A ++ + + E E + VE+E + H +V+L+G +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 224 AEGAHRMLVNEYVDNGNLEQ-WLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG----- 277
+G +++ E+ G ++ L D G P +I++ I + L YLH
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLELDRGLTEP---QIQV-ICRQMLEALQYLHSMKIIHR 134
Query: 278 --------LEPKWNPKLSDFGLA----KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 325
L + KL+DFG++ K L S++ GT ++APE + +
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCETMKD 189
Query: 326 T-----SDVYSFGILIMEV 339
T +D++S GI ++E+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 22/68 (32%), Positives = 39/68 (57%), Gaps = 4/68 (5%)
Query: 278 LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIM 337
L+ K + K++DFG AK + +R++ + GT Y+APE + + D ++ G+L+
Sbjct: 151 LDNKGHVKVTDFGFAKKV-PDRTFT---LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLY 206
Query: 338 EVISGRNP 345
E I+G P
Sbjct: 207 EFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 47/215 (21%), Positives = 90/215 (41%), Gaps = 27/215 (12%)
Query: 154 EVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNL--LNNRGQAEKEFKVEVEAIGRV 211
E+ + F + +G G G+V++ + + + + L L + + E++ +
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 212 RHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 271
+V G + E++D G+L+Q L + +I + + KGL
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGL 116
Query: 272 TYL-------HEGLEP-------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 317
TYL H ++P + KL DFG++ G + +GT Y++PE
Sbjct: 117 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPER 173
Query: 318 ASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPP 352
+ SD++S G+ ++E+ GR P+ PP
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGRYPI----PP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 54/195 (27%), Positives = 86/195 (44%), Gaps = 23/195 (11%)
Query: 166 IGEGGYGIVYRG--VLEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGY 222
+GEG Y V++G L +N VA+K + L + A EV + ++H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 223 CAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY------LHE 276
LV EY+D +L+Q++ S +I + IL +GL Y LH
Sbjct: 73 VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQIL---RGLAYCHRRKVLHR 128
Query: 277 GLEP-------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-YASTGMLNETSD 328
L+P + KL+DFGLA+ + V+ T Y P+ + + D
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQID 187
Query: 329 VYSFGILIMEVISGR 343
++ G + E+ SGR
Sbjct: 188 MWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 28/207 (13%)
Query: 165 VIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVG-Y 222
++G G YG VY+G +A +++ G E+E K E+ + + H+N+ G +
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 223 CAEGAHRM-----LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277
+ M LV E+ G++ + G + L E I +GL++LH+
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH 130
Query: 278 -------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST---- 320
L KL DFG++ L T +GT ++APE +
Sbjct: 131 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIACDENP 189
Query: 321 -GMLNETSDVYSFGILIMEVISGRNPV 346
+ SD++S GI +E+ G P+
Sbjct: 190 DATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 24/61 (39%), Positives = 34/61 (55%), Gaps = 1/61 (1%)
Query: 286 LSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA-STGMLNETSDVYSFGILIMEVISGRN 344
L+DFGL+K +E T GT Y+APE G + D +S GILI E+++G +
Sbjct: 146 LTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGAS 205
Query: 345 P 345
P
Sbjct: 206 P 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 48/213 (22%), Positives = 90/213 (42%), Gaps = 37/213 (17%)
Query: 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL-------HEGLEP------ 280
E++D G+L+Q L + EI + + +GL YL H ++P
Sbjct: 83 EHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN 138
Query: 281 -KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEV 339
+ KL DFG++ G + +GT Y++PE + SD++S G+ ++E+
Sbjct: 139 SRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195
Query: 340 ISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG-VLDPRLQEKPSSRAL------K 392
GR P+ PP + + +F + +V E + PR +P R +
Sbjct: 196 AIGRYPI----PPPDAKELEAIFG--RPVVDGEEGEPHSISPR--PRPPGRPVSGHGMDS 247
Query: 393 RALLVALRCVDPNAHK-RPKMGHVIHMLEAEEF 424
R + +D ++ PK+ + + + +EF
Sbjct: 248 RPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEF 280
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 21/63 (33%), Positives = 35/63 (55%), Gaps = 1/63 (1%)
Query: 285 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRN 344
KL+D+G+ K G T+ GT Y+APE + D ++ G+L+ E+++GR+
Sbjct: 136 KLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRS 194
Query: 345 PVD 347
P D
Sbjct: 195 PFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 165 VIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEA-----IGRVRHKNLVR 218
VIG+G +G V + D + AVK +L + +K+ + + A + ++H LV
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 219 LVGYCAEGAHRM-LVNEYVDNGNLEQWLHGDVGPHSPLT--WEIRMNIILGTAKGLTYLH 275
L Y + A ++ V +YV+ G L L + P + + +G L ++
Sbjct: 61 L-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIY 119
Query: 276 EGLEP-------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSD 328
L+P + + L+DFGL K G E T+ GT Y+APE + T D
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKE-GVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVD 178
Query: 329 VYSFGILIMEVISGRNPVDYSR 350
+ G ++ E++ G P YSR
Sbjct: 179 WWCLGAVLYEMLYGLPPF-YSR 199
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 22/72 (30%), Positives = 33/72 (45%), Gaps = 5/72 (6%)
Query: 285 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRN 344
KL+DFGL++ + +GT Y+APE ++ SD +S G +I E + G
Sbjct: 137 KLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYP 191
Query: 345 PVDYSRPPGEFQ 356
P P F
Sbjct: 192 PFHAETPDAVFD 203
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 25/205 (12%)
Query: 166 IGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLVGY-- 222
IG+G YG V++ + + N + A +L+ ++E + E + + H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 223 ---CAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-- 277
G LV E + G++ + G + + I I+ GL +LH
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKT 145
Query: 278 -----------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY-ASTGMLNE 325
L + KL DFG++ L + R T V GT ++APE A L+
Sbjct: 146 IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQQLDS 204
Query: 326 T----SDVYSFGILIMEVISGRNPV 346
T DV+S GI +E+ G P+
Sbjct: 205 TYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 65/214 (30%)
Query: 166 IGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVR------ 218
+G+G +G VY+ ++ +A +++ + + E E + VE++ + H N+V+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 219 -------LVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILG-TAKG 270
L+ +CA GA VD LE PLT E ++ ++ T +
Sbjct: 73 YENNLWILIEFCAGGA--------VDAVMLEL--------ERPLT-EPQIRVVCKQTLEA 115
Query: 271 LTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTR---VMGTFGYVA 314
L YLHE + KL+DFG++ A+ + R +GT ++A
Sbjct: 116 LNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWMA 171
Query: 315 PEYASTGMLNETS---------DVYSFGILIMEV 339
PE ++ ETS DV+S GI ++E+
Sbjct: 172 PEV----VMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 57/196 (29%), Positives = 89/196 (45%), Gaps = 25/196 (12%)
Query: 166 IGEGGYGIVYRG--VLEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGY 222
+GEG Y VY+G L DN VA+K + L + A EV + ++H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 223 CAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY------LHE 276
LV EY+D +L+Q+L D G +S +++ + +GL Y LH
Sbjct: 73 IHTEKSLTLVFEYLDK-DLKQYLD-DCG-NSINMHNVKL-FLFQLLRGLNYCHRRKVLHR 128
Query: 277 GLEP-------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE--YASTGMLNETS 327
L+P + KL+DFGLA+ + V+ T Y P+ ST +
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQI- 186
Query: 328 DVYSFGILIMEVISGR 343
D++ G + E+ +GR
Sbjct: 187 DMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 24/67 (35%), Positives = 35/67 (52%), Gaps = 6/67 (8%)
Query: 285 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST------GMLNETSDVYSFGILIME 338
KL+DFG A L A + + +GT Y+APE +T G D +S G++ E
Sbjct: 142 KLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYE 201
Query: 339 VISGRNP 345
+I GR+P
Sbjct: 202 MIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 26/90 (28%), Positives = 44/90 (48%), Gaps = 14/90 (15%)
Query: 271 LTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 317
L +LHE L+ + + KL+D+G+ K G T+ GT Y+APE
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIAPEI 167
Query: 318 ASTGMLNETSDVYSFGILIMEVISGRNPVD 347
+ D ++ G+L+ E+++GR+P D
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 22/63 (34%), Positives = 39/63 (61%), Gaps = 5/63 (7%)
Query: 285 KLSDFGLAK--LLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISG 342
KL+DFGL+K + +++Y GT Y+APE + +++D +SFG+L+ E+++G
Sbjct: 138 KLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
Query: 343 RNP 345
P
Sbjct: 195 SLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 26/79 (32%), Positives = 40/79 (50%), Gaps = 8/79 (10%)
Query: 285 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRN 344
KL+DFG+ K G TT GT Y+APE + D ++ G+L+ E+++G
Sbjct: 136 KLADFGMCKE-GILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAG-- 192
Query: 345 PVDYSRPPGEFQFQVNLFE 363
+PP E + +LFE
Sbjct: 193 -----QPPFEADNEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.004
Identities = 61/232 (26%), Positives = 95/232 (40%), Gaps = 90/232 (38%)
Query: 166 IGEGGYGIVYRGVLEDNTN--VAVKNLLN---NRGQAEKEFKVEVEAIGRVR-HKNLVRL 219
+G+G YGIV++ + + T VA+K + + N A++ F+ E+ + + H N+V+L
Sbjct: 15 LGKGAYGIVWKAI-DRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKL 72
Query: 220 VGYCAEGAHRM-------LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNI--------- 263
+ + LV EY +E LH V IR NI
Sbjct: 73 LN-----VIKAENDKDIYLVFEY-----METDLHA-V---------IRANILEDVHKRYI 112
Query: 264 ---ILGTAKGLTYLHEG------LEP-------KWNPKLSDFGLAKLLGAERS------- 300
+L K L Y+H G L+P KL+DFGLA+ L
Sbjct: 113 MYQLL---KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL 169
Query: 301 --YVTTRVMGTFGYVAPE-------YASTGMLNETSDVYSFGILIMEVISGR 343
YV TR Y APE Y + G+ D++S G ++ E++ G+
Sbjct: 170 TDYVATR-----WYRAPEILLGSTRY-TKGV-----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 53/231 (22%), Positives = 98/231 (42%), Gaps = 36/231 (15%)
Query: 165 VIGEGGYGIVYRGVLEDN-TNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLVR 218
++G+G +G VY D +AVK + + E +V E++ + + H+ +V+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 219 LVGYCAEGAHRML--VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276
G + R L E++ G+++ L + LT + +G++YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHS 124
Query: 277 GL-------------EPKWNPKLSDFGLAKLLGAERSYVT--TRVMGTFGYVAPEYASTG 321
+ + N KL DFG +K L T V GT +++PE S
Sbjct: 125 NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE 184
Query: 322 MLNETSDVYSFGILIMEVISGRNPVDYSRPP-GEFQFQVNLFEWLKTMVTN 371
+D++S G ++E+++ +PP EF+ +F+ + T TN
Sbjct: 185 GYGRKADIWSVGCTVVEMLT-------EKPPWAEFEAMAAIFK-IATQPTN 227
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 64/210 (30%), Positives = 88/210 (41%), Gaps = 28/210 (13%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFK-VEVEA---IGRVRHKNLVRL 219
VIG+G +G V D AVK L +KE K + E + V+H LV L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 220 VGYCAEGAHRM-LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILG-TAKGLTYLHE- 276
Y + A ++ V +YV+ G L + H P E R A L YLH
Sbjct: 62 -HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFP---EPRARFYAAEIASALGYLHSL 115
Query: 277 -----GLEP-------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 324
L+P + + L+DFGL K G E S T+ GT Y+APE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174
Query: 325 ETSDVYSFGILIMEVISGRNPVDYSRPPGE 354
T D + G ++ E++ G P YSR E
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPF-YSRDTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 442 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.88 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.88 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.69 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.68 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.66 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.6 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.6 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.58 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.56 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.54 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.53 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.5 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.49 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.45 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.41 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.39 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.36 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.35 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.32 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.13 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.1 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.04 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 98.95 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.88 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.78 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.74 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.63 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.43 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.3 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.28 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.05 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 97.92 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.9 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.87 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.83 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 97.83 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.59 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.4 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 97.06 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.91 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 96.9 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.88 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 96.85 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.84 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.43 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 96.42 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.39 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.32 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.23 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 96.2 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 96.11 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 95.39 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 95.27 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 94.97 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 94.55 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 94.09 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 94.02 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 93.72 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 93.64 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 93.6 | |
| PF02439 | 38 | Adeno_E3_CR2: Adenovirus E3 region protein CR2; In | 93.45 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 93.21 | |
| PF01034 | 64 | Syndecan: Syndecan domain; InterPro: IPR001050 The | 92.61 | |
| PF08374 | 221 | Protocadherin: Protocadherin; InterPro: IPR013585 | 92.56 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 92.1 | |
| PF06365 | 202 | CD34_antigen: CD34/Podocalyxin family; InterPro: I | 91.99 | |
| PF14575 | 75 | EphA2_TM: Ephrin type-A receptor 2 transmembrane d | 91.38 | |
| PF07213 | 79 | DAP10: DAP10 membrane protein; InterPro: IPR009861 | 90.87 | |
| PF12877 | 684 | DUF3827: Domain of unknown function (DUF3827); Int | 90.72 | |
| PF13908 | 179 | Shisa: Wnt and FGF inhibitory regulator | 90.34 | |
| PF04478 | 154 | Mid2: Mid2 like cell wall stress sensor; InterPro: | 90.24 | |
| PF12273 | 130 | RCR: Chitin synthesis regulation, resistance to Co | 90.22 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 89.43 | |
| PF15102 | 146 | TMEM154: TMEM154 protein family | 88.76 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 87.83 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 87.77 | |
| PTZ00382 | 96 | Variant-specific surface protein (VSP); Provisiona | 86.69 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 86.57 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 84.88 | |
| PF15050 | 133 | SCIMP: SCIMP protein | 84.76 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 83.59 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 83.47 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 82.76 | |
| KOG4258 | 1025 | consensus Insulin/growth factor receptor (contains | 81.03 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 80.77 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=365.73 Aligned_cols=271 Identities=54% Similarity=0.940 Sum_probs=232.3
Q ss_pred ceeehhhHHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 047892 146 HWYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE 225 (442)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 225 (442)
..|++.++..++++|.....||+|+||.||+|...++..||||++.........+|.+|+.++.+++|||+|+|+|||.+
T Consensus 63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e 142 (361)
T KOG1187|consen 63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLE 142 (361)
T ss_pred ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEec
Confidence 45999999999999999999999999999999998889999998865433214569999999999999999999999999
Q ss_pred CC-eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC----------------CCCCCCeEEec
Q 047892 226 GA-HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG----------------LEPKWNPKLSD 288 (442)
Q Consensus 226 ~~-~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~----------------l~~~~~~kl~D 288 (442)
.+ ..+||+|||++|+|.++|+..... .++|..+++||.++|+||+|||.. ++.++++||+|
T Consensus 143 ~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 143 GGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred CCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 88 599999999999999999876432 889999999999999999999985 56688999999
Q ss_pred ccCccccCC-CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHH
Q 047892 289 FGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKT 367 (442)
Q Consensus 289 FGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 367 (442)
||+|+.... ........ .||.+|+|||++..+..+.|+|||||||+|.||+||+.|.+...+... .++..|...
T Consensus 221 FGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~----~~l~~w~~~ 295 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGE----LSLVEWAKP 295 (361)
T ss_pred ccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccc----ccHHHHHHH
Confidence 999976543 22211111 799999999999999999999999999999999999998876543222 347889888
Q ss_pred HhhcCCcccccCcccC-CCCcH-HHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 368 MVTNGNAEGVLDPRLQ-EKPSS-RALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 368 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....+.+.+++|+.+. ..... .....+..++.+|++.+|.+||+|.||++.|+...
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 8888899999999987 44443 67778999999999999999999999999996544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=366.55 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=209.7
Q ss_pred hhhHHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 047892 150 LRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 150 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 229 (442)
...+++....+..++.||+|.||+||.|.++....||+|.++.. ....+.|.+|+++|++|+|+|||+++++|..++.+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 34556666677788999999999999999988889999999764 34456788999999999999999999999998899
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhh------hcC-------CCCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL------HEG-------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yL------H~~-------l~~~~~~kl~DFGla~~~~ 296 (442)
|||||||+.|+|.+||+.. ....+...+.+.++.|||+||+|| |++ ++.++.+||+|||||+...
T Consensus 277 yIVtE~m~~GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred EEEEEecccCcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence 9999999999999999863 245788899999999999999999 555 5677899999999999665
Q ss_pred CCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 297 AERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
++.........-+..|.|||.+..+.|+.|||||||||+||||+| |+.||...... .+ .
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~-------ev-------------~ 414 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE-------EV-------------L 414 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH-------HH-------------H
Confidence 554444444445789999999999999999999999999999999 99998653321 11 1
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
+.++...+...+..|+.+++++|..||..+|++|||++.+...|+.+.
T Consensus 415 ~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 415 ELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred HHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 223444555667778899999999999999999999999999988764
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=384.11 Aligned_cols=250 Identities=28% Similarity=0.478 Sum_probs=207.2
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCcchh-hHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLVGYCAEG 226 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 226 (442)
++.+.+....+.||+|+||+||+|+.. ....||||.+++.... .+++|++|+++|..|+|||||+|+|+|..+
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 455666777899999999999999842 3467999999876555 778999999999999999999999999999
Q ss_pred CeeeeEEecCCCCCHHHHHccCCC------C----CCCCCHHHHHHHHHHHHHhhhhh------hcC-------CCCCCC
Q 047892 227 AHRMLVNEYVDNGNLEQWLHGDVG------P----HSPLTWEIRMNIILGTAKGLTYL------HEG-------LEPKWN 283 (442)
Q Consensus 227 ~~~~lv~E~~~~g~L~~~l~~~~~------~----~~~l~~~~~~~i~~qi~~~l~yL------H~~-------l~~~~~ 283 (442)
+..|||+|||..|||.+||+.+.. . ..+++..+.+.||.|||.||+|| |++ +..+..
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence 999999999999999999964321 1 23489999999999999999999 666 455678
Q ss_pred eEEecccCccccCCCcceeec-ccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhH
Q 047892 284 PKLSDFGLAKLLGAERSYVTT-RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNL 361 (442)
Q Consensus 284 ~kl~DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~ 361 (442)
|||+||||++.+...+.+... ...-.++|||||.+..++|+++||||||||+|||+++ |+.||.+....+ +
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------V 714 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------V 714 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------H
Confidence 999999999988776665443 3345789999999999999999999999999999999 999997654322 2
Q ss_pred HHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 362 FEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
+ ..+..+. + ...+..++.++++||..||+.+|++||+++||-.+|+...
T Consensus 715 I----e~i~~g~--------l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 715 I----ECIRAGQ--------L-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred H----HHHHcCC--------c-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 2 2222222 1 3566778889999999999999999999999999998754
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=353.36 Aligned_cols=257 Identities=24% Similarity=0.403 Sum_probs=206.8
Q ss_pred hhHHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcch-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 047892 151 RELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 151 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 229 (442)
.-.+++++...+.++||+|.||+|.+|....+..||||+++.... ....+|.+|+++|.+|+|||||+++|+|..++.+
T Consensus 531 al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred chhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 345677888999999999999999999998889999999976544 4458899999999999999999999999999999
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhh------hcC-------CCCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL------HEG-------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yL------H~~-------l~~~~~~kl~DFGla~~~~ 296 (442)
++|+|||++|+|.+|+..+..+ .+.......|+.||+.||+|| |++ ++.++++||+|||+++.+.
T Consensus 611 cmI~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccc
Confidence 9999999999999999876332 245566788999999999998 776 4556799999999999876
Q ss_pred CCccee-ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh--CCCCCCCCCCCCccchhhhHHHHHHHHhhcCC
Q 047892 297 AERSYV-TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS--GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373 (442)
Q Consensus 297 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt--g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (442)
..+.+. ....+-+++|||||.+..++|+++||||+||+++||+++ ...||...... .+.+....+...+.
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e-------~vven~~~~~~~~~ 761 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE-------QVVENAGEFFRDQG 761 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-------HHHHhhhhhcCCCC
Confidence 666553 345667899999999999999999999999999999987 77888643321 12222222222221
Q ss_pred cccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 374 AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
. ..-...+.-++..++++|.+||..|-++|||++++...|++.
T Consensus 762 ~------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 R------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred c------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1 112234456777899999999999999999999999888754
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=357.08 Aligned_cols=248 Identities=29% Similarity=0.494 Sum_probs=197.7
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-eeee
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA-HRML 231 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~l 231 (442)
+...++...+.||+|+||+||+|.+.....||||++.... ....+.|.+|+.+|.+++|||||+++|+|.+.. ..+|
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence 3344455667799999999999999655559999996543 222568999999999999999999999999887 7999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcCC--------------CCCC-CeEEecccCccccC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL--------------EPKW-NPKLSDFGLAKLLG 296 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~l--------------~~~~-~~kl~DFGla~~~~ 296 (442)
||||+++|+|.+++++. ....+++..++.++.|||.||.|||+.- +.++ ++||+|||+++...
T Consensus 118 VtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 99999999999999873 2468999999999999999999999873 3455 89999999998764
Q ss_pred CCcceeecccccccCCCCccccc--CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 297 AERSYVTTRVMGTFGYVAPEYAS--TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 297 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
... ...+...||+.|||||++. ...|+.|+||||||++||||+||+.||..... .+....+...
T Consensus 196 ~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----------~~~~~~v~~~--- 261 (362)
T KOG0192|consen 196 ISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP----------VQVASAVVVG--- 261 (362)
T ss_pred ccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----------HHHHHHHHhc---
Confidence 332 2233368999999999999 56899999999999999999999999976543 1111111111
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCC
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 424 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 424 (442)
..+...+..+...+..|+.+||+.||..||++.+++..|+.+..
T Consensus 262 ------~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 262 ------GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred ------CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 12223333366778889999999999999999999999997644
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=353.06 Aligned_cols=234 Identities=24% Similarity=0.368 Sum_probs=197.2
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
..|...+.||+|+|+.||.++. .+|+.||+|++.+. .....+.+.+|+++.+.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 3488899999999999999996 78999999999653 3445667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
|+|.+|+|..++++. .++++..++.+..||+.||.|||+. ++.+.++||+|||||..+..+.
T Consensus 98 ELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~- 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG- 172 (592)
T ss_pred EecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence 999999999999865 6899999999999999999999876 6678899999999999885432
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
....+.||||.|.|||++....++..+||||+||+||-||+|++||...+- .+..... ....+
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v----------kety~~I-k~~~Y------ 235 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV----------KETYNKI-KLNEY------ 235 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH----------HHHHHHH-HhcCc------
Confidence 234568999999999999999999999999999999999999999975322 1211111 11111
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
..+...+.+..+||.++|+.||.+|||+++|+.
T Consensus 236 ----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 236 ----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 123355567888999999999999999999984
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=339.96 Aligned_cols=236 Identities=22% Similarity=0.420 Sum_probs=188.2
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
.++|...+.||.|+||+||+|++ +++..||||.+... .....+.+..|+.+|+.++|||||+++++++.++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 35688889999999999999995 45899999999655 5566777899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCCC-------------CCeEEecccCccc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEPK-------------WNPKLSDFGLAKL 294 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~~-------------~~~kl~DFGla~~ 294 (442)
|||+||||.+||+++ +.+++..+..++.|++.||++||++ ++|+ -.+||+|||+|+.
T Consensus 89 EyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 999999999999876 5799999999999999999999654 5553 2579999999999
Q ss_pred cCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
+... ....+.||++.|||||++...+|+.|+|+||+|++||+|++|+.||+..+..+.+ .. ...+.
T Consensus 165 L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~-------~~----~~k~~- 230 (429)
T KOG0595|consen 165 LQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELL-------LY----IKKGN- 230 (429)
T ss_pred CCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHH-------HH----Hhccc-
Confidence 8643 3346689999999999999999999999999999999999999999876553321 11 11110
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHH
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVI 416 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl 416 (442)
......+...+..+.+|+...++.||.+|.++.+-+
T Consensus 231 ------~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 231 ------EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred ------cccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence 111122222333344566667777777777666554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=332.37 Aligned_cols=241 Identities=24% Similarity=0.391 Sum_probs=197.3
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-eeeeEE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA-HRMLVN 233 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~lv~ 233 (442)
.++++....||+|..|+||++.++ +++.+|+|.+... +....+++.+|++++++.+||+||.+||.|...+ .++|+|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 345667889999999999999964 5889999999533 5567788999999999999999999999999998 499999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc-------CC-------CCCCCeEEecccCccccCCCc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-------GL-------EPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-------~l-------~~~~~~kl~DFGla~~~~~~~ 299 (442)
|||++|+|.++++.. +.+++...-.++.+|++||.|||. ++ ...|++||||||.++.+.+.
T Consensus 158 EYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred hhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 999999999999764 679999999999999999999985 23 44689999999999987544
Q ss_pred ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
...+++||..|||||.+.+..|+.++||||||++++||.+|+.||....+.. .+..+.+.....+
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-----~~~~~Ll~~Iv~~-------- 297 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-----LDIFELLCAIVDE-------- 297 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-----CCHHHHHHHHhcC--------
Confidence 4567899999999999999999999999999999999999999997642111 1222222222211
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
..+..+...++.++.+|+..||++||.+|||+.|+++.
T Consensus 298 -ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 298 -PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11111222477889999999999999999999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=335.01 Aligned_cols=239 Identities=22% Similarity=0.365 Sum_probs=192.6
Q ss_pred hCCCCccCeeccCCcEEEEEEE-ECCCCeEEEEEecCcch-------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 047892 157 TNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRG-------QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAH 228 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 228 (442)
.+.|.+.+.||+|+||.|-+|. .++|+.||||++..... .....+.+|+++|++|+|||||+++++|...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 4557888999999999999999 56799999999954311 122335799999999999999999999999999
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCCCC----------CeEEecccCc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEPKW----------NPKLSDFGLA 292 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~~~----------~~kl~DFGla 292 (442)
.||||||++||+|.+++-.+ +.+.+.....++.|++.|+.|||++ ++|++ .+||+|||+|
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred eEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 99999999999999999765 5677788899999999999999765 66654 5799999999
Q ss_pred cccCCCcceeecccccccCCCCcccccCCC---CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHh
Q 047892 293 KLLGAERSYVTTRVMGTFGYVAPEYASTGM---LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMV 369 (442)
Q Consensus 293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 369 (442)
+..+ ......++|||+.|.|||++.++. +..++|+||+||+||-+++|.+||........ +.+.+
T Consensus 327 K~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s----------l~eQI 394 (475)
T KOG0615|consen 327 KVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS----------LKEQI 394 (475)
T ss_pred hccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc----------HHHHH
Confidence 9875 334567899999999999997665 33488999999999999999999976543321 11222
Q ss_pred hcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 370 TNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
..+.+. +......+.+++..+||.+||..||++|||+.|+|+
T Consensus 395 ~~G~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 395 LKGRYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred hcCccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 222221 122334577889999999999999999999999985
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=329.33 Aligned_cols=244 Identities=21% Similarity=0.319 Sum_probs=199.0
Q ss_pred hCCCCccCeeccCCcEEEEEEE-ECCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEE-EEEeCCe-eee
Q 047892 157 TNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVG-YCAEGAH-RML 231 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~-~~~~~~~-~~l 231 (442)
..+|.+.+.||+|+||+||++. ..+|..||.|.+... +....+.+..|+.+|++|+|||||++++ .+.+.+. ++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 3458889999999999999999 568999999998633 4556677899999999999999999998 4555555 899
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-----------------CCCCCCeEEecccCccc
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-----------------LEPKWNPKLSDFGLAKL 294 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-----------------l~~~~~~kl~DFGla~~ 294 (442)
|||||.+|||.+.|+........+++..+++++.|++.||..+|.. ++.+|.+||+||||++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999987666667899999999999999999999873 44578999999999999
Q ss_pred cCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
+...... ....+|||.||+||.+.+.+|+.||||||+||++|||+.-++||.+.+ ..+. ...+.+++
T Consensus 178 l~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n----------~~~L-~~KI~qgd- 244 (375)
T KOG0591|consen 178 LSSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN----------LLSL-CKKIEQGD- 244 (375)
T ss_pred hcchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc----------HHHH-HHHHHcCC-
Confidence 8654433 456899999999999999999999999999999999999999997642 1221 12222222
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHh
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 420 (442)
..+-+....+..+..|+..|+..||+.||+...++..+.
T Consensus 245 -------~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 245 -------YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred -------CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 223344677888999999999999999998554444443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=351.19 Aligned_cols=249 Identities=26% Similarity=0.453 Sum_probs=206.3
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEECC----CCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLED----NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAH 228 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 228 (442)
++......+.++||.|.||+|++|+++. ...||||.++... .+.+..|+.|..||.+++||||++|.|+.+....
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 4445557788999999999999999642 4579999997653 4556789999999999999999999999999999
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhh------hcC-------CCCCCCeEEecccCcccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL------HEG-------LEPKWNPKLSDFGLAKLL 295 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yL------H~~-------l~~~~~~kl~DFGla~~~ 295 (442)
..||+|||++|+|+.||+.+ .+.+++.+...++++|+.||.|| |++ ++.+..+|++||||++.+
T Consensus 705 vMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence 99999999999999999876 35688899999999999999988 776 456678899999999988
Q ss_pred CCCcceeeccc--ccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcC
Q 047892 296 GAERSYVTTRV--MGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372 (442)
Q Consensus 296 ~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (442)
.++.....++. .-+.+|.|||.+...+|+.+||||||||+|||.++ |..||.+....+. +
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV-------I---------- 844 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-------I---------- 844 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH-------H----------
Confidence 65442222222 33679999999999999999999999999999998 9999976443211 1
Q ss_pred CcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCC
Q 047892 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 425 (442)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 425 (442)
..+...++.+++-+++..+..||+.||++|-..||.+.||+..|+++...
T Consensus 845 ---kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 845 ---KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred ---HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 22334456667778889999999999999999999999999999987533
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=318.22 Aligned_cols=229 Identities=22% Similarity=0.318 Sum_probs=190.0
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 232 (442)
.++|++.++||+|+||+||.++. ++++.+|+|.+.+.. ....+....|..+|.+++||+||+++..|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 45799999999999999999995 458999999996542 23456688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
+||+.||+|+..|++. ..+++..+.-++.+|+.||.|||+. ++.+|+++|+||||++..- ..
T Consensus 104 ld~~~GGeLf~hL~~e----g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~-~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE----GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL-KD 178 (357)
T ss_pred EeccCCccHHHHHHhc----CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc-cC
Confidence 9999999999999876 6799999999999999999999986 6678999999999998542 22
Q ss_pred ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
...+.++|||+.|||||++.+..|+..+|+||+||++|||++|.+||...+.. .+........
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~----------~~~~~I~~~k------- 241 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK----------KMYDKILKGK------- 241 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH----------HHHHHHhcCc-------
Confidence 33456789999999999999999999999999999999999999999765432 2222222111
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCC
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRP 410 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP 410 (442)
...++.-.+.+..+++.+.|+.||++|.
T Consensus 242 ---~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 ---LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1122223455678899999999999996
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=355.82 Aligned_cols=249 Identities=27% Similarity=0.462 Sum_probs=203.0
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEECC--CC----eEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLED--NT----NVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA 227 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 227 (442)
+........+.||+|.||.||.|.+.+ +. .||||.+... +.....+|.+|..+|++++|||||+++|++.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 345556778899999999999999643 32 4999999665 4556678999999999999999999999999999
Q ss_pred eeeeEEecCCCCCHHHHHccCCC---CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccC
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGL 291 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGl 291 (442)
..+|++|||++|||..||++.+. ....++....+.++.|||+|+.||+++ ++....+||+|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999999986421 235688999999999999999999544 55667899999999
Q ss_pred ccccCCCcceeeccc-ccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHh
Q 047892 292 AKLLGAERSYVTTRV-MGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMV 369 (442)
Q Consensus 292 a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 369 (442)
|+.+...+.+..... .-...|||||.+..+.|+.|+|||||||+|||++| |..||...+..+. .. ...
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-------~~---~~~ 918 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-------LL---DVL 918 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH-------HH---HHH
Confidence 997766665544333 34579999999999999999999999999999999 9999976543221 11 111
Q ss_pred hcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 370 TNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
..+ +.+++..|++.++++|..||+.+|++||++..|++.+..+.
T Consensus 919 ~gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 919 EGG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred hCC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 111 34567778889999999999999999999999999988764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=329.11 Aligned_cols=240 Identities=24% Similarity=0.405 Sum_probs=197.6
Q ss_pred hHHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 152 ELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 152 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
.+++..+....++-||.|+-|.||+|++ .++.||||+++.. -..+|+.|++|+||||+.+.|+|.....+||
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCI 189 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRL-HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCI 189 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeec-cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEE
Confidence 3456666666778899999999999998 4688999988432 1247888999999999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~~~~~ 298 (442)
|||||..|.|.+.|+.. ..++......+..+||.||.|||.+ ++ .+-.|||+|||.++.+.+.
T Consensus 190 iMEfCa~GqL~~VLka~----~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKAG----RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred eeeccccccHHHHHhcc----CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 99999999999999865 5788888999999999999999765 33 3457899999999987543
Q ss_pred cceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 299 RSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
...-.++||..|||||++.+.+.++|+|||||||+|||||||..||.+-..... ...+-
T Consensus 266 --STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-------------------IwGVG 324 (904)
T KOG4721|consen 266 --STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-------------------IWGVG 324 (904)
T ss_pred --hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-------------------EEecc
Confidence 223458999999999999999999999999999999999999999965332111 12223
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCC
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 424 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 424 (442)
...+....+..+++.+.-|+++||+..|..||+|++|+..|+-..+
T Consensus 325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 3344555667788889999999999999999999999999885443
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=321.81 Aligned_cols=235 Identities=22% Similarity=0.317 Sum_probs=195.9
Q ss_pred CCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 159 GFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
.|+..+.||+|+||.||+|.. .+++.||+|.+.-. .....+.+++|+.+|..++++||.++|+.+..+..+|++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 477789999999999999995 56889999999543 3445577899999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceee
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT 303 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~ 303 (442)
.||++.+.++.. ..+.+..+..++++++.||.|||.+ +..+|.+||+|||++..+...... .
T Consensus 94 ~gGsv~~lL~~~----~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r-r 168 (467)
T KOG0201|consen 94 GGGSVLDLLKSG----NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR-R 168 (467)
T ss_pred cCcchhhhhccC----CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc-c
Confidence 999999999754 3447777888999999999999876 234589999999999887654443 3
Q ss_pred cccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccC
Q 047892 304 TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ 383 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (442)
.+++||+.|||||++.+..|+.|+||||||++.+||.+|.+|+....+... ...+....+
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv--------------------lflIpk~~P 228 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV--------------------LFLIPKSAP 228 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE--------------------EEeccCCCC
Confidence 778999999999999988999999999999999999999999976655322 223333333
Q ss_pred CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 384 EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 384 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
+.....++..+.+|+..||+.||+.||+|.++++.
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 33444667778999999999999999999999854
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=324.26 Aligned_cols=238 Identities=23% Similarity=0.358 Sum_probs=200.3
Q ss_pred hCCCCccCeeccCCcEEEEEEE-ECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 157 TNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
...|.....||+|+.|.||.|. ..+++.||||++........+-+.+|+.+|+..+|+|||++++.|.-++.+|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3457888899999999999999 456889999999776666677789999999999999999999999988999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
++||+|.+.+... .+++.++..|++++++||+|||.+ ++.+|.+||+|||++..+..... .
T Consensus 352 m~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 352 MEGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred cCCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 9999999998754 589999999999999999999876 45678999999999988765443 3
Q ss_pred ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCccc
Q 047892 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (442)
-.+.+||+.|||||++....|++|+||||||++++||+-|++||-..++ ...+..+..++..
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P----------lrAlyLIa~ng~P-------- 487 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP----------LRALYLIATNGTP-------- 487 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh----------HHHHHHHhhcCCC--------
Confidence 4567999999999999999999999999999999999999999965443 2223333333321
Q ss_pred CCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 383 QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 383 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
....+...+..+.+|+.+||+.|+++|++|.|+|+.
T Consensus 488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 222344566778899999999999999999999965
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=322.11 Aligned_cols=233 Identities=27% Similarity=0.386 Sum_probs=195.8
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
++|.+.+.||+|+||.||+|+. .+.+.||+|.+.+. ..+..+.+.+|++++++|+|||||.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4688889999999999999995 45889999998543 33456778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
||.| +|..+|... +.++++.+..++.+++.||.|||++ +...+.+|+||||+|+..+.+..
T Consensus 82 ~a~g-~L~~il~~d----~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~- 155 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD----GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS- 155 (808)
T ss_pred hhhh-hHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCce-
Confidence 9998 999999875 6899999999999999999999986 44567999999999998865433
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (442)
..+...|||.|||||++.+.+|+..+|.||+||++|||++|++||... .+.+.++....+.
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~----------si~~Lv~~I~~d~--------- 216 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR----------SITQLVKSILKDP--------- 216 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH----------HHHHHHHHHhcCC---------
Confidence 445678999999999999999999999999999999999999999642 2233333322221
Q ss_pred cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 382 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
..++...+..+..++...|.+||.+|.|..+++.
T Consensus 217 --v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 217 --VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred --CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1233466777889999999999999999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=316.57 Aligned_cols=252 Identities=21% Similarity=0.270 Sum_probs=196.9
Q ss_pred HhhCCCCccCeeccCCcEEEEEEE-ECCCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--Cee
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG--AHR 229 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~ 229 (442)
...+.|+.+++||+|.||.||+|+ ..+|+.||+|++.... ........+||.||++|+||||++|.+...+. ..+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 344568889999999999999999 5679999999996543 44456678999999999999999999998876 789
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~ 296 (442)
|||+|||++ ||.-++... .-.+++.++..++.|++.||+|+|.. ++.+|.+||+|||||++..
T Consensus 194 YlVFeYMdh-DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEEEecccc-hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999999999 999998653 35789999999999999999999876 6778999999999999886
Q ss_pred CCcceeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC--
Q 047892 297 AERSYVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN-- 373 (442)
Q Consensus 297 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 373 (442)
.......+..+-|+.|+|||++.+. .|++++|+||.||||.||++|++.|.+....+.+ +.+..+.....
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl-------~kIfklcGSP~e~ 342 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQL-------HKIFKLCGSPTED 342 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHH-------HHHHHHhCCCChh
Confidence 6665556667889999999999876 4999999999999999999999999876543221 11111111110
Q ss_pred cc--------cccCcccCC-----CCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 374 AE--------GVLDPRLQE-----KPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 374 ~~--------~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
+. ..+.+.... +.....+...++|+..+|..||++|.||.++|+
T Consensus 343 ~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 343 YWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00 011111000 001224556778999999999999999999885
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=300.23 Aligned_cols=255 Identities=20% Similarity=0.295 Sum_probs=194.5
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
+.|+.+.++|+|+||.||+|+.+ +|+.||||++.... ....+-..+|+++|++|+|||+|.++.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35778889999999999999954 59999999996542 3344557899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC-------CCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP-------KWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-------~~~~kl~DFGla~~~~~~~~~ 301 (442)
||+. ++.+-|.+. ...++......++.|++.|+.|+|++ ++| ++.+||||||+|+.+..+ ..
T Consensus 82 ~~dh-TvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-gd 156 (396)
T KOG0593|consen 82 YCDH-TVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-GD 156 (396)
T ss_pred ecch-HHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC-cc
Confidence 9998 666666554 24688899999999999999999875 444 678999999999998742 33
Q ss_pred eecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHH-----HHHHHHhhcCCcc
Q 047892 302 VTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF-----EWLKTMVTNGNAE 375 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 375 (442)
..+.++.|..|+|||.+.+ .+|+..+||||+||++.||++|.+.|.+.++.+..-...... ....-...+.-+.
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 3566788999999999987 679999999999999999999999998876644322111111 1111112222222
Q ss_pred cccCcccCCCCc-----HHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 376 GVLDPRLQEKPS-----SRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 376 ~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.+.-|......+ ...+.-+++|+..||+.||++|++.+|++.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 322222221111 234556889999999999999999999874
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=320.71 Aligned_cols=266 Identities=27% Similarity=0.416 Sum_probs=206.3
Q ss_pred ehhhHHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 047892 149 TLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG 226 (442)
Q Consensus 149 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 226 (442)
+.+++++..+.+.+.+.||+|+||+||+|.|- ..||||.+... .....+.|++|+..+++-+|.||+-++|+|...
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 34788888899999999999999999999983 36999999644 345667899999999999999999999999988
Q ss_pred CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcc
Q 047892 227 AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAK 293 (442)
Q Consensus 227 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~ 293 (442)
.. .||+.+|+|-+|..+|+.. ...+.....+.||.||++||.|||.. +..++.|||+||||+.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred ce-eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEeccccee
Confidence 77 9999999999999999865 35788899999999999999999875 4456899999999986
Q ss_pred ccCCCc-ceeecccccccCCCCccccc---CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHh
Q 047892 294 LLGAER-SYVTTRVMGTFGYVAPEYAS---TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMV 369 (442)
Q Consensus 294 ~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 369 (442)
.-..-. ........|...|||||++. ..+|++.+|||||||++|||++|..||..... +..- .++
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-dqIi----------fmV 605 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-DQII----------FMV 605 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-hheE----------EEe
Confidence 432111 11122345788999999984 45799999999999999999999999984332 2110 111
Q ss_pred hcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCCChhhhhhcccC
Q 047892 370 TNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDERRAGREH 436 (442)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~ 436 (442)
.. .++.+.+. .....+..++.+|+..||..++++||.+.+|+..|+.+....+.-++...++
T Consensus 606 Gr----G~l~pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS~S~P 667 (678)
T KOG0193|consen 606 GR----GYLMPDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRSASEP 667 (678)
T ss_pred cc----cccCccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccccCcCcc
Confidence 11 11111111 1234567788999999999999999999999999998876554444444333
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=327.39 Aligned_cols=253 Identities=27% Similarity=0.406 Sum_probs=200.2
Q ss_pred ehhhHHHhhCCCCccCeeccCCcEEEEEEEECC--C---CeEEEEEecC---cchhhHHHHHHHHHHHHhcCCCCcceEE
Q 047892 149 TLRELEVSTNGFADENVIGEGGYGIVYRGVLED--N---TNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLV 220 (442)
Q Consensus 149 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--~---~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~ 220 (442)
....+++..++..+.++||+|+||+||+|.+.. + ..||||..+. .......+|.+|.++|++++|||||+++
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 335667788888888999999999999999533 2 2389998874 2355667899999999999999999999
Q ss_pred EEEEeCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEe
Q 047892 221 GYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLS 287 (442)
Q Consensus 221 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~ 287 (442)
|++.....+++|||+|.||+|.++|++.. ..++..+.+.++.+.|.||+|||.. +..++.+||+
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeC
Confidence 99999999999999999999999998762 3699999999999999999999876 3445667999
Q ss_pred cccCccccCCCcceeec-ccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHH
Q 047892 288 DFGLAKLLGAERSYVTT-RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWL 365 (442)
Q Consensus 288 DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 365 (442)
|||+++.-. ...... ...-+..|+|||.+..+.|++++|||||||++||+++ |..||.+.... .+
T Consensus 305 DFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-------~v---- 371 (474)
T KOG0194|consen 305 DFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-------EV---- 371 (474)
T ss_pred ccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-------HH----
Confidence 999988642 111111 1235689999999999999999999999999999999 88899764321 11
Q ss_pred HHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCC
Q 047892 366 KTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 425 (442)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 425 (442)
...+ .....+...+...+..+..++.+||..||++||||.++.+.|+.+...
T Consensus 372 ~~kI--------~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 372 KAKI--------VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred HHHH--------HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 1111 111222333345566778889999999999999999999999876544
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=325.36 Aligned_cols=249 Identities=23% Similarity=0.395 Sum_probs=209.8
Q ss_pred hhHHHhhCCCCccCeeccCCcEEEEEEEECC-CCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 047892 151 RELEVSTNGFADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 151 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 229 (442)
+++++.+.+.....+||-|.||.||.|.|+. .-.||||.++.+ ....++|+.|..+|+.++|||+|+|+|+|+.+..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 6788888889999999999999999999865 678999998764 45668899999999999999999999999999999
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhh------hcC-------CCCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL------HEG-------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yL------H~~-------l~~~~~~kl~DFGla~~~~ 296 (442)
|||+|||..|+|.+||++.. ...++.-..+.++.||+.||+|| |++ +..+..+|++||||++++.
T Consensus 339 YIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 99999999999999998652 34567778899999999999998 666 4456678999999999986
Q ss_pred CCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 297 AERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
.+.........-.+.|.|||.+..+.|+.|+|||+|||+|||+.| |..||.+-+. .+ +.
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl----------Sq----------VY 476 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------SQ----------VY 476 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH----------HH----------HH
Confidence 554433333334688999999999999999999999999999999 9999975322 11 12
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.++...++.+.+..|+..+++||..||+++|.+||++.|+-+.++.+
T Consensus 477 ~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 477 GLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred HHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 33445566677788889999999999999999999999999998875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=307.90 Aligned_cols=251 Identities=21% Similarity=0.304 Sum_probs=198.0
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEE-ECCCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
....++|++.+.||.|..+.||+|+ .+.+..||||++.-. .....+.+.+|+..|+.++||||++++..|..+..+|+
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence 4556789999999999999999999 567899999999533 34446889999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
||.||.+|++.++++.... ..+.+..+..|.+++++||.|||.+ ++.+|.|||+|||.+..+...
T Consensus 102 VmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred eehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999999986532 3489999999999999999999876 677899999999998766432
Q ss_pred cce--ee-cccccccCCCCcccccC--CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC
Q 047892 299 RSY--VT-TRVMGTFGYVAPEYAST--GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373 (442)
Q Consensus 299 ~~~--~~-~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (442)
... .. .+++||+.|||||++.. ..|+.|+||||||++..||.+|..||....+... +.... ++.
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv----------Ll~tL-qn~ 248 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV----------LLLTL-QND 248 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH----------HHHHh-cCC
Confidence 211 11 56799999999999643 4599999999999999999999999975433211 11111 111
Q ss_pred cccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 374 AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.....-..+..+........+.+++..||+.||.+|||++++++
T Consensus 249 pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 249 PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11111112223333445667889999999999999999999985
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=296.73 Aligned_cols=226 Identities=25% Similarity=0.316 Sum_probs=189.3
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcch---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
...++|+.++.||.|+||+|.+++.+ +|..+|+|.+....- ...+...+|..+|+.+.||+++++++.|.+.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 34567889999999999999999954 588899999965432 33455778999999999999999999999999999
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
|||||++||.|+.++++. +.+++..++.+|.||+.||+|||+. ++.+|.+||+|||+|+.+..
T Consensus 121 mvmeyv~GGElFS~Lrk~----~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKS----GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EEEeccCCccHHHHHHhc----CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 999999999999999875 6799999999999999999999986 66789999999999998743
Q ss_pred CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
. +.+.||||.|+|||+++..+|+.++|+|||||++|||+.|.+||...++...+ ..+.++++
T Consensus 197 r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY-----------~KI~~~~v--- 258 (355)
T KOG0616|consen 197 R----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIY-----------EKILEGKV--- 258 (355)
T ss_pred c----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHH-----------HHHHhCcc---
Confidence 3 56789999999999999999999999999999999999999999876653221 11112211
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCC
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKR 409 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R 409 (442)
..+...+..+.+|+...|+.|-.+|
T Consensus 259 -------~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 -------KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -------cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2344455667889999999998888
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=316.95 Aligned_cols=255 Identities=22% Similarity=0.292 Sum_probs=195.5
Q ss_pred hCCCCccCeeccCCcEEEEEEE-ECCCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCC-eeeeE
Q 047892 157 TNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVR-HKNLVRLVGYCAEGA-HRMLV 232 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~-~~~lv 232 (442)
.++|..++.||.|+||.||+|+ ..++..||||+++..- ......-.+|+..|++|+ |||||++++++.+.+ .+|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4568899999999999999999 5668999999997653 333344578999999998 999999999998888 99999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCCC-------CCeEEecccCccccCCCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEPK-------WNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~~-------~~~kl~DFGla~~~~~~~ 299 (442)
||||+. +|.++++.+ ...+++..++.|+.||++||+|+|.+ ++|+ ..+||+|||+||.+....
T Consensus 89 fE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred HHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCC
Confidence 999998 999999876 46899999999999999999999765 5554 478999999999875443
Q ss_pred ceeecccccccCCCCccccc-CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHH------HHHH--HHh-
Q 047892 300 SYVTTRVMGTFGYVAPEYAS-TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF------EWLK--TMV- 369 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~------~~~~--~~~- 369 (442)
. .+.++.|..|+|||++. .+-|+.+.|+||+|||++|+.+-++.|.+.+..+..-....++ .|.. .+.
T Consensus 165 P--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 165 P--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred C--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 3 45678999999999875 5669999999999999999999999998876544321111111 0100 000
Q ss_pred -hcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 370 -TNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 370 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.+-.+.......+..-.+ .++.++.+++.+|+.+||++||||.|+++.
T Consensus 243 ~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 000111111111111122 367788899999999999999999999876
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=309.21 Aligned_cols=233 Identities=18% Similarity=0.343 Sum_probs=184.4
Q ss_pred cCeeccCCcEEEEEEEECCCCeEEEEEecCcch---hhHHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeeeeEEec
Q 047892 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLVGYCAE----GAHRMLVNEY 235 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~lv~E~ 235 (442)
...||+|++|.||+|.+ +|+.||||.+..... ...+.+.+|+.+|++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 688999999865422 224668899999999999999999999876 3567999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC--------------CCCCCCeEEecccCccccCCCcce
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
+++|+|.+++... ..+++.....++.|++.||.|||.. ++.++.+||+|||+++.+....
T Consensus 104 ~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 104 CTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 9999999999764 4688899999999999999999963 3346789999999998654322
Q ss_pred eecccccccCCCCcccccC--CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 302 VTTRVMGTFGYVAPEYAST--GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... +......... .
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~----------~~~~~i~~~~-~----- 239 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK----------EIYDLIINKN-N----- 239 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH----------HHHHHHHhcC-C-----
Confidence 23468899999999976 67999999999999999999999999754321 1111111111 0
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....+..++..+.+++.+||+.||++|||+.++++.|+...
T Consensus 240 ---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 240 ---SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ---CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11112234567889999999999999999999999998754
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=316.19 Aligned_cols=239 Identities=21% Similarity=0.285 Sum_probs=196.3
Q ss_pred HhhCCCCccCeeccCCcEEEEEEE-ECCCCeEEEEEecCc---chhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCee
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 229 (442)
...++|.+.+.||+|+|++|++|+ ..+++.+|||++.+. .....+.+.+|-.+|.+| .||.|++|+..|++...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345679999999999999999999 456999999988543 223334577899999999 899999999999999999
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~ 296 (442)
|+|+||+++|+|.++|++. +.+++...+.++.+|+.||+|||+. ++.++++||+|||.|+.+.
T Consensus 150 YFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 9999999999999999876 6899999999999999999999876 5667899999999999875
Q ss_pred CCcce----------ee--cccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHH
Q 047892 297 AERSY----------VT--TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEW 364 (442)
Q Consensus 297 ~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 364 (442)
..... .. ..++||..|.+||++..+..++.+|+|+||||||+|+.|.+||.+.+.-..|+..
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI------ 299 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI------ 299 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH------
Confidence 42211 11 4589999999999999999999999999999999999999999876553322211
Q ss_pred HHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 365 LKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.. +....+...++.+.+|+.+.|..||.+|+|+.||-+.
T Consensus 300 -~~--------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 300 -QA--------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -HH--------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 10 1112333444668889999999999999999888754
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=318.77 Aligned_cols=251 Identities=25% Similarity=0.402 Sum_probs=190.8
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEE------CCCCeEEEEEecCcc-hhhHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAE 225 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 225 (442)
+++.++|++.+.||+|+||.||+|.+ .++..||||.+.... ......+.+|+.++..+ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 45667899999999999999999974 235679999986433 23446788999999999 89999999998876
Q ss_pred C-CeeeeEEecCCCCCHHHHHccCCCC-----------------------------------------------------
Q 047892 226 G-AHRMLVNEYVDNGNLEQWLHGDVGP----------------------------------------------------- 251 (442)
Q Consensus 226 ~-~~~~lv~E~~~~g~L~~~l~~~~~~----------------------------------------------------- 251 (442)
. +.+++||||+++|+|.+++......
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 4 4578999999999999999753210
Q ss_pred -----CCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCCCeEEecccCccccCCCcce-eecccccccCC
Q 047892 252 -----HSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGY 312 (442)
Q Consensus 252 -----~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y 312 (442)
...+++.....++.|++.||.|||+. + +.++.+||+|||+++.+...... ......++..|
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 13477888999999999999999875 3 34678999999999865433221 12233467889
Q ss_pred CCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHH
Q 047892 313 VAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRAL 391 (442)
Q Consensus 313 ~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (442)
+|||++.+..++.++|||||||++|||++ |..||........ . ......+.. ...+...+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~----~~~~~~~~~---------~~~~~~~~ 303 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------F----CQRLKDGTR---------MRAPENAT 303 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------H----HHHHhcCCC---------CCCCCCCC
Confidence 99999999999999999999999999997 9999975432111 1 111111111 01122334
Q ss_pred HHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 392 KRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 392 ~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
..+.+|+.+||+.||++|||+.|+++.|+.+.
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 56888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=316.19 Aligned_cols=235 Identities=24% Similarity=0.363 Sum_probs=190.5
Q ss_pred hhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc----ch-hhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCe
Q 047892 156 STNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN----RG-QAEKEFKVEVEAIGRVR-HKNLVRLVGYCAEGAH 228 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~ 228 (442)
..+.|.+.+.||+|+||+|+.|.. .++..||+|.+... .. ...+.+.+|+.+++.++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 346799999999999999999984 56899999966442 11 23456778999999999 9999999999999999
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCC-CCeEEecccCccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPK-WNPKLSDFGLAKL 294 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~-~~~kl~DFGla~~ 294 (442)
+|+|||||.||+|.+++.+. ..+.+..+..++.|++.|++|||+. ++.+ +++||+|||++..
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~----g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK----GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEEEEecCCccHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 99999999999999999874 6788899999999999999999876 4556 8999999999998
Q ss_pred cCCCcceeecccccccCCCCcccccCCC-CC-CcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYASTGM-LN-ETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (442)
.. .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+..+.... ... ...+
T Consensus 171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l----------~~k-i~~~ 238 (370)
T KOG0583|consen 171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL----------YRK-IRKG 238 (370)
T ss_pred cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH----------HHH-HhcC
Confidence 63 2223456789999999999999877 86 679999999999999999999987433211 111 1111
Q ss_pred CcccccCcccCCCCcHHH-HHHHHHHHhhhhCCCCCCCCCHHHHH
Q 047892 373 NAEGVLDPRLQEKPSSRA-LKRALLVALRCVDPNAHKRPKMGHVI 416 (442)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~-~~~~~~li~~cl~~dP~~RPs~~evl 416 (442)
.+ ..+... +.++..|+.+||..||.+|+|+.+|+
T Consensus 239 ~~----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 239 EF----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred Cc----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 11 111111 56688899999999999999999998
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=325.16 Aligned_cols=233 Identities=24% Similarity=0.337 Sum_probs=191.9
Q ss_pred HHHhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC
Q 047892 153 LEVSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGA 227 (442)
Q Consensus 153 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 227 (442)
-.+..++|.++++||+|+||+|+++..+ +++.+|||.+++.. ....+....|.+|+... +||.+++++.+|+..+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 3456778999999999999999999964 58899999997653 34556678888888777 5999999999999999
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKL 294 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~ 294 (442)
++|+||||+.|||+..+.+. ..+++..+..++..|+.||+|||.+ ++.+|++||+|||+++.
T Consensus 443 ~l~fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred eEEEEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccc
Confidence 99999999999996655543 4789999999999999999999987 77899999999999986
Q ss_pred cCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
.-. ....+.++|||+.|||||++.+..|+.++|+|||||+||||+.|+.||.+.+..+.+. .....
T Consensus 518 ~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd----------sI~~d--- 583 (694)
T KOG0694|consen 518 GMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD----------SIVND--- 583 (694)
T ss_pred cCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH----------HHhcC---
Confidence 421 2235778999999999999999999999999999999999999999998765533321 11111
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCH
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKM 412 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~ 412 (442)
...++.-.+.+...++.++|..||++|..+
T Consensus 584 --------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 --------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --------CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 112333455678889999999999999866
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=309.28 Aligned_cols=240 Identities=25% Similarity=0.382 Sum_probs=187.3
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--eeeeEEec
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA--HRMLVNEY 235 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~lv~E~ 235 (442)
++...+.||+|+||.||++... +|...|||.+...+....+.+.+|+.+|++++|||||+++|...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 3667889999999999999964 48999999986554333667899999999999999999999854444 68999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCC-CCCeEEecccCccccCC--Cc
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEP-KWNPKLSDFGLAKLLGA--ER 299 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~-~~~~kl~DFGla~~~~~--~~ 299 (442)
+++|+|.+++.+.. ..+++..+..+++||++||.|||++ +++ ++.+||+|||+++.... ..
T Consensus 98 ~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 98 APGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred cCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999999998762 2699999999999999999999975 445 57999999999987653 11
Q ss_pred ceeecccccccCCCCcccccCCC-CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGM-LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
........||+.|||||++.++. ...++|||||||++.||+||+.||.... ....++........
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~---------~~~~~~~~ig~~~~----- 240 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF---------EEAEALLLIGREDS----- 240 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc---------chHHHHHHHhccCC-----
Confidence 22234578999999999998643 3359999999999999999999996420 01111111211111
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHH
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHML 419 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L 419 (442)
.| ..+...+.+..+++.+|+..||+.||||.++|+..
T Consensus 241 ~P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 241 LP----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred CC----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 11 23334566788899999999999999999999764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=283.83 Aligned_cols=260 Identities=20% Similarity=0.264 Sum_probs=197.6
Q ss_pred CCCccCeeccCCcEEEEEEE-ECCCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 159 GFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
+|...+.||+|.||.||+|+ .++|+.||||+++... ........+|++.|+.++|+||+.++++|...+.+-||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 57788999999999999999 5679999999996432 22345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
++. ||...|+.. ...++...+..++.++++|++|||++ +.++|.+||+|||+|+.........
T Consensus 83 m~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 83 MPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred ccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 998 999999765 46789999999999999999999875 4456899999999999987655433
Q ss_pred ecccccccCCCCcccccCCC-CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC--------
Q 047892 303 TTRVMGTFGYVAPEYASTGM-LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN-------- 373 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 373 (442)
+ ..+-|..|+|||.+.+.+ |+..+|+||.|||+.||+-|.+-|.+.++-+... .+-.......
T Consensus 159 ~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~-------~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 159 T-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLS-------KIFRALGTPTPDQWPEMT 230 (318)
T ss_pred c-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHH-------HHHHHcCCCCcccCcccc
Confidence 3 337799999999997754 9999999999999999999998887765432211 1111111000
Q ss_pred ----ccc--ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH--HhcCCCCChhhh
Q 047892 374 ----AEG--VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM--LEAEEFPFRDER 430 (442)
Q Consensus 374 ----~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~~~~ 430 (442)
+.. ..........-..++.+.++|+.++|..||.+|+|+.|++++ +.+...+-...+
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~ 295 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSK 295 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhh
Confidence 000 011111111223456667999999999999999999999965 555444433333
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=315.95 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=207.3
Q ss_pred hhHHHhhCCCCccCeeccCCcEEEEEEEECC---C--CeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 047892 151 RELEVSTNGFADENVIGEGGYGIVYRGVLED---N--TNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCA 224 (442)
Q Consensus 151 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 224 (442)
+.+++.++.....+.||+|.||.||+|.+.+ | -.||||..+.+ .....+.|..|..+|++++|||||+++|+|.
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 3455666677788999999999999999532 2 34899988764 4556778999999999999999999999998
Q ss_pred eCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccC
Q 047892 225 EGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGL 291 (442)
Q Consensus 225 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGl 291 (442)
+ ...|||||+++-|.|..||+.+ ...++......++.||+.||.|||+. +. ..-.+||+|||+
T Consensus 462 e-~P~WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 462 E-QPMWIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred c-cceeEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccch
Confidence 6 4689999999999999999876 35688889999999999999999654 32 334689999999
Q ss_pred ccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhh
Q 047892 292 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVT 370 (442)
Q Consensus 292 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 370 (442)
++.+.++..+..+...-++.|||||.+...+|+.+||||-|||++||++. |..||.+-...+.
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV---------------- 601 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV---------------- 601 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce----------------
Confidence 99998877766665566789999999999999999999999999999998 9999986544332
Q ss_pred cCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCC
Q 047892 371 NGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 424 (442)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 424 (442)
...+...-+.+.+..|+..++.|+.+||+.||.+||.+.++...|+.+.+
T Consensus 602 ----I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 602 ----IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ----EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 23344444556677788889999999999999999999999999887654
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=314.97 Aligned_cols=232 Identities=25% Similarity=0.325 Sum_probs=193.8
Q ss_pred CCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 160 FADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
|++.+.||.|+-|.|-+|++ .+|+.+|||++... .......+.+|+-+|+-+.||||+++|+++++..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 77889999999999999994 67999999999554 223345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++|.|++++-++ +++++..+.+++.||+.|+.|+|.. ++.++++||+|||+|..-.. ...
T Consensus 94 v~gGELFdylv~k----G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--gkl 167 (786)
T KOG0588|consen 94 VPGGELFDYLVRK----GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP--GKL 167 (786)
T ss_pred cCCchhHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC--Ccc
Confidence 9999999999876 7899999999999999999999764 45567899999999986432 334
Q ss_pred ecccccccCCCCcccccCCCCC-CcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcc
Q 047892 303 TTRVMGTFGYVAPEYASTGMLN-ETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (442)
..+.||++.|.|||++.+.+|+ .++||||.|||||.||||+.||++.+. .. +...+..+.+
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi----------r~-LLlKV~~G~f------- 229 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI----------RV-LLLKVQRGVF------- 229 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH----------HH-HHHHHHcCcc-------
Confidence 5567999999999999999986 689999999999999999999985432 11 2222333322
Q ss_pred cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 382 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
+.+...+.++.+|+.+|+..||+.|.|++||++.
T Consensus 230 ---~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 ---EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ---cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 2335566678889999999999999999999976
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=310.65 Aligned_cols=243 Identities=22% Similarity=0.317 Sum_probs=190.5
Q ss_pred hHHHhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 047892 152 ELEVSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA 227 (442)
Q Consensus 152 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 227 (442)
...+..++|+++..||+|+||.||+|+. .+|..+|+|++++.. ....+.++.|-.+|...++|+||+|+-.|++.+
T Consensus 135 R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 135 RTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred cccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 3456778999999999999999999994 569999999997653 234456788999999999999999999999999
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhh------hhhcCCCC-------CCCeEEecccCccc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT------YLHEGLEP-------KWNPKLSDFGLAKL 294 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~------yLH~~l~~-------~~~~kl~DFGla~~ 294 (442)
++||||||++|||+..+|.+. ..+++..+..++.+.+.|++ |+|++|+| .|++||+||||+..
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~----~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRK----DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred eeEEEEEecCCccHHHHHHhc----CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccch
Confidence 999999999999999999875 67899888888877776655 55666555 58999999999954
Q ss_pred cCCC---------------------ccee-----e--------------------cccccccCCCCcccccCCCCCCcCC
Q 047892 295 LGAE---------------------RSYV-----T--------------------TRVMGTFGYVAPEYASTGMLNETSD 328 (442)
Q Consensus 295 ~~~~---------------------~~~~-----~--------------------~~~~gt~~y~aPE~~~~~~~~~~sD 328 (442)
+... .... . ...+|||.|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 3110 0000 0 1247999999999999999999999
Q ss_pred chhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCC
Q 047892 329 VYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHK 408 (442)
Q Consensus 329 vwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~ 408 (442)
+||||||+||||.|.+||...++.+.+. ++..|-. .+........+.+..+||.+|+. ||++
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~r---kI~nwr~--------------~l~fP~~~~~s~eA~DLI~rll~-d~~~ 432 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYR---KIVNWRE--------------TLKFPEEVDLSDEAKDLITRLLC-DPEN 432 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhh--------------hccCCCcCcccHHHHHHHHHHhc-CHHH
Confidence 9999999999999999999877654432 2222221 12222233444778999999999 9999
Q ss_pred CCC---HHHHH
Q 047892 409 RPK---MGHVI 416 (442)
Q Consensus 409 RPs---~~evl 416 (442)
|.. +.||-
T Consensus 433 RLG~~G~~EIK 443 (550)
T KOG0605|consen 433 RLGSKGAEEIK 443 (550)
T ss_pred hcCcccHHHHh
Confidence 975 55554
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=299.50 Aligned_cols=243 Identities=26% Similarity=0.421 Sum_probs=190.1
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC----CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE----DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
.++|++.+.||+|+||.||+|.+. .+..||+|.+.... ......+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 456888999999999999999853 35689999986543 3344678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. ++.++.+|++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999754 24688999999999999999999875 455678999999987654322
Q ss_pred cceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 299 RSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
.........++..|+|||.+.+..++.++|||||||++||+++ |..||...... .... . ...+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-------~~~~---~-~~~~~---- 225 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-------DVIK---A-VEDGF---- 225 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHH---H-HHCCC----
Confidence 2222223345678999999999999999999999999999876 99999654321 1111 1 11111
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
....+..++..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 226 -----~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 -----RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1111233455688899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=309.10 Aligned_cols=238 Identities=22% Similarity=0.295 Sum_probs=197.5
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe-eeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAH-RMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-~~lv~ 233 (442)
++|..++++|+|+||.++.++.+ ++..+++|++.-. .....+...+|+.++++++|||||.+++.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46889999999999999999854 4778999998543 33344567889999999999999999999998888 89999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
+||+||+|.+.|.+.. ...+++..+..++.|++.|+.|||++ +..++.|||.|||+|+.+.....
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 9999999999998764 35689999999999999999999965 55678899999999999876542
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
...+.+||+.||+||++.+.+|+.|+|||||||++|||++-+++|.+.+.... +.+.. .
T Consensus 162 -~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L----------i~ki~----------~ 220 (426)
T KOG0589|consen 162 -LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL----------ILKIN----------R 220 (426)
T ss_pred -hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH----------HHHHh----------h
Confidence 34567899999999999999999999999999999999999999987544221 11111 1
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
......+...+.++..++..||..+|+.||++.++|..
T Consensus 221 ~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11223445666778889999999999999999999976
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=297.91 Aligned_cols=233 Identities=19% Similarity=0.350 Sum_probs=192.9
Q ss_pred CCCCccCeeccCCcEEEEEEE-ECCCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
.+|++.+.||+|.||+|-+|. ...|+.||||.++++. .+..-.+.+|++||+.|+||||+++|.+|++.+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 458888999999999999999 4679999999996653 344456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||..+|+|.+|+.+. +.+++..+..+++||..|+.|+|.+ ++.++++||+||||+..+....
T Consensus 133 EYaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k- 207 (668)
T KOG0611|consen 133 EYASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK- 207 (668)
T ss_pred EecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc-
Confidence 999999999999876 6899999999999999999999986 6789999999999998764433
Q ss_pred eeecccccccCCCCcccccCCCCC-CcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLN-ETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
...++||++-|.+||++.+.+|. +.+|-|||||+||-|+.|..||++.+.. .+-..+..+.+. .
T Consensus 208 -fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-----------~lvrQIs~GaYr---E 272 (668)
T KOG0611|consen 208 -FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-----------RLVRQISRGAYR---E 272 (668)
T ss_pred -HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-----------HHHHHhhccccc---C
Confidence 35678999999999999999985 7899999999999999999999864321 111222233222 1
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
+ ..+ ....-||.+||..||++|.|+.+|...
T Consensus 273 P----~~P----SdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 273 P----ETP----SDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred C----CCC----chHHHHHHHHHhcCcccchhHHHHhhh
Confidence 1 111 224458899999999999999999754
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=298.86 Aligned_cols=253 Identities=22% Similarity=0.373 Sum_probs=188.9
Q ss_pred hhCCCCccCeeccCCcEEEEEEEECC-----------------CCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcc
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLED-----------------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLV 217 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv 217 (442)
..++|.+.+.||+|+||.||+|.+++ +..||+|.+.... ......+.+|++++.+++||||+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 34578899999999999999998532 3369999886543 33456789999999999999999
Q ss_pred eEEEEEEeCCeeeeEEecCCCCCHHHHHccCCC---------------CCCCCCHHHHHHHHHHHHHhhhhhhcC-----
Q 047892 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVG---------------PHSPLTWEIRMNIILGTAKGLTYLHEG----- 277 (442)
Q Consensus 218 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~---------------~~~~l~~~~~~~i~~qi~~~l~yLH~~----- 277 (442)
++++++.+.+..++||||+++|+|.+++..... ....+++...+.++.|++.||.|||+.
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 999999999999999999999999999864311 113467888999999999999999875
Q ss_pred --------CCCCCCeEEecccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh--CCCCC
Q 047892 278 --------LEPKWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS--GRNPV 346 (442)
Q Consensus 278 --------l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt--g~~Pf 346 (442)
++.++.+||+|||+++.+...... ......++..|+|||++.++.++.++|||||||++|||++ +..||
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 345678999999999876443322 2233456889999999988899999999999999999987 56677
Q ss_pred CCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 347 DYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
...... ................. ....+..++..+.+|+.+||+.||++|||+.+|.+.|++
T Consensus 243 ~~~~~~-------~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 243 GELTDE-------QVIENAGEFFRDQGRQV------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CcCCHH-------HHHHHHHHHhhhccccc------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 543221 11121111111110000 001112334568889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=297.71 Aligned_cols=257 Identities=25% Similarity=0.404 Sum_probs=196.9
Q ss_pred CCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHh--cCCCCcceEEEEEEeCC----eeeeEE
Q 047892 160 FADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR--VRHKNLVRLVGYCAEGA----HRMLVN 233 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~~----~~~lv~ 233 (442)
..+.++||+|+||.||+|.+ +++.||||++ .....+.|.+|-+|.+. ++|+||++++++-.... .++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL-~~~~VAVKif---p~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQL-DNRLVAVKIF---PEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhc-cCceeEEEec---CHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 45568899999999999998 4589999999 45566778888888764 58999999999876555 789999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC----------------------CCCCCCeEEecccC
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG----------------------LEPKWNPKLSDFGL 291 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~----------------------l~~~~~~kl~DFGl 291 (442)
||.+.|+|.+||+.+ .++|....+++..+++||+|||.+ ++.++++.|+||||
T Consensus 288 ~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999876 799999999999999999999987 45577889999999
Q ss_pred ccccCCCcce-eecccccccCCCCcccccCCC-CC-----CcCCchhhHHHHHHHHhCCCCCCC-CCCCCccchh-----
Q 047892 292 AKLLGAERSY-VTTRVMGTFGYVAPEYASTGM-LN-----ETSDVYSFGILIMEVISGRNPVDY-SRPPGEFQFQ----- 358 (442)
Q Consensus 292 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDvwSlGvil~elltg~~Pf~~-~~~~~~~~~~----- 358 (442)
|..+...... .....+||.+|||||++.+.. +. .+.||||+|.+||||++...-++. .-++-...+.
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 9887543322 223478999999999997643 22 368999999999999998766542 2222122222
Q ss_pred hhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCCChh
Q 047892 359 VNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRD 428 (442)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 428 (442)
....+.++..+...+.+..+...+... ....-+.+.+..||+.||+.|.|+.-+-+++.+++...+.
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 223445555555555554454444443 2344567788899999999999999999999988766544
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=313.17 Aligned_cols=251 Identities=24% Similarity=0.406 Sum_probs=190.8
Q ss_pred HHHhhCCCCccCeeccCCcEEEEEEEE------CCCCeEEEEEecCc-chhhHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 047892 153 LEVSTNGFADENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCA 224 (442)
Q Consensus 153 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 224 (442)
+.+..++|++.+.||+|+||.||+|.+ .++..||||.+... .....+.+.+|+.++..+ +||||+++++++.
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 345566799999999999999999973 23568999998643 233456788999999999 8999999999999
Q ss_pred eCCeeeeEEecCCCCCHHHHHccCCC------------------------------------------------------
Q 047892 225 EGAHRMLVNEYVDNGNLEQWLHGDVG------------------------------------------------------ 250 (442)
Q Consensus 225 ~~~~~~lv~E~~~~g~L~~~l~~~~~------------------------------------------------------ 250 (442)
..+..++|||||++|+|.++++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 99999999999999999999964321
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCccccCCCcc
Q 047892 251 -----------------PHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 251 -----------------~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~~~~~~~ 300 (442)
....+++..++.++.|++.||.|||+. ++ .++.+||+|||+++.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 012478888999999999999999875 33 456789999999987643322
Q ss_pred ee-ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 301 YV-TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 301 ~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
.. .....++..|+|||++.+..++.++|||||||++|||++ |..||...... ...... ...+.
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~------~~~~~~----~~~~~----- 334 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD------SKFYKM----IKEGY----- 334 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch------HHHHHH----HHhCc-----
Confidence 11 122345678999999999999999999999999999998 89998653221 111111 11111
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
....+...+.++.+|+.+||+.||++|||+.||++.|++.
T Consensus 335 ----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 335 ----RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ----cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0011112235688899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=294.68 Aligned_cols=239 Identities=22% Similarity=0.394 Sum_probs=188.0
Q ss_pred CCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCC
Q 047892 158 NGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVD 237 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 237 (442)
++|++.+.||+|+||.||++.++++..+|+|.+.... .....+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4578889999999999999998778889999875432 334568889999999999999999999999999999999999
Q ss_pred CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeec
Q 047892 238 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTT 304 (442)
Q Consensus 238 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~ 304 (442)
+|+|.++++... ..+++..++.++.|++.||.|||.. ++.++.+||+|||+++...........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 83 NGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 999999997542 3588999999999999999999876 345678999999999865433332223
Q ss_pred ccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccC
Q 047892 305 RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ 383 (442)
Q Consensus 305 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (442)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +...... .+. ..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~----------~~~~~i~-~~~--~~------ 220 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY----------EVVEMIS-RGF--RL------ 220 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH----------HHHHHHH-CCC--CC------
Confidence 3345678999999988889999999999999999999 99999654321 1111111 111 00
Q ss_pred CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHh
Q 047892 384 EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420 (442)
Q Consensus 384 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 420 (442)
..+...+..+.+++.+||+.||++|||+.++++.|.
T Consensus 221 -~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 221 -YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011112346888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=295.49 Aligned_cols=245 Identities=22% Similarity=0.377 Sum_probs=193.7
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
+..++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++...+..+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 4456789999999999999999998788889999875432 335678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
|+++|+|.+++++.. ...+++..++.++.|++.||+|||.. ++.++.+||+|||+++........
T Consensus 82 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 82 YMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred cCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999999997542 24578888999999999999999876 445678999999999876443322
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
......++..|+|||.+.+..++.++|||||||++|||++ |..||...... .....+ ....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~----~~~~------- 221 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-------DVMSAL----QRGY------- 221 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-------HHHHHH----HcCC-------
Confidence 2233446778999999988889999999999999999998 99999643221 111111 1110
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
........+..+.+++.+||+.||++|||++++++.|++.
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 222 --RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred --CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0011122345688899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=302.20 Aligned_cols=249 Identities=20% Similarity=0.301 Sum_probs=189.7
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
..++|++.+.||+|+||.||++... ++..+|+|.+... .......+.+|++++++++||||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 3567999999999999999999965 5888999988643 2344567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC--------------CCCCCCeEEecccCccccCCCc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++.+...
T Consensus 83 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 83 EHMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 999999999999764 4588999999999999999999863 334678999999999865332
Q ss_pred ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC---Cc--
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG---NA-- 374 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-- 374 (442)
......||..|+|||++.+..++.++|||||||++|||++|+.||......+ +...+....... ..
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 228 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE-------LEAIFGRPVVDGEEGEPHS 228 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHhcccccccccCCccc
Confidence 1234578999999999998899999999999999999999999996432211 000000000000 00
Q ss_pred -----------------------------ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 375 -----------------------------EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 375 -----------------------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
................+.++.+|+.+||+.||++|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000011112345678899999999999999999999865
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=296.38 Aligned_cols=256 Identities=20% Similarity=0.228 Sum_probs=187.5
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
++|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36889999999999999999975 57889999986432 2334567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
|++++.+..+.... ..+++..++.++.|++.||.|||+. ++.++.+||+|||+++.+......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 99997776554322 4688999999999999999999875 455778999999999876443332
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhH-----HHHHHHHhhcCCccc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNL-----FEWLKTMVTNGNAEG 376 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 376 (442)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+........ ...............
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 233457899999999999888999999999999999999999999764322111000000 000000001110000
Q ss_pred ccCcccCC------CCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 377 VLDPRLQE------KPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 377 ~~~~~~~~------~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
...+.... ......+..+.+|+.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00010000 011124566889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=310.65 Aligned_cols=251 Identities=24% Similarity=0.401 Sum_probs=190.5
Q ss_pred HHHhhCCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 047892 153 LEVSTNGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLVGYCA 224 (442)
Q Consensus 153 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 224 (442)
+.+..++|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+++++.+ +||||+++++++.
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 3455668999999999999999999841 23579999996543 33456688999999999 8999999999999
Q ss_pred eCCeeeeEEecCCCCCHHHHHccCCC------------------------------------------------------
Q 047892 225 EGAHRMLVNEYVDNGNLEQWLHGDVG------------------------------------------------------ 250 (442)
Q Consensus 225 ~~~~~~lv~E~~~~g~L~~~l~~~~~------------------------------------------------------ 250 (442)
..+..|+|||||++|+|.++++....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 99999999999999999999864210
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce-eec
Q 047892 251 ------------PHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY-VTT 304 (442)
Q Consensus 251 ------------~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~-~~~ 304 (442)
....+++..++.++.|++.||.|||+. ++.++.+||+|||+++.+...... ...
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 112478888999999999999999865 334568999999999865433221 112
Q ss_pred ccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccC
Q 047892 305 RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ 383 (442)
Q Consensus 305 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (442)
...++..|||||++.+..++.++|||||||++|||++ |+.||........ . ......+ ..
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~----~~~~~~~---------~~ 333 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------F----YKMVKRG---------YQ 333 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------H----HHHHHcc---------cC
Confidence 2345678999999988899999999999999999997 9999965322110 1 1111111 01
Q ss_pred CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 384 EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 384 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
...+...+.++.+++.+||+.||++|||+.+|++.|+++
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011111245688899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=302.35 Aligned_cols=240 Identities=22% Similarity=0.287 Sum_probs=189.3
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++..++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 35888999999999999999965 48899999986432 223456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 999999999999754 4688999999999999999999875 45678999999999986533
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
......||+.|+|||++.+..++.++|||||||++|||++|..||......+. ...+. ... ..+..
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------~~~i~---~~~---~~~~~ 219 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-------WENLK---YWK---ETLQR 219 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-------HHHHH---hcc---ccccC
Confidence 23446799999999999988999999999999999999999999975432111 11110 000 00111
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
..........+.++.+++.+||..+|++||++.++++.
T Consensus 220 ~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 11111112345678889999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=294.90 Aligned_cols=246 Identities=26% Similarity=0.442 Sum_probs=192.3
Q ss_pred hCCCCccCeeccCCcEEEEEEEECC-C-----CeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLED-N-----TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 229 (442)
.++|++.+.||+|+||.||+|.... + ..||+|.+.... ......+.+|+.++..++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 3468889999999999999998533 2 579999886433 34456789999999999999999999999999999
Q ss_pred eeEEecCCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCe
Q 047892 230 MLVNEYVDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNP 284 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~ 284 (442)
|++|||+++|+|.+++..... ....+++...+.++.|++.||.|||.. ++.++.+
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcE
Confidence 999999999999999975321 114578889999999999999999876 3456789
Q ss_pred EEecccCccccCCCcc-eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHH
Q 047892 285 KLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLF 362 (442)
Q Consensus 285 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~ 362 (442)
||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... ...
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-------~~~ 236 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------EVI 236 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHH
Confidence 9999999986533322 12334467889999999988899999999999999999998 99999754321 111
Q ss_pred HHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 363 EWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
. ....+. ....+...+.++.+|+.+||+.||++||++.+|++.|++.
T Consensus 237 ~----~i~~~~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 237 E----MIRSRQ---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred H----HHHcCC---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1 111111 1112234557788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=310.03 Aligned_cols=237 Identities=25% Similarity=0.371 Sum_probs=191.6
Q ss_pred CCCccCeeccCCcEEEEEEEECC--C--CeEEEEEecCcchh-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 159 GFADENVIGEGGYGIVYRGVLED--N--TNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
+....++||+|.||.|++|.|.. | ..||||++...... ....|.+|+.+|.+|+|||+++|||+..+ ....|||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 34567899999999999999753 3 35899999765433 67889999999999999999999999887 6788999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhh------hcCCC-------CCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL------HEGLE-------PKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yL------H~~l~-------~~~~~kl~DFGla~~~~~~~~ 300 (442)
|+++.|+|.+.|+.. ....+.......++.|||.||.|| |+++. ....+||+||||.+.++.++.
T Consensus 190 ELaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred hhcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 999999999999872 345688888999999999999999 66643 345799999999999876554
Q ss_pred ee--ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 301 YV--TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 301 ~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
.. .....-...|.|||.+....|+.++|||+|||++||||| |+.||.+.... +.+ ..
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------qIL----------~~ 327 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------QIL----------KN 327 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------HHH----------Hh
Confidence 32 122334678999999999999999999999999999999 99999765432 111 11
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
+|..-+...+..|++++++++++||..+|++||||..|.+.
T Consensus 328 iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 328 IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 22222334566788999999999999999999999999744
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=292.42 Aligned_cols=237 Identities=22% Similarity=0.265 Sum_probs=185.0
Q ss_pred CCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 160 FADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999999999995 568999999885432 22334578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++|+|.+++.... ...+++..++.++.|++.||+|||+. ++.++.+||+|||++....... .
T Consensus 82 ~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 157 (285)
T cd05631 82 MNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--T 157 (285)
T ss_pred cCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--e
Confidence 99999998886431 23588999999999999999999875 4456889999999998753322 1
Q ss_pred ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCccc
Q 047892 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (442)
.....||..|+|||++.+..++.++|||||||++|||++|+.||........ ...+.......
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-------~~~~~~~~~~~---------- 220 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-------REEVDRRVKED---------- 220 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-------HHHHHHHhhcc----------
Confidence 2345789999999999999999999999999999999999999976433211 01111111110
Q ss_pred CCCCcHHHHHHHHHHHhhhhCCCCCCCCC-----HHHHHH
Q 047892 383 QEKPSSRALKRALLVALRCVDPNAHKRPK-----MGHVIH 417 (442)
Q Consensus 383 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~ 417 (442)
........+..+.+|+.+||+.||++||+ ++++++
T Consensus 221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 01122234456788999999999999997 778775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=308.70 Aligned_cols=252 Identities=24% Similarity=0.395 Sum_probs=192.5
Q ss_pred HHHhhCCCCccCeeccCCcEEEEEEEECC------CCeEEEEEecCcc-hhhHHHHHHHHHHHHhcC-CCCcceEEEEEE
Q 047892 153 LEVSTNGFADENVIGEGGYGIVYRGVLED------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVR-HKNLVRLVGYCA 224 (442)
Q Consensus 153 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~ 224 (442)
+++..++|.+.+.||+|+||.||+|.+.. +..||||++.... ....+.+.+|+++|+++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 35567789999999999999999998521 3469999986432 334567899999999996 999999999999
Q ss_pred eCCeeeeEEecCCCCCHHHHHccCCC------------------------------------------------------
Q 047892 225 EGAHRMLVNEYVDNGNLEQWLHGDVG------------------------------------------------------ 250 (442)
Q Consensus 225 ~~~~~~lv~E~~~~g~L~~~l~~~~~------------------------------------------------------ 250 (442)
+.+..|||||||++|+|.++|+....
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 99999999999999999999864310
Q ss_pred --------------------------------------CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CC
Q 047892 251 --------------------------------------PHSPLTWEIRMNIILGTAKGLTYLHEG-------------LE 279 (442)
Q Consensus 251 --------------------------------------~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~ 279 (442)
....+++..++.++.|++.||.|||.. ++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~ 271 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence 012477888899999999999999875 33
Q ss_pred CCCCeEEecccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccch
Q 047892 280 PKWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQF 357 (442)
Q Consensus 280 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~ 357 (442)
.++.+||+|||+++.+...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--- 348 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--- 348 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH---
Confidence 4567999999999865433221 1223456788999999988899999999999999999997 9999864321110
Q ss_pred hhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 358 QVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
. ......+ .....+...+..+.+++.+||+.||++|||+.+|.+.|+...
T Consensus 349 ---~----~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 ---F----YNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ---H----HHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1 1111111 011112234567889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=298.78 Aligned_cols=232 Identities=23% Similarity=0.275 Sum_probs=185.9
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999964 58899999985432 233456888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++|+|.+++... ..+++.....++.|++.||+|||+. ++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 999999999999764 4688899999999999999999876 455789999999999876432
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ...... ....
T Consensus 155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~----------~~~~i~-~~~~------ 215 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG----------IYEKIL-AGKL------ 215 (291)
T ss_pred --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------HHHHHH-hCCc------
Confidence 223578999999999998889999999999999999999999997543211 111111 1110
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCC-----HHHHHHH
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPK-----MGHVIHM 418 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~~ 418 (442)
..+...+..+.+|+.+||+.||.+||+ +.++++.
T Consensus 216 ----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 ----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 111222456788999999999999995 8888754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=291.59 Aligned_cols=244 Identities=23% Similarity=0.402 Sum_probs=191.7
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
...+|.+.+.||+|+||.||+|.+. .++.||+|.+... ......+.+|+++++.++||||+++++++...+..+++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 4456888899999999999999964 4888999988643 3345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
|+++|+|.+++.... ...+++..++.++.|++.||.|||+. ++.++.+||+|||++.........
T Consensus 83 ~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 83 FMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred eCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999999996532 24588999999999999999999976 445678999999999876443322
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
......++..|+|||.+.+..++.++|||||||++|||++ |..||...... .... .. ...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~---~~-~~~-------- 221 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYE---LL-EKG-------- 221 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHH---HH-HCC--------
Confidence 2222334678999999988899999999999999999998 99998653221 1111 11 110
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.....+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 222 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 -YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11122223456688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=302.33 Aligned_cols=232 Identities=21% Similarity=0.261 Sum_probs=185.4
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 232 (442)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 356889999999999999999964 58899999985432 23345688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
|||+.+|+|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++......
T Consensus 97 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EcCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 9999999999999764 4678889999999999999999876 4567899999999998764322
Q ss_pred ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
...+||+.|+|||++.+..++.++|||||||++|||++|..||...... ..... ...+..
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----------~~~~~-i~~~~~----- 232 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF----------RIYEK-ILAGRL----- 232 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH----------HHHHH-HhcCCc-----
Confidence 2357999999999999999999999999999999999999999653321 11111 111111
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCC-----HHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPK-----MGHVIH 417 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~ 417 (442)
..+...+..+.+|+.+||+.||.+||+ +.+++.
T Consensus 233 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 233 -----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 011113345778999999999999997 577764
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=289.90 Aligned_cols=244 Identities=25% Similarity=0.406 Sum_probs=192.3
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
+..++|++.+.||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+..|+|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 4566789999999999999999998778889999986533 335668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
|+++++|.+++.... ...+++.....++.|++.|+.|||.. ++.++.+||+|||+++........
T Consensus 82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 82 LMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 999999999997642 24688999999999999999999875 345678999999999876532221
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
.......+..|+|||.+.+..++.++|||||||++|||++ |+.||...... .... .. ... .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~---~~-~~~-~------ 221 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-------EVLQ---QV-DQG-Y------ 221 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHH---HH-HcC-C------
Confidence 1122223457999999988899999999999999999999 99999653221 1111 11 111 0
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
....+...+..+.+++.+||+.||++||++.++++.|++
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 222 --RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 011122334668889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=292.39 Aligned_cols=244 Identities=26% Similarity=0.470 Sum_probs=195.6
Q ss_pred hhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
+..+|.+.+.||.|+||.||+|...++..+|+|.+..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 45568899999999999999999877899999998766555566788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++|+|.++++... ...+++..++.++.|++.||.|||.. ++.++.+||+|||++........ .
T Consensus 84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-L 160 (261)
T ss_pred cccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-c
Confidence 99999999997642 24688999999999999999999876 34567899999999987643222 2
Q ss_pred ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcc
Q 047892 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (442)
.....++..|+|||.+.+..++.++|||||||++|+|++ |+.||...... ...... . ..
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-------~~~~~~---~-~~--------- 220 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-------EVYDQI---T-AG--------- 220 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-------HHHHHH---H-hC---------
Confidence 223446778999999988889999999999999999998 89999653321 111111 1 10
Q ss_pred cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 382 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.....+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 221 YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 01111223445688899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=297.49 Aligned_cols=236 Identities=31% Similarity=0.547 Sum_probs=180.3
Q ss_pred ccCeeccCCcEEEEEEEEC-----CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 162 DENVIGEGGYGIVYRGVLE-----DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 162 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
+.+.||.|.||.||+|.+. .+..|+||.+... .....+.+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999975 2567999999553 334467899999999999999999999999988889999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc-e
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS-Y 301 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~-~ 301 (442)
+++|+|.++|+.. ....+++..+..++.|++.||.|||+. ++.++.+||+|||++........ .
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999875 235689999999999999999999976 45578999999999987632222 2
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
......+...|+|||.+.+..++.++||||||+++|||++ |+.||..... .+..... ....
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~----------~~~~~~~-~~~~------- 222 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN----------EEIIEKL-KQGQ------- 222 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH----------HHHHHHH-HTTE-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc----------ccccccc-cccc-------
Confidence 2233456789999999988889999999999999999999 7899854321 1111111 1111
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHH
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHML 419 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L 419 (442)
....+..++..+.+++.+||+.||++|||+.++++.|
T Consensus 223 --~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 --RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112233456688899999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=290.17 Aligned_cols=239 Identities=23% Similarity=0.391 Sum_probs=187.8
Q ss_pred CCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCC
Q 047892 158 NGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVD 237 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 237 (442)
++|++.+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|+.++++++||||+++++++...+..++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4578889999999999999998777779999886432 334678899999999999999999999998889999999999
Q ss_pred CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeec
Q 047892 238 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTT 304 (442)
Q Consensus 238 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~ 304 (442)
+|+|.+++.... ..+++..++.++.|++.||.|||.. ++.++.+||+|||+++...........
T Consensus 83 ~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 83 NGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 999999997542 3689999999999999999999875 345678999999999866443322222
Q ss_pred ccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccC
Q 047892 305 RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ 383 (442)
Q Consensus 305 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (442)
...++..|+|||.+.+..++.++|||||||++|||++ |..||...... .... .. .....
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-------~~~~---~~-~~~~~--------- 219 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-------ETVE---KV-SQGLR--------- 219 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHH---HH-hcCCC---------
Confidence 2345678999999988889999999999999999999 99998643321 1111 11 11110
Q ss_pred CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHh
Q 047892 384 EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420 (442)
Q Consensus 384 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 420 (442)
...+...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 220 LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0111123466888999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=297.01 Aligned_cols=187 Identities=23% Similarity=0.365 Sum_probs=159.9
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
..++|++.+.||+|+||.||++... ++..+|+|.+... .......+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 4578999999999999999999965 5788999988643 3334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC--------------CCCCCCeEEecccCccccCCCc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
||+++|+|.+++.+. ..+++.....++.|++.||.|||.. ++.++.+||+|||++..+...
T Consensus 83 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 83 EHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 999999999999764 4678899999999999999999953 344678999999999765322
Q ss_pred ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCC
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYS 349 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~ 349 (442)
......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 123457899999999998888999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=283.25 Aligned_cols=251 Identities=22% Similarity=0.263 Sum_probs=189.5
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcch--hhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLVGYCAE--GAHRML 231 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l 231 (442)
.++|+.++.|++|+||.||+|++ ++++.||+|+++.... .-.-.-.+||.+|.+++|||||.+..+... -+.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 34588899999999999999995 4589999999964421 112235789999999999999999988753 367999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
|||||+. ||..++..- .+++....+..+..|++.|++|||.+ +...|.+||+|||+|+.++..
T Consensus 155 VMe~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eHHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999998 999999765 36789999999999999999999876 445789999999999988665
Q ss_pred cceeecccccccCCCCcccccCCC-CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhc--CCcc
Q 047892 299 RSYVTTRVMGTFGYVAPEYASTGM-LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTN--GNAE 375 (442)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 375 (442)
.. ..+..+-|..|+|||++.+.+ |+++.|+||+|||+.||+++++.|.+....+.... .+..+... ....
T Consensus 231 ~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~------If~llGtPte~iwp 303 (419)
T KOG0663|consen 231 LK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDK------IFKLLGTPSEAIWP 303 (419)
T ss_pred cc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHH------HHHHhCCCccccCC
Confidence 33 345567899999999998765 99999999999999999999999987655433211 11111110 0000
Q ss_pred cc--------------cCcccCCCCcHH-HHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 376 GV--------------LDPRLQEKPSSR-ALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 376 ~~--------------~~~~~~~~~~~~-~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.+ ....++...... .++.-++|+...|..||.+|.||+|.|+.
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00 000111111111 34667889999999999999999999854
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=299.53 Aligned_cols=228 Identities=20% Similarity=0.240 Sum_probs=181.0
Q ss_pred CeeccCCcEEEEEEEE-CCCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCC
Q 047892 164 NVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNG 239 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 239 (442)
+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999995 468899999986432 233456778999999999999999999999999999999999999
Q ss_pred CHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeeccc
Q 047892 240 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRV 306 (442)
Q Consensus 240 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~~ 306 (442)
+|.+++... ..+++..+..++.|++.||+|||+. ++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 155 (323)
T cd05571 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccce
Confidence 999998754 4688999999999999999999876 4567889999999987532211 123346
Q ss_pred ccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCC
Q 047892 307 MGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKP 386 (442)
Q Consensus 307 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (442)
+||+.|+|||++.+..++.++|||||||++|||++|..||...+.. .... ....... ..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~~~~----~~~~~~~----------~~ 214 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFE----LILMEEI----------RF 214 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-------HHHH----HHHcCCC----------CC
Confidence 7999999999999999999999999999999999999999653211 1111 1111110 11
Q ss_pred cHHHHHHHHHHHhhhhCCCCCCCC-----CHHHHHH
Q 047892 387 SSRALKRALLVALRCVDPNAHKRP-----KMGHVIH 417 (442)
Q Consensus 387 ~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 417 (442)
+...+.++.+|+.+||+.||++|| ++.++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 223445678899999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=292.56 Aligned_cols=245 Identities=26% Similarity=0.454 Sum_probs=191.1
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCcchh-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 229 (442)
.++|.+.+.||+|+||.||+|... ++..||+|.+...... ....+.+|+++++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 456888999999999999999853 2478999998654333 457899999999999999999999999999999
Q ss_pred eeEEecCCCCCHHHHHccCC----------CCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEE
Q 047892 230 MLVNEYVDNGNLEQWLHGDV----------GPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKL 286 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~----------~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl 286 (442)
++||||+++|+|.+++.... .....+++.....++.|++.|+.|||.. ++.++.+||
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEE
Confidence 99999999999999997542 1224578889999999999999999975 445678999
Q ss_pred ecccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHH
Q 047892 287 SDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEW 364 (442)
Q Consensus 287 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 364 (442)
+|||+++.+...... ......+++.|+|||++.+..++.++|||||||++|||++ |..||...... .....
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-------~~~~~ 236 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-------EVIEC 236 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHH
Confidence 999999865332221 1223456788999999999999999999999999999998 99998643321 11111
Q ss_pred HHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 365 LKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
. ..+.. ...+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 237 ~----~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 I----TQGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred H----HcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1 11111 01112344568889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=287.12 Aligned_cols=254 Identities=23% Similarity=0.351 Sum_probs=195.3
Q ss_pred HHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHh--cCCCCcceEEEEEEeC----
Q 047892 153 LEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR--VRHKNLVRLVGYCAEG---- 226 (442)
Q Consensus 153 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~---- 226 (442)
......+..+.+.||+|.||+||+|.| .|+.||||++ ....++.+.+|.++.+. |+|+||+.+++.-..+
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF---~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIF---SSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred HHhhhheeEEEEEecCccccceeeccc-cCCceEEEEe---cccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 344455677889999999999999999 5789999999 44556778888888775 5999999999875433
Q ss_pred CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC---------------------CCCCCCeE
Q 047892 227 AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---------------------LEPKWNPK 285 (442)
Q Consensus 227 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---------------------l~~~~~~k 285 (442)
..+|||++|.+.|+|+|||.+. .++....+++++.+|.||++||.. ++.++.+.
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 3579999999999999999874 789999999999999999999865 45678899
Q ss_pred EecccCccccCCCcce---eecccccccCCCCcccccCCC----CC--CcCCchhhHHHHHHHHhC----------CCCC
Q 047892 286 LSDFGLAKLLGAERSY---VTTRVMGTFGYVAPEYASTGM----LN--ETSDVYSFGILIMEVISG----------RNPV 346 (442)
Q Consensus 286 l~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~~--~~sDvwSlGvil~elltg----------~~Pf 346 (442)
|+|+|||......... ..+..+||.+|||||++...- |. ..+||||||.++||+... +.||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 9999999765433221 235578999999999995432 22 368999999999999853 4677
Q ss_pred CCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCC
Q 047892 347 DYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 424 (442)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 424 (442)
.+.-+.+. ..+.++..+.....+..++..+.. ......+.++|+.||..||..|-|+--+-+.|.++..
T Consensus 437 yd~Vp~DP------s~eeMrkVVCv~~~RP~ipnrW~s---~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 437 YDVVPSDP------SFEEMRKVVCVQKLRPNIPNRWKS---DPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ccCCCCCC------CHHHHhcceeecccCCCCCccccc---CHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 76544443 233344444444444444444333 4566778889999999999999999999998887763
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=308.95 Aligned_cols=234 Identities=27% Similarity=0.429 Sum_probs=192.6
Q ss_pred CeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCCCHH
Q 047892 164 NVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLE 242 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~ 242 (442)
-+||+|.||+||-|++. +....|||.+...+....+-+..|+.+.+.|+|.|||+++|.+..++++-|.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 36999999999999954 46678999998877777788999999999999999999999999999999999999999999
Q ss_pred HHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCCC--------CCeEEecccCccccCCCcceeeccccc
Q 047892 243 QWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEPK--------WNPKLSDFGLAKLLGAERSYVTTRVMG 308 (442)
Q Consensus 243 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~~--------~~~kl~DFGla~~~~~~~~~~~~~~~g 308 (442)
.+|+...++- .-.+...-.+..||++||.|||.+ ++.+ |.+||+|||.++.+.. -..++.++.|
T Consensus 661 sLLrskWGPl-KDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETFTG 738 (1226)
T KOG4279|consen 661 SLLRSKWGPL-KDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETFTG 738 (1226)
T ss_pred HHHHhccCCC-ccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccccccc
Confidence 9998765432 227778888999999999999876 4443 6789999999988743 3456778999
Q ss_pred ccCCCCcccccCCC--CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCC
Q 047892 309 TFGYVAPEYASTGM--LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKP 386 (442)
Q Consensus 309 t~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (442)
|..|||||++..++ |+.++|||||||++.||.||++||.....+....+ .-+-+ ...++.
T Consensus 739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF------------kVGmy------KvHP~i 800 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF------------KVGMY------KVHPPI 800 (1226)
T ss_pred chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh------------hhcce------ecCCCC
Confidence 99999999997765 99999999999999999999999975443322111 11100 123355
Q ss_pred cHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 387 SSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 387 ~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
+...+.+...++++|+.+||.+||+|.++|.
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 6778888999999999999999999999985
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=287.47 Aligned_cols=238 Identities=24% Similarity=0.401 Sum_probs=187.0
Q ss_pred CCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCC
Q 047892 158 NGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVD 237 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 237 (442)
.+|++.+.||+|+||.||+|.++++..+|+|.+.... .....+.+|+++++.++||||+++++++...+..|+||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4578899999999999999998777789999885432 234567889999999999999999999999999999999999
Q ss_pred CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeec
Q 047892 238 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTT 304 (442)
Q Consensus 238 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~ 304 (442)
+++|.+++.... ..+++...+.++.|++.||.|||+. ++.++.+||+|||+++...........
T Consensus 83 ~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 83 NGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 999999997542 3688999999999999999999875 455778999999999876433222222
Q ss_pred ccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccC
Q 047892 305 RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ 383 (442)
Q Consensus 305 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (442)
...++..|+|||.+.+..++.++|||||||++|||++ |..||......+ ... .. ... ..
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~---~~-~~~---------~~ 219 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-------VVE---SV-SAG---------YR 219 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-------HHH---HH-HcC---------Cc
Confidence 2234568999999998899999999999999999999 899996533211 111 11 111 00
Q ss_pred CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHH
Q 047892 384 EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHML 419 (442)
Q Consensus 384 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L 419 (442)
...+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 011122455688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=282.79 Aligned_cols=238 Identities=21% Similarity=0.301 Sum_probs=191.3
Q ss_pred hCCCCccCeeccCCcEEEEEEE-ECCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 157 TNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
.+.|++.+.||+|.|+.||++. ..+|+.+|+|++..+ .....+.+.+|++|.+.|+|||||+|.+.+...+..|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 3568888999999999999998 456999999988432 3345677899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCCCC----------CeEEecccCccccCC
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEPKW----------NPKLSDFGLAKLLGA 297 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~~~----------~~kl~DFGla~~~~~ 297 (442)
|+|.||+|..-|-.+ ...++..+...+.||+++|.|+|.+ ++|++ -+||+|||+|..++
T Consensus 90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 999999997655433 4578888999999999999999865 55543 57999999999886
Q ss_pred CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
.......++|||.|||||++...+|+..+|||+.||+||-|+.|.+||.+.+... +. +.+..+.+.
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-------ly----e~I~~g~yd-- 230 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LY----EQIKAGAYD-- 230 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-------HH----HHHhccccC--
Confidence 3334556799999999999999999999999999999999999999997643321 11 222222211
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
+........+++..+|+.+||..||.+|.|+.|.|+
T Consensus 231 ----~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 231 ----YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ----CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 111222345567888999999999999999999885
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=286.94 Aligned_cols=243 Identities=26% Similarity=0.386 Sum_probs=189.4
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
+..++|++.+.||+|+||.||+|..+++..+|+|.+..... ..+.+.+|+.++++++||||+++++++. .+..|++||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 34567899999999999999999988888899999865332 3456889999999999999999999875 456899999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
|+++++|.++++... ...+++..++.++.|++.||.|||+. + +.++.+||+|||++..+......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 81 YMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999999997532 24588999999999999999999876 3 34567999999999876443322
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
......++..|+|||.+.+..++.++|||||||++|||++ |..||...... +........
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----------~~~~~~~~~--------- 219 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR----------EVLEQVERG--------- 219 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH----------HHHHHHHcC---------
Confidence 2223345678999999988889999999999999999999 89999653221 111111111
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
.....+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 -YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111122344568889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=312.83 Aligned_cols=238 Identities=18% Similarity=0.261 Sum_probs=188.6
Q ss_pred CCccCeeccCCcEEEEEEEEC-C-CCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCC
Q 047892 160 FADENVIGEGGYGIVYRGVLE-D-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVD 237 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 237 (442)
|.+.+.||+|+||.||+|... + +..||+|.+..........+.+|+.+|+.++|||||++++++...+..||||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 778899999999999999853 3 67788888755555555668889999999999999999999999999999999999
Q ss_pred CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc-eee
Q 047892 238 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS-YVT 303 (442)
Q Consensus 238 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~-~~~ 303 (442)
+|+|.++++........+++..+..++.|++.||.|||+. ++.++.+||+|||+++.+..... ...
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~ 228 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccc
Confidence 9999998865433345788999999999999999999875 45577899999999987643322 123
Q ss_pred cccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccC
Q 047892 304 TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ 383 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (442)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.+..... +...
T Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~----------~~~~~~~~~-~~~~-------- 289 (478)
T PTZ00267 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ----------REIMQQVLY-GKYD-------- 289 (478)
T ss_pred cccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH----------HHHHHHHHh-CCCC--------
Confidence 456799999999999988999999999999999999999999964321 111111111 1110
Q ss_pred CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 384 EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 384 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
..+...+..+.+++.+||+.||++|||+.+++.
T Consensus 290 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 -PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 111223456888999999999999999999874
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=286.42 Aligned_cols=243 Identities=28% Similarity=0.471 Sum_probs=190.6
Q ss_pred hCCCCccCeeccCCcEEEEEEEECC----CCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLED----NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
.++|++.+.||+|+||.||+|.+.. ...||+|.+.... ......+.+|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4568899999999999999999642 4579999886443 3345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||+. ++.++.+||+|||+++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 999999999999997642 3688999999999999999999875 445678999999999877522
Q ss_pred cc-eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 299 RS-YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 299 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
.. .......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ...... ....
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-------~~~~~~----~~~~--- 225 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-------DVIKAV----EDGY--- 225 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-------HHHHHH----HcCC---
Confidence 22 12222345678999999988899999999999999999998 99998543211 111111 1110
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
....+...+..+.+++.+||+.||++||++.++++.|+++
T Consensus 226 ------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 ------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011223345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=312.96 Aligned_cols=243 Identities=23% Similarity=0.297 Sum_probs=196.2
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEECCC-CeEEEEEecCcchhhHHHHHHHHHHHHhcC-CCCcceEEEE-EEe------
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLEDN-TNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLVGY-CAE------ 225 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~-~~~------ 225 (442)
+...++++.+.|.+|||+.||+|....+ ..||+|++...+....+.+.+|+++|+.|+ |+|||.+++. ...
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3344577889999999999999997665 999999998778888889999999999996 9999999993 221
Q ss_pred CCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC---------------CCCCCCeEEeccc
Q 047892 226 GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---------------LEPKWNPKLSDFG 290 (442)
Q Consensus 226 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---------------l~~~~~~kl~DFG 290 (442)
.-.++|.||||.||.|.+|+..+. ...|++..+++|+.|+++|+.+||.. +..+|..||||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccc
Confidence 135689999999999999998653 23499999999999999999999865 4567899999999
Q ss_pred CccccCCCc-cee-------ecccccccCCCCcccc---cCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhh
Q 047892 291 LAKLLGAER-SYV-------TTRVMGTFGYVAPEYA---STGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQV 359 (442)
Q Consensus 291 la~~~~~~~-~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~ 359 (442)
.+....... ... .-....|+.|+|||++ .+.+.++|+|||||||+||-|+....||.....
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------- 263 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------- 263 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--------
Confidence 986432111 000 0112468999999987 567899999999999999999999999975422
Q ss_pred hHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 360 NLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
..++...+........+..+.+||..||+.||++||++-||+..+-.+
T Consensus 264 ---------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 264 ---------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred ---------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 244555555556678889999999999999999999999999887654
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=284.57 Aligned_cols=247 Identities=21% Similarity=0.327 Sum_probs=193.9
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|++.+.||+|+||.||+|+. .+++.||||.+... .......+.+|+++++.++||||+++++++...+..+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4688999999999999999995 46899999987532 2344456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++|+|.+++.........+++.....++.|++.||.|||+. ++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999999998864322334678899999999999999999976 44567899999999987643321
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
......|++.|+|||.+.+..++.++|+||||+++|||++|..||...... ......... ..
T Consensus 162 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~--------~~~~~~~~~-~~-------- 223 (267)
T cd08228 162 -AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--------LFSLCQKIE-QC-------- 223 (267)
T ss_pred -HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc--------HHHHHHHHh-cC--------
Confidence 122346889999999998888999999999999999999999998643211 111111111 10
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
..........+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 224 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 224 DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111122234556788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=300.00 Aligned_cols=234 Identities=20% Similarity=0.251 Sum_probs=186.0
Q ss_pred hhCCCCccCeeccCCcEEEEEEEECC--CCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLED--NTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
..++|.+.+.||+|+||.||+|.+.. +..||+|.+... .......+.+|+.+++.++||||+++++++.+.+..|
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 44578999999999999999998543 368999988532 2233456788999999999999999999999999999
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||.. ++.++.+||+|||+++.+..
T Consensus 108 lv~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999999764 4688999999999999999999875 45678999999999987643
Q ss_pred CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
. ....+||+.|||||++.+..++.++|||||||++|||++|..||...+... . . .....+..
T Consensus 184 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-------~---~-~~i~~~~~--- 245 (340)
T PTZ00426 184 R----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-------I---Y-QKILEGII--- 245 (340)
T ss_pred C----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-------H---H-HHHhcCCC---
Confidence 2 234579999999999998889999999999999999999999997543211 1 1 11111110
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCC-----CHHHHHHH
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 418 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~~ 418 (442)
. .+...+..+.+++.+||+.||++|+ +++++++.
T Consensus 246 ---~----~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 ---Y----FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---C----CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0 1112334577899999999999995 88888754
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=285.82 Aligned_cols=244 Identities=24% Similarity=0.414 Sum_probs=191.8
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++..++|++.++||+|+||.||+|..++++.||+|.+.... .....+.+|+.++++++||||+++++++. .+..+++|
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 34567799999999999999999998888999999986533 23457889999999999999999999874 45689999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+.+|+|.+++.... ...+++...+.++.|++.||+|||+. ++.++.++|+|||++........
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 80 EYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999999999986542 24688899999999999999999975 45567899999999987643322
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
.......++..|+|||++....++.++|||||||++|||++ |+.||....... ... .. ...
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~---~~-~~~------- 219 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-------VIQ---NL-ERG------- 219 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-------HHH---HH-HcC-------
Confidence 22233456778999999988889999999999999999999 999997543211 111 11 111
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
.....+...+.++.+++.+||+.||++|||++++++.|+.
T Consensus 220 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 220 --YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0111122334568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=294.02 Aligned_cols=226 Identities=19% Similarity=0.211 Sum_probs=177.9
Q ss_pred eccCCcEEEEEEEEC-CCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCCCH
Q 047892 166 IGEGGYGIVYRGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNL 241 (442)
Q Consensus 166 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L 241 (442)
||+|+||.||+|... +++.||+|.+... .......+.+|+.++.+++||||+++++++...+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999964 5889999998543 223345678899999999999999999999999999999999999999
Q ss_pred HHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeeccccc
Q 047892 242 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMG 308 (442)
Q Consensus 242 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 308 (442)
.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++...... ......+|
T Consensus 81 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g 155 (312)
T cd05585 81 FHHLQRE----GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCG 155 (312)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccC
Confidence 9999764 4688999999999999999999875 4457889999999998643222 22344679
Q ss_pred ccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcH
Q 047892 309 TFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSS 388 (442)
Q Consensus 309 t~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (442)
|+.|+|||++.+..++.++|||||||++|||++|..||...... ........ .. ...+.
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~----------~~~~~~~~-~~----------~~~~~ 214 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN----------EMYRKILQ-EP----------LRFPD 214 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH----------HHHHHHHc-CC----------CCCCC
Confidence 99999999999989999999999999999999999999753221 11111111 10 01122
Q ss_pred HHHHHHHHHHhhhhCCCCCCCCCH---HHHHH
Q 047892 389 RALKRALLVALRCVDPNAHKRPKM---GHVIH 417 (442)
Q Consensus 389 ~~~~~~~~li~~cl~~dP~~RPs~---~evl~ 417 (442)
..+..+.+++.+||+.||++||++ .+++.
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 344567889999999999999864 55543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=287.23 Aligned_cols=253 Identities=21% Similarity=0.249 Sum_probs=205.0
Q ss_pred hhhHHHhhCCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCcchh-hHHHHHHHHHHHHhcCCCCcceEEEE
Q 047892 150 LRELEVSTNGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLVGY 222 (442)
Q Consensus 150 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~ 222 (442)
+.++.+...+++...++-+|.||+||.|.|. +.+.|-+|.++..... ....+..|.-.+..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4677788888999999999999999999653 3456778888665443 34568889999999999999999998
Q ss_pred EE-eCCeeeeEEecCCCCCHHHHHccC----CCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCe
Q 047892 223 CA-EGAHRMLVNEYVDNGNLEQWLHGD----VGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNP 284 (442)
Q Consensus 223 ~~-~~~~~~lv~E~~~~g~L~~~l~~~----~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~ 284 (442)
+. +....+.++.++.-|+|..||... ....+.++..+...++.|++.||+|||+. +++..++
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeE
Confidence 75 456778999999999999999732 12235678888999999999999999876 5667789
Q ss_pred EEecccCccccCCCcceeec-ccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHH
Q 047892 285 KLSDFGLAKLLGAERSYVTT-RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLF 362 (442)
Q Consensus 285 kl~DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~ 362 (442)
||+|-.+++.+...+..+.. ....+..||+||.+.+..|+.++|||||||+||||+| |+.||..-++.+.
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm-------- 507 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM-------- 507 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH--------
Confidence 99999999988666554332 2345789999999999999999999999999999999 9999976544322
Q ss_pred HHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 363 EWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
..++....+...+.+++++++.+|.-||..+|++||+++|++.-|.+.
T Consensus 508 ------------~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 508 ------------EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ------------HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 122334445566778899999999999999999999999999988754
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=294.15 Aligned_cols=238 Identities=23% Similarity=0.247 Sum_probs=183.7
Q ss_pred CCCccCeeccCCcEEEEEEEE----CCCCeEEEEEecCc----chhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCee
Q 047892 159 GFADENVIGEGGYGIVYRGVL----EDNTNVAVKNLLNN----RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 229 (442)
+|++.+.||+|+||.||+++. .+++.||+|.+... .....+.+.+|+.++..+ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999985 35789999998542 122345677899999999 599999999999999999
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~ 296 (442)
|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 9999999999999998754 4688999999999999999999875 4567899999999998654
Q ss_pred CCcceeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 297 AERSYVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 297 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
..........+||+.|+|||++.+. .++.++|||||||++|||++|..||......... ..+......
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-------~~~~~~~~~---- 225 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-------SEVSRRILK---- 225 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH-------HHHHHHHhc----
Confidence 3333333456799999999999765 4788999999999999999999999754322110 111111111
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCC-----CHHHHHH
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRP-----KMGHVIH 417 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 417 (442)
.++. .+...+..+.+++.+||+.||++|| ++.++++
T Consensus 226 --~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 --CDPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred --CCCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 0111 1122345577899999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=293.09 Aligned_cols=235 Identities=21% Similarity=0.335 Sum_probs=178.9
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
++|+..+.||+|+||.||+|... +++.||||.+.... ......+.+|+++++.++|+||+++++++...+..|+||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45677889999999999999964 58999999985443 33456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++|+|.+.. ...+.....++.|++.||.|||+. ++.++.+||+|||+++.+..... .
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 224 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-P 224 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-c
Confidence 9999986532 345677888999999999999875 45678999999999987643221 1
Q ss_pred ecccccccCCCCcccccC-----CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 303 TTRVMGTFGYVAPEYAST-----GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||......+. ..........
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-------~~~~~~~~~~------ 291 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW-------ASLMCAICMS------ 291 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH-------HHHHHHHhcc------
Confidence 234579999999998743 2345689999999999999999999973322110 0101110000
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.........+.++.+|+.+||+.||++|||+.|+++.
T Consensus 292 ----~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 ----QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111122345668899999999999999999999975
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=288.79 Aligned_cols=255 Identities=21% Similarity=0.289 Sum_probs=185.1
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46889999999999999999964 58899999985432 22345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++ +|.+++... ...+++..+..++.|++.||+|||+. ++.++.+||+|||+++....... .
T Consensus 85 ~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~ 159 (288)
T cd07871 85 LDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-T 159 (288)
T ss_pred CCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-c
Confidence 985 999998654 23578889999999999999999876 44578899999999976533221 1
Q ss_pred ecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhH-----HHHHHHHhhcCCccc
Q 047892 303 TTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNL-----FEWLKTMVTNGNAEG 376 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 376 (442)
.....|++.|+|||++.+ ..++.++|||||||++|||++|+.||......+........ ...............
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 234568999999998865 56899999999999999999999999764432111000000 000000000001111
Q ss_pred ccCcccCCCC----cHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 377 VLDPRLQEKP----SSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 377 ~~~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
...+...... ....+.+..+|+.+||+.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111111100 1123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=285.83 Aligned_cols=243 Identities=24% Similarity=0.387 Sum_probs=188.9
Q ss_pred hhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
..++|++.+.||+|+||.||+|.+.+...||+|.+.... .....+.+|+++++.++||||+++++.+. .+..|+||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 456689999999999999999998776789999986432 23456889999999999999999999875 4568999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++|+|.+++.+.. ...+++..++.++.|++.||+|||+. ++.++.+||+|||+++.+.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 82 MSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 99999999997542 23578899999999999999999876 3446689999999998764433222
Q ss_pred ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcc
Q 047892 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (442)
.....++..|+|||+..+..++.++|||||||++|||++ |..||...... ... ... ...
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-------~~~---~~~-~~~--------- 219 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVL---DQV-ERG--------- 219 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-------HHH---HHH-hcC---------
Confidence 223346778999999988889999999999999999999 88898643221 111 111 110
Q ss_pred cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 382 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.........+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 220 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 220 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 00111233456688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=290.22 Aligned_cols=247 Identities=24% Similarity=0.410 Sum_probs=192.4
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
.++|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 456889999999999999999842 24568999887655556677999999999999999999999999999999
Q ss_pred eEEecCCCCCHHHHHccCC---------CCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEec
Q 047892 231 LVNEYVDNGNLEQWLHGDV---------GPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSD 288 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~D 288 (442)
+||||+++|+|.+++.... .....+++..++.++.|++.||+|||.. ++.++.+||+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEecc
Confidence 9999999999999997432 1123589999999999999999999876 34567899999
Q ss_pred ccCccccCCCcc-eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHH
Q 047892 289 FGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLK 366 (442)
Q Consensus 289 FGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 366 (442)
||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||....... . ..
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~---~~ 233 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------V---IE 233 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H---HH
Confidence 999986543322 12223446788999999988889999999999999999999 999986443211 1 11
Q ss_pred HHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 367 TMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
. ...+... . .+...+..+.+|+.+||+.||.+|||+.++++.|+++.
T Consensus 234 ~-i~~~~~~-----~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 234 C-ITQGRVL-----Q----RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred H-HHcCCcC-----C----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1 1111110 0 11123356888999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=294.95 Aligned_cols=229 Identities=21% Similarity=0.232 Sum_probs=181.0
Q ss_pred CeeccCCcEEEEEEEE-CCCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCC
Q 047892 164 NVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNG 239 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 239 (442)
+.||+|+||.||++.. .+++.||+|.+... .......+.+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999995 45899999998643 2233456788999999999999999999999999999999999999
Q ss_pred CHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeeccc
Q 047892 240 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRV 306 (442)
Q Consensus 240 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~~ 306 (442)
+|.+++... ..+++..+..++.|++.||+|||+. ++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 155 (328)
T cd05593 81 ELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTF 155 (328)
T ss_pred CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccc
Confidence 999998754 4688999999999999999999876 4567899999999987542221 123346
Q ss_pred ccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCC
Q 047892 307 MGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKP 386 (442)
Q Consensus 307 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (442)
+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... .... . ..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~----------~~~~~~-~~~~------~----~~ 214 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------KLFELI-LMED------I----KF 214 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH----------HHHHHh-ccCC------c----cC
Confidence 7999999999999889999999999999999999999999653221 111111 1110 0 11
Q ss_pred cHHHHHHHHHHHhhhhCCCCCCCC-----CHHHHHHH
Q 047892 387 SSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 418 (442)
Q Consensus 387 ~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~~ 418 (442)
+...+.++.+++.+||+.||++|| ++.++++.
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 122345678899999999999997 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=328.45 Aligned_cols=244 Identities=30% Similarity=0.562 Sum_probs=187.3
Q ss_pred CCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCC
Q 047892 159 GFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVD 237 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 237 (442)
.+...+.||+|+||.||+|.. .++..||||++...... ...|++++++++|||||+++++|.+.+..|+||||++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 466778999999999999996 56899999988543321 1346888999999999999999999999999999999
Q ss_pred CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC---------CCC-------CCCeEEecccCccccCCCcce
Q 047892 238 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---------LEP-------KWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 238 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---------l~~-------~~~~kl~DFGla~~~~~~~~~ 301 (442)
+|+|.++++ .++|..+..++.|+++||+|||.. +++ ++..++. ||.......
T Consensus 767 ~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 767 GKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred CCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 999999995 278999999999999999999943 222 3344443 555433211
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (442)
.....||+.|||||++.+..++.++|||||||++|||+||+.||+..... .....+|.+...........+++.
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-----HGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-----CCcHHHHHHHhcCccchhheeCcc
Confidence 12336789999999999999999999999999999999999999543221 123445554443333344445554
Q ss_pred cCC--CCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCC
Q 047892 382 LQE--KPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 424 (442)
Q Consensus 382 ~~~--~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 424 (442)
+.. ........++.+++.+||+.||++||||.|+++.|+++..
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 432 2334566678899999999999999999999999998754
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=301.00 Aligned_cols=238 Identities=22% Similarity=0.266 Sum_probs=184.1
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36889999999999999999964 58899999995432 233456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
|||++|+|.+++... ..+++..+..++.|++.||+|||+. ++.++.+||+|||+++.+.....
T Consensus 81 E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 999999999999764 4689999999999999999999876 45678999999999875432110
Q ss_pred e-------------------------------------eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCC
Q 047892 301 Y-------------------------------------VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGR 343 (442)
Q Consensus 301 ~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~ 343 (442)
. .....+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 011246999999999999889999999999999999999999
Q ss_pred CCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCC---HHHHHH
Q 047892 344 NPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPK---MGHVIH 417 (442)
Q Consensus 344 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs---~~evl~ 417 (442)
.||....... ......... ..+........+..+.+++.+|+. +|.+|++ +.|+++
T Consensus 237 ~Pf~~~~~~~----------~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCSDNPQE----------TYRKIINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCHHH----------HHHHHHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9997543211 111111100 001111111234567789989996 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=298.82 Aligned_cols=260 Identities=15% Similarity=0.155 Sum_probs=187.0
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
+..++|.+.+.||+|+||.||+|.. .+++.||+|... ...+.+|++++++|+||||+++++++......++|+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 3456799999999999999999995 458899999653 234678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
|++. ++|..++... ..+++..++.++.|++.||.|||+. ++.++.+||+|||+++.......
T Consensus 163 e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 163 PRYK-TDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred ecCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 9996 5899988654 4688999999999999999999875 34467899999999975433222
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhc-C-C-----
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTN-G-N----- 373 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~-~----- 373 (442)
......+||+.|+|||++.+..++.++|||||||++|||++|..||..................+...... . .
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 22344679999999999999899999999999999999999998875432211000000000000000000 0 0
Q ss_pred ---c--------c-cccCcccCCC--CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH--HHhcCCCC
Q 047892 374 ---A--------E-GVLDPRLQEK--PSSRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEAEEFP 425 (442)
Q Consensus 374 ---~--------~-~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~ 425 (442)
. . ....+..... .....+.++.+|+.+||+.||.+|||+.|+++ .++.+..+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 0 0 0000000000 01123557888999999999999999999984 35554433
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=295.15 Aligned_cols=228 Identities=21% Similarity=0.232 Sum_probs=179.7
Q ss_pred CeeccCCcEEEEEEEE-CCCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCC
Q 047892 164 NVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNG 239 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 239 (442)
+.||+|+||.||++.. .++..||+|.+... .......+.+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999995 45899999998643 2233455778999999999999999999999999999999999999
Q ss_pred CHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeeccc
Q 047892 240 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRV 306 (442)
Q Consensus 240 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~~ 306 (442)
+|..++... ..+++..++.++.|++.||.|||+. ++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 155 (323)
T cd05595 81 ELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccccc
Confidence 999988754 4688999999999999999999876 4557889999999987532221 122345
Q ss_pred ccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCC
Q 047892 307 MGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKP 386 (442)
Q Consensus 307 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (442)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...+... . ..... .... ..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-------~---~~~~~-~~~~----------~~ 214 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------L---FELIL-MEEI----------RF 214 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-------H---HHHHh-cCCC----------CC
Confidence 79999999999999999999999999999999999999996543211 1 11111 1100 11
Q ss_pred cHHHHHHHHHHHhhhhCCCCCCCC-----CHHHHHH
Q 047892 387 SSRALKRALLVALRCVDPNAHKRP-----KMGHVIH 417 (442)
Q Consensus 387 ~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 417 (442)
+...+..+.+++.+||+.||++|| ++.++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 123345678899999999999998 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=287.71 Aligned_cols=247 Identities=21% Similarity=0.402 Sum_probs=188.8
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA 227 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 227 (442)
+..++|++.+.||+|+||.||+|.+. .+..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45677999999999999999999853 24679999885432 234456889999999999999999999999999
Q ss_pred eeeeEEecCCCCCHHHHHccCCCC------CCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEec
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGP------HSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSD 288 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~D 288 (442)
..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||.. ++.++.+||+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence 999999999999999999653211 13467788899999999999999875 44567899999
Q ss_pred ccCccccCCCccee-ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHH
Q 047892 289 FGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLK 366 (442)
Q Consensus 289 FGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 366 (442)
||+++.+....... .....+++.|+|||++.+..++.++|||||||++|||++ |..||....... ..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-------~~---- 231 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------VL---- 231 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HH----
Confidence 99998654332221 122345788999999988889999999999999999999 788986533211 11
Q ss_pred HHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 367 TMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
......... ..+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 232 ~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 232 RFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111111110 1112234568889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=282.97 Aligned_cols=242 Identities=24% Similarity=0.332 Sum_probs=186.9
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
.++|++.+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.++++++||||+++++++...+..|+||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35699999999999999999995 46889999998654444456688899999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++|+|.++++.. ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++.+..... .
T Consensus 88 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06646 88 CGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K 162 (267)
T ss_pred CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence 9999999998754 4688999999999999999999875 44567899999999986532211 1
Q ss_pred ecccccccCCCCccccc---CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 303 TTRVMGTFGYVAPEYAS---TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
.....|+..|+|||.+. ...++.++|||||||++|||++|..||....+..... .. ... ....
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~----------~~-~~~---~~~~ 228 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF----------LM-SKS---NFQP 228 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe----------ee-ecC---CCCC
Confidence 23356889999999884 3457889999999999999999999986432211100 00 000 0001
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHML 419 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L 419 (442)
+... .....+..+.+++.+||+.||++|||++++++.|
T Consensus 229 ~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 229 PKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1111 1122346788999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=302.14 Aligned_cols=251 Identities=22% Similarity=0.391 Sum_probs=191.2
Q ss_pred HHHhhCCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcC-CCCcceEEEEEE
Q 047892 153 LEVSTNGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVR-HKNLVRLVGYCA 224 (442)
Q Consensus 153 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~ 224 (442)
+++..++|.+.+.||+|+||.||+|.+. .+..||+|++.... ....+.+.+|+++|.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4556667889999999999999999853 24579999996542 233456889999999997 999999999999
Q ss_pred eCCeeeeEEecCCCCCHHHHHccCCC------------------------------------------------------
Q 047892 225 EGAHRMLVNEYVDNGNLEQWLHGDVG------------------------------------------------------ 250 (442)
Q Consensus 225 ~~~~~~lv~E~~~~g~L~~~l~~~~~------------------------------------------------------ 250 (442)
..+..++|||||++|+|.+++++...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999965321
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHhhhhhhcC------C------
Q 047892 251 ----------------------------------------PHSPLTWEIRMNIILGTAKGLTYLHEG------L------ 278 (442)
Q Consensus 251 ----------------------------------------~~~~l~~~~~~~i~~qi~~~l~yLH~~------l------ 278 (442)
....+++...+.++.|++.||.|||.. +
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL 271 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL 271 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence 112467778889999999999999976 3
Q ss_pred -CCCCCeEEecccCccccCCCcc-eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCcc
Q 047892 279 -EPKWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEF 355 (442)
Q Consensus 279 -~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~ 355 (442)
+.++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~-- 349 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-- 349 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH--
Confidence 3456799999999986532221 11223457889999999988889999999999999999998 899986432211
Q ss_pred chhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 356 QFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
........+ .....+...+..+.+|+.+||+.||.+||++++|++.|+.+
T Consensus 350 --------~~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 350 --------QFYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred --------HHHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111111111 01111223346788899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=287.80 Aligned_cols=247 Identities=22% Similarity=0.290 Sum_probs=179.2
Q ss_pred CCCccCeeccCCcEEEEEEEE-C-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhc---CCCCcceEEEEEE-----eC
Q 047892 159 GFADENVIGEGGYGIVYRGVL-E-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRV---RHKNLVRLVGYCA-----EG 226 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~-----~~ 226 (442)
+|++.+.||+|+||.||+|.. . +++.||+|.+.... ......+.+|+.+++.+ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 588899999999999999986 3 46789999885432 22234556777777665 6999999999985 24
Q ss_pred CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcc
Q 047892 227 AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAK 293 (442)
Q Consensus 227 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~ 293 (442)
...++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+. ++.++.+||+|||+++
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 56899999997 59999987532 23588999999999999999999876 4557899999999998
Q ss_pred ccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhc--
Q 047892 294 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTN-- 371 (442)
Q Consensus 294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 371 (442)
..... .......||+.|+|||++.+..++.++|||||||++|||++|++||......+.. ..+......
T Consensus 159 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~-------~~i~~~~~~~~ 229 (290)
T cd07862 159 IYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL-------GKILDVIGLPG 229 (290)
T ss_pred eccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH-------HHHHHHhCCCC
Confidence 75433 2234457899999999998889999999999999999999999999765432211 111100000
Q ss_pred -CCc-------ccccCcccCC---CCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 372 -GNA-------EGVLDPRLQE---KPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 372 -~~~-------~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
... .......... ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 0000000000 000123456778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=300.69 Aligned_cols=245 Identities=19% Similarity=0.220 Sum_probs=189.2
Q ss_pred hHHHhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 047892 152 ELEVSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA 227 (442)
Q Consensus 152 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 227 (442)
+..+..++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 34456678999999999999999999964 58899999985421 223345778999999999999999999999999
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKL 294 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~ 294 (442)
..|+||||+++|+|.+++.+. .+++..+..++.|++.||.|||+. ++.++.+||+|||++..
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 999999999999999998653 478888899999999999999876 45678999999999987
Q ss_pred cCCCcceeecccccccCCCCcccccCC----CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhh
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYASTG----MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVT 370 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 370 (442)
............+||+.|+|||++.+. .++.++|||||||++|||++|..||....... .......
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----------~~~~i~~ 261 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----------TYSKIMD 261 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH----------HHHHHHc
Confidence 643332223456799999999998653 47899999999999999999999997543211 1111111
Q ss_pred cCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCC--CCCHHHHHHH
Q 047892 371 NGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHK--RPKMGHVIHM 418 (442)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~evl~~ 418 (442)
... .+........+..+.+|+.+||+.+|++ |+|+.++++.
T Consensus 262 ~~~-------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 262 HKN-------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCC-------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 100 0111111123566888999999999988 9999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=300.67 Aligned_cols=239 Identities=21% Similarity=0.258 Sum_probs=188.4
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999964 58999999986432 234456888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc-
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER- 299 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~- 299 (442)
||+++|+|.+++.+. ..+++..+..++.|++.||.|||.. ++.++.+||+|||+++.+....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999999764 5688999999999999999999875 4567899999999998764332
Q ss_pred ---------------------------ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCC
Q 047892 300 ---------------------------SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPP 352 (442)
Q Consensus 300 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~ 352 (442)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 11223457999999999999999999999999999999999999999754321
Q ss_pred CccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCC-HHHHHHH
Q 047892 353 GEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPK-MGHVIHM 418 (442)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-~~evl~~ 418 (442)
. ......... ..+........+..+.+|+.+||. ||.+||+ +.++++.
T Consensus 237 ~----------~~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 E----------TYNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H----------HHHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 111111100 001111111145668889999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=289.41 Aligned_cols=247 Identities=24% Similarity=0.422 Sum_probs=193.1
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
..+|.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 345778899999999999999842 34568999886655555677899999999999999999999999999999
Q ss_pred eEEecCCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeE
Q 047892 231 LVNEYVDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPK 285 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~k 285 (442)
+||||+++++|.+++..... ....+++..++.++.|++.||+|||+. ++.++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 99999999999999975321 123588999999999999999999876 34567899
Q ss_pred EecccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHH
Q 047892 286 LSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFE 363 (442)
Q Consensus 286 l~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 363 (442)
|+|||++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||...... ...+
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------~~~~ 236 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-------EVIE 236 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHH
Confidence 9999999765433221 2233456889999999988899999999999999999999 99998654321 1111
Q ss_pred HHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 364 WLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
. ...+... ......+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 237 ---~-~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 237 ---C-ITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred ---H-HhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1 1111110 111223456889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=289.04 Aligned_cols=250 Identities=24% Similarity=0.415 Sum_probs=193.1
Q ss_pred HHHhhCCCCccCeeccCCcEEEEEEEECC------CCeEEEEEecCc-chhhHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 047892 153 LEVSTNGFADENVIGEGGYGIVYRGVLED------NTNVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCA 224 (442)
Q Consensus 153 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 224 (442)
+.+..++|++.+.||+|+||.||++.... ...+|+|.+... .......+.+|++++.++ +||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 45566779999999999999999998532 357999988653 233445688999999999 8999999999999
Q ss_pred eCCeeeeEEecCCCCCHHHHHccCC------------CCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CC
Q 047892 225 EGAHRMLVNEYVDNGNLEQWLHGDV------------GPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LE 279 (442)
Q Consensus 225 ~~~~~~lv~E~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~ 279 (442)
..+..+++|||+++|+|.++++... .....+++..++.++.|++.||.|||.. ++
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 9999999999999999999996431 2235688999999999999999999875 44
Q ss_pred CCCCeEEecccCccccCCCccee-ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccch
Q 047892 280 PKWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQF 357 (442)
Q Consensus 280 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~ 357 (442)
.++.+||+|||+++.+....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 242 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 242 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH----
Confidence 56789999999998764432211 122335678999999988899999999999999999998 999986432211
Q ss_pred hhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 358 QVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
... ...... ....+...+..+.+|+.+||..||++|||+.++++.|+++
T Consensus 243 ---~~~----~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 ---LFK----LLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ---HHH----HHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 111 111110 1111223345688899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=296.23 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=190.0
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAE 225 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 225 (442)
+++.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.++ +|+||+++++++..
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 455667999999999999999999732 24789999986432 23345678899999999 89999999998864
Q ss_pred -CCeeeeEEecCCCCCHHHHHccCCCC-----------------------------------------------------
Q 047892 226 -GAHRMLVNEYVDNGNLEQWLHGDVGP----------------------------------------------------- 251 (442)
Q Consensus 226 -~~~~~lv~E~~~~g~L~~~l~~~~~~----------------------------------------------------- 251 (442)
+..++++|||+++|+|.+++......
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 45678999999999999998642110
Q ss_pred ----CCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCCCeEEecccCccccCCCcce-eecccccccCCC
Q 047892 252 ----HSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYV 313 (442)
Q Consensus 252 ----~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~ 313 (442)
...+++..+..++.|++.||.|||+. + +.++.+||+|||+++.+...... ......++..|+
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 12678999999999999999999875 3 34678999999999876433222 122345677899
Q ss_pred CcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHH
Q 047892 314 APEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALK 392 (442)
Q Consensus 314 aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (442)
|||++.+..++.++|||||||++|||++ |..||......+. ......... ....+...+.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~----------~~~~~~~~~---------~~~~~~~~~~ 303 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE----------FCRRLKEGT---------RMRAPEYATP 303 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH----------HHHHHhccC---------CCCCCccCCH
Confidence 9999999999999999999999999998 9999965322111 111111111 0011123345
Q ss_pred HHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 393 RALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 393 ~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
++.+++.+||+.+|++||++.|+++.|+.+.
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 6888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=298.83 Aligned_cols=239 Identities=18% Similarity=0.260 Sum_probs=181.7
Q ss_pred CCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 159 GFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
.|..++.||+|+||+||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 478899999999999999995 458899999985432 2334568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc-
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS- 300 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~- 300 (442)
|+++|+|.+++.+. ..+++..+..++.|++.||.|||.. ++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 99999999999764 4688889999999999999999875 44567899999999764311000
Q ss_pred ---------------------------------------------eeecccccccCCCCcccccCCCCCCcCCchhhHHH
Q 047892 301 ---------------------------------------------YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGIL 335 (442)
Q Consensus 301 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvi 335 (442)
......+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00123579999999999988889999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhh--hhCCCCCCCCCHH
Q 047892 336 IMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALR--CVDPNAHKRPKMG 413 (442)
Q Consensus 336 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~--cl~~dP~~RPs~~ 413 (442)
+|||++|..||........ ......... .+........+.++.+|+.+ |+..+|..||++.
T Consensus 238 l~elltG~~Pf~~~~~~~~----------~~~i~~~~~-------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTET----------QLKVINWEN-------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred HHHHHhCCCCCcCCCHHHH----------HHHHHcccc-------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 9999999999975432111 001110000 01111111234556777776 5666777799999
Q ss_pred HHHHH
Q 047892 414 HVIHM 418 (442)
Q Consensus 414 evl~~ 418 (442)
++++.
T Consensus 301 ~~l~h 305 (381)
T cd05626 301 DIKAH 305 (381)
T ss_pred HHhcC
Confidence 99864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=292.22 Aligned_cols=228 Identities=24% Similarity=0.323 Sum_probs=179.2
Q ss_pred CeeccCCcEEEEEEEE----CCCCeEEEEEecCcc----hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 164 NVIGEGGYGIVYRGVL----EDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
+.||+|+||.||+++. ..++.||+|.+.... ......+.+|+.+|+.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 357889999985421 22334577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++|+|.+++.+. ..+.+..+..++.|++.||.|||+. ++.++.+||+|||+++...... ..
T Consensus 82 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 156 (323)
T cd05584 82 LSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TV 156 (323)
T ss_pred CCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Cc
Confidence 9999999999764 4678888899999999999999876 4567899999999987542222 12
Q ss_pred ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCccc
Q 047892 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (442)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... .+..
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~----------~~~~~~~-~~~~-------- 217 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK----------KTIDKIL-KGKL-------- 217 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH----------HHHHHHH-cCCC--------
Confidence 33457999999999999888999999999999999999999999754321 1111111 1110
Q ss_pred CCCCcHHHHHHHHHHHhhhhCCCCCCCC-----CHHHHHH
Q 047892 383 QEKPSSRALKRALLVALRCVDPNAHKRP-----KMGHVIH 417 (442)
Q Consensus 383 ~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 417 (442)
..+...+..+.+++.+||+.||++|| ++.++++
T Consensus 218 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 --NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11122345678899999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=282.64 Aligned_cols=247 Identities=21% Similarity=0.321 Sum_probs=194.0
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|.+.+.||+|+||.||+|.. .++..+|||.+... .......+.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4588889999999999999995 56899999987542 2234467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++++|.+++.........+++...+.++.|++.||.|||+. ++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999999999875333345689999999999999999999976 45678899999999887643322
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
......|+..|+|||.+.+..++.++||||||+++|||++|..||...... ......... ..
T Consensus 162 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~---------~~ 223 (267)
T cd08229 162 -AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--------LYSLCKKIE---------QC 223 (267)
T ss_pred -ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch--------HHHHhhhhh---------cC
Confidence 123356889999999998888999999999999999999999999643211 111111110 00
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
..........+..+.+++.+||+.||++|||+.+|++.+.++
T Consensus 224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 224 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 111112234556788999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=288.92 Aligned_cols=241 Identities=21% Similarity=0.290 Sum_probs=184.1
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcch---------h-----hHHHHHHHHHHHHhcCCCCcce
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRG---------Q-----AEKEFKVEVEAIGRVRHKNLVR 218 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~-----~~~~~~~E~~~l~~l~hpnIv~ 218 (442)
....+.|++.+.||+|.||.|-+|+. .+++.||||++.+... . ..+...+||.+|++|+|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 44567899999999999999999995 4589999999943211 1 1246789999999999999999
Q ss_pred EEEEEEeC--CeeeeEEecCCCCCHHHHHccCCCCCCC-CCHHHHHHHHHHHHHhhhhhhcC-------------CCCCC
Q 047892 219 LVGYCAEG--AHRMLVNEYVDNGNLEQWLHGDVGPHSP-LTWEIRMNIILGTAKGLTYLHEG-------------LEPKW 282 (442)
Q Consensus 219 l~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~~~~-l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~ 282 (442)
|+.+..+. +.+|||+|||..|.+... ....+ +++.+++.++++++.||+|||.+ +..+|
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~-----p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWC-----PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccC-----CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC
Confidence 99998654 678999999999987542 22334 89999999999999999999876 44578
Q ss_pred CeEEecccCccccCCCc----ceeecccccccCCCCcccccCCC----CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCc
Q 047892 283 NPKLSDFGLAKLLGAER----SYVTTRVMGTFGYVAPEYASTGM----LNETSDVYSFGILIMEVISGRNPVDYSRPPGE 354 (442)
Q Consensus 283 ~~kl~DFGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~ 354 (442)
++||+|||.+....... .......+|||.|||||++.++. .+.+.||||+||+||-|+.|+.||.+....
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~-- 325 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL-- 325 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH--
Confidence 99999999998662221 11123368999999999987633 346789999999999999999999754321
Q ss_pred cchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 355 FQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
+... .++...+......+..+.+.+||+++|++||+.|.+..+|...
T Consensus 326 --------~l~~---------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 326 --------ELFD---------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred --------HHHH---------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 1111 1122222223333556778899999999999999999998754
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=282.86 Aligned_cols=245 Identities=27% Similarity=0.446 Sum_probs=193.0
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++..++|.+.+.||+|+||.||+|..++++.||||.+.... ...+.+.+|+.++++++||||+++++++......++||
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 35567899999999999999999998778889999886533 33467889999999999999999999999888999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++++|.+++.... ...+++..+..++.|++.|+.|||+. ++.++.+||+|||+++.+.....
T Consensus 81 e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 81 EYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred eccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999999997642 24688999999999999999999976 45677899999999987643222
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
.......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .... .....
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-------~~~~---~~~~~-------- 220 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-------EVLE---QVERG-------- 220 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHH---HHHcC--------
Confidence 11222334678999999988889999999999999999999 99999643211 1111 11110
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
.....+...+..+.+++.+||+.||++||++.++++.|+.
T Consensus 221 --~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 221 --YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011111224568889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=286.30 Aligned_cols=244 Identities=23% Similarity=0.381 Sum_probs=188.4
Q ss_pred CCCCccCeeccCCcEEEEEEEE-----CCCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-----EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
++|++.+.||+|+||.||+|.. ..+..||+|.+.... ......+.+|+++++.++||||+++++++..++..|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5688889999999999999984 246789999986432 3344678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCC-------------CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeE
Q 047892 232 VNEYVDNGNLEQWLHGDVG-------------PHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPK 285 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~-------------~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~k 285 (442)
||||+++|+|.+++..... ....+++...+.++.|++.||.|||+. ++.++.+|
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~k 164 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVK 164 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEE
Confidence 9999999999999853211 123578888999999999999999876 44567899
Q ss_pred EecccCccccCCCcc-eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHH
Q 047892 286 LSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFE 363 (442)
Q Consensus 286 l~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 363 (442)
|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||...... ...
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-------~~~- 236 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-------EVI- 236 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------HHH-
Confidence 999999986533321 12233456778999999988889999999999999999999 99998653221 111
Q ss_pred HHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 364 WLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
........ ...+...+..+.+++.+||+.||++||++.+|++.|.+
T Consensus 237 ---~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 ---EMVRKRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111 01122334568889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=282.60 Aligned_cols=242 Identities=24% Similarity=0.363 Sum_probs=188.3
Q ss_pred hhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
..++|.+.+.||+|+||.||+|....+..+|+|.+.... ...+.+.+|+++++.++||||+++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 345688899999999999999998777789999875432 33466888999999999999999999875 4568999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+.+|+|.++++... ...+++..+..++.|++.||.|||+. ++.++.+||+|||+++.........
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 82 MGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 99999999997542 23578899999999999999999975 4456789999999998764332222
Q ss_pred ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcc
Q 047892 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (442)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..... .. .. .
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~---~~-~~-~------- 220 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-------EVLEQ---VE-RG-Y------- 220 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHH---HH-cC-C-------
Confidence 223346778999999988889999999999999999999 99999653321 11111 11 11 0
Q ss_pred cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 382 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
....+...+..+.+++.+||+.||++||++.+|++.|++
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 221 -RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011122345668889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=288.85 Aligned_cols=241 Identities=20% Similarity=0.312 Sum_probs=200.1
Q ss_pred CCCccCeeccCCcEEEEEEE-ECCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 159 GFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
-|.+.+.||+|.|+.|-+|+ .=+|..||||++.+. +......+.+|++.|+.++|||||+||.+......+|||+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 47888999999999999998 347999999999543 334456688899999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhh------cCCCCC--------CCeEEecccCccccCCCcce
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH------EGLEPK--------WNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH------~~l~~~--------~~~kl~DFGla~~~~~~~~~ 301 (442)
-++|+|++||-++ ...+.+..+.+++.||++|+.|+| ++++|+ |-+||+|||++..+... .
T Consensus 99 GD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--~ 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--K 173 (864)
T ss_pred cCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc--c
Confidence 9999999999765 357899999999999999999986 457776 46799999999766433 2
Q ss_pred eecccccccCCCCcccccCCCCC-CcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLN-ETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
..++.||++.|-|||++.+..|+ +++||||||||||.|++|++||...+..+.+. .++|-
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT-------------------mImDC 234 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT-------------------MIMDC 234 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh-------------------hhhcc
Confidence 35678999999999999999998 57899999999999999999998776654421 22222
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH--HHhcCCCC
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEAEEFP 425 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~ 425 (442)
....+...+.++.+||..||..||++|.|.++|+. +|+....+
T Consensus 235 --KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 235 --KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred --cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 22346677888999999999999999999999984 57766544
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=296.72 Aligned_cols=239 Identities=18% Similarity=0.221 Sum_probs=186.6
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888999999999999999954 58899999986432 234456888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++|+|.+++.+. ...+++..+..++.|++.||.|||+. ++.++.+||+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999764 24689999999999999999999875 44568899999999987654433
Q ss_pred eeecccccccCCCCccccc------CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 301 YVTTRVMGTFGYVAPEYAS------TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
.......||+.|+|||++. ...++.++|||||||++|||++|..||....... ..........
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----------~~~~i~~~~~- 226 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK----------TYNNIMNFQR- 226 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH----------HHHHHHcCCC-
Confidence 3334457899999999986 4568899999999999999999999997543211 1111111110
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
. +........+..+.+|+.+||. ||.+|||+.++++
T Consensus 227 --~----~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 --F----LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred --c----cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 0111111234567889999997 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=281.10 Aligned_cols=244 Identities=23% Similarity=0.416 Sum_probs=191.2
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++..++|.+.+.||+|+||.||++....+..+|+|.+... ....+.+.+|++++++++|+||+++++++.. ...+++|
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 3456789999999999999999999777788999988643 2344678899999999999999999999887 7789999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +++++.+||+|||++..+.....
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 80 EFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999999999997642 24578888999999999999999875 44567899999999987643332
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
.......++..|+|||++....++.++|+|||||++|+|++ |..||...... ...... ....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~----~~~~------ 220 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-------EVIRAL----ERGY------ 220 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHH----hCCC------
Confidence 22223345678999999988889999999999999999999 99999653321 111111 1110
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
........+..+.+++.+||+.||++||++.++++.|+.
T Consensus 221 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 ---RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011112344568889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=280.60 Aligned_cols=235 Identities=27% Similarity=0.403 Sum_probs=181.4
Q ss_pred CeeccCCcEEEEEEEE-CCCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCCCH
Q 047892 164 NVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNL 241 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L 241 (442)
+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+++++.++||||+++++++...+..|+||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4689999999999996 468899999875432 34456789999999999999999999999999999999999999999
Q ss_pred HHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceee-cccc
Q 047892 242 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT-TRVM 307 (442)
Q Consensus 242 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~-~~~~ 307 (442)
.+++... ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++.......... ....
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999653 24578999999999999999999875 44567899999999986532211111 1112
Q ss_pred cccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCC
Q 047892 308 GTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKP 386 (442)
Q Consensus 308 gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (442)
++..|+|||.+.++.++.++|||||||++|||++ |..||...... . ........ .....
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-------~----~~~~~~~~---------~~~~~ 217 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-------Q----TREAIEQG---------VRLPC 217 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-------H----HHHHHHcC---------CCCCC
Confidence 3457999999988889999999999999999998 88898643211 0 11111111 01111
Q ss_pred cHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 387 SSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 387 ~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 22335578889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=279.22 Aligned_cols=248 Identities=21% Similarity=0.356 Sum_probs=195.2
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 46889999999999999999965 6899999988532 2334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++|+|.+++.........+++..++.++.|++.||.|||+. ++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999999999875433345689999999999999999999875 45678899999999886543221
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
......|+..|+|||.+.+..++.++|||||||++|+|++|..||..... +......... .+
T Consensus 162 -~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~-~~-------- 223 (267)
T cd08224 162 -AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--------NLYSLCKKIE-KC-------- 223 (267)
T ss_pred -ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc--------cHHHHHhhhh-cC--------
Confidence 12334688999999999888899999999999999999999999864321 1111111110 11
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
.....+....+..+.+++.+||..+|++|||+.+|++.|+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0111112244567888999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=285.87 Aligned_cols=247 Identities=22% Similarity=0.405 Sum_probs=191.4
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEECC------CCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLED------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA 227 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 227 (442)
+..++|.+.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 455678999999999999999998632 3679999986442 334456889999999999999999999999999
Q ss_pred eeeeEEecCCCCCHHHHHccCCCC------CCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEec
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGP------HSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSD 288 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~D 288 (442)
..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||.. ++.++.+||+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECC
Confidence 999999999999999999753211 23478889999999999999999975 44567899999
Q ss_pred ccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHH
Q 047892 289 FGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLK 366 (442)
Q Consensus 289 FGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 366 (442)
||+++.+...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------~~~~~~- 234 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE-------EVLKFV- 234 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH-------HHHHHH-
Confidence 9999866433221 2233456789999999988889999999999999999998 99998643321 111111
Q ss_pred HHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 367 TMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
...... ..+...+..+.+++.+||+.||++|||+.++++.|++
T Consensus 235 ---~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 ---IDGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ---hcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111110 1111235668899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=285.78 Aligned_cols=249 Identities=20% Similarity=0.343 Sum_probs=192.6
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEECC-----CCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CC
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLED-----NTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE-GA 227 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~ 227 (442)
+..++|.+.+.||+|+||.||+|.+.. +..|++|.+... .......+.+|+.++++++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 446678899999999999999999755 678999988644 33445668899999999999999999998765 46
Q ss_pred eeeeEEecCCCCCHHHHHccCCCC----CCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEeccc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGP----HSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFG 290 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFG 290 (442)
..++++||+++|+|.+++...... ...+++..++.++.|++.||+|||.. ++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 789999999999999999654221 14689999999999999999999876 3456789999999
Q ss_pred CccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHH
Q 047892 291 LAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTM 368 (442)
Q Consensus 291 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 368 (442)
+++.+...... ......++..|+|||++.+..++.++|||||||++||+++ |+.||...... ....++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~--- 232 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF-------EMAAYL--- 232 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH-------HHHHHH---
Confidence 99865433322 1223346778999999988889999999999999999999 99999654321 111111
Q ss_pred hhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 369 VTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
.... ........+..+.+++.+||..||++|||+.++++.|+.+.
T Consensus 233 -~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 233 -KDGY---------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred -HcCC---------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1110 00111223456888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=291.10 Aligned_cols=243 Identities=25% Similarity=0.427 Sum_probs=187.1
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCC----eEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNT----NVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
..+|+..+.||+|+||.||+|.+. ++. .||+|.+.... ....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 456899999999999999999853 333 38999986443 34556788999999999999999999998764 578
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+|+||+++|+|.+++... ...+++...+.++.|++.||+|||+. ++.++.+||+|||+++.+..
T Consensus 85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999999764 24578889999999999999999975 44567899999999987654
Q ss_pred Ccce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 298 ERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 298 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
.... ......++..|+|||++.+..++.++|||||||++|||++ |..||...... ... .......
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-------~~~----~~~~~~~-- 228 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------EIS----SILEKGE-- 228 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------HHH----HHHhCCC--
Confidence 3322 1222344678999999999999999999999999999998 99999643211 111 1111111
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....+..+...+.+++.+||+.||++|||+.+++..|..+.
T Consensus 229 -------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 229 -------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred -------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00111123345788999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=292.11 Aligned_cols=231 Identities=24% Similarity=0.311 Sum_probs=178.5
Q ss_pred CCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHH---HhcCCCCcceEEEEEEeCCeeeeE
Q 047892 160 FADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAI---GRVRHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~hpnIv~l~~~~~~~~~~~lv 232 (442)
|++.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|++++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999964 58899999986432 22334566676655 567899999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
|||+++|+|..+++. ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 999999999998864 3689999999999999999999876 4567899999999987532221
Q ss_pred ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........ ...
T Consensus 156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~----------~~~~~i~~-~~~----- 218 (324)
T cd05589 156 -DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE----------EVFDSIVN-DEV----- 218 (324)
T ss_pred -CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH----------HHHHHHHh-CCC-----
Confidence 1234467999999999999889999999999999999999999999754321 11111111 110
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCC-----CHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRP-----KMGHVIH 417 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 417 (442)
..+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 219 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 -----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 01122345677899999999999999 5666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=285.83 Aligned_cols=255 Identities=19% Similarity=0.239 Sum_probs=184.8
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 357999999999999999999965 58899999986432 2223457789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
|+. ++|.+++... ...++...+..++.|++.||+|||+. ++.++.+||+|||+++.......
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 158 (303)
T cd07869 84 YVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH- 158 (303)
T ss_pred CCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc-
Confidence 996 5888888654 24578889999999999999999876 44578899999999976432221
Q ss_pred eecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc------
Q 047892 302 VTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA------ 374 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 374 (442)
......||+.|+|||++.+ ..++.++|||||||++|||++|..||....... .....+.........
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ------DQLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH------HHHHHHHHHhCCCChhhccch
Confidence 1234568999999998865 458899999999999999999999997543210 111111111000000
Q ss_pred ---ccccCcccCCCCc---------HHHHHHHHHHHhhhhCCCCCCCCCHHHHHH--HHhcC
Q 047892 375 ---EGVLDPRLQEKPS---------SRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEAE 422 (442)
Q Consensus 375 ---~~~~~~~~~~~~~---------~~~~~~~~~li~~cl~~dP~~RPs~~evl~--~L~~~ 422 (442)
.......+....+ ...+..+.+|+.+||+.||++|||+.|+++ .+.++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 0000000000000 012245778999999999999999999986 34444
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=288.46 Aligned_cols=248 Identities=25% Similarity=0.410 Sum_probs=191.5
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAE 225 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 225 (442)
.+..++|.+.+.||+|+||.||+|... .+..||+|.+.... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 455567999999999999999999741 24579999886442 33446788999999999 89999999999999
Q ss_pred CCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCc
Q 047892 226 GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLA 292 (442)
Q Consensus 226 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla 292 (442)
.+..|+||||+.+|+|.++++... ...+++...+.++.|++.||.|||+. ++.++.+||+|||++
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 999999999999999999997542 23489999999999999999999976 344568899999999
Q ss_pred cccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhh
Q 047892 293 KLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVT 370 (442)
Q Consensus 293 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 370 (442)
+.+...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||........ . .....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------~----~~~~~ 258 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------F----YKLIK 258 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------H----HHHHH
Confidence 866433221 1223346788999999988899999999999999999998 9999865432111 1 11111
Q ss_pred cCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 371 NGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.+ .....+...+..+.+++.+||+.||++|||+.|+++.|++.
T Consensus 259 ~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 259 EG---------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cC---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11 01111112345688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=267.92 Aligned_cols=252 Identities=21% Similarity=0.268 Sum_probs=197.6
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEE-ECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----C
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG-----A 227 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~ 227 (442)
.+..++|++.+.||+|+|+.||+++ ..++..+|+|++.....+..+...+|++..++++||||++++++...+ .
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3556779999999999999999999 667899999999877777778889999999999999999998876433 3
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC--------CCC-------CCCeEEecccCc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--------LEP-------KWNPKLSDFGLA 292 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------l~~-------~~~~kl~DFGla 292 (442)
..||++.|...|+|.+.+.+.......+++.+.+.++.++++||++||.. ++| .+.++|.|||.+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 48999999999999999987655566899999999999999999998765 444 467899999998
Q ss_pred cccCCCccee--------ecccccccCCCCccccc---CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhH
Q 047892 293 KLLGAERSYV--------TTRVMGTFGYVAPEYAS---TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNL 361 (442)
Q Consensus 293 ~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~ 361 (442)
....-.-... ......|..|+|||.+. +...++++|||||||+||+|+.|..||+.....+.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg------- 249 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG------- 249 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-------
Confidence 7532111000 01123588999999884 44578899999999999999999999964211110
Q ss_pred HHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 362 FEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.-...+..+.+..+...+.++.+.+++..|++.||.+||++.+++..++..
T Consensus 250 ----------SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 250 ----------SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ----------eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 011123333444444445788899999999999999999999999998865
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=278.38 Aligned_cols=234 Identities=26% Similarity=0.405 Sum_probs=182.8
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCCCHH
Q 047892 164 NVIGEGGYGIVYRGVLEDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLE 242 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~ 242 (442)
++||+|+||.||+|...++..+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998788899999886543 333456889999999999999999999999999999999999999999
Q ss_pred HHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecccccc
Q 047892 243 QWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGT 309 (442)
Q Consensus 243 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 309 (442)
+++... ...+++...+.++.|++.||.|||.. ++.++.+||+|||++...............++
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 998654 23578999999999999999999865 44567899999999976433222222223446
Q ss_pred cCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcH
Q 047892 310 FGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSS 388 (442)
Q Consensus 310 ~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (442)
..|+|||++.+..++.++|||||||++|||++ |..||...... ... ....... ....+.
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------~~~----~~~~~~~---------~~~~~~ 217 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------QAR----EQVEKGY---------RMSCPQ 217 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------HHH----HHHHcCC---------CCCCCC
Confidence 78999999988889999999999999999998 99999643221 111 1111110 011112
Q ss_pred HHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHh
Q 047892 389 RALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420 (442)
Q Consensus 389 ~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 420 (442)
..+..+.+++.+||+.||++|||+.++++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 23456888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=290.39 Aligned_cols=237 Identities=23% Similarity=0.321 Sum_probs=196.4
Q ss_pred CCCCccCeeccCCcEEEEEEEECC-CCeEEEEEecCcch---hhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeeeE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVR-HKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv 232 (442)
..|.+.+.||+|.||.||+|+.+. |+.+|+|.+.+... .....+.+|+.+|+++. |||||+++++|++...+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 457888999999999999999654 99999999965432 24467899999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC-----------CCCeEEecccCcccc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP-----------KWNPKLSDFGLAKLL 295 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-----------~~~~kl~DFGla~~~ 295 (442)
||+|.||.|.+.|... .+++..+..++.|++.++.|||+. ++| ++.+|++|||++...
T Consensus 115 mEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 9999999999999764 289999999999999999999875 322 357999999999987
Q ss_pred CCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 296 GAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
.. .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.+......+. .+..+.+
T Consensus 190 ~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-----------~i~~~~~- 255 (382)
T KOG0032|consen 190 KP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-----------AILRGDF- 255 (382)
T ss_pred cC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----------HHHcCCC-
Confidence 55 334566799999999999988999999999999999999999999998765433211 1222222
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.+...+-...+..+.+++.+|+..||.+|+|+.++|+.
T Consensus 256 -----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 22333444556778899999999999999999999984
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=284.20 Aligned_cols=238 Identities=23% Similarity=0.261 Sum_probs=185.0
Q ss_pred CCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 160 FADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.+++.++||||+++++.+..++..|+||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 777899999999999999964 58899999985432 12234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++|+|.+++.... ...+++..+..++.|++.||.|||+. ++.++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 157 (285)
T cd05605 82 MNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-- 157 (285)
T ss_pred cCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc--
Confidence 99999998886431 24589999999999999999999876 44567899999999987543222
Q ss_pred ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCccc
Q 047892 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (442)
.....|++.|+|||++.+..++.++|||||||++|||++|..||........ ...+.......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~-------~~~~~~~~~~~---------- 220 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK-------REEVERRVKED---------- 220 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH-------HHHHHHHhhhc----------
Confidence 2345789999999999888899999999999999999999999975432111 11111111110
Q ss_pred CCCCcHHHHHHHHHHHhhhhCCCCCCCC-----CHHHHHHH
Q 047892 383 QEKPSSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 418 (442)
Q Consensus 383 ~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~~ 418 (442)
....+...+..+.+|+.+||+.||++|| ++.++++.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 1112233456678899999999999999 78887654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=282.84 Aligned_cols=234 Identities=22% Similarity=0.243 Sum_probs=180.2
Q ss_pred eccCCcEEEEEEEEC-CCCeEEEEEecCcch---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCCCH
Q 047892 166 IGEGGYGIVYRGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNL 241 (442)
Q Consensus 166 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L 241 (442)
||+|+||+||+|... +++.||+|.+..... .....+..|+++++.++||||+++.+++...+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999954 588999999854322 2234577899999999999999999999999999999999999999
Q ss_pred HHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeeccccc
Q 047892 242 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMG 308 (442)
Q Consensus 242 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 308 (442)
.+++.........+++..++.++.|++.||.|||+. ++.++.+||+|||++..+..... ......|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~g 159 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGYAG 159 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccccCC
Confidence 988854333345789999999999999999999876 44567899999999986643322 2334578
Q ss_pred ccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcH
Q 047892 309 TFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSS 388 (442)
Q Consensus 309 t~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (442)
|+.|+|||++.+..++.++|||||||++|||++|+.||........ ... ..... .... ...+.
T Consensus 160 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~------~~~-~~~~~--------~~~~--~~~~~ 222 (280)
T cd05608 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE------NKE-LKQRI--------LNDS--VTYPD 222 (280)
T ss_pred CcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh------HHH-HHHhh--------cccC--CCCcc
Confidence 9999999999999999999999999999999999999975432111 000 00000 0000 11122
Q ss_pred HHHHHHHHHHhhhhCCCCCCCC-----CHHHHHH
Q 047892 389 RALKRALLVALRCVDPNAHKRP-----KMGHVIH 417 (442)
Q Consensus 389 ~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 417 (442)
..+..+.+++.+||+.||++|| +++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 3456688899999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=279.68 Aligned_cols=238 Identities=22% Similarity=0.314 Sum_probs=186.5
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc-----hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR-----GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
++|.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999995 458999999885332 1223568889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
|+||+++++|.+++... ..+++.....++.|++.||.|||+. ++.++.+||+|||+++.....
T Consensus 82 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999999998764 4678899999999999999999875 455679999999999765332
Q ss_pred cceee--cccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 299 RSYVT--TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 299 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
..... ....|+..|+|||++.+..++.++|||||||++|||++|+.||...... ..........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----------~~~~~~~~~~---- 223 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----------AAIFKIATQP---- 223 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH----------HHHHHHhccC----
Confidence 21111 2346788999999999888999999999999999999999999643221 1011111110
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.....+...+..+.+++.+||..||++|||+.++++.
T Consensus 224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 -----TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0111222344567889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=295.57 Aligned_cols=189 Identities=24% Similarity=0.300 Sum_probs=159.8
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|+.++..++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46889999999999999999854 58899999985432 223356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
|||++|+|.+++.+. ..+++..+..++.|++.||+|||+. ++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 999999999999764 5689999999999999999999876 45678999999999875432110
Q ss_pred ----------------------------------eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCC
Q 047892 301 ----------------------------------YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPV 346 (442)
Q Consensus 301 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf 346 (442)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0012357999999999999999999999999999999999999999
Q ss_pred CCCC
Q 047892 347 DYSR 350 (442)
Q Consensus 347 ~~~~ 350 (442)
....
T Consensus 237 ~~~~ 240 (363)
T cd05628 237 CSET 240 (363)
T ss_pred CCCC
Confidence 7543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=288.67 Aligned_cols=237 Identities=22% Similarity=0.271 Sum_probs=180.4
Q ss_pred CeeccCCcEEEEEEEEC-CCCeEEEEEecCc---chhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 164 NVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
+.||+|+||.||+|... +++.||+|.+... .......+.+|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999964 5889999999643 223345578899999888 799999999999999999999999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecc
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTR 305 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~ 305 (442)
|+|.+++... ..+++..++.++.|++.||.|||+. ++.++.+||+|||+++..... ......
T Consensus 81 g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTST 155 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC-CCcccc
Confidence 9999998654 4689999999999999999999876 445788999999998753211 112334
Q ss_pred cccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCC
Q 047892 306 VMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEK 385 (442)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (442)
.+||+.|+|||++.+..++.++|||||||++|||++|+.||+......... .....+.......... .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~--~~~~~~~~~~~~~~~~------~---- 223 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD--QNTEDYLFQVILEKQI------R---- 223 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccc--ccchHHHHHHHHcCCC------C----
Confidence 679999999999999999999999999999999999999997432221100 0111222222222111 1
Q ss_pred CcHHHHHHHHHHHhhhhCCCCCCCCC------HHHHHH
Q 047892 386 PSSRALKRALLVALRCVDPNAHKRPK------MGHVIH 417 (442)
Q Consensus 386 ~~~~~~~~~~~li~~cl~~dP~~RPs------~~evl~ 417 (442)
.+...+..+.+++.+||+.||.+||| +.++++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 11123456788999999999999998 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=266.82 Aligned_cols=237 Identities=24% Similarity=0.334 Sum_probs=191.8
Q ss_pred hhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 156 STNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
..++|++.+.||+|.||.||.|+. +++-.||+|++.+.. .....++.+|+++-+.|+||||+++|++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 456799999999999999999995 557889999985432 2345678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~~~kl~DFGla~~~~~~ 298 (442)
++||..+|+|...|+... ...+++.....++.|+|.||.|+|.. + ...+.+||+|||-+..-.
T Consensus 100 ilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 999999999999998432 35688888899999999999999764 3 346789999999987643
Q ss_pred cceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 299 RSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
...-.+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||......+. ...+..
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et-------YkrI~k----------- 236 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET-------YKRIRK----------- 236 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH-------HHHHHH-----------
Confidence 2234567999999999999999999999999999999999999999975442211 111111
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.....+...+....++|.+|+..+|.+|.+..|++..
T Consensus 237 ---~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 ---VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ---ccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 0111224455668889999999999999999998764
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=307.84 Aligned_cols=245 Identities=20% Similarity=0.253 Sum_probs=190.2
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC---
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA--- 227 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--- 227 (442)
....++|.+.+.||+|+||.||+|.. .+++.||||.+... .......+.+|+.++..++|+||+++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 33456799999999999999999985 46899999998543 2344556888999999999999999988765332
Q ss_pred -----eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecc
Q 047892 228 -----HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDF 289 (442)
Q Consensus 228 -----~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DF 289 (442)
.+++||||+++|+|.++++........+++..+..++.|++.||.|||+. ++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 36899999999999999976544456789999999999999999999875 445778999999
Q ss_pred cCccccCCCcc-eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHH
Q 047892 290 GLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTM 368 (442)
Q Consensus 290 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 368 (442)
|+++.+..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+...
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~----------~~~~~~~ 257 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM----------EEVMHKT 257 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH----------HHHHHHH
Confidence 99987643221 223456799999999999999999999999999999999999999965322 1111111
Q ss_pred hhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 369 VTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
. .+.. . ..+...+.++.+++.+||+.||.+||++.++++.
T Consensus 258 ~-~~~~----~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 L-AGRY----D-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred h-cCCC----C-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1 1111 0 1122334568889999999999999999999863
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=296.99 Aligned_cols=246 Identities=18% Similarity=0.216 Sum_probs=187.7
Q ss_pred hhHHHhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 047892 151 RELEVSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG 226 (442)
Q Consensus 151 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 226 (442)
.++....++|++.+.||+|+||.||++... +++.||+|.+... .......+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 344566678999999999999999999964 5889999998532 122344578899999999999999999999999
Q ss_pred CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcc
Q 047892 227 AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAK 293 (442)
Q Consensus 227 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~ 293 (442)
+..|+||||+++|+|.+++... .+++..+..++.|++.||+|||+. ++.++.+||+|||+++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccce
Confidence 9999999999999999999653 478889999999999999999875 4457899999999998
Q ss_pred ccCCCcceeecccccccCCCCcccccCC----CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHh
Q 047892 294 LLGAERSYVTTRVMGTFGYVAPEYASTG----MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMV 369 (442)
Q Consensus 294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 369 (442)
.+...........+||+.|||||++.+. .++.++|||||||++|||++|+.||...... .......
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~----------~~~~~i~ 260 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV----------GTYSKIM 260 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH----------HHHHHHH
Confidence 7644333233456799999999998654 3788999999999999999999999754321 1111111
Q ss_pred hcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCC--CCCHHHHHHH
Q 047892 370 TNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHK--RPKMGHVIHM 418 (442)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~evl~~ 418 (442)
.... .+........+..+.+++.+||..++.. |+|+.|+++.
T Consensus 261 ~~~~-------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 261 DHKN-------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred hCCc-------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1110 0111111223455777888999855543 8899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=293.08 Aligned_cols=254 Identities=21% Similarity=0.295 Sum_probs=180.6
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----Ceee
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG-----AHRM 230 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~ 230 (442)
+|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.+++.++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 3778899999999999999954 5899999998542 223345688999999999999999999988543 2479
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+|||||. ++|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999996 5999998754 4689999999999999999999876 45578899999999986432
Q ss_pred Ccc--eeecccccccCCCCcccccC--CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhH-----HHHHHHH
Q 047892 298 ERS--YVTTRVMGTFGYVAPEYAST--GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNL-----FEWLKTM 368 (442)
Q Consensus 298 ~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~-----~~~~~~~ 368 (442)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............... ......
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 234 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR- 234 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH-
Confidence 211 11234579999999999865 67899999999999999999999999754321110000000 000000
Q ss_pred hhcCCcccc---cCcccCCCCc---HHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 369 VTNGNAEGV---LDPRLQEKPS---SRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 369 ~~~~~~~~~---~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
......... +......... ...+..+.+++.+||+.||++|||++|+++.
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000 0000000000 0123457889999999999999999999854
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=283.19 Aligned_cols=254 Identities=24% Similarity=0.336 Sum_probs=186.0
Q ss_pred CCccCeeccCCcEEEEEEEE-----CCCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--Ceeee
Q 047892 160 FADENVIGEGGYGIVYRGVL-----EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG--AHRML 231 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~l 231 (442)
|.+.+.||+|+||+||++.+ .++..||+|.+.... ......+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988753 357789999986543 23456788999999999999999999987653 45789
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
||||+++|+|.+++... .+++..++.++.|++.||.|||+. ++.++.+||+|||+++.....
T Consensus 86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 99999999999999653 589999999999999999999876 345678999999999876432
Q ss_pred cce--eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 299 RSY--VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 299 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
... ......++..|+|||++.+..++.++|||||||++|||++|..||........ .................
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-----EMIGPKQGQMTVVRLIE 235 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-----hhhcccccccchhhhhh
Confidence 211 11223456779999999888899999999999999999999999864321100 00000000000000001
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
.++.......+...+..+.+++.+||+.||++|||++++++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111111122334567889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=299.25 Aligned_cols=238 Identities=19% Similarity=0.251 Sum_probs=181.3
Q ss_pred CCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 159 GFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
+|++.+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|+++|+.++||||+++++.+.+++.+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 688999999999999999995 458899999985432 2234567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc--
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER-- 299 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~-- 299 (442)
||++|+|.+++.+. ..+++..+..++.|++.||+|||.. ++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 99999999999764 4678888999999999999999875 4457889999999975321000
Q ss_pred ----------------------------------------ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHH
Q 047892 300 ----------------------------------------SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEV 339 (442)
Q Consensus 300 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~el 339 (442)
.......+||+.|||||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0001235799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCC---CHHHHH
Q 047892 340 ISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRP---KMGHVI 416 (442)
Q Consensus 340 ltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP---s~~evl 416 (442)
++|+.||......+. ..... ... ..+........+..+.+++.+|+ .+|.+|+ |+.+++
T Consensus 238 l~G~~Pf~~~~~~~~----------~~~i~-~~~------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 238 LVGQPPFLADTPAET----------QLKVI-NWE------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred hhCCCCCCCCCHHHH----------HHHHh-ccC------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 999999976433111 01111 000 00111111123445667787876 5999999 889888
Q ss_pred HH
Q 047892 417 HM 418 (442)
Q Consensus 417 ~~ 418 (442)
+.
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=288.95 Aligned_cols=227 Identities=24% Similarity=0.324 Sum_probs=175.1
Q ss_pred CeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHh-cCCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 164 NVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGR-VRHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
+.||+|+||.||+|... +++.||+|.+.... ......+..|..++.. .+||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 57889999986432 2233445567777765 4899999999999999999999999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecc
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTR 305 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~ 305 (442)
|+|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSS----GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 9999998754 4688999999999999999999876 4567889999999998643222 22345
Q ss_pred cccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCC
Q 047892 306 VMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEK 385 (442)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (442)
.+||+.|+|||++.+..++.++|||||||++|||++|..||...... +...... .. .+ .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~----------~~~~~i~-~~------~~----~ 214 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED----------ELFDSIL-ND------RP----H 214 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH----------HHHHHHH-cC------CC----C
Confidence 67999999999999889999999999999999999999999754321 1111111 10 01 1
Q ss_pred CcHHHHHHHHHHHhhhhCCCCCCCCCHH-HHH
Q 047892 386 PSSRALKRALLVALRCVDPNAHKRPKMG-HVI 416 (442)
Q Consensus 386 ~~~~~~~~~~~li~~cl~~dP~~RPs~~-evl 416 (442)
.+...+.++.+++.+||+.||++||++. +++
T Consensus 215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1122345577899999999999999875 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=280.56 Aligned_cols=233 Identities=24% Similarity=0.331 Sum_probs=193.5
Q ss_pred CCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 160 FADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
|.++++||+|+||.||+|.+ +.|+.+|||++... ...+++.+|+.+|++++.|++|++||.+.....+|||||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 67789999999999999995 56999999998543 4567889999999999999999999999988999999999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecc
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTR 305 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~ 305 (442)
|++.+.++-+ ..++++..+..++...++||+|||.. +..+|..||+|||+|..+.+... ..++
T Consensus 113 GSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KRNT 188 (502)
T KOG0574|consen 113 GSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KRNT 188 (502)
T ss_pred CcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH-hhCc
Confidence 9999999754 46899999999999999999999753 45678999999999987754332 2345
Q ss_pred cccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC--cccC
Q 047892 306 VMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD--PRLQ 383 (442)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 383 (442)
..||+.|||||+++.-.|+.++||||||++..||..|++||.+-.+.... -++. +...
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI--------------------FMIPT~PPPT 248 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI--------------------FMIPTKPPPT 248 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee--------------------EeccCCCCCC
Confidence 78999999999999999999999999999999999999999765442210 0111 1111
Q ss_pred CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 384 EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 384 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
..-+...+.++-+++.+||-.+|++|-|+.++++.
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 12345677889999999999999999999998765
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=284.17 Aligned_cols=243 Identities=24% Similarity=0.409 Sum_probs=184.8
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCC----eEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNT----NVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
.++|++.+.||+|+||.||+|.+. +++ .+++|.+.... .....++..|+.++++++||||+++++++. ....+
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 346888999999999999999963 344 47788775432 233456778888999999999999999875 45578
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+++||+++|+|.+++... ...+++...+.++.|++.||.|||+. ++.++.+||+|||+++....
T Consensus 85 ~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999999754 24689999999999999999999875 44567899999999987643
Q ss_pred Ccc-eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 298 ERS-YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 298 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
... .......++..|+|||.+.++.++.++|||||||++|||++ |..||...... ... .....+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~----~~~~~~~~- 229 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-------EVP----DLLEKGER- 229 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHH----HHHHCCCc-
Confidence 322 12233456788999999988899999999999999999998 99999654321 111 11111110
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
. ..+..+...+.+++.+||..||++|||+.|+++.|..+.
T Consensus 230 -~-------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 230 -L-------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred -C-------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 0 011112345778999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=296.93 Aligned_cols=239 Identities=19% Similarity=0.233 Sum_probs=181.6
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|.+.+.||+|+||.||+|.. .+++.||||.+.... ......+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688899999999999999985 468899999985432 233456888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. ++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 999999999999754 4688899999999999999999875 34568899999999863311000
Q ss_pred ------------e----------------------------------eecccccccCCCCcccccCCCCCCcCCchhhHH
Q 047892 301 ------------Y----------------------------------VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGI 334 (442)
Q Consensus 301 ------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv 334 (442)
. .....+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001246999999999999889999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCC---CC
Q 047892 335 LIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKR---PK 411 (442)
Q Consensus 335 il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R---Ps 411 (442)
++|||++|..||........ ......... .+........+.++.+|+.+||. +|.+| +|
T Consensus 237 il~elltG~~Pf~~~~~~~~----------~~~i~~~~~-------~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 237 IMFECLIGWPPFCSENSHET----------YRKIINWRE-------TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHH----------HHHHHccCC-------ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 99999999999975432111 111111000 00101111234567789999997 77775 59
Q ss_pred HHHHHHH
Q 047892 412 MGHVIHM 418 (442)
Q Consensus 412 ~~evl~~ 418 (442)
+.|++..
T Consensus 299 ~~~~l~h 305 (377)
T cd05629 299 AHEIKSH 305 (377)
T ss_pred HHHHhcC
Confidence 9998864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=296.87 Aligned_cols=237 Identities=18% Similarity=0.247 Sum_probs=179.8
Q ss_pred CCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 159 GFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
.|+.++.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 478899999999999999995 458899999985432 2334568889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc--
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER-- 299 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~-- 299 (442)
||++|+|.+++.+. ..+++..+..++.|++.||+|||+. ++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 99999999999764 4678889999999999999999876 4457899999999975321000
Q ss_pred --------------------------------------------ceeecccccccCCCCcccccCCCCCCcCCchhhHHH
Q 047892 300 --------------------------------------------SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGIL 335 (442)
Q Consensus 300 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvi 335 (442)
.......+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCC---H
Q 047892 336 IMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPK---M 412 (442)
Q Consensus 336 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs---~ 412 (442)
+|||++|+.||...++... ........ ..+........+.++.+++.+|+ .||.+|++ +
T Consensus 238 l~elltG~~Pf~~~~~~~~----------~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~ 299 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLET----------QMKVINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA 299 (382)
T ss_pred HHHHHhCCCCCCCCCHHHH----------HHHHHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence 9999999999975432111 11111100 01111111223455677777765 59999997 7
Q ss_pred HHHHH
Q 047892 413 GHVIH 417 (442)
Q Consensus 413 ~evl~ 417 (442)
.++++
T Consensus 300 ~ei~~ 304 (382)
T cd05625 300 DEIKA 304 (382)
T ss_pred HHHhc
Confidence 77764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=291.83 Aligned_cols=225 Identities=22% Similarity=0.265 Sum_probs=177.5
Q ss_pred CeeccCCcEEEEEEEE----CCCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCC
Q 047892 164 NVIGEGGYGIVYRGVL----EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVD 237 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 237 (442)
+.||+|+||.||++.. .+++.||+|.+.... ......+.+|++++++++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 357899999986432 1233456789999999999999999999999999999999999
Q ss_pred CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeec
Q 047892 238 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTT 304 (442)
Q Consensus 238 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~ 304 (442)
+|+|.+++.+. ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++...... ....
T Consensus 82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~ 156 (318)
T cd05582 82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAY 156 (318)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Ccee
Confidence 99999999654 4689999999999999999999876 4567889999999998653322 1233
Q ss_pred ccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCC
Q 047892 305 RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQE 384 (442)
Q Consensus 305 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (442)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ..... ....
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-------~~---~~~i~-~~~~---------- 215 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-------ET---MTMIL-KAKL---------- 215 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-------HH---HHHHH-cCCC----------
Confidence 467999999999998888999999999999999999999999754321 11 11111 1110
Q ss_pred CCcHHHHHHHHHHHhhhhCCCCCCCCCHHH
Q 047892 385 KPSSRALKRALLVALRCVDPNAHKRPKMGH 414 (442)
Q Consensus 385 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~e 414 (442)
..+...+..+.+|+.+||+.||++|||+.+
T Consensus 216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 111223456778999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=277.94 Aligned_cols=255 Identities=21% Similarity=0.272 Sum_probs=188.2
Q ss_pred CCCccCeeccCCcEEEEEEEE-CCCCeEEEEEec--CcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEe-----CCeee
Q 047892 159 GFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLL--NNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE-----GAHRM 230 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~~~~ 230 (442)
.|...+.||+|+||.|..+.. .+|+.||||++. .......++..+|+.+|+.++|+||+.+++++.. -+.+|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 355578999999999999995 568999999996 3345556778899999999999999999999865 35689
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~~~~ 297 (442)
+|+|+|+. ||.+.|+.. ..++......++.|++.||.|+|+. ++ .+..+||+|||+|+....
T Consensus 103 iV~elMet-DL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 103 LVFELMET-DLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred EehhHHhh-HHHHHHHcC----ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 99999965 999999865 4589999999999999999999864 44 456889999999998753
Q ss_pred C-cceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHH----HHHHHHhhc
Q 047892 298 E-RSYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF----EWLKTMVTN 371 (442)
Q Consensus 298 ~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~----~~~~~~~~~ 371 (442)
. .....+..+-|..|.|||++.. ..|+.+.||||.|||+.||++|++.|.+.+....++....+. +.......+
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 2 1222356788999999998754 569999999999999999999999998765433322111110 000011111
Q ss_pred CCcccccCcc---cCCCC---cHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 372 GNAEGVLDPR---LQEKP---SSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 372 ~~~~~~~~~~---~~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
......+... .+... -........+|+.+||..||.+|+|++|.|+.
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111111110 00000 11345568889999999999999999999864
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=283.67 Aligned_cols=246 Identities=26% Similarity=0.445 Sum_probs=187.7
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAH 228 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 228 (442)
..++|.+.+.||+|+||.||+|.+. .+..||+|.+.... ......+.+|+.+++.++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3466889999999999999999964 35678999885433 3344568899999999999999999999999899
Q ss_pred eeeEEecCCCCCHHHHHccCCC---CCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC-------C---CCeEEecc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEG------LEP-------K---WNPKLSDF 289 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-------~---~~~kl~DF 289 (442)
.++||||+++|+|.+++.+... ....+++..++.++.|++.||+|||+. +++ + ..+||+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 9999999999999999975421 123588999999999999999999876 332 2 25899999
Q ss_pred cCccccCCCccee-ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHH
Q 047892 290 GLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKT 367 (442)
Q Consensus 290 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 367 (442)
|+++.+....... .....++..|+|||++.+..++.++|||||||++|||++ |..||....... .. .
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-------~~----~ 232 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-------VM----E 232 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HH----H
Confidence 9998763322211 112234568999999988899999999999999999997 999997543211 11 1
Q ss_pred HhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 368 MVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
...... ....+...+..+.+++.+||+.||++|||+.+|++.|+.
T Consensus 233 ~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 233 FVTGGG---------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HHHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 111110 011122334568889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=278.60 Aligned_cols=232 Identities=28% Similarity=0.447 Sum_probs=180.7
Q ss_pred eeccCCcEEEEEEEE---CCCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCC
Q 047892 165 VIGEGGYGIVYRGVL---EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNG 239 (442)
Q Consensus 165 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 239 (442)
.||+|+||.||+|.+ .++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999974 357889999885432 334567889999999999999999999876 45678999999999
Q ss_pred CHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee--ec
Q 047892 240 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV--TT 304 (442)
Q Consensus 240 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~--~~ 304 (442)
+|.+++... ..+++.....++.|++.||.|||+. ++.++.+||+|||+++.+....... ..
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999999754 4688999999999999999999876 3456679999999998765443321 12
Q ss_pred ccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccC
Q 047892 305 RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ 383 (442)
Q Consensus 305 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (442)
...++..|+|||.+....++.++|||||||++|||++ |..||...... .... ....+. .
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~----~i~~~~---------~ 216 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-------EVTQ----MIESGE---------R 216 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHH----HHHCCC---------C
Confidence 2334678999999988889999999999999999998 99999653221 1111 111111 1
Q ss_pred CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 384 EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 384 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
...+...+.++.+++.+||+.||++||++.+|.+.|++
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11122344668889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=284.43 Aligned_cols=247 Identities=20% Similarity=0.303 Sum_probs=186.5
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
++|++.+.||+|+||.||++... ++..+|+|.+... .......+.+|++++.+++||||+++++++..++..|+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36889999999999999999954 5788899988543 233445688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC--------------CCCCCCeEEecccCccccCCCcce
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
+++|+|.+++++. ..+++.....++.|+++||.|||+. ++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 9999999999764 4688999999999999999999963 345678999999998765322
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC--------
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN-------- 373 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 373 (442)
......|+..|+|||++.+..++.++|||||||++|||++|..||...+.... ............
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-------EAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-------HHhhcCccccccccCCcccc
Confidence 12345789999999999888899999999999999999999999964332110 000000000000
Q ss_pred ----------------cccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 374 ----------------AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 374 ----------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
............+....+.++.+++.+||..||++|||+.++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000111244568899999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=288.74 Aligned_cols=251 Identities=25% Similarity=0.404 Sum_probs=191.6
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEEC--------CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhc-CCCCcceEEEEE
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLE--------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLVGYC 223 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 223 (442)
++..++|.+.+.||+|+||.||++... +...+|+|.+.... ......+.+|+.+++.+ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 444567999999999999999999842 23469999886532 33445688899999999 799999999999
Q ss_pred EeCCeeeeEEecCCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------C
Q 047892 224 AEGAHRMLVNEYVDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEG-------------L 278 (442)
Q Consensus 224 ~~~~~~~lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l 278 (442)
...+..|+||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 173 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence 999999999999999999999975421 123588899999999999999999976 4
Q ss_pred CCCCCeEEecccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccc
Q 047892 279 EPKWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQ 356 (442)
Q Consensus 279 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~ 356 (442)
+.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---- 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 249 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----
Confidence 55778999999999765332211 1122234578999999988889999999999999999998 88898543211
Q ss_pred hhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCC
Q 047892 357 FQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 424 (442)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 424 (442)
+.. ....... ....+...+.++.+++.+||..+|++|||+.++++.|+.+..
T Consensus 250 ------~~~-~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 250 ------ELF-KLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred ------HHH-HHHHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 111 1111111 111122344578889999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=283.27 Aligned_cols=245 Identities=24% Similarity=0.402 Sum_probs=189.7
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
..+|...+.||+|+||.||++... ++..+|+|.+..........+.+|+++++.++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 456788899999999999999732 35678999887666666678999999999999999999999999999999
Q ss_pred eEEecCCCCCHHHHHccCCC-----------CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEE
Q 047892 231 LVNEYVDNGNLEQWLHGDVG-----------PHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKL 286 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl 286 (442)
++|||+++|+|.+++..... ....+++..++.++.|++.|++|||+. ++.++.+||
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEE
Confidence 99999999999999975421 113578899999999999999999875 345678999
Q ss_pred ecccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHH
Q 047892 287 SDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEW 364 (442)
Q Consensus 287 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 364 (442)
+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+ .
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----------~ 233 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE----------A 233 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH----------H
Confidence 999999765432221 1222345788999999988899999999999999999998 999986432211 1
Q ss_pred HHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 365 LKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
..... .+. ....+...+..+.+++.+||+.||.+||++.+|++.|+.
T Consensus 234 ~~~~~-~~~---------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 234 IECIT-QGR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHH-cCc---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11111 110 001112234567889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=293.22 Aligned_cols=229 Identities=20% Similarity=0.234 Sum_probs=179.5
Q ss_pred CeeccCCcEEEEEEEE-CCCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCC
Q 047892 164 NVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNG 239 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 239 (442)
+.||+|+||.||++.. .+++.||+|.+.... ......+.+|++++..++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999995 468899999986432 233456778999999999999999999999999999999999999
Q ss_pred CHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc-C-------------CCCCCCeEEecccCccccCCCcceeecc
Q 047892 240 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-G-------------LEPKWNPKLSDFGLAKLLGAERSYVTTR 305 (442)
Q Consensus 240 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~ 305 (442)
+|.+++... ..+++..+..++.|++.||.|||+ . ++.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (325)
T cd05594 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKT 155 (325)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cccc
Confidence 999998754 468999999999999999999996 3 34567899999999875422211 2234
Q ss_pred cccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCC
Q 047892 306 VMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEK 385 (442)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (442)
..||+.|+|||++.+..++.++|||||||++|||++|..||....... .. ........ .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-------~~----~~i~~~~~------~---- 214 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LF----ELILMEEI------R---- 214 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH-------HH----HHHhcCCC------C----
Confidence 579999999999999899999999999999999999999996533211 11 11111110 1
Q ss_pred CcHHHHHHHHHHHhhhhCCCCCCCC-----CHHHHHHH
Q 047892 386 PSSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 418 (442)
Q Consensus 386 ~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~~ 418 (442)
.+...+.++.+++.+||+.||++|+ ++.++++.
T Consensus 215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1112345678899999999999997 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=281.63 Aligned_cols=253 Identities=22% Similarity=0.325 Sum_probs=187.6
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-----CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeee
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-----DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE--GAHRM 230 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~ 230 (442)
.+|++.+.||+|+||.||+|... ++..||+|.+........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888999999999999999842 478899999876655566788999999999999999999998753 34679
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+||||+++|+|.+++.+. ...+++..++.++.|++.||.|||.. ++.++.+||+|||+++.+..
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999999999754 23588999999999999999999976 44567899999999987644
Q ss_pred Cccee--ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCcc--c---hhhhHHHHHHHHhh
Q 047892 298 ERSYV--TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEF--Q---FQVNLFEWLKTMVT 370 (442)
Q Consensus 298 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~--~---~~~~~~~~~~~~~~ 370 (442)
..... .....++..|+|||++.+..++.++|||||||++|||++|..|+......-.. . ........+.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 32211 11223445699999998888999999999999999999988776432110000 0 00000000111111
Q ss_pred cCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 371 NGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
. ..........+..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 241 ~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 241 N---------NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred c---------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1 111111223445688899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=283.63 Aligned_cols=245 Identities=26% Similarity=0.417 Sum_probs=188.8
Q ss_pred CCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 159 GFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
+|++.+.||+|+||.||+|... ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3678899999999999999852 23568888876443 3345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCC--------------------CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------C
Q 047892 232 VNEYVDNGNLEQWLHGDVG--------------------PHSPLTWEIRMNIILGTAKGLTYLHEG-------------L 278 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l 278 (442)
+|||+.+|+|.+++..... ....+++..++.++.|++.||.|||.. +
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 9999999999999864211 123578899999999999999999876 4
Q ss_pred CCCCCeEEecccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccc
Q 047892 279 EPKWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQ 356 (442)
Q Consensus 279 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~ 356 (442)
..++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||....+.
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---- 236 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE---- 236 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH----
Confidence 45678999999999865333221 1222345778999999988889999999999999999999 99999653321
Q ss_pred hhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 357 FQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
.+... .... .....+...+..+.+++.+||+.||++||++.++++.|+++.
T Consensus 237 ---~~~~~----~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 237 ---RLFNL----LKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred ---HHHHH----HhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 11111 1111 111122234456888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=286.32 Aligned_cols=232 Identities=23% Similarity=0.286 Sum_probs=176.8
Q ss_pred CeeccCCcEEEEEEEEC-CCCeEEEEEecCc---chhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 164 NVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 5789999998643 223445577898888776 899999999999999999999999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecc
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTR 305 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~ 305 (442)
|+|..++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTST 155 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccccc
Confidence 9999988654 4689999999999999999999876 4567899999999997532221 12334
Q ss_pred cccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCC
Q 047892 306 VMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEK 385 (442)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (442)
..||+.|+|||++.+..++.++|||||||++|||++|..||.......... .....++......... .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~--~~~~~~~~~~i~~~~~----------~ 223 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD--QNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcc--cccHHHHHHHHhcCCC----------C
Confidence 679999999999999999999999999999999999999996422211100 1111222222211111 1
Q ss_pred CcHHHHHHHHHHHhhhhCCCCCCCCCH
Q 047892 386 PSSRALKRALLVALRCVDPNAHKRPKM 412 (442)
Q Consensus 386 ~~~~~~~~~~~li~~cl~~dP~~RPs~ 412 (442)
.+...+..+.+++.+||+.||++||++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 112234557789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=289.37 Aligned_cols=228 Identities=23% Similarity=0.290 Sum_probs=178.0
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCC-CcceEEEEEEeCCeeeeEE
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHK-NLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~~~lv~ 233 (442)
+|++.+.||+|+||.||+|... +++.||+|.+... .....+.+..|.+++..++|+ +|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999964 4788999998643 223345677899999999765 5888999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05587 81 EYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG- 155 (324)
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence 999999999998754 4678899999999999999999876 4557789999999987532211
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... ... ... .
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~~~~---~i~-~~~------~ 218 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-------ELFQ---SIM-EHN------V 218 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHH---HHH-cCC------C
Confidence 1233457999999999999999999999999999999999999999754321 1111 111 110 0
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCH
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKM 412 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~ 412 (442)
..+...+..+.+++.+||+.||.+|++.
T Consensus 219 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 ----SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1112234567889999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=280.47 Aligned_cols=243 Identities=26% Similarity=0.485 Sum_probs=188.1
Q ss_pred hCCCCccCeeccCCcEEEEEEEECC-C---CeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLED-N---TNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
.++|+..+.||+|+||.||+|.... + ..+|+|.+... .....+.+.+|++++++++||||+++.+++...+..|+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4467888999999999999999642 3 36999988644 23445678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
||||+++++|.+++... ...+++..+..++.|++.|++|||.. ++.++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999753 24688999999999999999999876 445678999999999866432
Q ss_pred cceee--cccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 299 RSYVT--TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 299 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
..... .....+..|+|||++.+..++.++|||||||++|||++ |..||...... ...... ...
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~----------~~~~~i-~~~--- 226 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH----------EVMKAI-NDG--- 226 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH----------HHHHHH-hcC---
Confidence 22111 11223457999999988889999999999999999998 99999643221 111111 111
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.........+..+.+++.+||+.||++||++.+|++.|+++
T Consensus 227 ------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111223345688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=289.27 Aligned_cols=223 Identities=21% Similarity=0.279 Sum_probs=175.1
Q ss_pred CeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 164 NVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
+.||+|+||.||+|... +++.||+|.+.... ......+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 58899999985431 23345567788888776 799999999999999999999999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecc
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTR 305 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~ 305 (442)
|+|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKS----RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTST 155 (320)
T ss_pred chHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccccc
Confidence 9999998764 4688999999999999999999876 4567899999999987542221 12344
Q ss_pred cccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCC
Q 047892 306 VMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEK 385 (442)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (442)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .. .... ..... .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~~---~~~i-~~~~~----------~ 214 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-------DL---FEAI-LNDEV----------V 214 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------HH---HHHH-hcCCC----------C
Confidence 67999999999999889999999999999999999999999754321 11 1111 11110 1
Q ss_pred CcHHHHHHHHHHHhhhhCCCCCCCCCH
Q 047892 386 PSSRALKRALLVALRCVDPNAHKRPKM 412 (442)
Q Consensus 386 ~~~~~~~~~~~li~~cl~~dP~~RPs~ 412 (442)
.+...+.++.+++.+||+.||++||++
T Consensus 215 ~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 215 YPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 111234567889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=289.06 Aligned_cols=229 Identities=22% Similarity=0.289 Sum_probs=178.6
Q ss_pred CeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 164 NVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
+.||+|+||.||+|+.. +++.||+|.+.... ......+..|.+++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999964 47899999986432 23334567788888866 899999999999999999999999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecc
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTR 305 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~ 305 (442)
|+|..++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05591 81 GDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTT 155 (321)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccc
Confidence 9999998754 4688899999999999999999876 4567899999999987543222 12344
Q ss_pred cccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCC
Q 047892 306 VMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEK 385 (442)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (442)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+... .. .... .... .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-------~~---~~i~-~~~~----------~ 214 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-------LF---ESIL-HDDV----------L 214 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-------HH---HHHH-cCCC----------C
Confidence 579999999999998899999999999999999999999997543211 11 1111 1110 0
Q ss_pred CcHHHHHHHHHHHhhhhCCCCCCCC-------CHHHHHHH
Q 047892 386 PSSRALKRALLVALRCVDPNAHKRP-------KMGHVIHM 418 (442)
Q Consensus 386 ~~~~~~~~~~~li~~cl~~dP~~RP-------s~~evl~~ 418 (442)
.+...+.++.+++.+||+.||++|| ++.++++.
T Consensus 215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1112345678899999999999999 77777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=278.80 Aligned_cols=239 Identities=25% Similarity=0.444 Sum_probs=186.3
Q ss_pred CCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCC
Q 047892 158 NGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVD 237 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 237 (442)
.+|++.+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4578889999999999999998778899999886432 234568899999999999999999999999999999999999
Q ss_pred CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeec
Q 047892 238 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTT 304 (442)
Q Consensus 238 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~ 304 (442)
+|+|.+++... ...+++..+..++.|++.|+.|||+. ++.++.+||+|||+++...........
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 83 HGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99999998754 23578899999999999999999865 344568999999999865433222122
Q ss_pred ccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccC
Q 047892 305 RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ 383 (442)
Q Consensus 305 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (442)
...++..|+|||.+.++.++.++|||||||++|||++ |..||...... ...+ ...... ....
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~~~~---~~~~~~---~~~~---- 222 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-------EVVE---TINAGF---RLYK---- 222 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-------HHHH---HHhCCC---CCCC----
Confidence 2345678999999988889999999999999999998 99999643211 1111 111100 0011
Q ss_pred CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHh
Q 047892 384 EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420 (442)
Q Consensus 384 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 420 (442)
+...+..+.+|+.+||+.+|++|||+.++++.|.
T Consensus 223 ---~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 ---PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1112456888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=277.99 Aligned_cols=237 Identities=23% Similarity=0.368 Sum_probs=183.5
Q ss_pred CCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 159 GFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
+|++.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 578889999999999999995 46889999988543 3344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceee
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT 303 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~ 303 (442)
++|+|..+. .+++.....++.|++.||.|||+. ++.++.+||+|||++..+... ..
T Consensus 82 ~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~ 150 (279)
T cd06619 82 DGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IA 150 (279)
T ss_pred CCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cc
Confidence 999997652 367888899999999999999976 456789999999999865332 12
Q ss_pred cccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccC
Q 047892 304 TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ 383 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (442)
....||..|+|||++.+..++.++|||||||++|+|++|+.||............ .......... . .+.+
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~-~-----~~~~- 220 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP---LQLLQCIVDE-D-----PPVL- 220 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch---HHHHHHHhcc-C-----CCCC-
Confidence 3457899999999999889999999999999999999999999653322111100 1111111100 0 0111
Q ss_pred CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 384 EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 384 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.....+.++.+++.+||+.||++||+++++++.
T Consensus 221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111233467889999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=280.79 Aligned_cols=244 Identities=23% Similarity=0.350 Sum_probs=188.9
Q ss_pred hhCCCCccCeeccCCcEEEEEEEECC----CCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLED----NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
..++|.+.+.||+|+||.||+|.+.+ ...|++|...... ....+.+.+|+.+++.++||||+++++++.+ +..|
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 34568889999999999999998533 2468999886544 4455678999999999999999999998875 5578
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+||||+++|+|.+++.+. ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++....
T Consensus 83 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 83 IVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999999754 23589999999999999999999876 33457899999999987654
Q ss_pred CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
..........++..|+|||.+....++.++|||||||++|||++ |..||......+ .... . ..+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~~---~-~~~~--- 225 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-------VIGR---I-ENGE--- 225 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHH---H-HcCC---
Confidence 43322233345578999999988889999999999999999996 999996543211 1111 1 1111
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....+...+..+.+++.+||..+|++|||+.++++.|+++.
T Consensus 226 ------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 226 ------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00112233456888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=294.26 Aligned_cols=247 Identities=18% Similarity=0.217 Sum_probs=188.3
Q ss_pred hhhHHHhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 047892 150 LRELEVSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE 225 (442)
Q Consensus 150 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 225 (442)
+.++.+..++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4556677789999999999999999999964 5889999998532 12233457789999999999999999999999
Q ss_pred CCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCc
Q 047892 226 GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLA 292 (442)
Q Consensus 226 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla 292 (442)
++..|+||||+++|+|.++++.. .+++..+..++.|++.||.|||+. ++.++.+||+|||++
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999999998653 478888899999999999999875 445789999999999
Q ss_pred cccCCCcceeecccccccCCCCcccccCC----CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHH
Q 047892 293 KLLGAERSYVTTRVMGTFGYVAPEYASTG----MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTM 368 (442)
Q Consensus 293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 368 (442)
+.+...........+||+.|||||++.+. .++.++|||||||++|||++|..||...+.. ......
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----------~~~~~i 259 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----------GTYSKI 259 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH----------HHHHHH
Confidence 87654333333456799999999998654 3789999999999999999999999754321 111111
Q ss_pred hhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCC--CCCHHHHHHH
Q 047892 369 VTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHK--RPKMGHVIHM 418 (442)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~evl~~ 418 (442)
..... .+........+..+.+++.+||..++.+ |+++.++++.
T Consensus 260 ~~~~~-------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 260 MNHKN-------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HcCCC-------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 11110 0111111234556778999999843332 6789988874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=288.28 Aligned_cols=228 Identities=23% Similarity=0.310 Sum_probs=179.0
Q ss_pred CeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 164 NVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
+.||+|+||.||+|... +++.||+|.+.... ......+.+|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 47899999986432 23345567888998887 799999999999999999999999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecc
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTR 305 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~ 305 (442)
|+|..++.+. ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (318)
T cd05570 81 GDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTST 155 (318)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccccc
Confidence 9999998754 4689999999999999999999876 4567899999999987532221 12234
Q ss_pred cccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCC
Q 047892 306 VMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEK 385 (442)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (442)
.+||+.|+|||++.+..++.++|||||||++|||++|..||...... ... ... ..... .
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-------~~~---~~i-~~~~~----------~ 214 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-------ELF---QSI-LEDEV----------R 214 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-------HHH---HHH-HcCCC----------C
Confidence 57899999999999999999999999999999999999999654321 111 111 11110 1
Q ss_pred CcHHHHHHHHHHHhhhhCCCCCCCCCH-----HHHHH
Q 047892 386 PSSRALKRALLVALRCVDPNAHKRPKM-----GHVIH 417 (442)
Q Consensus 386 ~~~~~~~~~~~li~~cl~~dP~~RPs~-----~evl~ 417 (442)
.+...+..+.+|+.+||+.||++|||+ .++++
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 112234567889999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=283.87 Aligned_cols=253 Identities=22% Similarity=0.392 Sum_probs=187.0
Q ss_pred hhCCCCccCeeccCCcEEEEEEEECC---------------CCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceE
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLED---------------NTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRL 219 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l 219 (442)
..++|++.+.||+|+||.||+|.... ...||+|.+... .......+.+|++++++++||||+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 34578999999999999999987532 234899988654 23345678999999999999999999
Q ss_pred EEEEEeCCeeeeEEecCCCCCHHHHHccCCC--------CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------C
Q 047892 220 VGYCAEGAHRMLVNEYVDNGNLEQWLHGDVG--------PHSPLTWEIRMNIILGTAKGLTYLHEG-------------L 278 (442)
Q Consensus 220 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l 278 (442)
++++...+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+. +
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 9999999999999999999999999864311 112468888999999999999999876 3
Q ss_pred CCCCCeEEecccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh--CCCCCCCCCCCCcc
Q 047892 279 EPKWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS--GRNPVDYSRPPGEF 355 (442)
Q Consensus 279 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt--g~~Pf~~~~~~~~~ 355 (442)
+.++.+||+|||++..+...... ......++..|+|||.+.++.++.++|||||||++|||++ |..||......
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~--- 239 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE--- 239 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH---
Confidence 45678999999999865433221 1223345778999999988889999999999999999998 66777543221
Q ss_pred chhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 356 QFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
................ .........+..+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 240 ----~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 ----QVIENTGEFFRNQGRQ------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ----HHHHHHHHhhhhcccc------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111111111110000 0001111234568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=281.40 Aligned_cols=252 Identities=21% Similarity=0.283 Sum_probs=185.6
Q ss_pred CCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-----eeeeEE
Q 047892 160 FADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA-----HRMLVN 233 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~lv~ 233 (442)
|...+++|.|+||.||+|.. .+++.||||++..+.. .-.+|+++|+.++|||||++.-+|.... ...+||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 56678999999999999995 4579999999865432 1235999999999999999998885432 345899
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc------CCCC--------CCCeEEecccCccccCCCc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE------GLEP--------KWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~------~l~~--------~~~~kl~DFGla~~~~~~~ 299 (442)
||++. +|.++++........++...+.-+..|+.+||.|||. +++| .|.+||||||.|+.+..+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 99998 9999998644445678888889999999999999975 4554 3789999999999885544
Q ss_pred ceeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHH-----HHHHHHhhc--
Q 047892 300 SYVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF-----EWLKTMVTN-- 371 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~-----~~~~~~~~~-- 371 (442)
.. .....|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|.+.+..+.......+. +.+..+..+
T Consensus 181 pn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 181 PN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT 258 (364)
T ss_pred Cc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence 32 334568899999999875 59999999999999999999999998866544432222221 111111111
Q ss_pred -CCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 372 -GNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 372 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.....+....+..-.....+.+..+|+.++|..+|.+|.++.|++..
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11111111111111233456678899999999999999999998753
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=283.76 Aligned_cols=244 Identities=23% Similarity=0.347 Sum_probs=187.5
Q ss_pred CCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCcch-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
.+|.+.+.||+|+||.||+|... .+..||+|.+..... .....+.+|+.++..++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34778899999999999999853 247799999865432 33466889999999999999999999999999999
Q ss_pred eEEecCCCCCHHHHHccCC------------CCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeE
Q 047892 231 LVNEYVDNGNLEQWLHGDV------------GPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPK 285 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~k 285 (442)
+++||+.+++|.+++.... .....+++..++.++.|++.||.|||+. +..++.+|
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceE
Confidence 9999999999999985321 1123578888999999999999999875 34567899
Q ss_pred EecccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHH
Q 047892 286 LSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFE 363 (442)
Q Consensus 286 l~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 363 (442)
|+|||+++.+...... ......+++.|+|||.+.++.++.++|||||||++|||++ |..||..... .+
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----------~~ 234 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----------QD 234 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----------HH
Confidence 9999998866433221 1233456789999999988889999999999999999998 8888864321 11
Q ss_pred HHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 364 WLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
.... ....... ..+..++..+.+++.+||+.||++||++.+|+..|+.
T Consensus 235 ~~~~-i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEM-IRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHH-HHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111 1111110 1122345668889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=279.40 Aligned_cols=243 Identities=26% Similarity=0.440 Sum_probs=188.3
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-C---CCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-D---NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
.++|++.+.||+|+||.||+|... + +..+|+|.+.... ......+.+|+.++++++||||+++++++..++..|+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 346888999999999999999853 2 3369999886432 3345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
||||+++|+|.+++... ...+++...+.++.|++.||.|||+. ++.++.+||+|||+++.+...
T Consensus 83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999754 24578899999999999999999876 445678999999999876443
Q ss_pred cceee--cccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 299 RSYVT--TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 299 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
..... ....++..|+|||.+.+..++.++|||||||++||+++ |..||......+ ... .. ....
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-------~~~---~~-~~~~-- 226 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-------VIK---AI-EEGY-- 226 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-------HHH---HH-hCCC--
Confidence 22211 12234568999999998889999999999999999887 999996533211 111 11 1110
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
........+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 227 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 -------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0111122345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=277.57 Aligned_cols=239 Identities=28% Similarity=0.419 Sum_probs=190.2
Q ss_pred hhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
..++|.+.+.||.|+||.||+|... ++.||+|.+..... ..+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 3457889999999999999999874 78899999966543 456788999999999999999999999989999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++++|.+++.... ...+++..+..++.|++.||.|||.. ++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 82 MAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 99999999997542 13689999999999999999999876 34567899999999987632211
Q ss_pred ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcc
Q 047892 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (442)
...++..|+|||.+....++.++||||||+++|||++ |..||...... .+ ........
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~----~~~~~~~~-------- 216 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DV----VPHVEKGY-------- 216 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-------HH----HHHHhcCC--------
Confidence 2345678999999988889999999999999999998 99998643211 11 11111110
Q ss_pred cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 382 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
....+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 217 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 217 -RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1111223346688899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=277.07 Aligned_cols=237 Identities=22% Similarity=0.293 Sum_probs=187.1
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
+|++.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++||||+++++.+..++..|++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999964 5889999988532 3344567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceee
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT 303 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~ 303 (442)
++|+|.+++.... ...+++...+.++.|++.||.|||.. ++.++.++|+|||++........ ..
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YA 157 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-cc
Confidence 9999999986432 24578899999999999999999976 44567899999999986643322 22
Q ss_pred cccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccC
Q 047892 304 TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ 383 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (442)
....|++.|+|||++.+..++.++|+||||+++|+|++|..||...... ..... ...+...
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----------~~~~~-~~~~~~~-------- 218 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK----------NLILK-VCQGSYK-------- 218 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH----------HHHHH-HhcCCCC--------
Confidence 3456899999999998888999999999999999999999999753221 11111 1111111
Q ss_pred CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 384 EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 384 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
..+...+..+.+++.+||+.||++|||+.+++..
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 -PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1122334567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=286.67 Aligned_cols=228 Identities=22% Similarity=0.312 Sum_probs=176.1
Q ss_pred CeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHh-cCCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 164 NVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGR-VRHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
+.||+|+||.||+|... +++.||+|.+.... ......+..|..++.. ++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 47899999986431 2233456667888876 4999999999999999999999999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecc
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTR 305 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~ 305 (442)
|+|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (316)
T cd05619 81 GDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCT 155 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceee
Confidence 9999999754 4688899999999999999999876 45678899999999875322211 2334
Q ss_pred cccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCC
Q 047892 306 VMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEK 385 (442)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (442)
..||+.|+|||++.+..++.++|||||||++|||++|..||...... .+...+ . .. .+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~i---~-~~------~~~~--- 215 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-------ELFQSI---R-MD------NPCY--- 215 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-------HHHHHH---H-hC------CCCC---
Confidence 57999999999999889999999999999999999999999754321 111111 1 00 0111
Q ss_pred CcHHHHHHHHHHHhhhhCCCCCCCCCHH-HHHH
Q 047892 386 PSSRALKRALLVALRCVDPNAHKRPKMG-HVIH 417 (442)
Q Consensus 386 ~~~~~~~~~~~li~~cl~~dP~~RPs~~-evl~ 417 (442)
+...+..+.+++.+||+.||++||++. ++++
T Consensus 216 -~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 -PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 112345577899999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=279.50 Aligned_cols=252 Identities=23% Similarity=0.388 Sum_probs=190.1
Q ss_pred hCCCCccCeeccCCcEEEEEEEECC-----------------CCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcce
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLED-----------------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVR 218 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~ 218 (442)
.++|++.+.||+|+||.||+|.... +..||+|.+.... ......+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578999999999999999998532 2458999886543 344567889999999999999999
Q ss_pred EEEEEEeCCeeeeEEecCCCCCHHHHHccCCC-------CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------C
Q 047892 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVG-------PHSPLTWEIRMNIILGTAKGLTYLHEG-------------L 278 (442)
Q Consensus 219 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l 278 (442)
+++++..++..+++|||+++++|.+++.+... ....+++..++.++.|++.||.|||+. +
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili 163 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence 99999999999999999999999999976431 112689999999999999999999875 3
Q ss_pred CCCCCeEEecccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh--CCCCCCCCCCCCcc
Q 047892 279 EPKWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS--GRNPVDYSRPPGEF 355 (442)
Q Consensus 279 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt--g~~Pf~~~~~~~~~ 355 (442)
+.++.+||+|||+++.+...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~---- 239 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD---- 239 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh----
Confidence 44568999999999865433221 2233456788999999988889999999999999999998 6778754321
Q ss_pred chhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 356 QFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
................ ......+...+.++.+++.+||+.||++|||+.+|++.|+.
T Consensus 240 ---~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 ---QQVIENAGHFFRDDGR------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ---HHHHHHHHhccccccc------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1111211111111110 00011122334678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=288.36 Aligned_cols=228 Identities=22% Similarity=0.293 Sum_probs=178.4
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeeeEE
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
+|.+.+.||+|+||.||+|... +++.||+|.+.... ......+..|..++..+ +|++|+++++++...+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999965 47899999986432 22334566788888777 5899999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++|+|.+++... ..+++..++.++.|++.||.|||.. ++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~- 155 (323)
T cd05616 81 EYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG- 155 (323)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence 999999999998754 4688999999999999999999875 4567889999999997543221
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. ... ....
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-------~~~~---~i~-~~~~------ 218 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQ---SIM-EHNV------ 218 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-------HHHH---HHH-hCCC------
Confidence 1234467999999999999999999999999999999999999999754321 1111 111 1110
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCH
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKM 412 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~ 412 (442)
..+...+.++.+++.+||+.||++|++.
T Consensus 219 ----~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 ----AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ----CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1112334567889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=281.37 Aligned_cols=237 Identities=22% Similarity=0.346 Sum_probs=188.1
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
.+|++.+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++||||+++++.+......|+||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4688899999999999999995 458899999986655555567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceee
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT 303 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~ 303 (442)
++|+|.+++.+. .+++.....++.|++.||.|||.. ++.++.+||+|||++......... .
T Consensus 100 ~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~ 173 (296)
T cd06654 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R 173 (296)
T ss_pred CCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc-c
Confidence 999999998643 478889999999999999999876 445678999999998865433221 2
Q ss_pred cccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccC
Q 047892 304 TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ 383 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (442)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||........ ......... +.+
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~----------~~~~~~~~~------~~~- 236 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA----------LYLIATNGT------PEL- 236 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh----------HHHHhcCCC------CCC-
Confidence 334688999999999888899999999999999999999999965432110 001110000 001
Q ss_pred CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 384 EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 384 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
..+......+.+++.+||..||++|||+.++++.
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1122344567889999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=278.33 Aligned_cols=243 Identities=21% Similarity=0.234 Sum_probs=193.4
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEECC-CCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 229 (442)
.+..+.|++++.||.|.-|+||++...+ +..+|+|++.+.. .....+.+.|-+||+.++||.++.||+.|+.+...
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 3445568889999999999999999754 6899999996543 23334567799999999999999999999999999
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~~~ 296 (442)
|++||||+||+|..+.+++ +...+++..++.++.+++-||+|||-. ++ .+|++.|+||.|+....
T Consensus 153 cl~meyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEEEecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 9999999999999998865 356799999999999999999999964 44 46899999999874321
Q ss_pred C---------------------------------C-c---------------------ceeecccccccCCCCcccccCC
Q 047892 297 A---------------------------------E-R---------------------SYVTTRVMGTFGYVAPEYASTG 321 (442)
Q Consensus 297 ~---------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~ 321 (442)
. . . ......++||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0 0 0112246899999999999999
Q ss_pred CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhh
Q 047892 322 MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRC 401 (442)
Q Consensus 322 ~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 401 (442)
..+.++|+|+|||+||||+.|..||.+.+....+ ..++...+.-......+..+.+||.+.
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl-------------------~NIv~~~l~Fp~~~~vs~~akDLIr~L 371 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL-------------------RNIVGQPLKFPEEPEVSSAAKDLIRKL 371 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhH-------------------HHHhcCCCcCCCCCcchhHHHHHHHHH
Confidence 9999999999999999999999999887664432 122222222222235567789999999
Q ss_pred hCCCCCCCCC----HHHHHH
Q 047892 402 VDPNAHKRPK----MGHVIH 417 (442)
Q Consensus 402 l~~dP~~RPs----~~evl~ 417 (442)
|.+||.+|.. |.||-+
T Consensus 372 LvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 372 LVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred hccChhhhhccccchHHhhc
Confidence 9999999998 777753
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=276.08 Aligned_cols=237 Identities=24% Similarity=0.393 Sum_probs=188.2
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
+|.+.+.||+|+||.||+|... +++.|++|.+... .......+.+|+++++.++||||+++++++...+..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777889999999999999964 5889999988532 344556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++++|.+++.... ...+++...+.++.|++.||.|||.. ++.++.+||+|||+++.+......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~- 157 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF- 157 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch-
Confidence 99999999997542 24688999999999999999999975 345678999999999876443222
Q ss_pred ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCccc
Q 047892 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (442)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... .... .. ..+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~---~~-~~~~--------- 217 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-------ALIL---KI-IRGV--------- 217 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHH---HH-HcCC---------
Confidence 23456889999999999888999999999999999999999999654311 1111 11 1111
Q ss_pred CCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 383 QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 383 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
........+..+.+++.+||+.+|++||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 218 FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111122345668889999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=301.11 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=179.5
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--------C
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG--------A 227 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--------~ 227 (442)
..+|.+.+.||+|+||.||+|.. .+++.||||++.... ....+|+.+|+.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 45689999999999999999996 458899999885432 2245699999999999999999887432 2
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC-------C-CCeEEecccCcc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP-------K-WNPKLSDFGLAK 293 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-------~-~~~kl~DFGla~ 293 (442)
.+++||||+++ +|.+++.........+++..++.++.|++.||.|||+. +++ + +.+||+|||+++
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 46799999986 78887754333345789999999999999999999875 332 3 369999999998
Q ss_pred ccCCCcceeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhH-----HHHHHH
Q 047892 294 LLGAERSYVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNL-----FEWLKT 367 (442)
Q Consensus 294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~-----~~~~~~ 367 (442)
.+..... .....||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+....+........ .+....
T Consensus 220 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 297 (440)
T PTZ00036 220 NLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE 297 (440)
T ss_pred hccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 7643222 2345789999999998664 6999999999999999999999999765432211100000 000000
Q ss_pred HhhcCCcccc-----cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 368 MVTNGNAEGV-----LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 368 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
+ ...+... ....+....+...+.++.+|+.+||+.||.+|||+.|+++.
T Consensus 298 ~--~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 298 M--NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred h--chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 0000000 00011111112234678899999999999999999999843
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=279.72 Aligned_cols=253 Identities=22% Similarity=0.368 Sum_probs=187.9
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC-----------------CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcc
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE-----------------DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLV 217 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv 217 (442)
..++|++.+.||+|+||.||++... +...||+|.+... .......+.+|+.+++.++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3457899999999999999998632 2346899988654 334456789999999999999999
Q ss_pred eEEEEEEeCCeeeeEEecCCCCCHHHHHccCCCC-------CCCCCHHHHHHHHHHHHHhhhhhhcC-------------
Q 047892 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGP-------HSPLTWEIRMNIILGTAKGLTYLHEG------------- 277 (442)
Q Consensus 218 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~~l~yLH~~------------- 277 (442)
++++++...+..++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+.
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 9999999999999999999999999999754211 13477888999999999999999875
Q ss_pred CCCCCCeEEecccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh--CCCCCCCCCCCCc
Q 047892 278 LEPKWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS--GRNPVDYSRPPGE 354 (442)
Q Consensus 278 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt--g~~Pf~~~~~~~~ 354 (442)
++.++.+||+|||+++.+...... ......++..|+|||...++.++.++|||||||++|||++ |..||........
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence 344678999999999865333221 1222345678999999888889999999999999999998 7788864332111
Q ss_pred cchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 355 FQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
................. ..+..++..+.+|+.+||+.||++|||+.+|++.|++
T Consensus 243 -------~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 243 -------IENTGEFFRDQGRQVYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred -------HHHHHHHHhhccccccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111111110000000 1112234668889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=286.51 Aligned_cols=250 Identities=25% Similarity=0.429 Sum_probs=190.9
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEEC--------CCCeEEEEEecCc-chhhHHHHHHHHHHHHhc-CCCCcceEEEEE
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLE--------DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYC 223 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 223 (442)
.+..++|.+.+.||+|+||.||+|... ....+|+|.+... .......+.+|+.+++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 455667889999999999999999742 2456899988643 233456688999999999 699999999999
Q ss_pred EeCCeeeeEEecCCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------C
Q 047892 224 AEGAHRMLVNEYVDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEG-------------L 278 (442)
Q Consensus 224 ~~~~~~~lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l 278 (442)
...+..|++|||+++|+|.+++..... ....+++...+.++.|++.||.|||+. +
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 999999999999999999999975321 124588899999999999999999975 4
Q ss_pred CCCCCeEEecccCccccCCCccee-ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccc
Q 047892 279 EPKWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQ 356 (442)
Q Consensus 279 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~ 356 (442)
+.++.+||+|||+++......... .....++..|||||++.+..++.++|||||||++|||++ |..||......
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---- 243 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---- 243 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 456789999999998764322211 112234568999999988889999999999999999999 89998643221
Q ss_pred hhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 357 FQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
.... ...... ....+...+.++.+++.+||+.||++|||+.++++.|+++.
T Consensus 244 ---~~~~----~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 244 ---ELFK----LLREGH---------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred ---HHHH----HHHcCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111 111111 01112233456788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=282.43 Aligned_cols=246 Identities=24% Similarity=0.382 Sum_probs=189.2
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAH 228 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 228 (442)
..++|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++..++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 4567899999999999999999853 36789999886543 3445678899999999999999999999999999
Q ss_pred eeeEEecCCCCCHHHHHccCCC------------------CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVG------------------PHSPLTWEIRMNIILGTAKGLTYLHEG------------- 277 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~------------------~~~~l~~~~~~~i~~qi~~~l~yLH~~------------- 277 (442)
.++||||+++|+|.+++..... ....+++..++.++.|++.||.|||..
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 9999999999999999964311 113478888999999999999999875
Q ss_pred CCCCCCeEEecccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCcc
Q 047892 278 LEPKWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEF 355 (442)
Q Consensus 278 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~ 355 (442)
++.++.+||+|||+++.+...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~--- 239 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE--- 239 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 445678999999998765332211 1122345678999999988899999999999999999998 88888543221
Q ss_pred chhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 356 QFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
+.... ...+... ..+...+.++.+++.+||+.||++|||+.|+++.|+.
T Consensus 240 -------~~~~~-~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 -------EVIYY-VRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -------HHHHH-HhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111 1111110 1112234568889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=286.22 Aligned_cols=250 Identities=24% Similarity=0.404 Sum_probs=192.1
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEEC--------CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhc-CCCCcceEEEEE
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLE--------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLVGYC 223 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 223 (442)
.+..++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 455677899999999999999999741 23479999886432 34456788999999999 899999999999
Q ss_pred EeCCeeeeEEecCCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------C
Q 047892 224 AEGAHRMLVNEYVDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEG-------------L 278 (442)
Q Consensus 224 ~~~~~~~lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l 278 (442)
...+..|+||||+++|+|.+++.+... ....+++..++.++.|++.||.|||+. +
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili 170 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV 170 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence 999999999999999999999975421 123578888999999999999999876 3
Q ss_pred CCCCCeEEecccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccc
Q 047892 279 EPKWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQ 356 (442)
Q Consensus 279 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~ 356 (442)
+.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----- 245 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 245 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----
Confidence 34678999999999876433222 1222345678999999988889999999999999999998 8888854321
Q ss_pred hhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 357 FQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
.+..... .... ....+..++..+.+++.+||..+|++|||+.++++.|+++.
T Consensus 246 -----~~~~~~~-~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 246 -----EELFKLL-KEGH---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred -----HHHHHHH-HcCC---------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 1111111 1111 01112234566888999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=291.59 Aligned_cols=253 Identities=21% Similarity=0.284 Sum_probs=184.6
Q ss_pred CCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-----eee
Q 047892 159 GFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA-----HRM 230 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~ 230 (442)
+|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+++++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999996 46899999998543 2234467889999999999999999999998776 789
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+||||+.+ +|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++....
T Consensus 81 lv~e~~~~-~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQS-DLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeecccc-CHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 99999974 888888653 4689999999999999999999876 34567899999999987543
Q ss_pred CcceeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhH------------HHH
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNL------------FEW 364 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~------------~~~ 364 (442)
..........+|+.|+|||++.+. .++.++|||||||++|||++|+.||............... ...
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 333233345689999999998774 4789999999999999999999999765432211100000 000
Q ss_pred HHHHhhcCCcc-cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 365 LKTMVTNGNAE-GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 365 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
........... ...... .......+.++.+|+.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 236 ARAHILRGPHKPPSLPVL--YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhCCCCCCchHHh--cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000000 000000 00111224568889999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=277.47 Aligned_cols=243 Identities=23% Similarity=0.412 Sum_probs=185.0
Q ss_pred CCccCeeccCCcEEEEEEEECC----CCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe-----
Q 047892 160 FADENVIGEGGYGIVYRGVLED----NTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAH----- 228 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~----- 228 (442)
|.+.+.||+|+||.||+|.... +..||+|.+... .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998532 367999998643 23344678899999999999999999998865543
Q ss_pred -eeeEEecCCCCCHHHHHccCC--CCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCc
Q 047892 229 -RMLVNEYVDNGNLEQWLHGDV--GPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLA 292 (442)
Q Consensus 229 -~~lv~E~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla 292 (442)
.+++|||+++|+|..++.... .....+++...+.++.|++.||.|||+. ++.++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 799999999999999985432 1224689999999999999999999875 334568999999999
Q ss_pred cccCCCccee-ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhh
Q 047892 293 KLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVT 370 (442)
Q Consensus 293 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 370 (442)
+......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... .... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-------~~~~---~~~- 229 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-------EIYD---YLR- 229 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-------HHHH---HHH-
Confidence 8764333221 112235678999999988889999999999999999999 89998653321 1111 111
Q ss_pred cCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 371 NGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.+.. ...+...+..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 230 ~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 HGNR---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCC---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1110 011223455788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=284.53 Aligned_cols=245 Identities=23% Similarity=0.382 Sum_probs=185.9
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCC--eEEEEEecCc-chhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNT--NVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 231 (442)
.++|.+.+.||+|+||.||+|.+. ++. .+++|.+... .......+.+|++++.++ +||||+++++++..++..|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 457888999999999999999964 344 4577776543 233456788999999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEE
Q 047892 232 VNEYVDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKL 286 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl 286 (442)
||||+++|+|.++++.... ....+++..++.++.|++.||+|||+. ++.++.+||
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEe
Confidence 9999999999999975421 123578999999999999999999976 445678999
Q ss_pred ecccCccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHH
Q 047892 287 SDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWL 365 (442)
Q Consensus 287 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 365 (442)
+|||+++..... .......++..|+|||++.+..++.++|||||||++|||+| |..||......+ . .
T Consensus 166 ~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~---~ 233 (303)
T cd05088 166 ADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------L---Y 233 (303)
T ss_pred CccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-------H---H
Confidence 999998643211 11122234678999999988889999999999999999998 999996432211 1 1
Q ss_pred HHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 366 KTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
... ... .....+...+..+.+|+.+||+.||++||++.+++..|..+.
T Consensus 234 ~~~-~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 234 EKL-PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred HHH-hcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 110 011111123456788999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=282.92 Aligned_cols=244 Identities=25% Similarity=0.385 Sum_probs=185.4
Q ss_pred CCCCccCeeccCCcEEEEEEEECC-C--CeEEEEEecCc-chhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeeeE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLED-N--TNVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 232 (442)
++|++.+.||+|+||.||+|...+ + ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..|++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468889999999999999998643 3 34788887642 334456788999999999 799999999999999999999
Q ss_pred EecCCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEe
Q 047892 233 NEYVDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLS 287 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~ 287 (442)
|||+++|+|.++++.... ....+++..++.++.|++.||+|||+. ++.++.+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 999999999999965321 123588899999999999999999875 3446689999
Q ss_pred cccCccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHH
Q 047892 288 DFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLK 366 (442)
Q Consensus 288 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 366 (442)
|||++..... .........+..|+|||++.+..++.++|||||||++|||++ |..||....... ...
T Consensus 162 dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-------~~~--- 229 (297)
T cd05089 162 DFGLSRGEEV--YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------LYE--- 229 (297)
T ss_pred CcCCCccccc--eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHH---
Confidence 9999864321 111111233567999999988889999999999999999998 999996543211 111
Q ss_pred HHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 367 TMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
.. ..+ .....+...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 230 ~~-~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 230 KL-PQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred HH-hcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 110 111112234456888999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=279.15 Aligned_cols=242 Identities=27% Similarity=0.462 Sum_probs=186.6
Q ss_pred CCCCccCeeccCCcEEEEEEEECC-C---CeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLED-N---TNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 232 (442)
++|++.+.||+|+||.||+|.... + ..||+|.+... .......|..|+.+++.++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357788999999999999999643 3 36999998654 334456799999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
|||+++|+|.+++... ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++......
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999754 24588999999999999999999876 3456789999999988654322
Q ss_pred cee--eccc--ccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 300 SYV--TTRV--MGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 300 ~~~--~~~~--~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
... .... ..+..|+|||.+.+..++.++|||||||++|||++ |..||...... ....++ ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-------~~~~~i----~~~-- 227 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-------DVINAI----EQD-- 227 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-------HHHHHH----HcC--
Confidence 111 1111 12457999999998899999999999999999987 99999643221 111111 110
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.....+...+..+.+++.+||+.||++||++.+|+..|++.
T Consensus 228 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 -------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01111123345678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=293.51 Aligned_cols=256 Identities=18% Similarity=0.247 Sum_probs=193.3
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcC-C-----CCcceEEEEEEeCC
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-H-----KNLVRLVGYCAEGA 227 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pnIv~l~~~~~~~~ 227 (442)
...-+|.+.+.||+|+||.|.+|.. ++++.||||++++.. ....+-..|+.+|..|+ | -|+|+++++|...+
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 3334789999999999999999994 569999999997653 33445567999999997 4 38999999999999
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhh------cCCCCCC---------CeEEecccCc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH------EGLEPKW---------NPKLSDFGLA 292 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH------~~l~~~~---------~~kl~DFGla 292 (442)
++|||+|.+.. +|.+||+.+. ...++...++.++.||+.||.+|| .+++|++ .+||+|||.|
T Consensus 262 HlciVfELL~~-NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 262 HLCIVFELLST-NLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ceeeeehhhhh-hHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence 99999999987 9999998764 346899999999999999999995 4577654 7899999999
Q ss_pred cccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHH----HHHH
Q 047892 293 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEW----LKTM 368 (442)
Q Consensus 293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~----~~~~ 368 (442)
....... .+.+-+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.+..+.+..+..+... +-..
T Consensus 339 c~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 339 CFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred cccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 8764332 2567789999999999999999999999999999999999999887665544333332211 0000
Q ss_pred -------hhc-CCcc--------------------------cccCc-c---cCCCCcHHHHHHHHHHHhhhhCCCCCCCC
Q 047892 369 -------VTN-GNAE--------------------------GVLDP-R---LQEKPSSRALKRALLVALRCVDPNAHKRP 410 (442)
Q Consensus 369 -------~~~-~~~~--------------------------~~~~~-~---~~~~~~~~~~~~~~~li~~cl~~dP~~RP 410 (442)
... .... ....+ . +...........+.+++.+||++||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 000 0000 00000 0 00001112345678999999999999999
Q ss_pred CHHHHHHH
Q 047892 411 KMGHVIHM 418 (442)
Q Consensus 411 s~~evl~~ 418 (442)
|..++++.
T Consensus 495 tp~qal~H 502 (586)
T KOG0667|consen 495 TPAQALNH 502 (586)
T ss_pred CHHHHhcC
Confidence 99999864
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=281.67 Aligned_cols=250 Identities=24% Similarity=0.406 Sum_probs=189.1
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG 226 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 226 (442)
++..++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 345678999999999999999999743 24579999875433 23345678899999999999999999999999
Q ss_pred CeeeeEEecCCCCCHHHHHccCCC------CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEe
Q 047892 227 AHRMLVNEYVDNGNLEQWLHGDVG------PHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLS 287 (442)
Q Consensus 227 ~~~~lv~E~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~ 287 (442)
+..|+||||+++|+|.+++++... .....++..+..++.|++.||.|||+. ++.++.+||+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 999999999999999999975321 113456778889999999999999875 3456789999
Q ss_pred cccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHH
Q 047892 288 DFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWL 365 (442)
Q Consensus 288 DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 365 (442)
|||+++.+...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... +..
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~----------~~~ 231 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE----------QVL 231 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH----------HHH
Confidence 99999865332221 1122345778999999988899999999999999999999 78898643221 111
Q ss_pred HHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 366 KTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
.... .+... ..+...+..+.+++.+||+.||++|||+.++++.|++..
T Consensus 232 ~~~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 232 KFVM-DGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHH-cCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1111 11110 011123456888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=286.21 Aligned_cols=224 Identities=25% Similarity=0.284 Sum_probs=173.2
Q ss_pred CeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHH-HHHhcCCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 164 NVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVE-AIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
+.||+|+||+||+|... +++.||+|.+.... ......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999964 58999999985432 122334455554 56789999999999999999999999999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecc
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTR 305 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~ 305 (442)
|+|..++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (323)
T cd05575 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTST 155 (323)
T ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccccc
Confidence 9999998764 4688999999999999999999876 4567899999999987542221 22344
Q ss_pred cccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCC
Q 047892 306 VMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEK 385 (442)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (442)
.+||+.|+|||++.+..++.++|||||||++|||++|..||...+.. +...... .... .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~----------~~~~~i~-~~~~------~~~-- 216 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA----------EMYDNIL-NKPL------RLK-- 216 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH----------HHHHHHH-cCCC------CCC--
Confidence 57999999999999999999999999999999999999999653221 1111111 1110 111
Q ss_pred CcHHHHHHHHHHHhhhhCCCCCCCCCHH
Q 047892 386 PSSRALKRALLVALRCVDPNAHKRPKMG 413 (442)
Q Consensus 386 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ 413 (442)
...+..+.+++.+||+.||.+||++.
T Consensus 217 --~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 --PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 12245678899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=273.62 Aligned_cols=237 Identities=24% Similarity=0.368 Sum_probs=188.4
Q ss_pred hCCCCccCeeccCCcEEEEEEEECC-CCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
.++|+..+.||+|+||.||+|.... ++.+++|.+..... .+.+.+|++++++++||||+++++++......|+++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3568899999999999999999754 78999999854432 67799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++++|.+++... ...+++..+..++.|++.||.|||.. ++.++.+||+|||++........ .
T Consensus 80 ~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 80 CGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 9999999998653 24689999999999999999999875 44567899999999987644321 2
Q ss_pred ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCccc
Q 047892 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (442)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||........ . ..... ...+
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~------~-----~~~~~-----~~~~-- 217 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA------I-----FMIPN-----KPPP-- 217 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh------h-----hhhcc-----CCCC--
Confidence 2334578899999999888999999999999999999999999975332111 0 00000 0000
Q ss_pred CCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 383 QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 383 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
....+......+.+++.+||+.||++|||+.|+++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 11112234466888999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=278.99 Aligned_cols=235 Identities=22% Similarity=0.248 Sum_probs=178.5
Q ss_pred eccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCCCH
Q 047892 166 IGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNL 241 (442)
Q Consensus 166 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L 241 (442)
||+|+||.||++... +++.||+|.+.... ......+..|++++++++||||+++++++.++...|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999954 58999999985321 12234456799999999999999999999999999999999999999
Q ss_pred HHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeeccccc
Q 047892 242 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMG 308 (442)
Q Consensus 242 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 308 (442)
.+++.... ...+++..+..++.|++.||+|||+. ++.++.+||+|||++........ .....|
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~ 156 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAG 156 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eeccCC
Confidence 98886432 23578899999999999999999875 44567899999999987643322 233568
Q ss_pred ccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcH
Q 047892 309 TFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSS 388 (442)
Q Consensus 309 t~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (442)
+..|+|||++.+..++.++|||||||++|||++|..||....... .......... .. .... ...
T Consensus 157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~------~~~~~~~~~~-~~--------~~~~-~~~ 220 (277)
T cd05607 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV------AKEELKRRTL-ED--------EVKF-EHQ 220 (277)
T ss_pred CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh------hHHHHHHHhh-cc--------cccc-ccc
Confidence 999999999988889999999999999999999999996432211 0111111111 10 0000 111
Q ss_pred HHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHh
Q 047892 389 RALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420 (442)
Q Consensus 389 ~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 420 (442)
..+.++.+|+.+||+.||++||++.|+++.+.
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 23456888999999999999999987764433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=280.31 Aligned_cols=247 Identities=23% Similarity=0.318 Sum_probs=191.0
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
.++|++.+.||+|+||.||++... +++.||+|.+... .......+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 456888999999999999999964 5888999987543 23445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC--------------CCCCCCeEEecccCccccCCCcc
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
|+++|+|.+++... ..+++.....++.+++.||.|||.. +..++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 84 FMDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred cCCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 99999999998754 4689999999999999999999852 3456789999999987542221
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCcc-chhhhHHHHHHHHhhcCCcccccC
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEF-QFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
.....|+..|+|||++.+..++.++|||||||++|||++|..||......... .................
T Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 229 (284)
T cd06620 159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------- 229 (284)
T ss_pred --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-------
Confidence 23457899999999998888999999999999999999999999764432110 00111222222221110
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHML 419 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L 419 (442)
.........+..+.+|+.+||+.||++|||+.|+++..
T Consensus 230 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 --PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred --CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 01111122456688899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=272.83 Aligned_cols=235 Identities=28% Similarity=0.426 Sum_probs=184.2
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEecCcchh-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCCCHH
Q 047892 164 NVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLE 242 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~ 242 (442)
++||+|+||.||+|...+++.||+|.+...... ....+.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999999766999999988654333 5567899999999999999999999999999999999999999999
Q ss_pred HHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceee-ccccc
Q 047892 243 QWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT-TRVMG 308 (442)
Q Consensus 243 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~-~~~~g 308 (442)
+++... ...+++...+.++.+++.||.|||++ ++.++.+||+|||+++.......... ....+
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999653 23578889999999999999999976 45567899999999986542221111 12234
Q ss_pred ccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCc
Q 047892 309 TFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPS 387 (442)
Q Consensus 309 t~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (442)
+..|+|||.+.++.++.++|||||||++|||++ |..||....... ... ..... .....+
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~----~~~~~---------~~~~~~ 217 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRE----RIESG---------YRMPAP 217 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHH----HHhcC---------CCCCCC
Confidence 667999999988889999999999999999999 888986543211 111 11110 011112
Q ss_pred HHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 388 SRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 388 ~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 2345578889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=285.23 Aligned_cols=227 Identities=22% Similarity=0.293 Sum_probs=175.6
Q ss_pred CeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHh-cCCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 164 NVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGR-VRHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
+.||+|+||.||+|... +++.||+|.+.... ......+..|..++.. ++||||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 58899999986432 2233456678888775 4899999999999999999999999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecc
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTR 305 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~ 305 (442)
|+|.+++... ..+++..+..++.|++.||+|||+. ++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAST 155 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceec
Confidence 9999998754 4688899999999999999999876 4557889999999987532111 12345
Q ss_pred cccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCC
Q 047892 306 VMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEK 385 (442)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (442)
.+||+.|+|||++.+..++.++|||||||++|||++|..||...... ...+.+ ... .+.+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-------~~~~~~----~~~------~~~~--- 215 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-------ELFESI----RVD------TPHY--- 215 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHH----HhC------CCCC---
Confidence 67999999999999999999999999999999999999999754321 111111 110 0111
Q ss_pred CcHHHHHHHHHHHhhhhCCCCCCCCCHH-HHH
Q 047892 386 PSSRALKRALLVALRCVDPNAHKRPKMG-HVI 416 (442)
Q Consensus 386 ~~~~~~~~~~~li~~cl~~dP~~RPs~~-evl 416 (442)
+...+.++.+++.+||+.||++||++. +++
T Consensus 216 -~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 -PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 112345677899999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=286.99 Aligned_cols=243 Identities=21% Similarity=0.312 Sum_probs=187.3
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecC--cchhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeee
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLN--NRGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~ 230 (442)
.+....|++++.||+||.++||++...+.+.+|+|++.. .+......|.+|+.+|.+| .|.+||+|++|-..++.+|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 455567999999999999999999988888999998843 3556677899999999999 5899999999999999999
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc------CCCC------CCCeEEecccCccccCCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE------GLEP------KWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~------~l~~------~~~~kl~DFGla~~~~~~ 298 (442)
|||||-+. ||..+|++... ..+...++.+..|++.++.++|. +++| .|.+||+|||.|..+...
T Consensus 437 mvmE~Gd~-DL~kiL~k~~~---~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 437 MVMECGDI-DLNKILKKKKS---IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKGRLKLIDFGIANAIQPD 512 (677)
T ss_pred EEeecccc-cHHHHHHhccC---CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEeeeEEeeeechhcccCcc
Confidence 99998776 99999987632 23323677888999999998865 4666 478999999999987554
Q ss_pred cce-eecccccccCCCCcccccCCC-----------CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHH
Q 047892 299 RSY-VTTRVMGTFGYVAPEYASTGM-----------LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLK 366 (442)
Q Consensus 299 ~~~-~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 366 (442)
... .....+||+.||+||.+.... .+.++||||+|||||+|+.|++||.. ..+.+..+
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~---------~~n~~aKl- 582 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ---------IINQIAKL- 582 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH---------HHHHHHHH-
Confidence 432 334679999999999985332 55789999999999999999999952 12222222
Q ss_pred HHhhcCCcccccCcccCCCCcHHH-HHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 367 TMVTNGNAEGVLDPRLQEKPSSRA-LKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
..+.++....+++... ..++.++|+.||++||++|||+.++|+.
T Consensus 583 --------~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 583 --------HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred --------HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 2333332222222111 1228899999999999999999999975
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=283.34 Aligned_cols=230 Identities=23% Similarity=0.281 Sum_probs=176.7
Q ss_pred CeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 164 NVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++.++ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 57899999996432 23345678899999888 699999999999999999999999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecc
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTR 305 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~ 305 (442)
|+|..++... ..+++..+..++.|++.||+|||+. ++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTST 155 (327)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceec
Confidence 9999988654 4689999999999999999999876 4457899999999987532211 12344
Q ss_pred cccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCC
Q 047892 306 VMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEK 385 (442)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (442)
.+||+.|+|||++.+..++.++|||||||++|||++|..||......... +.............. .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~----~~~~~~~~~~~~~~~----------~ 221 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM----NTEDYLFQVILEKPI----------R 221 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc----ccHHHHHHHHHhCCC----------C
Confidence 67999999999999999999999999999999999999999653322111 111111121111110 1
Q ss_pred CcHHHHHHHHHHHhhhhCCCCCCCCCH
Q 047892 386 PSSRALKRALLVALRCVDPNAHKRPKM 412 (442)
Q Consensus 386 ~~~~~~~~~~~li~~cl~~dP~~RPs~ 412 (442)
.+...+..+.+++.+||+.||++|+++
T Consensus 222 ~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 222 IPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 111233557789999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=274.56 Aligned_cols=235 Identities=26% Similarity=0.444 Sum_probs=181.5
Q ss_pred CeeccCCcEEEEEEEECC----CCeEEEEEecCcch-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 164 NVIGEGGYGIVYRGVLED----NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
+.||+|+||.||+|.+.. +..+|+|.+..... ...+.+.+|+.+++.++||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998532 26899999865433 34567889999999999999999999876 4568999999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeec-
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTT- 304 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~- 304 (442)
|+|.+++... ..+++..++.++.|++.||.|||.. ++.++.+||+|||+++.+.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 9999999765 3688999999999999999999876 455678999999999876443322111
Q ss_pred -ccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCccc
Q 047892 305 -RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382 (442)
Q Consensus 305 -~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (442)
...++..|+|||.+.+..++.++|||||||++|||++ |..||...... .....+ ....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-------~~~~~~----~~~~--------- 215 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-------EVIAML----ESGE--------- 215 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHH----HcCC---------
Confidence 1223568999999988889999999999999999998 99999653221 111111 1111
Q ss_pred CCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 383 QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 383 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....+...+..+.+++.+||+.||++|||+.++++.|++..
T Consensus 216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 00112223456888999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=276.87 Aligned_cols=240 Identities=24% Similarity=0.338 Sum_probs=185.7
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
.++|.+.+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 34688889999999999999995 45889999998655444456688899999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++++|.+++... ..+++...+.++.|++.||.|||+. ++.++.+||+|||++....... ..
T Consensus 88 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06645 88 CGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK 162 (267)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence 9999999998754 4689999999999999999999875 3456789999999987654322 12
Q ss_pred ecccccccCCCCccccc---CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 303 TTRVMGTFGYVAPEYAS---TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
.....|+..|+|||++. ...++.++|||||||++|||++|..||....+... . ..... .. ...
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~----~~~~~-~~---~~~ 228 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------L----FLMTK-SN---FQP 228 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------H----Hhhhc-cC---CCC
Confidence 23457899999999874 45688999999999999999999999864332111 0 00000 00 001
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
+.... ....+..+.+++.+||+.||++|||+.++++
T Consensus 229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 229 PKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred Ccccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 11110 1123345778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=278.17 Aligned_cols=246 Identities=25% Similarity=0.426 Sum_probs=189.3
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCcchh-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 229 (442)
.++|.+.+.||+|+||.||+|+.+ +.+.|++|.+...... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 356889999999999999999953 2467999988654333 456789999999999999999999999998999
Q ss_pred eeEEecCCCCCHHHHHccCCCC-----CCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGP-----HSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGL 291 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGl 291 (442)
|+||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. ++.++.+||+|||+
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccccc
Confidence 9999999999999999754311 12689999999999999999999876 33466899999999
Q ss_pred ccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhh
Q 047892 292 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVT 370 (442)
Q Consensus 292 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 370 (442)
++..............++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ... . ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-------~~~---~-~~ 232 (275)
T cd05046 164 SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLN---R-LQ 232 (275)
T ss_pred ccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-------HHH---H-HH
Confidence 87653333222334456788999999988889999999999999999999 888985432211 111 1 11
Q ss_pred cCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 371 NGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
.+... .......+..+.+++.+||+.||++|||+.|++..|.+
T Consensus 233 ~~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 233 AGKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred cCCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 11110 11112234568889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=289.03 Aligned_cols=231 Identities=26% Similarity=0.359 Sum_probs=187.4
Q ss_pred CCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 160 FADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
|..++.||.|+||.||-|+. .+.+.||||++.-. .......+.+|+..|.+|+|||+|.+.|+|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 66778999999999999994 56889999999543 233456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
|-| +-.+++.-+ ..++.+..+..|+.+.++||.|||+. +...|.|||+|||.|.....
T Consensus 108 ClG-SAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----- 178 (948)
T KOG0577|consen 108 CLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----- 178 (948)
T ss_pred Hhc-cHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc-----
Confidence 976 777777544 25788889999999999999999875 55678999999999876543
Q ss_pred ecccccccCCCCccccc---CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 303 TTRVMGTFGYVAPEYAS---TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
...++|||.|||||++. .+.|+-++||||||+++.||.-.++|+.. .+....+.....+..
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn----------MNAMSALYHIAQNes------ 242 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN----------MNAMSALYHIAQNES------ 242 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC----------chHHHHHHHHHhcCC------
Confidence 34579999999999884 57899999999999999999999999743 233333333322221
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
|. ....+.+..+..|+..||+.-|.+|||..+++..
T Consensus 243 Pt---Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 PT---LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CC---CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 11 2245677888999999999999999999998864
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=274.82 Aligned_cols=234 Identities=27% Similarity=0.457 Sum_probs=179.9
Q ss_pred eeccCCcEEEEEEEEC---CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCCC
Q 047892 165 VIGEGGYGIVYRGVLE---DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGN 240 (442)
Q Consensus 165 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~ 240 (442)
.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.. ...++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999853 35569999886543 3344678999999999999999999998864 56899999999999
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceee--cc
Q 047892 241 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT--TR 305 (442)
Q Consensus 241 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~--~~ 305 (442)
|.+++... ...+++..++.++.|++.||.|||.. ++.++.+||+|||+++.+........ ..
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999753 24689999999999999999999876 34566899999999986543332211 12
Q ss_pred cccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCC
Q 047892 306 VMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQE 384 (442)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (442)
..++..|+|||++.+..++.++|||||||++|||++ |..||...... ... .....+. ..
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----------~~~-~~~~~~~---------~~ 217 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP----------EVM-SFIEQGK---------RL 217 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH----------HHH-HHHHCCC---------CC
Confidence 234578999999988889999999999999999996 99999654221 111 1111111 11
Q ss_pred CCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 385 KPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 385 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
..+...+.++.+++.+||..||++||++.+|.+.|+..
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 12223456788899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=275.91 Aligned_cols=242 Identities=24% Similarity=0.387 Sum_probs=182.1
Q ss_pred CccCeeccCCcEEEEEEEECC-CC--eEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------Cee
Q 047892 161 ADENVIGEGGYGIVYRGVLED-NT--NVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG------AHR 229 (442)
Q Consensus 161 ~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~~ 229 (442)
.+.+.||+|+||.||+|.+.. +. .||+|.+... .....+.+.+|+.+++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456889999999999999654 32 5899987543 234456788999999999999999999987432 246
Q ss_pred eeEEecCCCCCHHHHHccCC--CCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccc
Q 047892 230 MLVNEYVDNGNLEQWLHGDV--GPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKL 294 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~ 294 (442)
+++|||+.+|+|.+++.... .....+++.....++.|++.||+|||.. ++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence 89999999999999884321 1234588999999999999999999875 34567899999999987
Q ss_pred cCCCccee-ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcC
Q 047892 295 LGAERSYV-TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372 (442)
Q Consensus 295 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (442)
........ .....+++.|+|||.+.+..++.++|||||||++|||++ |..||...... ... .....+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~----~~~~~~ 230 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-------EIY----DYLRQG 230 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHH----HHHHcC
Confidence 64433221 122346778999999988889999999999999999999 88998653221 111 111111
Q ss_pred CcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
... ......+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 231 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 110 01122345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=275.03 Aligned_cols=235 Identities=25% Similarity=0.397 Sum_probs=183.6
Q ss_pred CeeccCCcEEEEEEEECC--C--CeEEEEEecCcch-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 164 NVIGEGGYGIVYRGVLED--N--TNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999643 3 3689999976544 556789999999999999999999999988 889999999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce--ee
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY--VT 303 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~--~~ 303 (442)
|+|.+++.+... ..+++...+.++.|++.||+|||.. ++.++.+||+|||+++.+...... ..
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 999999976522 4689999999999999999999876 345678999999999876443221 11
Q ss_pred cccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCccc
Q 047892 304 TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (442)
....++..|+|||.+.+..++.++|||||||++|||++ |..||......+ ... .......
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~---~~~~~~~--------- 218 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-------ILK---KIDKEGE--------- 218 (257)
T ss_pred cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-------HHH---HHHhcCC---------
Confidence 23457789999999988889999999999999999999 999996432211 111 1111110
Q ss_pred CCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHh
Q 047892 383 QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420 (442)
Q Consensus 383 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 420 (442)
....+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00111223456888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=274.92 Aligned_cols=237 Identities=24% Similarity=0.407 Sum_probs=185.1
Q ss_pred CCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcc------hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeE
Q 047892 159 GFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNR------GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 232 (442)
+|...+.||+|+||.||+|...+++.+|+|.+.... ......+.+|+++++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998788999999885332 12234588899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
|||+++++|.+++.+. ..+++..+..++.|++.||+|||.. ++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999999999764 4578899999999999999999975 4567889999999987652211
Q ss_pred -----ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 300 -----SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 300 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
........|+..|+|||.+.+..++.++|||||||++|||++|..||...+.... . ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~----~~~~~~~~- 225 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA------M----FYIGAHRG- 225 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH------H----HHhhhccC-
Confidence 1112335689999999999888899999999999999999999999964322110 0 00000000
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
..+. .+...+..+.+++.+||+.||++|||+.++++
T Consensus 226 ---~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 ---LMPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0111 12234456788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=275.98 Aligned_cols=235 Identities=23% Similarity=0.364 Sum_probs=187.3
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
+|.+.+.||.|+||.||+|... +++.||+|.+.... ......+.+|+++++.++||||+++++++.++...|+|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5788899999999999999964 58899999886443 334466889999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceee
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT 303 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~ 303 (442)
++++|.+++... .+++..+..++.|++.||.|||.. ++.++.++|+|||+++.+.... ...
T Consensus 82 ~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~ 155 (274)
T cd06609 82 GGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKR 155 (274)
T ss_pred CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-ccc
Confidence 999999998753 688999999999999999999976 4567889999999998765432 122
Q ss_pred cccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccC
Q 047892 304 TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ 383 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (442)
....|+..|+|||.+.+..++.++|||||||++|||++|..||....... .. ... ... ..+.+.
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-------~~---~~~-~~~-----~~~~~~ 219 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-------VL---FLI-PKN-----NPPSLE 219 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-------HH---HHh-hhc-----CCCCCc
Confidence 34568889999999988889999999999999999999999996543211 00 000 000 011111
Q ss_pred CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 384 EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 384 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.. ..+..+.+++.+||..||++|||++++++.
T Consensus 220 ~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 220 GN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred cc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11 144568889999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=311.35 Aligned_cols=250 Identities=22% Similarity=0.369 Sum_probs=189.4
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCe
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE--GAH 228 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~ 228 (442)
+...++|.+.+.||+|+||.||+|... ++..||+|.+... .......+..|+.+|+.|+|||||+++++|.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 445568999999999999999999964 4778999988543 23445678899999999999999999998854 356
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCC---------------
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEP--------------- 280 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~--------------- 280 (442)
+||||||+++|+|.++|.........+++..++.|+.||+.||.|||.. |+|
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 8999999999999999976433345799999999999999999999961 222
Q ss_pred ---------CCCeEEecccCccccCCCcceeecccccccCCCCcccccC--CCCCCcCCchhhHHHHHHHHhCCCCCCCC
Q 047892 281 ---------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST--GMLNETSDVYSFGILIMEVISGRNPVDYS 349 (442)
Q Consensus 281 ---------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~Pf~~~ 349 (442)
...+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||+||||++|..||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2248999999998764322 2234579999999999854 45889999999999999999999999643
Q ss_pred CCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHH--HHHhcCCCC
Q 047892 350 RPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVI--HMLEAEEFP 425 (442)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl--~~L~~~~~~ 425 (442)
... ...+... ... +.+ +....+..+.+||..||+.+|.+||++.|++ ..+..+..+
T Consensus 247 ~~~---------~qli~~l-k~~-------p~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p 304 (1021)
T PTZ00266 247 NNF---------SQLISEL-KRG-------PDL---PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP 304 (1021)
T ss_pred CcH---------HHHHHHH-hcC-------CCC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence 221 1111111 111 001 1112245688899999999999999999998 456655544
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=278.15 Aligned_cols=244 Identities=23% Similarity=0.396 Sum_probs=187.3
Q ss_pred hhCCCCccCeeccCCcEEEEEEEE-CCCC----eEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 047892 156 STNGFADENVIGEGGYGIVYRGVL-EDNT----NVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 229 (442)
..++|++.+.||+|+||.||+|.+ .++. .||+|.+... .......+.+|+.++..++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 345688899999999999999985 3444 4899988643 33445678899999999999999999999875 457
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~ 296 (442)
++++||+++|+|.++++.. ...+++..++.++.|++.||.|||+. +..++.+||+|||+++.+.
T Consensus 84 ~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 84 QLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 8999999999999999754 24688999999999999999999876 3345789999999998764
Q ss_pred CCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 297 AERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 297 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
..... ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .....++ ....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~~----~~~~- 228 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-------REIPDLL----EKGE- 228 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHH----HCCC-
Confidence 33221 1122345678999999988889999999999999999998 9999864321 1111111 1111
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....+...+..+.+++.+||+.||++||++.++++.|+.+.
T Consensus 229 --------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 229 --------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred --------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 01111234456888999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=271.77 Aligned_cols=229 Identities=22% Similarity=0.231 Sum_probs=186.2
Q ss_pred hhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 156 STNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
..++|..+++||+|.||+|.+|+- .+++.+|+|++++.- ......-..|-++|+..+||.+..+.-.|+..+.+|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 456788999999999999999994 468999999987642 3334445679999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
||||..||.|+-+|.+. ..+++...+.+...|+.||.|||++ ++.+|++||+|||+++.- -.
T Consensus 246 VMeyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~-I~ 320 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE-IK 320 (516)
T ss_pred EEEEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc-cc
Confidence 99999999999888765 5788888899999999999999987 788999999999999852 22
Q ss_pred cceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 299 RSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
....+.++||||.|+|||++....|+.++|+|.+||++|||++|+.||...+....+ +.+ .-.
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLF-------eLI----l~e------ 383 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLF-------ELI----LME------ 383 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHH-------HHH----Hhh------
Confidence 233567899999999999999999999999999999999999999999765443221 111 000
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCC
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRP 410 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP 410 (442)
+- ..+...+.+...|+...|..||.+|.
T Consensus 384 d~----kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 384 DL----KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred hc----cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 11 12233345567788899999999995
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=277.29 Aligned_cols=239 Identities=23% Similarity=0.342 Sum_probs=182.4
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC------C
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEG------A 227 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~------~ 227 (442)
+.+.|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++.++ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 3456888899999999999999954 58889999885432 3345688899999998 799999999998753 4
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKL 294 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~ 294 (442)
..|+||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. ++.++.+||+|||++..
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 6799999999999999987532 24688999999999999999999986 45677899999999986
Q ss_pred cCCCcceeecccccccCCCCccccc-----CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHh
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYAS-----TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMV 369 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 369 (442)
..... .......|+..|+|||++. +..++.++|||||||++|||++|..||....... ... ..
T Consensus 161 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~---------~~~--~~ 228 (272)
T cd06637 161 LDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR---------ALF--LI 228 (272)
T ss_pred ccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH---------HHH--HH
Confidence 53322 1233457899999999985 3458889999999999999999999996432210 000 00
Q ss_pred hcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 370 TNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
..... ........+..+.+|+.+||..||.+|||+.++++
T Consensus 229 ~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 PRNPA--------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred hcCCC--------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00000 00111123456788999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=282.14 Aligned_cols=242 Identities=18% Similarity=0.204 Sum_probs=181.1
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|++.+.||+|+||.||++... +++.||+|.+... .......+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46889999999999999999964 5889999998532 1223455788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++|+|.+++.+. ...+++..+..++.|++.||+|||+. ++.++.+||+|||++..+.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999999653 24688999999999999999999876 44578899999999976644333
Q ss_pred eeecccccccCCCCcccccC-----CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 301 YVTTRVMGTFGYVAPEYAST-----GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
.......||+.|||||++.. ..++.++|||||||++|||++|+.||...... +............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~----------~~~~~i~~~~~~~ 227 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV----------ETYGKIMNHKEHF 227 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH----------HHHHHHHcCCCcc
Confidence 22333569999999999863 45788999999999999999999999653221 1111111111100
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCC--CCCCCHHHHHHH
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNA--HKRPKMGHVIHM 418 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP--~~RPs~~evl~~ 418 (442)
. +.. .....+..+.+++.+|+..++ ..|+++.++++.
T Consensus 228 ~-----~~~-~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 228 Q-----FPP-DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred c-----CCC-ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 011 111234557778888775433 347899888865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=278.45 Aligned_cols=236 Identities=20% Similarity=0.314 Sum_probs=188.6
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
.+|.+.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..|+||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5688999999999999999995 568999999996655555567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceee
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT 303 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~ 303 (442)
++++|.+++.+. .+++..+..++.|++.||.|||+. ++.++.+||+|||++......... .
T Consensus 99 ~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~ 172 (297)
T cd06656 99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R 172 (297)
T ss_pred CCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-c
Confidence 999999998643 578889999999999999999875 445678999999999865433221 2
Q ss_pred cccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccC
Q 047892 304 TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ 383 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (442)
....+++.|+|||.+.+..++.++|||||||++|+|++|..||.......... ..... ....
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~----------~~~~~--------~~~~ 234 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY----------LIATN--------GTPE 234 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee----------eeccC--------CCCC
Confidence 33568899999999988889999999999999999999999997543321100 00000 0001
Q ss_pred CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 384 EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 384 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
...+...+..+.+++.+||+.||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112234456788999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=290.67 Aligned_cols=238 Identities=21% Similarity=0.281 Sum_probs=180.6
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++..++||||+++++.+.+.+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999964 58899999985422 233456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++|+|.+++.+. ..+++..+..++.|++.||+|||+. ++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 999999999999764 4688999999999999999999875 45678999999999875422110
Q ss_pred ----------------------------------eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCC
Q 047892 301 ----------------------------------YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPV 346 (442)
Q Consensus 301 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf 346 (442)
......+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0012357999999999999999999999999999999999999999
Q ss_pred CCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCC---HHHHHH
Q 047892 347 DYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPK---MGHVIH 417 (442)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs---~~evl~ 417 (442)
....+... ......... .+........+.++.+++.+|+ .||.+|++ +.++++
T Consensus 237 ~~~~~~~~----------~~~i~~~~~-------~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 237 CSETPQET----------YRKVMNWKE-------TLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCHHHH----------HHHHHcCCC-------ceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 75433211 111111000 0000111113445777887776 49999996 455553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=275.75 Aligned_cols=241 Identities=24% Similarity=0.351 Sum_probs=186.2
Q ss_pred CCCccCeeccCCcEEEEEEEECC--CCeEEEEEecCc----------chhhHHHHHHHHHHHHh-cCCCCcceEEEEEEe
Q 047892 159 GFADENVIGEGGYGIVYRGVLED--NTNVAVKNLLNN----------RGQAEKEFKVEVEAIGR-VRHKNLVRLVGYCAE 225 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~ 225 (442)
+|++.+.||+|+||.||+|.... ++.+|+|.+... .......+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37788999999999999999654 688999987432 12233456778888865 799999999999999
Q ss_pred CCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc-C-------------CCCCCCeEEecccC
Q 047892 226 GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-G-------------LEPKWNPKLSDFGL 291 (442)
Q Consensus 226 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~-------------l~~~~~~kl~DFGl 291 (442)
.+..|++|||+++++|.+++.........+++..++.++.|++.||.|||. . +..++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 999999999999999999885432233568999999999999999999995 2 34567899999999
Q ss_pred ccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhc
Q 047892 292 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTN 371 (442)
Q Consensus 292 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (442)
+....... ......|+..|+|||.+.+..++.++||||||+++|||++|..||...... ...... ..
T Consensus 161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~----------~~~~~~-~~ 227 (269)
T cd08528 161 AKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML----------SLATKI-VE 227 (269)
T ss_pred eeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH----------HHHHHH-hh
Confidence 98764433 233456899999999999888999999999999999999999999643221 111111 11
Q ss_pred CCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHh
Q 047892 372 GNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420 (442)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 420 (442)
... ........+..+.+++.+||+.||++||++.|+.++|.
T Consensus 228 ~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 AVY--------EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ccC--------CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111 11111123456888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=274.75 Aligned_cols=234 Identities=21% Similarity=0.338 Sum_probs=187.8
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
.|+..+.||.|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++.+.+..|+||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4777889999999999999964 58899999886432 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceee
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT 303 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~ 303 (442)
++|+|.+++.. ..+++.....++.|++.||.|||.. ++.++.++|+|||++..+..... ..
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-cc
Confidence 99999999864 3578888999999999999999876 34567899999999977643322 22
Q ss_pred cccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccC
Q 047892 304 TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ 383 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (442)
....++..|+|||++.+..++.++|+|||||++|||++|..||....+... ... +.....
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----------~~~----------~~~~~~ 218 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV----------LFL----------IPKNNP 218 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH----------hhh----------hhcCCC
Confidence 334678899999999888899999999999999999999999965432111 000 001111
Q ss_pred CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 384 EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 384 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.......+..+.+++.+||+.||++||++.+++..
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 22334566778899999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=273.43 Aligned_cols=241 Identities=24% Similarity=0.336 Sum_probs=176.1
Q ss_pred CeeccCCcEEEEEEEECC---CCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCC
Q 047892 164 NVIGEGGYGIVYRGVLED---NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNG 239 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 239 (442)
+.||+|+||.||+|.+.+ +..+|+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998543 4579999886543 234457888999999999999999999999989999999999999
Q ss_pred CHHHHHccCCC-CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee-ec
Q 047892 240 NLEQWLHGDVG-PHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV-TT 304 (442)
Q Consensus 240 ~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~-~~ 304 (442)
+|.+++..... .....++..+..++.|++.||.|||+. ++.++.+||+|||+++......... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD 160 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence 99999975321 123456777888999999999999865 3446689999999997643332221 12
Q ss_pred ccccccCCCCcccccCC-------CCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 305 RVMGTFGYVAPEYASTG-------MLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 305 ~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
...|+..|+|||++.+. .++.++|||||||++|||++ |..||........ ... . .......
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-------~~~---~-~~~~~~~ 229 (269)
T cd05087 161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-------LTY---T-VREQQLK 229 (269)
T ss_pred CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-------HHH---H-hhcccCC
Confidence 34578889999988542 35789999999999999996 9999965432111 000 0 1111111
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHh
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 420 (442)
...+.+.. .....+.+++.+|| .||++|||+++|+..|+
T Consensus 230 ~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 12222211 22345677899999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=274.38 Aligned_cols=237 Identities=27% Similarity=0.376 Sum_probs=185.1
Q ss_pred hCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEE-eCCeeeeEEec
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCA-EGAHRMLVNEY 235 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~~lv~E~ 235 (442)
..+|.+.+.||+|+||.||++.. .+..||+|.+.... ..+.+.+|+.++++++|+||+++++++. .++..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 45688999999999999999987 47789999885432 3456889999999999999999999764 55678999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++|+|.++++... ...+++...+.++.|++.||+|||.. ++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 82 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 99999999997542 23578899999999999999999976 4457789999999987643221
Q ss_pred ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcc
Q 047892 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (442)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+..... ..+
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~----------~~~~~~~-~~~--------- 215 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----------KDVVPRV-EKG--------- 215 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH----------HHHHHHH-hcC---------
Confidence 22345678999999988889999999999999999998 9999864321 1111111 111
Q ss_pred cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 382 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.........+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 216 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 216 YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 01111223445688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=288.69 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=187.5
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEE------CCCCeEEEEEecCcc-hhhHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAE 225 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 225 (442)
.+..++|++.+.||+|+||.||+|.+ .+++.||||.+.... ......+.+|+.++.++ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 45567899999999999999999973 246789999986533 33445688899999999 68999999998765
Q ss_pred C-CeeeeEEecCCCCCHHHHHccCCCC-----------------------------------------------------
Q 047892 226 G-AHRMLVNEYVDNGNLEQWLHGDVGP----------------------------------------------------- 251 (442)
Q Consensus 226 ~-~~~~lv~E~~~~g~L~~~l~~~~~~----------------------------------------------------- 251 (442)
. ...+++||||++|+|.++++.....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 4 5678999999999999998643210
Q ss_pred ----------CCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce-eecccc
Q 047892 252 ----------HSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY-VTTRVM 307 (442)
Q Consensus 252 ----------~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~ 307 (442)
...+++.....++.|++.||.|||+. ++.++.+||+|||+++........ ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 12367888899999999999999875 334678999999999865332211 122234
Q ss_pred cccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCC
Q 047892 308 GTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKP 386 (442)
Q Consensus 308 gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (442)
++..|+|||.+.+..++.++|||||||++|||++ |..||........ . ......+... ..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~----~~~~~~~~~~---------~~ 303 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------F----CRRLKEGTRM---------RA 303 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------H----HHHHhccCCC---------CC
Confidence 5678999999988899999999999999999997 9999865322110 1 1111111110 00
Q ss_pred cHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 387 SSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 387 ~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
+...+..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1112345788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=277.73 Aligned_cols=249 Identities=23% Similarity=0.333 Sum_probs=186.9
Q ss_pred hhhHHHhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhc-CCCCcceEEEEEE---
Q 047892 150 LRELEVSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCA--- 224 (442)
Q Consensus 150 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~--- 224 (442)
++.+....++|++.+.||+|+||.||+|... +++.+|+|.+... ......+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 4455566788999999999999999999964 5789999987542 22345678899999999 7999999999874
Q ss_pred --eCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecc
Q 047892 225 --EGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDF 289 (442)
Q Consensus 225 --~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DF 289 (442)
.++..++||||+++|+|.+++.........+++..+..++.|++.||.|||+. ++.++.+||+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccC
Confidence 34678999999999999998864333345688899999999999999999875 445678999999
Q ss_pred cCccccCCCcceeecccccccCCCCcccccC-----CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHH
Q 047892 290 GLAKLLGAERSYVTTRVMGTFGYVAPEYAST-----GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEW 364 (442)
Q Consensus 290 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 364 (442)
|+++.+..... ......|++.|+|||++.. ..++.++|||||||++|||++|+.||........ .
T Consensus 169 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~------~--- 238 (286)
T cd06638 169 GVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA------L--- 238 (286)
T ss_pred CceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH------H---
Confidence 99987643221 2233468999999998753 4478899999999999999999999965432110 0
Q ss_pred HHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 365 LKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.... . ...+.. ..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 239 -~~~~-~-----~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 239 -FKIP-R-----NPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred -hhcc-c-----cCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0000 0 000000 0111233468889999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=283.62 Aligned_cols=253 Identities=22% Similarity=0.230 Sum_probs=182.5
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA------ 227 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------ 227 (442)
.++|.+.+.||+|+||.||+|.. .++..||+|.+... .......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 46799999999999999999996 45889999998543 2334456788999999999999999999986543
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKL 294 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~ 294 (442)
..|+||||+++ +|.++++. .+++..+..++.|++.||.|||+. ++.++.+||+|||+++.
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 47999999986 67777643 377888899999999999999876 45678999999999976
Q ss_pred cCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchh------------hhHH
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQ------------VNLF 362 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~------------~~~~ 362 (442)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+..... ....
T Consensus 173 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 173 ACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred cccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 43221 233457899999999999999999999999999999999999999765321111000 0000
Q ss_pred HHHHHHhhcC-Ccc-----cccCccc-C--CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 363 EWLKTMVTNG-NAE-----GVLDPRL-Q--EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 363 ~~~~~~~~~~-~~~-----~~~~~~~-~--~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.......... ... ....... . .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0011111100 000 0000000 0 00111224567889999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=285.86 Aligned_cols=229 Identities=24% Similarity=0.260 Sum_probs=175.3
Q ss_pred CeeccCCcEEEEEEEE-CCCCeEEEEEecCcc---hhhHHHHHHHHH-HHHhcCCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 164 NVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVE-AIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
+.||+|+||.||+|.. .+++.||+|.+.... ......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999995 458899999985431 223344555655 46779999999999999999999999999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecc
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTR 305 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~ 305 (442)
|+|..++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (325)
T cd05604 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTT 155 (325)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCccc
Confidence 9999988754 4689999999999999999999976 4567899999999987532211 12344
Q ss_pred cccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCC
Q 047892 306 VMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEK 385 (442)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (442)
.+||+.|+|||++.+..++.++|||||||++|||++|..||...... +....... ... .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----------~~~~~~~~-~~~------~~~-- 216 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA----------EMYDNILH-KPL------VLR-- 216 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH----------HHHHHHHc-CCc------cCC--
Confidence 67999999999999999999999999999999999999999754321 11111111 100 011
Q ss_pred CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 386 PSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 386 ~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
...+..+.+++.+||+.||.+||++.+.++.
T Consensus 217 --~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 217 --PGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred --CCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 1234557789999999999999998644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=306.57 Aligned_cols=252 Identities=26% Similarity=0.456 Sum_probs=202.3
Q ss_pred hHHHhhCCCCccCeeccCCcEEEEEEEEC----C----CCeEEEEEecCcc-hhhHHHHHHHHHHHHhc-CCCCcceEEE
Q 047892 152 ELEVSTNGFADENVIGEGGYGIVYRGVLE----D----NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLVG 221 (442)
Q Consensus 152 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~ 221 (442)
.+++..++..+.+.||+|.||.|++|... . ...||||.++... ....+.+..|+++|+.+ +||||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 56777777788889999999999999832 1 4569999997543 34567799999999998 6999999999
Q ss_pred EEEeCCeeeeEEecCCCCCHHHHHccCC---C-------CC--CCCCHHHHHHHHHHHHHhhhhh------hcC------
Q 047892 222 YCAEGAHRMLVNEYVDNGNLEQWLHGDV---G-------PH--SPLTWEIRMNIILGTAKGLTYL------HEG------ 277 (442)
Q Consensus 222 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~-------~~--~~l~~~~~~~i~~qi~~~l~yL------H~~------ 277 (442)
+|..++..++|+||+..|+|.+|++... . .. ..++....+.++.|||.||+|| |++
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 9999999999999999999999998764 0 11 2389999999999999999999 444
Q ss_pred -CCCCCCeEEecccCccccCCCcceeeccccc--ccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCC
Q 047892 278 -LEPKWNPKLSDFGLAKLLGAERSYVTTRVMG--TFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPG 353 (442)
Q Consensus 278 -l~~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~ 353 (442)
+..+..+||+|||+|+.......+......| ...|||||.+....|+.++|||||||+|||++| |..||.+....
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~- 528 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT- 528 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH-
Confidence 4566789999999999766655554333333 456999999999999999999999999999999 99999652211
Q ss_pred ccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 354 EFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.++.+ .+....+...+..+..+++++|+.||+.+|++||++.++.+.|+..
T Consensus 529 -----~~l~~-------------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 529 -----EELLE-------------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred -----HHHHH-------------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 11211 1223334456667788899999999999999999999999999884
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=273.25 Aligned_cols=242 Identities=25% Similarity=0.401 Sum_probs=185.7
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeE
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 232 (442)
+...+.+.....||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 445566666779999999999999954 5788999998766555667899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCC--CHHHHHHHHHHHHHhhhhhhcC-------------CCC-CCCeEEecccCccccC
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPL--TWEIRMNIILGTAKGLTYLHEG-------------LEP-KWNPKLSDFGLAKLLG 296 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l--~~~~~~~i~~qi~~~l~yLH~~-------------l~~-~~~~kl~DFGla~~~~ 296 (442)
+||+++++|.+++.... ..+ ++..+..++.|++.||.|||+. ++. ++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 99999999999997542 234 7788889999999999999976 222 5689999999987653
Q ss_pred CCcceeecccccccCCCCcccccCCC--CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 297 AERSYVTTRVMGTFGYVAPEYASTGM--LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 297 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
.... ......|+..|+|||++.+.. ++.++|||||||++|+|++|..||........ ..+.....
T Consensus 161 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-------~~~~~~~~----- 227 (268)
T cd06624 161 GINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-------AMFKVGMF----- 227 (268)
T ss_pred cCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-------hHhhhhhh-----
Confidence 3221 122345789999999986644 78899999999999999999999964322110 00000000
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
......+.....++.+++.+||+.+|++|||+.|++.
T Consensus 228 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 228 ------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0011122234566888999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=296.99 Aligned_cols=239 Identities=25% Similarity=0.400 Sum_probs=192.9
Q ss_pred CCccCeeccCCcEEEEEEEE-CC----CCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 160 FADENVIGEGGYGIVYRGVL-ED----NTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~-~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
.+..++||+|+||+||+|.| .. .-+||+|.+... ..+...++..|+-+|.+|+|||+++|+++|.... +-||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34568899999999999995 33 346899988654 3455678999999999999999999999998766 88999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
+|++.|+|.+|++.++ ..+.....+.+..||++||.|||.+ ++.-..+||+|||+++.+.....
T Consensus 777 q~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 9999999999998763 5678888999999999999999765 45567899999999998855443
Q ss_pred e-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 301 Y-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 301 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
. ......-.+.|||-|.+....|+.++|||||||++||++| |..||++..-.+ +. .++
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-----------I~---------dll 913 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-----------IP---------DLL 913 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-----------hh---------HHH
Confidence 2 2233344678999999999999999999999999999999 999997643211 11 122
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
....+...+..++-+++-++.+||..|++.||+|+++...+.++
T Consensus 914 e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 914 EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 22233455667778899999999999999999999999887764
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=273.19 Aligned_cols=234 Identities=23% Similarity=0.390 Sum_probs=183.6
Q ss_pred CCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcch---------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 047892 160 FADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRG---------QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 229 (442)
|.+...||+|+||.||+|.. .+++.+|+|.+..... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 67788999999999999985 4578999998854321 1224678899999999999999999999999999
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~ 296 (442)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++++.+||+|||+++.+.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 9999999999999999764 4678889999999999999999975 4567789999999998764
Q ss_pred CCcce-----eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhc
Q 047892 297 AERSY-----VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTN 371 (442)
Q Consensus 297 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (442)
..... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------~~~~~~~~- 226 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----------QAIFKIGE- 226 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH----------HHHHHHhc-
Confidence 22111 112345889999999998888999999999999999999999999753221 00111100
Q ss_pred CCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 372 GNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
...+ ..+...+..+.+++.+||+.||.+||++.++++
T Consensus 227 -----~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 -----NASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----cCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0111 122234566888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=285.05 Aligned_cols=228 Identities=23% Similarity=0.259 Sum_probs=173.8
Q ss_pred CeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHH-HHHhcCCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 164 NVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVE-AIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
+.||+|+||.||+|+.. +++.||+|.+.... ......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 47889999985432 122233444444 56789999999999999999999999999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecc
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTR 305 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~ 305 (442)
|+|.+++... ..+.+..+..++.|++.||.|||+. ++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~ 155 (325)
T cd05602 81 GELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTST 155 (325)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCccc
Confidence 9999999764 4577888889999999999999876 4567899999999997542222 12345
Q ss_pred cccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCC
Q 047892 306 VMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEK 385 (442)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (442)
.+||+.|+|||++.+..++.++|||||||++|||++|..||...+.. +........ . . .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------~~~~~i~~~-~--------~--~ 214 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA----------EMYDNILNK-P--------L--Q 214 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH----------HHHHHHHhC-C--------c--C
Confidence 67999999999999999999999999999999999999999753321 111111111 0 0 0
Q ss_pred CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 386 PSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 386 ~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.....+..+.+++.+||+.||.+||++.+.+.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 11123455778999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=277.38 Aligned_cols=240 Identities=20% Similarity=0.267 Sum_probs=186.5
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
.+.|++.+.||.|+||.||+|... ++..|++|.+..........+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 456899999999999999999964 4889999998766666667788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++++|..++.+. ...+++..+..++.|++.||.|||+. ++.++.+||+|||++....... ..
T Consensus 91 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 166 (292)
T cd06644 91 CPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QR 166 (292)
T ss_pred CCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-cc
Confidence 9999999887643 24588999999999999999999875 3456789999999987542221 11
Q ss_pred ecccccccCCCCccccc-----CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 303 TTRVMGTFGYVAPEYAS-----TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
.....++..|+|||++. ...++.++|||||||++|||++|..||...... ......... .
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----------~~~~~~~~~-~---- 231 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM----------RVLLKIAKS-E---- 231 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH----------HHHHHHhcC-C----
Confidence 23346889999999984 345788999999999999999999999653321 111111100 0
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.+.. ..+...+.++.+++.+||+.||++||++.++++.
T Consensus 232 -~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 232 -PPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -CccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 1122334567889999999999999999999863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=283.17 Aligned_cols=228 Identities=22% Similarity=0.297 Sum_probs=177.9
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeeeEE
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVR-HKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~ 233 (442)
+|+..+.||+|+||.||+|... +++.||+|++.... ......+..|..++..+. |++|+++++++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999954 58899999986432 223355777888888885 577888999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++|+|.+++... ..+++..++.++.|++.||.|||+. ++.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG- 155 (323)
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence 999999999998754 4689999999999999999999975 4567889999999987643221
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
.......||+.|+|||++.+..++.++|||||||++|||++|..||...... .... ... ....
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~~~~---~i~-~~~~------ 218 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-------ELFQ---SIM-EHNV------ 218 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHH---HHH-hCCC------
Confidence 1233457999999999999889999999999999999999999999754321 1111 111 1110
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCH
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKM 412 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~ 412 (442)
..+...+..+.+++.+||+.||.+|++.
T Consensus 219 ----~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 ----SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1112234567889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=271.93 Aligned_cols=241 Identities=25% Similarity=0.357 Sum_probs=189.6
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
.++|.+.+.||+|+||.||+|... +++.+++|.+........+.+.+|++++++++||||+++++++.+.+..|++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 356888999999999999999964 5788999998765555667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++++|.+++... ...+++..+..++.|++.||.|||.. ++.++.+||+|||++........ .
T Consensus 82 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 157 (262)
T cd06613 82 CGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K 157 (262)
T ss_pred CCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence 9999999998653 24688999999999999999999875 34567899999999876543211 1
Q ss_pred ecccccccCCCCcccccCC---CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 303 TTRVMGTFGYVAPEYASTG---MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
.....++..|+|||.+.+. .++.++|||||||++|||++|..||........ .. .. ..... ..
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~------~~----~~-~~~~~---~~ 223 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA------LF----LI-SKSNF---PP 223 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------HH----HH-HhccC---CC
Confidence 2345688899999999776 789999999999999999999999965332110 00 00 00000 00
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.. .......+.++.+++.+||..||.+|||+.+|+.
T Consensus 224 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 01 1122345567889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=280.14 Aligned_cols=180 Identities=21% Similarity=0.289 Sum_probs=149.5
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
....+|.+.+.||+|+||.||+|... ++..||+|..... ....|+.++++++||||+++++++...+..++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 44567999999999999999999965 4678999975332 2345899999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+. |+|.+++... ...+++..++.++.|++.||.|||.. ++.++.+||+|||+++......
T Consensus 137 e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 137 PHYS-SDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred EccC-CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 9996 5899988653 24689999999999999999999875 3456789999999997543221
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCC
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPV 346 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf 346 (442)
......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 223457899999999999999999999999999999999955544
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=285.58 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=191.9
Q ss_pred hHHHhhCCCCccCeeccCCcEEEEEEEECC--------CCeEEEEEecCcc-hhhHHHHHHHHHHHHhc-CCCCcceEEE
Q 047892 152 ELEVSTNGFADENVIGEGGYGIVYRGVLED--------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLVG 221 (442)
Q Consensus 152 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~ 221 (442)
++++...+|.+.+.||+|+||.||+|.... ...||+|.+.... ....+.+.+|+++++++ +||||+++++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 345556678999999999999999997421 2368999886432 33456788999999999 8999999999
Q ss_pred EEEeCCeeeeEEecCCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHhhhhhhcC------------
Q 047892 222 YCAEGAHRMLVNEYVDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEG------------ 277 (442)
Q Consensus 222 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~yLH~~------------ 277 (442)
++...+..+++|||+++|+|.+++.+... ....+++..++.++.|++.||.|||..
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 99999999999999999999999975321 224578889999999999999999876
Q ss_pred -CCCCCCeEEecccCccccCCCccee-ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCc
Q 047892 278 -LEPKWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGE 354 (442)
Q Consensus 278 -l~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~ 354 (442)
+..++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--- 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--- 242 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH---
Confidence 3456789999999998764322211 122234567999999988899999999999999999998 8899864321
Q ss_pred cchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 355 FQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
.+..... .... ....+...+..+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus 243 -------~~~~~~~-~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 243 -------EELFKLL-KEGH---------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred -------HHHHHHH-HcCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 1111111 1111 11112233456888999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=277.30 Aligned_cols=240 Identities=20% Similarity=0.290 Sum_probs=187.9
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
.++|++.+.||.|+||.||+|... ++..+|+|.+........+.+.+|++++++++||||+++++++......|+||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456889999999999999999964 5889999998765555667788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++|+|.+++... ...+++..++.++.|++.||.|||.. ++.++.+||+|||++........ .
T Consensus 84 ~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (280)
T cd06611 84 CDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-K 159 (280)
T ss_pred cCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc-c
Confidence 9999999998653 24689999999999999999999875 44567899999999876533221 2
Q ss_pred ecccccccCCCCccccc-----CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 303 TTRVMGTFGYVAPEYAS-----TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
.....|+..|+|||.+. ...++.++|||||||++|||++|..||....... ...... ...
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~----------~~~~~~-~~~---- 224 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR----------VLLKIL-KSE---- 224 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH----------HHHHHh-cCC----
Confidence 23356899999999874 3457789999999999999999999996542211 111111 110
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.+.+ ..+...+..+.+++.+||+.||++||++.++++.
T Consensus 225 -~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 225 -PPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -CCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0011 1122344567889999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=275.66 Aligned_cols=237 Identities=22% Similarity=0.262 Sum_probs=182.9
Q ss_pred CCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 160 FADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.+++.++|+||+.+++.+.+.+..|+||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999964 58899999885432 22334577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++|+|.+++.... ...+++..+..++.|++.||.|||+. ++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 157 (285)
T cd05630 82 MNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-- 157 (285)
T ss_pred cCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--
Confidence 99999999986431 23588899999999999999999875 44567899999999976533222
Q ss_pred ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCccc
Q 047892 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (442)
.....|+..|+|||++.+..++.++|||||||++|||++|..||........ ...........
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-------~~~~~~~~~~~---------- 220 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-------REEVERLVKEV---------- 220 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-------HHHHHhhhhhh----------
Confidence 2234789999999999998999999999999999999999999975432111 00001110000
Q ss_pred CCCCcHHHHHHHHHHHhhhhCCCCCCCCC-----HHHHHH
Q 047892 383 QEKPSSRALKRALLVALRCVDPNAHKRPK-----MGHVIH 417 (442)
Q Consensus 383 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~ 417 (442)
........+..+.+|+.+||+.||++||| +.|+++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 221 QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 00111223455788999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=276.36 Aligned_cols=237 Identities=21% Similarity=0.297 Sum_probs=184.0
Q ss_pred CCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 160 FADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
|++.+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++||||+++++++...+..|+||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567788999999999999965 4778899988655555567788999999999999999999999999999999999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecc
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTR 305 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~ 305 (442)
|+|..++.+. ...+++..+..++.|++.||.|||.. ++.++.+||+|||++....... .....
T Consensus 87 ~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~ 162 (282)
T cd06643 87 GAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDS 162 (282)
T ss_pred CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc-ccccc
Confidence 9999988653 24689999999999999999999875 3456789999999987653221 12234
Q ss_pred cccccCCCCccccc-----CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 306 VMGTFGYVAPEYAS-----TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 306 ~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
..|+..|+|||++. +..++.++|||||||++|||++|..||...... .......... .+
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----------~~~~~~~~~~------~~ 226 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM----------RVLLKIAKSE------PP 226 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH----------HHHHHHhhcC------CC
Confidence 56899999999884 345788999999999999999999999653221 1111111110 00
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.. ..+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 227 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 227 TL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 1122344668899999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=274.34 Aligned_cols=237 Identities=23% Similarity=0.394 Sum_probs=179.4
Q ss_pred CeeccCCcEEEEEEEECC-CC--eEEEEEecCc-chhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 164 NVIGEGGYGIVYRGVLED-NT--NVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
+.||+|+||.||+|...+ +. .+++|.+... .......+.+|++++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999644 43 4688887643 234456788999999999 899999999999999999999999999
Q ss_pred CCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcc
Q 047892 239 GNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAK 293 (442)
Q Consensus 239 g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~ 293 (442)
|+|.+++..... ....+++..++.++.|++.||+|||.. ++.++.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 999999975321 123578899999999999999999875 3456789999999986
Q ss_pred ccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcC
Q 047892 294 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372 (442)
Q Consensus 294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (442)
..... ........+..|+|||++.+..++.++|||||||++|||++ |..||...... ...... ...
T Consensus 161 ~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----------~~~~~~-~~~ 227 (270)
T cd05047 161 GQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----------ELYEKL-PQG 227 (270)
T ss_pred ccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH----------HHHHHH-hCC
Confidence 42211 11111234567999999988889999999999999999997 99999643221 111111 111
Q ss_pred CcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.....+...+..+.+++.+||+.||.+|||+.+++..|+.+
T Consensus 228 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 ---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ---------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 01111122345688899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=270.74 Aligned_cols=237 Identities=29% Similarity=0.488 Sum_probs=187.0
Q ss_pred CeeccCCcEEEEEEEECC----CCeEEEEEecCcchh-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 164 NVIGEGGYGIVYRGVLED----NTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
+.||+|+||.||+|.... +..|++|.+...... ..+.+.+|++++..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999643 788999998654333 367789999999999999999999999999999999999999
Q ss_pred CCHHHHHccCCCC-----CCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 239 GNLEQWLHGDVGP-----HSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 239 g~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
|+|.+++...... ...+++..++.++.|++.||.|||+. ++.++.+||+|||.+........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 9999999764211 35789999999999999999999875 44567899999999987654321
Q ss_pred -eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 301 -YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 301 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
.......++..|+|||.+....++.++|||||||++|||++ |..||...... .... .. ....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~---~~-~~~~----- 224 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-------EVLE---YL-RKGY----- 224 (262)
T ss_pred cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-------HHHH---HH-HcCC-----
Confidence 12234567889999999988889999999999999999999 69999754221 1111 11 1110
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHh
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 420 (442)
....+...+.++.+++.+||+.||++|||+.|+++.|+
T Consensus 225 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 ----RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11112233567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=278.75 Aligned_cols=237 Identities=22% Similarity=0.351 Sum_probs=188.5
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
.+|+..+.||.|+||.||+|.. .+++.|++|.+..........+.+|+.+++.++||||+++++++...+..|+|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4588889999999999999985 568999999986555455667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceee
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT 303 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~ 303 (442)
++++|..++... .+++..+..++.|++.||.|||+. ++.++.+||+|||++..+...... .
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~ 172 (296)
T cd06655 99 AGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-R 172 (296)
T ss_pred CCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-C
Confidence 999999998643 578999999999999999999876 445788999999998865433221 2
Q ss_pred cccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccC
Q 047892 304 TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ 383 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (442)
....|+..|+|||.+.+..++.++|||||||++|+|++|..||....... .......... +.+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~----------~~~~~~~~~~------~~~- 235 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR----------ALYLIATNGT------PEL- 235 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------HHHHHHhcCC------ccc-
Confidence 33568899999999988889999999999999999999999996543211 1111111100 000
Q ss_pred CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 384 EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 384 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
..+...+..+.+++.+||..||++|||+.+++..
T Consensus 236 -~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 236 -QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred -CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 1122334567889999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=270.39 Aligned_cols=238 Identities=21% Similarity=0.329 Sum_probs=188.5
Q ss_pred CCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 159 GFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
+|+..+.||.|+||.||.++. .+++.+++|.+... .......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 378889999999999999984 45889999988543 234456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++|+|.+++.+.. ...+++..+..++.|++.||.|||+. ++.++.+||+|||++........ .
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~ 157 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-M 157 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-c
Confidence 99999999997542 24688999999999999999999875 34467899999999987644332 2
Q ss_pred ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCccc
Q 047892 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (442)
.....|++.|+|||.+.+..++.++|||||||++|||++|..||...... +...... .+..
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----------~~~~~~~-~~~~-------- 218 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL----------NLVVKIV-QGNY-------- 218 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH----------HHHHHHH-cCCC--------
Confidence 33456899999999998888999999999999999999999999653321 1111111 1111
Q ss_pred CCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHH
Q 047892 383 QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHML 419 (442)
Q Consensus 383 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L 419 (442)
. ......+..+.+++.+||..||++||++.++++.+
T Consensus 219 ~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 219 T-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred C-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1 11123445688899999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=277.08 Aligned_cols=233 Identities=23% Similarity=0.360 Sum_probs=184.3
Q ss_pred CCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCC
Q 047892 160 FADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVD 237 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 237 (442)
|...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++...+..|+||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 666788999999999999854 57889999886432 3445678899999999999999999999999999999999999
Q ss_pred CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeec
Q 047892 238 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTT 304 (442)
Q Consensus 238 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~ 304 (442)
+++|.+++.. ..+++..+..++.|++.|+.|||.. ++.++.+||+|||++..+..... ...
T Consensus 86 ~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~ 159 (277)
T cd06642 86 GGSALDLLKP-----GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRN 159 (277)
T ss_pred CCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch-hhh
Confidence 9999999864 3578899999999999999999976 34567899999999987643321 123
Q ss_pred ccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCC
Q 047892 305 RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQE 384 (442)
Q Consensus 305 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (442)
...|+..|+|||++.+..++.++|||||||++|||++|..||........ .... ......
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----------~~~~----------~~~~~~ 219 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV----------LFLI----------PKNSPP 219 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH----------Hhhh----------hcCCCC
Confidence 34688899999999888899999999999999999999999864322110 0000 000111
Q ss_pred CCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 385 KPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 385 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
......+..+.+++.+||+.+|++|||+.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1222345568889999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=283.77 Aligned_cols=242 Identities=17% Similarity=0.205 Sum_probs=182.3
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|.+.+.||+|+||.||+++.. +++.||+|.+... .......+.+|..++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999964 5788999998542 1223345788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++|+|.+++.+. ...+++..+..++.|++.||+|||+. ++.++.+||+|||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999999753 24688899999999999999999875 44567899999999987654433
Q ss_pred eeecccccccCCCCcccccC-----CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 301 YVTTRVMGTFGYVAPEYAST-----GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
.......||+.|+|||++.+ +.++.++|||||||++|||++|+.||...... +.......... .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----------~~~~~i~~~~~-~ 226 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV----------ETYGKIMNHEE-R 226 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH----------HHHHHHHcCCC-c
Confidence 33344579999999999865 46889999999999999999999999653321 11111111110 0
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCC--CCCHHHHHHH
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHK--RPKMGHVIHM 418 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~evl~~ 418 (442)
. .+. ......+.++.+++.+|+..++++ |++++++++.
T Consensus 227 ~----~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 227 F----QFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred c----cCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 001 011123456788999999865544 4678887653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=275.03 Aligned_cols=237 Identities=27% Similarity=0.463 Sum_probs=181.0
Q ss_pred eeccCCcEEEEEEEECC-------CCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 165 VIGEGGYGIVYRGVLED-------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 165 ~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
.||+|+||.||+|...+ +..+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998642 2578999875432 234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCC---CCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCC-----CeEEecccCcccc
Q 047892 237 DNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKW-----NPKLSDFGLAKLL 295 (442)
Q Consensus 237 ~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~-----~~kl~DFGla~~~ 295 (442)
++|+|.+++..... ....+++..++.++.|++.||.|||+. + +.++ .+||+|||+++.+
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~ 161 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI 161 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccccc
Confidence 99999999975321 123478899999999999999999976 2 2333 7999999999865
Q ss_pred CCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCC
Q 047892 296 GAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373 (442)
Q Consensus 296 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (442)
...... ......++..|+|||.+.++.++.++|||||||++|||++ |..||...... .....+ ...
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-------~~~~~~----~~~- 229 (269)
T cd05044 162 YKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-------EVLQHV----TAG- 229 (269)
T ss_pred ccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-------HHHHHH----hcC-
Confidence 433221 1122345788999999998999999999999999999998 99999643221 111111 110
Q ss_pred cccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 374 AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
.........+..+.+++.+||+.+|++||++.++++.|++
T Consensus 230 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 --------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0111122345678899999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=278.84 Aligned_cols=255 Identities=20% Similarity=0.296 Sum_probs=183.9
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++..++..|+||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888999999999999999964 57889999985432 22334577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++ +|.+++... ...+++..+..++.|++.||.|||+. ++.++.+||+|||+++....... .
T Consensus 86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 160 (309)
T cd07872 86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-T 160 (309)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-c
Confidence 986 898888654 24578889999999999999999876 45577899999999976533222 1
Q ss_pred ecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHH-----HHHHHHhhcCCccc
Q 047892 303 TTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF-----EWLKTMVTNGNAEG 376 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 376 (442)
.....+|+.|+|||++.+ ..++.++|||||||++|||+||+.||......+......... ..............
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 223467899999998865 458899999999999999999999997654322211100000 00000000000000
Q ss_pred ccCcccCC----CCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 377 VLDPRLQE----KPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 377 ~~~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.-.+.... ......+.++.+|+.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000 001123456788999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=266.33 Aligned_cols=258 Identities=21% Similarity=0.289 Sum_probs=191.5
Q ss_pred CCCCccCeeccCCcEEEEEEE-ECCCCeEEEEEecCcch--hhHHHHHHHHHHHHhcCCCC-cceEEEEEEeCC------
Q 047892 158 NGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKN-LVRLVGYCAEGA------ 227 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~------ 227 (442)
..|...++||+|+||+||+|+ ..+|+.||+|++.-... .......+|+.+|+.|+|+| ||++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 346777889999999999999 45689999999964432 23455688999999999999 999999998877
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKL 294 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~ 294 (442)
.+++|+||++. +|..++.........++...+..++.|++.||+|||++ +++.|.+||+|||+|+.
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 78999999998 99999986533224577788999999999999999876 45578999999999997
Q ss_pred cCCCcceeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC-
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG- 372 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 372 (442)
..-+... .++.++|..|.|||++.+. .|++..||||+|||++||++++..|.+....+. +......+....
T Consensus 170 ~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q------l~~If~~lGtP~e 242 (323)
T KOG0594|consen 170 FSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ------LFRIFRLLGTPNE 242 (323)
T ss_pred hcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH------HHHHHHHcCCCCc
Confidence 6533322 3456789999999999887 699999999999999999999999987654211 122222211110
Q ss_pred -Ccccc-----cCcccCCCC-c----H---HHHHHHHHHHhhhhCCCCCCCCCHHHHHHH--HhcCC
Q 047892 373 -NAEGV-----LDPRLQEKP-S----S---RALKRALLVALRCVDPNAHKRPKMGHVIHM--LEAEE 423 (442)
Q Consensus 373 -~~~~~-----~~~~~~~~~-~----~---~~~~~~~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 423 (442)
....+ .+..+.... + . .......+++.+||+.+|.+|.|+..++.. ++...
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 00000 000111111 1 1 111367789999999999999999999976 55543
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=270.09 Aligned_cols=235 Identities=20% Similarity=0.319 Sum_probs=179.4
Q ss_pred CCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc-----hhhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeee
Q 047892 159 GFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR-----GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE--GAHRM 230 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~ 230 (442)
+|...+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.+++.++||||+++++++.. ....+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 588899999999999999996 458899999885321 2234568889999999999999999998875 36778
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+++||+++++|.+++... ..+++...+.++.|++.||.|||+. ++.++.+||+|||+++.+..
T Consensus 83 l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 999999999999999754 3578889999999999999999976 45667899999999976532
Q ss_pred Ccc--eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 298 ERS--YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 298 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
... .......++..|+|||.+.+..++.++|||||||++|||++|+.||...... ..........
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~----------~~~~~~~~~~--- 225 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM----------AAIFKIATQP--- 225 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH----------HHHHHHhcCC---
Confidence 111 1112345889999999998888999999999999999999999999643211 1111111100
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.....+......+.+++ +||..||++|||++||++
T Consensus 226 ------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 ------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 01112223344566666 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=274.51 Aligned_cols=245 Identities=24% Similarity=0.354 Sum_probs=185.8
Q ss_pred hhhHHHhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhc-CCCCcceEEEEEEe--
Q 047892 150 LRELEVSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAE-- 225 (442)
Q Consensus 150 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~-- 225 (442)
+.++....+.|++.+.||+|+||.||+|.. .+++.+|+|.+.... .....+..|+.++.++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 344455667899999999999999999996 458899999875432 3345678899999988 79999999999853
Q ss_pred ----CCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEec
Q 047892 226 ----GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSD 288 (442)
Q Consensus 226 ----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~D 288 (442)
.+..|++|||+++|+|.+++.... ...+++..++.++.|++.||.|||+. ++.++.+||+|
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~d 164 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVD 164 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEee
Confidence 467899999999999999997532 24578888999999999999999976 45678899999
Q ss_pred ccCccccCCCcceeecccccccCCCCccccc-----CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHH
Q 047892 289 FGLAKLLGAERSYVTTRVMGTFGYVAPEYAS-----TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFE 363 (442)
Q Consensus 289 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~ 363 (442)
||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|..||....+.... .
T Consensus 165 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~------~- 236 (282)
T cd06636 165 FGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL------F- 236 (282)
T ss_pred Ccchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh------h-
Confidence 999876532211 123456899999999885 345888999999999999999999999653321110 0
Q ss_pred HHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 364 WLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.. ... .. ........+..+.+++.+||..||.+|||+.|+++
T Consensus 237 ---~~-~~~-----~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 ---LI-PRN-----PP---PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---hH-hhC-----CC---CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 000 00 11111234567889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=276.45 Aligned_cols=247 Identities=24% Similarity=0.318 Sum_probs=177.9
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhc---CCCCcceEEEEEEe-----CC
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRV---RHKNLVRLVGYCAE-----GA 227 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~-----~~ 227 (442)
+|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 3788899999999999999964 58899999885432 12223455677777655 79999999998864 34
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKL 294 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~ 294 (442)
..++||||+.+ +|.+++.... ...+++..+..++.|++.||.|||+. ++.++.+||+|||+++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 57999999985 8999987532 23589999999999999999999875 44578899999999987
Q ss_pred cCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC--
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG-- 372 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-- 372 (442)
..... ......||..|+|||++.+..++.++|||||||++|||++|.+||......+... . +.......
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~------~-~~~~~~~~~~ 228 (288)
T cd07863 158 YSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG------K-IFDLIGLPPE 228 (288)
T ss_pred ccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHH------H-HHHHhCCCCh
Confidence 64322 1234568999999999988899999999999999999999999996543321110 0 10000000
Q ss_pred -Cc-------ccccCcccCC---CCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 373 -NA-------EGVLDPRLQE---KPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 373 -~~-------~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.. .....+.... ......+..+.+++.+||+.||++|||+.|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 0000000000 011123456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=275.93 Aligned_cols=250 Identities=20% Similarity=0.278 Sum_probs=182.9
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
+|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999964 5889999988543 223345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
++ ++|.+++.... ....+++..+..++.|++.||.|||+. ++.++.+||+|||++........ .
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-V 157 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-c
Confidence 98 58999986532 234689999999999999999999986 45678999999999976543221 1
Q ss_pred ecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhc----------
Q 047892 303 TTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTN---------- 371 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---------- 371 (442)
.....+++.|+|||++.+. .++.++|||||||++|||+||+.||........ ...........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ------LFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHHHhCCCChhhhhcchh
Confidence 2234678899999988654 478999999999999999999999975432111 00000000000
Q ss_pred -CCcccccCc---ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 372 -GNAEGVLDP---RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 372 -~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
......... ..........+.++.+++.+||+.||++|||+.+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 0000001123456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=272.17 Aligned_cols=237 Identities=23% Similarity=0.265 Sum_probs=182.2
Q ss_pred CCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 160 FADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
|+..+.||+|+||+||+|.. .+++.||+|.+.... ......+.+|+++++.++|+||+.+++++..++..|+||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678899999999999996 458899999985432 22334577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++|+|.+++.... ...+++..+..++.|++.||.|||.. ++.++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-- 157 (285)
T cd05632 82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-- 157 (285)
T ss_pred ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc--
Confidence 99999998886431 23689999999999999999999876 34567899999999976533221
Q ss_pred ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCccc
Q 047892 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (442)
.....|+..|+|||++.+..++.++|+|||||++|||++|..||....... ....+........
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-------~~~~~~~~~~~~~--------- 221 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-------KREEVDRRVLETE--------- 221 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHHhhhccc---------
Confidence 234578999999999988899999999999999999999999997532211 0111111111110
Q ss_pred CCCCcHHHHHHHHHHHhhhhCCCCCCCCC-----HHHHHH
Q 047892 383 QEKPSSRALKRALLVALRCVDPNAHKRPK-----MGHVIH 417 (442)
Q Consensus 383 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~ 417 (442)
.......+..+.+|+.+||+.||++||+ +.+++.
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 222 -EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 0111223445778999999999999999 666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=276.79 Aligned_cols=251 Identities=22% Similarity=0.366 Sum_probs=187.2
Q ss_pred CCCccCeeccCCcEEEEEEEE-----CCCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--Ceee
Q 047892 159 GFADENVIGEGGYGIVYRGVL-----EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG--AHRM 230 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~ 230 (442)
-|.+.+.||+|+||.||+|.+ .++..||+|.+... .......+.+|+.+++.++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 367889999999999999984 34778999998644 234456789999999999999999999998765 5679
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+||||+++++|.+++.+. ...+++..+..++.|++.||+|||+. ++.++.+||+|||+++.+..
T Consensus 85 lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999999999999654 23589999999999999999999876 44567899999999987644
Q ss_pred Ccce--eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCc-----cchhhhHHHHHHHHhh
Q 047892 298 ERSY--VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGE-----FQFQVNLFEWLKTMVT 370 (442)
Q Consensus 298 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~-----~~~~~~~~~~~~~~~~ 370 (442)
.... ......++..|+|||.+.+..++.++|||||||++|||+++..|+........ ........... ....
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 240 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-RVLE 240 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-HHHH
Confidence 3221 12334577789999999888899999999999999999998776532211000 00000011111 1111
Q ss_pred cCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 371 NGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.+. ........+..+.+|+.+||+.||++|||+.++++.|+++
T Consensus 241 ~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111 1111223456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=291.56 Aligned_cols=239 Identities=19% Similarity=0.283 Sum_probs=189.8
Q ss_pred CCCCccCeeccCCcEEEEEEEECC-CCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 158 NGFADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
+-|.++..||.|+||+||+|..+. +-..|.|.+........+.+.-||+||..++||+||+|++.|...+.+||+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 346677889999999999999654 4455678776666667778899999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceee
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT 303 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~ 303 (442)
.||-+...+-.- ...+++.++..++.|++.||.|||++ +.-+|.++|+|||++...... ....
T Consensus 112 ~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qkR 187 (1187)
T KOG0579|consen 112 GGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQKR 187 (1187)
T ss_pred CCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH-Hhhh
Confidence 999998887542 45799999999999999999999986 345789999999998653221 1223
Q ss_pred cccccccCCCCccccc-----CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 304 TRVMGTFGYVAPEYAS-----TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
..+.|||+|||||++. ..+|+.++||||||++|.||..+.+|....++. ..+.......
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM----------RVllKiaKSe------ 251 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM----------RVLLKIAKSE------ 251 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH----------HHHHHHhhcC------
Confidence 4689999999999874 457999999999999999999999998654432 1111111111
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.|. ...+...+..+.+++.+||..||..||++.++++.
T Consensus 252 PPT--LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 252 PPT--LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred CCc--ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 111 12355677889999999999999999999999864
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=278.56 Aligned_cols=224 Identities=22% Similarity=0.255 Sum_probs=172.3
Q ss_pred CeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHH-HHHhcCCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 164 NVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVE-AIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
+.||+|+||.||+|+.. +++.||+|.+.... ......+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 58899999985432 122334555554 67889999999999999999999999999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecc
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTR 305 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~ 305 (442)
|+|..++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05603 81 GELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTST 155 (321)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccccc
Confidence 9999988654 4678888999999999999999875 4567899999999987532222 22344
Q ss_pred cccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCC
Q 047892 306 VMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEK 385 (442)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (442)
.+||+.|+|||++.+..++.++|||||||++|||++|..||...+. ........ ... . .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------~~~~~~i~-~~~--------~--~ 214 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV----------SQMYDNIL-HKP--------L--Q 214 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH----------HHHHHHHh-cCC--------C--C
Confidence 6799999999999888999999999999999999999999965321 11111111 110 0 1
Q ss_pred CcHHHHHHHHHHHhhhhCCCCCCCCCHH
Q 047892 386 PSSRALKRALLVALRCVDPNAHKRPKMG 413 (442)
Q Consensus 386 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ 413 (442)
.+...+..+.+++.+||+.||.+||++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1112344577899999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=304.41 Aligned_cols=247 Identities=19% Similarity=0.275 Sum_probs=186.5
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46889999999999999999964 5889999998643 2234567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCC-------CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcc
Q 047892 234 EYVDNGNLEQWLHGDVG-------PHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAK 293 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~ 293 (442)
||++||+|.+++..... ....+++...+.++.|++.||+|||+. ++.++.+||+|||+++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 99999999999864211 123456777889999999999999875 3456789999999998
Q ss_pred ccCCCcc-----------------eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccc
Q 047892 294 LLGAERS-----------------YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQ 356 (442)
Q Consensus 294 ~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~ 356 (442)
....... ......+||+.|||||++.+..++.++|||||||++|||+||..||........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki-- 239 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI-- 239 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh--
Confidence 6521110 011235699999999999999999999999999999999999999965322111
Q ss_pred hhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCC-CHHHHHHHHhcC
Q 047892 357 FQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRP-KMGHVIHMLEAE 422 (442)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-s~~evl~~L~~~ 422 (442)
. .. . ....+ ....+....+..+.+++.+||+.||++|| +++++++.|+..
T Consensus 240 -----~---~~----~---~i~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 240 -----S---YR----D---VILSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred -----h---hh----h---hccCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 00 0 00000 00011123345677899999999999996 567777777664
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=270.64 Aligned_cols=227 Identities=22% Similarity=0.375 Sum_probs=173.2
Q ss_pred CeeccCCcEEEEEEEECC-------------CCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 164 NVIGEGGYGIVYRGVLED-------------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
+.||+|+||.||+|.+.. ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2358889876554455567888999999999999999999999999999
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCCC-------C-------CeEEeccc
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEPK-------W-------NPKLSDFG 290 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~~-------~-------~~kl~DFG 290 (442)
+||||+++|+|..++.+. ...+++..++.++.|+++||+|||+. ++++ + .+|++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998653 24689999999999999999999875 3332 2 28999999
Q ss_pred CccccCCCcceeecccccccCCCCccccc-CCCCCCcCCchhhHHHHHHHH-hCCCCCCCCCCCCccchhhhHHHHHHHH
Q 047892 291 LAKLLGAERSYVTTRVMGTFGYVAPEYAS-TGMLNETSDVYSFGILIMEVI-SGRNPVDYSRPPGEFQFQVNLFEWLKTM 368 (442)
Q Consensus 291 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~ell-tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 368 (442)
++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||......+. ...
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-----------~~~ 221 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-----------ERF 221 (262)
T ss_pred CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-----------HHH
Confidence 98754322 2345788999999886 466899999999999999998 48888864322110 011
Q ss_pred hhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHh
Q 047892 369 VTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420 (442)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 420 (442)
. .... . ........+.+|+.+||+.||.+||++.+|++.|+
T Consensus 222 ~-~~~~--------~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 222 Y-EGQC--------M--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred H-hcCc--------c--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 0000 0 00112346788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=273.25 Aligned_cols=240 Identities=23% Similarity=0.391 Sum_probs=185.8
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
++|++.+.||+|+||.||++... ++..||+|.+... .......+.+|+.++++++||||+++++++...+..|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35888999999999999999965 6899999988643 333456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC--------------CCCCCCeEEecccCccccCCCcce
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
+++++|..++.... ....+++..+..++.|++.||.|||.. ++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 99999999987531 124689999999999999999999953 3456789999999997653221
Q ss_pred eecccccccCCCCcccccCC------CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 302 VTTRVMGTFGYVAPEYASTG------MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||....... ....+.... ...
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~-~~~-- 226 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-------IFAQLSAIV-DGD-- 226 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-------HHHHHHHHh-hcC--
Confidence 2334688899999998544 35789999999999999999999996532211 111111111 100
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
....+...+..+.+++.+||+.||++||++.+++..
T Consensus 227 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 -------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111222356678889999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=281.44 Aligned_cols=242 Identities=18% Similarity=0.216 Sum_probs=181.5
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|.+.+.||+|+||.||++..+ +++.+|+|.+.... ......+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888999999999999999965 47889999985321 222345788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++|+|.+++.+. ...+++..+..++.|++.||.|||+. ++.++.+||+|||++..+.....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999999753 24688889999999999999999875 44578899999999976543333
Q ss_pred eeecccccccCCCCccccc-----CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 301 YVTTRVMGTFGYVAPEYAS-----TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
......+||+.|+|||++. ...++.++|||||||++|||++|+.||...... +.......... .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~----------~~~~~i~~~~~-~ 226 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV----------ETYGKIMNHKE-R 226 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH----------HHHHHHhCCCc-c
Confidence 3334457999999999986 346889999999999999999999999754321 11111111110 0
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCC--CCCHHHHHHH
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHK--RPKMGHVIHM 418 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~evl~~ 418 (442)
. .+. ......+..+.+|+.+|+..+++. |+++.++++.
T Consensus 227 ~----~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 F----QFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred c----cCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 001 111233556778888888654444 6889988765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=279.69 Aligned_cols=243 Identities=25% Similarity=0.419 Sum_probs=184.7
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCC----eEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNT----NVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
.++|+..+.||+|+||.||+|.+. ++. .||+|.+.... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 456888899999999999999853 344 47888876443 23344688999999999999999999998754 467
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+++||+++|+|.+++... ...+++..++.++.|++.||.|||.. ++.++.+||+|||+++.+..
T Consensus 85 ~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999998754 23578889999999999999999876 34567899999999987643
Q ss_pred Ccce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 298 ERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 298 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
.... ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..... ....+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-------~~~~~----~~~~~~~- 229 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-------REIPD----LLEKGER- 229 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHH----HHHCCCC-
Confidence 3221 1223345778999999988889999999999999999998 9999864321 11111 1111110
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
......++..+.+++.+||..||++||++.++++.|+.+.
T Consensus 230 --------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 230 --------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0011122345788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=270.84 Aligned_cols=237 Identities=26% Similarity=0.412 Sum_probs=176.5
Q ss_pred CeeccCCcEEEEEEEECC----CCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEE-eCCeeeeEEecCC
Q 047892 164 NVIGEGGYGIVYRGVLED----NTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCA-EGAHRMLVNEYVD 237 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~~lv~E~~~ 237 (442)
+.||+|+||.||+|.+.+ ...||+|.+... .......+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998532 357999988543 3344567889999999999999999999775 4556799999999
Q ss_pred CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce---
Q 047892 238 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY--- 301 (442)
Q Consensus 238 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~--- 301 (442)
+|+|.+++.+.. ....+...+.++.|++.||.|||+. ++.++.+||+|||+++.+......
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999997542 3457777889999999999999875 445678999999999865432211
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhC-CCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISG-RNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
......++..|+|||.+.+..++.++|||||||++|||++| .+||..... ....... ..+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----------~~~~~~~-~~~~------- 219 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS----------FDITVYL-LQGR------- 219 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH----------HHHHHHH-hcCC-------
Confidence 11233457789999999888899999999999999999994 566643221 1111111 1110
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....+...+..+.+++.+||+.||++||++.++++.|+++.
T Consensus 220 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 220 --RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 00111123456888999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=270.33 Aligned_cols=246 Identities=23% Similarity=0.318 Sum_probs=186.5
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG--AHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~ 233 (442)
++|+..+.||.|++|.||+|... +++.+|+|.+... .......+.+|+++++.++||||+++++++.+. +.+|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35778899999999999999964 5888999988643 234456789999999999999999999988653 4689999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++++|.+++.........++......++.|++.||.|||.. ++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL- 159 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-
Confidence 99999999998764332345688899999999999999999876 3456789999999987653221
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
.....++..|+|||.+.+..++.++|||||||++|||++|..||........ .......+... ... +
T Consensus 160 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~----~~~-----~ 226 (287)
T cd06621 160 --AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL--GPIELLSYIVN----MPN-----P 226 (287)
T ss_pred --cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC--ChHHHHHHHhc----CCc-----h
Confidence 1234578899999999888999999999999999999999999976533111 11112222111 000 0
Q ss_pred ccCCCCc--HHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 381 RLQEKPS--SRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 381 ~~~~~~~--~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.+..... ...+..+.+++.+||+.||.+|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 227 ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1111111 224567889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=268.57 Aligned_cols=240 Identities=22% Similarity=0.333 Sum_probs=174.4
Q ss_pred eeccCCcEEEEEEEECCC---CeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCCC
Q 047892 165 VIGEGGYGIVYRGVLEDN---TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGN 240 (442)
Q Consensus 165 ~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~ 240 (442)
.||+|+||.||+|...++ ..+++|.+.... ......+.+|+.+++.++||||+++++.+.+....|+||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999985333 345677665432 3445678999999999999999999999999999999999999999
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc-eeeccc
Q 047892 241 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS-YVTTRV 306 (442)
Q Consensus 241 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~-~~~~~~ 306 (442)
|.+++++........++.....++.|+++||.|||+. ++.++.+||+|||++........ ......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 161 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDK 161 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCC
Confidence 9999976433334567778889999999999999876 34567899999999864322211 122345
Q ss_pred ccccCCCCcccccC-------CCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 307 MGTFGYVAPEYAST-------GMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 307 ~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
.++..|+|||++.. ..++.++|||||||++|||++ |..||...... +........ ......
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----------~~~~~~~~~-~~~~~~ 230 (268)
T cd05086 162 CVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR----------EVLNHVIKD-QQVKLF 230 (268)
T ss_pred cCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH----------HHHHHHHhh-cccccC
Confidence 68899999998743 245789999999999999997 57787543221 111111111 111222
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHh
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 420 (442)
++.+... ....+.+++..|| .+|++||++++|++.|.
T Consensus 231 ~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3332222 3345777888999 68999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=290.66 Aligned_cols=261 Identities=20% Similarity=0.284 Sum_probs=180.3
Q ss_pred hhHHHhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCC------CCcceEEEEE
Q 047892 151 RELEVSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH------KNLVRLVGYC 223 (442)
Q Consensus 151 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~l~~~~ 223 (442)
+++....++|.+.+.||+|+||+||+|.. .+++.||||++.... .....+..|+.++..++| ++|+++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 34455678899999999999999999995 457889999985432 233445667777776654 4588899988
Q ss_pred EeC-CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------CCC-------CC------
Q 047892 224 AEG-AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------LEP-------KW------ 282 (442)
Q Consensus 224 ~~~-~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------l~~-------~~------ 282 (442)
... .+.|+|||++ +++|.+++.+. ..+++..+..++.|++.||.|||.+ |++ ++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccc
Confidence 754 5789999998 56899988754 4689999999999999999999962 222 22
Q ss_pred ----------CeEEecccCccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCC
Q 047892 283 ----------NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPP 352 (442)
Q Consensus 283 ----------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~ 352 (442)
.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||......
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 489999998864321 133568999999999999999999999999999999999999999765432
Q ss_pred CccchhhhHH-----HHHH--------HHhh-cCCcccccCcc-----cCC--CCcHHHHHHHHHHHhhhhCCCCCCCCC
Q 047892 353 GEFQFQVNLF-----EWLK--------TMVT-NGNAEGVLDPR-----LQE--KPSSRALKRALLVALRCVDPNAHKRPK 411 (442)
Q Consensus 353 ~~~~~~~~~~-----~~~~--------~~~~-~~~~~~~~~~~-----~~~--~~~~~~~~~~~~li~~cl~~dP~~RPs 411 (442)
+......... .|.. .... ........++. ... .........+.+|+.+||+.||++|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 1111000000 0000 0000 00000000000 000 000012345779999999999999999
Q ss_pred HHHHHH--HHhc
Q 047892 412 MGHVIH--MLEA 421 (442)
Q Consensus 412 ~~evl~--~L~~ 421 (442)
+.|+++ .+..
T Consensus 432 a~e~L~Hp~~~~ 443 (467)
T PTZ00284 432 ARQMTTHPYVLK 443 (467)
T ss_pred HHHHhcCccccc
Confidence 999996 3444
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=273.46 Aligned_cols=243 Identities=24% Similarity=0.413 Sum_probs=187.6
Q ss_pred hCCCCccCeeccCCcEEEEEEEECC-CC----eEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLED-NT----NVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
..+|.+.+.||+|+||.||+|.+.. +. .+|+|.+.... ......+.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 4568889999999999999998533 33 58999876543 3345678899999999999999999999887 7889
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+||||+++|+|.+++.+. ...+++..++.++.|++.||+|||+. ++.++.+||+|||+++.+..
T Consensus 85 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999999764 23589999999999999999999976 34567899999999987643
Q ss_pred Cccee-ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 298 ERSYV-TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 298 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
..... .....++..|+|||.+....++.++|||||||++||+++ |..||...... .+. .......
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~----~~~~~~~-- 228 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-------EIP----DLLEKGE-- 228 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH-------HHH----HHHhCCC--
Confidence 32221 112234578999999988889999999999999999999 99999654321 111 1111111
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....+..++..+.+++.+||..||.+|||+.++++.|+++.
T Consensus 229 -------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 229 -------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00111123345788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=268.61 Aligned_cols=236 Identities=19% Similarity=0.268 Sum_probs=181.4
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc-----hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--Cee
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR-----GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG--AHR 229 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~ 229 (442)
.+|++.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688899999999999999996 458899999885321 22345688899999999999999999988763 567
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~ 296 (442)
+++|||+++|+|.+++.+. ..+++...+.++.|++.||.|||+. +++++.+||+|||+++.+.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 8999999999999998754 3578888999999999999999976 4567899999999998653
Q ss_pred CCcc--eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 297 AERS--YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 297 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
.... .......|+..|+|||++.+..++.++|||||||++|||++|+.||...... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----------~~~~~~~~~--- 224 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----------AAIFKIATQ--- 224 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----------HHHHHHhcC---
Confidence 2211 1122346889999999998888999999999999999999999999643111 001111100
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
......+......+.+++.+||. +|++||+++|+++
T Consensus 225 ------~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 225 ------PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ------CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 01112233445667789999995 9999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=282.27 Aligned_cols=254 Identities=22% Similarity=0.256 Sum_probs=183.1
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG------ 226 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------ 226 (442)
..++|.+.+.||+|+||.||+|... .++.||||.+... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3467999999999999999999854 5889999998643 233445678899999999999999999988643
Q ss_pred CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcc
Q 047892 227 AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAK 293 (442)
Q Consensus 227 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~ 293 (442)
...|+||||+++ +|.+++.. .+++..+..++.|++.||.|||+. ++.++.+||+|||+++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 356999999976 78777753 378888999999999999999876 4457889999999998
Q ss_pred ccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhh------------hH
Q 047892 294 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQV------------NL 361 (442)
Q Consensus 294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~------------~~ 361 (442)
..... .......||..|+|||++.+..++.++|||||||++|||++|+.||......+...... ..
T Consensus 168 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 168 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 65332 22334578999999999998899999999999999999999999997643211110000 00
Q ss_pred HHHHHHHhhc-CCcccccCcc------cC--CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 362 FEWLKTMVTN-GNAEGVLDPR------LQ--EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 362 ~~~~~~~~~~-~~~~~~~~~~------~~--~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.......... ........+. .. ..........+.+|+.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000011000 0000000000 00 00111224567889999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=284.02 Aligned_cols=249 Identities=18% Similarity=0.206 Sum_probs=184.1
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC---CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE---DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
..+|.+.+.||+|+||.||+|... .+..||+|.+... ....+|+++|++++||||+++++++......|+||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 456999999999999999999853 3578999987543 23467999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
|++. ++|.+++... ..+++..++.++.|++.||.|||.. ++.++.+||+|||+++.+.....
T Consensus 166 e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 166 PKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred hhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 9997 5899998543 5789999999999999999999876 44567899999999986644322
Q ss_pred -eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC-------
Q 047892 301 -YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG------- 372 (442)
Q Consensus 301 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------- 372 (442)
.......||+.|+|||++.+..|+.++|||||||++|||++|+.||........... +...........
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQ---LRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHH---HHHHHHHhccCccccCCcc
Confidence 122346799999999999999999999999999999999999999976543321110 111110000000
Q ss_pred ---------CcccccCcccCCCC---cHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 373 ---------NAEGVLDPRLQEKP---SSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 373 ---------~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.+.....+...... ......++.+++.+||..||++|||+.|++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000000 01123457789999999999999999999875
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=272.66 Aligned_cols=239 Identities=24% Similarity=0.361 Sum_probs=180.3
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc-hhhHHHHHHHHHH-HHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEA-IGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+..|+.+ ++.++||||+++++++...+..|++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888999999999999999964 58999999986432 2334455566665 666799999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC--------------CCCCCCeEEecccCccccCCCcc
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
|++ |+|.+++.........+++..++.++.|++.||.|||++ ++.++.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 997 589888865433345789999999999999999999974 3457789999999998653321
Q ss_pred eeecccccccCCCCcccccC----CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 301 YVTTRVMGTFGYVAPEYAST----GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
......|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||...... .+........
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------~~~~~~~~~~----- 223 (283)
T cd06617 159 -AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---------FQQLKQVVEE----- 223 (283)
T ss_pred -ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC---------HHHHHHHHhc-----
Confidence 1233468899999998864 45788999999999999999999999642211 0111111110
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
..+. .+....+..+.+++.+||..||++|||+.++++
T Consensus 224 -~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 -PSPQ---LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -CCCC---CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011 111234566888999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=268.55 Aligned_cols=238 Identities=27% Similarity=0.494 Sum_probs=185.5
Q ss_pred CCccCeeccCCcEEEEEEEECC-----CCeEEEEEecCcchh-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 160 FADENVIGEGGYGIVYRGVLED-----NTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
+++.+.||.|+||.||+|.... +..||+|.+...... ..+.+..|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999999643 378999999654433 5677899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++++|.+++..... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++.......
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999975421 1289999999999999999999876 44566899999999987654433
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..... .. .....
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-------~~~~~---~~-~~~~~----- 222 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-------EEVLE---YL-KKGYR----- 222 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHH---HH-hcCCC-----
Confidence 22222346789999999988889999999999999999999 8888864221 11111 11 11110
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHML 419 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L 419 (442)
.......+..+.+++.+||+.||++|||+.|+++.|
T Consensus 223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 ----LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011122456688899999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=268.46 Aligned_cols=233 Identities=21% Similarity=0.334 Sum_probs=184.4
Q ss_pred CCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc-----hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 160 FADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR-----GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
|+..+.||+|+||.||+|... ++..|++|.+.... ....+.+.+|+.+++.++||||+++++++.+....|+++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 677789999999999999965 68999999885432 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++++|.+++.+. ..+++.....++.|++.||.|||.. ++.++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 82 ELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 999999999999764 4588999999999999999999875 4467889999999988754332
Q ss_pred eeecccccccCCCCcccccCCC-CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 301 YVTTRVMGTFGYVAPEYASTGM-LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
......|+..|+|||.+.... ++.++|+|||||++|+|++|..||...... ............
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~----------~~~~~~~~~~~~----- 220 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV----------AAVFKIGRSKEL----- 220 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH----------HHHHHHHhcccC-----
Confidence 233456889999999987766 899999999999999999999999653210 111111110100
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
...+......+.+++.+||+.||++||++.+++.
T Consensus 221 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 ----PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0111223456788999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=273.42 Aligned_cols=253 Identities=23% Similarity=0.369 Sum_probs=189.9
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-----CCCeEEEEEecCcchh-hHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCee
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-----DNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLVGYCAE--GAHR 229 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~ 229 (442)
..|.+.+.||+|+||.||+|.+. ++..+|||.+...... ....+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35778899999999999999853 3678999998654433 45679999999999999999999999877 5678
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~ 296 (442)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||.. ++.++.+||+|||++....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 99999999999999997642 3589999999999999999999876 4456789999999998765
Q ss_pred CCcce--eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCcc----chhhhHHHHHHHHhh
Q 047892 297 AERSY--VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEF----QFQVNLFEWLKTMVT 370 (442)
Q Consensus 297 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~ 370 (442)
..... ......++..|+|||.+.+..++.++|||||||++|||++|..||......... .........+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 33221 111234566799999998888999999999999999999999998643221100 000000111111111
Q ss_pred cCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 371 NGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.. .....+..++.++.+++.+||+.||++|||+.||+++|+.+
T Consensus 241 ~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EG---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cC---------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11 11111223346688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=268.72 Aligned_cols=239 Identities=24% Similarity=0.353 Sum_probs=187.9
Q ss_pred CCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeeeeEE
Q 047892 159 GFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE--GAHRMLVN 233 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~ 233 (442)
+|++.+.||.|+||.||++.. .+++.||+|.+... .....+.+..|++++++++||||+++++++.. +...|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999985 45789999988543 23445668889999999999999999998753 45679999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhh-----cC-------------CCCCCCeEEecccCcccc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-----EG-------------LEPKWNPKLSDFGLAKLL 295 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH-----~~-------------l~~~~~~kl~DFGla~~~ 295 (442)
||+++++|.+++.........+++..++.++.|++.||.||| .. ++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999764444467899999999999999999999 43 455689999999999876
Q ss_pred CCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 296 GAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
...... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ..... ....+.
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~----~~~~~~-- 226 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-------LQLAS----KIKEGK-- 226 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-------HHHHH----HHhcCC--
Confidence 543321 2345689999999999888899999999999999999999999975431 11111 111111
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
....+...+..+.+++.+||+.||++|||+.+|++.
T Consensus 227 -------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 -------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111223445678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=272.73 Aligned_cols=237 Identities=21% Similarity=0.315 Sum_probs=187.9
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
++|.+.+.||+|+||.||++.. .++..||+|.+........+.+.+|+.+++.++||||+++++++...+..|+|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5688899999999999999985 457889999986544445567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceee
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT 303 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~ 303 (442)
++|+|.+++.+. .+++..+..++.|++.||.|||+. ++.++.+||+|||++........ ..
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~ 172 (293)
T cd06647 99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 172 (293)
T ss_pred CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cc
Confidence 999999998653 478889999999999999999976 44567899999999876543322 12
Q ss_pred cccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccC
Q 047892 304 TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ 383 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (442)
....|++.|+|||.+.+..++.++|||||||++|+|++|..||.......... ..... ....
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~----------~~~~~--------~~~~ 234 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY----------LIATN--------GTPE 234 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee----------ehhcC--------CCCC
Confidence 33468899999999988889999999999999999999999997543321100 00000 0001
Q ss_pred CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 384 EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 384 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.......+..+.+++.+||+.||++||++.+++..
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122344567889999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=281.56 Aligned_cols=253 Identities=23% Similarity=0.264 Sum_probs=182.7
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------C
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG------A 227 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~ 227 (442)
.++|.+.+.||+|+||.||+|... .++.||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 467999999999999999999954 5889999998643 233445678899999999999999999987543 3
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKL 294 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~ 294 (442)
..|+||||+++ +|.+++.. .+++..+..++.|++.||.|||+. ++.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 57999999976 78887753 377888999999999999999875 45578999999999986
Q ss_pred cCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhh--------hHHH---
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQV--------NLFE--- 363 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~--------~~~~--- 363 (442)
..... ......||..|+|||++.+..++.++|||||||++|||++|+.||...+..+...... ....
T Consensus 176 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 176 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred cCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 53322 2334578999999999999999999999999999999999999997643221110000 0000
Q ss_pred -HHHHHhhcC-Cccc-----ccCccc---CCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 364 -WLKTMVTNG-NAEG-----VLDPRL---QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 364 -~~~~~~~~~-~~~~-----~~~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.......+. .... ...... ...........+.+|+.+||+.||.+|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000 0000 000000 000111223567889999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=274.11 Aligned_cols=184 Identities=20% Similarity=0.334 Sum_probs=146.4
Q ss_pred cCeeccCCcEEEEEEEEC---CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeeeeEEecCC
Q 047892 163 ENVIGEGGYGIVYRGVLE---DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE--GAHRMLVNEYVD 237 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~ 237 (442)
.++||+|+||.||+|... +++.||+|.+.... ....+.+|+.++++++||||+++++++.. ....|++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 467999999999999854 46789999885432 23456789999999999999999998854 456899999997
Q ss_pred CCCHHHHHccCC-----CCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-----------CCCCCeEEecccCcccc
Q 047892 238 NGNLEQWLHGDV-----GPHSPLTWEIRMNIILGTAKGLTYLHEG------L-----------EPKWNPKLSDFGLAKLL 295 (442)
Q Consensus 238 ~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-----------~~~~~~kl~DFGla~~~ 295 (442)
+ +|.+++.... .....+++..+..++.|++.||.|||+. + ..++.+||+|||+++..
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 5 8988875321 1123588999999999999999999876 2 23468999999999876
Q ss_pred CCCcc--eeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCC
Q 047892 296 GAERS--YVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYS 349 (442)
Q Consensus 296 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~ 349 (442)
..... .......||+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 43321 122345789999999998764 5899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=268.39 Aligned_cols=237 Identities=19% Similarity=0.315 Sum_probs=186.9
Q ss_pred CCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 159 GFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
+|++.+.||+|+||.||++.. .+++.||+|.+... .......+.+|+.++++++||||+++++++...+..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478889999999999999995 45889999998532 233446788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+.+++|.+++.... ...+++...+.++.|++.||.|||+. ++.++.++|+|||++........ .
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~ 157 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-L 157 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-h
Confidence 99999999986532 23578889999999999999999976 45577899999999986643321 1
Q ss_pred ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCccc
Q 047892 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (442)
.....|++.|+|||++.+..++.++|+|||||++|+|++|..||..... ......... +..
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~----------~~~~~~~~~-~~~-------- 218 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM----------KNLVLKIIR-GSY-------- 218 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH----------HHHHHHHhc-CCC--------
Confidence 2234688899999999888899999999999999999999999964321 111111111 110
Q ss_pred CCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 383 QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 383 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
...+...+..+.+++.+||+.+|++||++.+|++.
T Consensus 219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 -PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 01122345568889999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=270.33 Aligned_cols=242 Identities=29% Similarity=0.381 Sum_probs=185.1
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC------
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGA------ 227 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~------ 227 (442)
..++|++.+.||+|+||.||+|... +++.+++|.+.... .....+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 3567999999999999999999964 57889999886543 2346788999999999 7999999999997644
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKL 294 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~ 294 (442)
..|+||||+++++|.+++.........+++..+..++.|++.||.|||+. ++.++.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 48999999999999999875432335789999999999999999999976 45678899999999876
Q ss_pred cCCCcceeecccccccCCCCcccccC-----CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHh
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYAST-----GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMV 369 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 369 (442)
..... .......|+..|+|||.+.. ..++.++|||||||++|+|++|..||....... ... ...
T Consensus 163 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~----~~~ 231 (275)
T cd06608 163 LDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------ALF----KIP 231 (275)
T ss_pred cccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------HHH----Hhh
Confidence 53322 12234568999999998753 347789999999999999999999996432211 011 111
Q ss_pred hcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 370 TNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
... .+.+ ......+..+.+++.+||..||++|||+.++++
T Consensus 232 -~~~-----~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 -RNP-----PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -ccC-----CCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000 0011 112234567889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=266.61 Aligned_cols=243 Identities=25% Similarity=0.384 Sum_probs=189.5
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
++|++.+.||.|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++|+||+++++.+...+..|+||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36889999999999999999954 57889999885432 33556789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce-
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY- 301 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~- 301 (442)
+++++|.+++..... ...+++.....++.|++.||.|||+. +++++.+||+|||++..+......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 999999999975321 24688999999999999999999976 455788999999999876543222
Q ss_pred --eecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 302 --VTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 302 --~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
......|+..|+|||++... .++.++|+|||||++|||++|+.||........ .. ..... .
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~----~~~~~------~ 223 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV------LM----LTLQN------D 223 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh------HH----HHhcC------C
Confidence 12334689999999998776 789999999999999999999999975433211 11 11111 0
Q ss_pred CcccCCCC-cHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 379 DPRLQEKP-SSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 379 ~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.+.+.... ....+..+.+++.+||+.||++|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11111111 1244567889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=275.03 Aligned_cols=255 Identities=20% Similarity=0.288 Sum_probs=183.3
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
++|.+.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46889999999999999999964 5789999998543 223344677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++ +|.+++... ...+++..+..++.|++.||.|||+. ++.++.+||+|||++........ .
T Consensus 86 ~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 160 (301)
T cd07873 86 LDK-DLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T 160 (301)
T ss_pred ccc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-c
Confidence 985 999988654 24578899999999999999999986 44577899999999976533221 1
Q ss_pred ecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhH-----HHHHHHHhhcCCccc
Q 047892 303 TTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNL-----FEWLKTMVTNGNAEG 376 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 376 (442)
.....+++.|+|||++.+. .++.++|||||||++|||++|+.||......+........ ...............
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 2234578899999988654 4788999999999999999999999754321110000000 000000000000000
Q ss_pred ccCcccCC----CCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 377 VLDPRLQE----KPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 377 ~~~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
...+.... ......+..+.+|+.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00011100 011123456788999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=258.02 Aligned_cols=237 Identities=21% Similarity=0.304 Sum_probs=189.3
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc--------hhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR--------GQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGA 227 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 227 (442)
+.|.-.+.||.|..+.|-+|.. ++++.+|+|++.... ....+.-.+|+.+|+++ .||+|+++.++++.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 3477778999999999999884 568899999884221 11234456799999998 7999999999999999
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKL 294 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~ 294 (442)
.+++|+|.|+.|.|+++|... -.+++.....|++|+.+|++|||.. ++++.++||+|||++..
T Consensus 97 F~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeec
Confidence 999999999999999999765 5789999999999999999999865 45677999999999998
Q ss_pred cCCCcceeecccccccCCCCcccccC------CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHH
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYAST------GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTM 368 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 368 (442)
+.... .....||||+|+|||.+.. ..|+..+|+||+|||||-|+.|.+||.... .-.+..+
T Consensus 173 l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-----------QmlMLR~ 239 (411)
T KOG0599|consen 173 LEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-----------QMLMLRM 239 (411)
T ss_pred cCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-----------HHHHHHH
Confidence 75433 3566899999999998843 347889999999999999999999995311 1112233
Q ss_pred hhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 369 VTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
+..+++. +..+.-.+.+....+|+.+||+.||.+|.|++|+|.
T Consensus 240 ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 240 IMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 3344331 223334566777899999999999999999999985
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=269.71 Aligned_cols=234 Identities=27% Similarity=0.428 Sum_probs=183.0
Q ss_pred CCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCC
Q 047892 158 NGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVD 237 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 237 (442)
++|.+.+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.+++.++||||+++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688899999999999999985 67789999885432 345788999999999999999999998754 4799999999
Q ss_pred CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeec
Q 047892 238 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTT 304 (442)
Q Consensus 238 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~ 304 (442)
+|+|.+++.... ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++..... ..
T Consensus 82 ~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----~~ 155 (254)
T cd05083 82 KGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----VD 155 (254)
T ss_pred CCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc----CC
Confidence 999999997542 23578899999999999999999876 345678999999998764321 11
Q ss_pred ccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccC
Q 047892 305 RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ 383 (442)
Q Consensus 305 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (442)
....+..|+|||.+.+..++.++|+|||||++|||++ |..||...... ... .....+ ..
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~~~----~~~~~~---------~~ 215 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-------EVK----ECVEKG---------YR 215 (254)
T ss_pred CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-------HHH----HHHhCC---------CC
Confidence 2234568999999988899999999999999999998 99999653321 111 111111 11
Q ss_pred CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 384 EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 384 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
.......+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 216 MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11222345668889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=271.87 Aligned_cols=226 Identities=23% Similarity=0.384 Sum_probs=172.0
Q ss_pred eeccCCcEEEEEEEECC-------------------------CCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceE
Q 047892 165 VIGEGGYGIVYRGVLED-------------------------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 219 (442)
Q Consensus 165 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l 219 (442)
.||+|+||.||+|.+.. ...|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 13488898865444445678889999999999999999
Q ss_pred EEEEEeCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCCCC-----------
Q 047892 220 VGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEPKW----------- 282 (442)
Q Consensus 220 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~~~----------- 282 (442)
++++.+.+..++||||+++|+|..++.+. ...+++..++.++.|++.||+|||+. +++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999998653 24678999999999999999999876 33322
Q ss_pred ---CeEEecccCccccCCCcceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHH-hCCCCCCCCCCCCccch
Q 047892 283 ---NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVI-SGRNPVDYSRPPGEFQF 357 (442)
Q Consensus 283 ---~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~ell-tg~~Pf~~~~~~~~~~~ 357 (442)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||....+...
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--- 230 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--- 230 (274)
T ss_pred ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH---
Confidence 3799999988643221 12357888999998865 56899999999999999995 69999965432111
Q ss_pred hhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHh
Q 047892 358 QVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420 (442)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 420 (442)
..... .. ..... .....+.+++.+||+.||++|||+.+|++.|.
T Consensus 231 ----~~~~~----~~-------~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ----ERFYE----KK-------HRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ----HHHHH----hc-------cCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11110 00 00111 11235788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=273.31 Aligned_cols=250 Identities=25% Similarity=0.357 Sum_probs=187.9
Q ss_pred ehhhHHHhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 047892 149 TLRELEVSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEG 226 (442)
Q Consensus 149 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 226 (442)
.+.++....++|.+.+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +||||+++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 3445555678899999999999999999996 458899999885432 2345677899999998 899999999998653
Q ss_pred -----CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEec
Q 047892 227 -----AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSD 288 (442)
Q Consensus 227 -----~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~D 288 (442)
+..|+||||+++|+|.++++........+++..++.++.|++.||.|||.. ++.++.+||+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~d 171 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVD 171 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEee
Confidence 358999999999999999865333345689999999999999999999975 44567899999
Q ss_pred ccCccccCCCcceeecccccccCCCCcccccCC-----CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHH
Q 047892 289 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-----MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFE 363 (442)
Q Consensus 289 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~ 363 (442)
||+++.+..... ......|+..|+|||.+... .++.++|||||||++|||++|+.||....... ...
T Consensus 172 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~------~~~- 243 (291)
T cd06639 172 FGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK------TLF- 243 (291)
T ss_pred cccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH------HHH-
Confidence 999986543221 12334688999999988543 36889999999999999999999996532211 111
Q ss_pred HHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 364 WLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.... ... +.+. .+......+.+++.+||+.||++||++.++++.
T Consensus 244 ---~~~~-~~~-----~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 ---KIPR-NPP-----PTLL--HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ---HHhc-CCC-----CCCC--cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1110 100 0011 112234468889999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=272.19 Aligned_cols=255 Identities=20% Similarity=0.298 Sum_probs=184.8
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
++|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 35888899999999999999965 58899999885432 2234567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
|++++.|..++... ..+++..++.++.|++.||.|||.. ++.++.+||+|||++..+.....
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 99998888877543 4589999999999999999999975 44567899999999987644321
Q ss_pred eecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhh-h---HHHHHHHHhhcCCc-c
Q 047892 302 VTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQV-N---LFEWLKTMVTNGNA-E 375 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~-~---~~~~~~~~~~~~~~-~ 375 (442)
......++..|+|||.+.+ ..++.++|||||||++|||++|..||.+....+...... . .............. .
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 1223467889999999866 458899999999999999999999997544321110000 0 00000000000000 0
Q ss_pred cccCcccCCCC-----cHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 376 GVLDPRLQEKP-----SSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 376 ~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
....+...... ....+..+.+|+.+||+.||++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000000000 0123466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=267.15 Aligned_cols=239 Identities=21% Similarity=0.397 Sum_probs=185.7
Q ss_pred CCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc------hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 159 GFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR------GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
+|+..+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 377889999999999999985 568899999885322 1234678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCC-CeEEecccCccccCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKW-NPKLSDFGLAKLLGA 297 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~-~~kl~DFGla~~~~~ 297 (442)
||||+++++|.+++.+. ..+++.....++.|++.||.|||+. ++.++ .+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 99999999999999754 4688899999999999999999976 22343 589999999977643
Q ss_pred Ccc---eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 298 ERS---YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 298 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
... .......|+..|+|||.+.+..++.++||||+||++|+|++|..||........ ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~--- 226 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-------LALIFKIASA--- 226 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-------HHHHHHHhcc---
Confidence 211 112234688999999999888899999999999999999999999964332111 1111111000
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
......+...+.++.+++.+||..||++|||+.++++
T Consensus 227 ------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 ------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0111233345567888999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=274.38 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=184.7
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++..++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 35888899999999999999975 48899999875432 2234568889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
|+++++|..+.... ..+++..++.++.|++.||.|||+. ++.++.+||+|||++..+.....
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 81 FVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred cCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence 99999998877543 3589999999999999999999976 45678899999999987643322
Q ss_pred eecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHH-------HHHhhcCC
Q 047892 302 VTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWL-------KTMVTNGN 373 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~-------~~~~~~~~ 373 (442)
......++..|+|||.+.+ ..++.++|||||||++|||++|..||......+.. .....+. ........
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQL---YHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHH---HHHHHHhCCCchhhHHHhccch
Confidence 2234568899999998865 34788999999999999999999999644321100 0000000 00000000
Q ss_pred -cccccCcccCCC-----CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 374 -AEGVLDPRLQEK-----PSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 374 -~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
......+..... .....+..+.+++.+||+.||++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000000 01123566888999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=266.64 Aligned_cols=238 Identities=26% Similarity=0.385 Sum_probs=185.8
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcch--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
+|...+.||+|+||.||+|... +++.|++|.+..... ...+.+..|+.+++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 3778899999999999999964 688999999865433 3567789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++++|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999999754 3578889999999999999999976 4567789999999998764433221
Q ss_pred e---cccccccCCCCcccccCCC---CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 303 T---TRVMGTFGYVAPEYASTGM---LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 303 ~---~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
. ....++..|+|||++.+.. ++.++||||||+++|||++|..||....... ........ .
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~---------~~~~~~~~-~---- 222 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF---------QIMFHVGA-G---- 222 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH---------HHHHHHhc-C----
Confidence 1 1356788999999997766 8899999999999999999999996432110 00101100 0
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
..+.+. ........+.+++.+||+.||++|||+.+++.
T Consensus 223 -~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 -HKPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 011111 11123455778999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=273.26 Aligned_cols=243 Identities=22% Similarity=0.298 Sum_probs=186.8
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|.+.+.||+|+||.||++... .++.|++|.+.... ......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999964 47899999886442 223456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc-
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER- 299 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~- 299 (442)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999999764 4688999999999999999999876 4556789999999986421100
Q ss_pred -------------ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHH
Q 047892 300 -------------SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLK 366 (442)
Q Consensus 300 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 366 (442)
........|+..|+|||.+.+..++.++|||||||++|||++|..||...... +...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~----------~~~~ 226 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----------ELFG 226 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------HHHH
Confidence 00112345788999999998888999999999999999999999999643221 1111
Q ss_pred HHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 367 TMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
..... .. ..+. .....+..+.+++.+||+.||++||++.++++.|+..
T Consensus 227 ~~~~~-~~---~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 227 QVISD-DI---EWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred HHHhc-cc---CCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 11110 00 0000 1113445678899999999999999988888877764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=267.93 Aligned_cols=240 Identities=24% Similarity=0.363 Sum_probs=174.3
Q ss_pred eeccCCcEEEEEEEECC---CCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCCC
Q 047892 165 VIGEGGYGIVYRGVLED---NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGN 240 (442)
Q Consensus 165 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~ 240 (442)
.||+|+||.||+|...+ ...+++|.+.... ......+.+|+.+++.++||||+++++.+...+..|+||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997433 3468888775432 3344568899999999999999999999999999999999999999
Q ss_pred HHHHHccCCCC-CCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee-ecc
Q 047892 241 LEQWLHGDVGP-HSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV-TTR 305 (442)
Q Consensus 241 L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~-~~~ 305 (442)
|.+++...... ....++...+.++.|++.||+|||+. ++.++.+||+|||+++......... ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDC 161 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCC
Confidence 99999764321 23356778889999999999999876 4456789999999987543322211 122
Q ss_pred cccccCCCCcccccC-------CCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 306 VMGTFGYVAPEYAST-------GMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 306 ~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
..++..|+|||++.. ..++.++|||||||++|||++ |..||......+ ......... ....
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----------~~~~~~~~~-~~~~ 230 (269)
T cd05042 162 HAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ----------VLKQVVREQ-DIKL 230 (269)
T ss_pred CCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH----------HHHHHhhcc-CccC
Confidence 345778999998743 356789999999999999999 788886432211 111111111 1111
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHh
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 420 (442)
..+.+ ....+..+.+++..|| .||++|||+++|++.|.
T Consensus 231 ~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11211 2234455667888999 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=267.96 Aligned_cols=240 Identities=22% Similarity=0.329 Sum_probs=182.9
Q ss_pred CCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc----------hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 047892 160 FADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR----------GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAH 228 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 228 (442)
|...+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 67788999999999999985 458899999874321 1123457889999999999999999999999999
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLL 295 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~ 295 (442)
.++||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++..
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred eEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 99999999999999999765 4688899999999999999999976 445778999999999765
Q ss_pred CCCcc-eeecccccccCCCCcccccCCC--CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC
Q 047892 296 GAERS-YVTTRVMGTFGYVAPEYASTGM--LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372 (442)
Q Consensus 296 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (442)
..... .......|+..|+|||.+.... ++.++|+||||+++|||++|..||...... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----------~~~~~~~~~- 227 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----------AAMFKLGNK- 227 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH----------HHHHHhhcc-
Confidence 32211 1223456889999999987654 889999999999999999999999532211 101111111
Q ss_pred CcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
. ....+........+..+.+++.+||+.||++|||+.+|++.
T Consensus 228 ~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 R----SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred c----cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0 01111111122345678889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=266.55 Aligned_cols=237 Identities=20% Similarity=0.276 Sum_probs=184.5
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeeeeEEe
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE-GAHRMLVNE 234 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~E 234 (442)
+|++.+.||+|++|.||++... +++.||+|.+... .....+.+.+|++++++++||||+++++.+.. ....|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999954 4788999998543 23344568889999999999999999998764 446799999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
|+++++|.+++.... ...+++..+..++.|++.|+.|||+. ++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~- 157 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD- 157 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC-
Confidence 999999999997532 24589999999999999999999875 33456899999999987643222
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (442)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...+. ........ .+..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~----------~~~~~~~~-~~~~------- 219 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM----------NSLVYRII-EGKL------- 219 (257)
T ss_pred ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH----------HHHHHHHH-hcCC-------
Confidence 23345689999999999988899999999999999999999999964321 11111111 1111
Q ss_pred cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 382 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
...+...+..+.+++.+||+.||++|||+.++++.
T Consensus 220 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 --PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11223445678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=272.69 Aligned_cols=255 Identities=22% Similarity=0.297 Sum_probs=186.3
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
+|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5888999999999999999965 5889999988543 233446788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
++++.+..++.+. ..+++..+..++.|++.||.|||.. ++.++.+||+|||++..........
T Consensus 82 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 82 VERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 9987776665443 4588999999999999999999876 4567899999999998765443222
Q ss_pred ecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHH-----HHHHHHhhcCCccc
Q 047892 303 TTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF-----EWLKTMVTNGNAEG 376 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 376 (442)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||......+......... ..............
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 3345688999999999887 78999999999999999999999997543211100000000 00000000000000
Q ss_pred --ccCcc----cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 377 --VLDPR----LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 377 --~~~~~----~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
..... .....+...+.++.+++.+||+.||++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 000111123577889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=271.70 Aligned_cols=231 Identities=24% Similarity=0.309 Sum_probs=184.9
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|.+.+.||+|+||.||++... +++.||+|.+.... ......+.+|++++++++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888999999999999999964 58999999885432 233456888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++|+|.+++... ..++...+..++.|++.||.|||+. ++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999999764 5688999999999999999999975 456789999999999876433
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||...... ... .... .+. .
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~---~~~~-~~~------~ 215 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-------QIY---EKIL-EGK------V 215 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHH---HHHh-cCC------c
Confidence 23456899999999998888999999999999999999999999654311 011 1111 111 0
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCC-----CHHHHHH
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRP-----KMGHVIH 417 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 417 (442)
..+...+..+.+++.+||+.||.+|+ +++|+++
T Consensus 216 ----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 ----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11112245678899999999999999 7777763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=274.95 Aligned_cols=238 Identities=23% Similarity=0.265 Sum_probs=185.6
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcch---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
+|...+.||+|+||.||+|... +++.||+|.+..... ...+.+..|+++++.++||||+++++.+......|+|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5788899999999999999965 489999999865422 244568889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc-
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS- 300 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~- 300 (442)
|+.+++|.+++.+. ....+++.....++.|++.||.|||.. ++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 82 YCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred ecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 99999999998753 234689999999999999999999875 44577899999999875432111
Q ss_pred ---------------------------eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCC
Q 047892 301 ---------------------------YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPG 353 (442)
Q Consensus 301 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~ 353 (442)
.......||..|+|||++.+..++.++|||||||++|+|++|..||...+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 01123468899999999988889999999999999999999999997543211
Q ss_pred ccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCC----HHHHHH
Q 047892 354 EFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPK----MGHVIH 417 (442)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs----~~evl~ 417 (442)
. ..... ............+..+.+++.+||+.||++||| +.+++.
T Consensus 240 ~----------~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 240 T----------FSNIL---------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred H----------HHHHh---------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1 11111 001111111124567889999999999999999 777775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=267.85 Aligned_cols=233 Identities=22% Similarity=0.355 Sum_probs=184.4
Q ss_pred CCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCC
Q 047892 160 FADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVD 237 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 237 (442)
|+..+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.++++++||||+++++++..++..|+||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 67788999999999999985 458899999875432 3344668899999999999999999999999999999999999
Q ss_pred CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeec
Q 047892 238 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTT 304 (442)
Q Consensus 238 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~ 304 (442)
+|+|.+++.. ..+++.....++.|++.|+.|||.. ++.++.++|+|||++..+..... ...
T Consensus 86 ~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~ 159 (277)
T cd06641 86 GGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRN 159 (277)
T ss_pred CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-hhc
Confidence 9999999864 3578999999999999999999876 44567899999999876643221 123
Q ss_pred ccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCC
Q 047892 305 RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQE 384 (442)
Q Consensus 305 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (442)
...|+..|+|||.+.+..++.++|+|||||++|+|++|..||...... ...... .... ..
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----------~~~~~~-~~~~---------~~ 219 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM----------KVLFLI-PKNN---------PP 219 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH----------HHHHHH-hcCC---------CC
Confidence 346888999999998888999999999999999999999999643211 111111 1110 01
Q ss_pred CCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 385 KPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 385 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
......+..+.+++.+||+.||.+||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1122334567889999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=267.15 Aligned_cols=241 Identities=24% Similarity=0.366 Sum_probs=189.0
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
++|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778899999999999999965 58899999886543 34556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc-C-------------CCCCCCeEEecccCccccCCCcce
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-G-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
+++++|.+++.... ..+++.....++.|++.||+|||+ . ++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 99999999997542 568889999999999999999999 4 45578899999999876532221
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (442)
....++..|+|||.+.+..++.++|||||||++|+|++|..||........ ...+.+....... .
T Consensus 157 --~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~------~-- 221 (265)
T cd06605 157 --KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-----GIFELLQYIVNEP------P-- 221 (265)
T ss_pred --hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-----cHHHHHHHHhcCC------C--
Confidence 125788999999999888999999999999999999999999965422111 1112121111110 0
Q ss_pred cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 382 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
........+..+.+++.+||..||++|||+.+++..
T Consensus 222 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 222 -PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111111255668899999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=264.17 Aligned_cols=236 Identities=22% Similarity=0.368 Sum_probs=185.2
Q ss_pred CCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 159 GFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
+|+..+.||+|+||.||++.. .+++.+|+|.+... .......+.+|+++++.++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999995 45889999988543 233456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCC-CCCeEEecccCccccCCCcce
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEP-KWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~-~~~~kl~DFGla~~~~~~~~~ 301 (442)
+++++|.+++.... ...+++..++.++.|++.||.|||+. ++. ++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK- 157 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-
Confidence 99999999997532 23578999999999999999999976 222 34579999999987643321
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (442)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+... ....... ..
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~----------~~~~~~~-~~-------- 217 (256)
T cd08220 158 -AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA----------LVLKIMS-GT-------- 217 (256)
T ss_pred -ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH----------HHHHHHh-cC--------
Confidence 233568899999999988889999999999999999999999996543211 1111111 00
Q ss_pred cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 382 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
....+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 218 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 -FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 001112244568889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=271.44 Aligned_cols=227 Identities=21% Similarity=0.369 Sum_probs=172.8
Q ss_pred CeeccCCcEEEEEEEECC--------CCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 164 NVIGEGGYGIVYRGVLED--------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
+.||+|+||.||+|.... ...+++|.+........+.+..|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998532 234888887554445556788899999999999999999999998999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC-------CC--------CeEEecccCccc
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP-------KW--------NPKLSDFGLAKL 294 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-------~~--------~~kl~DFGla~~ 294 (442)
+++|+|.++++... ..+++..++.++.|++.||.|||+. +++ ++ .+|++|||++..
T Consensus 81 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999997642 3678999999999999999999875 333 22 269999999875
Q ss_pred cCCCcceeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCC-CCCCCCCCCCccchhhhHHHHHHHHhhcC
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGR-NPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (442)
.... ....++..|+|||++.+. .++.++|||||||++|||++|. .||....... ... .....
T Consensus 158 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-------~~~----~~~~~ 221 (258)
T cd05078 158 VLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-------KLQ----FYEDR 221 (258)
T ss_pred cCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-------HHH----HHHcc
Confidence 4322 234678899999999764 5889999999999999999984 5554322110 000 00000
Q ss_pred CcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHh
Q 047892 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420 (442)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 420 (442)
. ..+.....++.+++.+||+.||++|||++++++.|+
T Consensus 222 -------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 -------H----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -------c----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 111122345788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=266.90 Aligned_cols=235 Identities=25% Similarity=0.405 Sum_probs=184.0
Q ss_pred CCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc-chhhHHHHHHHHHHHHhcC---CCCcceEEEEEEeCCeeeeEE
Q 047892 159 GFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVR---HKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~ 233 (442)
.|+..+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.+++.++ ||||+++++++..+...|+||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 377788999999999999995 56889999988543 3344566888999999986 999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++++|.++++.. .+++...+.++.|++.||.|||.. ++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999999998643 688999999999999999999876 45578899999999987654332
Q ss_pred eeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 301 YVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
......|+..|+|||.+.++ .++.++|||||||++|+|++|..||........ .... . ....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~----------~~~~-~-----~~~~ 219 (277)
T cd06917 157 -KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA----------MMLI-P-----KSKP 219 (277)
T ss_pred -ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh----------hhcc-c-----cCCC
Confidence 22345689999999988654 478999999999999999999999975432111 0000 0 0011
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
+.+.. ...+..+.+++.+||+.||++||++.+++..
T Consensus 220 ~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 220 PRLED---NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 11111 1144568889999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=262.88 Aligned_cols=239 Identities=22% Similarity=0.387 Sum_probs=191.2
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcch-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
++|++.+.||+|++|.||+|... +++.|++|++..... .....+.+|+..+.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 35788899999999999999965 489999999865433 4557789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc-C-------------CCCCCCeEEecccCccccCCCcce
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-G-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
+++++|.+++... ..+++...+.++.|++.|+.|||. . ++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999999764 568999999999999999999998 5 556789999999999876433322
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (442)
.....++..|+|||.+.+..++.++||||||+++|||++|..||....... ..+...... ... .+
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-------~~~~~~~~~-~~~-----~~- 221 (264)
T cd06623 157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS-------FFELMQAIC-DGP-----PP- 221 (264)
T ss_pred -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC-------HHHHHHHHh-cCC-----CC-
Confidence 224467899999999988889999999999999999999999997553211 111111111 100 01
Q ss_pred cCCCCcHH-HHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 382 LQEKPSSR-ALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 382 ~~~~~~~~-~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
..... .+..+.+++.+||..+|++|||+.++++.
T Consensus 222 ---~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 ---SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11112 45678889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=267.48 Aligned_cols=249 Identities=21% Similarity=0.289 Sum_probs=185.7
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
+|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999964 58899999986443 33456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+ +++|.+++.... ..+++..++.++.|++.||.|||+. ++.++.++|+|||++..........
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 999999987542 5689999999999999999999876 4456789999999998765433222
Q ss_pred ecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC---------
Q 047892 303 TTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG--------- 372 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 372 (442)
.....|+..|+|||.+.+. .++.++||||+||++|||++|.+||........ ...........
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ-------LAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH-------HHHHHHHcCCCChHHHhhcc
Confidence 3345689999999988654 468999999999999999999888865432111 11111100000
Q ss_pred ---CcccccCcccCC----CCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 373 ---NAEGVLDPRLQE----KPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 373 ---~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.......+.... .........+.+++.+||+.||++|||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000 0001234678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=281.91 Aligned_cols=252 Identities=17% Similarity=0.211 Sum_probs=182.1
Q ss_pred hCCCCccCeeccCCcEEEEEEEECC-CCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
..+|.+.+.||+|+||.||+|.... ++.||||.... ..+.+|+++|++|+|||||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999999654 78899996422 2356799999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce-
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY- 301 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~- 301 (442)
+. ++|.+++... ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++.+......
T Consensus 242 ~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 242 YR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred cC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 96 6999988653 23689999999999999999999876 445678999999999876432221
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCC-CCCccchhhhHHHHHHHHhhc-CCccc---
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSR-PPGEFQFQVNLFEWLKTMVTN-GNAEG--- 376 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~--- 376 (442)
......||..|+|||++.+..++.++|||||||+||||++|..|+.... ..........+...+...... .....
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 2234579999999999999999999999999999999999877653322 111111111122211111000 00000
Q ss_pred -------------ccCcccCCCC---cHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 377 -------------VLDPRLQEKP---SSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 377 -------------~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
...+...... .......+.+|+.+||+.||.+|||+.|+|+.
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000000 01123457789999999999999999999874
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=281.58 Aligned_cols=250 Identities=21% Similarity=0.286 Sum_probs=179.0
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------C
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG------A 227 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~ 227 (442)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 36799999999999999999995 458899999986432 22345577899999999999999999987543 3
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKL 294 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~ 294 (442)
..|+++|++ +++|.++++. ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++.
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence 468999998 6699988754 3589999999999999999999876 34567899999999987
Q ss_pred cCCCcceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhH-----HHHHHHH
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNL-----FEWLKTM 368 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~-----~~~~~~~ 368 (442)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||............... .......
T Consensus 168 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 168 ADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred cCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 5432 234578999999999876 56899999999999999999999999754321110000000 0000000
Q ss_pred hhcCCcccccCcccCCCCc-------HHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 369 VTNGNAEGVLDPRLQEKPS-------SRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
........+. .+..... ......+.+|+.+||+.||++|||+.|+++.
T Consensus 244 -~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 244 -SSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred -chhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 0000000 0112346789999999999999999999954
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=280.63 Aligned_cols=227 Identities=21% Similarity=0.246 Sum_probs=170.8
Q ss_pred eccCCcEEEEEEEEC-CCCeEEEEEecCcch---hhHHHHHHHHHHHHhc---CCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 166 IGEGGYGIVYRGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRV---RHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 166 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
||+|+||.||+|+.. +++.||+|.+..... .....+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999964 589999999854221 2223345567776655 799999999999999999999999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecc
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTR 305 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~ 305 (442)
|+|.+++... ..+++..+..++.|++.||+|||+. ++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 155 (330)
T cd05586 81 GELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNT 155 (330)
T ss_pred ChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccC
Confidence 9999998754 4688999999999999999999876 4557889999999987543222 12344
Q ss_pred cccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCC
Q 047892 306 VMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQE 384 (442)
Q Consensus 306 ~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (442)
.+||+.|+|||++.+. .++.++|||||||++|||++|..||...... +.... ...+.. .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~----------~~~~~-i~~~~~------~~~- 217 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ----------QMYRN-IAFGKV------RFP- 217 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH----------HHHHH-HHcCCC------CCC-
Confidence 6799999999998764 4899999999999999999999999653221 11111 111111 111
Q ss_pred CCcHHHHHHHHHHHhhhhCCCCCCCCC----HHHHHH
Q 047892 385 KPSSRALKRALLVALRCVDPNAHKRPK----MGHVIH 417 (442)
Q Consensus 385 ~~~~~~~~~~~~li~~cl~~dP~~RPs----~~evl~ 417 (442)
....+..+.+++.+||+.||++||+ +.++++
T Consensus 218 --~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 --KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1123455778999999999999984 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=268.13 Aligned_cols=239 Identities=25% Similarity=0.420 Sum_probs=183.1
Q ss_pred CCccCeeccCCcEEEEEEEECC-CCeEEEEEecCcchhhH--HHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 160 FADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNRGQAE--KEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
|++.+.||+|+||.||++.... ++.||+|.+........ ....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5667899999999999999755 66899999966543322 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceee
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT 303 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~ 303 (442)
++++|.+++... ..+++..++.++.|++.||.|||+. ++.++.++|+|||.+..... .....
T Consensus 81 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENF 155 (260)
T ss_dssp TTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEB
T ss_pred cccccccccccc----cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccc
Confidence 999999999832 5789999999999999999999876 45578899999999976422 22234
Q ss_pred cccccccCCCCccccc-CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCccc
Q 047892 304 TRVMGTFGYVAPEYAS-TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (442)
....++..|+|||++. +..++.++||||+|+++|+|++|..||...... +............ .....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~-------~~~~~~~~~~~~~-----~~~~~ 223 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD-------DQLEIIEKILKRP-----LPSSS 223 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-------HHHHHHHHHHHTH-----HHHHT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccch-------hhhhhhhhccccc-----ccccc
Confidence 4567899999999998 788999999999999999999999999754110 1111111111000 00000
Q ss_pred CCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 383 QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 383 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.........+.+++.+||+.||++|||+.++++
T Consensus 224 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 --QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp --TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred --cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000011266888999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=271.61 Aligned_cols=248 Identities=19% Similarity=0.273 Sum_probs=180.6
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
+|++.+.||+|+||.||+|... +|+.||+|.+.... ......+.+|++++++++||||+++++++.+.+..|+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3778899999999999999964 58899999985432 22335677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++ +|.+++... ...+++..++.++.|++.||.|||.. ++.++.+||+|||+++....... .
T Consensus 81 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (284)
T cd07839 81 CDQ-DLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-C 155 (284)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-C
Confidence 985 888887653 24689999999999999999999976 45678899999999986543221 1
Q ss_pred ecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC--------
Q 047892 303 TTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN-------- 373 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 373 (442)
.....++..|+|||++.+. .++.++|||||||++|||+||..||........ ....+........
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD------QLKRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH------HHHHHHHHhCCCChHHhHHhh
Confidence 2334678899999998664 478999999999999999999888643322110 0010000000000
Q ss_pred -ccc-ccCcccCC-----CCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 374 -AEG-VLDPRLQE-----KPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 374 -~~~-~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
... ...+.... ......+.++.+++.+||+.||.+|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 00000000 011124566788999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=272.15 Aligned_cols=186 Identities=17% Similarity=0.194 Sum_probs=149.1
Q ss_pred ccCeeccC--CcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 162 DENVIGEG--GYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 162 ~~~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
+.++||+| +|++||++.. .+++.||+|.+... .......+.+|+++++.++||||+++++++..++..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7889999985 56899999998643 2334456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc-e-
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS-Y- 301 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~-~- 301 (442)
++|+|.+++.... ...+++..++.++.|++.||.|||+. ++.++.++++|||.......... .
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9999999996532 23588999999999999999999876 34467889999986544321110 0
Q ss_pred ----eecccccccCCCCcccccC--CCCCCcCCchhhHHHHHHHHhCCCCCCCC
Q 047892 302 ----VTTRVMGTFGYVAPEYAST--GMLNETSDVYSFGILIMEVISGRNPVDYS 349 (442)
Q Consensus 302 ----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~Pf~~~ 349 (442)
......++..|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 0122356788999999876 45899999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=270.44 Aligned_cols=235 Identities=24% Similarity=0.323 Sum_probs=184.3
Q ss_pred CCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 160 FADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
|.....||+|+||.||++.. .++..||||.+........+.+.+|+.+++.++||||+++++.+...+..|+||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 44456799999999999995 45889999998655555566788999999999999999999999999999999999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecc
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTR 305 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~ 305 (442)
++|.+++.. ..+++.....++.|++.||.|||+. ++.++.+||+|||++........ ....
T Consensus 104 ~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~ 177 (292)
T cd06658 104 GALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKS 177 (292)
T ss_pred CcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCce
Confidence 999998854 3578899999999999999999876 45678999999999876533222 1233
Q ss_pred cccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCC
Q 047892 306 VMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEK 385 (442)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (442)
..|+..|+|||.+.+..++.++|||||||++|||++|..||....... . +.... ....+.+..
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-------~---~~~~~------~~~~~~~~~- 240 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-------A---MRRIR------DNLPPRVKD- 240 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------H---HHHHH------hcCCCcccc-
Confidence 568999999999988889999999999999999999999996533211 1 11110 001111111
Q ss_pred CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 386 PSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 386 ~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
....+..+.+++.+||..||.+|||+.++++.
T Consensus 241 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 -SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11234457789999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=270.50 Aligned_cols=233 Identities=25% Similarity=0.321 Sum_probs=181.2
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
..|...+.||+|+||.||+|... +++.||+|.+... .......+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 44888899999999999999964 5889999988532 2233456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+.+ +|.+++... ...+++..+..++.|++.||.|||.. ++.++.+||+|||++......
T Consensus 95 e~~~g-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 95 EYCLG-SASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HhhCC-CHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 99984 887777543 24589999999999999999999976 345678999999998765322
Q ss_pred eeecccccccCCCCccccc---CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 301 YVTTRVMGTFGYVAPEYAS---TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
....++..|+|||++. ...++.++||||||+++|||++|..||...+... .........
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~----------~~~~~~~~~----- 230 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----------ALYHIAQND----- 230 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH----------HHHHHhcCC-----
Confidence 2346788999999874 4568899999999999999999999996432211 011111000
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.........+..+.+++.+||+.||++||++.+++..
T Consensus 231 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 231 ----SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ----CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0111122345678899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=263.46 Aligned_cols=225 Identities=24% Similarity=0.418 Sum_probs=172.7
Q ss_pred CeeccCCcEEEEEEEECCCC-----------eEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeE
Q 047892 164 NVIGEGGYGIVYRGVLEDNT-----------NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 232 (442)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999975422 4778876543332 6778899999999999999999999988 778999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC-------CC-------CeEEecccCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP-------KW-------NPKLSDFGLA 292 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-------~~-------~~kl~DFGla 292 (442)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||+. +++ ++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999997642 2688999999999999999999875 333 33 6999999999
Q ss_pred cccCCCcceeecccccccCCCCcccccCC--CCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHh
Q 047892 293 KLLGAERSYVTTRVMGTFGYVAPEYASTG--MLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMV 369 (442)
Q Consensus 293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 369 (442)
..... .....++..|+|||++.+. .++.++|||||||++|||++ |..||........ ..+. .
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-------~~~~---~ 220 (259)
T cd05037 156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-------ERFY---Q 220 (259)
T ss_pred ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-------HHHH---h
Confidence 87543 1223567789999999776 78999999999999999999 6778765432110 0000 0
Q ss_pred hcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHh
Q 047892 370 TNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420 (442)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 420 (442)
... ..... ....+.+++.+||+.||.+|||+.++++.|+
T Consensus 221 -~~~-------~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 -DQH-------RLPMP----DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -cCC-------CCCCC----CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 00000 0156888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=272.33 Aligned_cols=235 Identities=23% Similarity=0.320 Sum_probs=183.6
Q ss_pred CCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 160 FADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
|.....||+|+||.||+|... +++.||+|.+..........+.+|+.++..++||||+++++++..++..|+||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 444567999999999999954 5889999998654444456688999999999999999999999999999999999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecc
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTR 305 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~ 305 (442)
++|..++.. ..+++..++.++.|++.||.|||+. ++.++.+||+|||++..+..... ....
T Consensus 103 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~ 176 (297)
T cd06659 103 GALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKS 176 (297)
T ss_pred CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccc
Confidence 999998754 3578999999999999999999976 45678999999999876533221 2234
Q ss_pred cccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCC
Q 047892 306 VMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEK 385 (442)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (442)
..|+..|+|||++.+..++.++|||||||++|||++|+.||...... ..+.... ... .... .
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----------~~~~~~~-~~~-----~~~~--~ 238 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV----------QAMKRLR-DSP-----PPKL--K 238 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------HHHHHHh-ccC-----CCCc--c
Confidence 56899999999998888999999999999999999999999643221 1111110 000 0000 0
Q ss_pred CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 386 PSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 386 ~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.....+..+.+++.+||+.||++||++.++++.
T Consensus 239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 111233457789999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=268.59 Aligned_cols=183 Identities=20% Similarity=0.331 Sum_probs=145.4
Q ss_pred CeeccCCcEEEEEEEEC---CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeeeeEEecCCC
Q 047892 164 NVIGEGGYGIVYRGVLE---DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE--GAHRMLVNEYVDN 238 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~~ 238 (442)
..||+|+||.||+|... ++..||+|.+.... ....+.+|+++++.++||||+++++++.. ....|+||||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999964 35789999885432 23457789999999999999999998853 5678999999986
Q ss_pred CCHHHHHccCC-----CCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-----------CCCCCeEEecccCccccC
Q 047892 239 GNLEQWLHGDV-----GPHSPLTWEIRMNIILGTAKGLTYLHEG------L-----------EPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 239 g~L~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-----------~~~~~~kl~DFGla~~~~ 296 (442)
+|.+++.... .....+++..+..++.|++.||.|||+. + ..++.+||+|||+++...
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence 8888875321 1123588899999999999999999875 2 235689999999998764
Q ss_pred CCcce--eecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCC
Q 047892 297 AERSY--VTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYS 349 (442)
Q Consensus 297 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~ 349 (442)
..... ......||+.|+|||++.+. .++.++|||||||++|||+||++||...
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 33221 22345789999999998764 5889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=285.60 Aligned_cols=231 Identities=23% Similarity=0.364 Sum_probs=180.7
Q ss_pred CccCeeccCCcEEEEEEEEC-CCCeEEEEEec----CcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe--eeeEE
Q 047892 161 ADENVIGEGGYGIVYRGVLE-DNTNVAVKNLL----NNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAH--RMLVN 233 (442)
Q Consensus 161 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~--~~lv~ 233 (442)
+...+||+|+|-+||+|.+. +|..||--.++ .......+.|..|+++|+.|+|||||++|++|.+... +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34578999999999999964 47777643331 1234455789999999999999999999999987665 67999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC--------C--------CCCCCeEEecccCccccCC
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--------L--------EPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------l--------~~~~~~kl~DFGla~~~~~ 297 (442)
|++..|+|..|+++. ..++......+++||++||.|||++ + .+.|.|||+|+|||..+..
T Consensus 123 EL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 999999999999876 5788899999999999999999987 2 2357899999999998754
Q ss_pred CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
.. .....|||.|||||+.. ..|++.+||||||++|+||+|+..||.....+ ..+.+.+..+.....
T Consensus 199 s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~----------AQIYKKV~SGiKP~s 264 (632)
T KOG0584|consen 199 SH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP----------AQIYKKVTSGIKPAA 264 (632)
T ss_pred cc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH----------HHHHHHHHcCCCHHH
Confidence 43 23478999999999986 78999999999999999999999999754332 222333333322111
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
+ ..-...++.+||.+||.. ..+|||+.|+|+-
T Consensus 265 l--------~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 265 L--------SKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred h--------hccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 1 111134577899999999 9999999999853
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=263.28 Aligned_cols=229 Identities=23% Similarity=0.268 Sum_probs=180.9
Q ss_pred eccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCCCH
Q 047892 166 IGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNL 241 (442)
Q Consensus 166 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L 241 (442)
||.|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+++..|++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999964 48899999985432 23446788999999999999999999999999999999999999999
Q ss_pred HHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeeccccc
Q 047892 242 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMG 308 (442)
Q Consensus 242 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 308 (442)
.+++.+. ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++...... ......|
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 9999764 3588899999999999999999976 4567899999999998764432 2233568
Q ss_pred ccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcH
Q 047892 309 TFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSS 388 (442)
Q Consensus 309 t~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (442)
+..|+|||.+.+..++.++|+||||+++|||++|..||...... ............ .....+.
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~---------~~~~~~~ 217 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED--------PMEIYNDILKGN---------GKLEFPN 217 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC--------HHHHHHHHhccC---------CCCCCCc
Confidence 89999999998888999999999999999999999999754321 111111111100 0111122
Q ss_pred HHHHHHHHHHhhhhCCCCCCCCC-----HHHHHH
Q 047892 389 RALKRALLVALRCVDPNAHKRPK-----MGHVIH 417 (442)
Q Consensus 389 ~~~~~~~~li~~cl~~dP~~RPs-----~~evl~ 417 (442)
..+..+.+++.+||+.||++||+ +.|+++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 22567889999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=266.12 Aligned_cols=240 Identities=24% Similarity=0.329 Sum_probs=188.8
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
..+.|+..+.||+|+||.||+|... ++..|++|.+..... ....+.+|+++++.++|+||+++++++...+..|+|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 3455888899999999999999975 588999999865443 45678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
|+++++|.+++.... ..+++..+..++.|++.||.|||.. ++.++.+||+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 999999999998652 3789999999999999999999976 44567899999999876543221
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (442)
......++..|+|||.+.+..++.++|||||||++|+|++|..||...... ........ ....
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~----------~~~~~~~~-~~~~------ 234 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL----------RALFLITT-KGIP------ 234 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH----------HHHHHHHh-cCCC------
Confidence 122345788999999998888999999999999999999999999643221 00111111 0000
Q ss_pred cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 382 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
........+..+.+++.+||+.||.+|||+.++++.
T Consensus 235 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 235 -PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 011112244668889999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=267.01 Aligned_cols=249 Identities=20% Similarity=0.273 Sum_probs=180.7
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56889999999999999999965 58899999985432 22234567899999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+.+ +|.+++.+. ...+++.....++.|++.||.|||+. ++.++.+||+|||+++........
T Consensus 85 ~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~- 159 (291)
T cd07844 85 LDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT- 159 (291)
T ss_pred CCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc-
Confidence 985 999998754 23678899999999999999999976 456789999999998764322211
Q ss_pred ecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhc----------
Q 047892 303 TTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTN---------- 371 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---------- 371 (442)
.....++..|+|||++.+ ..++.++|||||||++|||++|..||........ ...........
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED------QLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH------HHHHHHHhcCCCChhhhhhhh
Confidence 122356889999998865 4588999999999999999999999965431110 00000000000
Q ss_pred --CCcccccC-----cccCCC-CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 372 --GNAEGVLD-----PRLQEK-PSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 372 --~~~~~~~~-----~~~~~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
........ ..+... ........+.+++.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000 000000 00011256778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=268.62 Aligned_cols=258 Identities=18% Similarity=0.261 Sum_probs=183.6
Q ss_pred CCCccCeeccCCcEEEEEEEEC---CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--Ceee
Q 047892 159 GFADENVIGEGGYGIVYRGVLE---DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG--AHRM 230 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~ 230 (442)
+|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+. +..|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3778889999999999999964 47899999986532 33345678899999999999999999999888 8899
Q ss_pred eEEecCCCCCHHHHHccCCCCC-CCCCHHHHHHHHHHHHHhhhhhhcC-------------CCC----CCCeEEecccCc
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPH-SPLTWEIRMNIILGTAKGLTYLHEG-------------LEP----KWNPKLSDFGLA 292 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~----~~~~kl~DFGla 292 (442)
+||||+++ +|.+++....... ..+++..+..++.|++.||.|||+. ++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999986 7877775432222 3688999999999999999999876 445 788999999999
Q ss_pred cccCCCcc--eeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCcc--chhhhHHHHHHH
Q 047892 293 KLLGAERS--YVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEF--QFQVNLFEWLKT 367 (442)
Q Consensus 293 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~--~~~~~~~~~~~~ 367 (442)
+....... .......++..|+|||++.+. .++.++|||||||++|||++|..||......... .........+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 87643322 122345678999999988664 5889999999999999999999999765433210 000011111101
Q ss_pred Hhhc------------CCccc----ccCcccCC-CCcH------HHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 368 MVTN------------GNAEG----VLDPRLQE-KPSS------RALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 368 ~~~~------------~~~~~----~~~~~~~~-~~~~------~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.... ..... ........ .... ..+..+.+++.+||+.||++|||+.|+++
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1000 00000 00000000 0000 23346888999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=269.50 Aligned_cols=252 Identities=22% Similarity=0.254 Sum_probs=184.1
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcch-----hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeE
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRG-----QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 232 (442)
+|.+.+.||+|+||.||+|... +++.||+|.+..... .....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677889999999999999964 588999999964432 2334577899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
|||+ +|+|.+++.... ..+++..++.++.|+++||.|||+. ++.++.+||+|||+++......
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 889999997642 3689999999999999999999876 4557789999999998764432
Q ss_pred ceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHH-----HHhhcCC
Q 047892 300 SYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLK-----TMVTNGN 373 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 373 (442)
. ......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||......+... ....... .......
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 157 R-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLG---KIFEALGTPTEENWPGVTS 232 (298)
T ss_pred c-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHH---HHHHHcCCCchhhhhhccc
Confidence 1 1223356788999998854 457899999999999999999988886543321110 0000000 0000000
Q ss_pred cccccCcccCCC-----CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 374 AEGVLDPRLQEK-----PSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 374 ~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
............ .....+..+.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000 112335678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=275.80 Aligned_cols=235 Identities=20% Similarity=0.271 Sum_probs=191.3
Q ss_pred hhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeE
Q 047892 156 STNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 232 (442)
....|.+...||+|.|++|.+|+. .++..||||.+.+. +......+.+|+++|+.|+|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 445689999999999999999994 46899999998654 334445588999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
|||+.+|.+++++.++ ....+..+..++.|+.+|++|||++ ++.+.++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-- 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY-- 207 (596)
T ss_pred EEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc--
Confidence 9999999999999876 4566688899999999999999987 55667899999999998753
Q ss_pred ceeecccccccCCCCcccccCCCCC-CcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLN-ETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
.....++||++.|.|||++.+..|+ +.+|+||+|++||-|+.|..||++..-.+.- ...+
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-------------------~rvl 268 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-------------------PRVL 268 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-------------------chhe
Confidence 3345678999999999999988875 7899999999999999999999875443220 1111
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
...++. +.-.+.++.+++.++|-.+|.+|++.+++.+
T Consensus 269 ~gk~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 269 RGKYRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eeeecc--cceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 122221 1223344667888999999999999999864
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=267.87 Aligned_cols=248 Identities=21% Similarity=0.294 Sum_probs=181.7
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
+|+..+.||.|+||.||+|... +++.||||.+.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999964 58899999885432 22335688899999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+. ++|..++.... ...+++..+..++.|++.||+|||+. ++.++.+||+|||+++.+......
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~- 156 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT- 156 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc-
Confidence 96 58999886532 34688999999999999999999876 456789999999998865432211
Q ss_pred ecccccccCCCCcccccCCC-CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC---------
Q 047892 303 TTRVMGTFGYVAPEYASTGM-LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG--------- 372 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 372 (442)
.....++..|+|||++.+.. ++.++|||||||++|||+||+.||........ ............
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ------LFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHHHhCCCChhhhhhhhH
Confidence 22345788999999886654 68899999999999999999999975432111 111110000000
Q ss_pred ------CcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 373 ------NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 373 ------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.........+. .........+.+++.+||+.||++|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 000122355778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=260.16 Aligned_cols=239 Identities=22% Similarity=0.345 Sum_probs=190.4
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
+|.+.+.||.|+||.||++... ++..|++|.+.... ......+.+|+++++.++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999964 58899999986542 24556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++++|.+++.........+++.....++.+++.||.|||.. +++++.+||+|||++....... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 159 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DL 159 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-ce
Confidence 999999999976533346789999999999999999999976 4456889999999998764432 22
Q ss_pred ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCccc
Q 047892 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (442)
.....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...... ...... ..... +
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----------~~~~~~-~~~~~-----~-- 221 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL----------ELALKI-LKGQY-----P-- 221 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH----------HHHHHH-hcCCC-----C--
Confidence 33457889999999998888999999999999999999999999654321 111111 11111 1
Q ss_pred CCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 383 QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 383 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
..+...+..+.+++.+||+.||++|||+.++++.
T Consensus 222 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 222 --PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111334568889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=263.50 Aligned_cols=243 Identities=23% Similarity=0.414 Sum_probs=182.6
Q ss_pred CCccCeeccCCcEEEEEEEEC----CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------
Q 047892 160 FADENVIGEGGYGIVYRGVLE----DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA------ 227 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------ 227 (442)
|.+.+.||+|+||.||+|.+. +++.||||.+... .....+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999853 3678999988643 2334567889999999999999999999886432
Q ss_pred eeeeEEecCCCCCHHHHHccCC--CCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDV--GPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLA 292 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla 292 (442)
..++++||+.+|+|.+++.... .....+++...+.++.|++.||+|||+. ++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 2478999999999998875321 1123578889999999999999999876 345678999999999
Q ss_pred cccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhh
Q 047892 293 KLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVT 370 (442)
Q Consensus 293 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 370 (442)
+........ ......++..|++||.+.+..++.++|||||||++|||++ |..||...... ....+. .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-------~~~~~~----~ 229 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-------EIYNYL----I 229 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-------HHHHHH----H
Confidence 876433221 1223345678999999988889999999999999999999 88998643221 111111 1
Q ss_pred cCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 371 NGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.... + ......+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 230 ~~~~-------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 KGNR-------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCc-------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1110 0 01122345688899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=256.68 Aligned_cols=236 Identities=25% Similarity=0.387 Sum_probs=188.4
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCC
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVD 237 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 237 (442)
+|...+.||+|++|.||++... ++..+++|++..........+.+|+++++.++||||+++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4777899999999999999975 588999999966554566788999999999999999999999999999999999999
Q ss_pred CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeec
Q 047892 238 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTT 304 (442)
Q Consensus 238 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~ 304 (442)
+++|.+++.... ..+++..+..++.|++.||.|||.. +++++.+||+|||.+........ ..
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 999999987542 4689999999999999999999985 45578899999999987654332 23
Q ss_pred ccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCC
Q 047892 305 RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQE 384 (442)
Q Consensus 305 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (442)
...|+..|+|||.+.+..++.++||||||+++|+|++|..||...... ........ .... .+.
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------~~~~~~~~-~~~~-----~~~- 218 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM----------KALFKIAT-NGPP-----GLR- 218 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH----------HHHHHHHh-cCCC-----CcC-
Confidence 456889999999998888999999999999999999999999653221 11111110 1110 011
Q ss_pred CCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 385 KPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 385 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.....+..+.+++.+||+.||++|||+.++++
T Consensus 219 -~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 219 -NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11112456888999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=264.63 Aligned_cols=234 Identities=24% Similarity=0.335 Sum_probs=184.3
Q ss_pred CCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 160 FADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
|...+.||+|++|.||++.. .+++.+++|.+........+.+.+|+.+++.++||||+++++++...+..|+++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 55567999999999999995 46889999988654445556688999999999999999999999999999999999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecc
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTR 305 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~ 305 (442)
++|.+++.. ..+++..+..++.|++.||.|||+. ++.++.+||+|||++........ ....
T Consensus 101 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 174 (285)
T cd06648 101 GALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKS 174 (285)
T ss_pred CCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cccc
Confidence 999999875 2578889999999999999999876 45577899999999876543221 1233
Q ss_pred cccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCC
Q 047892 306 VMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEK 385 (442)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (442)
..|+..|+|||.+.+..++.++|||||||++|||++|..||...... ........ .. .+....
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~----------~~~~~~~~-~~-----~~~~~~- 237 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL----------QAMKRIRD-NL-----PPKLKN- 237 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH----------HHHHHHHh-cC-----CCCCcc-
Confidence 56899999999998888999999999999999999999999653221 11111111 10 011111
Q ss_pred CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 386 PSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 386 ~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
....+..+.+++.+||+.||++|||+.++++
T Consensus 238 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 -LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1123456888999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=287.11 Aligned_cols=258 Identities=16% Similarity=0.231 Sum_probs=174.1
Q ss_pred hhCCCCccCeeccCCcEEEEEEEECC--CCeEEEEE--------------ec---CcchhhHHHHHHHHHHHHhcCCCCc
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLED--NTNVAVKN--------------LL---NNRGQAEKEFKVEVEAIGRVRHKNL 216 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~--------------~~---~~~~~~~~~~~~E~~~l~~l~hpnI 216 (442)
..++|++++.||+|+||+||+|..+. +...+.|. +. .........+.+|+.+|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35689999999999999999987532 22222221 10 1122234567899999999999999
Q ss_pred ceEEEEEEeCCeeeeEEecCCCCCHHHHHccCC-CCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCC
Q 047892 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDV-GPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKW 282 (442)
Q Consensus 217 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~ 282 (442)
+++++++...+..|+|+|++.+ +|.+++.... .............++.|++.||.|||+. ++.++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 9999999999999999999965 8888775431 1112234566778999999999999875 44577
Q ss_pred CeEEecccCccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCC-CCCCCCCCccchhhhH
Q 047892 283 NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNP-VDYSRPPGEFQFQVNL 361 (442)
Q Consensus 283 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~P-f~~~~~~~~~~~~~~~ 361 (442)
.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..+ |..... .........
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~-~~~~~~~~~ 383 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG-KPGKQLLKI 383 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC-CHHHHHHHH
Confidence 899999999987754433334456899999999999999999999999999999999998754 432221 111000000
Q ss_pred HHH--------------HHHHhhcCCcc---cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 362 FEW--------------LKTMVTNGNAE---GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 362 ~~~--------------~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
... +.......... ..+...+.. ......+.+++.+||+.||.+|||+.|++..
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRN---LGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHh---cCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 00000000000 000000000 0123346678899999999999999999864
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=263.46 Aligned_cols=255 Identities=20% Similarity=0.257 Sum_probs=183.3
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeeeeE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG--AHRMLV 232 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv 232 (442)
++|++.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.++++++||||+++++++... +..|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999975 58899999986432 22234567899999999999999999998877 889999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
|||+++ +|.+++.... ..+++...+.++.|++.||+|||+. ++.++.+||+|||+++......
T Consensus 85 ~e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999985 9999987542 3689999999999999999999976 4567889999999998765432
Q ss_pred ceeecccccccCCCCcccccCCC-CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhH--------HHHHHHHh-
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGM-LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNL--------FEWLKTMV- 369 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~- 369 (442)
.. .....+++.|+|||.+.+.. ++.++|||||||++|||++|..||............... +.......
T Consensus 161 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 KP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred cc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 11 22345788999999886544 689999999999999999999999754432111000000 00000000
Q ss_pred -hcCCcccccCcccCCCCcHH-HHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 370 -TNGNAEGVLDPRLQEKPSSR-ALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 370 -~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
............+....+.. .+..+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000000111111111 3556788999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=259.09 Aligned_cols=236 Identities=19% Similarity=0.278 Sum_probs=181.9
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc-----chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--Cee
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN-----RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG--AHR 229 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~ 229 (442)
.+|++.+.||+|+||.||+|.. .++..||+|.+... .......+.+|++++++++||||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999995 45889999987422 123345788999999999999999999998764 468
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~ 296 (442)
+++|||+++++|.+++... ..+++...+.++.|++.||.|||+. ++.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 8999999999999998754 3578888999999999999999976 4567889999999998653
Q ss_pred CCc--ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 297 AER--SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 297 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
... ........|+..|+|||++.+..++.++|||||||++|||++|+.||...... ..+......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------~~~~~~~~~--- 224 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM----------AAIFKIATQ--- 224 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH----------HHHHHHHcC---
Confidence 211 11123456889999999998888999999999999999999999999643211 111111100
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
......+...+..+.+++.+||+ +|..|||+.+++.
T Consensus 225 ------~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 225 ------PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ------CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 01112233455668889999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=265.83 Aligned_cols=243 Identities=26% Similarity=0.354 Sum_probs=180.6
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeeeEEe
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVR-HKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E 234 (442)
++|...+.||+|+||.||++... +++.||+|.+... .......+.+|+.++.++. ||||+++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35667788999999999999964 5899999998643 2344567889999999996 9999999999999999999999
Q ss_pred cCCCCCHHHHHccC-CCCCCCCCHHHHHHHHHHHHHhhhhhhcC--------------CCCCCCeEEecccCccccCCCc
Q 047892 235 YVDNGNLEQWLHGD-VGPHSPLTWEIRMNIILGTAKGLTYLHEG--------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 235 ~~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
|+.. +|.++.... ......+++.....++.|++.||+|||.. ++.++.+||+|||+++.+....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 9875 655543210 01125689999999999999999999853 3446789999999997654322
Q ss_pred ceeecccccccCCCCcccccCC---CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 300 SYVTTRVMGTFGYVAPEYASTG---MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
. .....|+..|+|||++.+. .++.++|||||||++|||++|+.||.... ...+.+..... .
T Consensus 163 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---------~~~~~~~~~~~-~---- 226 (288)
T cd06616 163 A--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---------SVFDQLTQVVK-G---- 226 (288)
T ss_pred c--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---------hHHHHHhhhcC-C----
Confidence 1 2334688999999999766 68999999999999999999999996432 11111111111 0
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
..+.+........+..+.+|+.+||+.||++|||+.+|++.
T Consensus 227 -~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 227 -DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11112222223455678899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=260.99 Aligned_cols=237 Identities=20% Similarity=0.344 Sum_probs=183.8
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
+|.+.+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|+.+++.++|+||+++++.+...+..|+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 3677899999999999999964 4888999988543 123445678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCC-CeEEecccCccccCCCcce
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKW-NPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~-~~kl~DFGla~~~~~~~~~ 301 (442)
+++++|.+++.... ...+++...+.++.|++.||.|||.. ++.++ .+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (257)
T cd08225 81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME- 157 (257)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-
Confidence 99999999997542 23578999999999999999999875 33343 469999999987643322
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (442)
......|++.|+|||++.+..++.++|+|||||++|||++|..||..... .+...... ... ..
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----------~~~~~~~~-~~~----~~-- 220 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL----------HQLVLKIC-QGY----FA-- 220 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHHHHh-ccc----CC--
Confidence 22334688999999999888899999999999999999999999964321 11111111 111 10
Q ss_pred cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 382 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
......+..+.+++.+||+.+|++|||+.++++.
T Consensus 221 ---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 ---PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111234568889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=263.13 Aligned_cols=234 Identities=20% Similarity=0.226 Sum_probs=186.2
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
+|.+.+.||.|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999965 58899999985432 2345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
|+.+++|.+++... ..+++..+..++.|+++||.|||.. ++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999999754 4688999999999999999999976 4567899999999988764332
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (442)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....... ...+......
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~---------- 216 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--------RDQIRAKQET---------- 216 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH--------HHHHHHHhcc----------
Confidence 1233568889999999988889999999999999999999999997654321 1111111110
Q ss_pred cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCH--HHHH
Q 047892 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKM--GHVI 416 (442)
Q Consensus 382 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~--~evl 416 (442)
.....+...+..+.+++.+||+.||.+||++ .|++
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0111222334678889999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=262.94 Aligned_cols=254 Identities=18% Similarity=0.199 Sum_probs=179.4
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
.++|.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++|+||+++++++..++..|+|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 35688999999999999999985 458899999985432 2223456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
|+. ++|.+++... ...+++..+..++.|++.||.|||+. ++.++.+||+|||+++........
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 84 YMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred ccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 996 6888877543 23577888889999999999999876 345678999999999764332211
Q ss_pred eecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHH--------HHHhhcC
Q 047892 302 VTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWL--------KTMVTNG 372 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~--------~~~~~~~ 372 (442)
.....+++.|+|||.+.+. .++.++|||||||++|||++|..||........ ......... .......
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 160 -YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred -CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHHHHHHcCCCChhhhhhhhhcc
Confidence 2234578999999998754 478899999999999999999999975432110 000000000 0000000
Q ss_pred Ccc-cccCcccCCC-----CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 373 NAE-GVLDPRLQEK-----PSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 373 ~~~-~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
... .......... ........+.+++.+|++.||.+|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000 0000000000 00011345778999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=267.11 Aligned_cols=233 Identities=25% Similarity=0.327 Sum_probs=180.5
Q ss_pred CCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 160 FADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
|...+.||+|+||.||++.. .++..||+|.+... .......+.+|+++++.++|||++++++++.+++..|+||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 67788999999999999995 45889999988533 223345688899999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+.+ +|.+++... ...+++..+..++.|++.||.|||.. ++.++.+||+|||++......
T Consensus 107 ~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CCC-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 975 888877543 24589999999999999999999876 334678999999998764322
Q ss_pred ecccccccCCCCccccc---CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 303 TTRVMGTFGYVAPEYAS---TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
....|+..|+|||.+. .+.++.++|||||||++|||++|..||...... ..........
T Consensus 179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----------~~~~~~~~~~------- 240 (317)
T cd06635 179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----------SALYHIAQNE------- 240 (317)
T ss_pred -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH----------HHHHHHHhcc-------
Confidence 2346888999999873 456889999999999999999999998643211 1111111111
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHh
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 420 (442)
.........+..+.+++.+||+.+|.+||++.++++.+-
T Consensus 241 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 241 --SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred --CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 011112234456888999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=262.17 Aligned_cols=247 Identities=23% Similarity=0.260 Sum_probs=182.9
Q ss_pred CCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeeeeEEe
Q 047892 160 FADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG--AHRMLVNE 234 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~E 234 (442)
|.+.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+++++.++||||+++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999965 48899999996542 33445688899999999999999999999887 88999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
|+++ +|.+++... ...+++..++.++.|++.||+|||.. ++.++.+||+|||++.........
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9985 999988654 24689999999999999999999976 456789999999999876544322
Q ss_pred eecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC---cc--
Q 047892 302 VTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN---AE-- 375 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-- 375 (442)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ...+........ ..
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-------LEKIFELCGSPTDENWPGV 229 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHHHHhCCCchhhcccc
Confidence 2233456888999998765 4588999999999999999999999975443211 111111000000 00
Q ss_pred -c-----------ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 376 -G-----------VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 376 -~-----------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
. .....+........+..+.+++.+||+.||.+||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 00000000000112567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=261.19 Aligned_cols=237 Identities=22% Similarity=0.286 Sum_probs=188.0
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
+|++.+.||+|+||.||++... +++.+++|.+... .......+.+|+++++.++||||+++++++......|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999854 5789999998543 233445678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++++|.+++.+.......+++..++.++.|++.||.|||+. ++.++.+||+|||++...... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---M 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---C
Confidence 999999999876433335689999999999999999999876 334568999999999876543 2
Q ss_pred ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCccc
Q 047892 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (442)
.....++..|+|||.+.+..++.++|+||||+++|||++|+.||...+.. .. .........
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-------~~----~~~~~~~~~-------- 218 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-------DL----RYKVQRGKY-------- 218 (256)
T ss_pred cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HH----HHHHhcCCC--------
Confidence 22346889999999998888999999999999999999999999654321 01 111111111
Q ss_pred CCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 383 QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 383 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
...+...+.++.+++.+||+.+|++|||+.++++.
T Consensus 219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 -PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11223456678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=255.54 Aligned_cols=237 Identities=23% Similarity=0.346 Sum_probs=188.7
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeeeeEE
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG--AHRMLVN 233 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~ 233 (442)
+|...+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+.++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3677889999999999999975 68899999885543 24567789999999999999999999999888 8899999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++++|.+++.+. ..+++..+..++.|++.||.|||+. +++++.+||+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 999999999999764 3789999999999999999999986 45578999999999987654432
Q ss_pred e-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 301 Y-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 301 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
. ......++..|+|||.+.+..++.++||||||+++|+|++|..||...... ........ .
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---------~~~~~~~~---------~ 218 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---------MAALYKIG---------S 218 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---------HHHHHhcc---------c
Confidence 1 123356889999999998888999999999999999999999999754310 11111110 0
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.......+...+..+.+++.+||+.||++||++.+++.
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 01111222233567888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=260.98 Aligned_cols=231 Identities=23% Similarity=0.260 Sum_probs=176.7
Q ss_pred eccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCCCH
Q 047892 166 IGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNL 241 (442)
Q Consensus 166 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L 241 (442)
||+|+||+||+|... +++.||+|.+.... ......+.+|+++++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 58899999885432 22334567899999999999999999999999999999999999999
Q ss_pred HHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeeccccc
Q 047892 242 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMG 308 (442)
Q Consensus 242 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 308 (442)
.+++.+... ..+++..++.++.|++.||.|||.. ++.++.+||+|||++....... ......+
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~ 156 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAG 156 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccccC
Confidence 999975421 3688999999999999999999976 4566789999999988654321 1233467
Q ss_pred ccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcH
Q 047892 309 TFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSS 388 (442)
Q Consensus 309 t~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (442)
+..|+|||.+.+..++.++|||||||++|+|++|+.||........ ...+...... .....+.
T Consensus 157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~----------~~~~~~~ 219 (277)
T cd05577 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-------KEELKRRTLE----------MAVEYPD 219 (277)
T ss_pred CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-------HHHHHhcccc----------ccccCCc
Confidence 8899999999888899999999999999999999999965432111 0001000000 0111122
Q ss_pred HHHHHHHHHHhhhhCCCCCCCC-----CHHHHHH
Q 047892 389 RALKRALLVALRCVDPNAHKRP-----KMGHVIH 417 (442)
Q Consensus 389 ~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 417 (442)
..+..+.+++.+||+.||.+|| ++.+++.
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 2355678899999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=261.19 Aligned_cols=243 Identities=23% Similarity=0.269 Sum_probs=186.3
Q ss_pred CCCccCeeccCCcEEEEEEEE----CCCCeEEEEEecCcc----hhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCee
Q 047892 159 GFADENVIGEGGYGIVYRGVL----EDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 229 (442)
+|.+.+.||+|+||.||++.. .++..||||.+.... ......+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367789999999999999984 246789999886432 22345678899999999 699999999999999999
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~ 296 (442)
|+||||+++|+|.+++... ..+++.....++.|++.||.|||.. ++.++.++|+|||+++.+.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 9999999999999998653 4588889999999999999999975 4457789999999998764
Q ss_pred CCcceeecccccccCCCCcccccCCC--CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 297 AERSYVTTRVMGTFGYVAPEYASTGM--LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 297 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
...........|+..|+|||.+.+.. .+.++||||||+++|||++|..||........ ...........
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~~~~~~~~~--- 227 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS------QSEISRRILKS--- 227 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch------HHHHHHHHHcc---
Confidence 44333333456899999999987655 78899999999999999999999964322111 01111111110
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.+ ..+...+..+.+++.+||+.||++|||+.++.+.|+..
T Consensus 228 ----~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 ----KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ----CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 00 11122345578899999999999999999988887765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=263.94 Aligned_cols=248 Identities=21% Similarity=0.295 Sum_probs=181.4
Q ss_pred CCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 160 FADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
|++.+.||.|++|.||+|... +|..||+|++.... ......+.+|+++++.++||||+++++++.+.+..|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999964 68999999885432 223356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceee
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT 303 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~ 303 (442)
+ ++|.+++.... ...+++..++.++.|++.||+|||+. ++.++.+||+|||+++........ .
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~ 156 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-Y 156 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-c
Confidence 6 59999987542 13689999999999999999999976 445789999999999765332211 1
Q ss_pred cccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC----------
Q 047892 304 TRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG---------- 372 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 372 (442)
....++..|+|||++.+. .++.++|||||||++|||++|+.||........ ............
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ------LFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHHHhCCCChHHhhhhhhc
Confidence 223568899999988654 578999999999999999999999975432111 111111000000
Q ss_pred -CcccccCcc---cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 373 -NAEGVLDPR---LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 373 -~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
......... .........+..+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 000111123356788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=267.74 Aligned_cols=253 Identities=23% Similarity=0.246 Sum_probs=183.3
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------C
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG------A 227 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~ 227 (442)
.++|+..+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.++++++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 46799999999999999999995 46899999998542 233445677899999999999999999988643 3
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKL 294 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~ 294 (442)
..|+||||+.+ +|.+++.. .++...+..++.|++.||+|||.. ++.++.+||+|||+++.
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred cEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 56999999975 89888753 278888999999999999999876 45678999999999987
Q ss_pred cCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhh--------hHHHH--
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQV--------NLFEW-- 364 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~--------~~~~~-- 364 (442)
..... ......++..|+|||++.+..++.++|||||||++|+|++|+.||...+......... .....
T Consensus 168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 168 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred CCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 64322 1234568899999999999999999999999999999999999997543211110000 00000
Q ss_pred --HHHHhhcCC------cccccCcc----cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 365 --LKTMVTNGN------AEGVLDPR----LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 365 --~~~~~~~~~------~~~~~~~~----~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
......... ........ .........+..+.+++.+||+.||++|||+.|++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 00000000 0011122345667899999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=258.64 Aligned_cols=232 Identities=21% Similarity=0.239 Sum_probs=175.0
Q ss_pred CeeccCCcEEEEEEEE-CCCCeEEEEEecCcch---hhHHHHHHHHHHH-HhcCCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 164 NVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRG---QAEKEFKVEVEAI-GRVRHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
+.||+|+||.||+|.. .+++.||+|.+..... .....+..|..++ ...+||||+++++++..++..|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999996 4588999999854321 1223344555544 455899999999999999999999999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecc
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTR 305 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~ 305 (442)
++|.++++.. ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++.... ...
T Consensus 82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 9999999754 4688999999999999999999976 45567899999999876432 223
Q ss_pred cccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCC
Q 047892 306 VMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEK 385 (442)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (442)
..|+..|+|||.+.+..++.++||||||+++|||++|..||...... ... .... .... .....
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~---~~~~-~~~~------~~~~~ 215 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------AVF---DNIL-SRRI------NWPEE 215 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------HHH---HHHH-hccc------CCCCc
Confidence 46889999999998888999999999999999999999999643221 111 1111 1100 01111
Q ss_pred CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 386 PSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 386 ~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
.....+..+.+++.+||+.||++|||+.++.+.|..
T Consensus 216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 112345668889999999999999988766665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=259.81 Aligned_cols=251 Identities=20% Similarity=0.223 Sum_probs=178.6
Q ss_pred CCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcC-CCCcceEEEEEEeC--CeeeeEEe
Q 047892 160 FADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVR-HKNLVRLVGYCAEG--AHRMLVNE 234 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~--~~~~lv~E 234 (442)
|++.+.||+|+||.||+|.. .+++.||+|.+.... ........+|+.++.++. ||||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56678899999999999995 458899999886432 222234457888898885 99999999999887 88999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
|+++ +|.+++... ...+++..++.++.|++.||.|||.. ++. +.+||+|||+++.+.....
T Consensus 81 ~~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 81 LMDM-NLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred cCCc-cHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 9975 888888653 24689999999999999999999876 344 7899999999987643322
Q ss_pred eecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhH-----HHHHHHHhhcCCcc
Q 047892 302 VTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNL-----FEWLKTMVTNGNAE 375 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 375 (442)
.....++..|+|||.+.. ..++.++|||||||++|||++|..||...+..+........ ..+. .........
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (282)
T cd07831 155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVL-KKFRKSRHM 232 (282)
T ss_pred -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHH-Hhhcccccc
Confidence 123467899999997644 55788999999999999999999999765432211100000 0000 000000000
Q ss_pred cc-cCcccCC---CCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 376 GV-LDPRLQE---KPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 376 ~~-~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.. ....... ......+..+.+++.+||+.||++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00 0000000 0012346778999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=261.59 Aligned_cols=256 Identities=20% Similarity=0.282 Sum_probs=183.9
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
+|+..+.||.|++|.||+|... ++..||||.+.... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999964 58899999986442 223456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceee
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT 303 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~ 303 (442)
++ +|.+++.... ....+++..+..++.|++.||.|||+. ++.++.+||+|||+++....... ..
T Consensus 81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (284)
T cd07836 81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TF 157 (284)
T ss_pred Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-cc
Confidence 85 8999886542 124689999999999999999999876 45678999999999976533221 12
Q ss_pred cccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHH-----HHHHHHhhcCCcccc
Q 047892 304 TRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF-----EWLKTMVTNGNAEGV 377 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 377 (442)
....++..|++||++.+. .++.++|||||||++|||++|..||...+..+......... ...............
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 234578899999988654 47889999999999999999999997654322111000000 000000000000000
Q ss_pred cCccc---CCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 378 LDPRL---QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 378 ~~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
..... ........+..+.+++.+||+.||.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 00011123456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=261.02 Aligned_cols=251 Identities=24% Similarity=0.279 Sum_probs=183.3
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA---- 227 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~---- 227 (442)
...++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45667999999999999999999975 48899999985432 233356778999999999999999999987654
Q ss_pred ------eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEec
Q 047892 228 ------HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSD 288 (442)
Q Consensus 228 ------~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~D 288 (442)
..|+|+||+++ +|..++... ...+++..++.++.|++.||+|||.. ++.++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999987 787777653 24689999999999999999999976 45677899999
Q ss_pred ccCccccCCCcceeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHH
Q 047892 289 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKT 367 (442)
Q Consensus 289 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 367 (442)
||++..+............++..|+|||.+.+. .++.++|||||||++|||++|+.||...+... ....+..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-------~~~~~~~ 232 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA-------QLELISR 232 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHHH
Confidence 999987644332222223567889999988653 57899999999999999999999997543211 1111111
Q ss_pred HhhcCC---cccc--------cC------cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 368 MVTNGN---AEGV--------LD------PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 368 ~~~~~~---~~~~--------~~------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
...... ...+ .+ ..... .....+..+.+++.+||+.||.+|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111000 0000 00 00000 01123466889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=266.35 Aligned_cols=250 Identities=23% Similarity=0.287 Sum_probs=181.4
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--Ceeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG--AHRML 231 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~l 231 (442)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 456899999999999999999964 58999999985432 22233466799999999999999999998755 56899
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
||||+.+ +|.+++... ...+++..+..++.|++.||.|||+. ++.++.+||+|||++......
T Consensus 86 v~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999975 898888653 24689999999999999999999876 445689999999999876433
Q ss_pred cceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC-----
Q 047892 299 RSYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG----- 372 (442)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----- 372 (442)
... .....++..|+|||.+.+ ..++.++|||||||++|||++|..||...+..... ..+.......
T Consensus 162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~-------~~~~~~~~~~~~~~~ 233 (309)
T cd07845 162 AKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQL-------DLIIQLLGTPNESIW 233 (309)
T ss_pred cCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHHhcCCCChhhc
Confidence 211 222345788999999865 45889999999999999999999999765432211 1111100000
Q ss_pred ------Cc-ccc-cCcccCCC---CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 373 ------NA-EGV-LDPRLQEK---PSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 373 ------~~-~~~-~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.. ... +....... .....+..+.+++.+||+.||++|||+.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 000 00000000 001135567889999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=259.96 Aligned_cols=233 Identities=22% Similarity=0.320 Sum_probs=181.1
Q ss_pred eccCCcEEEEEEEECC-CCeEEEEEecCcch---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCCCH
Q 047892 166 IGEGGYGIVYRGVLED-NTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNL 241 (442)
Q Consensus 166 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L 241 (442)
||.|+||.||++.... ++.+++|.+..... .....+.+|++++++++||||+++++.+..+...|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999754 89999999854432 3456688899999999999999999999999999999999999999
Q ss_pred HHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc-------e
Q 047892 242 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS-------Y 301 (442)
Q Consensus 242 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~-------~ 301 (442)
.+++.+. ..+++..+..++.|++.||.|||.. +++++.+||+|||++........ .
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 9999764 3689999999999999999999876 55678999999999876432211 1
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (442)
......++..|+|||.+....++.++||||||+++|||++|..||...... ........ +..
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----------~~~~~~~~-~~~------- 218 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE----------EIFQNILN-GKI------- 218 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----------HHHHHHhc-CCc-------
Confidence 223346788999999998888999999999999999999999999654321 11111111 110
Q ss_pred cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 382 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
........+..+.+++.+||+.||++|||+.++.+.|+.
T Consensus 219 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 219 -EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred -CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 000111125667889999999999999999666666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=261.63 Aligned_cols=251 Identities=20% Similarity=0.243 Sum_probs=180.5
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCe-----
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVR-HKNLVRLVGYCAEGAH----- 228 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~----- 228 (442)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 35888999999999999999964 58899999875432 223356788999999995 6999999999877665
Q ss_pred eeeEEecCCCCCHHHHHccCCCC-CCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCC-CCCeEEecccCcc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGP-HSPLTWEIRMNIILGTAKGLTYLHEG-------------LEP-KWNPKLSDFGLAK 293 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~-~~~~kl~DFGla~ 293 (442)
.|+||||+++ +|.+++...... ...+++..++.++.|++.||.|||+. ++. ++.+||+|||+++
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 7999999996 899988653222 34689999999999999999999976 344 6789999999998
Q ss_pred ccCCCcceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC
Q 047892 294 LLGAERSYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372 (442)
Q Consensus 294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (442)
....... ......+++.|+|||.+.+ ..++.++|||||||++|||++|..||........ ........ ...
T Consensus 160 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~------~~~~~~~~-~~~ 231 (295)
T cd07837 160 AFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ------LLHIFKLL-GTP 231 (295)
T ss_pred ecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHHHh-CCC
Confidence 6533221 1223356889999998865 4578999999999999999999999975433211 11101000 000
Q ss_pred Ccc---cc-------cCcccCC----CCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 373 NAE---GV-------LDPRLQE----KPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 373 ~~~---~~-------~~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
... .. ..+.... ......+..+.+++.+||+.||.+|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 00 0000000 001124566888999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=263.57 Aligned_cols=246 Identities=19% Similarity=0.269 Sum_probs=178.1
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-------
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA------- 227 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------- 227 (442)
++|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46889999999999999999964 58899999885432 222345668999999999999999999986553
Q ss_pred -eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcc
Q 047892 228 -HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAK 293 (442)
Q Consensus 228 -~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~ 293 (442)
..++||||+.+ +|.+++... ...+++..++.++.|++.||.|||+. ++.++.+||+|||++.
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 45999999975 888888653 23689999999999999999999976 4557889999999998
Q ss_pred ccCCCcce---eecccccccCCCCcccccCCC-CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHh
Q 047892 294 LLGAERSY---VTTRVMGTFGYVAPEYASTGM-LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMV 369 (442)
Q Consensus 294 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 369 (442)
........ ......++..|+|||.+.+.. ++.++||||||+++|||++|..||........ ...+....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~-------~~~~~~~~ 240 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ-------LTLISQLC 240 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHHHh
Confidence 66432211 122346788999999886654 78899999999999999999999975433111 11111110
Q ss_pred hc---------------------CCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 370 TN---------------------GNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 370 ~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.. ..........+. .......+.+++.+||..||++|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~---~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLK---PYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CCCChhhcccccchhhhhhccCCCccchhhHHhcc---cccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00 000000000000 0012345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=259.65 Aligned_cols=239 Identities=20% Similarity=0.268 Sum_probs=181.9
Q ss_pred CCCccCeeccCCcEEEEEEEE----CCCCeEEEEEecCcc----hhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCee
Q 047892 159 GFADENVIGEGGYGIVYRGVL----EDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 229 (442)
+|++.+.||+|+||.||+|.. .+|..||+|.+.... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 377889999999999999985 368899999986432 22345678899999999 699999999999999999
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~ 296 (442)
|+||||+++++|.+++... ..+++..+..++.|++.||.|||.. ++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 9999999999999999754 4578888999999999999999876 4567899999999998764
Q ss_pred CCcceeecccccccCCCCcccccCC--CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 297 AERSYVTTRVMGTFGYVAPEYASTG--MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 297 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
...........|+..|+|||.+... .++.++||||||+++|+|++|..||........ ...........
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~~~~~~~~~~--- 227 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS------QAEISRRILKS--- 227 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc------HHHHHHHhhcc---
Confidence 4332223345689999999998653 477899999999999999999999964332211 11111111110
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCC-----CHHHHHHH
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 418 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~~ 418 (442)
.+ ..+......+.+++.+||+.||++|| ++.+++..
T Consensus 228 ----~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 ----EP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ----CC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 00 11122345677899999999999997 66776653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=270.12 Aligned_cols=255 Identities=19% Similarity=0.309 Sum_probs=182.8
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeee
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE----GAHRM 230 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~ 230 (442)
++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++.. ....|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 5688899999999999999995 458999999986432 2344567789999999999999999998753 35689
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+||||+. |+|.+++... ..+++..+..++.|++.||.|||.. ++.++.+||+|||+++....
T Consensus 85 lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 9999996 5999998654 4589999999999999999999976 45678999999999976533
Q ss_pred Ccc---eeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHH-----HHHHHH
Q 047892 298 ERS---YVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF-----EWLKTM 368 (442)
Q Consensus 298 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~-----~~~~~~ 368 (442)
... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||................ ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 221 11234578899999998865 458899999999999999999999997643321110000000 000000
Q ss_pred hhcCCcccccCc-ccCCCC-----cHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 369 VTNGNAEGVLDP-RLQEKP-----SSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 369 ~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
........... ...... ....+..+.+++.+||+.||++|||+.+++..
T Consensus 240 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 240 -GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred -chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000000 000000 11235678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=263.93 Aligned_cols=232 Identities=22% Similarity=0.280 Sum_probs=185.8
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCe
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAH 228 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 228 (442)
.+...+|..+.+||+|+||+|.+|..+ +.+.+|||+++++- ....+--..|-++|... +-|.+++++.+|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 344567899999999999999999854 47789999986541 22233344577777655 57899999999999999
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLL 295 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~ 295 (442)
+|+||||+.||+|.-.|++- +.+.+..+..+|..|+-||-|||+. ++.+|++||+|||+++.-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeeEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999999999875 5677788899999999999999987 677899999999999852
Q ss_pred CCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 296 GAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
- -....+.++|||+.|+|||++...+|+..+|+|||||+||||+.|++||++.+..+.++. +.. .
T Consensus 501 i-~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~a-------I~e----h--- 565 (683)
T KOG0696|consen 501 I-FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQA-------IME----H--- 565 (683)
T ss_pred c-cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-------HHH----c---
Confidence 1 123346789999999999999999999999999999999999999999988765433221 111 1
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCC
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPK 411 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs 411 (442)
...++...+.+..+++...|...|.+|..
T Consensus 566 -------nvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 566 -------NVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -------cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 11345566777888999999999999954
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=258.82 Aligned_cols=229 Identities=19% Similarity=0.243 Sum_probs=171.6
Q ss_pred eeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHH---HhcCCCCcceEEEEEEeCCeeeeEEecCC
Q 047892 165 VIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAI---GRVRHKNLVRLVGYCAEGAHRMLVNEYVD 237 (442)
Q Consensus 165 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 237 (442)
.||+|+||.||++... +++.+|+|.+.... ......+.+|..++ ...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 58899999885432 11222334444333 34579999999999999999999999999
Q ss_pred CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeec
Q 047892 238 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTT 304 (442)
Q Consensus 238 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~ 304 (442)
+|+|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||++....... ..
T Consensus 81 ~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~ 153 (279)
T cd05633 81 GGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (279)
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---cc
Confidence 99999998754 4689999999999999999999876 3456789999999987653322 22
Q ss_pred ccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccC
Q 047892 305 RVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ 383 (442)
Q Consensus 305 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (442)
...|+..|+|||.+.+ ..++.++|||||||++|||++|..||........ ........ ...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------~~~~~~~~----------~~~ 215 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--------HEIDRMTL----------TVN 215 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--------HHHHHHhh----------cCC
Confidence 3468999999998864 5589999999999999999999999975432211 11111100 011
Q ss_pred CCCcHHHHHHHHHHHhhhhCCCCCCCC-----CHHHHHHH
Q 047892 384 EKPSSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 418 (442)
Q Consensus 384 ~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~~ 418 (442)
...+...+.++.+++.+||..||++|| |+.++++.
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 112233456688899999999999999 59888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=259.14 Aligned_cols=233 Identities=24% Similarity=0.323 Sum_probs=181.9
Q ss_pred ccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCCC
Q 047892 162 DENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGN 240 (442)
Q Consensus 162 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~ 240 (442)
....||+|+||.||++.. .+++.||+|++..........+.+|+.+++.++|+||+++++++...+..|+||||+++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 346799999999999986 4688999999865444556678899999999999999999999999999999999999999
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecccc
Q 047892 241 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVM 307 (442)
Q Consensus 241 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 307 (442)
|.+++.. ..+++.....++.|++.||+|||+. ++.++.++|+|||++........ ......
T Consensus 104 L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 177 (292)
T cd06657 104 LTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV 177 (292)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccc
Confidence 9998754 2578899999999999999999876 45677899999999876543221 123346
Q ss_pred cccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCc
Q 047892 308 GTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPS 387 (442)
Q Consensus 308 gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (442)
|+..|+|||.+.+..++.++|+|||||++|||++|..||...... ......... ....+.. .
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-------~~~~~~~~~---------~~~~~~~--~ 239 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMKMIRDN---------LPPKLKN--L 239 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhh---------CCcccCC--c
Confidence 889999999998888999999999999999999999999643221 011111100 0111111 1
Q ss_pred HHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 388 SRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 388 ~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
...+..+.+++.+||+.||.+||++.++++.
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 1233457789999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=265.16 Aligned_cols=244 Identities=22% Similarity=0.245 Sum_probs=195.7
Q ss_pred ehhhHHHhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcch---hhHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 047892 149 TLRELEVSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLVGYCA 224 (442)
Q Consensus 149 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 224 (442)
.++.+.+..+.|+.-++||+|+||.||-|+. .+|+.+|.|++.+..- .......+|-.+|.+++.+.||.+--.|+
T Consensus 176 ~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe 255 (591)
T KOG0986|consen 176 WLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE 255 (591)
T ss_pred HHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec
Confidence 3444667778899999999999999999994 5699999998854322 22344678999999999999999999999
Q ss_pred eCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccC
Q 047892 225 EGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGL 291 (442)
Q Consensus 225 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGl 291 (442)
..+.+|+||..|+||||.-+|.+... ..+++..++.++.+|+.||++||+. ++++|+++|+|+||
T Consensus 256 Tkd~LClVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGL 333 (591)
T KOG0986|consen 256 TKDALCLVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGL 333 (591)
T ss_pred CCCceEEEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccce
Confidence 99999999999999999988866422 4689999999999999999999986 67889999999999
Q ss_pred ccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhc
Q 047892 292 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTN 371 (442)
Q Consensus 292 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (442)
|..+...... ...+||.+|||||++.++.|+...|+|||||+||||+.|+.||...... .-.+.+..+...
T Consensus 334 Avei~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK-------vk~eEvdrr~~~ 404 (591)
T KOG0986|consen 334 AVEIPEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK-------VKREEVDRRTLE 404 (591)
T ss_pred EEecCCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh-------hhHHHHHHHHhc
Confidence 9988655433 3448999999999999999999999999999999999999999542211 011112222221
Q ss_pred CCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHH
Q 047892 372 GNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMG 413 (442)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ 413 (442)
. ....+...+++..+|+...|+.||.+|....
T Consensus 405 ~----------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 405 D----------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred c----------hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 1 2234566778888999999999999997544
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=270.76 Aligned_cols=258 Identities=21% Similarity=0.271 Sum_probs=184.3
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----Cee
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG-----AHR 229 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~ 229 (442)
++|.+.+.||+|+||.||+|.. .+++.||||.+... .......+.+|+.+++.++||||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 4588899999999999999995 45899999998543 223345677899999999999999999987644 357
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~ 296 (442)
|+|+||+. ++|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 99999997 5899998654 4689999999999999999999976 4567889999999998764
Q ss_pred CCcceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHH----HHHHhhc
Q 047892 297 AERSYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEW----LKTMVTN 371 (442)
Q Consensus 297 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~----~~~~~~~ 371 (442)
... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...+.............. .......
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 160 EKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred CCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 332 12234467889999998865 46889999999999999999999999754321111000000000 0000000
Q ss_pred CCccccc-------CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH--HhcC
Q 047892 372 GNAEGVL-------DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM--LEAE 422 (442)
Q Consensus 372 ~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~--L~~~ 422 (442)
......+ ..... ......+.++.+++.+||+.||++|||+.++++. +..+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000000 00000 0011345668899999999999999999999866 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=253.04 Aligned_cols=234 Identities=24% Similarity=0.401 Sum_probs=186.7
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcch--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
+|.+.+.||+|++|.||++... +++.|++|.+..... .....+.+|++++++++|||++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 3778899999999999999864 578999999865433 4556789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++++|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999999764 5689999999999999999999976 445678999999999876543321
Q ss_pred ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCccc
Q 047892 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (442)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||...... ........ ...
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----------~~~~~~~~-~~~-------- 216 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----------AALFRIVQ-DDH-------- 216 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----------HHHHHHhc-cCC--------
Confidence 23356889999999998877899999999999999999999999643210 00111111 000
Q ss_pred CCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 383 QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 383 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
...+...+..+.+++.+||..||++|||+.+++.
T Consensus 217 -~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 -PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1112233456788999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=258.20 Aligned_cols=247 Identities=22% Similarity=0.286 Sum_probs=180.2
Q ss_pred CCccCeeccCCcEEEEEEEECC-CCeEEEEEecCcc--hhhHHHHHHHHHHHHhc---CCCCcceEEEEEEeCCe-----
Q 047892 160 FADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNR--GQAEKEFKVEVEAIGRV---RHKNLVRLVGYCAEGAH----- 228 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~----- 228 (442)
|++.+.||+|+||.||+|.... ++.||+|.+.... ......+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999999754 8999999986332 22234566788777665 69999999999988776
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLL 295 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~ 295 (442)
.+++|||+.+ +|.+++.... ...+++..++.++.|++.||.|||+. ++.++.+||+|||++...
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 8999999985 8999887542 13589999999999999999999976 456788999999999876
Q ss_pred CCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc-
Q 047892 296 GAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA- 374 (442)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 374 (442)
..... .....++..|+|||.+.+..++.++|||||||++|||++|..||......+. ..............
T Consensus 158 ~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~ 229 (287)
T cd07838 158 SFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ------LDKIFDVIGLPSEEE 229 (287)
T ss_pred cCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH------HHHHHHHcCCCChHh
Confidence 43322 2234578899999999988999999999999999999999999975443211 11111110000000
Q ss_pred --------ccccCcccC---CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 375 --------EGVLDPRLQ---EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 375 --------~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
......... ..........+.+++.+||+.||++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000 0111234566788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=260.98 Aligned_cols=235 Identities=23% Similarity=0.313 Sum_probs=186.1
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc---chhhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeeeE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVR-HKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv 232 (442)
++|.+.+.||+|+||.||+|... +++.||+|.+... .......+.+|.+++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888999999999999999964 6899999988542 2233466888999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
|||+++++|.+++.+. ..+++..++.++.|++.||.|||+. +..++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 9999999999999764 4689999999999999999999976 4567899999999998764332
Q ss_pred c-------------------eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhh
Q 047892 300 S-------------------YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVN 360 (442)
Q Consensus 300 ~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~ 360 (442)
. .......|+..|+|||.+....++.++||||||+++|++++|..||...... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~ 229 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-------L 229 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-------H
Confidence 1 1223346789999999998888999999999999999999999999754311 0
Q ss_pred HHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCH----HHHHH
Q 047892 361 LFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKM----GHVIH 417 (442)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~----~evl~ 417 (442)
. ..... .. ....+...+..+.+++.+||+.||.+|||+ .++++
T Consensus 230 ~---~~~~~-~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 T---FQKIL-KL----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred H---HHHHH-hc----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1 11111 00 111122235568889999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=266.89 Aligned_cols=252 Identities=21% Similarity=0.311 Sum_probs=182.1
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----Ceee
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG-----AHRM 230 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~ 230 (442)
++|.+.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.++++++||||+++++++... ...|
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 5689999999999999999985 46889999998532 233445678899999999999999999987544 3579
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+|+||+.+ +|.+++.. ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++....
T Consensus 85 lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 85 IVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 99999985 89888754 3689999999999999999999876 45567899999999986543
Q ss_pred Ccce--eecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC--
Q 047892 298 ERSY--VTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG-- 372 (442)
Q Consensus 298 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-- 372 (442)
.... ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ...+.......
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~-------~~~~~~~~~~~~~ 231 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ-------LNLILGVLGTPSQ 231 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHHHcCCCCH
Confidence 2211 1123568999999998754 4688999999999999999999999965432110 11010000000
Q ss_pred ---------CcccccCc-ccCCC-----CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH--HhcC
Q 047892 373 ---------NAEGVLDP-RLQEK-----PSSRALKRALLVALRCVDPNAHKRPKMGHVIHM--LEAE 422 (442)
Q Consensus 373 ---------~~~~~~~~-~~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~--L~~~ 422 (442)
.....+.. ..... .....+.++.+++.+||+.||++|||+.|+++. +...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 00000000 00000 001234568899999999999999999999876 4443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=265.59 Aligned_cols=261 Identities=21% Similarity=0.285 Sum_probs=184.3
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC--Ceee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEG--AHRM 230 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~--~~~~ 230 (442)
.++|.+.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +||||+++++++... ...|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 456888999999999999999965 5889999988542 223345577899999999 999999999998643 4689
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+||||+++ +|.+++... .+.+.....++.|++.||.|||+. ++.++.+||+|||+++.+..
T Consensus 86 lv~e~~~~-~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 86 LVFEYMET-DLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEeccccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 99999985 999998653 578888899999999999999876 45678999999999986643
Q ss_pred Ccc----eeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhh--------HHHH
Q 047892 298 ERS----YVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVN--------LFEW 364 (442)
Q Consensus 298 ~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~--------~~~~ 364 (442)
... .......||..|+|||.+.+ ..++.++|||||||++|||++|+.||.............. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 322 12234568999999998755 4578899999999999999999999965433211100000 0000
Q ss_pred HHHHhhcCCcccccCcccC--CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH--HhcCC
Q 047892 365 LKTMVTNGNAEGVLDPRLQ--EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM--LEAEE 423 (442)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 423 (442)
+.................. .......+..+.+++.+||+.||++|||+.++++. ++...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 0000000000000000000 00011135678899999999999999999999964 54443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=258.31 Aligned_cols=238 Identities=17% Similarity=0.263 Sum_probs=181.0
Q ss_pred CCCccCeeccCCcEEEEEEEECC-CCeEEEEEecCc-----chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeE
Q 047892 159 GFADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNN-----RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 232 (442)
+|.+.+.||+|+||.||++.... +..+++|.++.. .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 37788999999999999998643 445555555321 222334567799999999999999999999988999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC------CCCCeEEecccCccccCCCcc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE------PKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~------~~~~~kl~DFGla~~~~~~~~ 300 (442)
|||+++++|.+++.........+++..++.++.|++.||.|||+. ++ .++.+||+|||+++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~~~~l~d~g~~~~~~~~~~ 160 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCD 160 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecCCEeecccCceeecCCCcc
Confidence 999999999999875333345789999999999999999999876 22 245799999999987643221
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ........ .+.
T Consensus 161 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~----------~~~~~~~~-~~~------- 221 (260)
T cd08222 161 -LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF----------LSVVLRIV-EGP------- 221 (260)
T ss_pred -cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHHHHH-cCC-------
Confidence 22345688899999999888899999999999999999999999964221 11111111 110
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
....+...+.++.+++.+||..||++||++.++++
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 --TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11123345567888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=261.04 Aligned_cols=233 Identities=24% Similarity=0.322 Sum_probs=179.1
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
.|...+.||+|+||.||+|... ++..+|+|.+... .......+.+|+++++.++|+|++++++++...+..|+|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3667788999999999999964 5788999988532 22334567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
|+. |+|.+++... ...+++..+..++.|++.||.|||.. ++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 96 YCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred ccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 997 5888877543 24578899999999999999999875 345678999999998765332
Q ss_pred eecccccccCCCCccccc---CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 302 VTTRVMGTFGYVAPEYAS---TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
....|+..|+|||.+. ...++.++|||||||++|||++|..||...... ......... .
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----------~~~~~~~~~-~----- 230 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----------SALYHIAQN-E----- 230 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH----------HHHHHHhhc-C-----
Confidence 2346889999999874 356888999999999999999999998543211 111111100 0
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHH
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHML 419 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L 419 (442)
.........+..+.+++.+||+.+|++||++.++++..
T Consensus 231 ---~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 231 ---SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred ---CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 01111223456678899999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=255.08 Aligned_cols=229 Identities=19% Similarity=0.263 Sum_probs=171.8
Q ss_pred eeccCCcEEEEEEEE-CCCCeEEEEEecCcch---hhHHHHHHHH---HHHHhcCCCCcceEEEEEEeCCeeeeEEecCC
Q 047892 165 VIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRG---QAEKEFKVEV---EAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVD 237 (442)
Q Consensus 165 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 237 (442)
.||+|+||.||+|.. .+++.||+|.+..... .....+..|. .+++..+||||+++++++...+..|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 4588999998854321 1112233343 34455689999999999999999999999999
Q ss_pred CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeec
Q 047892 238 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTT 304 (442)
Q Consensus 238 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~ 304 (442)
+|+|.+++... ..+++..++.++.|++.||.|||+. ++.++.+||+|||++..+.... ..
T Consensus 81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~ 153 (278)
T cd05606 81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (278)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---Cc
Confidence 99999998654 4689999999999999999999875 4457789999999987653322 22
Q ss_pred ccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccC
Q 047892 305 RVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ 383 (442)
Q Consensus 305 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (442)
...|+..|+|||++.++ .++.++||||+||++|||++|..||......... ........ ....+
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--------~~~~~~~~------~~~~~- 218 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--------EIDRMTLT------MAVEL- 218 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--------HHHHHhhc------cCCCC-
Confidence 34789999999998754 5899999999999999999999999754322110 00011000 01111
Q ss_pred CCCcHHHHHHHHHHHhhhhCCCCCCCC-----CHHHHHHH
Q 047892 384 EKPSSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 418 (442)
Q Consensus 384 ~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~~ 418 (442)
+...+..+.+++.+||..||.+|| ++.++++.
T Consensus 219 ---~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 219 ---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ---CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 112345688899999999999999 99999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-32 Score=259.86 Aligned_cols=231 Identities=25% Similarity=0.335 Sum_probs=177.6
Q ss_pred CCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 160 FADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
|...+.||+|+||.||+|.. .+++.|++|.+... .......+.+|+++++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 56677899999999999995 45889999998532 223345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+. |+|.+++... ...+++..++.++.|++.|+.|||.. +..++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 96 4888887643 24688999999999999999999876 34567899999999865322
Q ss_pred ecccccccCCCCccccc---CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 303 TTRVMGTFGYVAPEYAS---TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
.....|+..|+|||++. ...++.++|||||||++|||++|..||....... ......... .
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~----------~~~~~~~~~-~----- 237 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----------ALYHIAQND-S----- 237 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH----------HHHHHHhcC-C-----
Confidence 22356889999999984 4568899999999999999999999986543211 111111110 0
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
........+..+.+++.+||+.+|.+||++.+++..
T Consensus 238 ---~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 ---PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001112233457889999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=261.37 Aligned_cols=249 Identities=21% Similarity=0.307 Sum_probs=179.7
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
++|++.+.||+|++|.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999964 58899999885432 2334567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC--------CCCCeEEecccCccccCCCcc
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE--------PKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~--------~~~~~kl~DFGla~~~~~~~~ 300 (442)
|+++ +|.+++.... ...+++.....++.|++.||+|||+. ++ .++.+||+|||++........
T Consensus 82 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 82 YLDL-DLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred cccc-cHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 9975 8888876432 23467888889999999999999876 22 234689999999976533211
Q ss_pred eeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC------
Q 047892 301 YVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN------ 373 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 373 (442)
......+++.|+|||.+.+. .++.++|||||||++|+|+||..||......+. ...... ......
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~------~~~~~~-~~~~~~~~~~~~ 230 (294)
T PLN00009 159 -TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE------LFKIFR-ILGTPNEETWPG 230 (294)
T ss_pred -ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHH-HhCCCChhhccc
Confidence 12334678899999988664 578999999999999999999999975432211 111000 000000
Q ss_pred ---cccc--cCcccCCC----CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 374 ---AEGV--LDPRLQEK----PSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 374 ---~~~~--~~~~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.... ..+..... .....+..+.+++.+||+.||++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00000000 01123455788999999999999999999986
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=260.63 Aligned_cols=242 Identities=24% Similarity=0.399 Sum_probs=181.0
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEECC-CCeEEEEEecCcc-hhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeee
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~ 230 (442)
.+..++|++.+.||+|+||.||+|.+.. ++.||||.+.... ......+.+|+.++.++ .||||+++++++......|
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 3445678999999999999999999765 8899999986432 23345566778777666 5999999999999999999
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC--------------CCCCCCeEEecccCccccC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--------------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------------l~~~~~~kl~DFGla~~~~ 296 (442)
++|||+.+ +|.+++... ...+++..+..++.|++.||+|||.. ++.++.+||+|||++..+.
T Consensus 91 ~v~e~~~~-~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 91 ICMELMST-CLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred EEeeccCc-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99999865 787777543 24688999999999999999999963 3457789999999997654
Q ss_pred CCcceeecccccccCCCCcccccCCC----CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC
Q 047892 297 AERSYVTTRVMGTFGYVAPEYASTGM----LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372 (442)
Q Consensus 297 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (442)
.... .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... .+.........
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------~~~~~~~~~~~ 235 (296)
T cd06618 167 DSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---------FEVLTKILQEE 235 (296)
T ss_pred CCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH---------HHHHHHHhcCC
Confidence 3222 12335788999999987553 788999999999999999999999642110 11111111111
Q ss_pred CcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
. +... .....+.++.+++.+||+.||++||++.+++..
T Consensus 236 -~-----~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 236 -P-----PSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -C-----CCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0011 111234568889999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=260.83 Aligned_cols=248 Identities=21% Similarity=0.298 Sum_probs=185.7
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-----eee
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA-----HRM 230 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~ 230 (442)
+|.+.+.||.|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999964 48899999986543 344567889999999999999999999987765 789
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+||||+++ +|.+++.+. ..+++..++.++.|++.||.|||+. ++.++.++|+|||++.....
T Consensus 81 lv~e~~~~-~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELMET-DLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchhh-hHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 99999985 899998754 3789999999999999999999876 45678999999999987644
Q ss_pred Ccc--eeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhh----
Q 047892 298 ERS--YVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVT---- 370 (442)
Q Consensus 298 ~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---- 370 (442)
... .......++..|+|||.+.+. .++.++|||||||++|+|++|..||......... ..+.....
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~-------~~i~~~~~~~~~ 228 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL-------NLIVEVLGTPSE 228 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH-------HHHHHhcCCCCh
Confidence 321 112344678899999999887 7899999999999999999999999765432111 00000000
Q ss_pred -------cCCcccccC---cccCC---CCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 371 -------NGNAEGVLD---PRLQE---KPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 371 -------~~~~~~~~~---~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.......+. ..... ......+..+.+++.+||+.||++|||+.+++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000000 00000 0011235668889999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=258.69 Aligned_cols=246 Identities=22% Similarity=0.274 Sum_probs=184.4
Q ss_pred CCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcch--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 160 FADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
|.+.+.||+|++|.||+|... +++.+++|.+..... .....+.+|++++++++||||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 556788999999999999964 688999998854322 34567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceee
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT 303 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~ 303 (442)
++ +|.+++... ...+++..++.++.|++.||.|||.. ++.++.+||+|||.+........ ..
T Consensus 81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-~~ 155 (283)
T cd05118 81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PY 155 (283)
T ss_pred CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-cc
Confidence 86 898888653 24689999999999999999999976 45578899999999987654331 12
Q ss_pred cccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC---CcccccC
Q 047892 304 TRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG---NAEGVLD 379 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 379 (442)
....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+... ......... .......
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF-------KIFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHHHcCCCchHhcccchh
Confidence 234578899999998776 68999999999999999999999997544321110 000000000 0000000
Q ss_pred ---------cccC----CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 380 ---------PRLQ----EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 380 ---------~~~~----~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
+... .......+.++.+++.+||+.||.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0111235677889999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=262.11 Aligned_cols=252 Identities=21% Similarity=0.320 Sum_probs=181.0
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeeee
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE-GAHRML 231 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~l 231 (442)
..++|.+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+++++.++||||+++++++.. ....|+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 4677999999999999999999954 6899999988532 22344667889999999999999999999865 567899
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
||||+. ++|.++++.. .++......++.|++.||.|||+. ++.++.+||+|||++......
T Consensus 88 v~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 88 VTELLG-TDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred Eeehhc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 999995 5999888643 577888889999999999999976 345678999999999764322
Q ss_pred cceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhH-----HHHHHHHhhcC
Q 047892 299 RSYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNL-----FEWLKTMVTNG 372 (442)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 372 (442)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........+....+. .++........
T Consensus 162 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 162 ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred ----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 223467889999998765 56899999999999999999999999754321111000000 00000000000
Q ss_pred CcccccCc-ccCCCCc-----HHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 373 NAEGVLDP-RLQEKPS-----SRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 373 ~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
. ..++.. ......+ ...+..+.+++.+||+.||++|||+.+++..
T Consensus 238 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 238 T-LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred h-HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000000 0000000 1234668889999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=251.47 Aligned_cols=231 Identities=19% Similarity=0.207 Sum_probs=173.1
Q ss_pred hhCCCCccCee--ccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeee
Q 047892 156 STNGFADENVI--GEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 156 ~~~~~~~~~~l--G~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 231 (442)
..++|.+.+.+ |+|+||.||++.. .++..+|+|.+........ |+.....+ +||||+++++.+...+..|+
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34567776666 9999999999995 4578899998854321111 22222222 79999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCC-CeEEecccCccccCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKW-NPKLSDFGLAKLLGA 297 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~-~~kl~DFGla~~~~~ 297 (442)
||||+++|+|.++++.. ..+++..+..++.|+++||.|||+. ++.++ .++|+|||+++....
T Consensus 87 v~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 99999999999999764 3789999999999999999999876 33445 899999999986543
Q ss_pred CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
. ....|+..|+|||++.+..++.++|||||||++|||++|..||........ ....+.... ..
T Consensus 163 ~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~--~~----- 225 (267)
T PHA03390 163 P-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-----DLESLLKRQ--QK----- 225 (267)
T ss_pred C-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-----hHHHHHHhh--cc-----
Confidence 2 224688999999999988999999999999999999999999974332110 111111111 00
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCC-HHHHHH
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPK-MGHVIH 417 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-~~evl~ 417 (442)
........+..+.+++.+||+.||.+||+ ++++++
T Consensus 226 -----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 -----KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -----cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00111245566888999999999999996 688874
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=256.95 Aligned_cols=254 Identities=20% Similarity=0.252 Sum_probs=181.8
Q ss_pred CCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcch-hhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeeeEEecC
Q 047892 160 FADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVR-HKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
|.+.+.||+|+||.||+|... +++.|++|.+..... .......+|+..+++++ ||||+++++++.+++..|+||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999975 478899998854322 23334567999999999 999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceee
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT 303 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~ 303 (442)
+|+|.+++.... ...+++..++.++.|++.+|.|||+. ++.++.++|+|||++........ .
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 155 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--Y 155 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--c
Confidence 779999987642 24689999999999999999999976 44567999999999987643222 2
Q ss_pred cccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhH------HHHHHHHhhcCCccc
Q 047892 304 TRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNL------FEWLKTMVTNGNAEG 376 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~ 376 (442)
....++..|+|||++.. ..++.++|+||||+++|||++|+.||......+........ ..|............
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 23467889999998854 45789999999999999999999999765432221100000 001000000000000
Q ss_pred ccCcccCCC---CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 377 VLDPRLQEK---PSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 377 ~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.+....... ........+.+++.+||+.||++|||+.|++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000 001124568899999999999999999999763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=257.32 Aligned_cols=248 Identities=17% Similarity=0.172 Sum_probs=176.6
Q ss_pred ccCeeccCCcEEEEEEEECCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCC
Q 047892 162 DENVIGEGGYGIVYRGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNG 239 (442)
Q Consensus 162 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 239 (442)
+.+.+|.|+++.||++.. +++.||+|++... .......+.+|+++++.++||||+++++++...+..|++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344455555555555544 6899999998643 3445567999999999999999999999999999999999999999
Q ss_pred CHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc------
Q 047892 240 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS------ 300 (442)
Q Consensus 240 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~------ 300 (442)
+|.+++.... ...+++.....++.|++.||.|||+. ++.++.+||+|||.+..+.....
T Consensus 85 ~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 85 SCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred CHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 9999997542 23578889999999999999999976 34567899999998875532111
Q ss_pred eeecccccccCCCCcccccCC--CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHH----hh----
Q 047892 301 YVTTRVMGTFGYVAPEYASTG--MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTM----VT---- 370 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~----~~---- 370 (442)
.......++..|+|||++... .++.++|||||||++|||++|..||........ ..+..... ..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~------~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM------LLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhccCccccccCch
Confidence 112234577889999998663 588999999999999999999999975432111 01100000 00
Q ss_pred ---cCCccc----ccC----cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 371 ---NGNAEG----VLD----PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 371 ---~~~~~~----~~~----~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
...... ... .............++.+++.+||+.||++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 000 001111223445678899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=273.41 Aligned_cols=246 Identities=24% Similarity=0.332 Sum_probs=196.3
Q ss_pred hhHHHhhCCCCccCeeccCCcEEEEEEE-ECCCCeEEEEEecCcchhhHHHHHHHHHHHHhc-CCCCcceEEEEEEe---
Q 047892 151 RELEVSTNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAE--- 225 (442)
Q Consensus 151 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~--- 225 (442)
..+...++-|++.++||.|.+|.||+++ .++++.+|+|++... ....+++..|.++|+.+ +|||++.++|+|..
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 3444556678999999999999999999 556889999987543 34456677889999887 79999999999853
Q ss_pred --CCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEeccc
Q 047892 226 --GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFG 290 (442)
Q Consensus 226 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFG 290 (442)
++.+|||||||.+|+..+++++.. ...+.|..+..|++.++.|+.+||.+ +..++.|||+|||
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeee
Confidence 578999999999999999998765 56799999999999999999999986 5567899999999
Q ss_pred CccccCCCcceeecccccccCCCCcccccCC-----CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHH
Q 047892 291 LAKLLGAERSYVTTRVMGTFGYVAPEYASTG-----MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWL 365 (442)
Q Consensus 291 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 365 (442)
++..+.... ....+.+||+.|||||++... .|+..+|+||||++..||--|.+|+.+..+...
T Consensus 169 vSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra----------- 236 (953)
T KOG0587|consen 169 VSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA----------- 236 (953)
T ss_pred eeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-----------
Confidence 998764332 234567899999999999543 377899999999999999999999976544211
Q ss_pred HHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 366 KTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
+ +.-...|......+...+.++-++|..||..|-++||++.++++.
T Consensus 237 --L-----F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 237 --L-----FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --h-----ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 0 001112222233456788899999999999999999999998865
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-31 Score=256.51 Aligned_cols=253 Identities=20% Similarity=0.245 Sum_probs=177.0
Q ss_pred CeeccC--CcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 164 NVIGEG--GYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 164 ~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
..||+| +||.||++.. .+++.||+|.+... .....+.+.+|+.+++.++||||+++++++..++..|+||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 9999999996 46899999998543 233446788999999999999999999999999999999999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce----
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY---- 301 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~---- 301 (442)
|+|.+++.+.. ...+++..+..++.|++.||+|||+. +..++.+|++|||.+.........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 99999987642 23588899999999999999999875 345678999999865432111100
Q ss_pred --eecccccccCCCCcccccCC--CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhh----------hHHHHHHH
Q 047892 302 --VTTRVMGTFGYVAPEYASTG--MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQV----------NLFEWLKT 367 (442)
Q Consensus 302 --~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~----------~~~~~~~~ 367 (442)
......++..|+|||++.+. .++.++|||||||++|||++|..||............. ........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 00112346679999998764 47899999999999999999999997543211000000 00000000
Q ss_pred H----------------hhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 368 M----------------VTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 368 ~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
. .............+........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 00000001111122222334566788999999999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=257.44 Aligned_cols=250 Identities=19% Similarity=0.258 Sum_probs=178.3
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-------
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG------- 226 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------- 226 (442)
.++|.+.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467899999999999999999964 58899999885432 22234567899999999999999999987543
Q ss_pred -CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCc
Q 047892 227 -AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLA 292 (442)
Q Consensus 227 -~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla 292 (442)
..+++||||+.+ +|..++... ...+++..+..++.|+++||.|||+. ++.++.+||+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 346999999986 787777643 24689999999999999999999976 456788999999999
Q ss_pred cccCCCcce----------eecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhH
Q 047892 293 KLLGAERSY----------VTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNL 361 (442)
Q Consensus 293 ~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~ 361 (442)
+........ ..+...|++.|+|||.+.+. .++.++|||||||++|||++|+.||...+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~------ 236 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL------ 236 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH------
Confidence 865332211 11233568889999987654 5889999999999999999999999754432111
Q ss_pred HHHHHHHhhc---------CCccc----ccCcccCCCC---cHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 362 FEWLKTMVTN---------GNAEG----VLDPRLQEKP---SSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 362 ~~~~~~~~~~---------~~~~~----~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
..+...... ..... .......... .......+.+++.+||+.||++|||+.+++.
T Consensus 237 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 237 -HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred -HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000000 00000 0000000000 0112356788999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=259.95 Aligned_cols=246 Identities=21% Similarity=0.240 Sum_probs=178.8
Q ss_pred CCC-ccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhh--------------HHHHHHHHHHHHhcCCCCcceEEEE
Q 047892 159 GFA-DENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQA--------------EKEFKVEVEAIGRVRHKNLVRLVGY 222 (442)
Q Consensus 159 ~~~-~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~hpnIv~l~~~ 222 (442)
+|. +.+.||.|+||.||+|... +++.||||.+....... ...+.+|+++++.++||||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 454 4577999999999999954 58899999885432111 1246789999999999999999999
Q ss_pred EEeCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecc
Q 047892 223 CAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDF 289 (442)
Q Consensus 223 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DF 289 (442)
+...+..++||||+. |+|.+++... ..+++.....++.|++.||.|||.. ++.++.+||+||
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 999999999999997 5999998654 4688999999999999999999976 456778999999
Q ss_pred cCccccCCCc-------------ceeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCcc
Q 047892 290 GLAKLLGAER-------------SYVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEF 355 (442)
Q Consensus 290 Gla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~ 355 (442)
|+++...... ........++..|+|||.+.+. .++.++|||||||++|||++|..||...+..+.
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~- 242 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ- 242 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 9997654111 0111223568889999998764 478999999999999999999999976543211
Q ss_pred chhhhHHHHHHHHhhcCCcc---------------cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 356 QFQVNLFEWLKTMVTNGNAE---------------GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
...+.......... ......+. ......+..+.+++.+||+.||++|||+.|++.
T Consensus 243 ------~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 ------LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred ------HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11111111100000 00000000 001123456888999999999999999999986
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=264.10 Aligned_cols=258 Identities=21% Similarity=0.279 Sum_probs=180.6
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC----------
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG---------- 226 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~---------- 226 (442)
.+|.+.+.||.|+||.||+|.. .+++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5688899999999999999996 45889999998665555567788999999999999999999776543
Q ss_pred ----CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC--------CCCCeEEec
Q 047892 227 ----AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE--------PKWNPKLSD 288 (442)
Q Consensus 227 ----~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~--------~~~~~kl~D 288 (442)
...|+||||+++ +|.+++.. ..+++..++.++.|++.||.|||.. ++ .++.+||+|
T Consensus 85 ~~~~~~~~lv~e~~~~-~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYMET-DLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeecccc-cHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 357899999985 99988854 3588999999999999999999876 22 345689999
Q ss_pred ccCccccCCCcce--eecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhH----
Q 047892 289 FGLAKLLGAERSY--VTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNL---- 361 (442)
Q Consensus 289 FGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~---- 361 (442)
||+++.+...... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...............
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999865332111 1122357889999998754 45888999999999999999999999754432111100000
Q ss_pred -HHHHHHHhhcCCcccccCcccCC-CC----cHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH--HHhcC
Q 047892 362 -FEWLKTMVTNGNAEGVLDPRLQE-KP----SSRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEAE 422 (442)
Q Consensus 362 -~~~~~~~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~li~~cl~~dP~~RPs~~evl~--~L~~~ 422 (442)
....... ............... .+ ....+.++.+++.+||+.||++|||+.+++. .++..
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 239 REEDRNEL-LNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred ChHHhhhh-hhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0000000 000000000000000 00 0123456788999999999999999999984 35544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=269.54 Aligned_cols=186 Identities=28% Similarity=0.401 Sum_probs=157.1
Q ss_pred CccCeeccCCcEEEEEEE-ECCCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------eeeeE
Q 047892 161 ADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA------HRMLV 232 (442)
Q Consensus 161 ~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~~~lv 232 (442)
...+.||+|+||.||+|+ ..+|+.||||.+... .....+...+|+++|++|+|||||+++++-.+.. ...+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 445789999999999999 567999999998653 3345567889999999999999999999865443 45899
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc------CCCCCCC-----------eEEecccCcccc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE------GLEPKWN-----------PKLSDFGLAKLL 295 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~------~l~~~~~-----------~kl~DFGla~~~ 295 (442)
||||.+|||...|.+.. +...+++...+.+..+++.||.|||. +++|.+. -||+|||.|+.+
T Consensus 96 mEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred EeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 99999999999997643 34579999999999999999999964 4777542 499999999998
Q ss_pred CCCcceeecccccccCCCCccccc-CCCCCCcCCchhhHHHHHHHHhCCCCCCCC
Q 047892 296 GAERSYVTTRVMGTFGYVAPEYAS-TGMLNETSDVYSFGILIMEVISGRNPVDYS 349 (442)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~elltg~~Pf~~~ 349 (442)
.++. .....+||..|.+||++. .+.|+..+|.|||||++||+.||..||-..
T Consensus 175 ~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 175 DDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred CCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 6654 456689999999999998 488999999999999999999999999643
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=253.10 Aligned_cols=248 Identities=16% Similarity=0.199 Sum_probs=170.5
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEECC----CCeEEEEEecCcchhh--H---------HHHHHHHHHHHhcCCCCcceE
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLED----NTNVAVKNLLNNRGQA--E---------KEFKVEVEAIGRVRHKNLVRL 219 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~--~---------~~~~~E~~~l~~l~hpnIv~l 219 (442)
+..++|.+.+.||+|+||.||+|...+ +..+|+|......... . .....+...+..++|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 344679999999999999999999644 3456666542221111 0 112233445567799999999
Q ss_pred EEEEEeCC----eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCC
Q 047892 220 VGYCAEGA----HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKW 282 (442)
Q Consensus 220 ~~~~~~~~----~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~ 282 (442)
++++.... ..++++|++.. ++.+.+... ...++..+..++.|++.||+|||+. +++++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN 163 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence 99765543 34788888765 677766543 2356788899999999999999875 44567
Q ss_pred CeEEecccCccccCCCcc------eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccc
Q 047892 283 NPKLSDFGLAKLLGAERS------YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQ 356 (442)
Q Consensus 283 ~~kl~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~ 356 (442)
.+||+|||+++.+..... .......||+.|+|||+..+..++.++|||||||++|||++|..||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 899999999986632211 11123469999999999999999999999999999999999999997653322110
Q ss_pred hhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHh
Q 047892 357 FQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420 (442)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 420 (442)
. ....++..... .+ ... ...++..+.+++..||+.+|++||++.++++.|+
T Consensus 244 ~-~~~~~~~~~~~-~~--------~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 H-AAKCDFIKRLH-EG--------KIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred H-HhHHHHHHHhh-hh--------hhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0 00011111111 11 111 1122456888999999999999999999998763
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=262.04 Aligned_cols=250 Identities=21% Similarity=0.313 Sum_probs=179.4
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA------ 227 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------ 227 (442)
.++|.+.+.||+|+||.||+|.. .++..||||.+... .......+.+|+++++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 56799999999999999999985 46899999988532 2233456789999999999999999999987553
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKL 294 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~ 294 (442)
..++||||+ +++|.+++.. ..+++..++.++.|++.||.|||+. ++.++.+||+|||++..
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 358999999 6699988864 3588999999999999999999976 44578899999999986
Q ss_pred cCCCcceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhH-----HHHHHHH
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNL-----FEWLKTM 368 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~-----~~~~~~~ 368 (442)
.... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||............... ..+...
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 242 (343)
T cd07880 168 TDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK- 242 (343)
T ss_pred cccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh-
Confidence 5332 223467889999999866 45889999999999999999999999754321111000000 000000
Q ss_pred hhcCCcccccC--cccCC----CCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 369 VTNGNAEGVLD--PRLQE----KPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 369 ~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
........... +.... ......+..+.+++.+|++.||++|||+.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000 00000 001123445788999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=261.68 Aligned_cols=258 Identities=21% Similarity=0.261 Sum_probs=183.0
Q ss_pred hhhHHHhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 047892 150 LRELEVSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG 226 (442)
Q Consensus 150 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 226 (442)
..++....++|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 445566678899999999999999999985 468899999986432 22345678899999999999999999988643
Q ss_pred ------CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEe
Q 047892 227 ------AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLS 287 (442)
Q Consensus 227 ------~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~ 287 (442)
...|++++++ +++|.+++.. ..+++..+..++.|++.||+|||+. ++.++.+||+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEe
Confidence 3467888887 6799988864 2588999999999999999999976 4567889999
Q ss_pred cccCccccCCCcceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHH----
Q 047892 288 DFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF---- 362 (442)
Q Consensus 288 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~---- 362 (442)
|||+++..... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||................
T Consensus 163 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (345)
T cd07877 163 DFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 238 (345)
T ss_pred ccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99998865322 233467899999998866 568899999999999999999999996543211110000000
Q ss_pred HHHHHHhhcCCc-------ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 363 EWLKTMVTNGNA-------EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 363 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
............ .......+.. .....+..+.+++.+||+.||.+|||+.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 239 AELLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHhhcccHhHHHHHHHhcccCCcchhh-hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000000000 0000000000 000124567889999999999999999999854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=254.37 Aligned_cols=253 Identities=23% Similarity=0.293 Sum_probs=182.9
Q ss_pred CCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 160 FADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
|+..+.||+|+||.||+|... +++.||+|.+.... ......+..|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999965 48999999986542 333456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceee
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT 303 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~ 303 (442)
++ +|.+++.+.. ..+++..++.++.|++.||.|||.. ++.++.+||+|||+++....... ..
T Consensus 81 ~~-~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (282)
T cd07829 81 DM-DLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY 155 (282)
T ss_pred Cc-CHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence 85 9999997642 4689999999999999999999876 34567899999999987643322 12
Q ss_pred cccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHH----HHHHHHhhcCC-cccc
Q 047892 304 TRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF----EWLKTMVTNGN-AEGV 377 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~----~~~~~~~~~~~-~~~~ 377 (442)
....++..|+|||.+.+. .++.++|||||||++|||++|..||......+......... ........... ....
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 234567889999998766 78999999999999999999999997644221110000000 00000000000 0000
Q ss_pred cCcccCC---CCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 378 LDPRLQE---KPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 378 ~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
....... ......+..+.+++.+||+.||++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000 001112556889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=245.48 Aligned_cols=245 Identities=20% Similarity=0.286 Sum_probs=190.0
Q ss_pred cCeeccCCcEEEEEEE-ECCCCeEEEEEecCcchhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeeeEEecCCCCC
Q 047892 163 ENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRMLVNEYVDNGN 240 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~g~ 240 (442)
.+.||+|+|+.|--|. +.++..+|||++.+.....+.++.+|++++... .|+||++|+++|+++..+|||||-|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 3679999999999998 778999999999887777888899999999988 69999999999999999999999999999
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCCCC----------CeEEecccCccccCCCc-----
Q 047892 241 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEPKW----------NPKLSDFGLAKLLGAER----- 299 (442)
Q Consensus 241 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~~~----------~~kl~DFGla~~~~~~~----- 299 (442)
|...|+++ ..+++..+..+..+|+.||.|||.. ++|++ -+|||||.|..-+....
T Consensus 163 lLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 163 LLSHIQKR----KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred HHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 99999876 5789999999999999999999765 66654 47999998875432211
Q ss_pred -ceeecccccccCCCCccccc-----CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCcc---chhhhH-HHHHHHHh
Q 047892 300 -SYVTTRVMGTFGYVAPEYAS-----TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEF---QFQVNL-FEWLKTMV 369 (442)
Q Consensus 300 -~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~---~~~~~~-~~~~~~~~ 369 (442)
.....+.+|+..|||||+.. ...|+.++|.||||||||-|++|.+||.+.-..+-- ...... .+.+-..+
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI 318 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI 318 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH
Confidence 11223568999999999872 235899999999999999999999999764332110 000011 11111222
Q ss_pred hcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 370 TNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.++.+ .++...-...+.+..+++...|..|+.+|.++.++++
T Consensus 319 QEGkY------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 319 QEGKY------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred hccCC------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 23322 1222333567788899999999999999999999887
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=240.32 Aligned_cols=241 Identities=22% Similarity=0.369 Sum_probs=184.7
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc-chhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeee
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 231 (442)
...++...+..||.|+.|.|+++++. +|...|||.+... +....+++...++++.+- +.|.||+.+|+|..+...++
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI 168 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence 33455667788999999999999964 4889999999654 445567788888887665 48999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhh-------hcCC-------CCCCCeEEecccCccccCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL-------HEGL-------EPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yL-------H~~l-------~~~~~~kl~DFGla~~~~~ 297 (442)
.||.|.. -+..++++- .+++++..+-++...++.||.|| |+++ +..|++||||||++-.+-+
T Consensus 169 cMelMs~-C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 169 CMELMST-CAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHHH-HHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence 9999865 555555543 35789999999999999999999 6664 4568999999999987744
Q ss_pred CcceeecccccccCCCCcccccC---CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYAST---GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
.. ..+...|.+.|||||-+.- ..|+-++||||||++|+||.||+.||...... ++.+.....+
T Consensus 245 Sk--AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td---------Fe~ltkvln~--- 310 (391)
T KOG0983|consen 245 SK--AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD---------FEVLTKVLNE--- 310 (391)
T ss_pred cc--ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc---------HHHHHHHHhc---
Confidence 33 3455689999999998853 45899999999999999999999999764332 1112222211
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
..|.++... ..+..+.+++..||..|+.+||...++++.
T Consensus 311 ---ePP~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 311 ---EPPLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ---CCCCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 112232221 266778889999999999999999998864
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-33 Score=284.45 Aligned_cols=247 Identities=19% Similarity=0.244 Sum_probs=193.3
Q ss_pred ehhhHHHhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 047892 149 TLRELEVSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCA 224 (442)
Q Consensus 149 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 224 (442)
.+.++.+..++|.++++||+|+||.|..++. .+++.||+|++.+. .......|..|-++|..-+.+-|++++-.|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 3567889999999999999999999999995 45889999998553 2233456888999999999999999999999
Q ss_pred eCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHH------hhhhhhcCCCCC-------CCeEEecccC
Q 047892 225 EGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK------GLTYLHEGLEPK-------WNPKLSDFGL 291 (442)
Q Consensus 225 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~------~l~yLH~~l~~~-------~~~kl~DFGl 291 (442)
+..++|+|||||+||||..++.+. ..+++..++.++..++. -|.|+|++++|+ |++||+|||.
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999999775 36888888777666654 456778887775 7999999999
Q ss_pred ccccCCCcceeecccccccCCCCccccc----C-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHH
Q 047892 292 AKLLGAERSYVTTRVMGTFGYVAPEYAS----T-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLK 366 (442)
Q Consensus 292 a~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 366 (442)
+-.+..+..-.....+|||.|.+||+++ + +.|++.+|+||+||++|||+.|..||...+-.+.+ .
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY----------~ 291 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY----------G 291 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH----------H
Confidence 9888766666667789999999999984 3 56999999999999999999999999754332221 1
Q ss_pred HHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCC---HHHHHH
Q 047892 367 TMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPK---MGHVIH 417 (442)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs---~~evl~ 417 (442)
..+.... .+..+.....+++..+||.+.+. +|+.|.. +.++-.
T Consensus 292 KIm~hk~-------~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 292 KIMNHKE-------SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred HHhchhh-------hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 1111111 11111123366778888877664 7999988 777754
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=245.57 Aligned_cols=261 Identities=19% Similarity=0.256 Sum_probs=187.1
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-C----CCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCe
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-D----NTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE-GAH 228 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~ 228 (442)
...|+.+..||+|.||.||+|... + ...+|+|+++.. .........+|+.+++.++||||+.|..+|.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 345889999999999999999632 2 236899999643 22334557789999999999999999998876 788
Q ss_pred eeeEEecCCCCCHHHHHccCCC-CCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC-----------CCCeEEeccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVG-PHSPLTWEIRMNIILGTAKGLTYLHEG------LEP-----------KWNPKLSDFG 290 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-----------~~~~kl~DFG 290 (442)
+|+++||.+. ||.+.|+-+.. ....++......|+.||+.|+.|||++ ++| .|.+||+|||
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999999998 99999974322 224788899999999999999999876 333 4899999999
Q ss_pred CccccCCCcce--eecccccccCCCCcccccCCC-CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCc--cchhhhHHHHH
Q 047892 291 LAKLLGAERSY--VTTRVMGTFGYVAPEYASTGM-LNETSDVYSFGILIMEVISGRNPVDYSRPPGE--FQFQVNLFEWL 365 (442)
Q Consensus 291 la~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~--~~~~~~~~~~~ 365 (442)
+++.+.+.-.. .....+-|..|+|||++.+.. |+++.||||+|||+.||+|-++.|.+.+..-. ..++.+....+
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 99987554322 234456799999999998866 89999999999999999999999976532211 12223322222
Q ss_pred HHHhhcCCcccc------------c---CcccCCCCc--------HHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 366 KTMVTNGNAEGV------------L---DPRLQEKPS--------SRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 366 ~~~~~~~~~~~~------------~---~~~~~~~~~--------~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.....-...... + ......... ..-+...++|+.++|+.||.+|.|+++.++.
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 222111110000 0 000000000 0012236789999999999999999998865
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=258.38 Aligned_cols=254 Identities=20% Similarity=0.320 Sum_probs=179.5
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------Ce
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG------AH 228 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~ 228 (442)
++|.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 5788999999999999999995 468999999985432 22335678899999999999999999998654 34
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLL 295 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~ 295 (442)
.|+|+||+.. +|..++. ..+++..+..++.|++.||+|||+. ++.++.+||+|||+++..
T Consensus 95 ~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 95 FYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred EEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 6899999975 8877653 2478899999999999999999876 456789999999999765
Q ss_pred CCCcceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhH-----HHHHHHHh
Q 047892 296 GAERSYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNL-----FEWLKTMV 369 (442)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~ 369 (442)
... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............... .... ...
T Consensus 168 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 242 (342)
T cd07879 168 DAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV-QKL 242 (342)
T ss_pred CCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH-HHh
Confidence 322 223467889999999866 46889999999999999999999999754321110000000 0000 000
Q ss_pred hcCCcccccC--ccc-CCCC---cHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH--HhcCC
Q 047892 370 TNGNAEGVLD--PRL-QEKP---SSRALKRALLVALRCVDPNAHKRPKMGHVIHM--LEAEE 423 (442)
Q Consensus 370 ~~~~~~~~~~--~~~-~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 423 (442)
.......... +.. .... ....+..+.+++.+||+.||++||++.+++.. ++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000000000 000 0000 01123457889999999999999999999854 65554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=240.64 Aligned_cols=239 Identities=21% Similarity=0.264 Sum_probs=183.1
Q ss_pred CCCCcc-CeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhc-CCCCcceEEEEEEe----CCeee
Q 047892 158 NGFADE-NVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAE----GAHRM 230 (442)
Q Consensus 158 ~~~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~----~~~~~ 230 (442)
++|.+. ++||-|-.|.|-.|.. .+++.+|+|.+.+. ....+|+++.-.. .|||||+++++|.+ ...+.
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 344443 6799999999999995 45899999988543 2345678765444 79999999999864 34567
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC----------CCCeEEecccCccc
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP----------KWNPKLSDFGLAKL 294 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~----------~~~~kl~DFGla~~ 294 (442)
+|||.|+||+|+..++.+. ...+++..+..|+.||+.|+.|||+. +++ +..+||+|||+|+.
T Consensus 136 iVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence 9999999999999998652 46799999999999999999999864 444 44789999999997
Q ss_pred cCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
... .....+.|-|+.|.|||++...+|+..+|+||+||++|-|++|.+||....... +...++..+..+.+
T Consensus 214 t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-------ispgMk~rI~~gqy 284 (400)
T KOG0604|consen 214 TQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-------ISPGMKRRIRTGQY 284 (400)
T ss_pred cCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-------CChhHHhHhhccCc
Confidence 532 222345678999999999998999999999999999999999999997543321 11222222222222
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.++...-...++...++|..+|..+|.+|.|+.++++.
T Consensus 285 ------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 285 ------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 12333335667888999999999999999999999853
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-32 Score=264.49 Aligned_cols=251 Identities=21% Similarity=0.295 Sum_probs=180.7
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe-----
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAH----- 228 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~----- 228 (442)
.++|.+.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++||||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 457899999999999999999964 5789999988543 22334567789999999999999999988766554
Q ss_pred -eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccc
Q 047892 229 -RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKL 294 (442)
Q Consensus 229 -~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~ 294 (442)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+. ++.++.+||+|||++..
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 89999999 4599999864 3689999999999999999999876 44578899999999986
Q ss_pred cCCCcceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHH-----HHHHHH
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF-----EWLKTM 368 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~-----~~~~~~ 368 (442)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.............+.. .+....
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 5332 233467889999998865 367899999999999999999999997543321111000000 000000
Q ss_pred hhcCCcccccC---cccCCCC---cHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 369 VTNGNAEGVLD---PRLQEKP---SSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 369 ~~~~~~~~~~~---~~~~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
. ......++. ...+... ....+..+.+++.+||+.||++|||+.+|++.
T Consensus 244 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 244 S-SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred c-chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 000000000 0000000 01125678899999999999999999999863
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-33 Score=289.25 Aligned_cols=237 Identities=22% Similarity=0.313 Sum_probs=185.9
Q ss_pred CCCccCeeccCCcEEEEEEE-ECCCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 159 GFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
++....+||.|.||.||.|. .++|...|+|-++... ......+.+|..+|..|+|||+|+++|+-.+.+..+|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 45567789999999999999 5669999999885433 33345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce-
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY- 301 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~- 301 (442)
|++|+|.+.+... ...++.....+..|++.|+.|||.. ++.+|.+|++|||.|..+..+...
T Consensus 1316 C~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred hccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 9999999998754 3566777778889999999999875 445678999999999887554211
Q ss_pred --eecccccccCCCCcccccCCC---CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 302 --VTTRVMGTFGYVAPEYASTGM---LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 302 --~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
......||+.|||||++.+.. ...++||||+||++.||+||+.||...+.. ++.+....
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---------~aIMy~V~------- 1455 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---------WAIMYHVA------- 1455 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---------hHHHhHHh-------
Confidence 123568999999999997643 567899999999999999999999643221 11111111
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
..-.+..+.+.+.+-.+++.+||+.||+.|-++.|+++.
T Consensus 1456 ---~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1456 ---AGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ---ccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 111223444577778889999999999999999888764
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=245.85 Aligned_cols=223 Identities=24% Similarity=0.291 Sum_probs=175.8
Q ss_pred eccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCCCH
Q 047892 166 IGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNL 241 (442)
Q Consensus 166 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L 241 (442)
||+|+||.||++... +++.+|+|.+.... ......+..|+.++++++||||+++++.+..++..|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 48899999885432 22445788899999999999999999999999999999999999999
Q ss_pred HHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeeccccc
Q 047892 242 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMG 308 (442)
Q Consensus 242 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 308 (442)
.+++... ..+++.....++.|++.||.|||.. ++.++.++|+|||++....... .......+
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG 155 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence 9999764 3688999999999999999999876 3456789999999998754332 12334568
Q ss_pred ccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcH
Q 047892 309 TFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSS 388 (442)
Q Consensus 309 t~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (442)
+..|+|||.+.+...+.++|+||||+++|||++|..||..... ..... .... . ....+.
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~---~~~~-~----------~~~~~~ 214 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KEIYE---KILK-D----------PLRFPE 214 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHH---HHhc-C----------CCCCCC
Confidence 8899999999888889999999999999999999999964322 01111 1111 0 011122
Q ss_pred HHHHHHHHHHhhhhCCCCCCCCCHHH
Q 047892 389 RALKRALLVALRCVDPNAHKRPKMGH 414 (442)
Q Consensus 389 ~~~~~~~~li~~cl~~dP~~RPs~~e 414 (442)
..+..+.+++.+||..||++|||+.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 22456788999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=252.31 Aligned_cols=253 Identities=21% Similarity=0.247 Sum_probs=176.3
Q ss_pred CCCccCeeccCCcEEEEEEEEC-C--CCeEEEEEecCc--chhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC----Ce
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-D--NTNVAVKNLLNN--RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEG----AH 228 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~----~~ 228 (442)
+|.+.+.||+|+||.||++... . +..||+|.+... .....+.+.+|+++++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3677889999999999999953 3 678999988542 222345678899999999 599999999875432 45
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLL 295 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~ 295 (442)
.|+++||+. ++|.+++... ..+++..++.++.|++.||.|||+. ++.++.+||+|||+++.+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 789999987 5999998654 4688999999999999999999976 446778999999999865
Q ss_pred CCCcce---eecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhH-----HHHHH
Q 047892 296 GAERSY---VTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNL-----FEWLK 366 (442)
Q Consensus 296 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~-----~~~~~ 366 (442)
...... ......||..|+|||.+.+ ..++.++|||||||++|+|++|..||............... .+...
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 432211 1233578999999998765 46899999999999999999999999754321111000000 00000
Q ss_pred HHhhcC------CcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 367 TMVTNG------NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 367 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
...... .........+. ......+..+.+++.+||+.||++|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000 00000000000 000112456888999999999999999999974
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=250.95 Aligned_cols=257 Identities=18% Similarity=0.255 Sum_probs=189.9
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCC--C----CcceEEEEEEeC
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH--K----NLVRLVGYCAEG 226 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--p----nIv~l~~~~~~~ 226 (442)
....++|.+..++|+|.||.|-.+.+ +.+..||||+++.- ....+..+-|+++|.++.+ | -+|++.++|.-.
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 33477899999999999999999995 34789999988653 3455666779999999942 3 278888899999
Q ss_pred CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC--------------------
Q 047892 227 AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP-------------------- 280 (442)
Q Consensus 227 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-------------------- 280 (442)
++.|||+|.+.- ++.+||..+ ...+++...+..++.|++++++|||+. ++|
T Consensus 164 ghiCivfellG~-S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 164 GHICIVFELLGL-STFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred CceEEEEeccCh-hHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence 999999999854 999999865 346789999999999999999999876 333
Q ss_pred -------CCCeEEecccCccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCC
Q 047892 281 -------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPG 353 (442)
Q Consensus 281 -------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~ 353 (442)
+..+||+|||.|+...... ...+.|..|.|||++.+-.++.++||||+||||+|+.||...|+..+..+
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 2368999999998754443 44577999999999999999999999999999999999999998765433
Q ss_pred ccchhhh--------HHHHH--HHHhhcC-----------CcccccCcccC----CCCcHHHHHHHHHHHhhhhCCCCCC
Q 047892 354 EFQFQVN--------LFEWL--KTMVTNG-----------NAEGVLDPRLQ----EKPSSRALKRALLVALRCVDPNAHK 408 (442)
Q Consensus 354 ~~~~~~~--------~~~~~--~~~~~~~-----------~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dP~~ 408 (442)
.+....- +.... .+....+ ....+.++..+ .........++++|+.+||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 2111110 00000 0000000 00111111111 1123345667999999999999999
Q ss_pred CCCHHHHHHH
Q 047892 409 RPKMGHVIHM 418 (442)
Q Consensus 409 RPs~~evl~~ 418 (442)
|+|+.|++..
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999999853
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=254.73 Aligned_cols=243 Identities=23% Similarity=0.383 Sum_probs=182.9
Q ss_pred HhhCCCCccCeeccCCcEEEEEEE-ECCCCeEEEEEecCcc-------hhhHHHHHHHHHHHHhcCCCCcceEEEEEE-e
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNR-------GQAEKEFKVEVEAIGRVRHKNLVRLVGYCA-E 225 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~ 225 (442)
...++|-.+.+||+|+|++||+|. +...+.||||+-..+. ....+...+|.+|.+.|+||.||++|++|. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 344567788899999999999999 4557889999763221 112344678999999999999999999986 5
Q ss_pred CCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhh--------cCCCCC----------CCeEEe
Q 047892 226 GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH--------EGLEPK----------WNPKLS 287 (442)
Q Consensus 226 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH--------~~l~~~----------~~~kl~ 287 (442)
.+.+|-|+|||+|.+|.-||+.+ ..+++..++.|+.||+.||.||. -+++|. |.+||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cccceeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence 67789999999999999999876 67899999999999999999994 445553 578999
Q ss_pred cccCccccCCCcce------eecccccccCCCCcccccCC----CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccch
Q 047892 288 DFGLAKLLGAERSY------VTTRVMGTFGYVAPEYASTG----MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQF 357 (442)
Q Consensus 288 DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~ 357 (442)
||||++.+.++... .+....||..|++||++.-+ +.+.|+||||+|||+|.++.|+.||......
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ----- 690 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ----- 690 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-----
Confidence 99999988654322 34567899999999988433 4788999999999999999999999753221
Q ss_pred hhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHH
Q 047892 358 QVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVI 416 (442)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl 416 (442)
.++.+. .+.... ..+..++.+..+.+..++|.+||++.-++|....++.
T Consensus 691 -QdILqe-------NTIlkA--tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 691 -QDILQE-------NTILKA--TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -HHHHhh-------hchhcc--eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111111 010000 1112222333455677899999999999998877765
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=260.73 Aligned_cols=233 Identities=23% Similarity=0.279 Sum_probs=191.2
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEECCCC-eEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLEDNT-NVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 229 (442)
.+...++..+..||-|+||.|=++..+... .+|+|++++. +....+.+..|-++|..++.|.||++|-.|.+..++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 345567788889999999999999865433 4888888654 345566788899999999999999999999999999
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~ 296 (442)
|++||-|-||.|...|+.+ +.++...+..++..+++|++|||+. ++.+|-+||.|||+|+.+.
T Consensus 496 YmLmEaClGGElWTiLrdR----g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDR----GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred hhhHHhhcCchhhhhhhhc----CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 9999999999999999875 5778888888999999999999986 5567899999999999886
Q ss_pred CCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 297 AERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
... .+.++|||+.|.|||++.++..+.++|.||||+++|||++|.+||.+.++...+......++
T Consensus 572 ~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid------------- 636 (732)
T KOG0614|consen 572 SGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID------------- 636 (732)
T ss_pred cCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh-------------
Confidence 543 46789999999999999999999999999999999999999999988766444322111111
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCC
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPK 411 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs 411 (442)
....+........+|+++....+|.+|..
T Consensus 637 ------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 637 ------KIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ------hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 11234455566778999999999999976
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=218.92 Aligned_cols=249 Identities=21% Similarity=0.291 Sum_probs=184.0
Q ss_pred CCCccCeeccCCcEEEEEEE-ECCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 159 GFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
+|...++||+|.||+||+|+ +++++.||+|.++-+ +........+|+.+|+.++|.|||+++++...+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46677899999999999999 566899999998543 333446678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
|.. +|..|...- ++.++......++.|+++||.|+|+. +..+|++|++|||+++.++-....
T Consensus 83 cdq-dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrc- 157 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC- 157 (292)
T ss_pred hhH-HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe-
Confidence 987 898887653 46789999999999999999999875 455789999999999987655432
Q ss_pred ecccccccCCCCcccccCCC-CCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHh--hcCCccc--
Q 047892 303 TTRVMGTFGYVAPEYASTGM-LNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMV--TNGNAEG-- 376 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-- 376 (442)
....+-|..|.+|.++.+.+ |++..|+||-|||+.|+.. |.+.|.+.+-.+. +...++... .+.....
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq------lkrif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ------LKRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH------HHHHHHHhCCCccccCCccc
Confidence 33446799999999998765 8999999999999999998 7777766433221 111111111 1111111
Q ss_pred -ccC----cccCCCC-----cHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 377 -VLD----PRLQEKP-----SSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 377 -~~~----~~~~~~~-----~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
+-+ +...... -......-.+++++.+.-+|.+|.++++.++.
T Consensus 232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 101 0011000 01122234568888888999999999987753
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=271.93 Aligned_cols=132 Identities=27% Similarity=0.344 Sum_probs=114.8
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|.+.+.||+|+||.||+|.+. +++.||||++.... ......+..|+.++..++||||+++++++...+..||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888999999999999999965 58899999986432 233466888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAK 293 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~ 293 (442)
||+.+|+|.+++... ..+++..++.++.||+.||.|||.. ++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999754 4578889999999999999999876 4456899999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=273.09 Aligned_cols=237 Identities=24% Similarity=0.333 Sum_probs=172.0
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--------
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG-------- 226 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-------- 226 (442)
.++|+.++.||+|+||.||+++. -+|+.+|||++.-. .......+.+|+.+|++|+|||||+++..|.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 46788899999999999999994 37999999999654 333445688999999999999999997654110
Q ss_pred --------------------------------------------------------------------------------
Q 047892 227 -------------------------------------------------------------------------------- 226 (442)
Q Consensus 227 -------------------------------------------------------------------------------- 226 (442)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhh
Q 047892 227 -------------------------------AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 275 (442)
Q Consensus 227 -------------------------------~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH 275 (442)
..+||-||||+.-.|.++++++.... .....++++++|++||.|+|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHH
Confidence 01588999999988888887652111 45678899999999999998
Q ss_pred cC-------------CCCCCCeEEecccCccccC--------------C---CcceeecccccccCCCCcccccCC---C
Q 047892 276 EG-------------LEPKWNPKLSDFGLAKLLG--------------A---ERSYVTTRVMGTFGYVAPEYASTG---M 322 (442)
Q Consensus 276 ~~-------------l~~~~~~kl~DFGla~~~~--------------~---~~~~~~~~~~gt~~y~aPE~~~~~---~ 322 (442)
.. +++++.|||+|||+|.... . ......+..+||.-|+|||++.+. .
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 75 4557799999999998721 0 011123557899999999999764 4
Q ss_pred CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCC--CcHHHHHHHHHHHhh
Q 047892 323 LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEK--PSSRALKRALLVALR 400 (442)
Q Consensus 323 ~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~ 400 (442)
|+.|+|+|||||+++||+. ||... +.-...+..+. +..++.+ ........-..+|.+
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~Ts---------MERa~iL~~LR---------~g~iP~~~~f~~~~~~~e~slI~~ 853 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTS---------MERASILTNLR---------KGSIPEPADFFDPEHPEEASLIRW 853 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCch---------HHHHHHHHhcc---------cCCCCCCcccccccchHHHHHHHH
Confidence 9999999999999999985 56431 11111111111 1111211 122222335568999
Q ss_pred hhCCCCCCCCCHHHHHH
Q 047892 401 CVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 401 cl~~dP~~RPs~~evl~ 417 (442)
+++.||.+||||.|+|.
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999985
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=238.82 Aligned_cols=247 Identities=24% Similarity=0.328 Sum_probs=184.1
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc-hhhHHHHHHHHHHH-HhcCCCCcceEEEEEEeCCeeee
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR-GQAEKEFKVEVEAI-GRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l-~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
+..++.+.+..||.|+||+|++..+ +.|+..|||++.... ...++++..|.++. +.-+.||||++||.+..++..||
T Consensus 61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWi 140 (361)
T KOG1006|consen 61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWI 140 (361)
T ss_pred cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceee
Confidence 3445566778899999999999985 459999999997554 36667888898865 44578999999999999999999
Q ss_pred EEecCCCCCHHHHHccC-CCCCCCCCHHHHHHHHHHHHHhhhhh-------hcCCCC-------CCCeEEecccCccccC
Q 047892 232 VNEYVDNGNLEQWLHGD-VGPHSPLTWEIRMNIILGTAKGLTYL-------HEGLEP-------KWNPKLSDFGLAKLLG 296 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~qi~~~l~yL-------H~~l~~-------~~~~kl~DFGla~~~~ 296 (442)
.||+|+- +|..+-+.- .-....+++...-.|....+.||.|| |++++| .|.+||||||.+..+.
T Consensus 141 CMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 141 CMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred eHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 9999986 776654320 01124678888888888888898887 777555 6799999999997663
Q ss_pred CCcceeecccccccCCCCcccccC--CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 297 AERSYVTTRVMGTFGYVAPEYAST--GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 297 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
++...+.-+|...|||||-+.. ..|+-+|||||||++|||+.||..||... .++++.+...+.. ..
T Consensus 220 --~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w---------~svfeql~~Vv~g-dp 287 (361)
T KOG1006|consen 220 --DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW---------DSVFEQLCQVVIG-DP 287 (361)
T ss_pred --HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH---------HHHHHHHHHHHcC-CC
Confidence 2333455678999999998853 35899999999999999999999998643 2234444333322 21
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
..+.. .....+.+..+..++..||.+|-.+||...++++.
T Consensus 288 p~l~~----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 288 PILLF----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CeecC----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11111 11123456678889999999999999999998754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=237.00 Aligned_cols=240 Identities=22% Similarity=0.274 Sum_probs=184.9
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc---chhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCe
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAH 228 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 228 (442)
.+..++|.++++||+|+|++|..+++ ++.+.+|+|++++. .....+-.+.|-.+..+. +||.+|.++.+|..+..
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 45678899999999999999999995 55888999988643 333444566777777665 79999999999999999
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLL 295 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~ 295 (442)
+++|.||++||+|.-.+++. ..++++.+..+...|+.||.|||+. ++.+|++||+|+|+++.-
T Consensus 326 lffvieyv~ggdlmfhmqrq----rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEEEecCcceeeehhhh----hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC
Confidence 99999999999998877765 5799999999999999999999986 667899999999999852
Q ss_pred CCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 296 GAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
-.....+.++|||+.|.|||++.+..|+..+|+|+|||+++||+.|+.||+.-...... .+.-+++-..+.+...+
T Consensus 402 -l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d---~ntedylfqvilekqir 477 (593)
T KOG0695|consen 402 -LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD---MNTEDYLFQVILEKQIR 477 (593)
T ss_pred -CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcc---cchhHHHHHHHhhhccc
Confidence 22334567899999999999999999999999999999999999999999753321111 12223332222222111
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCC
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPK 411 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs 411 (442)
++. ..+.....+++.-|++||.+|..
T Consensus 478 ------ipr----slsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 478 ------IPR----SLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ------ccc----eeehhhHHHHHHhhcCCcHHhcC
Confidence 111 12223444777889999999853
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=252.15 Aligned_cols=231 Identities=24% Similarity=0.369 Sum_probs=186.6
Q ss_pred cCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCC
Q 047892 163 ENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNG 239 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g 239 (442)
.++||.|.||+||-|.. ++|+.||||.+.+. .......+.+|+.||+++.||.||.+...|+..+.+|+|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 47899999999999994 56999999999543 334557789999999999999999999999999999999999976
Q ss_pred CHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCCCC----------CeEEecccCccccCCCcceee
Q 047892 240 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEPKW----------NPKLSDFGLAKLLGAERSYVT 303 (442)
Q Consensus 240 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~~~----------~~kl~DFGla~~~~~~~~~~~ 303 (442)
|..+.|-.. ..+.+++.....++.||+.||.|||.. ++|++ ++||||||+|+.++.... .
T Consensus 648 DMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF--R 723 (888)
T KOG4236|consen 648 DMLEMILSS--EKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF--R 723 (888)
T ss_pred hHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh--h
Confidence 666665432 246789999999999999999999754 66654 689999999999865432 3
Q ss_pred cccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccC
Q 047892 304 TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ 383 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (442)
...+||+.|+|||++.++.|+..-|+||.|||+|--++|..||...+.... .+.+.. + .++
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd-------------QIQNAa---F---MyP 784 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND-------------QIQNAA---F---MYP 784 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH-------------Hhhccc---c---ccC
Confidence 457899999999999999999999999999999999999999975433111 111111 1 123
Q ss_pred CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 384 EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 384 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
..+-.+.+....+||...|+..=.+|-|....+.
T Consensus 785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 3455677778899999999999999999988764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=234.90 Aligned_cols=207 Identities=18% Similarity=0.132 Sum_probs=160.6
Q ss_pred CCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCCCHHHHHcc
Q 047892 169 GGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHG 247 (442)
Q Consensus 169 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~ 247 (442)
|.||.||++.. .+++.||+|.+.... .+.+|...+....||||+++++++.+.+..|+||||+++|+|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999995 458899999985432 233455555666799999999999999999999999999999999875
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecccccccCCCC
Q 047892 248 DVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 314 (442)
Q Consensus 248 ~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~a 314 (442)
. ..+++..+..++.|++.||.|||+. ++.++.++++|||++...... .....++..|+|
T Consensus 79 ~----~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a 150 (237)
T cd05576 79 F----LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA 150 (237)
T ss_pred h----cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence 4 3589999999999999999999875 445678999999988765332 123356778999
Q ss_pred cccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHH
Q 047892 315 PEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRA 394 (442)
Q Consensus 315 PE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (442)
||.+.+..++.++||||+||++|||++|..||........ ... ....+...+..+
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---------------------~~~----~~~~~~~~~~~~ 205 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN---------------------THT----TLNIPEWVSEEA 205 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc---------------------ccc----ccCCcccCCHHH
Confidence 9999888899999999999999999999988753211000 000 001112234567
Q ss_pred HHHHhhhhCCCCCCCCCHH
Q 047892 395 LLVALRCVDPNAHKRPKMG 413 (442)
Q Consensus 395 ~~li~~cl~~dP~~RPs~~ 413 (442)
.+++.+||+.||++|||+.
T Consensus 206 ~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHccCCHHHhcCCC
Confidence 8899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-32 Score=237.55 Aligned_cols=257 Identities=19% Similarity=0.275 Sum_probs=180.9
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEe--------C
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE--------G 226 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--------~ 226 (442)
+.|....+||+|.||+||+|+. ++|+.||+|++... .........+|+++|..|+|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3467778999999999999995 45888999877432 22233456789999999999999999887743 2
Q ss_pred CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcc
Q 047892 227 AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAK 293 (442)
Q Consensus 227 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~ 293 (442)
..+|+||++|+. ||.-+|.+. ...++...+..++.+++.||.|+|++ ++.++.+||+|||+++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 458999999998 999998654 35788899999999999999999876 5668999999999998
Q ss_pred ccCCCcce---eecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHH----
Q 047892 294 LLGAERSY---VTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWL---- 365 (442)
Q Consensus 294 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~---- 365 (442)
.+...+.. ..+..+-|..|.+||.+.+. .|+++.|||+-||++.||+||.+-|.+............+....
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 76543322 22344569999999998775 49999999999999999999999987654322221111111000
Q ss_pred HHHhhcCCcccccC-cccCCCCc---HH------HHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 366 KTMVTNGNAEGVLD-PRLQEKPS---SR------ALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 366 ~~~~~~~~~~~~~~-~~~~~~~~---~~------~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
+..+.+-.+...+. +.+..... .+ -..+..+|+.+++..||.+|+++++++..
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 00000000000010 00100000 01 12356789999999999999999998854
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=228.76 Aligned_cols=225 Identities=24% Similarity=0.355 Sum_probs=176.5
Q ss_pred CcEEEEEEEEC-CCCeEEEEEecCcchhh-HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCCCHHHHHcc
Q 047892 170 GYGIVYRGVLE-DNTNVAVKNLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHG 247 (442)
Q Consensus 170 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~ 247 (442)
+||.||+|... +++.+++|.+....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999975 48999999986544333 67889999999999999999999999999999999999999999999875
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecccccccCCCC
Q 047892 248 DVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 314 (442)
Q Consensus 248 ~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~a 314 (442)
. ..+++.....++.+++.++.|||.. ++.++.++|+|||++....... ......++..|++
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 4 2388899999999999999999876 4556899999999998765432 2334568889999
Q ss_pred cccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHH
Q 047892 315 PEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRA 394 (442)
Q Consensus 315 PE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (442)
||.+.+..++.++||||||+++|+|++|..||...... ..... ........ ........+..+
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~------~~~~~----~~~~~~~~-------~~~~~~~~~~~~ 217 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL------LELFK----KIGKPKPP-------FPPPEWKISPEA 217 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH------HHHHH----HHhccCCC-------CccccccCCHHH
Confidence 99998888999999999999999999999999653111 11111 11111100 000000034568
Q ss_pred HHHHhhhhCCCCCCCCCHHHHHH
Q 047892 395 LLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 395 ~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.+++.+||..||++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 88999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=249.58 Aligned_cols=227 Identities=22% Similarity=0.250 Sum_probs=177.5
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeeeEEe
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
.++|.+...+|.|+|+.|-.|.. .+++..++|++.... ....+|+.++... +||||+++.+.+.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 55688888899999999999984 568899999985542 2233466555544 89999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------C-CCCCCeEEecccCccccCCCcc
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------L-EPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l-~~~~~~kl~DFGla~~~~~~~~ 300 (442)
++.||-|.+-+... ......+..|+++++.|+.|||++ + ...++++|+|||.++.+...
T Consensus 397 ~l~g~ell~ri~~~-----~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSK-----PEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred hccccHHHHHHHhc-----chhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 99999988877653 222267778999999999999986 3 35678999999999877544
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
..+.+-|..|.|||++....|++++||||||++||+|++|+.||...... ..+ ...+..
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei----~~~i~~--------- 528 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEI----HTRIQM--------- 528 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHH----HHhhcC---------
Confidence 22345688999999999889999999999999999999999999754332 011 111111
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.......+....+|+.+||+.||.+||++.++...
T Consensus 529 ---~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 529 ---PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ---CccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 11224556778899999999999999999999743
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=244.12 Aligned_cols=254 Identities=19% Similarity=0.308 Sum_probs=167.8
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEE-----------------CCCCeEEEEEecCcchhhHHH--------------HHH
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVL-----------------EDNTNVAVKNLLNNRGQAEKE--------------FKV 203 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~ 203 (442)
...++|.+.++||+|+||.||+|.+ ..++.||||++........+. ...
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 4577899999999999999999963 235679999986543322222 334
Q ss_pred HHHHHHhcCCCCc-----ceEEEEEEe--------CCeeeeEEecCCCCCHHHHHccCCCC-------------------
Q 047892 204 EVEAIGRVRHKNL-----VRLVGYCAE--------GAHRMLVNEYVDNGNLEQWLHGDVGP------------------- 251 (442)
Q Consensus 204 E~~~l~~l~hpnI-----v~l~~~~~~--------~~~~~lv~E~~~~g~L~~~l~~~~~~------------------- 251 (442)
|+.++.+++|.++ ++++++|.. .+..||||||+++|+|.++++.....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6777777766654 667777643 35679999999999999999753211
Q ss_pred -CCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecccccccCCCCccc
Q 047892 252 -HSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 317 (442)
Q Consensus 252 -~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (442)
...+++..+..++.|++.||.|||.. ++.++.+||+|||+++..............+|+.|+|||.
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 12346778889999999999999875 3446789999999997653322222222345789999998
Q ss_pred ccCCC--------------------CC--CcCCchhhHHHHHHHHhCCC-CCCCCCCCCc-cc-hhhhHHHHHHHHhhcC
Q 047892 318 ASTGM--------------------LN--ETSDVYSFGILIMEVISGRN-PVDYSRPPGE-FQ-FQVNLFEWLKTMVTNG 372 (442)
Q Consensus 318 ~~~~~--------------------~~--~~sDvwSlGvil~elltg~~-Pf~~~~~~~~-~~-~~~~~~~~~~~~~~~~ 372 (442)
+.... |+ .+.||||+||++|||++|.. ||........ .. .......|. .....
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~~~~~ 459 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR--MYKGQ 459 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--hhccc
Confidence 75432 12 24799999999999999875 7643211110 00 000111111 11111
Q ss_pred CcccccCcccCCCCcHHHHHHHHHHHhhhhCCCC---CCCCCHHHHHHH
Q 047892 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNA---HKRPKMGHVIHM 418 (442)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP---~~RPs~~evl~~ 418 (442)
..........+....+|+.++|..+| .+|+|+.|+|+.
T Consensus 460 --------~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 --------KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred --------CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11111122345668889999999766 689999999863
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=227.49 Aligned_cols=261 Identities=18% Similarity=0.227 Sum_probs=188.5
Q ss_pred hhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcC-----C---CCcceEEEEEEe-
Q 047892 156 STNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-----H---KNLVRLVGYCAE- 225 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---pnIv~l~~~~~~- 225 (442)
...+|.+.++||.|.|++||+|.+ .+.+.||+|+.+. .....+....||++|++++ | .+||+|++.|..
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 347799999999999999999995 4577899998865 3445566778999999883 3 369999999964
Q ss_pred ---CCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------------------
Q 047892 226 ---GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------------------------- 277 (442)
Q Consensus 226 ---~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------------------------- 277 (442)
+.++|||+|++.. +|..+|+.. ....++...+..|+.||+.||.|||+.
T Consensus 155 GpNG~HVCMVfEvLGd-nLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~ 231 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVLGD-NLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKD 231 (590)
T ss_pred CCCCcEEEEEehhhhh-HHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhh
Confidence 5689999999965 999999865 345689999999999999999999975
Q ss_pred --------------------------------------------------------------------------------
Q 047892 278 -------------------------------------------------------------------------------- 277 (442)
Q Consensus 278 -------------------------------------------------------------------------------- 277 (442)
T Consensus 232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~ 311 (590)
T KOG1290|consen 232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING 311 (590)
T ss_pred hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence
Q ss_pred ------------------------CCC---------------------------------------------------CC
Q 047892 278 ------------------------LEP---------------------------------------------------KW 282 (442)
Q Consensus 278 ------------------------l~~---------------------------------------------------~~ 282 (442)
.+. +.
T Consensus 312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di 391 (590)
T KOG1290|consen 312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI 391 (590)
T ss_pred cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence 000 01
Q ss_pred CeEEecccCccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCcc------c
Q 047892 283 NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEF------Q 356 (442)
Q Consensus 283 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~------~ 356 (442)
++||+|||-|...... .+.-..|..|+|||++.+..|++.+||||++|++|||.||...|+.....+-- .
T Consensus 392 ~vKIaDlGNACW~~kh----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA 467 (590)
T KOG1290|consen 392 RVKIADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA 467 (590)
T ss_pred eEEEeeccchhhhhhh----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence 3678888887764221 12235688999999999999999999999999999999999999765433211 1
Q ss_pred hhhhHHHHH-HHHhhcCCc-ccccCc--------cc-----------CCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHH
Q 047892 357 FQVNLFEWL-KTMVTNGNA-EGVLDP--------RL-----------QEKPSSRALKRALLVALRCVDPNAHKRPKMGHV 415 (442)
Q Consensus 357 ~~~~~~~~~-~~~~~~~~~-~~~~~~--------~~-----------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ev 415 (442)
.++.+...+ +.+...+.. +.++.. .+ ....+.+...++.+|+.-||+.+|++||||.+.
T Consensus 468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c 547 (590)
T KOG1290|consen 468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC 547 (590)
T ss_pred HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence 111221111 111222211 111110 01 123456677889999999999999999999999
Q ss_pred HHH--HhcCCC
Q 047892 416 IHM--LEAEEF 424 (442)
Q Consensus 416 l~~--L~~~~~ 424 (442)
++. |..+..
T Consensus 548 l~hPwLn~~~~ 558 (590)
T KOG1290|consen 548 LKHPWLNPVAG 558 (590)
T ss_pred hcCccccCCCC
Confidence 953 665443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-28 Score=249.27 Aligned_cols=249 Identities=19% Similarity=0.230 Sum_probs=155.5
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC-C----CCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEE------EE
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE-D----NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGY------CA 224 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~------~~ 224 (442)
..++|.+.+.||+|+||.||+|.+. + +..||+|++..... .+....| .+....+.+++.+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999964 4 68899998754321 1111111 1122222333322221 24
Q ss_pred eCCeeeeEEecCCCCCHHHHHccCCCC----------------CCCCCHHHHHHHHHHHHHhhhhhhcC------CCC--
Q 047892 225 EGAHRMLVNEYVDNGNLEQWLHGDVGP----------------HSPLTWEIRMNIILGTAKGLTYLHEG------LEP-- 280 (442)
Q Consensus 225 ~~~~~~lv~E~~~~g~L~~~l~~~~~~----------------~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-- 280 (442)
.....++||||+.+++|.++++..... ........+..++.|++.||.|||+. +++
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 556789999999999999998753110 00112334567999999999999875 332
Q ss_pred ------CCCeEEecccCccccCCCcceeecccccccCCCCcccccCC----------------------CCCCcCCchhh
Q 047892 281 ------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG----------------------MLNETSDVYSF 332 (442)
Q Consensus 281 ------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDvwSl 332 (442)
++.+||+|||+++.+............+|+.|||||.+... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 46899999999987654444444567899999999966322 23456799999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCccchh-------hhHHHHHHHHhhcCCcccccCcccCC--CCcHHHHHHHHHHHhhhhC
Q 047892 333 GILIMEVISGRNPVDYSRPPGEFQFQ-------VNLFEWLKTMVTNGNAEGVLDPRLQE--KPSSRALKRALLVALRCVD 403 (442)
Q Consensus 333 Gvil~elltg~~Pf~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~ 403 (442)
||+||||+++..|++.. ..++. .+...|.... ... ..+.+.. ...........+|+.+||+
T Consensus 366 GviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLV-EPR-----ASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhh-ccc-----cchhhhhhhhhccccchHHHHHHHHHcc
Confidence 99999999977665321 00000 0011111100 000 0000000 0000112235579999999
Q ss_pred CCCCCCCCHHHHHHH
Q 047892 404 PNAHKRPKMGHVIHM 418 (442)
Q Consensus 404 ~dP~~RPs~~evl~~ 418 (442)
.||++|||+.|+++.
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-29 Score=213.41 Aligned_cols=195 Identities=23% Similarity=0.321 Sum_probs=160.5
Q ss_pred HHHhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc-chhhHHHHHHHHHHHH-hcCCCCcceEEEEEEeCCee
Q 047892 153 LEVSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIG-RVRHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 153 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~~~ 229 (442)
+++..+++..+..||+|++|.|-+.++ .+|...|+|.+... ..+..+.+.+|+++.. ...+|.+|++||...+....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 566677778889999999999988884 56999999999643 4556677888998754 45899999999999999999
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC--------------CCCCCCeEEecccCcccc
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--------------LEPKWNPKLSDFGLAKLL 295 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------------l~~~~~~kl~DFGla~~~ 295 (442)
||.||.|+. +|..|-++-......+++...-+|+..+.+||.|||++ ++.+|++|+||||.+-.+
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 999999987 89888665444567899999999999999999999765 445789999999999887
Q ss_pred CCCcceeecccccccCCCCcccccC----CCCCCcCCchhhHHHHHHHHhCCCCCCCCC
Q 047892 296 GAERSYVTTRVMGTFGYVAPEYAST----GMLNETSDVYSFGILIMEVISGRNPVDYSR 350 (442)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvil~elltg~~Pf~~~~ 350 (442)
.+.- ..+...|...|||||.+.. ..|+-+|||||||+++.||.+++.||+...
T Consensus 200 ~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 200 VDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred hhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 4432 2233568889999998843 369999999999999999999999997543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=244.90 Aligned_cols=233 Identities=26% Similarity=0.380 Sum_probs=172.0
Q ss_pred CCccCeeccCCcEE-EEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeeeEEecCC
Q 047892 160 FADENVIGEGGYGI-VYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRMLVNEYVD 237 (442)
Q Consensus 160 ~~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~ 237 (442)
|...+++|.|+.|+ ||+|.+ .++.||||++.. .......+|+..|+.- +|||||++++.-.+..+.||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 34457889998874 799999 578999999843 3345567899999887 69999999999999999999999998
Q ss_pred CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc------CCCCC------------CCeEEecccCccccCCCc
Q 047892 238 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE------GLEPK------------WNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 238 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~------~l~~~------------~~~kl~DFGla~~~~~~~ 299 (442)
. +|.+++...............+.+..|++.||++||+ +++|. ..++|+|||+++.+....
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 7 9999998741111111113456778889999988865 45553 367999999999986655
Q ss_pred ce--eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 300 SY--VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 300 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
.. ...+..||-+|+|||++....-+.++||+|+||++|+.++ |.+||...... +.++.. .+..+.
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-----~~NIl~------~~~~L~- 733 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-----QANILT------GNYTLV- 733 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-----hhhhhc------Ccccee-
Confidence 43 2345689999999999998888889999999999999999 59999653211 111110 000000
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.+. +..++ +..+||.+|++.||..||+|.+|+.
T Consensus 734 ----~L~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 ----HLE--PLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ----eec--cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 111 11112 6788999999999999999999964
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=238.45 Aligned_cols=200 Identities=21% Similarity=0.323 Sum_probs=160.5
Q ss_pred hhHHHhhCCCCccCeeccCCcEEEEEEE-ECCCCeEEEEEecCcch---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 047892 151 RELEVSTNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG 226 (442)
Q Consensus 151 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 226 (442)
+.-.....-|..++.||-|+||+|.+++ .++...+|+|.+.+.+- ......+.|-+||...+++-||+||-.|.++
T Consensus 622 kRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk 701 (1034)
T KOG0608|consen 622 KRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK 701 (1034)
T ss_pred HHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC
Confidence 3334555668888999999999999998 45577899999966543 2334577899999999999999999999999
Q ss_pred CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhh------hhcCCCC-------CCCeEEecccCcc
Q 047892 227 AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY------LHEGLEP-------KWNPKLSDFGLAK 293 (442)
Q Consensus 227 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~y------LH~~l~~-------~~~~kl~DFGla~ 293 (442)
+.+|+||||++|||+..+|.+. +.+.+..++.++.++..|+++ +|++|++ +|++||+||||+.
T Consensus 702 dnLYFVMdYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 702 DNLYFVMDYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 777 (1034)
T ss_pred CceEEEEeccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccc
Confidence 9999999999999999998765 568888888888887777665 5566554 6899999999996
Q ss_pred ccCC---Ccce--------------------------------------eecccccccCCCCcccccCCCCCCcCCchhh
Q 047892 294 LLGA---ERSY--------------------------------------VTTRVMGTFGYVAPEYASTGMLNETSDVYSF 332 (442)
Q Consensus 294 ~~~~---~~~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 332 (442)
-+.- ...+ .....+||+.|+|||++....|+..+|+||.
T Consensus 778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~ 857 (1034)
T KOG0608|consen 778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV 857 (1034)
T ss_pred cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence 4310 0000 0012479999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCc
Q 047892 333 GILIMEVISGRNPVDYSRPPGE 354 (442)
Q Consensus 333 Gvil~elltg~~Pf~~~~~~~~ 354 (442)
|||||||+.|+.||....+.+.
T Consensus 858 gvil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 858 GVILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred hHHHHHHhhCCCCccCCCCCcc
Confidence 9999999999999988776554
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-29 Score=238.77 Aligned_cols=266 Identities=20% Similarity=0.206 Sum_probs=194.6
Q ss_pred eeehhhHHHhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcC------CCCcceE
Q 047892 147 WYTLRELEVSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR------HKNLVRL 219 (442)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~l 219 (442)
+|.+.-.++..+.|.+....|+|-|++|.+|... .|+.||||+|.++. ...+.=++|+++|++|+ --|+++|
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 5777777888899999999999999999999954 48899999997653 33345567999999995 3489999
Q ss_pred EEEEEeCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhh------hhhcCCCCCC--------CeE
Q 047892 220 VGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT------YLHEGLEPKW--------NPK 285 (442)
Q Consensus 220 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~------yLH~~l~~~~--------~~k 285 (442)
+-.|...+++|||+|-+.- +|.+.|++. +.+..|....+..++.|+..||. .||.+|+|++ .+|
T Consensus 500 ~r~F~hknHLClVFE~Lsl-NLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPLSL-NLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HHHhhhcceeEEEehhhhc-hHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceee
Confidence 9999999999999999876 999999864 23344666666666666666555 5699999875 579
Q ss_pred EecccCccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHH
Q 047892 286 LSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWL 365 (442)
Q Consensus 286 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 365 (442)
|||||.|...+.+.. +.+.-+..|.|||++.+.+|+...|+||.||+||||.||+..|.+......+...+.+..-+
T Consensus 578 LCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~ 654 (752)
T KOG0670|consen 578 LCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF 654 (752)
T ss_pred eccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence 999999988755442 23345678999999999999999999999999999999999998866544332222221110
Q ss_pred -HHHhhcCCc---------------------------ccccCc------cc-----CCCCcHHHHHHHHHHHhhhhCCCC
Q 047892 366 -KTMVTNGNA---------------------------EGVLDP------RL-----QEKPSSRALKRALLVALRCVDPNA 406 (442)
Q Consensus 366 -~~~~~~~~~---------------------------~~~~~~------~~-----~~~~~~~~~~~~~~li~~cl~~dP 406 (442)
..++..+.+ ...+.| .+ ...........+.+|+.+||..||
T Consensus 655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP 734 (752)
T KOG0670|consen 655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP 734 (752)
T ss_pred cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence 111111110 001111 00 011223456678899999999999
Q ss_pred CCCCCHHHHHHH
Q 047892 407 HKRPKMGHVIHM 418 (442)
Q Consensus 407 ~~RPs~~evl~~ 418 (442)
++|.|..+.|+.
T Consensus 735 ~KRit~nqAL~H 746 (752)
T KOG0670|consen 735 EKRITVNQALKH 746 (752)
T ss_pred hhcCCHHHHhcC
Confidence 999999998763
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-29 Score=244.90 Aligned_cols=241 Identities=24% Similarity=0.341 Sum_probs=190.3
Q ss_pred hhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 156 STNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
..++|..+..+|.|.||.||+++. ..++..|+|.++-........++.|+-+++..+|||||.++|.+...+..|++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 456799999999999999999995 4589999999987766677778889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
||.+|+|.+.-+.. +++++.++..+++..+.||.|||+. +...|.+|++|||.+..++..-.
T Consensus 93 ycgggslQdiy~~T----gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~- 167 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA- 167 (829)
T ss_pred ecCCCcccceeeec----ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhh-
Confidence 99999999877654 6899999999999999999999976 55678999999999876644322
Q ss_pred eecccccccCCCCcccc---cCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 302 VTTRVMGTFGYVAPEYA---STGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
....+.||+.|||||+. ..+.|...+|||++|++..|+---++|.....+ .+.+.-+ ....+ -
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp----------mr~l~Lm-TkS~~---q 233 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP----------MRALFLM-TKSGF---Q 233 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch----------HHHHHHh-hccCC---C
Confidence 23457899999999987 356799999999999999999888888543222 1111111 11111 1
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.+.+.. .....+.+-+|++.|+..+|++|||++.+|.
T Consensus 234 pp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 PPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 122221 2234556778999999999999999987653
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=218.92 Aligned_cols=256 Identities=20% Similarity=0.299 Sum_probs=187.8
Q ss_pred CCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-----eeee
Q 047892 160 FADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA-----HRML 231 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~l 231 (442)
.+-.+.||-|+||.||.+.+ ++|+.||+|++.+- +-...+.+.+|+++|..++|.|++..+++..... .+|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 44567899999999999996 45999999998643 2344577889999999999999999998876542 4689
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC-------CCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP-------KWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-------~~~~kl~DFGla~~~~~~ 298 (442)
++|+|.. ||...|-.. +.++...+.-+..||++||.|||+. ++| +..+||||||+++.....
T Consensus 135 ~TELmQS-DLHKIIVSP----Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSP----QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHh-hhhheeccC----CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence 9999986 888777543 6788888889999999999999754 555 346799999999987666
Q ss_pred cceeecccccccCCCCcccccCCC-CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHH-----HHHHHhhcC
Q 047892 299 RSYVTTRVMGTFGYVAPEYASTGM-LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFE-----WLKTMVTNG 372 (442)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 372 (442)
+....+..+-|-.|.|||++.+.+ |+.+.||||.|||+.||+..+..|...++....+...++.. .++ ...++
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr-~ACEG 288 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMK-YACEG 288 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHH-HHhhh
Confidence 555566667789999999998865 99999999999999999999999988777554443333221 111 11111
Q ss_pred CcccccCcccC---------CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 373 NAEGVLDPRLQ---------EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 373 ~~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
...-++....+ ...+...-.+.+.+...++..||++|.+..+.+..+..
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 11111111111 11112233456677888999999999999988876543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-25 Score=197.35 Aligned_cols=198 Identities=31% Similarity=0.545 Sum_probs=166.3
Q ss_pred eccCCcEEEEEEEECC-CCeEEEEEecCcchh-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCCCHHH
Q 047892 166 IGEGGYGIVYRGVLED-NTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQ 243 (442)
Q Consensus 166 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~ 243 (442)
||+|.+|.||++.... ++.+++|.+...... ....+.+|++.++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999998654332 34678899999999999999999999999899999999999999999
Q ss_pred HHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCC-CCCeEEecccCccccCCCcceeecccccc
Q 047892 244 WLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEP-KWNPKLSDFGLAKLLGAERSYVTTRVMGT 309 (442)
Q Consensus 244 ~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt 309 (442)
++.... ..+++..+..++.+++.++.|||.. +.+ ++.++|+|||.+........ ......+.
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 987531 3688999999999999999999876 344 68899999999987644321 12234578
Q ss_pred cCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcH
Q 047892 310 FGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSS 388 (442)
Q Consensus 310 ~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (442)
..|++||.+... .++.++|+|++|+++++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 899999999777 788999999999999998
Q ss_pred HHHHHHHHHHhhhhCCCCCCCCCHHHHHHHH
Q 047892 389 RALKRALLVALRCVDPNAHKRPKMGHVIHML 419 (442)
Q Consensus 389 ~~~~~~~~li~~cl~~dP~~RPs~~evl~~L 419 (442)
..+.+++.+|++.||++||++.++++.|
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3366789999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-26 Score=198.70 Aligned_cols=249 Identities=19% Similarity=0.311 Sum_probs=180.1
Q ss_pred hCCCCccCeeccCCcEEEEEEE-ECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCC--eeeeE
Q 047892 157 TNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLVGYCAEGA--HRMLV 232 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~--~~~lv 232 (442)
.++|++.+++|+|.|++||.|. ..+++.++||.++ +...+.+.+|+.+|..|. ||||++++++..+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK---PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK---PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeec---hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4578999999999999999999 5678899999994 445577899999999997 999999999987653 45799
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCCCC--------CeEEecccCccccCCC
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEPKW--------NPKLSDFGLAKLLGAE 298 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~~~--------~~kl~DFGla~~~~~~ 298 (442)
+||+.+.+...+- ..++...+..++.+++.||.|+|+. ++|++ .++|+|+|+|.+....
T Consensus 114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 9999998887764 3567777888999999999999765 66654 6899999999987655
Q ss_pred cceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCC-Cccchh------hhHHHHHHHHhh
Q 047892 299 RSYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPP-GEFQFQ------VNLFEWLKTMVT 370 (442)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~-~~~~~~------~~~~~~~~~~~~ 370 (442)
..+. -.+.+..|.-||.+.. ..|+..-|+|||||+|..|+..+.||...... +..... ..+..++.....
T Consensus 187 ~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 187 KEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred ceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 5433 2356788999998865 45889999999999999999999998654332 111111 111122211111
Q ss_pred --cCCcccccCcc--------cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 371 --NGNAEGVLDPR--------LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 371 --~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
+..+..++... ...+-..-...+.++|+.+.|..|-.+|+||.|...
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 01111111110 011111123467888999999999999999998865
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-25 Score=201.34 Aligned_cols=186 Identities=29% Similarity=0.433 Sum_probs=156.7
Q ss_pred CCccCeeccCCcEEEEEEEECC-CCeEEEEEecCcchh-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCC
Q 047892 160 FADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVD 237 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 237 (442)
|.+.+.||+|++|.||++.... ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999755 889999999765444 56788899999999999999999999998899999999999
Q ss_pred CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeec
Q 047892 238 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTT 304 (442)
Q Consensus 238 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~ 304 (442)
+++|.+++.... ..+++.....++.+++.++.|||.. +++++.++|+|||++............
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 999999997642 1178899999999999999999876 445689999999999876543211223
Q ss_pred ccccccCCCCcccc-cCCCCCCcCCchhhHHHHHHHHhCCCCCCC
Q 047892 305 RVMGTFGYVAPEYA-STGMLNETSDVYSFGILIMEVISGRNPVDY 348 (442)
Q Consensus 305 ~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvil~elltg~~Pf~~ 348 (442)
...++..|++||.+ ....++.++|||+||+++|||++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 45678899999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-26 Score=220.44 Aligned_cols=183 Identities=21% Similarity=0.343 Sum_probs=152.4
Q ss_pred CCCCccCeeccCCcEEEEEEEECC-CCeEEEEEecCcch----h----hHHHHHHHHHHHHhcC---CCCcceEEEEEEe
Q 047892 158 NGFADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNRG----Q----AEKEFKVEVEAIGRVR---HKNLVRLVGYCAE 225 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~----~----~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~ 225 (442)
.+|..++.+|+|+||.|+.|.++. ...|+||.+.+.+- . ..-.+-.|++||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 468899999999999999999654 66789998854321 1 1112456999999997 9999999999999
Q ss_pred CCeeeeEEecC-CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccC
Q 047892 226 GAHRMLVNEYV-DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGL 291 (442)
Q Consensus 226 ~~~~~lv~E~~-~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGl 291 (442)
++++||+||-. ++-+|+++|..+ ..+++..+..|+.||+.|+++||++ ++.+|.+||+|||.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 99999999975 556999999765 6789999999999999999999876 44568899999999
Q ss_pred ccccCCCcceeecccccccCCCCcccccCCCCC-CcCCchhhHHHHHHHHhCCCCCC
Q 047892 292 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN-ETSDVYSFGILIMEVISGRNPVD 347 (442)
Q Consensus 292 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvil~elltg~~Pf~ 347 (442)
+...... .-..++||..|.|||++.+.+|- ..-|||++|++||-++....||.
T Consensus 717 aa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 8775332 23457899999999999998875 45799999999999999999984
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-26 Score=203.29 Aligned_cols=238 Identities=19% Similarity=0.303 Sum_probs=176.8
Q ss_pred CCCCccCeeccCCcEEEEEEEECCCCeEEEEEecC--cchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 158 NGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLN--NRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
.++.++.+|.+...|+.|+|+|+.+ .+++|++.- ......+.|..|.-.|+-+.||||+.+++.|....++.++..|
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 3455667789999999999999544 455676632 2344556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC---------------CCCCCCeEEecccCccccCCCcc
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
|+.|+|+..++... ...++..++.++++++++|++|||+- ++.+.+.+|+- +-+++ +
T Consensus 269 mp~gslynvlhe~t--~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarism-ad~kf-----s 340 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----S 340 (448)
T ss_pred ccchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheec-cccee-----e
Confidence 99999999998752 34567789999999999999999985 33333333321 10111 1
Q ss_pred eeecccccccCCCCcccccCCCCC---CcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLN---ETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~---~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
+......-.+.||+||.++..+-+ .++|+|||.+++|||.|...||.+..+.+.-. .+
T Consensus 341 fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-------------------ki 401 (448)
T KOG0195|consen 341 FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-------------------KI 401 (448)
T ss_pred eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-------------------hh
Confidence 111223447899999999877644 47899999999999999999998765533210 11
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
--..++...+...+..+.+|+.-|++.||.+||.+..|+-.|+++.
T Consensus 402 aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 402 ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1122333444455566778999999999999999999999988753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-25 Score=194.23 Aligned_cols=160 Identities=22% Similarity=0.184 Sum_probs=116.6
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcCC-------CCCCCeEEecccCccccCCCcceeecccccccC
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL-------EPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 311 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~l-------~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~ 311 (442)
|+|.++++.. ...+++..++.++.|++.||.|||+.- +.++.+|+ ||+++...... ..||+.
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~kp~Nil~~~~~~~~~--fG~~~~~~~~~------~~g~~~ 69 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQAKSGNILLTWDGLLKL--DGSVAFKTPEQ------SRVDPY 69 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccEeEcCccceee--ccceEeecccc------CCCccc
Confidence 6899999754 246999999999999999999999863 44567788 99988754321 268999
Q ss_pred CCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHH
Q 047892 312 YVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRAL 391 (442)
Q Consensus 312 y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (442)
|||||++.+..++.++|||||||++|||++|+.||....... .......... ... .+. .........
T Consensus 70 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-----~~~~~~~~~~-~~~------~~~-~~~~~~~~~ 136 (176)
T smart00750 70 FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-----AILEILLNGM-PAD------DPR-DRSNLESVS 136 (176)
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-----HHHHHHHHHh-ccC------Ccc-ccccHHHHH
Confidence 999999999999999999999999999999999996432211 0111111111 000 000 001112233
Q ss_pred H--HHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 392 K--RALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 392 ~--~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
. .+.+++.+||+.||++|||+.|+++.+...
T Consensus 137 ~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 137 AARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred hhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 3 588999999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-25 Score=201.21 Aligned_cols=250 Identities=23% Similarity=0.232 Sum_probs=177.9
Q ss_pred CCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------ee
Q 047892 159 GFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA------HR 229 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~~ 229 (442)
+|.-+..+|.|.- .|..+.+ -.++.||+|++... .....++..+|..++..++|+||++++.+|+-.. ..
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4666778888887 5555543 24889999988432 2334456778999999999999999999996543 46
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCCC-------CCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEPK-------WNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~~-------~~~kl~DFGla~~~~ 296 (442)
|+|||||.. +|.+.++. .++-.....+..|++.|+.|||+. ++|. ..+||.|||+|+.-.
T Consensus 97 y~v~e~m~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 97 YLVMELMDA-NLCQVILM------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHHHhhhh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 999999987 99999873 366778899999999999999865 5554 578999999998643
Q ss_pred CCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchh------------hhHHHH
Q 047892 297 AERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQ------------VNLFEW 364 (442)
Q Consensus 297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~------------~~~~~~ 364 (442)
. ....+..+.|..|.|||++.+..|.+.+||||+||++.||++|+.-|.+....+.+... ..+...
T Consensus 170 ~--~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 170 T--DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred c--ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 2 24567788999999999999988999999999999999999999999865443322111 111111
Q ss_pred HHHHhhcC-C-----ccccc-CcccCCC--CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 365 LKTMVTNG-N-----AEGVL-DPRLQEK--PSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 365 ~~~~~~~~-~-----~~~~~-~~~~~~~--~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.+..+... . ..+.+ |..++.. .+......+.+++.+||-.||++|.+++++|..
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 11111110 0 00111 1111111 111234457789999999999999999999875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=191.16 Aligned_cols=256 Identities=21% Similarity=0.317 Sum_probs=178.9
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEE-C---CCCeEEEEEecCcchhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCe
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVL-E---DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAH 228 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 228 (442)
....+.|..+++||+|.|+.||++.+ . ..+.||+|.+... .....+.+|+++|..+ .+.||+++.+++...+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 34456689999999999999999984 2 4678999998543 3345688999999998 58999999999999999
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCCCC--------CeEEecccCccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEPKW--------NPKLSDFGLAKL 294 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~~~--------~~kl~DFGla~~ 294 (442)
.++|+||++..+..++... ++...+..+++.+..||.++|.+ ++|.+ .-.|.|||+|..
T Consensus 110 v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred eEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 9999999999999988753 56788888999999999988654 66653 457999999972
Q ss_pred cC-----------------C----------------Ccce-e---------ecccccccCCCCcccccCC-CCCCcCCch
Q 047892 295 LG-----------------A----------------ERSY-V---------TTRVMGTFGYVAPEYASTG-MLNETSDVY 330 (442)
Q Consensus 295 ~~-----------------~----------------~~~~-~---------~~~~~gt~~y~aPE~~~~~-~~~~~sDvw 330 (442)
.. . ...+ . .....||++|.|||++... .-++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 10 0 0000 0 0124699999999998654 477899999
Q ss_pred hhHHHHHHHHhCCCCCCCCCCC-CccchhhhHHHH--HHHHh-hcCC--c----------------ccc----cCcc---
Q 047892 331 SFGILIMEVISGRNPVDYSRPP-GEFQFQVNLFEW--LKTMV-TNGN--A----------------EGV----LDPR--- 381 (442)
Q Consensus 331 SlGvil~elltg~~Pf~~~~~~-~~~~~~~~~~~~--~~~~~-~~~~--~----------------~~~----~~~~--- 381 (442)
|.|||+.-+++++.||...... +.......+..+ +++.. ..+. + ..+ +.+.
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 9999999999999998643221 111111111111 11100 0000 0 000 0000
Q ss_pred -cC-CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 382 -LQ-EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 382 -~~-~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.. .......+..+++|+.+|++.||.+|.|+++.|+.
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00 11112234468899999999999999999999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=180.69 Aligned_cols=236 Identities=19% Similarity=0.327 Sum_probs=166.6
Q ss_pred CCCCccCeeccCCcEEEEEEEECC-CCeEEEEEecCcchhhHHHHHHHHHHHHhc-CCCCcceEEEE-EEeCCeeeeEEe
Q 047892 158 NGFADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVGY-CAEGAHRMLVNE 234 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~-~~~~~~~~lv~E 234 (442)
+.|.+.+.||+|.||.+-+|.++. ++.+++|.+... ....++|.+|...--.| .|.||+.-|++ |+..+.+++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 568999999999999999999654 677889987553 34567899998876666 58999988875 677788889999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC---------CCCeEEecccCccccCCCc
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP---------KWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~---------~~~~kl~DFGla~~~~~~~ 299 (442)
|++.|||..-+.. ..+.+.....++.|+++|++|+|+. ++. ..++||||||+.+..+..-
T Consensus 103 ~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred cCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence 9999999987643 3577888899999999999999875 332 2378999999987653221
Q ss_pred ceeecccccccCCCCcccccC---CC--CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 300 SYVTTRVMGTFGYVAPEYAST---GM--LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~---~~--~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
....-+..|.+||.+.. +. ..+.+|||.||+++|.++||++||+.....+. .-++|..... +..
T Consensus 178 ----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-----~Y~~~~~w~~--rk~ 246 (378)
T KOG1345|consen 178 ----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-----PYWEWEQWLK--RKN 246 (378)
T ss_pred ----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-----hHHHHHHHhc--ccC
Confidence 12234567899997643 22 46789999999999999999999974332211 1122222111 111
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHH
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVI 416 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl 416 (442)
+.++.. -...++.+..+.++-|..+|++|--..++.
T Consensus 247 -----~~~P~~-F~~fs~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 247 -----PALPKK-FNPFSEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred -----ccCchh-hcccCHHHHHHHHHhcCCcccccchhHHHH
Confidence 111111 112345566777789999999994444443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.2e-23 Score=221.13 Aligned_cols=183 Identities=19% Similarity=0.252 Sum_probs=125.3
Q ss_pred hcCC-CCcceEEEEE-------EeCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC----
Q 047892 210 RVRH-KNLVRLVGYC-------AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---- 277 (442)
Q Consensus 210 ~l~h-pnIv~l~~~~-------~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---- 277 (442)
.++| +||++++++| .....+++++||+. ++|.++|... ...+++..++.++.||+.||.|||+.
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 3455 5888888877 23346778899885 4999999643 24689999999999999999999876
Q ss_pred --CCC--------------------------CCCeEEecccCccccCCCc---------------ceeecccccccCCCC
Q 047892 278 --LEP--------------------------KWNPKLSDFGLAKLLGAER---------------SYVTTRVMGTFGYVA 314 (442)
Q Consensus 278 --l~~--------------------------~~~~kl~DFGla~~~~~~~---------------~~~~~~~~gt~~y~a 314 (442)
++| ++.+||+|||+++...... .......+||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 333 2345677777775421100 000112468899999
Q ss_pred cccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHH
Q 047892 315 PEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRA 394 (442)
Q Consensus 315 PE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (442)
||++.+..|+.++|||||||+||||++|..|+.... .....+.. ..+.+.. .......
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---------~~~~~~~~--------~~~~~~~-----~~~~~~~ 241 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---------RTMSSLRH--------RVLPPQI-----LLNWPKE 241 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---------HHHHHHHH--------hhcChhh-----hhcCHHH
Confidence 999999999999999999999999999988864211 00110100 0011111 1112335
Q ss_pred HHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 395 LLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 395 ~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
..++.+||+.||.+|||+.|+++.
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhc
Confidence 578889999999999999999853
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.4e-18 Score=162.66 Aligned_cols=248 Identities=26% Similarity=0.367 Sum_probs=180.3
Q ss_pred CCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchh---hHHHHHHHHHHHHhcCCC-CcceEEEEEEeCCeeeeEEec
Q 047892 160 FADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQ---AEKEFKVEVEAIGRVRHK-NLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~~~lv~E~ 235 (442)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +|+++++.+......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999976 78999988654322 467789999999999988 799999999877778999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCC-CeEEecccCccccCCCcce
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKW-NPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~-~~kl~DFGla~~~~~~~~~ 301 (442)
+.++++.+++...... ..+.......+..|++.++.|+|+. + +..+ .++++|||+++........
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999999877654211 2688899999999999999999865 2 2344 6899999999865443321
Q ss_pred -----eecccccccCCCCcccccC---CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC
Q 047892 302 -----VTTRVMGTFGYVAPEYAST---GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373 (442)
Q Consensus 302 -----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (442)
......||..|+|||.+.+ ..++...|+||+|++++++++|..||........ .......+......
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~-- 233 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA---TSQTLKIILELPTP-- 233 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcccc---HHHHHHHHHhcCCc--
Confidence 2356789999999999987 5788899999999999999999999765432100 01111111111100
Q ss_pred cccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 374 AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.................+.+++.+|+..+|..|.+..+....
T Consensus 234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000001111002223457778899999999999998877654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-19 Score=176.77 Aligned_cols=204 Identities=25% Similarity=0.458 Sum_probs=148.6
Q ss_pred HHhcCCCCcceEEEEEEeCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC----------
Q 047892 208 IGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---------- 277 (442)
Q Consensus 208 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---------- 277 (442)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+... ...+++.....+.++++.||+|||..
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecc
Confidence 45689999999999999999999999999999999999763 46789999999999999999999976
Q ss_pred ----CCCCCCeEEecccCccccCCCc-ceeecccccccCCCCcccccCCC-------CCCcCCchhhHHHHHHHHhCCCC
Q 047892 278 ----LEPKWNPKLSDFGLAKLLGAER-SYVTTRVMGTFGYVAPEYASTGM-------LNETSDVYSFGILIMEVISGRNP 345 (442)
Q Consensus 278 ----l~~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDvwSlGvil~elltg~~P 345 (442)
++..+.+||+|||+........ ........-..-|.|||.+.... .+.++||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 4445688999999988763210 01111112345799999986632 35679999999999999999999
Q ss_pred CCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCC
Q 047892 346 VDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 424 (442)
Q Consensus 346 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 424 (442)
|+........ ..+...+.. .....+.|.+.... ...+.+..++.+||..+|.+||++++|-..++.+..
T Consensus 158 ~~~~~~~~~~---~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 158 FDLRNLVEDP---DEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccccCCh---HHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9865433221 112222211 11122222222111 333468889999999999999999999988877654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.4e-19 Score=170.33 Aligned_cols=159 Identities=19% Similarity=0.234 Sum_probs=115.0
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC--CCCeEEEEEecCc-----chhhHHHHHHHHHHHHhcCCCCcce-EEEEEEeCCe
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE--DNTNVAVKNLLNN-----RGQAEKEFKVEVEAIGRVRHKNLVR-LVGYCAEGAH 228 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~-l~~~~~~~~~ 228 (442)
.++|.+.+.||+|+||+||+|.+. +++.||||++... .......+.+|+++|++++|+||+. ++++ +.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~ 92 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK 92 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence 456999999999999999999864 4777899987432 1223566899999999999999985 4432 45
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-CC-------CCCeEEecccCccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-EP-------KWNPKLSDFGLAKL 294 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-~~-------~~~~kl~DFGla~~ 294 (442)
.|+||||++|++|... ... . ...++.|+++||.|||+. + +| ++.+||+|||+|+.
T Consensus 93 ~~LVmE~~~G~~L~~~-~~~----~------~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-RPH----G------DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred cEEEEEccCCCCHHHh-Ccc----c------hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 7999999999999732 110 1 135678889999998764 6 55 45799999999987
Q ss_pred cCCCcce-------eecccccccCCCCcccccCCC------CCCcCCch
Q 047892 295 LGAERSY-------VTTRVMGTFGYVAPEYASTGM------LNETSDVY 330 (442)
Q Consensus 295 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~------~~~~sDvw 330 (442)
+...... ..+...+++.|+|||.+.... .+..+|-|
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 6432210 013467889999999985432 23346666
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.8e-20 Score=191.68 Aligned_cols=240 Identities=19% Similarity=0.230 Sum_probs=168.4
Q ss_pred CccCeeccCCcEEEEEEEE-CCCCeEEEEEec----Cc-ch-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 161 ADENVIGEGGYGIVYRGVL-EDNTNVAVKNLL----NN-RG-QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 161 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~----~~-~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
.....+|.|++|.|+.+.. .....++.|... .. .. .....+..|+.+-..+.|||++..+..+.+....+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999998877763 234444444332 11 11 11122667888888999999988877776666666669
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
|||++ ||+.++... ..+....+..++.|++.|+.|+|.. +..+|.+||+|||.+........
T Consensus 401 E~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 99999 999999764 4577888899999999999999875 33457899999999876532222
Q ss_pred ---eeecccccccCCCCcccccCCCCCCc-CCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 301 ---YVTTRVMGTFGYVAPEYASTGMLNET-SDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 301 ---~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
......+|+-.|+|||.+.+..|++. .||||.|+++..|.+|+.||......+.... ....... ..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~---------~~~~~~~-~~ 545 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK---------TNNYSDQ-RN 545 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh---------hhccccc-cc
Confidence 34556789999999999999999975 6999999999999999999976544322100 0000000 00
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
... -........+.....++.++|+.||.+|.|+.+|++
T Consensus 546 ~~~--~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 IFE--GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccc--ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000 000111233455667899999999999999999985
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.4e-17 Score=159.54 Aligned_cols=245 Identities=16% Similarity=0.191 Sum_probs=173.5
Q ss_pred CCCccCeeccCCcEEEEEEEECCC--CeEEEEEecCcchhhHHHHHHHHHHHHhcCC----CCcceEEEEE-EeCCeeee
Q 047892 159 GFADENVIGEGGYGIVYRGVLEDN--TNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH----KNLVRLVGYC-AEGAHRML 231 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----pnIv~l~~~~-~~~~~~~l 231 (442)
+|.+.+.||+|+||.||+|..... ..+|+|............+..|..++..+.+ +++..+++.. ......|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 688999999999999999996543 4788887654322222267789999988863 6899999988 57778899
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc------CCCCC------------CCeEEecccCcc
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE------GLEPK------------WNPKLSDFGLAK 293 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~------~l~~~------------~~~kl~DFGla~ 293 (442)
||+.+.. +|.++..... ...++....+.++.|++.+|++||+ +++|. ..+.|.|||+++
T Consensus 99 VM~l~G~-sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 99 VMSLLGP-SLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEeccCc-cHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9999854 9999876543 4679999999999999999976654 44432 358999999998
Q ss_pred --ccCCCcc-----e--eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHH
Q 047892 294 --LLGAERS-----Y--VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEW 364 (442)
Q Consensus 294 --~~~~~~~-----~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 364 (442)
....... . ....+.||..|+++.+..+...+.+.|+||++-++.|++.|..||......... ..
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~-------~~ 248 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK-------SK 248 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH-------HH
Confidence 3211111 1 122356999999999999999999999999999999999999999654432221 11
Q ss_pred HHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 365 LKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
+........ ... .....+..+..+...+-..+...+|....+...|...
T Consensus 249 ~~~~~~~~~----~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 249 FEKDPRKLL----TDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHHhhhhc----ccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 111110000 000 1111223344455555558999999999998887654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.5e-19 Score=178.55 Aligned_cols=221 Identities=24% Similarity=0.246 Sum_probs=166.6
Q ss_pred eeccCCcEEEEEEE----ECCCCeEEEEEecCcch--hhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeeeEEecCC
Q 047892 165 VIGEGGYGIVYRGV----LEDNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVR-HKNLVRLVGYCAEGAHRMLVNEYVD 237 (442)
Q Consensus 165 ~lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~ 237 (442)
++|+|+||.|+++. .+.+..+|+|.+.+... ........|..++..++ ||.+|++.-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999876 23477788887754321 11114455788888886 9999999999999999999999999
Q ss_pred CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeec
Q 047892 238 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTT 304 (442)
Q Consensus 238 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~ 304 (442)
+|+|...+... ..+.+.....+...++-+++++|.. ++.+|++|+.|||+++..-....
T Consensus 81 gg~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKE----VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred cchhhhccccC----CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence 99999887654 4566677777777888899999875 56688999999999987643322
Q ss_pred ccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCC
Q 047892 305 RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQE 384 (442)
Q Consensus 305 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (442)
.|||..|||||++. .....+|+||||++++||+||..||... . +... + ....
T Consensus 153 -~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~-----------~---~~~I---------l--~~~~ 204 (612)
T KOG0603|consen 153 -ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD-----------T---MKRI---------L--KAEL 204 (612)
T ss_pred -cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH-----------H---HHHH---------h--hhcc
Confidence 28999999999986 5678999999999999999999999640 1 1111 1 1122
Q ss_pred CCcHHHHHHHHHHHhhhhCCCCCCCCCH--HHHHHHHhc
Q 047892 385 KPSSRALKRALLVALRCVDPNAHKRPKM--GHVIHMLEA 421 (442)
Q Consensus 385 ~~~~~~~~~~~~li~~cl~~dP~~RPs~--~evl~~L~~ 421 (442)
..+........+++..++..+|..|.-. ..+.+.++.
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h 243 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQH 243 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhcc
Confidence 3445556667778889999999999765 455555544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=7.2e-17 Score=145.83 Aligned_cols=160 Identities=11% Similarity=0.116 Sum_probs=114.4
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHH---H------HHHHHHHHHhcCCCCcceEEEEEE
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEK---E------FKVEVEAIGRVRHKNLVRLVGYCA 224 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~hpnIv~l~~~~~ 224 (442)
.+..++|+..++||.|+||.||+... ++..+|+|.+......... . +.+|+..+.+++||+|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 45678899999999999999999766 5778999999644322222 2 678999999999999999998865
Q ss_pred eC--------CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc------CC-------CCCCC
Q 047892 225 EG--------AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE------GL-------EPKWN 283 (442)
Q Consensus 225 ~~--------~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~------~l-------~~~~~ 283 (442)
.. +..+|||||++|.+|.++.. ++.. ...+++.++..+|+ ++ ++++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh--------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-
Confidence 43 35789999999999988742 2222 23456666666655 43 3456
Q ss_pred eEEecccCccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHH
Q 047892 284 PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVI 340 (442)
Q Consensus 284 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ell 340 (442)
++|+|||..+........ ..++....|+.++|+||||+++..+.
T Consensus 173 i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988754221110 01334556778999999999886543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.1e-16 Score=142.90 Aligned_cols=186 Identities=19% Similarity=0.279 Sum_probs=149.1
Q ss_pred CCCccCeeccCCcEEEEEEE-ECCCCeEEEEEecCcchhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeeeEEecC
Q 047892 159 GFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
.|++.++||+|+||+++.|. +-+++.||||.-... ...-++..|.+..+.| ..++|..++-+-..+-+-.||+|++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 48999999999999999999 557899999964322 2223466678777777 4699999998888888889999998
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCCC------------CCeEEecccCccccCCC
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEPK------------WNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~~------------~~~kl~DFGla~~~~~~ 298 (442)
.. +|.++..-. ...++.....-+|.|++.-++|+|.. ++|+ +.+.|+|||+|+...+.
T Consensus 107 GP-SLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 107 GP-SLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred Cc-CHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 54 776665432 24688999999999999999999976 6665 35789999999987554
Q ss_pred cce------eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCC
Q 047892 299 RSY------VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSR 350 (442)
Q Consensus 299 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~ 350 (442)
... ......||.+||+--.-.+..-+.+.|+=|+|-++...|.|..||.+..
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 422 1234679999999888888888999999999999999999999998753
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.7e-16 Score=139.38 Aligned_cols=192 Identities=19% Similarity=0.249 Sum_probs=150.7
Q ss_pred HhhCCCCccCeeccCCcEEEEEEE-ECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCC-CCcceEEEEEEeCCeeeeE
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH-KNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv 232 (442)
+..+.|.+++.||.|+||.+|.|. ..+|..||||.-.... ....+..|..+...|+| ..|..+..+..++.+-.+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 445679999999999999999999 6779999999753322 22346678888888865 6788888888889999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhh------cCCCCCC----------CeEEecccCccccC
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH------EGLEPKW----------NPKLSDFGLAKLLG 296 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH------~~l~~~~----------~~kl~DFGla~~~~ 296 (442)
||+... +|.++..-. ...++....+-++-|++.-++|+| ++++|++ .+-|+|||+|+...
T Consensus 90 MdLLGP-sLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 90 MDLLGP-SLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeccCc-cHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 999854 887776432 235788888999999998888775 5688875 57899999998764
Q ss_pred CCcc------eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCC
Q 047892 297 AERS------YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPP 352 (442)
Q Consensus 297 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~ 352 (442)
+... .......||.+|.+--...+...+.+.|+=|+|-+|.....|..||++....
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 3321 1234568999999987777777788999999999999999999999875543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.4e-16 Score=160.57 Aligned_cols=240 Identities=20% Similarity=0.194 Sum_probs=160.7
Q ss_pred CCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcc-hhhHHHHH---HHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 159 GFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNR-GQAEKEFK---VEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~---~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
++...+.||.+.|=+|.+|+++.|. |+||.+.+.. .-..+.+. .|++ ...++|||++.+..+-......|||=+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4667789999999999999987776 9999985543 22333333 3444 556699999998877666677799999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCCCC-------CeEEecccCcccc--CCCc
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEPKW-------NPKLSDFGLAKLL--GAER 299 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~~~-------~~kl~DFGla~~~--~~~~ 299 (442)
|..+ +|.|.|..+ .-+.....+-|+.|++.||.-+|+. ++.++ -+.|+||.--+.. ..++
T Consensus 102 yvkh-nLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHhh-hhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 9988 999988754 3466667788999999999988875 43333 2458999766543 1111
Q ss_pred ce----eecccccccCCCCcccccC----------CC-CCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHH
Q 047892 300 SY----VTTRVMGTFGYVAPEYAST----------GM-LNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFE 363 (442)
Q Consensus 300 ~~----~~~~~~gt~~y~aPE~~~~----------~~-~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 363 (442)
.. .-.+...-..|.|||-+-. .. .+++-||||+||++.||++ |++||... +
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-------------Q 243 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-------------Q 243 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-------------H
Confidence 11 1111122346999997733 12 5677899999999999999 89998531 1
Q ss_pred HHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCC
Q 047892 364 WLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 425 (442)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 425 (442)
.+.-...+....+.+-..+. ...+..++..|++.||.+|.+|++.|+.-.+..+|
T Consensus 244 L~aYr~~~~~~~e~~Le~Ie-------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP 298 (1431)
T KOG1240|consen 244 LLAYRSGNADDPEQLLEKIE-------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFP 298 (1431)
T ss_pred HHhHhccCccCHHHHHHhCc-------CccHHHHHHHHHccCchhccCHHHHHHhhhccccH
Confidence 11000000000000000111 11366799999999999999999999987766544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.7e-15 Score=132.78 Aligned_cols=127 Identities=14% Similarity=0.101 Sum_probs=93.3
Q ss_pred cCeeccCCcEEEEEEEECCCCeEEEEEecCcchh--h------------------------HHHHHHHHHHHHhcCCCCc
Q 047892 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQ--A------------------------EKEFKVEVEAIGRVRHKNL 216 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~hpnI 216 (442)
...||+|+||.||+|...+|+.||||+++..... . .....+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999878999999998643210 0 1122459999999988877
Q ss_pred ceEEEEEEeCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhh-hcC------CCC------CCC
Q 047892 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL-HEG------LEP------KWN 283 (442)
Q Consensus 217 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yL-H~~------l~~------~~~ 283 (442)
.....+... ..+|||||++++++...+... ..++......++.|++.+|.|| |+. ++| ++.
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~~~ 155 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHDGK 155 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEECCc
Confidence 443333222 238999999998776543222 4678889999999999999998 553 333 468
Q ss_pred eEEecccCcccc
Q 047892 284 PKLSDFGLAKLL 295 (442)
Q Consensus 284 ~kl~DFGla~~~ 295 (442)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.3e-15 Score=141.00 Aligned_cols=184 Identities=19% Similarity=0.200 Sum_probs=124.1
Q ss_pred CCCCcceEEEEEEeC---------------------------CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHH
Q 047892 212 RHKNLVRLVGYCAEG---------------------------AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNII 264 (442)
Q Consensus 212 ~hpnIv~l~~~~~~~---------------------------~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~ 264 (442)
+|||||+++++|.+. ..+|+||.-++. +|.+|+-.+ ..+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-----~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-----HRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-----CCchHHHHHHH
Confidence 599999999887542 246899998887 999999654 45666777789
Q ss_pred HHHHHhhhhhhcC------CCCCC-----------CeEEecccCccccCC-----CcceeecccccccCCCCcccccCCC
Q 047892 265 LGTAKGLTYLHEG------LEPKW-----------NPKLSDFGLAKLLGA-----ERSYVTTRVMGTFGYVAPEYASTGM 322 (442)
Q Consensus 265 ~qi~~~l~yLH~~------l~~~~-----------~~kl~DFGla~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~ 322 (442)
.|+++|+.|||++ ++.++ .+.|+|||++-.-.. .-....-..-|...-||||+....+
T Consensus 348 aQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 9999999999765 44333 468999998753211 0011112234677889999875322
Q ss_pred -----C-CCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHH
Q 047892 323 -----L-NETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALL 396 (442)
Q Consensus 323 -----~-~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (442)
. -.|+|.|+.|.+.||+++...||......- .....+++..-|. .+..++..+.+
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~---------------L~~r~Yqe~qLPa----lp~~vpp~~rq 488 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML---------------LDTRTYQESQLPA----LPSRVPPVARQ 488 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchhe---------------echhhhhhhhCCC----CcccCChHHHH
Confidence 1 258999999999999999999996522110 0011111212222 23344455778
Q ss_pred HHhhhhCCCCCCCCCHHHHHHHHh
Q 047892 397 VALRCVDPNAHKRPKMGHVIHMLE 420 (442)
Q Consensus 397 li~~cl~~dP~~RPs~~evl~~L~ 420 (442)
++...|+.||.+|++..-..+.|+
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 889999999999999765555554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.5e-16 Score=162.23 Aligned_cols=201 Identities=23% Similarity=0.328 Sum_probs=133.7
Q ss_pred hCCCCccCeeccCCcEEEEEEEECC-CCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
.++|+.+++|..|+||.||.++++. .+.+|+| +.+++- +.+. ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCccee------------------
Confidence 4578999999999999999998653 6778884 422211 1111 33333444444
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC-------CCCeEEecccCccccCCC----
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP-------KWNPKLSDFGLAKLLGAE---- 298 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-------~~~~kl~DFGla~~~~~~---- 298 (442)
||....++.- +.++... +.+++|||+. +++ -|++|++|||+++.....
T Consensus 136 ---gDc~tllk~~----g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ---GDCATLLKNI----GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ---chhhhhcccC----CCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 6777776653 3343332 5678899865 443 478999999998753110
Q ss_pred ----------cceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhh-hHHHHHHH
Q 047892 299 ----------RSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQV-NLFEWLKT 367 (442)
Q Consensus 299 ----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~-~~~~~~~~ 367 (442)
........+||+.|.|||++....|+..+|+|++|+|+||.+.|+.||.++.+.+.+.... +.+.|
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w--- 277 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW--- 277 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc---
Confidence 1122345689999999999999999999999999999999999999999887655432110 00010
Q ss_pred HhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 368 MVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
. +.......++.+++.+.|+.+|..|---...++
T Consensus 278 ---------------p-E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~e 311 (1205)
T KOG0606|consen 278 ---------------P-EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALE 311 (1205)
T ss_pred ---------------c-ccCcCCCHHHHHHHHHHHHhChHhhcccchhhh
Confidence 1 112223345778899999999999954333333
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.1e-16 Score=150.34 Aligned_cols=163 Identities=19% Similarity=0.386 Sum_probs=115.1
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhh---hhcCCCC-------CCCeEEecccCccccCC
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY---LHEGLEP-------KWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~y---LH~~l~~-------~~~~kl~DFGla~~~~~ 297 (442)
.+||.|++|...+|.+||.+.. .....++.....++.|++.|++| +|+++++ +..+||.|||+......
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~yk~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~ 408 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEYKGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDK 408 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhhccchhhhccccccccccchhhhhhhhhheeeccc
Confidence 5789999999999999997542 23456778889999999999974 6877654 34799999999876543
Q ss_pred Cc-----ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhc
Q 047892 298 ER-----SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTN 371 (442)
Q Consensus 298 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (442)
.. ....+...||..||+||.+.+..|+.++||||||++|+||++ =..+|... .... . ..
T Consensus 409 ~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------~t~~---d-~r- 473 (516)
T KOG1033|consen 409 DETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------ATLT---D-IR- 473 (516)
T ss_pred CCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------Hhhh---h-hh-
Confidence 33 223456789999999999999999999999999999999998 33333210 0000 0 00
Q ss_pred CCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHH
Q 047892 372 GNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGH 414 (442)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~e 414 (442)
...+++....+.+ .-..|+++++...|.+||++.+
T Consensus 474 ---~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 474 ---DGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred ---cCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHH
Confidence 1112222222222 2345888999999999995443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.9e-14 Score=126.45 Aligned_cols=128 Identities=18% Similarity=0.135 Sum_probs=95.7
Q ss_pred cCeeccCCcEEEEEEEECCCCeEEEEEecCcchh--------------------------hHHHHHHHHHHHHhcCCCCc
Q 047892 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQ--------------------------AEKEFKVEVEAIGRVRHKNL 216 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~hpnI 216 (442)
...||+|+||.||+|...+|+.||||.+...... ....+.+|.+.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999778999999998643210 01224678999999999988
Q ss_pred ceEEEEEEeCCeeeeEEecCCCCCHHHH-HccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc-C------CCC------CC
Q 047892 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQW-LHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-G------LEP------KW 282 (442)
Q Consensus 217 v~l~~~~~~~~~~~lv~E~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~------l~~------~~ 282 (442)
.....+.... .||||||++++++... +.. ..++......++.|++.++.++|. . ++| ++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~~~ 154 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYHDG 154 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEECC
Confidence 5544443332 4899999998865433 322 356778889999999999999987 4 333 56
Q ss_pred CeEEecccCccccCC
Q 047892 283 NPKLSDFGLAKLLGA 297 (442)
Q Consensus 283 ~~kl~DFGla~~~~~ 297 (442)
.++|+|||++..+..
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 899999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.1e-14 Score=133.82 Aligned_cols=219 Identities=20% Similarity=0.301 Sum_probs=131.8
Q ss_pred CccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCC----------CCcceEEEEE---
Q 047892 161 ADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRH----------KNLVRLVGYC--- 223 (442)
Q Consensus 161 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h----------pnIv~l~~~~--- 223 (442)
...+.||.|+++.||.+++. +++.+|+|.+... .....+.+++|.-....+.+ -.++--++..
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 45678999999999999974 4899999988432 22344556666544443322 1122111211
Q ss_pred ------EeC---C-----eeeeEEecCCCCCHHHHHc---cCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC---------
Q 047892 224 ------AEG---A-----HRMLVNEYVDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--------- 277 (442)
Q Consensus 224 ------~~~---~-----~~~lv~E~~~~g~L~~~l~---~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------- 277 (442)
... . +.+++|+-+.+ ||.+++. ........+....++.+..|+++.+++||+.
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~ 173 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKP 173 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SG
T ss_pred CCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccce
Confidence 111 1 23678888865 8888764 2111122344556677778999999999876
Q ss_pred ----CCCCCCeEEecccCccccCCCcceeecccccccCCCCcccccCC--------CCCCcCCchhhHHHHHHHHhCCCC
Q 047892 278 ----LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG--------MLNETSDVYSFGILIMEVISGRNP 345 (442)
Q Consensus 278 ----l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~sDvwSlGvil~elltg~~P 345 (442)
++++|.++|+||+.....+. .. .. ...+..|.+||..... .++.+.|.|+||+++|.|++|..|
T Consensus 174 ~nfll~~~G~v~Lg~F~~~~r~g~--~~-~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP 249 (288)
T PF14531_consen 174 ENFLLDQDGGVFLGDFSSLVRAGT--RY-RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP 249 (288)
T ss_dssp GGEEE-TTS-EEE--GGGEEETTE--EE-EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred eeEEEcCCCCEEEcChHHHeecCc--ee-ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence 56789999999987765432 11 11 3345789999977432 478899999999999999999999
Q ss_pred CCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCC
Q 047892 346 VDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKR 409 (442)
Q Consensus 346 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R 409 (442)
|....+.... +..+. ... +.++.+..||..+|+.||.+|
T Consensus 250 f~~~~~~~~~-----------------------~~~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 250 FGLSSPEADP-----------------------EWDFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TCCCGGGSTS-----------------------GGGGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCccccc-----------------------cccch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 9754321110 00122 223 677888999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=9.5e-14 Score=123.08 Aligned_cols=173 Identities=14% Similarity=0.076 Sum_probs=119.3
Q ss_pred CccCeeccCCcEEEEEEEECCCCeEEEEEecCcchh----hHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeeeEEec
Q 047892 161 ADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQ----AEKEFKVEVEAIGRVR-HKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 161 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
.....|++|+||+||.+.. .+.+++.+.+...... ....+.+|+++|++|. |++|++++++ +..|++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3457899999999997765 6778887777543221 1235789999999995 5889999886 346999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc------CC-CC-------CCCeEEecccCccccCCCcce
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE------GL-EP-------KWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~------~l-~~-------~~~~kl~DFGla~~~~~~~~~ 301 (442)
+.|.+|.+.+.. . ...++.|++.+|.++|+ ++ ++ ++.++|+|||++.........
T Consensus 80 I~G~~L~~~~~~-----~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 80 LAGAAMYQRPPR-----G------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ecCccHHhhhhh-----h------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999998764321 1 12355666777777765 46 33 568999999999854332210
Q ss_pred ----e--------ecccccccCCCCcccccCC-CCC-CcCCchhhHHHHHHHHhCCCCCCCC
Q 047892 302 ----V--------TTRVMGTFGYVAPEYASTG-MLN-ETSDVYSFGILIMEVISGRNPVDYS 349 (442)
Q Consensus 302 ----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwSlGvil~elltg~~Pf~~~ 349 (442)
. ..-...++.|++|+.-.-. ..+ ...++++.|+-+|.++|+..++..+
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0012357778888744221 233 5679999999999999998887543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=4.3e-14 Score=149.42 Aligned_cols=187 Identities=19% Similarity=0.214 Sum_probs=140.6
Q ss_pred hhHHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcC---CCCcceEEEEEEeCC
Q 047892 151 RELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR---HKNLVRLVGYCAEGA 227 (442)
Q Consensus 151 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~ 227 (442)
.+.++....|.+.+.||+|+||.||+|...+|+.||+|.=+...... |---.+++.+|+ -+.|..+..++.-.+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 35566777899999999999999999998779999999765443221 111123333443 244555555555566
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc------CCCCCC--------------CeEEe
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE------GLEPKW--------------NPKLS 287 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~------~l~~~~--------------~~kl~ 287 (442)
.-+||+||.+.|+|.+++... +.+++...+.++.|++.-++.||. +|+|++ .++|+
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred cceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence 678999999999999999744 578888888888888877777765 477654 57999
Q ss_pred cccCccccCC-CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCC
Q 047892 288 DFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRN 344 (442)
Q Consensus 288 DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~ 344 (442)
|||.+-.+.. .+...-...++|-.+-.+|+..|.+++..+|.|.|..+++-||.|+.
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999865422 11223345678889999999999999999999999999999999874
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.2e-13 Score=120.86 Aligned_cols=124 Identities=15% Similarity=0.235 Sum_probs=90.2
Q ss_pred CCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhc-----CCCCcceEEEEEEeCC---eee-
Q 047892 160 FADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-----RHKNLVRLVGYCAEGA---HRM- 230 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~~~---~~~- 230 (442)
+.-.+.||+|+||.||. ++.....+||++........+.+.+|+.+++.+ +||||++++|++.++. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34457899999999996 433333479988654444557789999999999 6799999999998763 434
Q ss_pred eEEec--CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhh-hhhhcC------CCC-----------CCCeEEeccc
Q 047892 231 LVNEY--VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL-TYLHEG------LEP-----------KWNPKLSDFG 290 (442)
Q Consensus 231 lv~E~--~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l-~yLH~~------l~~-----------~~~~kl~DFG 290 (442)
+|+|| +.+|+|.+++++. .+++. ..++.|++.++ +|||++ +++ +..++|+||+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 5589999999653 24444 34567777777 899875 332 2379999944
Q ss_pred Cc
Q 047892 291 LA 292 (442)
Q Consensus 291 la 292 (442)
-+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.5e-14 Score=149.47 Aligned_cols=237 Identities=20% Similarity=0.267 Sum_probs=171.1
Q ss_pred CCCccCeeccCCcEEEEEEEEC--CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeeeEE
Q 047892 159 GFADENVIGEGGYGIVYRGVLE--DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVR-HKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~ 233 (442)
.|.+.+.||+|+|+.|-..... ....+|+|.+.... .........|..+-..+. |+|++++++........++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4777788999999999888753 34556777664332 233344556777777776 999999999999999999999
Q ss_pred ecCCCCCHHHHH-ccCCCCCCCCCHHHHHHHHHHHHHhhhhhh-cC-------------CCCCC-CeEEecccCccccCC
Q 047892 234 EYVDNGNLEQWL-HGDVGPHSPLTWEIRMNIILGTAKGLTYLH-EG-------------LEPKW-NPKLSDFGLAKLLGA 297 (442)
Q Consensus 234 E~~~~g~L~~~l-~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH-~~-------------l~~~~-~~kl~DFGla~~~~~ 297 (442)
+|..+|++.+.+ +... ...+....-.++.|+..++.|+| .. ++..+ .+|++|||+|.....
T Consensus 101 ~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred CcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999888 4331 13455566778899999999999 33 33345 799999999987655
Q ss_pred --Ccceeeccccc-ccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC
Q 047892 298 --ERSYVTTRVMG-TFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373 (442)
Q Consensus 298 --~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (442)
.........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+.........
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~------------------ 239 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR------------------ 239 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc------------------
Confidence 22333445678 9999999999874 4567889999999999999999999765433211
Q ss_pred cccccCcc--cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHH
Q 047892 374 AEGVLDPR--LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVI 416 (442)
Q Consensus 374 ~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl 416 (442)
........ ....+.........+++.+++..+|..|.+.+++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 240 YSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ceeecccccccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 01111111 11222333445566788899999999999988775
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.7e-12 Score=117.84 Aligned_cols=122 Identities=19% Similarity=0.275 Sum_probs=96.5
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEecCcch--------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 164 NVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRG--------QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
+.||+|++|.||+|.+ .+..|++|....... .....+.+|++++..+.|+||.....++.+.+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 677899997643221 1123577899999999999988877777777888999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC------CCCeEEecccCccc
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP------KWNPKLSDFGLAKL 294 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~------~~~~kl~DFGla~~ 294 (442)
++|++|.+++... .. ....++.+++.+|.++|.. +.+ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEECCCEEEEECCcccC
Confidence 9999999998643 11 6778899999999999864 333 46788999998764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.4e-12 Score=118.65 Aligned_cols=129 Identities=16% Similarity=0.087 Sum_probs=94.2
Q ss_pred CCCccCeeccCCcEEEEEEE--ECCCCeEEEEEecCcchh------------------------hHHHHHHHHHHHHhcC
Q 047892 159 GFADENVIGEGGYGIVYRGV--LEDNTNVAVKNLLNNRGQ------------------------AEKEFKVEVEAIGRVR 212 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 212 (442)
.|.+.+.||+|+||.||+|. ..+|+.||+|.+...... ....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 38889999999999999998 467999999998643110 1123568999999997
Q ss_pred CCC--cceEEEEEEeCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------CCC---
Q 047892 213 HKN--LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------LEP--- 280 (442)
Q Consensus 213 hpn--Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------l~~--- 280 (442)
+.+ +.++++. ...++||||+++++|..+.... ..........++.|++.++.+||.. +++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhE
Confidence 633 4444442 2358999999998887654322 2345556678999999999888754 333
Q ss_pred ---CCCeEEecccCcccc
Q 047892 281 ---KWNPKLSDFGLAKLL 295 (442)
Q Consensus 281 ---~~~~kl~DFGla~~~ 295 (442)
++.++|+|||.+...
T Consensus 181 li~~~~i~LiDFg~a~~~ 198 (237)
T smart00090 181 LVHDGKVVIIDVSQSVEL 198 (237)
T ss_pred EEECCCEEEEEChhhhcc
Confidence 457999999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.4e-12 Score=114.70 Aligned_cols=118 Identities=20% Similarity=0.315 Sum_probs=89.4
Q ss_pred eeccCCcEEEEEEEECCCCeEEEEEecCcch--------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 165 VIGEGGYGIVYRGVLEDNTNVAVKNLLNNRG--------QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 165 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
.||+|+||.||+|.+ ++..|++|....... .....+.+|++++..+.|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 568899998643211 11255778999999999887665555555666779999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC------CCCeEEecccCccc
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP------KWNPKLSDFGLAKL 294 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~------~~~~kl~DFGla~~ 294 (442)
+|++|.+++... .. .++.+++.+|.+||+. +.+ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVRDDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEECCcEEEEECCCCcC
Confidence 999999987542 10 6778888888888764 333 56789999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.35 E-value=6.8e-12 Score=129.83 Aligned_cols=123 Identities=20% Similarity=0.278 Sum_probs=95.1
Q ss_pred CCCccCeeccCCcEEEEEEEECCCCeEEEEEe-cCc-c------hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 159 GFADENVIGEGGYGIVYRGVLEDNTNVAVKNL-LNN-R------GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~-~------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
.|...+.||+|+||.||+|.+... .+++|+. ... . ....+.+.+|++++..++|+||+....++......+
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 356678999999999999987544 3444433 111 1 112356789999999999999998888777777889
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC------CCCCeEEecccCccc
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE------PKWNPKLSDFGLAKL 294 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~------~~~~~kl~DFGla~~ 294 (442)
+||||+++++|.+++. ....++.+++.+|.|||+. ++ .++.++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVRDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEECCcEEEEeCccccc
Confidence 9999999999999874 2467888999999999765 44 356899999999975
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.7e-11 Score=110.14 Aligned_cols=125 Identities=16% Similarity=0.061 Sum_probs=90.4
Q ss_pred CCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcch----------------------hhHHHHHHHHHHHHhcCCCC-
Q 047892 159 GFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRG----------------------QAEKEFKVEVEAIGRVRHKN- 215 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~hpn- 215 (442)
.|.+.+.||+|+||.||+|...+|+.||||.+..... .......+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 3788899999999999999987899999998743210 01123567899999998874
Q ss_pred -cceEEEEEEeCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCC
Q 047892 216 -LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPK 281 (442)
Q Consensus 216 -Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~ 281 (442)
+...++ ....++||||+++++|..+... .....++.+++.++.++|.. ++.+
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC
Confidence 444444 2446899999999999765421 12345677777777777654 3446
Q ss_pred CCeEEecccCccccCC
Q 047892 282 WNPKLSDFGLAKLLGA 297 (442)
Q Consensus 282 ~~~kl~DFGla~~~~~ 297 (442)
+.++|+|||++..+..
T Consensus 162 ~~~~liDfg~~~~~~~ 177 (198)
T cd05144 162 EKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcEEEEECCccccCCC
Confidence 7899999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.5e-12 Score=117.26 Aligned_cols=190 Identities=21% Similarity=0.266 Sum_probs=123.3
Q ss_pred HHHHHhcCCCCcceEEEEEEeC-----CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC--
Q 047892 205 VEAIGRVRHKNLVRLVGYCAEG-----AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-- 277 (442)
Q Consensus 205 ~~~l~~l~hpnIv~l~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-- 277 (442)
+.-|-.+.|.|||+++.|+.+. ....+++|||..|+|.+||++.......+......+++.||..||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 3445667899999999998654 346899999999999999987666667788888999999999999999986
Q ss_pred -------------CCCCCCeEEecccCccccCCC----cceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHH
Q 047892 278 -------------LEPKWNPKLSDFGLAKLLGAE----RSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVI 340 (442)
Q Consensus 278 -------------l~~~~~~kl~DFGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ell 340 (442)
+.+++-+||. -+.-...... .........+-++|.|||.-.....+.++|||+||....||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig-~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIG-SVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEec-ccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 3334445542 2111111000 000011123567899999766666778999999999999999
Q ss_pred hCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 341 SGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 341 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.+..--......-. ...+.. .....+...++ ..++.+|++..|..||+|++++-.
T Consensus 277 ilEiq~tnseS~~~--~ee~ia----------~~i~~len~lq-----------r~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKVE--VEENIA----------NVIIGLENGLQ-----------RGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcceee--hhhhhh----------hheeeccCccc-----------cCcCcccccCCCCCCcchhhhhcC
Confidence 87653211111000 000000 00001111111 236779999999999999998754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.1e-11 Score=119.06 Aligned_cols=236 Identities=20% Similarity=0.222 Sum_probs=165.2
Q ss_pred hCCCCccCeecc--CCcEEEEEEEE---CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCe
Q 047892 157 TNGFADENVIGE--GGYGIVYRGVL---EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAH 228 (442)
Q Consensus 157 ~~~~~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 228 (442)
...+.+...+|. |.+|.||.+.. .++..+|+|+-+.. .......-.+|+....++ .|+|.++.+..+..++.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 344677788999 99999999885 35788999874322 222333334566666666 59999999999999999
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHH----hhhhhhcC-------------CCCC-CCeEEeccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK----GLTYLHEG-------------LEPK-WNPKLSDFG 290 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~----~l~yLH~~-------------l~~~-~~~kl~DFG 290 (442)
.|+-+|+|. .+|..+.+.. ...++....+....+... ||.++|.+ +..+ ..++++|||
T Consensus 193 lfiqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred ceeeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 999999998 4898888754 233666677777778777 99999987 2334 678999999
Q ss_pred CccccCCCcce----eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHH
Q 047892 291 LAKLLGAERSY----VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLK 366 (442)
Q Consensus 291 la~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 366 (442)
+...++..... ......|...|++||.+ .+.++..+|||++|.+..+..++..++....... |
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~----------W-- 335 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS----------W-- 335 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC----------c--
Confidence 99887655421 12233577889999987 5678999999999999999999877654321110 0
Q ss_pred HHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 367 TMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.+.-...++.+.....+.++...+..+++.+|-.|+++..+..
T Consensus 336 --------~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 336 --------SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --------cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0000011222222223334455788999999999999877654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.7e-09 Score=108.91 Aligned_cols=224 Identities=19% Similarity=0.182 Sum_probs=142.3
Q ss_pred ECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHH
Q 047892 179 LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWE 258 (442)
Q Consensus 179 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~ 258 (442)
..++.+|.|...............+-++.|+.++||||+++++.+...+..|||+|-+. .|..++++. ...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HHH
Confidence 44688888888765554334456777888999999999999999999999999999986 677777653 355
Q ss_pred HHHHHHHHHHHhhhhhhcC--------------CCCCCCeEEecccCccccCCCcceeecccccccCCCCcccccCCCCC
Q 047892 259 IRMNIILGTAKGLTYLHEG--------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 324 (442)
Q Consensus 259 ~~~~i~~qi~~~l~yLH~~--------------l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 324 (442)
.....+.||+.||.|||.+ ++..|+.||++|-++........ ......--..|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--
Confidence 5667789999999999865 56788999999987754322111 000011112355665442221
Q ss_pred CcCCchhhHHHHHHHHhCCCCCCCCCC-CCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhC
Q 047892 325 ETSDVYSFGILIMEVISGRNPVDYSRP-PGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVD 403 (442)
Q Consensus 325 ~~sDvwSlGvil~elltg~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 403 (442)
-..|.|-|||++||++.|..+-..... .+... ........+...... .. -+. ..+++..|..
T Consensus 182 ~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ip--k~~~~~~~k~~~~~~--------~~------r~n-~~~~~~~~~~ 244 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIP--KALIELYCKKLGATE--------LK------RPN-KLRFILECRL 244 (690)
T ss_pred cchhhhhHHHHHHHHhCcccCcchhhhccCccc--hhHHHHHHHHhcccc--------cc------ccc-hhhHHHHHHh
Confidence 346999999999999999333211100 00000 011111111111100 00 001 3456777888
Q ss_pred CCCCCCCCHHHHHHHHhcCCCCChhhhh
Q 047892 404 PNAHKRPKMGHVIHMLEAEEFPFRDERR 431 (442)
Q Consensus 404 ~dP~~RPs~~evl~~L~~~~~~~~~~~~ 431 (442)
.-+-.|=-+-+++..|+++...-.+++.
T Consensus 245 ~~gff~n~fvd~~~fLeel~lks~~eK~ 272 (690)
T KOG1243|consen 245 LGGFFRNDFVDTLLFLEELRLKSVEEKQ 272 (690)
T ss_pred ccccccchHHHHHHHHHhcccCcHHHHH
Confidence 8888888888888888888766666654
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.1e-10 Score=95.04 Aligned_cols=119 Identities=16% Similarity=0.134 Sum_probs=93.0
Q ss_pred ccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCC--CCcceEEEEEEeCCeeeeEEecCCCC
Q 047892 162 DENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH--KNLVRLVGYCAEGAHRMLVNEYVDNG 239 (442)
Q Consensus 162 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~lv~E~~~~g 239 (442)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999999754 7899998855433 4568889999999976 58999999888888899999999987
Q ss_pred CHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc---------CCC-------CCCCeEEecccCccc
Q 047892 240 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE---------GLE-------PKWNPKLSDFGLAKL 294 (442)
Q Consensus 240 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~---------~l~-------~~~~~kl~DFGla~~ 294 (442)
.+..+ +......++.++++++.+||. ++. +.+.++++|||.++.
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 344556677888888887775 333 346789999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.2e-09 Score=97.09 Aligned_cols=124 Identities=19% Similarity=0.164 Sum_probs=81.7
Q ss_pred cCeeccCCcEEEEEEEECCCCeEEEEEecCcchh--hHHH----------------------HHHHHHHHHhcCCCC--c
Q 047892 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQ--AEKE----------------------FKVEVEAIGRVRHKN--L 216 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~hpn--I 216 (442)
.+.||+|+||.||+|...+++.||||.+...... .... ...|...+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999878999999988543211 1111 134666666664443 4
Q ss_pred ceEEEEEEeCCeeeeEEecCCCCCHHHH-HccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc-C------CCC------CC
Q 047892 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQW-LHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-G------LEP------KW 282 (442)
Q Consensus 217 v~l~~~~~~~~~~~lv~E~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~------l~~------~~ 282 (442)
.+.+++ ...++||||++++++... +... ... .....++.+++.++.++|. . +++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVDDG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEECC
Confidence 444443 246899999999654321 1110 001 4567788899999998887 3 333 56
Q ss_pred CeEEecccCccccC
Q 047892 283 NPKLSDFGLAKLLG 296 (442)
Q Consensus 283 ~~kl~DFGla~~~~ 296 (442)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 88999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.95 E-value=9.3e-09 Score=94.99 Aligned_cols=122 Identities=18% Similarity=0.233 Sum_probs=86.7
Q ss_pred cCeec-cCCcEEEEEEEECCCCeEEEEEecCcc-------------hhhHHHHHHHHHHHHhcCCCCc--ceEEEEEEeC
Q 047892 163 ENVIG-EGGYGIVYRGVLEDNTNVAVKNLLNNR-------------GQAEKEFKVEVEAIGRVRHKNL--VRLVGYCAEG 226 (442)
Q Consensus 163 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~hpnI--v~l~~~~~~~ 226 (442)
...|| .|+.|+||.+... +..++||.+.... ......+.+|++++..|+|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 7888999998874 6789998774211 1223457889999999998875 6777764332
Q ss_pred -C---eeeeEEecCCC-CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEec
Q 047892 227 -A---HRMLVNEYVDN-GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSD 288 (442)
Q Consensus 227 -~---~~~lv~E~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~D 288 (442)
. ..++||||++| .+|.+++... .++.. .+.+++.++.+||+. +++++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEE
Confidence 2 22599999997 6999988642 34443 356778888888765 33456899999
Q ss_pred ccCccc
Q 047892 289 FGLAKL 294 (442)
Q Consensus 289 FGla~~ 294 (442)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=5e-10 Score=117.26 Aligned_cols=237 Identities=20% Similarity=0.209 Sum_probs=154.4
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
..-+++.+.+-+-+|.++.++.+.- ..+...++|..... .....+....+-.++-...||.+++...-+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 3445667777788899999888763 23444444433221 1112233334444444456677777666666678889
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~~~kl~DFGla~~~~~ 297 (442)
|+++|..+++|...++.. ...+..........+..+++|||.. + ..++..+++|||+....+.
T Consensus 881 L~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence 999999999999998865 2445555556666777888998765 2 3357889999984432110
Q ss_pred C----------c--------------------ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCC
Q 047892 298 E----------R--------------------SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVD 347 (442)
Q Consensus 298 ~----------~--------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~ 347 (442)
- . ........||+.|.+||.+.+......+|+|++|++++|.++|.+||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 0 001123468999999999999999999999999999999999999998
Q ss_pred CCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHH
Q 047892 348 YSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMG 413 (442)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ 413 (442)
...+...+... ....+. + ...+...+....+++.+.+..+|.+|..+.
T Consensus 1037 a~tpq~~f~ni---------------~~~~~~--~-p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQIFENI---------------LNRDIP--W-PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccchhhhhhcc---------------ccCCCC--C-CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 77664432110 001111 1 111223344566678888899999997765
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.78 E-value=5.6e-09 Score=106.33 Aligned_cols=137 Identities=14% Similarity=0.073 Sum_probs=88.2
Q ss_pred CCCccCeeccCCcEEEEEEEECC-CCeEEEEEecCcch----------------------------------hhHHH---
Q 047892 159 GFADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNRG----------------------------------QAEKE--- 200 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~----------------------------------~~~~~--- 200 (442)
+|+. +.||.|++|.||+|++.+ |+.||||++...-. ...+.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4665 789999999999999877 99999999864310 00111
Q ss_pred ---HHHHHHHHHhc----CCCCcceEEEEEEe-CCeeeeEEecCCCCCHHHHH--ccCCCCCCCCCHHHHHHHHHHHHHh
Q 047892 201 ---FKVEVEAIGRV----RHKNLVRLVGYCAE-GAHRMLVNEYVDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKG 270 (442)
Q Consensus 201 ---~~~E~~~l~~l----~hpnIv~l~~~~~~-~~~~~lv~E~~~~g~L~~~l--~~~~~~~~~l~~~~~~~i~~qi~~~ 270 (442)
+.+|...+.++ .+.+.+.+-.++.+ ....+|||||++|++|.++- .........+.......++.|+..
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~- 278 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFR- 278 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHh-
Confidence 23344444443 24444554444433 34568999999999998752 221101113444455566677764
Q ss_pred hhhhhcCCC-------CCC----CeEEecccCccccCC
Q 047892 271 LTYLHEGLE-------PKW----NPKLSDFGLAKLLGA 297 (442)
Q Consensus 271 l~yLH~~l~-------~~~----~~kl~DFGla~~~~~ 297 (442)
-.+.|.+++ +++ .+++.|||++..++.
T Consensus 279 ~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 279 DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 678999844 355 899999999987644
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.7e-08 Score=100.02 Aligned_cols=131 Identities=19% Similarity=0.176 Sum_probs=80.0
Q ss_pred cCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhH----------------------------------------HHHH
Q 047892 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAE----------------------------------------KEFK 202 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 202 (442)
.+.||.|++|.||+|++.+|+.||||+.+..-.... -.|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999998999999998854311000 0134
Q ss_pred HHHHHHHhc----CCCCcceEEEEEE-eCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHH-----HHHHHHHHHHhhh
Q 047892 203 VEVEAIGRV----RHKNLVRLVGYCA-EGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEI-----RMNIILGTAKGLT 272 (442)
Q Consensus 203 ~E~~~l~~l----~hpnIv~l~~~~~-~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~-----~~~i~~qi~~~l~ 272 (442)
+|...+.++ +|.+-+.+-.++. -.+..+|||||++|++|.++..... ....... ...++.| +..-.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~~~~~ia~~~~~~~l~q-l~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGLDRKALAENLARSFLNQ-VLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCCCHHHHHHHHHHHHHHH-HHhCC
Confidence 455555544 2333333333332 2345689999999999988764321 0111111 1112222 23445
Q ss_pred hhhcCCC-------CCCCeEEecccCccccCC
Q 047892 273 YLHEGLE-------PKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 273 yLH~~l~-------~~~~~kl~DFGla~~~~~ 297 (442)
++|.+++ +++.++++|||++..+..
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 6788754 467899999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.63 E-value=4.4e-08 Score=97.71 Aligned_cols=233 Identities=16% Similarity=0.140 Sum_probs=155.3
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEE--CCCCeEEEEEecCcchhhHHH--HHHHHHHHHhc-CCCCcceEEEEEEeCCe
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVL--EDNTNVAVKNLLNNRGQAEKE--FKVEVEAIGRV-RHKNLVRLVGYCAEGAH 228 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 228 (442)
.....+|..+..||.|.|+.|+.+.. .++..+++|.+.+.......+ -..|+-+...+ .|.++++++..|....+
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34456788899999999999999884 457889999886543322222 23455555555 58999998888877778
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC--------CCCeEEecccCccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP--------KWNPKLSDFGLAKL 294 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~--------~~~~kl~DFGla~~ 294 (442)
.|+-.|||+++++...+.- ...+.+...+.+..|++.++.++|.. +++ .+..++.|||+...
T Consensus 341 ~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred ccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence 8899999999998876632 24577778889999999999999875 221 15667888888764
Q ss_pred cCCCcceeecccccccCCC--CcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC
Q 047892 295 LGAERSYVTTRVMGTFGYV--APEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (442)
+.-. .....+.-+++ +++......+..++|++|||..+.|..++..--.. ..+|
T Consensus 417 ~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~------------~~~~-------- 472 (524)
T KOG0601|consen 417 LAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES------------GVQS-------- 472 (524)
T ss_pred ccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcc------------cccc--------
Confidence 2111 11112233344 55556667788999999999999999998653211 0000
Q ss_pred CcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
..+........ +.. ...+..+...+...|+..||.+.++...
T Consensus 473 --~~i~~~~~p~~-~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~ 514 (524)
T KOG0601|consen 473 --LTIRSGDTPNL-PGL-KLQLQVLLKVMINPDRKRRPSAVELSLH 514 (524)
T ss_pred --eeeecccccCC-Cch-HHhhhhhhhhhcCCccccchhhhhhccc
Confidence 01111111111 111 1456667778889999999998877654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.2e-08 Score=99.12 Aligned_cols=178 Identities=15% Similarity=0.099 Sum_probs=126.4
Q ss_pred CCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCC-cceEEEEEEeCCeeeeEEecCCC
Q 047892 160 FADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN-LVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
+....-+++|++++++|.+-...+....+.+... ....-++++|.+++||| .+..++-+..++..+++++++.+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 3444567899999999987422333334544221 33455889999999999 77777777888889999999998
Q ss_pred C-CHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC--------CCCCCCeEEecccCccccCCCcceeecccccc
Q 047892 239 G-NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGT 309 (442)
Q Consensus 239 g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 309 (442)
| +-..... .....+..-+...+.+.-.+++++||+. +..++..|..||+....+.... ..+...+|
T Consensus 319 ~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d~~l~s~~~~~~~~~~v~~~L~~~~--~~~t~~~~ 393 (829)
T KOG0576|consen 319 GRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRDNILGSEEEVKLLDFAVPPQLTRTM--KPRTAIGT 393 (829)
T ss_pred CccccccCC---hhhHhhhhhhhhhhhhhhcccccccccccccCcccccccccccccccccCCcccCccc--ccccCCCC
Confidence 7 2221110 0112233334455566667899999986 3345678999999988775433 34567899
Q ss_pred cCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCC
Q 047892 310 FGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVD 347 (442)
Q Consensus 310 ~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~ 347 (442)
+.|+|||+...+.+..+.|+|++|+--.+|--|.+|-.
T Consensus 394 ~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 394 PEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 99999999999999999999999988778877877643
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.9e-06 Score=81.39 Aligned_cols=156 Identities=19% Similarity=0.264 Sum_probs=105.2
Q ss_pred cEEEEEEE-ECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEE----eCCeeeeEEecCCC-CCHHHH
Q 047892 171 YGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCA----EGAHRMLVNEYVDN-GNLEQW 244 (442)
Q Consensus 171 ~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~----~~~~~~lv~E~~~~-g~L~~~ 244 (442)
-.+.|++. .-+|..|++|++.............-++.++++.|+|||.+.++|. .+..+++|++|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 34678888 3468999999994433222222233577899999999999999886 34567999999887 577665
Q ss_pred HccCC-----------CCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCccccCCCcc
Q 047892 245 LHGDV-----------GPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 245 l~~~~-----------~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~~~~~~~ 300 (442)
--... .....+++...+.++.|+..||.++|+. ++ .+.+++|+..|..-.+..+.
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~- 447 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP- 447 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC-
Confidence 42211 1224578899999999999999999986 22 22356666665554432221
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCC
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRN 344 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~ 344 (442)
+ |-+.. ..+-|.=.||.++..|.||..
T Consensus 448 -------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 448 -------T-------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred -------C-------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 0 11111 235688899999999999853
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.7e-06 Score=75.25 Aligned_cols=115 Identities=19% Similarity=0.092 Sum_probs=74.2
Q ss_pred cCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcc-eEEEEEEeCCeeeeEEecCCCCCH
Q 047892 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV-RLVGYCAEGAHRMLVNEYVDNGNL 241 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~l~~~~~~~~~~~lv~E~~~~g~L 241 (442)
.+.|+.|.++.||++... +..|++|....... ....+.+|+.++..+.+.+++ +++.+. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356889999999999874 77899998744321 223467899999988665544 555543 3345899999999887
Q ss_pred HHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhh-----------cCCCC------CCCeEEecccCcc
Q 047892 242 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-----------EGLEP------KWNPKLSDFGLAK 293 (442)
Q Consensus 242 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH-----------~~l~~------~~~~kl~DFGla~ 293 (442)
.+.- ... ..++.+++.+|+.|| .++.+ ++.++++|||.+.
T Consensus 79 ~~~~--------~~~----~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED--------FSD----PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDDGRLWLIDWEYAG 135 (170)
T ss_pred cccc--------ccC----HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEECCeEEEEeccccc
Confidence 6430 011 123445555555555 44333 2457888888765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.28 E-value=2.7e-06 Score=77.34 Aligned_cols=109 Identities=16% Similarity=0.171 Sum_probs=84.3
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEecCcch-hhHHHHHHHHHHHHhcCC--CCcceEEEEEEeC---CeeeeEEecCC
Q 047892 164 NVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRH--KNLVRLVGYCAEG---AHRMLVNEYVD 237 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~---~~~~lv~E~~~ 237 (442)
+.|+.|.++.||++...+|..+++|....... .....+.+|.+++..+.+ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999986668899998754322 134567889999999876 4467777776553 25689999999
Q ss_pred CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC
Q 047892 238 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277 (442)
Q Consensus 238 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 277 (442)
|.++.+.+.. ..++......++.+++..|..||+.
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~ 118 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSV 118 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCC
Confidence 9888765431 2467788889999999999999974
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.05 E-value=8.5e-05 Score=65.99 Aligned_cols=124 Identities=15% Similarity=0.115 Sum_probs=80.0
Q ss_pred CeeccCCcEEEEEEEECC-------CCeEEEEEecCc-------------c---------hhhHHHH----HHHHHHHHh
Q 047892 164 NVIGEGGYGIVYRGVLED-------NTNVAVKNLLNN-------------R---------GQAEKEF----KVEVEAIGR 210 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~-------------~---------~~~~~~~----~~E~~~l~~ 210 (442)
..||.|.-+.||.|...+ +..+|||..+.. + ......+ .+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 478999977321 0 0012223 379999998
Q ss_pred cCC--CCcceEEEEEEeCCeeeeEEecCCCCCHHH-HHccCCCCCCCCCHHHHHHHHHHHHHhhhhh-h------cCCCC
Q 047892 211 VRH--KNLVRLVGYCAEGAHRMLVNEYVDNGNLEQ-WLHGDVGPHSPLTWEIRMNIILGTAKGLTYL-H------EGLEP 280 (442)
Q Consensus 211 l~h--pnIv~l~~~~~~~~~~~lv~E~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yL-H------~~l~~ 280 (442)
+.. -++.+.+++ ...+|||||+.++.+.. .++. ..++......+..+++.+|..| | .++++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 843 566667764 45689999998754422 2221 1234444555667777777666 4 34332
Q ss_pred ------CCCeEEecccCccccC
Q 047892 281 ------KWNPKLSDFGLAKLLG 296 (442)
Q Consensus 281 ------~~~~kl~DFGla~~~~ 296 (442)
++.+.|+|||.+....
T Consensus 154 ~NIL~~~~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWHDGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEECCcEEEEECCCceeCC
Confidence 5789999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00013 Score=63.20 Aligned_cols=125 Identities=18% Similarity=0.262 Sum_probs=77.9
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEecCcc---h-----hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 164 NVIGEGGYGIVYRGVLEDNTNVAVKNLLNNR---G-----QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
..+++|+-+.+|.+.+. |..+++|.-..+. + -....-.+|+.++.+++--.|..-.=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999873 4456777543221 1 1123457799999988654444433344566677899999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcCCCCC------CCeEEecccCccc
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK------WNPKLSDFGLAKL 294 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~l~~~------~~~kl~DFGla~~ 294 (442)
++|-.|.+++... ..+....+-....-++--.+.|.+++.. +.+.++||||+..
T Consensus 81 I~G~~lkd~l~~~-----~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGRIYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCcEEEEECCcccc
Confidence 9999999888653 1111111222222234444556665553 3589999999975
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.0001 Score=71.16 Aligned_cols=258 Identities=14% Similarity=0.122 Sum_probs=136.8
Q ss_pred ccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhc-CCCCcceEEEEE------EeCC-eeeeEE
Q 047892 162 DENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVGYC------AEGA-HRMLVN 233 (442)
Q Consensus 162 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~------~~~~-~~~lv~ 233 (442)
..+.||+|+-+.+|-.-- -+..| .|+............ +..|... .||-+..=+.+= -++. ..-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e-~~d~V-AKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE-VRDQV-AKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecch-hhchh-heeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 346799999999996431 12223 366654333222222 2223333 566443311110 1122 245777
Q ss_pred ecCCCC-CHHHHHcc--CCCCCCCCCHHHHHHHHHHHHHhhhhhhcCCC-----CCCCeEEecccCccccCCCcce----
Q 047892 234 EYVDNG-NLEQWLHG--DVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE-----PKWNPKLSDFGLAKLLGAERSY---- 301 (442)
Q Consensus 234 E~~~~g-~L~~~l~~--~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~l~-----~~~~~kl~DFGla~~~~~~~~~---- 301 (442)
..+++. .+..+..- +........|...++.++.++.+.+-||..-. ..+++-++|=|..+.++.++..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~n 169 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINAN 169 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeeccC
Confidence 777663 23333321 11223457899999999999999999998611 1123445555544444322211
Q ss_pred --eecccccccCCCCccccc-----CCCCCCcCCchhhHHHHHHHHhC-CCCCCCCCCCCcc--chhhhHHHHHHHHhhc
Q 047892 302 --VTTRVMGTFGYVAPEYAS-----TGMLNETSDVYSFGILIMEVISG-RNPVDYSRPPGEF--QFQVNLFEWLKTMVTN 371 (442)
Q Consensus 302 --~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg-~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~ 371 (442)
.....+|...|.+||.-. +-.-+...|-|.|||++++++.| ++||.+-.-.... .....+.... ....
T Consensus 170 g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~--f~ya 247 (637)
T COG4248 170 GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR--FAYA 247 (637)
T ss_pred CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce--eeec
Confidence 112347889999999653 23345689999999999999995 9999763211000 0000000000 0000
Q ss_pred CCcccccCcccCCCCcHHHHHHHHHHHhhhhCC--CCCCCCCHHHHHHHHhcCCCCC
Q 047892 372 GNAEGVLDPRLQEKPSSRALKRALLVALRCVDP--NAHKRPKMGHVIHMLEAEEFPF 426 (442)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~--dP~~RPs~~evl~~L~~~~~~~ 426 (442)
.+...-..+.....+-.-.+..+..|..+|+.. ++.-|||++.-+..|.+....+
T Consensus 248 ~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 248 SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 000001111111112223344566677788874 3568999999998888765543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=4.8e-06 Score=84.74 Aligned_cols=136 Identities=19% Similarity=0.263 Sum_probs=87.3
Q ss_pred HHHHHHhhhhhhcC--------------CCCCCCeEEecccCccccCCCcceee--------cccccccCCCCcccccCC
Q 047892 264 ILGTAKGLTYLHEG--------------LEPKWNPKLSDFGLAKLLGAERSYVT--------TRVMGTFGYVAPEYASTG 321 (442)
Q Consensus 264 ~~qi~~~l~yLH~~--------------l~~~~~~kl~DFGla~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~~ 321 (442)
+.+++.||.|+|+. +...+..||+.|+.+........+.. .-..-...|.|||++.+.
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 34455899999886 44567899999998765433111100 011235679999999888
Q ss_pred CCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhh
Q 047892 322 MLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALR 400 (442)
Q Consensus 322 ~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 400 (442)
..+.++|++|+||++|-+.. |+.-+........+.... ..+..-........+.++.+-+.+
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-----------------~~~~~~~~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-----------------NLLNAGAFGYSNNLPSELRESLKK 247 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-----------------cccccccccccccCcHHHHHHHHH
Confidence 88899999999999999994 666665443222211100 011111112224455667778889
Q ss_pred hhCCCCCCCCCHHHHH
Q 047892 401 CVDPNAHKRPKMGHVI 416 (442)
Q Consensus 401 cl~~dP~~RPs~~evl 416 (442)
++..|+..||++.++.
T Consensus 248 ~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 248 LLNGDSAVRPTLDLLL 263 (700)
T ss_pred HhcCCcccCcchhhhh
Confidence 9999999999777664
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.83 E-value=7e-05 Score=80.61 Aligned_cols=183 Identities=18% Similarity=0.211 Sum_probs=126.7
Q ss_pred HHHHHHHHHhcCCCCcceEEEEEEeCC----eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc
Q 047892 201 FKVEVEAIGRVRHKNLVRLVGYCAEGA----HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276 (442)
Q Consensus 201 ~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~ 276 (442)
...|...+.++.|+|++.++.+....- ...+..|+|..-++...+..- ..++....+.+..++.+||.|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v----~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV----GSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc----cccCHHHHHHHHHHHhhhHHHHHH
Confidence 445777788899999999998865432 234567889888888888654 567888888899999999999998
Q ss_pred C----------------CCCCCCeEEe--cccCccccCCCcceeecccccccCCCCcccccCCCCCCc--CCchhhHHHH
Q 047892 277 G----------------LEPKWNPKLS--DFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNET--SDVYSFGILI 336 (442)
Q Consensus 277 ~----------------l~~~~~~kl~--DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--sDvwSlGvil 336 (442)
. .+.++...++ ||+.++.+...... ....-+..|.++|......++.+ .|+|.+|..+
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 6 2334556666 88888776544322 12234556788888876665554 7999999999
Q ss_pred HHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHH
Q 047892 337 MEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVI 416 (442)
Q Consensus 337 ~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl 416 (442)
..+..|..+-..... ....+..... ....+...+|+..|+++|+++.+++
T Consensus 383 ~~~~~~~~i~~~~~~--------------------------~~~~l~~~~~----~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAV--------------------------PVSLLDVLST----SELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred hhhhhcCcccccccc--------------------------hhhhhccccc----hhhhhhhhhhcchhhhhccchhhhh
Confidence 999887654211100 0000011111 1355677799999999999999998
Q ss_pred HHH
Q 047892 417 HML 419 (442)
Q Consensus 417 ~~L 419 (442)
...
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 763
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00021 Score=61.74 Aligned_cols=130 Identities=17% Similarity=0.223 Sum_probs=86.0
Q ss_pred ccCeeccCCcEEEEEEEECCCCeEEEEEecCc--------chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 162 DENVIGEGGYGIVYRGVLEDNTNVAVKNLLNN--------RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 162 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
....|-+|+-+.|+++.+ .|+...||.-... ..-...+..+|+++|.++.--.|..-.=++.+...-+|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567889999999999998 5777777754221 1123355778999999886555555444566677778999
Q ss_pred ecCCC-CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CC-C--CeEEecccCccc
Q 047892 234 EYVDN-GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PK-W--NPKLSDFGLAKL 294 (442)
Q Consensus 234 E~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~-~--~~kl~DFGla~~ 294 (442)
||++| -++.+|+...... .........++..|-..+.-||.+ +. ++ + .+-++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 5788888654211 112222255666666677777665 22 22 2 347999999864
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00013 Score=74.19 Aligned_cols=133 Identities=18% Similarity=0.183 Sum_probs=83.6
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEecCcchhh------------------------------HH----------HHHH
Q 047892 164 NVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQA------------------------------EK----------EFKV 203 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~----------~~~~ 203 (442)
+-|+.++-|.||+|++.+|+.||||+.+..-... .+ .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5789999999999999999999999875431100 00 1234
Q ss_pred HHHHHHhc----CCCCcceEEEEEEe-CCeeeeEEecCCCCCHHHHH--ccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc
Q 047892 204 EVEAIGRV----RHKNLVRLVGYCAE-GAHRMLVNEYVDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276 (442)
Q Consensus 204 E~~~l~~l----~hpnIv~l~~~~~~-~~~~~lv~E~~~~g~L~~~l--~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~ 276 (442)
|..-+.++ ++.-=+++-.++++ .+...|+|||++|-.+.+.. +........+...-...++.|+.. -.|.|.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~-dgffHa 289 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLR-DGFFHA 289 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHh-cCcccc
Confidence 54444443 22222333344432 35568999999998888874 332111112333444455556555 788999
Q ss_pred C-------CCCCCCeEEecccCccccCC
Q 047892 277 G-------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 277 ~-------l~~~~~~kl~DFGla~~~~~ 297 (442)
+ +..++.+-+.|||+...+..
T Consensus 290 DpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 290 DPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CCCccceEEecCCcEEEEcCcceecCCH
Confidence 8 44567889999999877643
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00096 Score=57.42 Aligned_cols=120 Identities=18% Similarity=0.238 Sum_probs=79.8
Q ss_pred CccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcc-eEEEEEEeCCeeeeEEecCCCC
Q 047892 161 ADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV-RLVGYCAEGAHRMLVNEYVDNG 239 (442)
Q Consensus 161 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~l~~~~~~~~~~~lv~E~~~~g 239 (442)
...+.||+|.+|.||+|.+. |..+|+|.-..+ .....+..|.++|..+.-.++. +++.+-. .++.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence 44678999999999999984 558898876443 3456788999999998776654 3444422 34669999998
Q ss_pred CHHHHHccCCCCCCCCCHHHHHHHHHH--HHHhhhhhhcC--------CCCCCCeEEecccCccc
Q 047892 240 NLEQWLHGDVGPHSPLTWEIRMNIILG--TAKGLTYLHEG--------LEPKWNPKLSDFGLAKL 294 (442)
Q Consensus 240 ~L~~~l~~~~~~~~~l~~~~~~~i~~q--i~~~l~yLH~~--------l~~~~~~kl~DFGla~~ 294 (442)
.|.++-... +-.....++-. .+..+...|.. +..++.+-|+||.-|+.
T Consensus 98 ~L~~~~~~~-------~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG-------DRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc-------cHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 887765321 12222222211 23344455665 44566899999988874
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0022 Score=56.69 Aligned_cols=118 Identities=21% Similarity=0.201 Sum_probs=64.1
Q ss_pred EEEEEEECCCCeEEEEEecCcc-------------h-------------hhHHHHHHHHHHHHhcCCC--CcceEEEEEE
Q 047892 173 IVYRGVLEDNTNVAVKNLLNNR-------------G-------------QAEKEFKVEVEAIGRVRHK--NLVRLVGYCA 224 (442)
Q Consensus 173 ~Vy~~~~~~~~~vavK~~~~~~-------------~-------------~~~~~~~~E~~~l~~l~hp--nIv~l~~~~~ 224 (442)
.||.|...+|..+|||..+... . .......+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998889999999773210 0 0122356899999999765 566666542
Q ss_pred eCCeeeeEEecCC--CCCHHHHHccCCCCCCCCCHHH---HHHHHHHHHHhhhhhhcCCCC------CCCeEEecccCcc
Q 047892 225 EGAHRMLVNEYVD--NGNLEQWLHGDVGPHSPLTWEI---RMNIILGTAKGLTYLHEGLEP------KWNPKLSDFGLAK 293 (442)
Q Consensus 225 ~~~~~~lv~E~~~--~g~L~~~l~~~~~~~~~l~~~~---~~~i~~qi~~~l~yLH~~l~~------~~~~kl~DFGla~ 293 (442)
..+|||||++ |..+..+...... ....... .+..+..+.+.....|.++.. ++.+.|+|||.+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~~~--~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~~~~iIDf~qav 154 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVDLS--PEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDGKVYIIDFGQAV 154 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCGGG--GSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETTCEEE--GTTEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcccc--chhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecceEEEEecCcce
Confidence 3479999999 6555443322100 0111111 122222233445667877554 3489999999887
Q ss_pred ccC
Q 047892 294 LLG 296 (442)
Q Consensus 294 ~~~ 296 (442)
...
T Consensus 155 ~~~ 157 (188)
T PF01163_consen 155 DSS 157 (188)
T ss_dssp ETT
T ss_pred ecC
Confidence 643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0017 Score=64.62 Aligned_cols=164 Identities=20% Similarity=0.211 Sum_probs=91.1
Q ss_pred HHHHHHHHHHhcCCCCcceEEEEEEeC-CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcCC
Q 047892 200 EFKVEVEAIGRVRHKNLVRLVGYCAEG-AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 278 (442)
Q Consensus 200 ~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~l 278 (442)
.+.-....++.+.|+|...++++.... ....+|||++.. +|.+.+.... +. .....+++...+|
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~-----l~------~~s~~~~~~~~~~--- 92 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGN-----LK------DESLLAHGVLHLN--- 92 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcc-----cc------hhhhcccccceeh---
Confidence 345567788999999999999887543 346789999976 9999887541 11 1111123222222
Q ss_pred CCCCCeEEecccCccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchh
Q 047892 279 EPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQ 358 (442)
Q Consensus 279 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~ 358 (442)
..+++| ..... | | .+..+|+||||+|.++.|+.-|..-+.....
T Consensus 93 ----~~~~td----~~~t~--------------~--~-----~~~~pKsdVwsl~~i~~el~L~~~l~~~~~~------- 136 (725)
T KOG1093|consen 93 ----IIYITD----HFLTK--------------Y--P-----SPIGPKSDVWSLGFIILELYLGISLEAELTE------- 136 (725)
T ss_pred ----hhhccc----ccccc--------------C--C-----CCCCcchhhhhHHHHHHHHHHhhHHHHHHHH-------
Confidence 345555 11000 0 1 0112599999999999999998766532111
Q ss_pred hhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHH
Q 047892 359 VNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVI 416 (442)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl 416 (442)
.+....+............+. ........+...+..+..+|+-..|..||...++.
T Consensus 137 s~~l~~i~k~~~~d~~~~~~a--~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 137 SEYLEILLKYYTDDQELLSTA--MEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred HHHHHHHHHhccCchhHHHHH--HHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 111111111111110000000 00012234556677788899999999988665554
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0047 Score=56.90 Aligned_cols=125 Identities=19% Similarity=0.120 Sum_probs=81.7
Q ss_pred CCccCeeccCCcEEEEEEEECCCCeEEEEEecCcc----------------------hhhHHHHHHHHHHHHhcCCC--C
Q 047892 160 FADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNR----------------------GQAEKEFKVEVEAIGRVRHK--N 215 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~hp--n 215 (442)
..+...||.|.-+.||.|..+.|.++|||.=+... ........+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 46678999999999999999899999999432110 01123457899999998654 6
Q ss_pred cceEEEEEEeCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHH-HHHHHHHHHH--hhhhhhcC-------CCCCCCeE
Q 047892 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEI-RMNIILGTAK--GLTYLHEG-------LEPKWNPK 285 (442)
Q Consensus 216 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~-~~~i~~qi~~--~l~yLH~~-------l~~~~~~k 285 (442)
|.+-+++ +...+||||++|-.|...-- ..-.... .-.|+..+.. -..|.|.+ ++++|.+.
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 6666553 45689999999976654320 0111122 2223333322 45688988 56688999
Q ss_pred EecccCccc
Q 047892 286 LSDFGLAKL 294 (442)
Q Consensus 286 l~DFGla~~ 294 (442)
++||--+..
T Consensus 243 vIDwPQ~v~ 251 (304)
T COG0478 243 VIDWPQAVP 251 (304)
T ss_pred EEeCccccc
Confidence 999965443
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0049 Score=67.46 Aligned_cols=109 Identities=16% Similarity=0.210 Sum_probs=78.0
Q ss_pred cCeeccCCcEEEEEEEECCC---CeEEEEEecCcc-hhhHHHHHHHHHHHHhcC-CCCc--ceEEEEEEeC---CeeeeE
Q 047892 163 ENVIGEGGYGIVYRGVLEDN---TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVR-HKNL--VRLVGYCAEG---AHRMLV 232 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnI--v~l~~~~~~~---~~~~lv 232 (442)
.+.++.|.++.+|+....++ ..+++|+..... ......+.+|+++|+.+. |++| .+++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999886553 367777654322 122346889999999995 6665 7888887764 467899
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 277 (442)
|||++|..+.+- ....++...+..++.+++..|..||.-
T Consensus 123 ME~v~G~~~~~~------~~~~~~~~~r~~l~~~l~~~La~LH~v 161 (822)
T PLN02876 123 MEYLEGRIFVDP------KLPGVAPERRRAIYRATAKVLAALHSA 161 (822)
T ss_pred EEecCCcccCCc------cCCCCCHHHHHHHHHHHHHHHHHHhCC
Confidence 999998543321 012345667778999999999999974
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.035 Score=52.09 Aligned_cols=128 Identities=16% Similarity=0.074 Sum_probs=79.9
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEecCcchh-hH----------HHHHHHHHHHHhcCCCC--cceEEEEEEe-----
Q 047892 164 NVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQ-AE----------KEFKVEVEAIGRVRHKN--LVRLVGYCAE----- 225 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~hpn--Iv~l~~~~~~----- 225 (442)
+.+-+.....|++..+ +|+.+.||........ .. ..+.+|...+.+|..-+ +....++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444344445777766 5678999976432211 11 13678888888874333 3334444432
Q ss_pred CCeeeeEEecCCCC-CHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCC-------CCCe
Q 047892 226 GAHRMLVNEYVDNG-NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEP-------KWNP 284 (442)
Q Consensus 226 ~~~~~lv~E~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~-------~~~~ 284 (442)
...-+||||++++- +|.+++.... ....+......++.+++..+.-||.. ++. +..+
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceE
Confidence 23468999999986 8999985321 12345566678888888888888765 222 3577
Q ss_pred EEecccCccc
Q 047892 285 KLSDFGLAKL 294 (442)
Q Consensus 285 kl~DFGla~~ 294 (442)
.|+||+.++.
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 8889987753
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0096 Score=52.88 Aligned_cols=117 Identities=26% Similarity=0.382 Sum_probs=75.3
Q ss_pred CCCCccCeeccCCc-EEEEEEEECCCCeEEEEEecCc---c--------h----------hhHHHHHHHHHHHHhc---C
Q 047892 158 NGFADENVIGEGGY-GIVYRGVLEDNTNVAVKNLLNN---R--------G----------QAEKEFKVEVEAIGRV---R 212 (442)
Q Consensus 158 ~~~~~~~~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~---~--------~----------~~~~~~~~E~~~l~~l---~ 212 (442)
.+++.++.||.|.- |.||++.+ +|+.+|+|.+... . . .....|..|.+...+| .
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 46788899999999 99999998 5779999983210 0 0 1123477888887776 4
Q ss_pred CCCc--ceEEEEEEeC------------------CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 047892 213 HKNL--VRLVGYCAEG------------------AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 272 (442)
Q Consensus 213 hpnI--v~l~~~~~~~------------------~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~ 272 (442)
+.++ |+.+|+..-. ....||.||.+... .+.. .-+.++.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~----~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI----RDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch----hHHHHHHHHHH
Confidence 5566 8889987322 01246777776532 1222 23445556667
Q ss_pred hhhcC------CCCCC--CeEEecccCc
Q 047892 273 YLHEG------LEPKW--NPKLSDFGLA 292 (442)
Q Consensus 273 yLH~~------l~~~~--~~kl~DFGla 292 (442)
.+|.. +...+ .-||+|||.+
T Consensus 179 ~~~k~gI~~~Dv~~~ny~~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLGIVPRDVKPRNYRGGKLVDFSSS 206 (207)
T ss_pred HHHHCCeeeccCccccccCCEEEecccC
Confidence 77765 33333 4589999864
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.00031 Score=77.64 Aligned_cols=145 Identities=12% Similarity=0.010 Sum_probs=100.7
Q ss_pred HHHHHHHHHhcCCCCcceEEEEEEe--CCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-
Q 047892 201 FKVEVEAIGRVRHKNLVRLVGYCAE--GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG- 277 (442)
Q Consensus 201 ~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~- 277 (442)
...|.+.++...|+++...+.-... ....|..++|+.+|++++.|-+.......+..........+...+..-+|+.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3445556667789998887665432 3456899999999999999876544444454444333333324444444433
Q ss_pred -----------------CCCCCCeEEecccCccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHH
Q 047892 278 -----------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVI 340 (442)
Q Consensus 278 -----------------l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ell 340 (442)
+..+..+|+.++|+.+...... .......+++.|++|++...-.++.++|+|..|+.+|+..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~-sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL-SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchH-hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 3445678999999998433222 2234456788999999988888999999999999999998
Q ss_pred hCCCCC
Q 047892 341 SGRNPV 346 (442)
Q Consensus 341 tg~~Pf 346 (442)
-|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 888776
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.02 Score=52.06 Aligned_cols=102 Identities=19% Similarity=0.270 Sum_probs=75.8
Q ss_pred cCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCC--CcceEEEEEEe---CCeeeeEEecCC
Q 047892 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK--NLVRLVGYCAE---GAHRMLVNEYVD 237 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~~~---~~~~~lv~E~~~ 237 (442)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+... .+.+++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578999999999999866 68999987443 4556677888888887533 35566765433 335689999999
Q ss_pred CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC
Q 047892 238 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277 (442)
Q Consensus 238 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 277 (442)
|..+.. ..+......++.++++.+.-||..
T Consensus 79 g~~~~~----------~~~~~~~~~~~~~~~~~l~~lh~~ 108 (239)
T PF01636_consen 79 GRPLDD----------ELSPEQRPELLRQLGRALAQLHQV 108 (239)
T ss_dssp SEEHHH----------TSTHHHHHHHHHHHHHHHHHHHHS
T ss_pred cccccc----------cccccccccccccchhhhhhcccc
Confidence 988876 245667788889999999999975
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.013 Score=59.72 Aligned_cols=134 Identities=19% Similarity=0.202 Sum_probs=75.1
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEecCcchhh-------------------------------HH------HHHHHHH
Q 047892 164 NVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQA-------------------------------EK------EFKVEVE 206 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~E~~ 206 (442)
+.||.-+.|.||+|+.++|+.||||+-+..-... .+ .|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5789999999999999999999999764321100 01 1223333
Q ss_pred HHH----hcCCCCc---ceEEEEEEe-CCeeeeEEecCCCCCHHHH--HccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc
Q 047892 207 AIG----RVRHKNL---VRLVGYCAE-GAHRMLVNEYVDNGNLEQW--LHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276 (442)
Q Consensus 207 ~l~----~l~hpnI---v~l~~~~~~-~~~~~lv~E~~~~g~L~~~--l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~ 276 (442)
-.. .+.|-+. |.+-.++++ .....|+||||+|..+.+. |.+..-....+.......++.||.. -.|+|.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~-~GffHa 325 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFK-TGFFHA 325 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHh-cCCccC
Confidence 222 2345551 112233322 2456899999999866544 3332111111111222223333332 238898
Q ss_pred C-------CC----CCCCeEEecccCccccCCC
Q 047892 277 G-------LE----PKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 277 ~-------l~----~~~~~kl~DFGla~~~~~~ 298 (442)
+ +. .++.+.+-|||+...+...
T Consensus 326 DPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 326 DPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred CCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 8 22 2567899999998876443
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.026 Score=53.93 Aligned_cols=105 Identities=13% Similarity=0.010 Sum_probs=74.2
Q ss_pred CccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCC---CCcceEEEEEEe---CCeeeeEEe
Q 047892 161 ADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH---KNLVRLVGYCAE---GAHRMLVNE 234 (442)
Q Consensus 161 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pnIv~l~~~~~~---~~~~~lv~E 234 (442)
...+.||.|..+.||+....++ .+.+|..+. ......+..|.+.|+.|.- ..+.++++++.. .+..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3456799999999999876555 466676432 1123578889999988843 467888887754 366899999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 277 (442)
+++++++.+. .........+..+++.+|.-||+.
T Consensus 94 ~i~G~~~~~~---------~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 94 RLRGVSVEAP---------ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred ccCCEecCCC---------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 9999877651 122334456667788999999973
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.014 Score=51.79 Aligned_cols=87 Identities=24% Similarity=0.294 Sum_probs=60.5
Q ss_pred HHHHHHHHhcCC-CCcceEEEEEEeCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC---
Q 047892 202 KVEVEAIGRVRH-KNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--- 277 (442)
Q Consensus 202 ~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--- 277 (442)
..|.-+|+.+.+ +++.+++|+|-+ ++++||...+++... ..........+|..+.+||.++++.+.+|+..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~-~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGI-YRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccc-ccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 347888888876 699999999833 679999998766421 00000112468999999999999999999764
Q ss_pred -------------CCCCCCeEEecccCcc
Q 047892 278 -------------LEPKWNPKLSDFGLAK 293 (442)
Q Consensus 278 -------------l~~~~~~kl~DFGla~ 293 (442)
+..++++|++|...+.
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 3344566666665443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.13 Score=46.06 Aligned_cols=125 Identities=16% Similarity=0.166 Sum_probs=82.1
Q ss_pred eccCCcEEEEEEEECCCCeEEEEEecCcc------hhhHHHHHHHHHHHHhcCCCC--cceEEEEEEe--C--CeeeeEE
Q 047892 166 IGEGGYGIVYRGVLEDNTNVAVKNLLNNR------GQAEKEFKVEVEAIGRVRHKN--LVRLVGYCAE--G--AHRMLVN 233 (442)
Q Consensus 166 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~--~--~~~~lv~ 233 (442)
-|+|+-+-|+...++ |..+-+|.-.+.- +.....|.+|+..|..|..-+ +.+....... + -.-+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 367888899998774 4468888764211 234567899999999885322 4444422111 1 2347999
Q ss_pred ecCCC-CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCC--eEEecccCcc
Q 047892 234 EYVDN-GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWN--PKLSDFGLAK 293 (442)
Q Consensus 234 E~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~--~kl~DFGla~ 293 (442)
|-+++ -+|.+++.... ..+.+......+..+++..+.-||+. ++.++. ++++||--++
T Consensus 105 e~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97764 58999886531 12456677788999999999999876 233444 7888886554
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.046 Score=49.95 Aligned_cols=100 Identities=18% Similarity=0.118 Sum_probs=71.1
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCC--cceEEEEEEeCCeeeeEEecCCCCC-
Q 047892 164 NVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN--LVRLVGYCAEGAHRMLVNEYVDNGN- 240 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~~~~~lv~E~~~~g~- 240 (442)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-+ +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 24567788765422 2345688999998886433 4677888777778889999999963
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc
Q 047892 241 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276 (442)
Q Consensus 241 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~ 276 (442)
+...+. .+......++.+++..+.-||.
T Consensus 82 ~~~~~~--------~~~~~~~~l~~~la~~l~~lH~ 109 (226)
T TIGR02172 82 FSRIIS--------DNPSRLEEIAKIFAEMAKKLHS 109 (226)
T ss_pred hhhhhc--------CCHHHHHHHHHHHHHHHHHHhC
Confidence 333321 2334455677888888888996
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.095 Score=48.33 Aligned_cols=98 Identities=17% Similarity=0.144 Sum_probs=67.5
Q ss_pred eccCCc-EEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeeeEEecCCCCCHHH
Q 047892 166 IGEGGY-GIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQ 243 (442)
Q Consensus 166 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~ 243 (442)
|-.|.. +.||+.... +..+.+|...... ...+.+|++++..+. +--+.+++++....+..++|||+++|.+|.+
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444544 789998764 4678888764432 334667888888773 3446677887776667899999999988764
Q ss_pred HHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC
Q 047892 244 WLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277 (442)
Q Consensus 244 ~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 277 (442)
... ......++.+++..+.-||+.
T Consensus 82 ~~~----------~~~~~~~~~~l~~~l~~lH~i 105 (244)
T cd05150 82 LWE----------ELEPERLVDALAEALRRLHAL 105 (244)
T ss_pred hhc----------ccCHHHHHHHHHHHHHHHhcC
Confidence 321 112335778888899999974
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.26 Score=44.53 Aligned_cols=131 Identities=11% Similarity=0.144 Sum_probs=77.6
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHH---------HHHHHHHHhcCC---CCcceEEE
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEF---------KVEVEAIGRVRH---KNLVRLVG 221 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h---pnIv~l~~ 221 (442)
.+..++|...+++-......|.+-.. +|+.+++|.........++.| .+++..+.++.. -..+.++.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 45667888888888888887877776 568899998765433322222 234444444432 23333333
Q ss_pred EEEe-----CCeeeeEEecCCCCCHHHHHccCCCCCCCCCHH---HHHHHHHHHHHhhhhhhcCCCC------CCCeEEe
Q 047892 222 YCAE-----GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWE---IRMNIILGTAKGLTYLHEGLEP------KWNPKLS 287 (442)
Q Consensus 222 ~~~~-----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~---~~~~i~~qi~~~l~yLH~~l~~------~~~~kl~ 287 (442)
+... ....+|+|||++|..|.++.. ++.. .+... ..=++...++|.+..+ ++.+++.
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e~~~~ki~~~-ikqlH~~G~~HGD~hpgNFlv~~~~i~iI 176 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDEDLAEKIVEA-IKQLHKHGFYHGDPHPGNFLVSNNGIRII 176 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh--------cCHHHHHHHHHH-HHHHHHcCCccCCCCcCcEEEECCcEEEE
Confidence 3222 134468999999988876532 2221 12222 2334667778887554 4568899
Q ss_pred cccCccc
Q 047892 288 DFGLAKL 294 (442)
Q Consensus 288 DFGla~~ 294 (442)
||+..+.
T Consensus 177 D~~~k~~ 183 (229)
T PF06176_consen 177 DTQGKRM 183 (229)
T ss_pred ECccccc
Confidence 9977653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.97 E-value=0.16 Score=46.54 Aligned_cols=128 Identities=17% Similarity=0.143 Sum_probs=72.3
Q ss_pred eeccCCcEEEEEEEECCCCeEEEEEecCcchhh-------------------HH-----HHHHHHHHHHhcC--CCCcce
Q 047892 165 VIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQA-------------------EK-----EFKVEVEAIGRVR--HKNLVR 218 (442)
Q Consensus 165 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~~-----~~~~E~~~l~~l~--hpnIv~ 218 (442)
.|++|.-+.||+|...++..+|||+.+...... .. -..+|+.-|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 456788889999998789999999885432110 00 1245777777763 334444
Q ss_pred EEEEEEeCCeeeeEEecCCCCC-HHHHHccCCCCCC--CCCHHHHHHHHHHHHHhhhhhhcCCC------CCCCeEEecc
Q 047892 219 LVGYCAEGAHRMLVNEYVDNGN-LEQWLHGDVGPHS--PLTWEIRMNIILGTAKGLTYLHEGLE------PKWNPKLSDF 289 (442)
Q Consensus 219 l~~~~~~~~~~~lv~E~~~~g~-L~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~l~------~~~~~kl~DF 289 (442)
-+++.. -.|||||+.... -.-.|+.-..... .--+...+..+..+.+...+.|.++. .++.+.|+||
T Consensus 135 Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~~~p~iID~ 210 (268)
T COG1718 135 PIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHDGEPYIIDV 210 (268)
T ss_pred ceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEECCeEEEEEC
Confidence 444432 369999997631 1111111100000 00022334444444555566788844 3688999999
Q ss_pred cCccccC
Q 047892 290 GLAKLLG 296 (442)
Q Consensus 290 Gla~~~~ 296 (442)
|-|....
T Consensus 211 ~QaV~~~ 217 (268)
T COG1718 211 SQAVTID 217 (268)
T ss_pred ccccccC
Confidence 9887653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=94.55 E-value=0.31 Score=43.75 Aligned_cols=92 Identities=21% Similarity=0.231 Sum_probs=60.3
Q ss_pred HHHHHHHHHHHhcCC--CCcceEEEEEEeCC----eeeeEEecCCCC-CHHHHHccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047892 199 KEFKVEVEAIGRVRH--KNLVRLVGYCAEGA----HRMLVNEYVDNG-NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 271 (442)
Q Consensus 199 ~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~----~~~lv~E~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l 271 (442)
....+|...+..|.. =.+.+.+++..... ..++|+|++++. +|.+++.... ..+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence 356778887777643 23445555554422 348999999984 8999987531 244556677778888777
Q ss_pred hhhhcC------C-------CCCC---CeEEecccCccc
Q 047892 272 TYLHEG------L-------EPKW---NPKLSDFGLAKL 294 (442)
Q Consensus 272 ~yLH~~------l-------~~~~---~~kl~DFGla~~ 294 (442)
.-||.. + +++. .+.++||+.++.
T Consensus 132 ~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 777765 2 2233 678899987765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.09 E-value=0.47 Score=47.15 Aligned_cols=82 Identities=21% Similarity=0.258 Sum_probs=57.5
Q ss_pred cCeeccCCcEEEEEEEECCC-CeEEEEEecCc-----c--hhhHHHHHHHHHHHHhcC---CCCcceEEEEEEeCCeeee
Q 047892 163 ENVIGEGGYGIVYRGVLEDN-TNVAVKNLLNN-----R--GQAEKEFKVEVEAIGRVR---HKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~l 231 (442)
.+.||.|.+..||++...+| +.|+||.-... . ....+....|.+.|..+. -.++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 45799999999999998776 48999975311 1 123456677888887762 3467778776 4455789
Q ss_pred EEecCCCCC-HHHHHc
Q 047892 232 VNEYVDNGN-LEQWLH 246 (442)
Q Consensus 232 v~E~~~~g~-L~~~l~ 246 (442)
||||+++.. +.+.+.
T Consensus 109 VME~L~~~~~lr~~Ll 124 (401)
T PRK09550 109 VMEDLSDHKILRKGLI 124 (401)
T ss_pred EEecCCCccHHHHHHh
Confidence 999998754 555544
|
|
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=94.02 E-value=0.046 Score=44.18 Aligned_cols=13 Identities=31% Similarity=0.521 Sum_probs=5.3
Q ss_pred HHHHHHhhheeee
Q 047892 30 VLFLISLWFTSKR 42 (442)
Q Consensus 30 ~~~~~~~~~~~~~ 42 (442)
++++++|+++|+|
T Consensus 80 ~Illi~y~irR~~ 92 (122)
T PF01102_consen 80 IILLISYCIRRLR 92 (122)
T ss_dssp HHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHh
Confidence 3334444444333
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=93.72 E-value=0.0054 Score=38.56 Aligned_cols=26 Identities=23% Similarity=0.583 Sum_probs=12.9
Q ss_pred HHHHHHHHHHHHHHHHHHhhheeeee
Q 047892 18 VLGICVGAGIVLVLFLISLWFTSKRN 43 (442)
Q Consensus 18 ~i~i~~~~~~~~~~~~~~~~~~~~~~ 43 (442)
.+|+++.+++++++++++|++++||+
T Consensus 14 a~~VvVPV~vI~~vl~~~l~~~~rR~ 39 (40)
T PF08693_consen 14 AVGVVVPVGVIIIVLGAFLFFWYRRK 39 (40)
T ss_pred EEEEEechHHHHHHHHHHhheEEecc
Confidence 34444444444555555555555554
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=93.64 E-value=0.96 Score=40.34 Aligned_cols=85 Identities=20% Similarity=0.365 Sum_probs=61.6
Q ss_pred ccCeeccCCcEEEEEEEECCCCeEEEEEecCcc----------------hhhHHHHHHHHHHHHhcC------CCCcceE
Q 047892 162 DENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNR----------------GQAEKEFKVEVEAIGRVR------HKNLVRL 219 (442)
Q Consensus 162 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------hpnIv~l 219 (442)
....||+|+.-.||.- +......||+..... ....++..+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3467999999999964 456677888885544 122355666776665555 8899999
Q ss_pred EEEEEeCCeeeeEEecCCC------CCHHHHHccC
Q 047892 220 VGYCAEGAHRMLVNEYVDN------GNLEQWLHGD 248 (442)
Q Consensus 220 ~~~~~~~~~~~lv~E~~~~------g~L~~~l~~~ 248 (442)
+|+..++-..-+|+|.+.+ -+|.+++...
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~ 117 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG 117 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC
Confidence 9999998888899998643 3678888543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=93.60 E-value=0.038 Score=44.92 Aligned_cols=45 Identities=22% Similarity=0.289 Sum_probs=34.9
Q ss_pred cCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHh
Q 047892 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR 210 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~ 210 (442)
.+.||.|+.|.||+|++.+|+.||||..+ +...+.+...+.+|+.
T Consensus 16 ~~PlasASiaQVh~a~l~~g~~VaVKV~r---P~i~~~i~~Dl~~l~~ 60 (119)
T PF03109_consen 16 PEPLASASIAQVHRARLKDGEEVAVKVQR---PGIEEQIEADLRILRR 60 (119)
T ss_pred cchhhheehhhheeeeecccchhhhhhcc---hHHHHHHHHHHHHHHH
Confidence 35799999999999999899999999884 3444555566666654
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host [] | Back alignment and domain information |
|---|
Probab=93.45 E-value=0.14 Score=31.64 Aligned_cols=11 Identities=27% Similarity=0.646 Sum_probs=5.1
Q ss_pred HHHHHHHHHHH
Q 047892 15 IWVVLGICVGA 25 (442)
Q Consensus 15 ~~~~i~i~~~~ 25 (442)
+.+++++++|.
T Consensus 6 IaIIv~V~vg~ 16 (38)
T PF02439_consen 6 IAIIVAVVVGM 16 (38)
T ss_pred hhHHHHHHHHH
Confidence 34445554443
|
This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=93.21 E-value=0.023 Score=56.71 Aligned_cols=72 Identities=22% Similarity=0.396 Sum_probs=58.0
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEECC-CCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG 226 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 226 (442)
...++|.....+|.|+||+|+.+.... +..+|||.|... .........+|...+.++.|++|++++..|..+
T Consensus 46 r~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~ 119 (516)
T KOG1033|consen 46 REANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYER 119 (516)
T ss_pred hhhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceecC
Confidence 345678899999999999999998544 558999998543 445556788899999999999999998887644
|
|
| >PF01034 Syndecan: Syndecan domain; InterPro: IPR001050 The syndecans are transmembrane proteoglycans which are involved in the organisation of cytoskeleton and/or actin microfilaments, and have important roles as cell surface receptors during cell-cell and/or cell-matrix interactions [, ] | Back alignment and domain information |
|---|
Probab=92.61 E-value=0.036 Score=38.70 Aligned_cols=25 Identities=16% Similarity=0.373 Sum_probs=1.5
Q ss_pred HHHHHHHHhhheeeeeccccccccc
Q 047892 28 VLVLFLISLWFTSKRNSNNSKRQLN 52 (442)
Q Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~ 52 (442)
++++++++|+++|.|++.-.+..+.
T Consensus 23 l~ailLIlf~iyR~rkkdEGSY~l~ 47 (64)
T PF01034_consen 23 LFAILLILFLIYRMRKKDEGSYDLD 47 (64)
T ss_dssp --------------S------SS--
T ss_pred HHHHHHHHHHHHHHHhcCCCCccCC
Confidence 3444555566666665554444443
|
Structurally, these proteins consist of four separate domains: A signal sequence; An extracellular domain (ectodomain) of variable length whose sequence is not evolutionary conserved in the various forms of syndecans. The ectodomain contains the sites of attachment of the heparan sulphate glycosaminoglycan side chains; A transmembrane region; A highly conserved cytoplasmic domain of about 30 to 35 residues, which could interact with cytoskeletal proteins. The proteins known to belong to this family are: Syndecan 1. Syndecan 2 or fibroglycan. Syndecan 3 or neuroglycan or N-syndecan. Syndecan 4 or amphiglycan or ryudocan. Drosophila syndecan. Caenorhabditis elegans probable syndecan (F57C7.3). Syndecan-4, a transmembrane heparan sulphate proteoglycan, is a coreceptor with integrins in cell adhesion. It has been suggested to form a ternary signalling complex with protein kinase Calpha and phosphatidylinositol 4,5-bisphosphate (PIP2). Structural studies have demonstrated that the cytoplasmic domain undergoes a conformational transition and forms a symmetric dimer in the presence of phospholipid activator PIP2, and whose overall structure in solution exhibits a twisted clamp shape having a cavity in the centre of dimeric interface. In addition, it has been observed that the syndecan-4 variable domain interacts, strongly, not only with fatty acyl groups but also the anionic head group of PIP2. These findings indicate that PIP2 promotes oligomerisation of the syndecan-4 cytoplasmic domain for transmembrane signalling and cell-matrix adhesion [, ].; GO: 0008092 cytoskeletal protein binding, 0016020 membrane; PDB: 1EJQ_B 1EJP_B 1YBO_C 1OBY_Q. |
| >PF08374 Protocadherin: Protocadherin; InterPro: IPR013585 The structure of protocadherins is similar to that of classic cadherins (IPR002126 from INTERPRO), but they also have some unique features associated with the cytoplasmic domains | Back alignment and domain information |
|---|
Probab=92.56 E-value=0.038 Score=48.50 Aligned_cols=38 Identities=18% Similarity=0.292 Sum_probs=23.8
Q ss_pred CCCCccccchhHHHHHHHHHHHHHHHHHHHHHhhhe-ee
Q 047892 4 GFPLTSIFGLRIWVVLGICVGAGIVLVLFLISLWFT-SK 41 (442)
Q Consensus 4 ~~~~~~~~~~~~~~~i~i~~~~~~~~~~~~~~~~~~-~~ 41 (442)
|.+..+...-+.+++|||+.|+++++|+++++.+++ ||
T Consensus 26 ~d~~~~~~~d~~~I~iaiVAG~~tVILVI~i~v~vR~CR 64 (221)
T PF08374_consen 26 GDPASSRSKDYVKIMIAIVAGIMTVILVIFIVVLVRYCR 64 (221)
T ss_pred CCCCccccccceeeeeeeecchhhhHHHHHHHHHHHHHh
Confidence 445555555678888999888766555555444444 44
|
They are expressed in a variety of organisms and are found in high concentrations in the brain where they seem to be localised mainly at cell-cell contact sites. Their expression seems to be developmentally regulated []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=92.10 E-value=0.69 Score=42.21 Aligned_cols=97 Identities=16% Similarity=0.057 Sum_probs=61.2
Q ss_pred CeeccCCcEEEEEEEECC--CCeEEEEEecCcchhhHHHHHHHHHHHHhcCCC-CcceEEEEEEeCCeeeeEEecCCCCC
Q 047892 164 NVIGEGGYGIVYRGVLED--NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK-NLVRLVGYCAEGAHRMLVNEYVDNGN 240 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~~~lv~E~~~~g~ 240 (442)
+.|..|-...+|+....+ +..|++|....... ..-...+|+.++..+... -..++++.+. -.++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 457788888999998654 67888886643221 112234688888888433 3445554432 248999999865
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC
Q 047892 241 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277 (442)
Q Consensus 241 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 277 (442)
+..-. + ....++.++++.|+-||..
T Consensus 79 l~~~~---------~---~~~~~~~~la~~l~~lH~~ 103 (235)
T cd05157 79 LEPED---------L---RNPKIYRLIARELAKLHSI 103 (235)
T ss_pred CCHHH---------c---cChHHHHHHHHHHHHHhcc
Confidence 53221 0 0123567788889999975
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF06365 CD34_antigen: CD34/Podocalyxin family; InterPro: IPR013836 This family consists of several mammalian CD34 antigen proteins | Back alignment and domain information |
|---|
Probab=91.99 E-value=0.4 Score=42.39 Aligned_cols=28 Identities=14% Similarity=0.294 Sum_probs=11.5
Q ss_pred HHHHHHHHH-HHHHHHHHHHhhheeeeec
Q 047892 17 VVLGICVGA-GIVLVLFLISLWFTSKRNS 44 (442)
Q Consensus 17 ~~i~i~~~~-~~~~~~~~~~~~~~~~~~~ 44 (442)
++|++++.+ ++|+++++++.|++..||+
T Consensus 101 ~lI~lv~~g~~lLla~~~~~~Y~~~~Rrs 129 (202)
T PF06365_consen 101 TLIALVTSGSFLLLAILLGAGYCCHQRRS 129 (202)
T ss_pred EEEehHHhhHHHHHHHHHHHHHHhhhhcc
Confidence 344444433 3444444444343333333
|
The CD34 antigen is a human leukocyte membrane protein expressed specifically by lymphohematopoietic progenitor cells. CD34 is a phosphoprotein. Activation of protein kinase C (PKC) has been found to enhance CD34 phosphorylation [, ]. This family contains several eukaryotic podocalyxin proteins. Podocalyxin is a major membrane protein of the glomerular epithelium and is thought to be involved in maintenance of the architecture of the foot processes and filtration slits characteristic of this unique epithelium by virtue of its high negative charge. Podocalyxin functions as an anti-adhesin that maintains an open filtration pathway between neighbouring foot processes in the glomerular epithelium by charge repulsion []. |
| >PF14575 EphA2_TM: Ephrin type-A receptor 2 transmembrane domain; PDB: 3KUL_A 2XVD_A 2VX1_A 2VWV_A 2VX0_A 2VWY_A 2VWZ_A 2VWW_A 2VWU_A 2VWX_A | Back alignment and domain information |
|---|
Probab=91.38 E-value=0.18 Score=37.14 Aligned_cols=23 Identities=30% Similarity=0.481 Sum_probs=10.6
Q ss_pred HHHHHHHHHHHHHHHHHHHhhhe
Q 047892 17 VVLGICVGAGIVLVLFLISLWFT 39 (442)
Q Consensus 17 ~~i~i~~~~~~~~~~~~~~~~~~ 39 (442)
+++++++|++++++++++++++.
T Consensus 2 ii~~~~~g~~~ll~~v~~~~~~~ 24 (75)
T PF14575_consen 2 IIASIIVGVLLLLVLVIIVIVCF 24 (75)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCCC
T ss_pred EEehHHHHHHHHHHhheeEEEEE
Confidence 44555555444444444433333
|
... |
| >PF07213 DAP10: DAP10 membrane protein; InterPro: IPR009861 This family consists of several mammalian DAP10 membrane proteins | Back alignment and domain information |
|---|
Probab=90.87 E-value=0.4 Score=35.13 Aligned_cols=34 Identities=18% Similarity=0.356 Sum_probs=20.7
Q ss_pred cchhHHHHHHHHHHH-HHHHHHHHHHhhheeeeec
Q 047892 11 FGLRIWVVLGICVGA-GIVLVLFLISLWFTSKRNS 44 (442)
Q Consensus 11 ~~~~~~~~i~i~~~~-~~~~~~~~~~~~~~~~~~~ 44 (442)
+.++..+++||++|= ++-+++++.+|++-|.|++
T Consensus 29 ~~ls~g~LaGiV~~D~vlTLLIv~~vy~car~r~r 63 (79)
T PF07213_consen 29 YPLSPGLLAGIVAADAVLTLLIVLVVYYCARPRRR 63 (79)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHHHHHhhcccccC
Confidence 456789999999984 4444444455555444433
|
In activated mouse natural killer (NK) cells, the NKG2D receptor associates with two intracellular adaptors, DAP10 and DAP12, which trigger phosphatidyl inositol 3 kinase (PI3K) and Syk family protein tyrosine kinases, respectively. It has been suggested that the DAP10-PI3K pathway is sufficient to initiate NKG2D-mediated killing of target cells []. |
| >PF12877 DUF3827: Domain of unknown function (DUF3827); InterPro: IPR024606 The function of the proteins in this entry is not currently known, but one of the human proteins (Q9HCM3 from SWISSPROT) has been implicated in pilocytic astrocytomas [, , ] | Back alignment and domain information |
|---|
Probab=90.72 E-value=0.099 Score=53.35 Aligned_cols=34 Identities=24% Similarity=0.583 Sum_probs=25.1
Q ss_pred cchhHHHHHHHHHHHHHHHHHHHHHhhheeeeec
Q 047892 11 FGLRIWVVLGICVGAGIVLVLFLISLWFTSKRNS 44 (442)
Q Consensus 11 ~~~~~~~~i~i~~~~~~~~~~~~~~~~~~~~~~~ 44 (442)
-...+|||||+++.+++++++++|++|++||+.+
T Consensus 265 ~~~NlWII~gVlvPv~vV~~Iiiil~~~LCRk~K 298 (684)
T PF12877_consen 265 PPNNLWIIAGVLVPVLVVLLIIIILYWKLCRKNK 298 (684)
T ss_pred CCCCeEEEehHhHHHHHHHHHHHHHHHHHhcccc
Confidence 3456899999988877777777777776666554
|
In the majority of cases of pilocytic astrocytomas a tandem duplication produces an in-frame fusion of the gene encoding this protein and the BRAF oncogene. The resulting fusion protein has constitutive BRAF kinase activity and is capable of transforming cells. |
| >PF13908 Shisa: Wnt and FGF inhibitory regulator | Back alignment and domain information |
|---|
Probab=90.34 E-value=0.94 Score=39.68 Aligned_cols=24 Identities=17% Similarity=0.317 Sum_probs=13.0
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHh
Q 047892 13 LRIWVVLGICVGAGIVLVLFLISL 36 (442)
Q Consensus 13 ~~~~~~i~i~~~~~~~~~~~~~~~ 36 (442)
..+++++||+++++++++++++++
T Consensus 76 ~~~~iivgvi~~Vi~Iv~~Iv~~~ 99 (179)
T PF13908_consen 76 FITGIIVGVICGVIAIVVLIVCFC 99 (179)
T ss_pred ceeeeeeehhhHHHHHHHhHhhhe
Confidence 345566777666555444444443
|
|
| >PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region | Back alignment and domain information |
|---|
Probab=90.24 E-value=0.037 Score=45.99 Aligned_cols=29 Identities=28% Similarity=0.560 Sum_probs=14.4
Q ss_pred HHHHHHHHHHHH--HHHHHHHHhhheeeeec
Q 047892 16 WVVLGICVGAGI--VLVLFLISLWFTSKRNS 44 (442)
Q Consensus 16 ~~~i~i~~~~~~--~~~~~~~~~~~~~~~~~ 44 (442)
-++||++||+++ ++++++++|++|+|+++
T Consensus 49 nIVIGvVVGVGg~ill~il~lvf~~c~r~kk 79 (154)
T PF04478_consen 49 NIVIGVVVGVGGPILLGILALVFIFCIRRKK 79 (154)
T ss_pred cEEEEEEecccHHHHHHHHHhheeEEEeccc
Confidence 355666666433 33344444445544444
|
The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway []. |
| >PF12273 RCR: Chitin synthesis regulation, resistance to Congo red; InterPro: IPR020999 RCR proteins are ER membrane proteins that regulate chitin deposition in fungal cell walls | Back alignment and domain information |
|---|
Probab=90.22 E-value=0.16 Score=42.00 Aligned_cols=9 Identities=33% Similarity=0.911 Sum_probs=4.6
Q ss_pred HHHHHHHHH
Q 047892 16 WVVLGICVG 24 (442)
Q Consensus 16 ~~~i~i~~~ 24 (442)
|++++|+|+
T Consensus 2 W~l~~iii~ 10 (130)
T PF12273_consen 2 WVLFAIIIV 10 (130)
T ss_pred eeeHHHHHH
Confidence 555555433
|
Although chitin, a linear polymer of beta-1,4-linked N-acetylglucosamine, constitutes only 2% of the cell wall it plays a vital role in the overall protection of the cell wall against stress, noxious chemicals and osmotic pressure changes. Congo red is a cell wall-disrupting benzidine-type dye extensively used in many cell wall mutant studies that specifically targets chitin in yeast cells and inhibits growth. RCR proteins render the yeasts resistant to Congo red by diminishing the content of chitin in the cell wall []. RCR proteins are probably regulating chitin synthase III interact directly with ubiquitin ligase Rsp5, and the VPEY motif is necessary for this, via interaction with the WW domains of Rsp5 []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=89.43 E-value=1.3 Score=40.52 Aligned_cols=97 Identities=13% Similarity=0.113 Sum_probs=60.2
Q ss_pred CeeccCCcE-EEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCC---CcceEEEEEEeC---CeeeeEEecC
Q 047892 164 NVIGEGGYG-IVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK---NLVRLVGYCAEG---AHRMLVNEYV 236 (442)
Q Consensus 164 ~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~l~~~~~~~---~~~~lv~E~~ 236 (442)
+.|+.|+.. .||+. +..+++|..... .....+.+|.+++..|... -+.++++..... ...|++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457766665 58875 235677764332 2345688899999877532 344444443322 2358999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 277 (442)
+|.++.+.. .. ....++.++++.+.-||+-
T Consensus 77 ~G~~l~~~~---------~~--~~~~l~~~la~~l~~LH~i 106 (235)
T cd05155 77 EGETATAAA---------LS--DPSEFAEDLADFLAALRQI 106 (235)
T ss_pred cCCCCCccc---------cC--CHHHHHHHHHHHHHHHhCC
Confidence 998775431 11 1225778888888899963
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF15102 TMEM154: TMEM154 protein family | Back alignment and domain information |
|---|
Probab=88.76 E-value=0.21 Score=41.37 Aligned_cols=8 Identities=25% Similarity=0.210 Sum_probs=3.1
Q ss_pred HHhhheee
Q 047892 34 ISLWFTSK 41 (442)
Q Consensus 34 ~~~~~~~~ 41 (442)
+++++++|
T Consensus 76 V~lv~~~k 83 (146)
T PF15102_consen 76 VCLVIYYK 83 (146)
T ss_pred HHheeEEe
Confidence 33344333
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=87.83 E-value=0.5 Score=45.12 Aligned_cols=127 Identities=19% Similarity=0.149 Sum_probs=79.1
Q ss_pred CCCccCeeccCCcEEEEEEEECCCCeEEEEEec----------Ccc---------h-h--hHHHHHHHHHHHHhcC-CCC
Q 047892 159 GFADENVIGEGGYGIVYRGVLEDNTNVAVKNLL----------NNR---------G-Q--AEKEFKVEVEAIGRVR-HKN 215 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~----------~~~---------~-~--~~~~~~~E~~~l~~l~-hpn 215 (442)
-+.+.+.||-|.-+.||.+..+.|++.++|.=. .+. . . .+-...+|+..|+.|. |-.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 467789999999999999999889998888321 100 0 0 1122457888888884 322
Q ss_pred -cceEEEEEEeCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------CCCCCCeEEe
Q 047892 216 -LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------LEPKWNPKLS 287 (442)
Q Consensus 216 -Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------l~~~~~~kl~ 287 (442)
+.+.++ .+..++|||++.+-.|.+.-+-. ..+--....+.++..++. -.++|.+ ++.+..++++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~---d~~~ly~~lm~~Iv~la~-~GlIHgDFNEFNimv~dd~~i~vI 244 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHVE---DPPTLYDDLMGLIVRLAN-HGLIHGDFNEFNIMVKDDDKIVVI 244 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeecC---ChHHHHHHHHHHHHHHHH-cCceecccchheeEEecCCCEEEe
Confidence 333343 35568999999998887653211 111112233334433332 3578887 5567889999
Q ss_pred cccCcc
Q 047892 288 DFGLAK 293 (442)
Q Consensus 288 DFGla~ 293 (442)
||--..
T Consensus 245 DFPQmv 250 (465)
T KOG2268|consen 245 DFPQMV 250 (465)
T ss_pred echHhh
Confidence 996443
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=87.77 E-value=3.3 Score=40.49 Aligned_cols=127 Identities=16% Similarity=0.160 Sum_probs=72.8
Q ss_pred ccCeeccCCcEEEEEEEECCCCeEEEEEecCc------chh----------------hHHH----HHHHHHHHHhcCCCC
Q 047892 162 DENVIGEGGYGIVYRGVLEDNTNVAVKNLLNN------RGQ----------------AEKE----FKVEVEAIGRVRHKN 215 (442)
Q Consensus 162 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~------~~~----------------~~~~----~~~E~~~l~~l~hpn 215 (442)
+-..|..|.-+.||.|.-.+|..+|||+.+.. ... .++. ...|++-|.+|+.-.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 34567889999999999888999999977421 000 0111 245888888887655
Q ss_pred cceEEEEEEeCCeeeeEEecCCCCCH-HHHHccCCCCCCCCCHHHHHHHHHHHHHhh-------hhhhcCC------CCC
Q 047892 216 LVRLVGYCAEGAHRMLVNEYVDNGNL-EQWLHGDVGPHSPLTWEIRMNIILGTAKGL-------TYLHEGL------EPK 281 (442)
Q Consensus 216 Iv~l~~~~~~~~~~~lv~E~~~~g~L-~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l-------~yLH~~l------~~~ 281 (442)
|..---+... ...|||+|+....- .-.|+. -.++...+..+-.|++.-| ...|.++ -.+
T Consensus 228 IP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd-----~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd 300 (520)
T KOG2270|consen 228 IPCPEPILLK--NHVLVMEFLGRDGWAAPKLKD-----ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD 300 (520)
T ss_pred CCCCCceeee--cceEeeeeccCCCCcCccccc-----ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC
Confidence 4422212111 23699999964211 111211 2344444443333433333 3447763 357
Q ss_pred CCeEEecccCcccc
Q 047892 282 WNPKLSDFGLAKLL 295 (442)
Q Consensus 282 ~~~kl~DFGla~~~ 295 (442)
|.+.|+|-+-+...
T Consensus 301 G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEH 314 (520)
T ss_pred CEEEEEEccccccC
Confidence 88999998877543
|
|
| >PTZ00382 Variant-specific surface protein (VSP); Provisional | Back alignment and domain information |
|---|
Probab=86.69 E-value=0.13 Score=39.88 Aligned_cols=34 Identities=24% Similarity=0.441 Sum_probs=18.4
Q ss_pred cccchhHHHHHHHHHHHHHHH--HHHHHHhhheeee
Q 047892 9 SIFGLRIWVVLGICVGAGIVL--VLFLISLWFTSKR 42 (442)
Q Consensus 9 ~~~~~~~~~~i~i~~~~~~~~--~~~~~~~~~~~~~ 42 (442)
...+++...++||++|+++++ ++.+++|||.+||
T Consensus 59 ~~~~ls~gaiagi~vg~~~~v~~lv~~l~w~f~~r~ 94 (96)
T PTZ00382 59 NRSGLSTGAIAGISVAVVAVVGGLVGFLCWWFVCRG 94 (96)
T ss_pred CCCCcccccEEEEEeehhhHHHHHHHHHhheeEEee
Confidence 335666777788777754433 2334444444443
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=86.57 E-value=2 Score=39.87 Aligned_cols=95 Identities=12% Similarity=0.050 Sum_probs=57.4
Q ss_pred eccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeeeeEEecCCCCCHHHH
Q 047892 166 IGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL-VRLVGYCAEGAHRMLVNEYVDNGNLEQW 244 (442)
Q Consensus 166 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~~g~L~~~ 244 (442)
+..|-.+.+|+... ++..+++|..........-...+|.++++.+..-++ .+++.... -++||||++|..+..-
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677788998874 566788886543222111134678888888854333 34444332 3689999998665421
Q ss_pred HccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC
Q 047892 245 LHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277 (442)
Q Consensus 245 l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 277 (442)
. ... ...+.++++.|.-||+.
T Consensus 79 ~--------~~~----~~~~~~la~~l~~lH~~ 99 (256)
T TIGR02721 79 Q--------FVA----LDLLLELAALLHQLHSQ 99 (256)
T ss_pred c--------ccC----chhHHHHHHHHHHHhCC
Confidence 0 001 12456778888888875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=84.88 E-value=3 Score=39.58 Aligned_cols=75 Identities=16% Similarity=0.224 Sum_probs=47.9
Q ss_pred CccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcC---CCCcceEEEEEEeCCeeeeEEecCC
Q 047892 161 ADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR---HKNLVRLVGYCAEGAHRMLVNEYVD 237 (442)
Q Consensus 161 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~E~~~ 237 (442)
+..+.++-|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+.+++++....+..||||||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 345678889999999987 567889999764 233456777888887773 4457788888877777899999998
Q ss_pred CC
Q 047892 238 NG 239 (442)
Q Consensus 238 ~g 239 (442)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 75
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF15050 SCIMP: SCIMP protein | Back alignment and domain information |
|---|
Probab=84.76 E-value=1.9 Score=34.16 Aligned_cols=13 Identities=15% Similarity=0.304 Sum_probs=6.6
Q ss_pred HhhCCCCccCeec
Q 047892 155 VSTNGFADENVIG 167 (442)
Q Consensus 155 ~~~~~~~~~~~lG 167 (442)
-..++|...+.-+
T Consensus 115 ePe~DYDDVeipa 127 (133)
T PF15050_consen 115 EPENDYDDVEIPA 127 (133)
T ss_pred Ccccccccccccc
Confidence 3445566555443
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=83.59 E-value=4.6 Score=38.20 Aligned_cols=96 Identities=11% Similarity=0.084 Sum_probs=61.7
Q ss_pred cCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCC--cceEEEE------EEeCCeeeeEEe
Q 047892 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN--LVRLVGY------CAEGAHRMLVNE 234 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~------~~~~~~~~lv~E 234 (442)
.+.|..|....+|+....+ ..+++|.... .....+..|++++..|.+-+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 5567788878999987644 4688887753 22345667888877774322 4444431 223456689999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 277 (442)
|++|..+.. .+. ..+.++++.|+-||..
T Consensus 95 ~i~G~~~~~-----------~~~----~~~~~lg~~La~lH~~ 122 (296)
T cd05153 95 FLAGEHLTR-----------PTA----AHCRQIGEALARLHLA 122 (296)
T ss_pred eCCCCCCCC-----------CCH----HHHHHHHHHHHHHHHH
Confidence 999965432 111 2456777888888864
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=83.47 E-value=3.2 Score=39.45 Aligned_cols=98 Identities=18% Similarity=0.185 Sum_probs=61.4
Q ss_pred CeeccCCcEEEEEEEECC-------CCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCC-cceEEEEEEeCCeeeeEEec
Q 047892 164 NVIGEGGYGIVYRGVLED-------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN-LVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~E~ 235 (442)
+.|..|-...+|+....+ ++.+++|...... .......+|.+++..+...+ ..++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 345667677899988654 4788899864432 22234567888888774333 3355555432 368999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcCC
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 278 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~l 278 (442)
++|..+...... ...++.++++.|.-||+..
T Consensus 79 i~G~~l~~~~~~------------~~~~~~~ia~~L~~lH~~~ 109 (302)
T cd05156 79 IPSRTLTTEELR------------DPDISAEIARRMAKLHSIV 109 (302)
T ss_pred eCCCcCCHhHcC------------CcHHHHHHHHHHHHhhCCC
Confidence 988665432110 0235678888999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=82.76 E-value=11 Score=37.71 Aligned_cols=101 Identities=15% Similarity=0.103 Sum_probs=61.8
Q ss_pred cCeeccCCcEEEEEEEECCCCeEEEEEecCc-----c--hhhHHHHHHHHHHHHhcC---CCCcceEEEEEEeCCeeeeE
Q 047892 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNN-----R--GQAEKEFKVEVEAIGRVR---HKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lv 232 (442)
.+.||.|....||+.... +..++||.-... . .....+-..|.+.|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 567899999999998864 456899976411 1 012333344566666553 357888888876 446789
Q ss_pred EecCCC--CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhh
Q 047892 233 NEYVDN--GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 271 (442)
Q Consensus 233 ~E~~~~--g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l 271 (442)
|||+++ ..+.+-+-.. ......+..+...++..|
T Consensus 114 ME~L~~~~~ilr~~Ll~G-----~~~p~~a~~ig~~la~tL 149 (418)
T PLN02756 114 MRYLEPPHIILRKGLIAG-----IEYPLLAEHMSDYMAKTL 149 (418)
T ss_pred EeecCCcceehhhhhccC-----CCCHHHHHHHHHHHHHHH
Confidence 999987 3455444322 222344555555555543
|
|
| >KOG4258 consensus Insulin/growth factor receptor (contains protein kinase domain) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=81.03 E-value=1.8 Score=45.99 Aligned_cols=31 Identities=35% Similarity=0.649 Sum_probs=25.0
Q ss_pred eehhhHHHhhCCCCccCeeccCCcEEEEEEEE
Q 047892 148 YTLRELEVSTNGFADENVIGEGGYGIVYRGVL 179 (442)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~ 179 (442)
|-.+++++..+ ....+.||+|+||.||.|.-
T Consensus 985 yv~deWe~~r~-it~~relg~gsfg~Vy~g~~ 1015 (1025)
T KOG4258|consen 985 YVPDEWEVSRE-ITLGRELGQGSFGMVYEGNA 1015 (1025)
T ss_pred CChhHHHHHHH-HhhhhhhccCccceEEEecC
Confidence 33467777777 77889999999999999864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=80.77 E-value=10 Score=36.18 Aligned_cols=117 Identities=10% Similarity=0.024 Sum_probs=0.0
Q ss_pred CCCCceeehhhHHHhhCCCCc-----cCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhc--CCC
Q 047892 142 LGWGHWYTLRELEVSTNGFAD-----ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV--RHK 214 (442)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hp 214 (442)
|+.-...+.+++....+.|.+ ++.++.|....+|+....++ .+++|.... ......+..|.+++..| ..-
T Consensus 1 ~~~~~~~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~--~~~~~~i~~e~~~l~~L~~~g~ 77 (307)
T TIGR00938 1 MAVYTSVSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEK--RVKAEELPFFLALTTHLAARGL 77 (307)
T ss_pred CCccccCCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecC--CCCHHHHHHHHHHHHHHHHCCC
Q ss_pred CcceEEE------EEEeCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc
Q 047892 215 NLVRLVG------YCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276 (442)
Q Consensus 215 nIv~l~~------~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~ 276 (442)
.+.+++. +....+..++++||++| ...... ....+.++.+.|+-||.
T Consensus 78 pvp~~i~t~~g~~~~~~~g~~~~l~e~i~G--------------~~~~~~-~~~~~~~~G~~LA~lH~ 130 (307)
T TIGR00938 78 PVPKPVKSRDGRQLSTLAGKPACLVEFLQG--------------LSVGRP-TAMHCRPVGEVLAWMHL 130 (307)
T ss_pred CCCccccCCCCCeehhcCCeEEEEEEeCCC--------------CCCCCC-CHHHHHHHHHHHHHHHh
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 442 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-50 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-49 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-42 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-42 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-31 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-31 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-29 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-05 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-05 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-05 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-05 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-05 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-05 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-05 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-05 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-05 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-05 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-05 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-05 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-05 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-05 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-05 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-05 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-05 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-05 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-05 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-05 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-05 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-04 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-04 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-04 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-04 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-04 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-04 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-04 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-04 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-04 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-04 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-04 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-04 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-04 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-04 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-04 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-04 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-04 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-04 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 462 bits (1191), Expect = e-163
Identities = 116/315 (36%), Positives = 177/315 (56%), Gaps = 19/315 (6%)
Query: 141 HLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQA-EK 199
HLG ++LREL+V+++ F+++N++G GG+G VY+G L D T VAVK L R Q E
Sbjct: 13 HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGEL 72
Query: 200 EFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEI 259
+F+ EVE I H+NL+RL G+C R+LV Y+ NG++ L PL W
Sbjct: 73 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132
Query: 260 RMNIILGTAKGLTYLHEGLEPK----------------WNPKLSDFGLAKLLGAERSYVT 303
R I LG+A+GL YLH+ +PK + + DFGLAKL+ + ++VT
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 192
Query: 304 TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFE 363
T V GT G++APEY STG +E +DV+ +G++++E+I+G+ D +R + V L +
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND--DDVMLLD 250
Query: 364 WLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423
W+K ++ E ++D LQ +++ + VAL C + +RPKM V+ MLE +
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310
Query: 424 FPFRDERRAGREHGR 438
R E E R
Sbjct: 311 LAERWEEWQKEEMFR 325
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 431 bits (1110), Expect = e-151
Identities = 105/291 (36%), Positives = 164/291 (56%), Gaps = 18/291 (6%)
Query: 144 WGHWYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKV 203
+ L +LE +TN F + +IG G +G VY+GVL D VA+K Q +EF+
Sbjct: 25 ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFET 84
Query: 204 EVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNI 263
E+E + RH +LV L+G+C E +L+ +Y++NGNL++ L+G P ++WE R+ I
Sbjct: 85 EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 264 ILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKL-LGAERSYVTTRVMGT 309
+G A+GL YLH L+ + PK++DFG++K ++++++T V GT
Sbjct: 145 CIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
Query: 310 FGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMV 369
GY+ PEY G L E SDVYSFG+++ EV+ R+ + S P VNL EW
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM----VNLAEWAVESH 260
Query: 370 TNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
NG E ++DP L +K +L++ A++C+ ++ RP MG V+ LE
Sbjct: 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 354 bits (912), Expect = e-121
Identities = 92/300 (30%), Positives = 157/300 (52%), Gaps = 35/300 (11%)
Query: 146 HWYTLRELEVSTNGFADE------NVIGEGGYGIVYRGVLEDNTNVAVKNLLNNR----G 195
H ++ EL+ TN F + N +GEGG+G+VY+G + +NT VAVK L
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 196 QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPL 255
+ +++F E++ + + +H+NLV L+G+ ++G LV Y+ NG+L L G PL
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPL 130
Query: 256 TWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE-RSY 301
+W +R I G A G+ +LHE L+ + K+SDFGLA+ ++
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNL 361
+T+R++GT Y+APE G + SD+YSFG++++E+I+G VD R P L
Sbjct: 191 MTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP------QLL 243
Query: 362 FEWLKTMVTN-GNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
+ + + E +D ++ + S +++ VA +C+ +KRP + V +L+
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 9e-73
Identities = 63/312 (20%), Positives = 115/312 (36%), Gaps = 50/312 (16%)
Query: 149 TLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAI 208
L + V G +G V++ L N VAVK + + + + + EV ++
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVK-IFPIQDKQSWQNEYEVYSL 72
Query: 209 GRVRHKNLVRLVGYCAEGAH----RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNII 264
++H+N+++ +G G L+ + + G+L +L + ++W +I
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHIA 127
Query: 265 LGTAKGLTYLHEGLEPK-----------------------WNPKLSDFGLAKLLGAERSY 301
A+GL YLHE + ++DFGLA A +S
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 302 V-TTRVMGTFGYVAPEYASTGMLNET-----SDVYSFGILIMEVISGRNPVDYSRPPGEF 355
T +GT Y+APE + + D+Y+ G+++ E+ S D
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 356 QFQVNL-----FEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALL-VALRCVDPNAHKR 409
F+ + E ++ +V + P L++ A L C D +A R
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 410 PKMGHVIHMLEA 421
G V +
Sbjct: 304 LSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-49
Identities = 67/322 (20%), Positives = 104/322 (32%), Gaps = 65/322 (20%)
Query: 152 ELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE--AIG 209
E + + +IG G YG VY+G L D VAVK + F E +
Sbjct: 7 EPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNIYRVP 62
Query: 210 RVRHKNLVRLVGYCAEG-----AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNII 264
+ H N+ R + +LV EY NG+L ++L W +
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSCRLA 117
Query: 265 LGTAKGLTYLHEGLEP----------------------KWNPKLSDFGLAKLLG------ 296
+GL YLH L +SDFGL+ L
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 297 -AERSYVTTRVMGTFGYVAPEYASTGM-------LNETSDVYSFGILIMEVISGRNPVDY 348
E +GT Y+APE + + D+Y+ G++ E+ +
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 349 SRPPGEFQ--FQVNL-----FEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVAL-- 399
E+Q FQ + FE ++ +V+ P+ E +L L
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKETIE 293
Query: 400 RCVDPNAHKRPKMGHVIHMLEA 421
C D +A R +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAE 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-47
Identities = 74/287 (25%), Positives = 122/287 (42%), Gaps = 39/287 (13%)
Query: 152 ELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIG 209
++++ + IG G +G V+R ++VAVK L+ + EF EV +
Sbjct: 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMK 89
Query: 210 RVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 269
R+RH N+V +G + + +V EY+ G+L + LH G L R+++ AK
Sbjct: 90 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAK 148
Query: 270 GLTYLHEG---------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 314
G+ YLH ++ K+ K+ DFGL++L A + GT ++A
Sbjct: 149 GMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK-ASTFLSSKSAAGTPEWMA 207
Query: 315 PEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374
PE NE SDVYSFG+++ E+ + + P + QV V
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQP--W---GNLNPAQV------VAAVGFKCK 256
Query: 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421
RL E P + + A ++ C KRP ++ +L
Sbjct: 257 ------RL-EIPRNLNPQVAAIIE-GCWTNEPWKRPSFATIMDLLRP 295
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 9e-46
Identities = 65/302 (21%), Positives = 125/302 (41%), Gaps = 58/302 (19%)
Query: 151 RELEVSTNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAE-------KEFK 202
R ++ N E IG+GG+G+V++G ++D + VA+K+L+ + E +EF+
Sbjct: 12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71
Query: 203 VEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMN 262
EV + + H N+V+L G +V E+V G+L L P+ W +++
Sbjct: 72 REVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLL---DKAHPIKWSVKLR 126
Query: 263 IILGTAKGLTYLH--------------------EGLEPKWNPKLSDFGLAKLLGAERSYV 302
++L A G+ Y+ K++DFGL++ + +
Sbjct: 127 LMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHS 182
Query: 303 TTRVMGTFGYVAPE--YASTGMLNETSDVYSFGILIMEVISGRNPVDYS-RPPGEFQFQV 359
+ ++G F ++APE A E +D YSF +++ +++G P + G+ +F
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP--FDEYSYGKIKFIN 240
Query: 360 NLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHML 419
M+ R P + ++ C + KRP +++ L
Sbjct: 241 --------MIREEGL------RP-TIPEDCPPRLRNVIE-LCWSGDPKKRPHFSYIVKEL 284
Query: 420 EA 421
Sbjct: 285 SE 286
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-45
Identities = 74/298 (24%), Positives = 121/298 (40%), Gaps = 58/298 (19%)
Query: 153 LEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLL----NNRGQAEKEFKVEVEAI 208
LE+ E +IG GG+G VYR VAVK + Q + + E +
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 209 GRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 268
++H N++ L G C + + LV E+ G L + L G + +I +N + A
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIA 115
Query: 269 KGLTYLH------------------------EGLEPKWNPKLSDFGLAKLLGAERSYVTT 304
+G+ YLH G K++DFGLA+ R+ +
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMS 173
Query: 305 RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEW 364
G + ++APE M ++ SDV+S+G+L+ E+++G P + G V
Sbjct: 174 AA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP--F---RGIDGLAV----- 222
Query: 365 LKTMVTNGNAEGVLDPRLQ-EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421
A GV +L PS+ A L+ C +P+ H RP +++ L
Sbjct: 223 ---------AYGVAMNKLALPIPSTCPEPFAKLM-EDCWNPDPHSRPSFTNILDQLTT 270
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-44
Identities = 68/294 (23%), Positives = 118/294 (40%), Gaps = 44/294 (14%)
Query: 149 TLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVE 206
+ E+ IG G +G VY+G + +VAVK L Q + FK EV
Sbjct: 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 207 AIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 266
+ + RH N++ +GY +V ++ + +L LH + + ++I
Sbjct: 73 VLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQ 128
Query: 267 TAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGY 312
TA+G+ YLH L K+ DFGLA S+ ++ G+ +
Sbjct: 129 TARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188
Query: 313 VAPE---YASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMV 369
+APE + + SDVY+FGI++ E+++G+ P + V
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG--------- 239
Query: 370 TNGNAEGVLDPRLQEKPSS--RALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421
G L P L + S+ + +KR + C+ +RP ++ +E
Sbjct: 240 -----RGSLSPDLSKVRSNCPKRMKRLM---AECLKKKRDERPSFPRILAEIEE 285
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-44
Identities = 77/299 (25%), Positives = 123/299 (41%), Gaps = 55/299 (18%)
Query: 154 EVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 213
+ E V+G G +G+V + +VA+K + + K F VE+ + RV H
Sbjct: 4 MIDYKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNH 60
Query: 214 KNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 273
N+V+L G C LV EY + G+L LHG P T M+ L ++G+ Y
Sbjct: 61 PNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 274 LHEGLEPK-----------------WN-PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 315
LH ++PK K+ DFG A + T G+ ++AP
Sbjct: 118 LH-SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAP 172
Query: 316 EYASTGMLNETSDVYSFGILIMEVISGRNP-VDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374
E +E DV+S+GI++ EVI+ R P + P F++ V NG
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRI------MWAVHNGT- 221
Query: 375 EGVLDPRLQEKPSS--RALKRALLVALRCVDPNAHKRPKMGHVIHMLEA--EEFPFRDE 429
R + + ++ L+ RC + +RP M ++ ++ FP DE
Sbjct: 222 ------RP-PLIKNLPKPIES-LMT--RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-44
Identities = 63/287 (21%), Positives = 109/287 (37%), Gaps = 52/287 (18%)
Query: 163 ENVIGEGGYGIVYRGVLEDNTN-VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVG 221
V+G+G +G + + + +K L+ + ++ F EV+ + + H N+++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 222 YCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---- 277
+ + EY+ G L + S W R++ A G+ YLH
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHSMNIIH 131
Query: 278 ---------LEPKWNPKLSDFGLAKLL-------------GAERSYVTTRVMGTFGYVAP 315
+ N ++DFGLA+L+ V+G ++AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 316 EYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375
E + +E DV+SFGI++ E+I N P +TM N
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP--------------RTMDFGLNVR 237
Query: 376 GVLDPRLQEKPSS--RALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
G LD P + + + +RC D + KRP + H LE
Sbjct: 238 GFLDR---YCPPNCPPSFFP---ITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 4e-43
Identities = 55/295 (18%), Positives = 106/295 (35%), Gaps = 54/295 (18%)
Query: 151 RELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAI 208
+ + + E G +++G ++ VK L + ++F E +
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRL 61
Query: 209 GRVRHKNLVRLVGYCAE--GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 266
H N++ ++G C H L+ ++ G+L LH G + + + L
Sbjct: 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALD 119
Query: 267 TAKGLTYLHEGLEP----------------KWNPKLSDFGLAKLLGAERSYVTTRVMGTF 310
A+G+ +LH LEP ++S + S+ + M
Sbjct: 120 MARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVK------FSFQSPGRMYAP 172
Query: 311 GYVAPE---YASTGMLNETSDVYSFGILIMEVISGRNP-VDYSRPPGEFQFQVNLFEWLK 366
+VAPE ++D++SF +L+ E+++ P D S E +V
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS--NMEIGMKV------- 223
Query: 367 TMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421
G R P + + L+ C++ + KRPK ++ +LE
Sbjct: 224 --ALEGL-------RP-TIPPGISPHVSKLMK-ICMNEDPAKRPKFDMIVPILEK 267
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-43
Identities = 61/301 (20%), Positives = 104/301 (34%), Gaps = 53/301 (17%)
Query: 149 TLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVE 206
L+E ++ +IG+G +G VY G + VA++ + R K FK EV
Sbjct: 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVM 81
Query: 207 AIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 266
A + RH+N+V +G C H ++ L + L I
Sbjct: 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQE 138
Query: 267 TAKGLTYLHEG------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVM----GTF 310
KG+ YLH ++DFGL + G ++ + G
Sbjct: 139 IVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 311 GYVAPEYASTGML---------NETSDVYSFGILIMEVISGRNPVDYSR-PPGEFQFQVN 360
++APE ++ SDV++ G + E+ + P + P +Q+
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP--FKTQPAEAIIWQM- 255
Query: 361 LFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
G+ P L + + + L L C +RP ++ MLE
Sbjct: 256 -------------GTGMK-PNLSQIGMGKEISDIL---LFCWAFEQEERPTFTKLMDMLE 298
Query: 421 A 421
Sbjct: 299 K 299
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-39
Identities = 62/298 (20%), Positives = 104/298 (34%), Gaps = 52/298 (17%)
Query: 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE--AIGRVRHKNLVRLV 220
+G+G YG V+RG NVAVK + EK + E E +RH+N++ +
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 221 GYCAEGAHR----MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276
H L+ Y + G+L +L + L + I+L A GL +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 277 GLEP---------------------KWNPKLSDFGLAKLL---GAERSYVTTRVMGTFGY 312
+ ++D GLA + + +GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 313 VAPE------YASTGMLNETSDVYSFGILIMEVISGRNPV----DYSRPPGEFQFQVNLF 362
+APE + D+++FG+++ EV DY P + F
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 363 EWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
E ++ +V + R P+ +L + L+ C N R + L
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK-LMK--ECWYQNPSARLTALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-38
Identities = 57/299 (19%), Positives = 102/299 (34%), Gaps = 54/299 (18%)
Query: 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGY 222
IG+G YG V+ G VAVK + +A + E+ +RH+N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVK-VFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 223 CAEGAHR----MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 278
+G L+ +Y +NG+L +L + L + + + + GL +LH +
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 279 EP---------------------KWNPKLSDFGLAKLLGAERS---YVTTRVMGTFGYVA 314
++D GLA ++ + +GT Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 315 PE------YASTGMLNETSDVYSFGILIMEVISGRNP---VDYSRPP--GEFQFQVNLFE 363
PE + +D+YSFG+++ EV V+ + P + +
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274
Query: 364 WLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVAL--RCVDPNAHKRPKMGHVIHMLE 420
+ + L P + SS R + L C N R V L
Sbjct: 275 MREIVCIKK-----LRPSFPNRWSSDECLRQ-MGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 59/315 (18%), Positives = 109/315 (34%), Gaps = 59/315 (18%)
Query: 146 HWYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEV 205
R + + + IG+G +G V+RG VAVK + E+ + E
Sbjct: 37 QRTIARTIVL-------QESIGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREA 85
Query: 206 E--AIGRVRHKNLVRLVGYC----AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEI 259
E +RH+N++ + LV++Y ++G+L +L+ +T E
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEG 140
Query: 260 RMNIILGTAKGLTYLHEGLEP---------------------KWNPKLSDFGLAKLLGAE 298
+ + L TA GL +LH + ++D GLA +
Sbjct: 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 200
Query: 299 RS---YVTTRVMGTFGYVAPE------YASTGMLNETSDVYSFGILIMEVISGRNPV--- 346
+GT Y+APE + +D+Y+ G++ E+ +
Sbjct: 201 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260
Query: 347 -DYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPN 405
DY P + E ++ +V + R Q + R + + ++ C N
Sbjct: 261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAK-IMR--ECWYAN 317
Query: 406 AHKRPKMGHVIHMLE 420
R + L
Sbjct: 318 GAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 71/279 (25%), Positives = 111/279 (39%), Gaps = 46/279 (16%)
Query: 163 ENVIGEGGYGIVYRGVL-EDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLV 220
IG G +G V+ G L DNT VAVK+ + +F E + + H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--- 277
G C + +V E V G+ +L + L + + ++ A G+ YL
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 278 ----------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGMLNE 325
+ K K+SDFG+++ A+ Y + + APE + G +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREE-ADGVYAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 326 TSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQE 384
SDV+SFGIL+ E S G +P Y P Q + V G RL
Sbjct: 295 ESDVWSFGILLWETFSLGASP--Y---PNLSNQQT------REFVEKGG-------RL-P 335
Query: 385 KPSS--RALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421
P A+ R + +C +RP + L++
Sbjct: 336 CPELCPDAVFR---LMEQCWAYEPGQRPSFSTIYQELQS 371
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-28
Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 22/199 (11%)
Query: 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGY 222
IG G +G+V+ G + VA+K + +E++F E E + ++ H LV+L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 223 CAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL------HE 276
C E A LV E++++G L +L G E + + L +G+ YL H
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEACVIHR 128
Query: 277 GL-------EPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGMLNETS 327
L K+SDFG+ + + T+ F +PE S + S
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 328 DVYSFGILIMEVIS-GRNP 345
DV+SFG+L+ EV S G+ P
Sbjct: 187 DVWSFGVLMWEVFSEGKIP 205
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 69/274 (25%), Positives = 112/274 (40%), Gaps = 42/274 (15%)
Query: 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGY 222
E +G+G +G V+ G T VA+K L + + F E + + ++RH+ LV+L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKT-LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 223 CAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG----- 277
+E +V EY+ G+L +L G+ G + L +++ A G+ Y+
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERMNYVHR 304
Query: 278 --------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDV 329
+ K++DFGLA+L+ + APE A G SDV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 330 YSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPS- 387
+SFGIL+ E+ + GR P Y PG +V V G R+ P
Sbjct: 365 WSFGILLTELTTKGRVP--Y---PGMVNREV------LDQVERGY-------RM-PCPPE 405
Query: 388 -SRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
+L + +C +RP ++ LE
Sbjct: 406 CPESLHD---LMCQCWRKEPEERPTFEYLQAFLE 436
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 24/203 (11%)
Query: 163 ENVIGEGGYGIVYRGVL---EDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVR 218
+ +G G +G V +GV + +VA+K L +E E + + ++ + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG- 277
L+G C A MLV E G L ++L G + ++ + G+ YL E
Sbjct: 75 LIGVCQAEAL-MLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 278 ------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGML 323
L + K+SDFGL+K LGA+ SY T R G + + APE +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 324 NETSDVYSFGILIMEVIS-GRNP 345
+ SDV+S+G+ + E +S G+ P
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP 213
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 62/288 (21%), Positives = 111/288 (38%), Gaps = 44/288 (15%)
Query: 163 ENVIGEGGYGIVYRGVL-----EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV 217
+ +G+G +G V VAVK L ++ +++F+ E++ + + +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 218 RLVGYCAEGAHR--MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 275
+ G + LV EY+ +G L +L L + KG+ YL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLG 144
Query: 276 EG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYAST 320
+E + + K++DFGLAKLL ++ Y R G + APE S
Sbjct: 145 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204
Query: 321 GMLNETSDVYSFGILIMEVIS-GRNP----VDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375
+ + SDV+SFG+++ E+ + ++ R G + L L+ ++ G
Sbjct: 205 NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE-LLEEGQ-- 261
Query: 376 GVLDPRLQEKPS--SRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421
RL P + + C P+ RP + L+
Sbjct: 262 -----RL-PAPPACPAEVHE---LMKLCWAPSPQDRPSFSALGPQLDM 300
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 26/204 (12%)
Query: 163 ENVIGEGGYGIVYRGVL---EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLV 217
+ +G G +G V +G + VAVK L N + E E + ++ + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277
R++G C + MLV E + G L ++L + + + + ++ + G+ YL E
Sbjct: 82 RMIGICEAESW-MLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES 136
Query: 278 -------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGM 322
L + K+SDFGL+K L A+ +Y + G + + APE +
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 323 LNETSDVYSFGILIMEVIS-GRNP 345
+ SDV+SFG+L+ E S G+ P
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-27
Identities = 56/221 (25%), Positives = 89/221 (40%), Gaps = 36/221 (16%)
Query: 145 GHWYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVE 204
GH E+ +G G +G+V G + +VAVK + +E EF E
Sbjct: 1 GHM------ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQE 53
Query: 205 VEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNII 264
+ + ++ H LV+ G C++ +V EY+ NG L +L G + + M
Sbjct: 54 AQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEM--C 110
Query: 265 LGTAKGLTYL------H-----------EGLEPKWNPKLSDFGLAKLLGAERSYVTTRVM 307
+G+ +L H L K+SDFG+ + + + V
Sbjct: 111 YDVCEGMAFLESHQFIHRDLAARNCLVDRDLC----VKVSDFGMTRYV--LDDQYVSSVG 164
Query: 308 GTFGY--VAPEYASTGMLNETSDVYSFGILIMEVIS-GRNP 345
F APE + SDV++FGIL+ EV S G+ P
Sbjct: 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 163 ENVIGEGGYGIVYRGVL----EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLV 217
+ V+G G +G V G L + +VA+K L + ++ +F E +G+ H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL--- 274
RL G + M+V EY++NG+L+ +L T + ++ G A G+ YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLSDM 166
Query: 275 ---HEGL-------EPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGM 322
H L K+SDFGL ++L + T G +PE +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 323 LNETSDVYSFGILIMEVIS-GRNP 345
SDV+S+GI++ EV+S G P
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERP 250
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-27
Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 163 ENVIGEGGYGIVYRGVL----EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLV 217
E +IG G G V G L + + VA+K L + ++ +F E +G+ H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL--- 274
RL G G M+V EY++NG+L+ +L G T + ++ G G+ YL
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 275 ---HEGL-------EPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGM 322
H L + K+SDFGL+++L + T G APE +
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 323 LNETSDVYSFGILIMEVIS-GRNP 345
+ SDV+SFG+++ EV++ G P
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERP 254
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-27
Identities = 52/224 (23%), Positives = 90/224 (40%), Gaps = 36/224 (16%)
Query: 142 LGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEF 201
LG+G W E+ +G G +G+V G +VA+K + +E EF
Sbjct: 14 LGYGSW------EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEF 66
Query: 202 KVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRM 261
E + + + H+ LV+L G C + ++ EY+ NG L +L + +
Sbjct: 67 IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLL 123
Query: 262 NIILGTAKGLTYL------H-----------EGLEPKWNPKLSDFGLAKLLGAERSYVTT 304
+ + + YL H + K+SDFGL++ + T+
Sbjct: 124 EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV----VKVSDFGLSRYV--LDDEYTS 177
Query: 305 RVMGTFGY--VAPEYASTGMLNETSDVYSFGILIMEVIS-GRNP 345
V F PE + SD+++FG+L+ E+ S G+ P
Sbjct: 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 69/274 (25%), Positives = 112/274 (40%), Gaps = 42/274 (15%)
Query: 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGY 222
E +G+G +G V+ G T VA+K L + + F E + + ++RH+ LV+L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKT-LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 223 CAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG----- 277
+E +V EY+ G+L +L G+ G + L +++ A G+ Y+
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERMNYVHR 387
Query: 278 --------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDV 329
+ K++DFGLA+L+ + APE A G SDV
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 330 YSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPS- 387
+SFGIL+ E+ + GR P Y PG +V V G R+ P
Sbjct: 448 WSFGILLTELTTKGRVP--Y---PGMVNREV------LDQVERGY-------RM-PCPPE 488
Query: 388 -SRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
+L + +C +RP ++ LE
Sbjct: 489 CPESLHD---LMCQCWRKEPEERPTFEYLQAFLE 519
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 29/206 (14%)
Query: 163 ENVIGEGGYGIVYRGVLED-----NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNL 216
V+G G +G VY+G+ VA+K L +A KE E + V + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276
RL+G C + L+ + + G L ++ + + +N + AKG+ YL +
Sbjct: 80 CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLED 135
Query: 277 G-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEYAST 320
++ + K++DFGLAKLLGAE G ++A E
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALESILH 193
Query: 321 GMLNETSDVYSFGILIMEVIS-GRNP 345
+ SDV+S+G+ + E+++ G P
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 65/295 (22%), Positives = 113/295 (38%), Gaps = 50/295 (16%)
Query: 163 ENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVG 221
++ +G G YG VY GV + + VAVK L +EF E + ++H NLV+L+G
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 222 YCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---- 277
C ++ E++ GNL +L ++ + + + + + YL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKNFIH 341
Query: 278 ---------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGMLNET 326
+ K++DFGL++L+ T F APE + +
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 327 SDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEK 385
SDV++FG+L+ E+ + G +P Y PG QV ++ R+ E+
Sbjct: 400 SDVWAFGVLLWEIATYGMSP--Y---PGIDLSQV------YELLEKDY-------RM-ER 440
Query: 386 PS--SRALKRALLVALRCVDPNAHKRPKMGHVIHMLE----AEEFPFRDERRAGR 434
P + + C N RP + E E+ G+
Sbjct: 441 PEGCPEKVYE---LMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGK 492
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 50/206 (24%), Positives = 82/206 (39%), Gaps = 27/206 (13%)
Query: 163 ENVIGEGGYGIVYRGVL----EDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKN 215
+G+G +G+V RG +VAVK L + ++ +A +F EV A+ + H+N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 275
L+RL G +V E G+L L G + A+G+ YL
Sbjct: 83 LIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLE 138
Query: 276 EG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYAST 320
L + K+ DFGL + L + + + APE T
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 321 GMLNETSDVYSFGILIMEVIS-GRNP 345
+ SD + FG+ + E+ + G+ P
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 29/206 (14%)
Query: 163 ENVIGEGGYGIVYRGVLED-----NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNL 216
V+G G +G V++GV V +K + + G Q+ + + AIG + H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276
VRL+G C G+ LV +Y+ G+L + G P +N + AKG+ YL E
Sbjct: 78 VRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQL---LLNWGVQIAKGMYYLEE 133
Query: 277 G-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEYAST 320
L+ +++DFG+A LL + + ++A E
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--EAKTPIKWMALESIHF 191
Query: 321 GMLNETSDVYSFGILIMEVIS-GRNP 345
G SDV+S+G+ + E+++ G P
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 152 ELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 211
E+ E +G G +G V+ +T VAVK + + + F E + +
Sbjct: 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKT-MKPGSMSVEAFLAEANVMKTL 240
Query: 212 RHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 271
+H LV+L + ++ E++ G+L +L D G S ++ A+G+
Sbjct: 241 QHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGM 297
Query: 272 TYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPE 316
++ + + K++DFGLA+++ E + T R F APE
Sbjct: 298 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPE 355
Query: 317 YASTGMLNETSDVYSFGILIMEVIS-GRNP 345
+ G SDV+SFGIL+ME+++ GR P
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 59/289 (20%), Positives = 112/289 (38%), Gaps = 45/289 (15%)
Query: 163 ENVIGEGGYGIVYRGVLE-----DNTNVAVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNL 216
+GEG +G V + VAVK+L G + K E+E + + H+N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 217 VRLVGYCAEGAHR--MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 274
V+ G C E L+ E++ +G+L+++L + + + ++ + KG+ YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYL 142
Query: 275 HEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYAS 319
+E + K+ DFGL K + ++ Y T + + APE
Sbjct: 143 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM 202
Query: 320 TGMLNETSDVYSFGILIMEVIS-----GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374
SDV+SFG+ + E+++ + + G Q+ + + + G
Sbjct: 203 QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN-TLKEGK- 260
Query: 375 EGVLDPRLQEKPS--SRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421
RL P + + + +C + R ++I EA
Sbjct: 261 ------RL-PCPPNCPDEVYQ---LMRKCWEFQPSNRTSFQNLIEGFEA 299
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 57/204 (27%), Positives = 82/204 (40%), Gaps = 36/204 (17%)
Query: 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGY 222
IG+G +G V G VAVK + + F E + ++RH NLV+L+G
Sbjct: 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 223 CAEGAHR-MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL------H 275
E +V EY+ G+L +L S L + + L + + YL H
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNNFVH 140
Query: 276 -----------EGLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGM 322
E K+SDFGL + +T+ G APE
Sbjct: 141 RDLAARNVLVSEDN----VAKVSDFGLT------KEASSTQDTGKLPVKWTAPEALREKK 190
Query: 323 LNETSDVYSFGILIMEVIS-GRNP 345
+ SDV+SFGIL+ E+ S GR P
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRVP 214
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-26
Identities = 60/310 (19%), Positives = 104/310 (33%), Gaps = 64/310 (20%)
Query: 163 ENVIGEGGYGIVYRGVL--------EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK 214
+G+G + +++GV T V +K L + F + ++ HK
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 215 NLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 274
+LV G C G +LV E+V G+L+ +L + + W++ + A + +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEV--AKQLAAAMHFL 129
Query: 275 ------H------------EGLEPKWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGYV 313
H E NP KLSD G++ + + + R+
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQERIPWV---- 184
Query: 314 APEYASTG-MLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTN 371
PE LN +D +SFG + E+ S G P + +
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP--L---SALDSQRK------LQFYED 233
Query: 372 GNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDERR 431
+ +L P + L + C+D RP +I L + F +
Sbjct: 234 RH-------QL-PAPKAAELAN---LINNCMDYEPDHRPSFRAIIRDLNSL---FTPDLV 279
Query: 432 AGREHGRSPH 441
H H
Sbjct: 280 PRGSHHHHHH 289
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-26
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 24/203 (11%)
Query: 163 ENVIGEGGYGIVYRGVLE---DNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVR 218
+ +G G +G V +GV +VA+K L +E E + + ++ + +VR
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG- 277
L+G C A MLV E G L ++L G + ++ + G+ YL E
Sbjct: 401 LIGVCQAEAL-MLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 278 ------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGML 323
L + K+SDFGL+K LGA+ SY T R G + APE +
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 324 NETSDVYSFGILIMEVIS-GRNP 345
+ SDV+S+G+ + E +S G+ P
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKP 539
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 47/201 (23%), Positives = 87/201 (43%), Gaps = 25/201 (12%)
Query: 163 ENVIGEGGYGIVYRGVLE-----DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV 217
+G+G +G V + VAVK L ++ + ++F+ E+E + ++H N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 218 RLVGYCAEGAHR--MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 275
+ G C R L+ EY+ G+L +L + + KG+ YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLG 131
Query: 276 EG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYAST 320
+E + K+ DFGL K+L ++ + + G + APE +
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 321 GMLNETSDVYSFGILIMEVIS 341
+ SDV+SFG+++ E+ +
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 25/199 (12%)
Query: 166 IGEGGYGIVYRGVLED---NTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 219
+G GG VY ED N VA+K + + + K F+ EV ++ H+N+V +
Sbjct: 19 LGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 220 VGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-- 277
+ E LV EY++ L +++ H PL+ + +N G+ + H+
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 278 -----------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNET 326
++ K+ DFG+AK L T V+GT Y +PE A +E
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 327 SDVYSFGILIMEVISGRNP 345
+D+YS GI++ E++ G P
Sbjct: 193 TDIYSIGIVLYEMLVGEPP 211
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 25/205 (12%)
Query: 163 ENVIGEGGYGIVYRGVL-----EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNL 216
+ VIG G +G VY+G+L + VA+K L + ++ +F E +G+ H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL-- 274
+RL G ++ M++ EY++NG L+++L G + + ++ G A G+ YL
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLAN 165
Query: 275 ----HEGL-------EPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTG 321
H L K+SDFGL+++L + T G APE S
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 322 MLNETSDVYSFGILIMEVIS-GRNP 345
SDV+SFGI++ EV++ G P
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGERP 250
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 22/199 (11%)
Query: 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGY 222
+G G +G V+ G +T VAVK+ L + F E + +++H+ LVRL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 223 CAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL------HE 276
+ ++ EY++NG+L +L G LT +++ A+G+ ++ H
Sbjct: 77 VTQE-PIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 277 GL-------EPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGMLNETS 327
L + K++DFGLA+L+ + Y T R F APE + G S
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLI-EDNEY-TAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 328 DVYSFGILIMEVIS-GRNP 345
DV+SFGIL+ E+++ GR P
Sbjct: 192 DVWSFGILLTEIVTHGRIP 210
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 55/200 (27%), Positives = 81/200 (40%), Gaps = 28/200 (14%)
Query: 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGY 222
IG+G +G V G VAVK + + F E + ++RH NLV+L+G
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 223 CAEGAHR-MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---- 277
E +V EY+ G+L +L S L + + L + + YL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNNFVH 312
Query: 278 ---------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGMLNET 326
+ K+SDFGL + +T+ G APE +
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLT------KEASSTQDTGKLPVKWTAPEALREKKFSTK 366
Query: 327 SDVYSFGILIMEVIS-GRNP 345
SDV+SFGIL+ E+ S GR P
Sbjct: 367 SDVWSFGILLWEIYSFGRVP 386
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 48/201 (23%), Positives = 87/201 (43%), Gaps = 25/201 (12%)
Query: 163 ENVIGEGGYGIVYRGVLE-----DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV 217
+G+G +G V + VAVK L ++ + ++F+ E+E + ++H N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 218 RLVGYCAEGAHR--MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 275
+ G C R L+ EY+ G+L +L + + KG+ YL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLG 162
Query: 276 EG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYAST 320
+E + K+ DFGL K+L ++ Y + G + APE +
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 222
Query: 321 GMLNETSDVYSFGILIMEVIS 341
+ SDV+SFG+++ E+ +
Sbjct: 223 SKFSVASDVWSFGVVLYELFT 243
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 52/204 (25%), Positives = 89/204 (43%), Gaps = 30/204 (14%)
Query: 163 ENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVG 221
++ +G G YG VY GV + + VAVK L +EF E + ++H NLV+L+G
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 222 YCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL------H 275
C ++ E++ GNL +L ++ + + + + + YL H
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 276 -----------EGLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGM 322
E K++DFGL++L+ T F APE +
Sbjct: 135 RDLAARNCLVGENH----LVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 323 LNETSDVYSFGILIMEVIS-GRNP 345
+ SDV++FG+L+ E+ + G +P
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 63/289 (21%), Positives = 108/289 (37%), Gaps = 47/289 (16%)
Query: 163 ENVIGEGGYGIVYRGVLED-----NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNL 216
+GEG +G V + VAVK L + G Q +K E++ + + H+++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 217 VRLVGYCAEGAHR--MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 274
++ G C + LV EYV G+L +L + L + +G+ YL
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYL 150
Query: 275 HEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYAS 319
H L+ K+ DFGLAK + Y R G + APE
Sbjct: 151 HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 210
Query: 320 TGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQF----QVNLFEWLKTMVTNGNA 374
SDV+SFG+ + E+++ + E Q+ + + ++ G
Sbjct: 211 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE-LLERGE- 268
Query: 375 EGVLDPRLQEKPS--SRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421
RL +P + + C + A RP ++I +L+
Sbjct: 269 ------RL-PRPDKCPAEVYH---LMKNCWETEASFRPTFENLIPILKT 307
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 30/212 (14%)
Query: 163 ENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKN 215
+G G +G VY G + VAVK L + ++ +F +E I + H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLT 272
+VR +G + R ++ E + G+L+ +L S L +++ A G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 273 YLHE----------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFG--YVA 314
YL E P K+ DFG+A+ + SY ++
Sbjct: 155 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPVKWMP 213
Query: 315 PEYASTGMLNETSDVYSFGILIMEVIS-GRNP 345
PE G+ +D +SFG+L+ E+ S G P
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 63/269 (23%), Positives = 103/269 (38%), Gaps = 49/269 (18%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVG 221
IG G + VY+G+ E VA + FK E E + ++H N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 222 YCAEGAHRM----LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277
LV E + +G L+ +L + ++ + KGL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 278 LEP----------------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 321
P + K+ D GLA L A + V+GT ++APE
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEEK 205
Query: 322 MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381
+E+ DVY+FG+ ++E+ + P YS E Q ++ VT+G P
Sbjct: 206 -YDESVDVYAFGMCMLEMATSEYP--YS----ECQNAAQIY----RRVTSGVK-----PA 249
Query: 382 LQEKPSSRALKRALLVALRCVDPNAHKRP 410
+K + +K + C+ N +R
Sbjct: 250 SFDKVAIPEVKEII---EGCIRQNKDERY 275
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 29/206 (14%)
Query: 163 ENVIGEGGYGIVYRGVLED-----NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNL 216
V+G G +G VY+G+ VA+K L +A KE E + V + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276
RL+G C + L+ + + G L ++ + + +N + AKG+ YL +
Sbjct: 80 CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLED 135
Query: 277 G-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEYAST 320
++ + K++DFGLAKLLGAE G ++A E
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALESILH 193
Query: 321 GMLNETSDVYSFGILIMEVIS-GRNP 345
+ SDV+S+G+ + E+++ G P
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 50/212 (23%), Positives = 84/212 (39%), Gaps = 30/212 (14%)
Query: 163 ENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKN 215
+G G +G VY G + VAVK L + ++ +F +E I + H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLT 272
+VR +G + R ++ E + G+L+ +L S L +++ A G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 273 YLHE----------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFG--YVA 314
YL E P K+ DFG+A+ + Y ++
Sbjct: 196 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRAGYYRKGGCAMLPVKWMP 254
Query: 315 PEYASTGMLNETSDVYSFGILIMEVIS-GRNP 345
PE G+ +D +SFG+L+ E+ S G P
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 52/219 (23%), Positives = 93/219 (42%), Gaps = 40/219 (18%)
Query: 163 ENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL 216
+ +GEG +G V+ +D VAVK L A ++F+ E E + ++H+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQWL-----------HGDVGPHSPLTWEIRMNIIL 265
VR G C EG ++V EY+ +G+L ++L G+ PL + +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 266 GTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 312
A G+ YL + K+ DFG+++ + + Y +G
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY----RVGGRTM 221
Query: 313 V-----APEYASTGMLNETSDVYSFGILIMEVIS-GRNP 345
+ PE SDV+SFG+++ E+ + G+ P
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 52/230 (22%), Positives = 95/230 (41%), Gaps = 36/230 (15%)
Query: 148 YTLRELEVSTNGFADENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNNRGQAEK-E 200
Y E EV+ +G+G +G+VY GV E T VA+K + E+ E
Sbjct: 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 74
Query: 201 FKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWL------HGDVGPHSP 254
F E + ++VRL+G ++G +++ E + G+L+ +L + +P
Sbjct: 75 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 255 LTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301
+ + + A G+ YL+ + + K+ DFG+ + + Y
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 302 VTTRVMGTFGYV-----APEYASTGMLNETSDVYSFGILIMEVIS-GRNP 345
G G + +PE G+ SDV+SFG+++ E+ + P
Sbjct: 195 ----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 5e-23
Identities = 44/202 (21%), Positives = 76/202 (37%), Gaps = 23/202 (11%)
Query: 163 ENVIGEGGYGIVYRGVL----EDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLV 217
IGEG +G V++G+ VA+K ++F E + + H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL--- 274
+L+G E ++ E G L +L L + + L YL
Sbjct: 455 KLIGVITENP-VWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLESK 510
Query: 275 ---HEGL-------EPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 324
H + KL DFGL++ + Y ++ ++APE +
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 325 ETSDVYSFGILIMEVIS-GRNP 345
SDV+ FG+ + E++ G P
Sbjct: 571 SASDVWMFGVCMWEILMHGVKP 592
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 6e-23
Identities = 45/217 (20%), Positives = 80/217 (36%), Gaps = 23/217 (10%)
Query: 148 YTLRELEVSTNGFADENVIGEGGYGIVYRGVL----EDNTNVAVKNL-LNNRGQAEKEFK 202
+ R+ E+ IGEG +G V++G+ VA+K ++F
Sbjct: 5 SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 64
Query: 203 VEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMN 262
E + + H ++V+L+G ++ E G L +L L +
Sbjct: 65 QEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS---LDLASLIL 120
Query: 263 IILGTAKGLTYL------HEGL-------EPKWNPKLSDFGLAKLLGAERSYVTTRVMGT 309
+ L YL H + KL DFGL++ + Y ++
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 180
Query: 310 FGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNP 345
++APE + SDV+ FG+ + E++ G P
Sbjct: 181 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 6e-23
Identities = 41/203 (20%), Positives = 73/203 (35%), Gaps = 27/203 (13%)
Query: 163 ENVIGEGGYGIVYRGVLEDNT---NVAVKNLLNNRGQAEKE----FKVEVEAIGRVRHKN 215
++G GG G VY ED VA+K L++ ++ + E GR++ +
Sbjct: 39 RRLVGRGGMGDVYEA--EDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 275
+V + + + ++ +L L PL + I+ L H
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAH 151
Query: 276 EG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 322
+ L DFG+A E+ +GT Y+APE S
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH 211
Query: 323 LNETSDVYSFGILIMEVISGRNP 345
+D+Y+ ++ E ++G P
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP 234
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 6e-23
Identities = 53/222 (23%), Positives = 92/222 (41%), Gaps = 45/222 (20%)
Query: 163 ENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL 216
+ +GEG +G V+ +D VAVK L + A K+F+ E E + ++H+++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQWL------------HGDVGPHSPLTWEIRMNII 264
V+ G C +G ++V EY+ +G+L ++L L ++I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 265 LGTAKGLTYL------HEGL-------EPKWNPKLSDFGLAKLLGAERSYVTT------- 304
A G+ YL H L K+ DFG+++ + + Y
Sbjct: 140 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 305 RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNP 345
R M PE SDV+SFG+++ E+ + G+ P
Sbjct: 200 RWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 7e-23
Identities = 76/287 (26%), Positives = 117/287 (40%), Gaps = 56/287 (19%)
Query: 163 ENVIGEGGYGIVYRGVLEDN----TNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLV 217
VIG G +G VY G L DN + AVK+L E +F E + H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 218 RLVGYCAEGAH-RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276
L+G C ++V Y+ +G+L ++ + T + + L AKG+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKYLAS 146
Query: 277 G-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFG------YVAPEY 317
L+ K+ K++DFGLA+ + + Y V G ++A E
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAKLPVKWMALES 203
Query: 318 ASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376
T SDV+SFG+L+ E+++ G P Y P VN F+ + G
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAPP--Y---PD-----VNTFDITV-YLLQGR--- 249
Query: 377 VLDPRLQEKPS--SRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421
RL +P L V L+C P A RP ++ + A
Sbjct: 250 ----RL-LQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISA 288
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 7e-23
Identities = 58/227 (25%), Positives = 92/227 (40%), Gaps = 54/227 (23%)
Query: 163 ENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKN 215
+GE +G VY+G L E VA+K L + G +EF+ E R++H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWL------------HGDVGPHSPLTWEIRMNI 263
+V L+G + ++ Y +G+L ++L D S L +++
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 264 ILGTAKGLTYL------H-----------EGLEPKWNPKLSDFGLAKLLGAERSYVTT-- 304
+ A G+ YL H + L N K+SD GL + + A Y
Sbjct: 134 VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL----NVKISDLGLFREVYAADYYKLLGN 189
Query: 305 -----RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNP 345
R M APE G + SD++S+G+++ EV S G P
Sbjct: 190 SLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 7e-23
Identities = 47/202 (23%), Positives = 82/202 (40%), Gaps = 23/202 (11%)
Query: 163 ENVIGEGGYGIVYRGVL----EDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLV 217
++GEG +G VY GV + NVAVK + +++F E + + H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277
+L+G E ++ E G L +L + L + L K + YL
Sbjct: 77 KLIGIIEEEP-TWIIMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLESI 132
Query: 278 -------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 324
+ KL DFGL++ + E Y + +++PE +
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 192
Query: 325 ETSDVYSFGILIMEVIS-GRNP 345
SDV+ F + + E++S G+ P
Sbjct: 193 TASDVWMFAVCMWEILSFGKQP 214
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 8e-23
Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 31/205 (15%)
Query: 166 IGEGGYGIVYRGVLEDNT---NVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 219
+G GG V+ D +VAVK L L F+ E + + H +V +
Sbjct: 20 LGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 220 --VGYCAEGAHRM--LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 275
G A + +V EYVD L +H P+T + + +I + L + H
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSH 133
Query: 276 EG-------------LEPKWNPKLSDFGLAKLLGAERSYVTT--RVMGTFGYVAPEYAST 320
+ + K+ DFG+A+ + + VT V+GT Y++PE A
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 321 GMLNETSDVYSFGILIMEVISGRNP 345
++ SDVYS G ++ EV++G P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 53/232 (22%), Positives = 94/232 (40%), Gaps = 40/232 (17%)
Query: 148 YTLRELEVSTNGFADENVIGEGGYGIVYRGVLED----NTNVAVKNL-LNNRGQAEK-EF 201
L ++ + N ++GEG +G V G L+ + VAVK + L+N Q E EF
Sbjct: 24 NKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEF 83
Query: 202 KVEVEAIGRVRHKNLVRLVGYCAEG-----AHRMLVNEYVDNGNLEQWL--HGDVGPHSP 254
E + H N++RL+G C E M++ ++ G+L +L
Sbjct: 84 LSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH 143
Query: 255 LTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301
+ + + ++ A G+ YL L ++DFGL+K + + Y
Sbjct: 144 IPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY 203
Query: 302 VTTRV-------MGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNP 345
R+ + A E + + SDV++FG+ + E+ + G P
Sbjct: 204 RQGRIAKMPVKWI------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 30/208 (14%)
Query: 163 ENVIGEGGYGIVYRGVLED----NTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLV 217
+ VIG+G +G+VY G D A+K+L + F E + + H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 218 RLVGYCAEGA-HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL-- 274
L+G ++ Y+ +G+L Q++ P T + ++ L A+G+ YL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIR---SPQRNPTVKDLISFGLQVARGMEYLAE 142
Query: 275 ----HEGL-------EPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV-----APEYA 318
H L + + K++DFGLA+ + +R Y + + + A E
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQ-QHRHARLPVKWTALESL 200
Query: 319 STGMLNETSDVYSFGILIMEVIS-GRNP 345
T SDV+SFG+L+ E+++ G P
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 82/402 (20%), Positives = 141/402 (35%), Gaps = 88/402 (21%)
Query: 47 SKRQLNATKSSSLCNNYNSSSGNPTIPNISKEIQEIRIDLDSKSISNCKPHSAPNPEPLP 106
++ S G I +I + + S+++ ++
Sbjct: 12 HHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSAL 71
Query: 107 EPEPILVEDSPVRGRNRIHIEIGKDHRIAYRRVSHLGWGHWYTLRELEVSTNGFADENVI 166
PE + V G + + + + VI
Sbjct: 72 NPELVQAVQHVVIGPSSLIVHFNE----------------------------------VI 97
Query: 167 GEGGYGIVYRGVLEDN----TNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLVG 221
G G +G VY G L DN + AVK+L E +F E + H N++ L+G
Sbjct: 98 GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLG 157
Query: 222 YCAEGAH-RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--- 277
C ++V Y+ +G+L ++ + T + + L AKG+ +L
Sbjct: 158 ICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASKKFV 214
Query: 278 ----------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV-----APEYASTGM 322
L+ K+ K++DFGLA+ + ++ + + T + A E T
Sbjct: 215 HRDLAARNCMLDEKFTVKVADFGLARDM-YDKEFDSVH-NKTGAKLPVKWMALESLQTQK 272
Query: 323 LNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381
SDV+SFG+L+ E+++ G P Y P VN F+ + G R
Sbjct: 273 FTTKSDVWSFGVLLWELMTRGAPP--Y---PD-----VNTFDITV-YLLQGR-------R 314
Query: 382 LQEKPS--SRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421
L +P L V L+C P A RP ++ + A
Sbjct: 315 L-LQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISA 352
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 4e-22
Identities = 41/203 (20%), Positives = 73/203 (35%), Gaps = 36/203 (17%)
Query: 165 VIGEGGYGIVYRG---VLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLV 220
I GG G +Y + V +K L+++ + E + + V H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRP-VVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 221 GYCAEGAHRM-----LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 275
+ +V EYV +L++ L + +L L+YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLH 199
Query: 276 EG------LEPKWN-------PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 322
L+P+ N KL D G + + + GT G+ APE TG
Sbjct: 200 SIGLVYNDLKPE-NIMLTEEQLKLIDLGAVSRINS-----FGYLYGTPGFQAPEIVRTGP 253
Query: 323 LNETSDVYSFGILIMEVISGRNP 345
+D+Y+ G + +
Sbjct: 254 -TVATDIYTVGRTLAALTLDLPT 275
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-22
Identities = 57/306 (18%), Positives = 111/306 (36%), Gaps = 55/306 (17%)
Query: 148 YTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDN----TNVAVKNL-LNNRGQAEKE-F 201
L ++ + F ++G+G +G V L+ VAVK L + ++ E F
Sbjct: 13 EKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEF 72
Query: 202 KVEVEAIGRVRHKNLVRLVGYCAEG------AHRMLVNEYVDNGNLEQWL--HGDVGPHS 253
E + H ++ +LVG M++ ++ +G+L +L
Sbjct: 73 LREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132
Query: 254 PLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300
L + + ++ A G+ YL L ++DFGL++ +
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI-YSGD 191
Query: 301 YVTTRVMGTF--GYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQF 357
Y ++A E + + SDV++FG+ + E+++ G+ P Y G
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP--Y---AG---- 242
Query: 358 QVNLFEWLKTMVTNGNAEGVLDPRLQEKPS--SRALKRALLVALRCVDPNAHKRPKMGHV 415
+ E + GN RL ++P + + +C + +RP +
Sbjct: 243 -IENAEIYN-YLIGGN-------RL-KQPPECMEEVYD---LMYQCWSADPKQRPSFTCL 289
Query: 416 IHMLEA 421
LE
Sbjct: 290 RMELEN 295
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 6e-22
Identities = 51/220 (23%), Positives = 94/220 (42%), Gaps = 45/220 (20%)
Query: 163 ENVIGEGGYGIVYRGVL---EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-RHKNLV 217
++VIGEG +G V + + + A+K + + + +F E+E + ++ H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWL------------HGDVGPHSPLTWEIRMNIIL 265
L+G C + L EY +GNL +L S L+ + ++
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 266 GTAKGLTYL------H-----------EGLEPKWNPKLSDFGLAKLLGAERSYVTTRVMG 308
A+G+ YL H E K++DFGL++ + + MG
Sbjct: 150 DVARGMDYLSQKQFIHRDLAARNILVGENY----VAKIADFGLSR----GQEVYVKKTMG 201
Query: 309 TF--GYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNP 345
++A E + + SDV+S+G+L+ E++S G P
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 53/269 (19%), Positives = 98/269 (36%), Gaps = 47/269 (17%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVK--NLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLV 220
IG G + VYR L D VA+K + + + + E++ + ++ H N+++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--- 277
E +V E D G+L + + + + L ++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVM 158
Query: 278 ----------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE------YASTG 321
+ KL D GL + ++ + + V GT Y++PE Y
Sbjct: 159 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGY---- 213
Query: 322 MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381
N SD++S G L+ E+ + ++P F L + + P
Sbjct: 214 --NFKSDIWSLGCLLYEMAALQSP---------FYGDKMNLYSLCKKIEQCDY-----PP 257
Query: 382 LQEKPSSRALKRALLVALRCVDPNAHKRP 410
L S L++ + C++P+ KRP
Sbjct: 258 LPSDHYSEELRQLV---NMCINPDPEKRP 283
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-21
Identities = 66/301 (21%), Positives = 109/301 (36%), Gaps = 49/301 (16%)
Query: 151 RELEVSTNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG 209
+ + + +GEGG+ V L D A+K +L + Q +E + E +
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 210 RVRHKNLVRLVGYCAEGAHRM----LVNEYVDNGNLEQWLHGDVGPHSPLT-WEIRMNII 264
H N++RLV YC L+ + G L + + LT +I + ++
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI-LWLL 140
Query: 265 LGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVM---- 307
LG +GL +H L + P L D G +
Sbjct: 141 LGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 308 ----GTFGYVAPE---YASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVN 360
T Y APE S +++E +DV+S G ++ ++ G P D G+
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD------ 254
Query: 361 LFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
+ PR S AL LL ++ VDP+ +RP + ++ LE
Sbjct: 255 ----SVALAVQNQLSIPQSPRH-----SSAL-WQLLNSMMTVDPH--QRPHIPLLLSQLE 302
Query: 421 A 421
A
Sbjct: 303 A 303
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 7e-21
Identities = 63/290 (21%), Positives = 105/290 (36%), Gaps = 70/290 (24%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYC 223
V+G+G +G V + D+ A+K + + + EV + + H+ +VR
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIK-KIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 224 AEGAHRM-------------LVNEYVDNGNLEQWLHGDVGPHSP--LTWEIRMNIILGTA 268
E + + + EY +NG L +H + W + I+
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH-SENLNQQRDEYWRLFRQILEA-- 128
Query: 269 KGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV------------- 302
L+Y+H ++ N K+ DFGLAK + +
Sbjct: 129 --LSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 303 -TTRVMGTFGYVAPE-YASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVN 360
T+ + GT YVA E TG NE D+YS GI+ E+I P +VN
Sbjct: 187 LTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---------PFSTGMERVN 236
Query: 361 LFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRP 410
+ + L+ + P + + ++ L DPN KRP
Sbjct: 237 ILKKLR------SVSIEFPPDFDDNKMKVE--KKIIRLLIDHDPN--KRP 276
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 9e-21
Identities = 58/235 (24%), Positives = 92/235 (39%), Gaps = 62/235 (26%)
Query: 163 ENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKN 215
+GEG +G V + T VAVK L N +E + E + +V H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWL--------------------HGDVGPHSPL 255
+++L G C++ +L+ EY G+L +L D L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 256 TWEIRMNIILGTAKGLTYL------H-----------EGLEPKWNPKLSDFGLAKLLGAE 298
T ++ ++G+ YL H EG K+SDFGL++ + E
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR----KMKISDFGLSRDVYEE 203
Query: 299 RSYVTT-------RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNP 345
SYV + M A E + SDV+SFG+L+ E+++ G NP
Sbjct: 204 DSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 54/230 (23%), Positives = 94/230 (40%), Gaps = 57/230 (24%)
Query: 163 ENVIGEGGYGIVYRGVL--------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-R 212
+GEG +G V ++ VAVK L ++ + + + E+E + + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 213 HKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWL------------HGDVGPHSPLTWEIR 260
HKN++ L+G C + ++ EY GNL ++L + P +T++
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 261 MNIILGTAKGLTYL------H-----------EGLEPKWNPKLSDFGLAKLLGAERSYVT 303
++ A+G+ YL H E K++DFGLA+ + Y
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN----VMKIADFGLARDINNIDYYKK 215
Query: 304 TRV-------MGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNP 345
T M APE + SDV+SFG+L+ E+ + G +P
Sbjct: 216 TTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 68/307 (22%), Positives = 120/307 (39%), Gaps = 81/307 (26%)
Query: 163 ENVIGEGGYGIVYRGVL--------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-R 212
+GEG +G V ++ VAVK L ++ + + + E+E + + +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 213 HKNLVRLVGYCAEGAHRMLVNEYVDNGNL------------EQWLHGDVGPHSPLTWEIR 260
HKN++ L+G C + ++ EY GNL E + P +T++
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 261 MNIILGTAKGLTYL------H-----------EGLEPKWNPKLSDFGLAKLLGAERSYVT 303
++ A+G+ YL H E K++DFGLA+ + Y
Sbjct: 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN----VMKIADFGLARDINNIDYYKK 261
Query: 304 TRV-------MGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEF 355
T M APE + SDV+SFG+L+ E+ + G +P Y PG
Sbjct: 262 TTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--Y---PG-- 308
Query: 356 QFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPS--SRALKRALLVALRCVDPNAHKRPKMG 413
+ + E K ++ G+ R+ +KP+ + L + C +RP
Sbjct: 309 ---IPVEELFK-LLKEGH-------RM-DKPANCTNELYM---MMRDCWHAVPSQRPTFK 353
Query: 414 HVIHMLE 420
++ L+
Sbjct: 354 QLVEDLD 360
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 71/321 (22%), Positives = 110/321 (34%), Gaps = 79/321 (24%)
Query: 148 YTLRELEVSTNGFADENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNNRGQAEK-E 200
Y + E + +G G +G V VAVK L +E
Sbjct: 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 201 FKVEVEAIGRV-RHKNLVRLVGYC-AEGAHRMLVNEYVDNGNLEQWL------------H 246
E++ + + H N+V L+G C G M++ E+ GNL +L
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 247 GDVGPHSPLTWEIRMNIILGTAKGLTYL------H-----------EGLEPKWNPKLSDF 289
+ LT E + AKG+ +L H E K+ DF
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN----VVKICDF 192
Query: 290 GLAKLLGAERSYVTT-------RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS- 341
GLA+ + + YV + M APE + SDV+SFG+L+ E+ S
Sbjct: 193 GLARDIYKDPDYVRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSL 246
Query: 342 GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPS--SRALKRALLVAL 399
G +P Y PG V + E + G R+ P + + + L
Sbjct: 247 GASP--Y---PG-----VKIDEEFCRRLKEGT-------RM-RAPDYTTPEMYQ---TML 285
Query: 400 RCVDPNAHKRPKMGHVIHMLE 420
C +RP ++ L
Sbjct: 286 DCWHGEPSQRPTFSELVEHLG 306
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 56/242 (23%), Positives = 91/242 (37%), Gaps = 50/242 (20%)
Query: 150 LRELEVSTNGFADENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNNRGQAEK-EFK 202
L LE N IGEG +G V++ E T VAVK L + +F+
Sbjct: 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 98
Query: 203 VEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWL----------------- 245
E + + N+V+L+G CA G L+ EY+ G+L ++L
Sbjct: 99 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 246 ---HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDF 289
PL+ ++ I A G+ YL E + K++DF
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 218
Query: 290 GLAKLLGAERSYVTTRVMGTFGYV-----APEYASTGMLNETSDVYSFGILIMEVIS-GR 343
GL++ + + Y + PE SDV+++G+++ E+ S G
Sbjct: 219 GLSRNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274
Query: 344 NP 345
P
Sbjct: 275 QP 276
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 4e-20
Identities = 51/262 (19%), Positives = 103/262 (39%), Gaps = 39/262 (14%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNL-LNNRGQAEKEF-KVEVEAIGRVRHKNLVRLVG 221
IGEG +G ED +K + ++ E+E + EV + ++H N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 222 YCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---- 277
E +V +Y + G+L + ++ G + ++ + L ++H+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDRKILH 148
Query: 278 ---------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSD 328
L +L DFG+A++L + + GT Y++PE N SD
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYNNKSD 207
Query: 329 VYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSS 388
+++ G ++ E+ + ++ F+ + L + +G+ P + S
Sbjct: 208 IWALGCVLYELCTLKHA-----------FEAGSMKNLVLKIISGSF-----PPVSLHYSY 251
Query: 389 RALKRALLVALRCVDPNAHKRP 410
R+L+ L +P RP
Sbjct: 252 DL--RSLVSQLFKRNPR--DRP 269
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-20
Identities = 56/204 (27%), Positives = 86/204 (42%), Gaps = 24/204 (11%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVRHKNLVRLVG 221
IG G YG + D + K L + +AEK+ V EV + ++H N+VR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 222 YCAEGAHRML--VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-- 277
+ + L V EY + G+L + L E + ++ L H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 278 ----------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 321
L+ K N KL DFGLA++L + S+ T V GT Y++PE +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRM 191
Query: 322 MLNETSDVYSFGILIMEVISGRNP 345
NE SD++S G L+ E+ + P
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPP 215
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 7e-20
Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 53/226 (23%)
Query: 163 ENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-RHK 214
+G G +G V + VAVK L + EK E++ + + +H+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 215 NLVRLVGYCAEGAHRMLVNEYVDNGNLEQWL----------HGDVGPHSPLTWEIRMNII 264
N+V L+G C G +++ EY G+L +L +S + ++
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 265 LGTAKGLTYL------H-----------EGLEPKWNPKLSDFGLAKLLGAERSYVTT--- 304
A+G+ +L H G K+ DFGLA+ + + +Y+
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGH----VAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 305 ----RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNP 345
+ M APE + SDV+S+GIL+ E+ S G NP
Sbjct: 227 RLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 8e-20
Identities = 52/226 (23%), Positives = 84/226 (37%), Gaps = 49/226 (21%)
Query: 163 ENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-RHK 214
+G G +G V + VAVK L + E+ E++ + + H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 215 NLVRLVGYCAEGAHRMLVNEYVDNGNLEQWL--------------HGDVGPHSPLTWEIR 260
N+V L+G C G +++ EY G+L +L L E
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 261 MNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTT--- 304
++ AKG+ +L L K+ DFGLA+ + + +YV
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 305 ----RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNP 345
+ M APE + SDV+S+GI + E+ S G +P
Sbjct: 208 RLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 90.5 bits (224), Expect = 1e-19
Identities = 61/280 (21%), Positives = 99/280 (35%), Gaps = 40/280 (14%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLV-- 220
+G GG+G V R + + VA+K +E + +E++ + ++ H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 221 ----GYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLT-WEIR--MNIILGTAKGLTY 273
A +L EY + G+L ++L+ L IR ++ I L Y
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSDIS---SALRY 136
Query: 274 LHE----------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 317
LHE + K+ D G AK L + T V GT Y+APE
Sbjct: 137 LHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV-GTLQYLAPEL 194
Query: 318 ASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377
T D +SFG L E I+G P + P ++ +V +V + V
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAV 254
Query: 378 LDPRLQEKPSSR-----ALKRALLVALRCVDPNAHKRPKM 412
+ P+ L + +R
Sbjct: 255 KFSSVLPTPNHLSGILAGKLERWLQCMLMWHQ--RQRGTD 292
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 55/226 (24%), Positives = 93/226 (41%), Gaps = 49/226 (21%)
Query: 163 ENVIGEGGYGIVYRGVL--------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-R 212
+GEG +G V T VAVK L ++ + + + E+E + + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 213 HKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWL------------HGDVGPHSPLTWEIR 260
HKN++ L+G C + ++ EY GNL ++L + P L+ +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 261 MNIILGTAKGLTYL------HEGL-------EPKWNPKLSDFGLAKLLGAERSYVTT--- 304
++ A+G+ YL H L K++DFGLA+ + Y T
Sbjct: 194 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 305 ----RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNP 345
+ M APE + SDV+SFG+L+ E+ + G +P
Sbjct: 254 RLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 66/263 (25%), Positives = 108/263 (41%), Gaps = 37/263 (14%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYC 223
V+G+G YGIVY G L + +A+K + + + E+ ++HKN+V+ +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------ 277
+E + E V G+L L GP + +GL YLH+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGP-LKDNEQTIGFYTKQILEGLKYLHDNQIVHRD 147
Query: 278 -------LEPKW-NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE--YASTGMLNETS 327
+ K+SDFG +K L T GT Y+APE + +
Sbjct: 148 IKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGKAA 206
Query: 328 DVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPS 387
D++S G I+E+ +G+ P + L E M G + + P + E S
Sbjct: 207 DIWSLGCTIIEMATGKPP--FY----------ELGEPQAAMFKVGMFK--VHPEIPESMS 252
Query: 388 SRALKRALLVALRCVDPNAHKRP 410
+ A +A + L+C +P+ KR
Sbjct: 253 AEA--KAFI--LKCFEPDPDKRA 271
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 68/308 (22%), Positives = 117/308 (37%), Gaps = 77/308 (25%)
Query: 163 ENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-RHK 214
V+G G +G V + VAVK L +E+ E++ + ++ H+
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 215 NLVRLVGYCAEGAHRMLVNEYVDNGNLEQWL-------------------HGDVGPHSPL 255
N+V L+G C L+ EY G+L +L + + L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 256 TWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302
T+E + AKG+ +L + K+ DFGLA+ + ++ +YV
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 303 TT-------RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGE 354
+ M APE G+ SDV+S+GIL+ E+ S G NP Y PG
Sbjct: 230 VRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP--Y---PG- 277
Query: 355 FQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPS--SRALKRALLVALRCVDPNAHKRPKM 412
V+ ++ NG ++ ++P + + + C ++ KRP
Sbjct: 278 --IPVD--ANFYKLIQNGF-------KM-DQPFYATEEIYI---IMQSCWAFDSRKRPSF 322
Query: 413 GHVIHMLE 420
++ L
Sbjct: 323 PNLTSFLG 330
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-19
Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 38/216 (17%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 218
F + +IG GG+G V++ D +K + N +AE+E V+A+ ++ H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVH 68
Query: 219 LVGYCAEGAHRM----------------LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMN 262
G + + E+ D G LEQW+ G L + +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALE 126
Query: 263 IILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGT 309
+ KG+ Y+H L K+ DFGL L + TR GT
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL--KNDGKRTRSKGT 184
Query: 310 FGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNP 345
Y++PE S+ + D+Y+ G+++ E++ +
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-19
Identities = 50/288 (17%), Positives = 98/288 (34%), Gaps = 75/288 (26%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRV-RHKNLVRLV 220
IG G +G V++ V D A+K G +++ + EV A + +H ++VR
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE---- 276
AE H ++ NEY + G+L + + S +++L +GL Y+H
Sbjct: 78 SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLV 137
Query: 277 ----------------------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMG 308
K K+ D G + + + G
Sbjct: 138 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE-----G 192
Query: 309 TFGYVAPEYASTGMLNET------SDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF 362
++A E +L E +D+++ + ++ P
Sbjct: 193 DSRFLANE-----VLQENYTHLPKADIFALALTVVCAAGAE------PLPRNGD------ 235
Query: 363 EWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRP 410
+W + + G PR+ + S+ L+ + + P+ +RP
Sbjct: 236 QWHE--IRQGRL-----PRIPQV-LSQEFTE--LLKV-MIHPDPERRP 272
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 6e-19
Identities = 44/212 (20%), Positives = 80/212 (37%), Gaps = 39/212 (18%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGY 222
+G GG+G+V+ D+ N A+K + L NR A ++ EV+A+ ++ H +VR
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 223 CAEGAHRM------------LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 270
E + + NL+ W++G + ++I L A+
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHIFLQIAEA 130
Query: 271 LTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVM---------- 307
+ +LH K+ DFGL + + T
Sbjct: 131 VEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQ 190
Query: 308 -GTFGYVAPEYASTGMLNETSDVYSFGILIME 338
GT Y++PE + D++S G+++ E
Sbjct: 191 VGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 4e-18
Identities = 51/285 (17%), Positives = 99/285 (34%), Gaps = 46/285 (16%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL-- 219
++G+G V+RG + A+K N ++ + + + E E + ++ HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLFA 74
Query: 220 VGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE--- 276
+ H++L+ E+ G+L L + L + ++ G+ +L E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLRENGI 133
Query: 277 --------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 322
G + + KL+DFG A+ L + + GT Y+ P+ +
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLHPDMYERAV 191
Query: 323 L--------NETSDVYSFGILIMEVISGRNPVDYSRPPGEFQ----------FQVNLFEW 364
L T D++S G+ +G P P + +
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGV 251
Query: 365 LKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKR 409
K + G + + L +L + D K
Sbjct: 252 QKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE--KC 294
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 65/282 (23%), Positives = 103/282 (36%), Gaps = 52/282 (18%)
Query: 160 FADENVIGEGGYGIVYRGVLEDNTNVAVKNLL-NNRGQAEKEFKVEVEAIGRVRHKNLVR 218
F ++V+G G G + + DN +VAVK +L A++E ++ E+ H N++R
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDE---HPNVIR 82
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-- 276
+ + + E L++++ + ++ T GL +LH
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138
Query: 277 ----------------GLEPKWNPKLSDFGLAKLLGAERSYVTTR--VMGTFGYVAPEY- 317
K +SDFGL K L R + R V GT G++APE
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 318 --ASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPP--GEFQFQVNLFEWLKTMVTNGN 373
T D++S G + VIS P Q Q N+
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISE------GSHPFGKSLQRQANIL----------L 242
Query: 374 AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHV 415
LD L + + R L+ + +DP KRP HV
Sbjct: 243 GACSLDC-LHPEKHEDVIARELIEKMIAMDPQ--KRPSAKHV 281
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 84.0 bits (207), Expect = 9e-18
Identities = 30/243 (12%), Positives = 59/243 (24%), Gaps = 51/243 (20%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLL---NNRGQAEKEFKVEVEAIGR---------- 210
V+G+ E + V A K+ K EV +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 211 ------------VRHKNLVRLVGYCAEGAHRMLVNEYV-------DNGNLEQWLHGDVGP 251
V+ +++ + +++ + + + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 252 HSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298
H L R+ + L + L LH L+ + L+ F GA
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS 264
Query: 299 RSYVTTRVMGTFGYVAPE-----YASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPG 353
R A ++ D ++ G+ I + P G
Sbjct: 265 AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALG 324
Query: 354 EFQ 356
+
Sbjct: 325 GSE 327
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 56/275 (20%), Positives = 99/275 (36%), Gaps = 51/275 (18%)
Query: 164 NVIGEGGYGIVYRGVLEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNL--VRL 219
IG GG V++ + E A+K NL Q ++ E+ + +++ + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 220 VGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-- 277
Y + +V E N +L WL + R + + + +H+
Sbjct: 75 YDYEITDQYIYMVMECG-NIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQHGI 129
Query: 278 ----LEP------KWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPE---------- 316
L+P KL DFG+A + S V +GT Y+ PE
Sbjct: 130 VHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 189
Query: 317 -YASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375
S ++ SDV+S G ++ + G + P FQ +N L ++ + N E
Sbjct: 190 NGKSKSKISPKSDVWSLGCILYYMTYG-------KTP--FQQIINQISKLHAII-DPNHE 239
Query: 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRP 410
+ L+ L C+ + +R
Sbjct: 240 IEFPDIP-----EKDLQDVL---KCCLKRDPKQRI 266
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 46/210 (21%), Positives = 80/210 (38%), Gaps = 33/210 (15%)
Query: 164 NVIGEGGYGIVYRGVLEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNL--VRL 219
IG GG V++ + E A+K NL Q ++ E+ + +++ + +RL
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 220 VGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-- 277
Y + +V E N +L WL + R + + + +H+
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQHGI 148
Query: 278 ----LEP------KWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPE---------- 316
L+P KL DFG+A + S V +GT Y+ PE
Sbjct: 149 VHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 208
Query: 317 -YASTGMLNETSDVYSFGILIMEVISGRNP 345
S ++ SDV+S G ++ + G+ P
Sbjct: 209 NGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 45/222 (20%), Positives = 87/222 (39%), Gaps = 34/222 (15%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL-- 219
++G+G V+RG + A+K N ++ + + + E E + ++ HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLFA 74
Query: 220 VGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE--- 276
+ H++L+ E+ G+L L + L + ++ G+ +L E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLRENGI 133
Query: 277 --------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 322
G + + KL+DFG A+ L + + GT Y+ P+ +
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLHPDMYERAV 191
Query: 323 L--------NETSDVYSFGILIMEVISGRNPVDYSRPPGEFQ 356
L T D++S G+ +G P P +
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 5e-17
Identities = 51/200 (25%), Positives = 79/200 (39%), Gaps = 26/200 (13%)
Query: 164 NVIGEGGYGIVYRGV-LEDNTNVAVKNL----LNNRGQAEKEFKVEVEAIGRVRHKNLVR 218
+G+G +G VY + +A+K L L G + + EVE +RH N++R
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG- 277
L GY + L+ EY G + + L S + I A L+Y H
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSKR 129
Query: 278 ------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 325
L K++DFG + + R GT Y+ PE M +E
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-DL--CGTLDYLPPEMIEGRMHDE 186
Query: 326 TSDVYSFGILIMEVISGRNP 345
D++S G+L E + G+ P
Sbjct: 187 KVDLWSLGVLCYEFLVGKPP 206
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 41/313 (13%), Positives = 86/313 (27%), Gaps = 49/313 (15%)
Query: 151 RELEVSTNGFADENVIGEGGYGIVYRGVLEDNTN------VAVKNLLNNRGQAEKEFKVE 204
E ++ + +++GEG + VY D + +K + EF +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ---KPANPWEFYIG 114
Query: 205 VEAIGRVR---HKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWL-HGDVGPHSPLTWEIR 260
+ + R++ ++ +LV E G L + P + +
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 261 MNIILGTAKGLTYLHEG------LEP---------------KWNP---KLSDFGLAKLLG 296
++ + + +H+ ++P L D G + +
Sbjct: 175 ISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 297 AERSYVTTRVM-GTFGYVAPEYASTGML-----NETSDVYSFGILIMEVISGRNPVDYSR 350
T G+ E ML N D + + ++ G
Sbjct: 235 LFPKGTIFTAKCETSGFQCVE-----MLSNKPWNYQIDYFGVAATVYCMLFGTYM-KVKN 288
Query: 351 PPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRP 410
GE + + + N +L+ S L R L + R
Sbjct: 289 EGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRA 348
Query: 411 KMGHVIHMLEAEE 423
+I +L +
Sbjct: 349 LRNRLIVLLLECK 361
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 6e-17
Identities = 61/267 (22%), Positives = 99/267 (37%), Gaps = 42/267 (15%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 218
IGEG GIV VAVK + + Q + EV + +H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYLHEG 277
+ G ++ E++ G L D+ L E ++ + + L YLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT-----DIVSQVRLN-EEQIATVCEAVLQALAYLHAQ 160
Query: 278 -------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 324
L KLSDFG + + + V GT ++APE S +
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYA 219
Query: 325 ETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQE 384
D++S GI+++E++ G PP F + + +K + + P+L+
Sbjct: 220 TEVDIWSLGIMVIEMVDG-------EPP---YFSDSPVQAMKRLRDSPP------PKLKN 263
Query: 385 KPS-SRALKRALLVALRCVDPNAHKRP 410
S L+ L L DP +R
Sbjct: 264 SHKVSPVLRDFLERML-VRDPQ--ERA 287
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 80.9 bits (199), Expect = 7e-17
Identities = 29/246 (11%), Positives = 52/246 (21%), Gaps = 51/246 (20%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLL---NNRGQAEKEFKVEVEAIGRVRHKNLVRLV 220
+ G +V+ +E + A+K N + A R+ ++
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 221 GYC--------------------AEGAHRMLVNEYV--------DNGNLEQWLHGDVGPH 252
+ G V Y+ D L L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 253 SPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299
+ + L + P L D +G
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-- 246
Query: 300 SYVTTRVMGTFGYVAPEY--ASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQF 357
Y E+ AST + + G+ I V P P + +
Sbjct: 247 --RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW 304
Query: 358 QVNLFE 363
+
Sbjct: 305 KRPSLR 310
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 8e-17
Identities = 61/267 (22%), Positives = 103/267 (38%), Gaps = 42/267 (15%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 218
+ IG+G G VY + + VA++ + + ++ E+ + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYLHEG 277
+ G +V EY+ G+L DV + + E ++ + + L +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLT-----DVVTETCMD-EGQIAAVCRECLQALEFLHSN 135
Query: 278 -------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 324
L + KL+DFG + E+S +T V GT ++APE +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 325 ETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQE 384
D++S GI+ +E+I G PP N L + TNG P LQ
Sbjct: 195 PKVDIWSLGIMAIEMIEG-------EPP---YLNENPLRALYLIATNGT------PELQN 238
Query: 385 KPS-SRALKRALLVALRCVDPNAHKRP 410
S + L L +D KR
Sbjct: 239 PEKLSAIFRDFLNRCL-EMDVE--KRG 262
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 54/282 (19%), Positives = 95/282 (33%), Gaps = 51/282 (18%)
Query: 92 SNCKPHSAPNPEPLPEPEPILVEDSPVRGRNRIHIEIGKDHRIAYRRVSHLGWGHWYTLR 151
S P + E DSP G + + + G Y++
Sbjct: 8 SGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVK------GRIYSIL 61
Query: 152 ELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIG 209
+ IG GG V++ + E A+K NL Q ++ E+ +
Sbjct: 62 KQ------------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN 109
Query: 210 RVRHKNL--VRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 267
+++ + +RL Y + +V E N +L WL + R +
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKK----KKSIDPWERKSYWKNM 164
Query: 268 AKGLTYLHEG------LEP------KWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVA 314
+ + +H+ L+P KL DFG+A + S V +G Y+
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224
Query: 315 PE-----------YASTGMLNETSDVYSFGILIMEVISGRNP 345
PE S ++ SDV+S G ++ + G+ P
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 65/268 (24%), Positives = 96/268 (35%), Gaps = 56/268 (20%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRV-RHKNLVRLV 220
+G G YG V++ ED AVK RG ++ K+ EV + +V +H VRL
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--- 277
EG L E +L+Q + L + T L +LH
Sbjct: 124 QAWEEGGILYLQTELCG-PSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQGLV 179
Query: 278 ----------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-----YASTGM 322
L P+ KL DFGL LG + G Y+APE Y
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQE-GDPRYMAPELLQGSY----- 232
Query: 323 LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382
+DV+S G+ I+EV P ++ L+ +G L P
Sbjct: 233 -GTAADVFSLGLTILEVACNM------ELP----HGGEGWQQLR--------QGYLPPEF 273
Query: 383 QEKPSSRALKRALLVALRCVDPNAHKRP 410
SS R++L + ++P+ R
Sbjct: 274 TAGLSSEL--RSVL--VMMLEPDPKLRA 297
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 45/201 (22%), Positives = 76/201 (37%), Gaps = 26/201 (12%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLV 220
+G+GG+ + + A K +LL Q EK +E+ + H+++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 81
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLT-WEIRMNIILGTAKGLTYLHEG-- 277
G+ + +V E +L + LT E R + G YLH
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEAR-YYLRQIVLGCQYLHRNRV 136
Query: 278 -----------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNET 326
L K+ DFGLA + + + GT Y+APE S +
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFE 195
Query: 327 SDVYSFGILIMEVISGRNPVD 347
DV+S G ++ ++ G+ P +
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFE 216
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 44/220 (20%), Positives = 75/220 (34%), Gaps = 44/220 (20%)
Query: 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVG 221
E ++G G G V VAVK +L + +E++ + H N++R
Sbjct: 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYC 76
Query: 222 YCAEGAHRMLVNEYVDNGNLEQWL--HGDVGPHSPLTWEIRM-NIILGTAKGLTYLHE-- 276
+ E N NL+ + + L E +++ A G+ +LH
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 135
Query: 277 ------------------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVM---GT 309
+SDFGL K L + +S T + GT
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGT 195
Query: 310 FGYVAPE-------YASTGMLNETSDVYSFGILIMEVISG 342
G+ APE + L + D++S G + ++S
Sbjct: 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 7e-16
Identities = 51/268 (19%), Positives = 96/268 (35%), Gaps = 25/268 (9%)
Query: 151 RELEVSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNL-LNNRGQAEKEFKVEVEAI 208
+ E+ + F + +G G G+V++ +A K + L + + E++ +
Sbjct: 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85
Query: 209 GRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 268
+V G + E++D G+L+Q L + +I + +
Sbjct: 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVI 141
Query: 269 KGLTYLHEG--------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 314
KGLTYL E + + KL DFG++ L S + V GT Y++
Sbjct: 142 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMS 198
Query: 315 PEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374
PE + SD++S G+ ++E+ GR P P + + +
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYP--IPPPDAKELELMFGCQVEGDAAETPPR 256
Query: 375 EGVLDPRLQEKPSSRALKRALLVALRCV 402
L + A+ L +
Sbjct: 257 PRTPGRPLNKFGMDSRPPMAIFELLDYI 284
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 1e-15
Identities = 52/199 (26%), Positives = 87/199 (43%), Gaps = 25/199 (12%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLV 220
+G+G + VYR + VA+K + G ++ + EV+ +++H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILELY 77
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLT-WEIRMNIILGTAKGLTYLHEG-- 277
Y + + LV E NG + ++L V P + E R + + G+ YLH
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP---FSENEAR-HFMHQIITGMLYLHSHGI 133
Query: 278 -----------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNET 326
L N K++DFGLA L T + GT Y++PE A+
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGLE 192
Query: 327 SDVYSFGILIMEVISGRNP 345
SDV+S G + ++ GR P
Sbjct: 193 SDVWSLGCMFYTLLIGRPP 211
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 45/199 (22%), Positives = 75/199 (37%), Gaps = 26/199 (13%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLV 220
+G+GG+ + + A K +LL Q EK +E+ + H+++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 107
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLT-WEIRMNIILGTAKGLTYLHEG-- 277
G+ + +V E +L + LT E R + G YLH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEAR-YYLRQIVLGCQYLHRNRV 162
Query: 278 -----------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNET 326
L K+ DFGLA + + + GT Y+APE S +
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFE 221
Query: 327 SDVYSFGILIMEVISGRNP 345
DV+S G ++ ++ G+ P
Sbjct: 222 VDVWSIGCIMYTLLVGKPP 240
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 54/280 (19%), Positives = 97/280 (34%), Gaps = 42/280 (15%)
Query: 153 LEVSTNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGR 210
+EV + +G G YG+V + + +AVK + Q +K ++++ R
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 211 -VRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 269
V V G + E +D +L+++ + + +I I + K
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 270 GLTYLHEG--------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 315
L +LH + K+ DFG++ L G Y+AP
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYMAP 178
Query: 316 E----YASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTN 371
E + + SD++S GI ++E+ R P Y FQ V
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFP--YDSWGTPFQ--------QLKQVVE 228
Query: 372 GNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPK 411
+ P+L S + +C+ N+ +RP
Sbjct: 229 EPS-----PQLPADKFSAEFVD--FTS-QCLKKNSKERPT 260
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 45/219 (20%), Positives = 80/219 (36%), Gaps = 40/219 (18%)
Query: 146 HWYTLRELEVSTNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVE 204
HW T + +G G +G V+R + AVK + + E E
Sbjct: 58 HWMTHQPR------------VGRGSFGEVHRMKDKQTGFQCAVKKV-----RLEVFRVEE 100
Query: 205 VEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNII 264
+ A + +V L G EG + E ++ G+L Q + L + + +
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK----QMGCLPEDRALYYL 156
Query: 265 LGTAKGLTYLHEG-------------LEPKWNP-KLSDFGLAKLLGAERSYVTTR----V 306
+GL YLH L + L DFG A L + + +
Sbjct: 157 GQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216
Query: 307 MGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNP 345
GT ++APE + D++S +++ +++G +P
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 3e-15
Identities = 48/201 (23%), Positives = 81/201 (40%), Gaps = 21/201 (10%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 217
F IG+G +G V++G+ VA+K + + E E + E+ + + +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277
+ G + ++ EY+ G+ D+ PL I+ KGL YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSAL-----DLLEPGPLDETQIATILREILKGLDYLHSE 138
Query: 278 -------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 324
L KL+DFG+A L + T +GT ++APE +
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSAYD 197
Query: 325 ETSDVYSFGILIMEVISGRNP 345
+D++S GI +E+ G P
Sbjct: 198 SKADIWSLGITAIELARGEPP 218
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 47/199 (23%), Positives = 79/199 (39%), Gaps = 26/199 (13%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNL----LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 219
+G+G +G VY ++ +A+K L L G E + + E+E +RH N++R+
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLRHPNILRM 79
Query: 220 VGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-- 277
Y + L+ E+ G L + L H + + A L Y HE
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKELQ----KHGRFDEQRSATFMEELADALHYCHERKV 135
Query: 278 -----------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNET 326
+ K K++DFG + + R + GT Y+ PE +E
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRTMCGTLDYLPPEMIEGKTHDEK 192
Query: 327 SDVYSFGILIMEVISGRNP 345
D++ G+L E + G P
Sbjct: 193 VDLWCAGVLCYEFLVGMPP 211
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 63/252 (25%), Positives = 101/252 (40%), Gaps = 51/252 (20%)
Query: 122 NRIHIEIGKDHRIAYRRVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYRGVL-E 180
+ + KD V+ G G R EVS + D VIG G +G+VY+ L +
Sbjct: 24 GSMKVSRDKDGSKVTTVVATPGQG---PDRPQEVS---YTDTKVIGNGSFGVVYQAKLCD 77
Query: 181 DNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLVGYCAEGAHRM------LVN 233
VA+K +L +K FK E++ + ++ H N+VRL + + LV
Sbjct: 78 SGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132
Query: 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEPK---WNP 284
+YV + + L + + L Y+H ++P+ +P
Sbjct: 133 DYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 191
Query: 285 -----KLSDFGLAKLLGAER---SYVTTRVMGTFGYVAPEYASTGMLNETS-----DVYS 331
KL DFG AK L SY+ +R Y APE + T DV+S
Sbjct: 192 DTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPEL----IFGATDYTSSIDVWS 242
Query: 332 FGILIMEVISGR 343
G ++ E++ G+
Sbjct: 243 AGCVLAELLLGQ 254
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 65/285 (22%), Positives = 103/285 (36%), Gaps = 44/285 (15%)
Query: 151 RELEVSTNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAI 208
+ + + D IG G YG V + V +AVK + + +K+ ++++ +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 209 GR-VRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 267
R +V+ G + E + + + + + EI I L T
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134
Query: 268 AKGLTYLHEG--------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 313
K L +L E L+ N KL DFG++ L S TR G Y+
Sbjct: 135 VKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRPYM 192
Query: 314 APEYASTGMLNET----SDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMV 369
APE + SDV+S GI + E+ +GR P Y + F T V
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFP--YPKWNSVFD--------QLTQV 242
Query: 370 TNGNAEGVLDPRLQEKPS---SRALKRALLVALRCVDPNAHKRPK 411
G+ P+L S + V C+ + KRPK
Sbjct: 243 VKGDP-----PQLSNSEEREFSPSFIN--FVN-LCLTKDESKRPK 279
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 43/222 (19%), Positives = 79/222 (35%), Gaps = 41/222 (18%)
Query: 163 ENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLV 220
V+ EGG+ VY + A+K LL+N + + EV + ++ H N+V+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 221 GYCAEGAHRM-------LVNEYVDNGNLEQWLHGDVGPHSPLT-WEIRMNIILGTAKGLT 272
+ G L+ + G L ++L + PL+ + I T + +
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVL-KIFYQTCRAVQ 150
Query: 273 YLHEG---------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVM---------- 307
++H L + KL DFG A + Y +
Sbjct: 151 HMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 308 -GTFGYVAPE---YASTGMLNETSDVYSFGILIMEVISGRNP 345
T Y PE S + E D+++ G ++ + ++P
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 52/200 (26%), Positives = 86/200 (43%), Gaps = 20/200 (10%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 218
F +GEG YG VY+ + E VA+K + +E E+ + + ++V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVK 88
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG- 277
G + +V EY G++ + + LT + I+ T KGL YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 278 ------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 325
L + + KL+DFG+A L + T + GT ++APE N
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNC 204
Query: 326 TSDVYSFGILIMEVISGRNP 345
+D++S GI +E+ G+ P
Sbjct: 205 VADIWSLGITAIEMAEGKPP 224
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 7e-14
Identities = 37/206 (17%), Positives = 83/206 (40%), Gaps = 25/206 (12%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 218
+ +G+G +G VY+ E A K + + +++ VE+E + H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYLHEG 277
L+G ++ E+ G ++ + + E ++ ++ + L +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT----EPQIQVVCRQMLEALNFLHSK 136
Query: 278 -------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 324
+ + + +L+DFG++ + +GT ++APE +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCETMK 195
Query: 325 ETS-----DVYSFGILIMEVISGRNP 345
+T D++S GI ++E+ P
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 35/218 (16%), Positives = 76/218 (34%), Gaps = 41/218 (18%)
Query: 165 VIGEGGYGIVYRGVLEDNTNVAVK-----------------NLLNNRGQAEKEFKVEVEA 207
+ +G + + +DN A+K N + +FK E++
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 208 IGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWL----HGDVGPHSPLTWEIRMNI 263
I ++++ + G ++ EY++N ++ ++ D + ++ I
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 264 ILGTAKGLTYLHEG--------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGT 309
I +Y+H ++ KLSDFG ++ + GT
Sbjct: 157 IKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEY--MVDKKIKG-SRGT 213
Query: 310 FGYVAPEYAST--GMLNETSDVYSFGILIMEVISGRNP 345
+ ++ PE+ S D++S GI + + P
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 54/226 (23%), Positives = 98/226 (43%), Gaps = 47/226 (20%)
Query: 147 WYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKV-EV 205
T + E++ + + VIG G +G+V++ L ++ VA+K +L +K FK E+
Sbjct: 32 GKTGEQREIA---YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNREL 83
Query: 206 EAIGRVRHKNLVRLVGYCAEGAHRM------LVNEYVDNGNLEQWLHGDVGPHSPLTWEI 259
+ + V+H N+V L + + LV EYV + + + +
Sbjct: 84 QIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLL 142
Query: 260 RMNIILGTAKGLTYLHEG------LEPK---WNP-----KLSDFGLAKLLGAER---SYV 302
+ + L Y+H ++P+ +P KL DFG AK+L A SY+
Sbjct: 143 IKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYI 202
Query: 303 TTRVMGTFGYVAPEYASTGMLNETS-----DVYSFGILIMEVISGR 343
+R Y APE + T+ D++S G ++ E++ G+
Sbjct: 203 CSRY-----YRAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 31/238 (13%), Positives = 64/238 (26%), Gaps = 62/238 (26%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLL---NNRGQAEKEFKVEVEAIGRVR-------- 212
V+G+ E + V A K+ K EV + +R
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 213 --------------HKNLVRLVGYCAEGAHRMLVNEYV-------DNGNLEQWLHGDVGP 251
+++ + +++ + + + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 252 HSPLTWEIRMNIILGTAKGLTYLHE-G------------LEPKWNPKLSDFGLAKLLGAE 298
H L R+ + L + L LH G L+ + L+ F GA
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR 259
Query: 299 RSYVTTRVMGTFGYVAPEYAST-----------GMLNETSDVYSFGILIMEVISGRNP 345
+ G+ PE + ++ + D ++ G++I + P
Sbjct: 260 VV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 53/284 (18%), Positives = 98/284 (34%), Gaps = 47/284 (16%)
Query: 151 RELEVSTNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAI 208
+ + N + +G G G V++ + +AVK + + + K ++++ +
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 209 GR-VRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 267
+ +V+ G + E + + P+ I + +
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKR----MQGPIPERILGKMTVAI 133
Query: 268 AKGLTYLHEG--------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 313
K L YL E L+ + KL DFG++ L R G Y+
Sbjct: 134 VKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYM 191
Query: 314 APE-----YASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTM 368
APE + + +DV+S GI ++E+ +G+ P Y +F+ + T
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP--YKNCKTDFE--------VLTK 241
Query: 369 VTNGNAEGVLDPRLQEKPS-SRALKRALLVALRCVDPNAHKRPK 411
V P L S + V C+ + KRPK
Sbjct: 242 VLQEEP-----PLLPGHMGFSGDFQS--FVK-DCLTKDHRKRPK 277
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 45/219 (20%), Positives = 80/219 (36%), Gaps = 43/219 (19%)
Query: 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN 215
+ F E + G+G +G V G +VA+K ++ + +E + ++ + + H N
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPN 80
Query: 216 LVRLVGY-CAEGAHRM------LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 268
+V+L Y G +V EYV + L + + +
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 269 KGLTYLHEG--------LEPK---WNP-----KLSDFGLAKLLGAER---SYVTTRVMGT 309
+ + LH ++P N KL DFG AK L +Y+ +R
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY--- 196
Query: 310 FGYVAPEYASTGMLNETS-----DVYSFGILIMEVISGR 343
Y APE + D++S G + E++ G
Sbjct: 197 --YRAPEL----IFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 44/202 (21%), Positives = 74/202 (36%), Gaps = 26/202 (12%)
Query: 163 ENVIGEGGYGIVYRGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 219
+G G YG V + A+K + + + EV + + H N+++L
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 220 VGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE--- 276
+ + + LV E G L + II G+TYLH+
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHNI 157
Query: 277 -------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 323
E K+ DFGL+ + E +GT Y+APE
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVF--ENQKKMKERLGTAYYIAPE-VLRKKY 214
Query: 324 NETSDVYSFGILIMEVISGRNP 345
+E DV+S G+++ +++G P
Sbjct: 215 DEKCDVWSIGVILFILLAGYPP 236
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 59/270 (21%), Positives = 110/270 (40%), Gaps = 33/270 (12%)
Query: 103 EPLPEPEPILV-EDSPVRGRNRIHIEIGKDHRIAYRRVSHLGWGHWYTLRELEVSTNGFA 161
+P P+L+ D R R E GK R S+ + ++
Sbjct: 92 KPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIK 151
Query: 162 DENV---------IGEGGYGIVYRGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGR 210
++V +G G +G+V+R E T A K ++ ++ + E++ +
Sbjct: 152 HDHVLDHYDIHEELGTGAFGVVHRVT-ERATGNNFAAKFVMTPHESDKETVRKEIQTMSV 210
Query: 211 VRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 270
+RH LV L + +++ E++ G L + + H+ ++ + + + KG
Sbjct: 211 LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKG 267
Query: 271 LTYLHE------GLEPK----WNP-----KLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 315
L ++HE L+P+ KL DFGL L ++S GT + AP
Sbjct: 268 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV--TTGTAEFAAP 325
Query: 316 EYASTGMLNETSDVYSFGILIMEVISGRNP 345
E A + +D++S G+L ++SG +P
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 60/277 (21%), Positives = 108/277 (38%), Gaps = 49/277 (17%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLV 217
F ++G G YG VY+G ++ A+K +++ G E+E K E+ + + H+N+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 218 R-----LVGYCAEGAHRM-LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 271
+ ++ LV E+ G++ + G + L E I +GL
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGL 142
Query: 272 TYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 318
++LH+ L KL DFG++ L T +GT ++APE
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVI 201
Query: 319 STGMLNETS-----DVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373
+ + + D++S GI +E+ G PP ++ L + N
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEG-------APP---LCDMHPMRALFLIPRNP- 250
Query: 374 AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRP 410
PRL+ K S+ + + L + +RP
Sbjct: 251 -----APRLKSKKWSKKFQSFIESCL-VKNH--SQRP 279
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 65/296 (21%), Positives = 120/296 (40%), Gaps = 43/296 (14%)
Query: 61 NNYNSSSGNPTIP-NISKEIQEIRIDLDSKSISNCKPHSAPNPEPLPEPEPILVEDSPVR 119
++++ SSG N+ + + D DS+S N + + L E P+ + +
Sbjct: 4 HHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHN-EAKEVWSNADLTERMPVKSKRTSAL 62
Query: 120 GRNRIHIEIGKDHRIAYRRVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYRGV- 178
+ DHRI + + +YT+ + E+ +G G +G V++
Sbjct: 63 AVDIPAPPAPFDHRIVTAKQGAVN--SFYTVSKTEI----------LGGGRFGQVHKCEE 110
Query: 179 LEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVD 237
+A K ++ RG +KE K E+ + ++ H NL++L +LV EYVD
Sbjct: 111 TATGLKLAAK-IIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169
Query: 238 NGNLEQWLHGDVGPHSPLT-WEIR--MNIILGTAKGLTYLHE------GLEP-------- 280
G L + + LT + M I G+ ++H+ L+P
Sbjct: 170 GGELFDRI---IDESYNLTELDTILFMKQICE---GIRHMHQMYILHLDLKPENILCVNR 223
Query: 281 KWNP-KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGIL 335
K+ DFGLA+ GT ++APE + ++ +D++S G++
Sbjct: 224 DAKQIKIIDFGLARRYKPREKLKV--NFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 46/204 (22%), Positives = 80/204 (39%), Gaps = 29/204 (14%)
Query: 163 ENVIGEGGYGIVYRGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLV 217
+ V+G+G +G V AVK + + E EV+ + ++ H N++
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES-LLREVQLLKQLDHPNIM 89
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE- 276
+L + + + LV E G L + + II G+TY+H+
Sbjct: 90 KLYEFFEDKGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 277 ---------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 321
N ++ DFGL+ A + +GT Y+APE G
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAPE-VLHG 202
Query: 322 MLNETSDVYSFGILIMEVISGRNP 345
+E DV+S G+++ ++SG P
Sbjct: 203 TYDEKCDVWSTGVILYILLSGCPP 226
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 2e-12
Identities = 40/198 (20%), Positives = 72/198 (36%), Gaps = 42/198 (21%)
Query: 163 ENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVG 221
V+G G + V+ A+K + + + + E+ + +++H+N+V L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 222 YCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRM---------NIILGTAKGLT 272
H LV + V G L + + +I +
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRI-------------LERGVYTEKDASLVIQQVLSAVK 120
Query: 273 YLHE----------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 316
YLHE E ++DFGL+K+ + ++T GT GYVAPE
Sbjct: 121 YLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTAC-GTPGYVAPE 177
Query: 317 YASTGMLNETSDVYSFGI 334
+ ++ D +S G+
Sbjct: 178 VLAQKPYSKAVDCWSIGV 195
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 41/193 (21%), Positives = 74/193 (38%), Gaps = 23/193 (11%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVK-----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 218
VIG+G + +V R + E AVK ++ G + ++ K E ++H ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-- 276
L+ + +V E++D +L + + + + + + L Y H+
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 150
Query: 277 --------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 322
E KL FG+A LG RV GT ++APE
Sbjct: 151 IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVKREP 209
Query: 323 LNETSDVYSFGIL 335
+ DV+ G++
Sbjct: 210 YGKPVDVWGCGVI 222
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 45/213 (21%), Positives = 78/213 (36%), Gaps = 37/213 (17%)
Query: 163 ENVIGEGGYGIVYRGV-LEDNTNVAVK-------------NLLNNRGQAEKEFKVEVEAI 208
+G G YG V ++ A+K + N + +E E+ +
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 209 GRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 268
+ H N+++L + + LV E+ + G L + + NI+
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQIL 156
Query: 269 KGLTYLHE----------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 312
G+ YLH+ N K+ DFGL+ + Y +GT Y
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDYKLRDRLGTAYY 214
Query: 313 VAPEYASTGMLNETSDVYSFGILIMEVISGRNP 345
+APE NE DV+S G+++ ++ G P
Sbjct: 215 IAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 45/218 (20%), Positives = 82/218 (37%), Gaps = 25/218 (11%)
Query: 148 YTLRELEVSTNGFAD----ENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFK 202
Y + +EV D +G G +G+V+R V K + + K
Sbjct: 37 YVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK 96
Query: 203 VEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMN 262
E+ + ++ H L+ L + +L+ E++ G L + + S M
Sbjct: 97 NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR 156
Query: 263 IILGTAKGLTYLHE------GLEP--------KWNP-KLSDFGLAKLLGAERSYVTTRVM 307
GL ++HE ++P K + K+ DFGLA L +
Sbjct: 157 QACE---GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV--TT 211
Query: 308 GTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNP 345
T + APE + +D+++ G+L ++SG +P
Sbjct: 212 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 47/217 (21%), Positives = 84/217 (38%), Gaps = 38/217 (17%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 217
+ + VIG G +V VA+K + + Q + E++A+ + H N+V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNL----EQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLT 272
LV + + G++ + + L E + IL +GL
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILREVLEGLE 135
Query: 273 YLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTF-G---YVAP 315
YLH+ L + +++DFG++ L +V TF G ++AP
Sbjct: 136 YLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195
Query: 316 E-------YASTGMLNETSDVYSFGILIMEVISGRNP 345
E Y + +D++SFGI +E+ +G P
Sbjct: 196 EVMEQVRGY------DFKADIWSFGITAIELATGAAP 226
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 24/193 (12%), Positives = 52/193 (26%), Gaps = 41/193 (21%)
Query: 165 VIGEGGYGIVYRGVLEDNT---NVAVKNLLNNRGQAE---KEFKVEVEAIGRVRHKNLVR 218
G ++ + D VA+ + + +E + R+ + R
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG- 277
++ A ++V E++ G+L++ P + + A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG------AIRAMQSLAAAADAAHRAG 149
Query: 278 -----LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSF 332
P ++S G L + N D+
Sbjct: 150 VALSIDHPS-RVRVSIDGDVVL-------------AYPATMPDA-------NPQDDIRGI 188
Query: 333 GILIMEVISGRNP 345
G + ++ R P
Sbjct: 189 GASLYALLVNRWP 201
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 46/234 (19%), Positives = 78/234 (33%), Gaps = 50/234 (21%)
Query: 118 VRGRNRI-----HIEIGKDHRIAYRRVSHLGWGHWYTLRELEVSTNGFADE----NVIGE 168
+G+ R I + + T+ + V DE +G
Sbjct: 93 GKGKRRPLNNNSEIALSLSRNKVFVFFD-------LTVDDQSVYPKALRDEYIMSKTLGS 145
Query: 169 GGYGIVYRGVLEDNTN--VAVK----NLLNNRGQAEKE----FKVEVEAIGRVRHKNLVR 218
G G V E T VA++ E + + E+E + ++ H +++
Sbjct: 146 GACGEVKLAF-ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 204
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-- 276
+ + + +V E ++ G L V + L + YLHE
Sbjct: 205 IKNFFDAEDY-YIVLELMEGGELFDK----VVGNKRLKEATCKLYFYQMLLAVQYLHENG 259
Query: 277 --------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 316
E K++DFG +K+LG E S + T GT Y+APE
Sbjct: 260 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC-GTPTYLAPE 311
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 35/222 (15%), Positives = 61/222 (27%), Gaps = 28/222 (12%)
Query: 150 LRELEVSTNGFADENVIGEG--GYGIVYRGV-LEDNTNVAVK--NLLNNRGQAEKEFKVE 204
+ + VIG+G V V V+ NL + + E
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76
Query: 205 VEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNII 264
+ H N+V +V ++ G+ + + + I+
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC--THFMDGMNELAIAYIL 134
Query: 265 LGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 311
G K L Y+H + LS + +
Sbjct: 135 QGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194
Query: 312 YV------APEYASTGML--NETSDVYSFGILIMEVISGRNP 345
V +PE + + SD+YS GI E+ +G P
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 2e-11
Identities = 47/213 (22%), Positives = 76/213 (35%), Gaps = 54/213 (25%)
Query: 164 NVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG-------------R 210
IGEG YG+V++ +N + A K+F + +
Sbjct: 9 GKIGEGSYGVVFKC----------RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQ 58
Query: 211 VRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 270
++H NLV L+ LV EY D+ + L D ++ +I T +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVK-SITWQTLQA 114
Query: 271 LTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE- 316
+ + H+ + KL DFG A+LL Y V T Y +PE
Sbjct: 115 VNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPEL 173
Query: 317 ------YASTGMLNETSDVYSFGILIMEVISGR 343
Y + DV++ G + E++SG
Sbjct: 174 LVGDTQY-GPPV-----DVWAIGCVFAELLSGV 200
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 45/207 (21%), Positives = 82/207 (39%), Gaps = 36/207 (17%)
Query: 163 ENVIGEGGYGIVYRGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 219
++G+G +G V + AVK N + + + EVE + ++ H N+++L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 220 VGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE--- 276
+ + +V E G L + + II G+TY+H+
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 277 -------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-----YA 318
E + K+ DFGL+ +++ +GT Y+APE Y
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYYIAPEVLRGTY- 199
Query: 319 STGMLNETSDVYSFGILIMEVISGRNP 345
+E DV+S G+++ ++SG P
Sbjct: 200 -----DEKCDVWSAGVILYILLSGTPP 221
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 67/272 (24%), Positives = 103/272 (37%), Gaps = 50/272 (18%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAE---KEFKVEVEAIGRVRHKN 215
F+D IG G +G VY + ++ VA+K + + Q+ ++ EV + ++RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYL 274
++ G LV EY G+ L P E+ + + G +GL YL
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ----EVEIAAVTHGALQGLAYL 170
Query: 275 HEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE---YA 318
H L KL DFG A ++ S+V GT ++APE
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAM 225
Query: 319 STGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378
G + DV+S GI +E+ +PP F +N L + N +
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAER-------KPP---LFNMNAMSALYHIAQNES----- 270
Query: 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRP 410
P LQ S + + L P RP
Sbjct: 271 -PALQSGHWSEYFRNFVDSCL-QKIPQ--DRP 298
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 4e-11
Identities = 38/188 (20%), Positives = 70/188 (37%), Gaps = 21/188 (11%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLVGY 222
+G G +G V+ +K + +R Q E + E+E + + H N++++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 223 CAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE------ 276
+ + +V E + G L + + L+ ++ L Y H
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHK 148
Query: 277 ----------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNET 326
P K+ DFGLA+L ++ T GT Y+APE +
Sbjct: 149 DLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-TNAA-GTALYMAPEVFK-RDVTFK 205
Query: 327 SDVYSFGI 334
D++S G+
Sbjct: 206 CDIWSAGV 213
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 4e-11
Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 42/209 (20%)
Query: 164 NVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNLV 217
IGEG YG V++ E + VA+K + R + E E+ + ++HKN+V
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277
RL LV E+ D +L+++ G P + + +L KGL + H
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL---KGLGFCHSR 120
Query: 278 -------------LEPKWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE------- 316
+ KL++FGLA+ G R Y + V+ T Y P+
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVV-TLWYRPPDVLFGAKL 178
Query: 317 YASTGMLNETSDVYSFGILIMEVISGRNP 345
Y ST + D++S G + E+ + P
Sbjct: 179 Y-STSI-----DMWSAGCIFAELANAGRP 201
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 46/191 (24%), Positives = 76/191 (39%), Gaps = 36/191 (18%)
Query: 151 RELEVSTNGFADE----NVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEV 205
++L ++ F D IG G Y + R + N AVK + ++ ++ E+
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEI 66
Query: 206 EAIGR-VRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRM--N 262
E + R +H N++ L +G + +V E + G L + S E R
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL-RQKFFS----E-REASA 120
Query: 263 IILGTAKGLTYLHEG--------------LEPKWNP---KLSDFGLAKLLGAERSYVTTR 305
++ K + YLH ++ NP ++ DFG AK L AE + T
Sbjct: 121 VLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP 180
Query: 306 VMGTFGYVAPE 316
T +VAPE
Sbjct: 181 C-YTANFVAPE 190
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 5e-11
Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 56/216 (25%)
Query: 164 NVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE------AIGR------- 210
+G G Y VY+G N A KE K++ E AI R
Sbjct: 11 EKLGNGTYATVYKG----------LNKTTGVYVALKEVKLDSEEGTPSTAI-REISLMKE 59
Query: 211 VRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTA 268
++H+N+VRL LV E++DN +L++++ L +
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 269 KGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVA 314
+GL + HE + + KL DFGLA+ G ++ ++ V+ T Y A
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF-SSEVV-TLWYRA 176
Query: 315 PE-------YASTGMLNETSDVYSFGILIMEVISGR 343
P+ Y ST + D++S G ++ E+I+G+
Sbjct: 177 PDVLMGSRTY-STSI-----DIWSCGCILAEMITGK 206
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 5e-11
Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 50/215 (23%)
Query: 164 NVIGEGGYGIVYRGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAI---------GRVR 212
IGEG YG V++ N VA+K + R Q +E + + I
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEE-GMPLSTIREVAVLRHLETFE 72
Query: 213 HKNLVRL----VGYCAEGAHRM-LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 267
H N+VRL + ++ LV E+VD +L +L D P + E +++
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIKDMMFQL 129
Query: 268 AKGLTYLHEG------LEP-------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 314
+GL +LH L+P KL+DFGLA++ + + T+ V+ T Y A
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVV-TLWYRA 187
Query: 315 PE------YASTGMLNETSDVYSFGILIMEVISGR 343
PE Y +T + D++S G + E+ +
Sbjct: 188 PEVLLQSSY-ATPV-----DLWSVGCIFAEMFRRK 216
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 52/211 (24%), Positives = 78/211 (36%), Gaps = 36/211 (17%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 219
++GEG YG V + E AVK L E K E++ + R+RHKN+++L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 220 --VGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLT-WEIR---MNIILGTAKGLTY 273
V Y E +V EY G E D P + +I GL Y
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEML---DSVPEKRFPVCQAHGYFCQLID----GLEY 124
Query: 274 LHEG-------------LEPKWNPKLSDFGLAKLLGAER--SYVTTRVMGTFGYVAPEYA 318
LH L K+S G+A+ L T G+ + PE A
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQPPEIA 183
Query: 319 STGMLNE--TSDVYSFGILIMEVISGRNPVD 347
+ D++S G+ + + +G P +
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 37/197 (18%), Positives = 82/197 (41%), Gaps = 22/197 (11%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYC 223
+G G +GIV+R V K + +G + K E+ + RH+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE------G 277
+++ E++ ++ + ++ + ++ + + L +LH
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC---EALQFLHSHNIGHFD 127
Query: 278 LEP-------KWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSD 328
+ P + + K+ +FG A+ L ++ + Y APE +++ +D
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEYYAPEVHQHDVVSTATD 185
Query: 329 VYSFGILIMEVISGRNP 345
++S G L+ ++SG NP
Sbjct: 186 MWSLGTLVYVLLSGINP 202
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 7e-11
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 45/208 (21%)
Query: 164 NVIGEGGYGIVYRGVLEDNTN--VAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNL 216
+GEG YG+VY+ +D+ VA+K + R AE E E+ + + H N+
Sbjct: 27 EKVGEGTYGVVYKA--KDSQGRIVALKRI---RLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276
V L+ LV E+++ +L++ L + +I + +L +G+ + H+
Sbjct: 82 VSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQ 137
Query: 277 G-------------LEPKWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE------ 316
+ KL+DFGLA+ G RSY T V+ T Y AP+
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-THEVV-TLWYRAPDVLMGSK 195
Query: 317 -YASTGMLNETSDVYSFGILIMEVISGR 343
Y ST + D++S G + E+I+G+
Sbjct: 196 KY-STSV-----DIWSIGCIFAEMITGK 217
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 8e-11
Identities = 47/252 (18%), Positives = 86/252 (34%), Gaps = 75/252 (29%)
Query: 153 LEVSTNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGR 210
LE S+ ++ +G G +GIV +E A+K +L + +K E++ +
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKV 56
Query: 211 VRHKNLVRL------VGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNII 264
+ H N+++L G + + G + + +N+I
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 265 LG-------------------------------TAKGLTYLHEG------LEPK---WNP 284
+ + + ++H ++P+ N
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 285 -----KLSDFGLAKLLGAER---SYVTTRVMGTFGYVAPEYASTGMLNETS-----DVYS 331
KL DFG AK L +Y+ +R Y APE ML T D++S
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPEL----MLGATEYTPSIDLWS 227
Query: 332 FGILIMEVISGR 343
G + E+I G+
Sbjct: 228 IGCVFGELILGK 239
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 40/227 (17%)
Query: 147 WYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNV-AVKNLLNNRGQAEKEF---K 202
W L + + F D V+G GG+G V+ ++ + A K L R + K +
Sbjct: 174 WKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM 233
Query: 203 VEVEAIGRVRHKNLVRLVGYCAEGAHRM-LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRM 261
VE + + +V + +V L Y E + LV ++ G++ ++ + E R
Sbjct: 234 VEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRA 291
Query: 262 N-----IILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT 303
I+ G L +LH+ L+ N ++SD GLA L A ++
Sbjct: 292 IFYTAQIVSG----LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK 347
Query: 304 TRVMGTFGYVAPEYASTGMLNETS-----DVYSFGILIMEVISGRNP 345
GT G++APE +L D ++ G+ + E+I+ R P
Sbjct: 348 GYA-GTPGFMAPE-----LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 9e-11
Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 45/208 (21%)
Query: 164 NVIGEGGYGIVYRGVLEDNTN--VAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNL 216
IGEG YG+VY+ ++N A+K + R + E E E+ + ++H N+
Sbjct: 8 EKIGEGTYGVVYKA--QNNYGETFALKKI---RLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276
V+L +LV E++D +L++ L G +T + + +L G+ Y H+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL---NGIAYCHD 118
Query: 277 G-------------LEPKWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE------ 316
+ + K++DFGLA+ G R Y T ++ T Y AP+
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIV-TLWYRAPDVLMGSK 176
Query: 317 -YASTGMLNETSDVYSFGILIMEVISGR 343
Y ST + D++S G + E+++G
Sbjct: 177 KY-STTI-----DIWSVGCIFAEMVNGT 198
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 43/179 (24%), Positives = 70/179 (39%), Gaps = 41/179 (22%)
Query: 164 NVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG-------------R 210
++GEG YG+V + +N R A K+F + +
Sbjct: 31 GLVGEGSYGMVMKC----------RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 211 VRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 270
+RH+NLV L+ C + LV E+VD+ + L ++ P+ L +++ + G
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPN-GLDYQVVQKYLFQIING 136
Query: 271 LTYLHE------GLEP-------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 316
+ + H ++P KL DFG A+ L A V T Y APE
Sbjct: 137 IGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPE 194
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 23/132 (17%), Positives = 43/132 (32%), Gaps = 31/132 (23%)
Query: 234 EYVDNGNLEQWLHGDVGPHSP---LTWEIRMNIILGTAKGLTYLHEG------------- 277
+ NL+ W++ + I + I + +LH
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA----VEFLHSKGLMHRDLKPSNIF 196
Query: 278 LEPKWNPKLSDFGLAKLLGAERSYVT-----------TRVMGTFGYVAPEYASTGMLNET 326
K+ DFGL + + T T +GT Y++PE +
Sbjct: 197 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK 256
Query: 327 SDVYSFGILIME 338
D++S G+++ E
Sbjct: 257 VDIFSLGLILFE 268
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 3e-04
Identities = 21/73 (28%), Positives = 35/73 (47%), Gaps = 2/73 (2%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLV 217
F +G GG+G+V+ D+ N A+K + L NR A ++ EV+A+ ++ H +V
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 218 RLVGYCAEGAHRM 230
R E
Sbjct: 68 RYFNAWLETPPEK 80
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 45/195 (23%), Positives = 71/195 (36%), Gaps = 30/195 (15%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVK-----NLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 217
+G G + IV + A K +R +E + EV + +V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE- 276
L +L+ E V G L +L S + IL G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILD---GVNYLHTK 134
Query: 277 ----------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 320
P + KL DFGLA + + + GT +VAPE +
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIVNY 192
Query: 321 GMLNETSDVYSFGIL 335
L +D++S G++
Sbjct: 193 EPLGLEADMWSIGVI 207
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 55/216 (25%), Positives = 85/216 (39%), Gaps = 50/216 (23%)
Query: 164 NVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEV-----------EAIGRV 211
IG G YG VY+ VA+K++ R + +
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGGGGGGGLPISTVREVALLRRLEAF 71
Query: 212 RHKNLVRLVGYCAEGAHR-----MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 266
H N+VRL+ CA LV E+VD +L +L D P L E +++
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQ 128
Query: 267 TAKGLTYLHEG------LEP-------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 313
+GL +LH L+P KL+DFGLA++ + + T V+ T Y
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-TPVVV-TLWYR 186
Query: 314 APE------YASTGMLNETSDVYSFGILIMEVISGR 343
APE Y +T + D++S G + E+ +
Sbjct: 187 APEVLLQSTY-ATPV-----DMWSVGCIFAEMFRRK 216
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 37/175 (21%), Positives = 65/175 (37%), Gaps = 32/175 (18%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLL--NNRGQAEKEFKVEVEAIGRVRHKNLVRLVG 221
+G+G + +V R V + A + + ++ + E ++H N+VRL
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 222 YCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIR----MNIILGTAKGLTYLHE- 276
+E H L+ + V G L + + +S E + IL + + H+
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIV-AREYYS----EADASHCIQQILE---AVLHCHQM 129
Query: 277 ---------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 316
KL+DFGLA + E+ GT GY++PE
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPE 183
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 45/195 (23%), Positives = 71/195 (36%), Gaps = 30/195 (15%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVK-----NLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 217
+G G + IV + A K +R +E + EV + +V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE- 276
L +L+ E V G L +L S + IL G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILD---GVNYLHTK 134
Query: 277 ----------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 320
P + KL DFGLA + + + GT +VAPE +
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIVNY 192
Query: 321 GMLNETSDVYSFGIL 335
L +D++S G++
Sbjct: 193 EPLGLEADMWSIGVI 207
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 2e-10
Identities = 43/192 (22%), Positives = 63/192 (32%), Gaps = 34/192 (17%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYC 223
IG G +G V V A K + + FK E+E + + H N++RL
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE------- 276
+ LV E G L + + I+ + Y H+
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLNVAHRD 131
Query: 277 ---------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-----YASTGM 322
P KL DFGLA + T+V GT YV+P+ Y
Sbjct: 132 LKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-RTKV-GTPYYVSPQVLEGLY----- 184
Query: 323 LNETSDVYSFGI 334
D +S G+
Sbjct: 185 -GPECDEWSAGV 195
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 46/192 (23%), Positives = 73/192 (38%), Gaps = 35/192 (18%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYC 223
+G G IVYR A+K L + +K + E+ + R+ H N+++L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE------- 276
LV E V G L + + + + + + YLHE
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENGIVHRD 173
Query: 277 ---------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETS 327
P K++DFGL+K++ + T V GT GY APE +L +
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--VCGTPGYCAPE-----ILRGCA 226
Query: 328 -----DVYSFGI 334
D++S GI
Sbjct: 227 YGPEVDMWSVGI 238
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 39/207 (18%)
Query: 164 NVIGEGGYGIVYRGV-LEDNTNVAVKNL-LNNRGQAEKEFKV----EVEAIGRVRHKNLV 217
+ +GEG + VY+ N VA+K + L +R +A+ E++ + + H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277
L+ ++ LV ++++ +LE + LT +L T +GL YLH+
Sbjct: 76 GLLDAFGHKSNISLVFDFMET-DLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH 131
Query: 278 -------------LEPKWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE------- 316
L+ KL+DFGLAK G+ R+Y T +V+ T Y APE
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVV-TRWYRAPELLFGARM 189
Query: 317 YASTGMLNETSDVYSFGILIMEVISGR 343
Y G+ D+++ G ++ E++
Sbjct: 190 Y-GVGV-----DMWAVGCILAELLLRV 210
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 4e-10
Identities = 48/196 (24%), Positives = 77/196 (39%), Gaps = 30/196 (15%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVK-----NLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 217
+G G + IV + A K L ++R +E + EV + +RH N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE- 276
L +L+ E V G L +L + + IL G+ YLH
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILD---GVHYLHSK 127
Query: 277 -----GLEP-------KWNP----KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 320
L+P K P KL DFG+A + A + + GT +VAPE +
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEFVAPEIVNY 185
Query: 321 GMLNETSDVYSFGILI 336
L +D++S G++
Sbjct: 186 EPLGLEADMWSIGVIT 201
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 40/178 (22%), Positives = 66/178 (37%), Gaps = 34/178 (19%)
Query: 165 VIGEGGYGIVYRGVLEDNTN--VAVK----NLLNNRGQAEKE----FKVEVEAIGRVRHK 214
+G G G V E T VA+K E + + E+E + ++ H
Sbjct: 17 TLGSGACGEVKLAF-ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 215 NLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 274
++++ + + +V E ++ G L + G + L + YL
Sbjct: 76 CIIKIKNFFDAEDY-YIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYL 130
Query: 275 HE----------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 316
HE E K++DFG +K+LG E S + T GT Y+APE
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC-GTPTYLAPE 186
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 42/219 (19%), Positives = 79/219 (36%), Gaps = 62/219 (28%)
Query: 164 NVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG-------------R 210
+GEG YG VY+ + + N A K ++E E G
Sbjct: 40 TKLGEGTYGEVYKA----------IDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKE 89
Query: 211 VRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 270
++H+N++ L L+ EY +N +L++++ + ++ + + + G
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD----KNPDVSMRVIKSFLYQLING 144
Query: 271 LTYLHE------------------GLEPKWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFG 311
+ + H K+ DFGLA+ G R + T ++ T
Sbjct: 145 VNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-THEII-TLW 202
Query: 312 YVAPE-------YASTGMLNETSDVYSFGILIMEVISGR 343
Y PE Y ST + D++S + E++
Sbjct: 203 YRPPEILLGSRHY-STSV-----DIWSIACIWAEMLMKT 235
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 54/288 (18%), Positives = 108/288 (37%), Gaps = 47/288 (16%)
Query: 85 DLDSKSISNCKPHSAPNPEPLPEPEPILVEDSPVRGRNRIHIEIGKDHRIAYRRVSHLGW 144
+I + + H + P L + + ++ + + + W
Sbjct: 123 PFSKSAIEHVQGHLVKK-----QVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQW 177
Query: 145 GHWYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNV-AVKNLLNNRGQAEKEF-- 201
L ++ N F+ +IG GG+G VY D + A+K L R + ++
Sbjct: 178 -KNVELNI-HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL 235
Query: 202 -KVE---VEAIGRVRHKNLVRLVGYCAEGAHRM-LVNEYVDNGNLEQWLHGDVGPHSPLT 256
E + + +V + Y ++ + + ++ G+L L +
Sbjct: 236 ALNERIMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVF 289
Query: 257 WEIRMN-----IILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298
E M IILG L ++H L+ + ++SD GLA +
Sbjct: 290 SEADMRFYAAEIILG----LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345
Query: 299 RSYVTTRVMGTFGYVAPEYASTGML-NETSDVYSFGILIMEVISGRNP 345
+ + V GT GY+APE G+ + ++D +S G ++ +++ G +P
Sbjct: 346 KPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 8e-10
Identities = 45/201 (22%), Positives = 74/201 (36%), Gaps = 38/201 (18%)
Query: 163 ENVIGEGGYGIVYRGV-LEDNTNVAVK-----NLLNNRGQAEKE-FKVEVEAIGRVRHKN 215
+G G + +V + A K ++R +E + EV + ++H N
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIR----MNIILGTAKGL 271
++ L +L+ E V G E L + LT E + IL G+
Sbjct: 76 VITLHEVYENKTDVILILELVAGG--E--LFDFLAEKESLT-EEEATEFLKQILN---GV 127
Query: 272 TYLHE-----------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 314
YLH PK K+ DFGLA + + + GT +VA
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVA 185
Query: 315 PEYASTGMLNETSDVYSFGIL 335
PE + L +D++S G++
Sbjct: 186 PEIVNYEPLGLEADMWSIGVI 206
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 9e-10
Identities = 35/171 (20%), Positives = 62/171 (36%), Gaps = 25/171 (14%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVG 221
++G+G +G V + AVK + + EVE + ++ H N+++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 222 YCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE----- 276
+ + +V E G L + S + + G+TY+H+
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEII-KRKRFSEHDAARIIKQVFS---GITYMHKHNIVH 144
Query: 277 -----------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 316
E + K+ DFGL+ R+ GT Y+APE
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-KDRI-GTAYYIAPE 193
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 36/171 (21%), Positives = 64/171 (37%), Gaps = 25/171 (14%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVG 221
+G+G + +V R V A K + + + ++ + E +++H N+VRL
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 222 YCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE----- 276
E + LV + V G L + D+ + + I + + Y H
Sbjct: 96 SIQEESFHYLVFDLVTGGELFE----DIVAREFYSEADASHCIQQILESIAYCHSNGIVH 151
Query: 277 -----------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 316
KL+DFGLA + ++ GT GY++PE
Sbjct: 152 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW-HGFA-GTPGYLSPE 200
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 42/190 (22%), Positives = 68/190 (35%), Gaps = 36/190 (18%)
Query: 156 STNGFADE----NVIGEGGYGIVYRGVLEDNTN--VAVK-------NLLNNRGQAEKEFK 202
ST+GF + ++G G +V R + T AVK + E
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCI-HKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 203 V--EVEAIGRV-RHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEI 259
EV+ + +V H N+++L LV + + G L +L L+ +
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKE 125
Query: 260 RMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRV 306
I+ + + LH+ L+ N KL+DFG + L
Sbjct: 126 TRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-REVC 184
Query: 307 MGTFGYVAPE 316
GT Y+APE
Sbjct: 185 -GTPSYLAPE 193
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 57/227 (25%), Positives = 92/227 (40%), Gaps = 43/227 (18%)
Query: 147 WYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNV-AVKNLLNNRGQAEKEF---K 202
W L V+ N F V+G+GG+G V + + A K L R + K
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL 232
Query: 203 VEVEAIGRVRHKNLVRLVGYCAEGAHRM-LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRM 261
E + + +V + +V L Y E + LV ++ G+L+ ++ P E R
Sbjct: 233 NEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---EARA 288
Query: 262 -----NIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT 303
I G L LH L+ + ++SD GLA + E +
Sbjct: 289 VFYAAEICCG----LEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQTIK 343
Query: 304 TRVMGTFGYVAPEYASTGMLNETS-----DVYSFGILIMEVISGRNP 345
RV GT GY+APE ++ D ++ G L+ E+I+G++P
Sbjct: 344 GRV-GTVGYMAPE-----VVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 3e-09
Identities = 43/172 (25%), Positives = 69/172 (40%), Gaps = 27/172 (15%)
Query: 165 VIGEGGYGIVYRGVLEDNTN--VAVKNLLNNRGQAEKEFKV--EVEAIGRVRHKNLVRLV 220
+G+G + +V R V T A K + + A K+ E +++H N+VRL
Sbjct: 13 ELGKGAFSVVRRCV-HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--- 277
E + LV + V G L + + +S + IL + + Y H
Sbjct: 72 DSIQEESFHYLVFDLVTGGELFEDIV-AREFYSEADASHCIQQIL---ESIAYCHSNGIV 127
Query: 278 ---LEP-------KWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 316
L+P K KL+DFGLA + ++ GT GY++PE
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW-HGFA-GTPGYLSPE 177
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 46/214 (21%), Positives = 79/214 (36%), Gaps = 52/214 (24%)
Query: 163 ENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLV 220
+ +GEG + I + V + N AVK + E + E+ A+ H N+V+L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLH 72
Query: 221 GYCAEGAHRMLVNEYVDNGNL-----------EQWLHGDVGPHSPLTWEIRMNIILGTAK 269
+ H LV E ++ G L E E I+
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKKKKHFSET--------------EAS-YIMRKLVS 117
Query: 270 GLTYLHE----------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 313
++++H+ K+ DFG A+L + + T T Y
Sbjct: 118 AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYA 176
Query: 314 APEYASTGMLNETSDVYSFGIL--IMEVISGRNP 345
APE + +E+ D++S G++ M +SG+ P
Sbjct: 177 APELLNQNGYDESCDLWSLGVILYTM--LSGQVP 208
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 47/289 (16%), Positives = 79/289 (27%), Gaps = 79/289 (27%)
Query: 64 NSSSGNPTIPNISKEIQEIRIDLDSKSISNCKPHSAPNPEPLPEPEPILVEDSPVRGRNR 123
P + + + D +N + + P+ L S
Sbjct: 24 REIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDEL 83
Query: 124 IHIEIGKDHRIAYRRVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYRGV-LEDN 182
K+ Y +VIG G +V R V
Sbjct: 84 PDWAAAKEFYQKYD----PK--------------------DVIGRGVSSVVRRCVHRATG 119
Query: 183 TNVAVK--------NLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLVGYCAEGAHRMLVN 233
AVK + + + E + +V H +++ L+ + LV
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179
Query: 234 EYVDNGNL-----------EQWLHGDVGPHSPLTWEIR--MNIILGTAKGLTYLHEG--- 277
+ + G L E+ E R M +L + +++LH
Sbjct: 180 DLMRKGELFDYLTEKVALSEK--------------ETRSIMRSLL---EAVSFLHANNIV 222
Query: 278 ----------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 316
L+ +LSDFG + L GT GY+APE
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL-RELC-GTPGYLAPE 269
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 4e-09
Identities = 48/249 (19%), Positives = 78/249 (31%), Gaps = 74/249 (29%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVK-----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 218
IG+G YG+V + + A+K + + + K EV + ++ H N+ R
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 219 LVGYCAEGAHRMLVNEYVDNGNL--------------------EQWLHGDVGPHSPLTWE 258
L + + LV E G+L + + +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 259 IRMNIILGTAKGLT----------------YLHE---------------GLEPKWNPKLS 287
YLH + KL
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLV 212
Query: 288 DFGLAKLLG----AERSYVTTRVMGTFGYVAPEYASTGMLNETS-------DVYSFGILI 336
DFGL+K E +TT+ GT +VAPE +LN T+ D +S G+L+
Sbjct: 213 DFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPE-----VLNTTNESYGPKCDAWSAGVLL 266
Query: 337 MEVISGRNP 345
++ G P
Sbjct: 267 HLLLMGAVP 275
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 34/191 (17%), Positives = 76/191 (39%), Gaps = 24/191 (12%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKV--EVEAIGRVRH-KNLVRLV 220
+G G + +V + + A K L R + ++ E+ + + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE---- 276
+ +L+ EY G + ++ ++ + +I +G+ YLH+
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEM--VSENDVIRLIKQILEGVYYLHQNNIV 153
Query: 277 ------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 324
+ P + K+ DFG+++ +G +MGT Y+APE + +
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPEYLAPEILNYDPIT 211
Query: 325 ETSDVYSFGIL 335
+D+++ GI+
Sbjct: 212 TATDMWNIGII 222
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 6e-09
Identities = 40/189 (21%), Positives = 68/189 (35%), Gaps = 50/189 (26%)
Query: 163 ENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLV 220
E+V+GEG + V + L + AVK + G EVE + + + H+N++ L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 221 GYCAEGAHRMLVNEYVDNGNL-----------EQWLHGDVGPHSPLTWEIRMNIILGTAK 269
+ E LV E + G++ E E ++ A
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL--------------EAS-VVVQDVAS 122
Query: 270 GLTYLH----------------EGLEPKWNPKLSDFGLAKLL--GAERSYVTTRVM---- 307
L +LH E K+ DF L + + S ++T +
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 308 GTFGYVAPE 316
G+ Y+APE
Sbjct: 183 GSAEYMAPE 191
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 53/214 (24%), Positives = 85/214 (39%), Gaps = 57/214 (26%)
Query: 164 NVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE------AIGR------- 210
+ +GEG Y VY+G K+ L + A KE ++E E AI R
Sbjct: 8 DKLGEGTYATVYKG----------KSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKD 56
Query: 211 VRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 270
++H N+V L LV EY+D +L+Q+L + + + +G
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLD---DCGNIINMHNVKLFLFQLLRG 112
Query: 271 LTYLHE-------------GLEPKWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE 316
L Y H + + KL+DFGLA+ ++Y V+ T Y P+
Sbjct: 113 LAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-DNEVV-TLWYRPPD 170
Query: 317 -------YASTGMLNETSDVYSFGILIMEVISGR 343
Y ST + D++ G + E+ +GR
Sbjct: 171 ILLGSTDY-STQI-----DMWGVGCIFYEMATGR 198
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 35/187 (18%), Positives = 67/187 (35%), Gaps = 46/187 (24%)
Query: 166 IGEGGYGIVYRGVLEDNTN---VAVKNLLNNRGQAEKEFKVEVEAIGRV------RHKNL 216
+G G YG VY+ +D + A+K + + + + A + +H N+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI--------EGTGISMSACREIALLRELKHPNV 80
Query: 217 VRLVGYCAEGAHR--MLVNEYVDNGNLEQWLH-----GDVGPHSPLTWEIRMNIILGTAK 269
+ L A R L+ +Y ++ +L + L + +++
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 270 GLTYLHE-----------------GLEPKWNPKLSDFGLAKLLGAE-RSY--VTTRVMGT 309
G+ YLH + K++D G A+L + + + V+ T
Sbjct: 140 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-T 198
Query: 310 FGYVAPE 316
F Y APE
Sbjct: 199 FWYRAPE 205
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 25/93 (26%), Positives = 37/93 (39%), Gaps = 9/93 (9%)
Query: 163 ENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNNRGQAE-KEFKVEVE-AIGRVRHK 214
+G G +G V VAVK L +E + E++ I H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 215 NLVRLVGYC-AEGAHRMLVNEYVDNGNLEQWLH 246
N+V L+G C G M++ E+ GNL +L
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR 119
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 22/63 (34%), Positives = 34/63 (53%), Gaps = 2/63 (3%)
Query: 285 KLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-G 342
K+ DFGLA+ + + YV ++APE + SDV+SFG+L+ E+ S G
Sbjct: 233 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 292
Query: 343 RNP 345
+P
Sbjct: 293 ASP 295
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 45/220 (20%), Positives = 89/220 (40%), Gaps = 56/220 (25%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVK----NLLNNRGQAEKEFKV--EVEAIGRVRHK--N 215
++G GG+G VY G+ + DN VA+K + +++ G+ +V EV + +V
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 216 LVRLVGYCAEGAHRMLVNEYVDN-GNLEQWL--HGDVGPHSPLTWEIRMN---------- 262
++RL+ + +L+ E + +L ++ G +
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG------------ALQEELARSFFWQ 157
Query: 263 IILGTAKGLTYLH-----------EGL---EPKWNPKLSDFGLAKLLGAERSYVTTRVMG 308
++ + + + H E + + KL DFG LL + + T G
Sbjct: 158 VL----EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFD-G 210
Query: 309 TFGYVAPEYASTGMLN-ETSDVYSFGILIMEVISGRNPVD 347
T Y PE+ + ++ V+S GIL+ +++ G P +
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 2e-08
Identities = 53/218 (24%), Positives = 83/218 (38%), Gaps = 59/218 (27%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKV--EVEAIGRVRHKNLVRLVGY 222
+GEG YG V V VAVK +++ + + + E+ + H+N+V+ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 223 CAEGAHRMLVNEYVDNGNLEQWL--HGDVGPHSPLTWEIRMN----------IILGTAKG 270
EG + L EY G L + M ++ G
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQRFFHQLMAGVV-- 119
Query: 271 LTYLHEG-------------LEPKWNPKLSDFGLAKL--LGAERSYVTTRVMGTFGYVAP 315
YLH L+ + N K+SDFGLA + + GT YVAP
Sbjct: 120 --YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAP 176
Query: 316 E------YASTGMLNETSDVYSFGILIMEVISGRNPVD 347
E + + E DV+S GI++ +++G P D
Sbjct: 177 ELLKRREFHA-----EPVDVWSCGIVLTAMLAGELPWD 209
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 48/242 (19%), Positives = 79/242 (32%), Gaps = 49/242 (20%)
Query: 137 RRVSHLGWGHWYTLRELEVSTNGFAD-----ENVIGEGGYGIVYRGV-LEDNTNVAVKNL 190
H G + E D + V+G G G V A+K L
Sbjct: 3 HHHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK-L 61
Query: 191 LNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM----LVNEYVDNGNL----- 241
L + +A +E +A G ++V ++ H ++ E ++ G L
Sbjct: 62 LYDSPKARQEVDHHWQASG---GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ 118
Query: 242 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE----------------GLEPKWNPK 285
E+ T I+ + +LH E K
Sbjct: 119 ER-------GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLK 171
Query: 286 LSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGIL--IMEVISGR 343
L+DFG AK + T T YVAPE +++ D++S G++ I+ + G
Sbjct: 172 LTDFGFAKETTQNA--LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL--LCGF 226
Query: 344 NP 345
P
Sbjct: 227 PP 228
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 46/222 (20%), Positives = 75/222 (33%), Gaps = 52/222 (23%)
Query: 160 FADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKE--FKVEVEA---------I 208
+ + I G YG V GV + VA+K + N +
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 209 GRVRHKNLVRLVG-YCAEGAHRM----LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNI 263
H N++ L + M LV E + +L Q +H ++ +
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH---DQRIVISPQHIQYF 139
Query: 264 ILGTAKGLTYLHEG------LEPKWN--------PKLSDFGLAKLLGAERS---YVTTRV 306
+ GL LHE L P N + DF LA+ A+ + YVT R
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPG-NILLADNNDITICDFNLAREDTADANKTHYVTHRW 198
Query: 307 MGTFGYVAPEYASTGMLNETS-----DVYSFGILIMEVISGR 343
Y APE ++ D++S G ++ E+ + +
Sbjct: 199 -----YRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 55/238 (23%), Positives = 86/238 (36%), Gaps = 66/238 (27%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEK-EFKV--EVEAIGRVRHKNLVRLVG 221
+GEG YG V V VAVK + + +A + E+ + H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 222 YCAEGAHRMLVNEYVDNGNLEQWL--HGDVGPHSPLTWEIRMN----------IILGTAK 269
+ EG + L EY G L + M ++
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQRFFHQLMA---- 116
Query: 270 GLTYLHEG-------------LEPKWNPKLSDFGLAKL--LGAERSYVTTRVMGTFGYVA 314
G+ YLH L+ + N K+SDFGLA + + GT YVA
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVA 175
Query: 315 PE------YASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLK 366
PE + + E DV+S GI++ +++G P D +W +
Sbjct: 176 PELLKRREFHA-----EPVDVWSCGIVLTAMLAGELPWD-----QPSDSCQEYSDWKE 223
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 6e-08
Identities = 42/212 (19%), Positives = 76/212 (35%), Gaps = 48/212 (22%)
Query: 165 VIGEGGYGIVYRGVLEDNTNV-AVKNLLNNRGQAEKEF---KVEVEAIGRVRHKNLVRLV 220
++GEG + V + A+K L E + E + + R+ H V+L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMN-------------IILGT 267
+ Y NG L +++ ++ I+
Sbjct: 97 FTFQDDEKLYFGLSYAKNGELLKYIR-------------KIGSFDETCTRFYTAEIVSA- 142
Query: 268 AKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVM-GTFGYV 313
L YLH L + +++DFG AK+L E GT YV
Sbjct: 143 ---LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 314 APEYASTGMLNETSDVYSFGILIMEVISGRNP 345
+PE + ++SD+++ G +I ++++G P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 52/227 (22%), Positives = 78/227 (34%), Gaps = 68/227 (29%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVK----NLLNNRGQAEKEFKV--EVEAIGRVR----H 213
++G+GG+G V+ G L D VA+K N + EV + +V H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 214 KNLVRLVGYCAEGAHRMLVNEY-----------VDNGNLE---------------QWLHG 247
++RL+ + MLV E + G L Q H
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS 157
Query: 248 ------DVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKWNPKLSDFGLAKLLGAERSY 301
D+ E NI++ +G KL DFG LL
Sbjct: 158 RGVVHRDIKD------E---NILIDLRRG------------CAKLIDFGSGALL--HDEP 194
Query: 302 VTTRVMGTFGYVAPEYASTGM-LNETSDVYSFGILIMEVISGRNPVD 347
T GT Y PE+ S + V+S GIL+ +++ G P +
Sbjct: 195 YTDFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 9e-08
Identities = 58/280 (20%), Positives = 97/280 (34%), Gaps = 58/280 (20%)
Query: 91 ISNCKPHSAPNPEPLPEPEPILVEDSPVRGRNRIHIEIGKDHRIAYRRVSHLGWGHWYTL 150
+SN + S P P P P P P + + + + +
Sbjct: 2 LSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSG---------- 51
Query: 151 RELEVSTNGFADE-----NVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVE 204
L++ N D+ V+G G G V + A+K +L + +A +E ++
Sbjct: 52 --LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELH 108
Query: 205 VEAIGRVRHKNLVRLVGYC----AEGAHRMLVNEYVDNGNL-----EQWLHGDVGPHSPL 255
A ++VR+V A ++V E +D G L ++
Sbjct: 109 WRASQ---CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-------GDQAF 158
Query: 256 TWEIRMNIILGTAKGLTYLHE----------------GLEPKWNPKLSDFGLAKLLGAER 299
T I+ + + YLH P KL+DFG AK +
Sbjct: 159 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218
Query: 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFG-IL-IM 337
S T T YVAPE +++ D++S G I+ I+
Sbjct: 219 SLTT--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 256
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 55/261 (21%), Positives = 101/261 (38%), Gaps = 63/261 (24%)
Query: 116 SPVRGRNRIHIEIGKDHRIAYRRVSHLG--WGHWYTLRELEVSTNGFADENVIGEGGYGI 173
PV R R++ ++ Y WG + + + +G G Y
Sbjct: 2 GPVPSRARVYTDVNTHRPREYWDYESHVVEWG----------NQDDYQLVRKLGRGKYSE 51
Query: 174 VYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRL--VGYCAEGAHR 229
V+ + + +N V VK L + +K+ K E++ + +R N++ L +
Sbjct: 52 VFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108
Query: 230 MLVNEYVDNGNLEQWLHGDVGPHSPLT-WEIR--MNIILGTAKGLTYLHEG------LEP 280
LV E+V+N + +Q LT ++IR M IL K L Y H ++P
Sbjct: 109 ALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEIL---KALDYCHSMGIMHRDVKP 158
Query: 281 K---WNP-----KLSDFGLAKLLGAERSY---VTTRVMGTFGYVAPEYASTGMLNETS-- 327
+ +L D+GLA+ + Y V +R + PE +++
Sbjct: 159 HNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPEL----LVDYQMYD 209
Query: 328 ---DVYSFGILIMEVISGRNP 345
D++S G ++ +I + P
Sbjct: 210 YSLDMWSLGCMLASMIFRKEP 230
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 43/185 (23%), Positives = 72/185 (38%), Gaps = 41/185 (22%)
Query: 164 NVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNLV 217
IG+G +G V++ + VA+K + + EKE F + E++ + ++H+N+V
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPITALREIKILQLLKHENVV 79
Query: 218 RLVGYCAEGAHRM--------LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 269
L+ C A LV ++ ++ +L L T ++
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLS---NVLVKFTLSEIKRVMQMLLN 135
Query: 270 GLTYLHEG-------------LEPKWNPKLSDFGLAKLLG-----AERSYVTTRVMGTFG 311
GL Y+H + KL+DFGLA+ Y T RV+ T
Sbjct: 136 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY-TNRVV-TLW 193
Query: 312 YVAPE 316
Y PE
Sbjct: 194 YRPPE 198
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 39/210 (18%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKN 215
+ + IG G GIV + NVA+K L N+ A++ ++ E+ + V HKN
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKN 122
Query: 216 LVRLVG-YCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 274
++ L+ + + + Y+ ++ L + L E ++ G+ +L
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--QMELDHERMSYLLYQMLCGIKHL 180
Query: 275 HEG------LEPKWN--------PKLSDFGLAKLLGAERS---YVTTRVMGTFGYVAPEY 317
H L+P N K+ DFGLA+ G YV TR Y APE
Sbjct: 181 HSAGIIHRDLKPS-NIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEV 234
Query: 318 ASTGMLN----ETSDVYSFGILIMEVISGR 343
+L E D++S G ++ E++ +
Sbjct: 235 ----ILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 46/216 (21%), Positives = 74/216 (34%), Gaps = 57/216 (26%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKV--EVEAIGRVRHKNLVRLVGY 222
IG+G + V + VA+K + + K+ EV + + H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 223 CAEGAHRMLVNEYVDNGNLEQWL--HGDVGPHSPLTWEIRMN----------IILGTAKG 270
L+ EY G + +L HG RM I+
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHG------------RMKEKEARSKFRQIVS----A 126
Query: 271 LTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE- 316
+ Y H+ L+ N K++DFG + + G Y APE
Sbjct: 127 VQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAFC-GAPPYAAPEL 184
Query: 317 -----YASTGMLNETSDVYSFGILIMEVISGRNPVD 347
Y DV+S G+++ ++SG P D
Sbjct: 185 FQGKKYDGP-----EVDVWSLGVILYTLVSGSLPFD 215
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 51/236 (21%), Positives = 85/236 (36%), Gaps = 69/236 (29%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVK------------------------NLLNNRGQAEKE 200
IG+G YG+V DNT A+K
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 201 FKVEVE-AIGR-VRHKNLVRL--VGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLT 256
+V E AI + + H N+V+L V H +V E V+ G + +V PL+
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVM-----EVPTLKPLS 135
Query: 257 ----WEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299
++I G + YLH + + K++DFG++
Sbjct: 136 EDQARFYFQDLIKG----IEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 300 SYVTTRVMGTFGYVAPEYASTGMLNET--------SDVYSFGILIMEVISGRNPVD 347
+ ++ V GT ++APE L+ET DV++ G+ + + G+ P
Sbjct: 192 ALLSNTV-GTPAFMAPE-----SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 49/220 (22%)
Query: 154 EVSTNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIG 209
E+ + +G G YG V + VA+K L + A++ ++ E+ +
Sbjct: 21 ELPKT-YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLK 78
Query: 210 RVRHKNLVRL--VGYCAEGAHRM----LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNI 263
++H+N++ L V A LV ++ +L++ + + E +
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG------LKFSEEKIQYL 131
Query: 264 ILGTAKGLTYLHEG------LEPKWN--------PKLSDFGLAKLLGAERS-YVTTRVMG 308
+ KGL Y+H L+P N K+ DFGLA+ AE + YV TR
Sbjct: 132 VYQMLKGLKYIHSAGVVHRDLKPG-NLAVNEDCELKILDFGLARHADAEMTGYVVTRW-- 188
Query: 309 TFGYVAPEYASTGMLN-----ETSDVYSFGILIMEVISGR 343
Y APE +L+ +T D++S G ++ E+++G+
Sbjct: 189 ---YRAPEV----ILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 5e-07
Identities = 47/221 (21%), Positives = 90/221 (40%), Gaps = 48/221 (21%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLV 217
+ D +G GG G+V+ V + + VA+K + L + + + E++ I R+ H N+V
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIV 71
Query: 218 RLVG-YCAEGAHRMLVNEYVDNGN--------LEQWLHGDVGPHSPLTWEIRMNIILGTA 268
++ G+ + N +E L +V PL E +
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLA-NVLEQGPLLEEHARLFMYQLL 130
Query: 269 KGLTYLHEG------LEPK---WNP-----KLSDFGLAKLLGAERS-------YVTTRVM 307
+GL Y+H L+P N K+ DFGLA+++ S + T+
Sbjct: 131 RGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK-- 188
Query: 308 GTFGYVAPEYASTGMLNETS-----DVYSFGILIMEVISGR 343
Y +P +L+ + D+++ G + E+++G+
Sbjct: 189 ---WYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 44/181 (24%), Positives = 63/181 (34%), Gaps = 51/181 (28%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKV--EVEAIGRVRHKNLVRLVGY 222
IG G +G+ VAVK + RG A E V E+ +RH N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDE-NVQREIINHRSLRHPNIVRFKEV 84
Query: 223 CAEGAHRMLVNEYVDNGNLEQWL--HGDVGPHSPLTWEIRMN----------IILGTAKG 270
H ++ EY G L + + G R + ++ G
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAG------------RFSEDEARFFFQQLLS----G 128
Query: 271 LTYLH-----------EGL----EPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 315
++Y H E P K+ DFG +K S + V GT Y+AP
Sbjct: 129 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTV-GTPAYIAP 186
Query: 316 E 316
E
Sbjct: 187 E 187
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 55/211 (26%), Positives = 86/211 (40%), Gaps = 41/211 (19%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKN 215
+ + IG G GIV NVA+K L N+ A++ ++ E+ + V HKN
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKN 85
Query: 216 LVRLVG-YCAEGAHRM-----LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 269
++ L+ + + + +V E +D NL Q + L E ++
Sbjct: 86 IIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLC 138
Query: 270 GLTYLHEG------LEPKWN--------PKLSDFGLAKLLGAERS---YVTTRVMGTFGY 312
G+ +LH L+P N K+ DFGLA+ G YV TR Y
Sbjct: 139 GIKHLHSAGIIHRDLKPS-NIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----Y 192
Query: 313 VAPEYASTGMLNETSDVYSFGILIMEVISGR 343
APE E D++S G ++ E+I G
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 47/214 (21%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKN 215
+ D +G G YG V V VA+K L + A++ ++ E+ + +RH+N
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHEN 85
Query: 216 LVRL--VGYCAEGAHRM----LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 269
++ L V E LV ++ +L + + + L + ++ K
Sbjct: 86 VIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE-----KLGEDRIQFLVYQMLK 139
Query: 270 GLTYLHEG------LEPKWN--------PKLSDFGLAKLLGAERS-YVTTRVMGTFGYVA 314
GL Y+H L+P N K+ DFGLA+ +E + YV TR Y A
Sbjct: 140 GLRYIHAAGIIHRDLKPG-NLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----YRA 193
Query: 315 PEYASTGMLN-----ETSDVYSFGILIMEVISGR 343
PE +LN +T D++S G ++ E+I+G+
Sbjct: 194 PEV----ILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 48/218 (22%), Positives = 81/218 (37%), Gaps = 60/218 (27%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLV 220
+G G +G V G VAVK + + K K E++ + RH ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK-IKREIQNLKLFRHPHIIKLY 77
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWL--HGDVGPHSPLTWEIRMN----------IILGTA 268
+ +V EYV G L ++ HG R+ I+
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHG------------RVEEMEARRLFQQIL---- 121
Query: 269 KGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 315
+ Y H L+ N K++DFGL+ ++ T+ G+ Y AP
Sbjct: 122 SAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAP 179
Query: 316 E------YASTGMLNETSDVYSFGILIMEVISGRNPVD 347
E YA D++S G+++ ++ G P D
Sbjct: 180 EVISGRLYAGP-----EVDIWSCGVILYALLCGTLPFD 212
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 44/214 (20%), Positives = 70/214 (32%), Gaps = 46/214 (21%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVK--------NLLNNRGQAEKEFKVEVEAIGRVRHKNL 216
+G G +G V+ V E N V VK + +E+ + RV H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDV----GPHSPLTWEIRMNIILGTAKGLT 272
++++ LV E +G D+ H L + I +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG-------LDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 273 YLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 319
YL + + KL DFG A L T GT Y APE
Sbjct: 145 YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL-ERGKLFYTFC-GTIEYCAPE--- 199
Query: 320 TGMLNETS------DVYSFGILIMEVISGRNPVD 347
+L +++S G+ + ++ NP
Sbjct: 200 --VLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 8e-06
Identities = 48/211 (22%), Positives = 84/211 (39%), Gaps = 46/211 (21%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLV 220
+G G +G V G VAVK + + K + E++ + RH ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK-IRREIQNLKLFRHPHIIKLY 82
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWL--HGDVGPHSPLTWEIRM---NIILGTAKGLTYLH 275
+ + +V EYV G L ++ +G + E R I+ G+ Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK-----ESRRLFQQIL----SGVDYCH 133
Query: 276 EG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE------ 316
L+ N K++DFGL+ ++ T+ G+ Y APE
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVISGRL 191
Query: 317 YASTGMLNETSDVYSFGILIMEVISGRNPVD 347
YA D++S G+++ ++ G P D
Sbjct: 192 YAGP-----EVDIWSSGVILYALLCGTLPFD 217
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 47/214 (21%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKN 215
+ + + +G G YG V + VAVK L + A++ ++ E+ + ++H+N
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHEN 89
Query: 216 LVRL--VGYCAEGAHRM----LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 269
++ L V A LV + +L + LT + +I +
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVK-----CQKLTDDHVQFLIYQILR 143
Query: 270 GLTYLHEG------LEPKWNP--------KLSDFGLAKLLGAERS-YVTTRVMGTFGYVA 314
GL Y+H L+P N K+ DFGLA+ E + YV TR Y A
Sbjct: 144 GLKYIHSADIIHRDLKPS-NLAVNEDCELKILDFGLARHTADEMTGYVATRW-----YRA 197
Query: 315 PEYASTGMLN-----ETSDVYSFGILIMEVISGR 343
PE MLN +T D++S G ++ E+++GR
Sbjct: 198 PEI----MLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 52/224 (23%)
Query: 154 EVSTNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLN--NRGQAEKEFKVEVEAIGR 210
+V + + + IGEG YG+V + VA+K + ++ ++ + E++ + R
Sbjct: 24 DVGPR-YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLR 81
Query: 211 VRHKNLVRLVG-YCAEGAHRM----LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIIL 265
RH+N++ + A +M +V + ++ +L + L L+ + +
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT-----QHLSNDHICYFLY 135
Query: 266 GTAKGLTYLHEG------LEPKWNP--------KLSDFGLAKLLGAERS-------YVTT 304
+GL Y+H L+P N K+ DFGLA++ + YV T
Sbjct: 136 QILRGLKYIHSANVLHRDLKPS-NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 305 RVMGTFGYVAPEYASTGMLN-----ETSDVYSFGILIMEVISGR 343
R Y APE MLN ++ D++S G ++ E++S R
Sbjct: 195 R-----WYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 45/225 (20%), Positives = 84/225 (37%), Gaps = 58/225 (25%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNL 216
F ++++GEG YG+V VA+K + A + + E++ + +H+N+
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENI 71
Query: 217 VRLVG-YCAEGAHRM----LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 271
+ + + ++ E + +L + + L+ + I T + +
Sbjct: 72 ITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQ-----MLSDDHIQYFIYQTLRAV 125
Query: 272 TYLHEG------LEPKWN--------PKLSDFGLAKLLGAERS--------------YVT 303
LH L+P N K+ DFGLA+++ + +V
Sbjct: 126 KVLHGSNVIHRDLKPS-NLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 304 TRVMGTFGYVAPEYASTGMLNETS-----DVYSFGILIMEVISGR 343
TR Y APE ML DV+S G ++ E+ R
Sbjct: 185 TR-----WYRAPEV----MLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 17/66 (25%), Positives = 31/66 (46%), Gaps = 5/66 (7%)
Query: 285 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-----YASTGMLNETSDVYSFGILIMEV 339
+L+DFG L + + ++ +GT Y++PE G D +S G+ + E+
Sbjct: 215 RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEM 274
Query: 340 ISGRNP 345
+ G P
Sbjct: 275 LYGETP 280
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 49/211 (23%), Positives = 81/211 (38%), Gaps = 47/211 (22%)
Query: 166 IGEGGYGIVYRGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLV 220
+GEG +G V + VA+K LL + + E+ + +RH ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHIIKLY 75
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWL--HGDVGPHSPLTWEIRM---NIILGTAKGLTYLH 275
++V EY G L ++ + E R II + Y H
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVEKKRMTED-----EGRRFFQQII----CAIEYCH 125
Query: 276 EG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE------ 316
L+ N K++DFGL+ ++ T+ G+ Y APE
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVINGKL 183
Query: 317 YASTGMLNETSDVYSFGILIMEVISGRNPVD 347
YA DV+S GI++ ++ GR P D
Sbjct: 184 YAGP-----EVDVWSCGIVLYVMLVGRLPFD 209
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 18/65 (27%), Positives = 28/65 (43%), Gaps = 4/65 (6%)
Query: 285 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE----YASTGMLNETSDVYSFGILIMEVI 340
KL+DFG + E +GT Y++PE G D +S G+ + E++
Sbjct: 208 KLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267
Query: 341 SGRNP 345
G P
Sbjct: 268 VGDTP 272
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 49/229 (21%), Positives = 88/229 (38%), Gaps = 45/229 (19%)
Query: 150 LRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNV-AVKNL----LNNRGQAEKEFKVE 204
L+E+ + + F VIG G + V ++ V A+K + + RG+ F+ E
Sbjct: 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC-FREE 111
Query: 205 VEAIGRVRHKNLVRLVGYCAEGAHRM-LVNEYVDNGNLEQWLHGDVGPHSPLTW------ 257
+ + + + +L + + + + LV EY G+L L G P
Sbjct: 112 RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAEMARFYLA 169
Query: 258 EIRMNIILGTAKGLTYLHEG------LEPKWNP--------KLSDFGLAKLLGAERSYVT 303
EI M + +H ++P N +L+DFG L A+ + +
Sbjct: 170 EIVM--------AIDSVHRLGYVHRDIKPD-NILLDRCGHIRLADFGSCLKLRADGTVRS 220
Query: 304 TRVMGTFGYVAPE-------YASTGMLNETSDVYSFGILIMEVISGRNP 345
+GT Y++PE TG D ++ G+ E+ G+ P
Sbjct: 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 20/64 (31%), Positives = 33/64 (51%), Gaps = 5/64 (7%)
Query: 285 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-YASTGML--NETSDVYSFGILIMEVIS 341
++DF +A +L E T + GT Y+APE ++S + D +S G+ E++
Sbjct: 155 HITDFNIAAMLPRETQ--ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR 212
Query: 342 GRNP 345
GR P
Sbjct: 213 GRRP 216
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 19/61 (31%), Positives = 32/61 (52%), Gaps = 4/61 (6%)
Query: 285 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRN 344
+++DFG AK + T + GT +APE + N+ D ++ G+LI E+ +G
Sbjct: 181 QVTDFGFAKRVKG----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 345 P 345
P
Sbjct: 237 P 237
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 43/253 (16%), Positives = 83/253 (32%), Gaps = 75/253 (29%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKN 215
+ ++IG G YG V + VA+K +L + ++ + E+ + R+ H +
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDH 113
Query: 216 LVRLVG-YCAEGAHRM----LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 270
+V+++ + + +V E + LT ++ G
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 271 LTYLHEG------LEPKWN--------PKLSDFGLAKLLGAERS---------------- 300
+ Y+H L+P N K+ DFGLA+ + +
Sbjct: 169 VKYVHSAGILHRDLKPA-NCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 301 ---------------YVTTRVMGTFGYVAPEYASTGMLNETS-----DVYSFGILIMEVI 340
+V TR Y APE +L + + DV+S G + E++
Sbjct: 228 VTFPHTKNLKRQLTGHVVTR-----WYRAPEL----ILLQENYTEAIDVWSIGCIFAELL 278
Query: 341 SGRNPVDYSRPPG 353
+
Sbjct: 279 NMIKENVAYHADR 291
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 48/240 (20%), Positives = 91/240 (37%), Gaps = 70/240 (29%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKN 215
+ +++IG G YG VY NVA+K + + ++ + E+ + R++
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDY 86
Query: 216 LVRLVG-YCAEGAHRM----LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 270
++RL + + +V E D+ +L++ + LT E I+ G
Sbjct: 87 IIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPI----FLTEEHIKTILYNLLLG 141
Query: 271 LTYLHEG------LEPKWN--------PKLSDFGLAKLLGAERS---------------- 300
++HE L+P N K+ DFGLA+ + +E+
Sbjct: 142 ENFIHESGIIHRDLKPA-NCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 301 ----------YVTTRVMGTFGYVAPEYASTGMLNETS-----DVYSFGILIMEVISGRNP 345
+V TR Y APE +L + + D++S G + E+++
Sbjct: 201 NKNLKKQLTSHVVTR-----WYRAPEL----ILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 20/64 (31%), Positives = 36/64 (56%), Gaps = 4/64 (6%)
Query: 285 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE---YASTGMLNETSDVYSFGILIMEVIS 341
L+DFGL+K A+ + GT Y+AP+ +G ++ D +S G+L+ E+++
Sbjct: 199 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH-DKAVDWWSLGVLMYELLT 257
Query: 342 GRNP 345
G +P
Sbjct: 258 GASP 261
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 442 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.74 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.44 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.0 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.32 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.82 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.68 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 97.52 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.07 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 96.71 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.42 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 96.41 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 96.32 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.11 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 95.45 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 95.39 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 95.23 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 95.17 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 95.02 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 94.93 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 94.86 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 94.79 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 93.41 | |
| 2knc_A | 54 | Integrin alpha-IIB; transmembrane signaling, prote | 92.05 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 91.87 | |
| 2k1a_A | 42 | Integrin alpha-IIB; single-PASS transmembrane segm | 91.47 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 88.32 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 87.2 | |
| 2l34_A | 33 | TYRO protein tyrosine kinase-binding protein; immu | 86.63 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 86.15 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 84.79 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 83.48 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 82.23 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 82.01 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 81.45 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=406.12 Aligned_cols=248 Identities=24% Similarity=0.431 Sum_probs=199.7
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAH 228 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 228 (442)
+..++|.+.+.||+|+||+||+|++. ++..||||++........+.|.+|+++|++|+|||||+++|+|.+++.
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 34567888999999999999999863 367899999987666677889999999999999999999999999999
Q ss_pred eeeEEecCCCCCHHHHHccCC---------CCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEE
Q 047892 229 RMLVNEYVDNGNLEQWLHGDV---------GPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKL 286 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl 286 (442)
+|||||||++|+|.++|+... .....+++..++.++.|++.||.|||+. ++.++.+||
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEE
Confidence 999999999999999997532 2335799999999999999999999875 344678999
Q ss_pred ecccCccccCCCccee-ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHH
Q 047892 287 SDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEW 364 (442)
Q Consensus 287 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 364 (442)
+|||+|+......... .....||+.|||||++.+..|+.++|||||||+||||+| |+.||...+. ..+..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-------~~~~~- 241 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-------NEVIE- 241 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHH-
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHH-
Confidence 9999998765444332 234579999999999999999999999999999999999 9999975432 11111
Q ss_pred HHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 365 LKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
. +..+.. ...+..++.++.+|+.+||+.||++||||.||++.|+++
T Consensus 242 --~-i~~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 242 --C-ITQGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp --H-HHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --H-HHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 111111 112234556788999999999999999999999999865
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-53 Score=405.86 Aligned_cols=247 Identities=25% Similarity=0.414 Sum_probs=192.4
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 229 (442)
..++|.+.+.||+|+||+||+|++. +++.||||++........+.|.+|+++|++|+|||||+++|+|.+.+.+
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3456778899999999999999864 4678999999876666778899999999999999999999999999999
Q ss_pred eeEEecCCCCCHHHHHccCCC-----------CCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCCCeE
Q 047892 230 MLVNEYVDNGNLEQWLHGDVG-----------PHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKWNPK 285 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~~~k 285 (442)
|||||||++|+|.++++.... ...++++..++.++.|++.||.|||+. + +.++.+|
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEE
Confidence 999999999999999976421 124699999999999999999999765 3 4567899
Q ss_pred EecccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHH
Q 047892 286 LSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFE 363 (442)
Q Consensus 286 l~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 363 (442)
|+|||+|+.+...... ..+..+||+.|||||++.+..|+.++|||||||+||||+| |+.||..... ..+..
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-------~~~~~ 271 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-------TEAID 271 (329)
T ss_dssp ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-------HHHHH
T ss_pred EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-------HHHHH
Confidence 9999999976443322 3345689999999999999999999999999999999999 9999975432 11111
Q ss_pred HHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 364 WLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.. ..+. +...+..++.++.+|+.+||+.||++||||.||++.|+.+
T Consensus 272 ---~i-~~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 272 ---CI-TQGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp ---HH-HHTC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred ---HH-HcCC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 11 1111 1122234556788999999999999999999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-53 Score=404.00 Aligned_cols=246 Identities=24% Similarity=0.356 Sum_probs=197.1
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 229 (442)
.+++++.+.||+|+||+||+|.+. +++.||||++... .....+.|.+|+.+|++++|||||+++|+|.+.+.+
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 445677899999999999999862 4678999999654 334457899999999999999999999999999999
Q ss_pred eeEEecCCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCe
Q 047892 230 MLVNEYVDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNP 284 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~ 284 (442)
|||||||++|+|.++|+.... ....+++..++.++.||+.||+|||+. ++.++.+
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCE
Confidence 999999999999999965321 124689999999999999999999875 4456789
Q ss_pred EEecccCccccCCCcc-eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHH
Q 047892 285 KLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLF 362 (442)
Q Consensus 285 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~ 362 (442)
||+|||+|+.+..... ...+..+||+.|||||++.++.|+.++|||||||+||||+| |..||.+.+. ..+.
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-------~~~~ 257 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------QDVV 257 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-------HHHH
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-------HHHH
Confidence 9999999987644332 23345689999999999999999999999999999999999 8999975432 1111
Q ss_pred HHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 363 EWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
..+..+.. ...+..++..+.+|+.+||+.||++||||.||++.|++.
T Consensus 258 ----~~i~~~~~---------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 258 ----EMIRNRQV---------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ----HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ----HHHHcCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 12222211 122334566788999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-52 Score=393.94 Aligned_cols=254 Identities=26% Similarity=0.411 Sum_probs=194.0
Q ss_pred HHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 153 LEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 153 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
+++..+++.+.+.||+|+||+||+|++. ..||||.++.. .....+.|.+|+++|++++|||||++++++.+ +.+|
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 3566788999999999999999999874 36999998643 34456789999999999999999999998865 5689
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~~~~ 297 (442)
||||||++|+|.++|+.. ...+++..++.++.||+.||+|||+. ++ .++.+||+|||+|+....
T Consensus 108 iVmEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEEECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 999999999999999754 24699999999999999999999865 44 456899999999987643
Q ss_pred Cc-ceeecccccccCCCCcccccC---CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC
Q 047892 298 ER-SYVTTRVMGTFGYVAPEYAST---GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373 (442)
Q Consensus 298 ~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (442)
.. .......+||+.|||||++.+ ++|+.++|||||||+||||+||+.||...+.. ..+......+.
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~----------~~~~~~~~~~~ 254 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR----------DQIIFMVGRGY 254 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----------HHHHHHHHTTC
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH----------HHHHHHHhcCC
Confidence 32 223455789999999999853 46999999999999999999999999754321 11111222211
Q ss_pred cccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCCCh
Q 047892 374 AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFR 427 (442)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 427 (442)
..+.+. ..+..++..+.+|+.+||+.||++||||.||++.|+.+..+++
T Consensus 255 ----~~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 255 ----ASPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp ----CCCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred ----CCCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 111111 1223455678899999999999999999999999887654443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=389.59 Aligned_cols=241 Identities=24% Similarity=0.309 Sum_probs=196.3
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
+.|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||+++++|.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45889999999999999999964 59999999996544444566889999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceee
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT 303 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~ 303 (442)
+||+|.+++.+. .+++..+..++.||+.||+|||+. ++.++.+||+|||+|+.+..... ..
T Consensus 154 ~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~ 227 (346)
T 4fih_A 154 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR 227 (346)
T ss_dssp TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CB
T ss_pred CCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cc
Confidence 999999999753 589999999999999999999875 45578999999999998754332 34
Q ss_pred cccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccC
Q 047892 304 TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ 383 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (442)
.+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+.. .... ...... .+.+
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------~~~~---~i~~~~------~~~~- 290 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMK---MIRDNL------PPRL- 290 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHH---HHHHSS------CCCC-
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHH---HHHcCC------CCCC-
Confidence 5679999999999999999999999999999999999999999754321 1111 111110 1111
Q ss_pred CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH--HHhcC
Q 047892 384 EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEAE 422 (442)
Q Consensus 384 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~--~L~~~ 422 (442)
......+.++.+|+.+||+.||++|||+.|+++ ++.+.
T Consensus 291 -~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 291 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp -SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 122344567889999999999999999999986 35543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=390.70 Aligned_cols=237 Identities=18% Similarity=0.307 Sum_probs=187.7
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
++|++++.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++|+|||||++++++.+.+.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5799999999999999999996 45899999999643 33455779999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
||+||+|.++|.... ...+++..++.++.||+.||+|||+. ++.++.+||+|||+|+.+.... .
T Consensus 104 y~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 180 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-E 180 (350)
T ss_dssp CCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-H
T ss_pred CCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-c
Confidence 999999999997542 24578999999999999999999875 4557899999999999764321 2
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (442)
..+..+||+.|||||++.+..|+.++|||||||+||||+||+.||...+. .+.+..... +...
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~----------~~~~~~i~~-~~~~------ 243 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM----------KNLVLKIIS-GSFP------ 243 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----------HHHHHHHHH-TCCC------
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----------HHHHHHHHc-CCCC------
Confidence 23456899999999999999999999999999999999999999975432 111112211 1111
Q ss_pred cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 382 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
..+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 244 ---~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 ---PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112234566888999999999999999999985
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=397.26 Aligned_cols=256 Identities=23% Similarity=0.352 Sum_probs=203.9
Q ss_pred eehhhHHHhhCCCCccCeeccCCcEEEEEEEECC------CCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCC-CCcceE
Q 047892 148 YTLRELEVSTNGFADENVIGEGGYGIVYRGVLED------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRH-KNLVRL 219 (442)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-pnIv~l 219 (442)
|...++++..++|++.+.||+|+||+||+|.+.. ++.||||.+.... ....+.|.+|+++|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4556788899999999999999999999998532 3579999996543 3445679999999999966 999999
Q ss_pred EEEEEeC-CeeeeEEecCCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHhhhhhhcC---------
Q 047892 220 VGYCAEG-AHRMLVNEYVDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEG--------- 277 (442)
Q Consensus 220 ~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~yLH~~--------- 277 (442)
+|+|... +.+|||||||++|+|.++|+.... ....+++..++.++.||+.||+|||+.
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~ 213 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 213 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCc
Confidence 9999764 568999999999999999975321 124589999999999999999999765
Q ss_pred ----CCCCCCeEEecccCccccCCCcc-eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCC
Q 047892 278 ----LEPKWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRP 351 (442)
Q Consensus 278 ----l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~ 351 (442)
++.++.+||+|||+|+.+..... ......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+...
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 34467899999999997754433 34456789999999999999999999999999999999998 9999976443
Q ss_pred CCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 352 PGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
... +. .....+. +...+..++.++.+|+.+||+.||++||||.||++.|+.+
T Consensus 294 ~~~------~~----~~i~~g~---------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 294 DEE------FC----RRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp SHH------HH----HHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH------HH----HHHHcCC---------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 211 11 1111111 1122233456788999999999999999999999998865
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-51 Score=386.65 Aligned_cols=234 Identities=20% Similarity=0.283 Sum_probs=192.5
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|++.+.||+|+||+||+|+. .+++.||||++... .....+.+.+|+++|++|+|||||++++++.+.+.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4689999999999999999996 45899999999543 2234567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc-
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER- 299 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~- 299 (442)
|||+||+|.++|++. ..+++..+..++.||+.||+|||++ ++.++.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 999999999999764 5799999999999999999999875 4457899999999999875432
Q ss_pred ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
.....+.+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+.. .+. .... ....
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------~~~---~~i~-~~~~----- 251 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG-------LIF---AKII-KLEY----- 251 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHH---HHHH-HTCC-----
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHH---HHHH-cCCC-----
Confidence 23345679999999999999999999999999999999999999999754321 111 1111 1111
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVI 416 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl 416 (442)
..+...+.++.+|+.+||+.||++|||+.|++
T Consensus 252 -----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -----CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11123345688899999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=375.80 Aligned_cols=231 Identities=25% Similarity=0.393 Sum_probs=182.1
Q ss_pred CccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeeeeEE
Q 047892 161 ADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE----GAHRMLVN 233 (442)
Q Consensus 161 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~lv~ 233 (442)
++.+.||+|+||+||+|.+. ++..||+|++... .....+.|.+|+++|++|+|||||+++++|.+ .+.+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999964 5889999999543 33455679999999999999999999999865 35689999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC---------------CC-CCCCeEEecccCccccCC
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---------------LE-PKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---------------l~-~~~~~kl~DFGla~~~~~ 297 (442)
|||++|+|.+++++. ..+++..+..++.||+.||+|||++ ++ .++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999999999864 5789999999999999999999864 22 357899999999986533
Q ss_pred CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
. ...+.+||+.|||||++.+ .|+.++|||||||+||||+||+.||...... .. +......+..
T Consensus 185 ~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~---------~~-~~~~i~~~~~--- 247 (290)
T 3fpq_A 185 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA---------AQ-IYRRVTSGVK--- 247 (290)
T ss_dssp T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---------HH-HHHHHTTTCC---
T ss_pred C---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH---------HH-HHHHHHcCCC---
Confidence 2 2345789999999998864 6999999999999999999999999653221 11 1111211111
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
... .+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 248 -~~~----~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 248 -PAS----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -CGG----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CCC----CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 11222345788999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=386.44 Aligned_cols=237 Identities=17% Similarity=0.169 Sum_probs=188.3
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
+.|.+.++||+|+||+||+|++. +|+.||||++..... ..+|+.+|+.|+|||||++++++.+++.+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45777889999999999999964 589999999964322 246999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCC-CeEEecccCccccCCCcce-
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKW-NPKLSDFGLAKLLGAERSY- 301 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~-~~kl~DFGla~~~~~~~~~- 301 (442)
+||+|.++|++. ..+++..+..++.||+.||+|||+. + +.++ .+||+|||+|+.+......
T Consensus 133 ~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 133 EGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp TTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 999999999864 5799999999999999999999875 3 3455 6999999999987543211
Q ss_pred ---eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 302 ---VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 302 ---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
.....+||+.|||||++.+..|+.++|||||||+||||+||+.||.......... .......
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----------~i~~~~~----- 273 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL----------KIASEPP----- 273 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH----------HHHHSCC-----
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH----------HHHcCCC-----
Confidence 2234689999999999999999999999999999999999999997655433211 1111110
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
.+ ...+...+..+.+|+.+||+.||++|||+.|+++.|..
T Consensus 274 --~~-~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 274 --PI-REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp --GG-GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --Cc-hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 00 01122345668889999999999999999999987754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=390.58 Aligned_cols=242 Identities=23% Similarity=0.305 Sum_probs=196.5
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
.+.|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 356999999999999999999964 5899999999655444556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
|+||+|.++++.. .+++..+..++.||+.||+|||+. | +.+|.+||+|||+|+.+..... .
T Consensus 230 ~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 303 (423)
T 4fie_A 230 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 303 (423)
T ss_dssp CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-C
T ss_pred CCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-c
Confidence 9999999999753 589999999999999999999865 4 4567999999999998754332 3
Q ss_pred ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCccc
Q 047892 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (442)
..+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+.. +.+....... .+.+
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----------~~~~~i~~~~------~~~~ 367 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----------KAMKMIRDNL------PPRL 367 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------HHHHHHHHSC------CCCC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----------HHHHHHHcCC------CCCC
Confidence 45679999999999999999999999999999999999999999754321 1111111111 1111
Q ss_pred CCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH--HHhcC
Q 047892 383 QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEAE 422 (442)
Q Consensus 383 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~--~L~~~ 422 (442)
. .....+.++.+|+.+||+.||++|||+.|+++ +|.+.
T Consensus 368 ~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 368 K--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp S--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred c--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 1 11234456888999999999999999999986 35543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=371.32 Aligned_cols=232 Identities=19% Similarity=0.302 Sum_probs=175.4
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|++.+.||+|+||+||+|.. .+++.||||.+... .......+.+|+++|++++|||||++++++.+.+.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999995 46999999999543 2234567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~~~~~~~ 300 (442)
||| +|+|.+++.+. ..+++..+..++.|++.||+|||++ ++ .++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp ECC-CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 999 57999999765 5799999999999999999999875 44 46789999999998764332
Q ss_pred eeecccccccCCCCcccccCCCC-CCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 301 YVTTRVMGTFGYVAPEYASTGML-NETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
...+.+||+.|||||++.+..| +.++||||+||++|||+||+.||...+. ....... ..+..
T Consensus 167 -~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~----------~~~~~~i-~~~~~----- 229 (275)
T 3hyh_A 167 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI----------PVLFKNI-SNGVY----- 229 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------HHHHHHH-HHTCC-----
T ss_pred -ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH----------HHHHHHH-HcCCC-----
Confidence 2345789999999999988876 5799999999999999999999975322 1111111 11111
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
..+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 230 -----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 -----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111223456788999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=378.87 Aligned_cols=254 Identities=22% Similarity=0.287 Sum_probs=185.8
Q ss_pred CCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----eeeeEEe
Q 047892 159 GFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA----HRMLVNE 234 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~lv~E 234 (442)
+|.+.+.||+|+||+||+|++ +|+.||||++.... .....+..|+..+.+++|||||++++++.+.+ .+|||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 467789999999999999998 68899999985432 12222345666667899999999999998654 5799999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC---------------------CCCCCCeEEecccCcc
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---------------------LEPKWNPKLSDFGLAK 293 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---------------------l~~~~~~kl~DFGla~ 293 (442)
||++|+|.++|++. .+++..++.++.|++.||+|||++ ++.++.+||+|||+|+
T Consensus 82 y~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999864 589999999999999999999852 4557899999999998
Q ss_pred ccCCCcce---eecccccccCCCCcccccCC------CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCc-cch---hhh
Q 047892 294 LLGAERSY---VTTRVMGTFGYVAPEYASTG------MLNETSDVYSFGILIMEVISGRNPVDYSRPPGE-FQF---QVN 360 (442)
Q Consensus 294 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~-~~~---~~~ 360 (442)
........ .....+||+.|||||++.+. .|+.++|||||||+||||+||..||........ +.. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76443322 22346899999999999754 367899999999999999999888754322111 000 001
Q ss_pred HHHHHHHHhhcCCcccccCcccCCC-CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 361 LFEWLKTMVTNGNAEGVLDPRLQEK-PSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....+........ +++.++.. .....+..+.+|+.+||+.||++||||.||++.|+++.
T Consensus 237 ~~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 237 SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1122222222222 12222211 12356677889999999999999999999999998753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=377.90 Aligned_cols=234 Identities=22% Similarity=0.236 Sum_probs=181.6
Q ss_pred CCCCccCeeccCCcEEEEEEEEC----CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE----DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
++|++.+.||+|+||+||+|+.. +++.||||.+.... ......+.+|+++|++++|||||++++++.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46899999999999999999852 46789999986432 2223467889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
|||||+||+|.+++++. ..+++..+..++.|++.||+|||+. ++.++.+||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 99999999999999865 5799999999999999999999875 445789999999999865433
Q ss_pred cceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 299 RSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
. ....+.+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+.. +...... ....
T Consensus 180 ~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~----------~~~~~i~-~~~~---- 243 (304)
T 3ubd_A 180 E-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK----------ETMTMIL-KAKL---- 243 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------HHHHHHH-HCCC----
T ss_pred C-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH----------HHHHHHH-cCCC----
Confidence 2 2234578999999999999999999999999999999999999999754321 1111111 1111
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCH-----HHHHH
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKM-----GHVIH 417 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~-----~evl~ 417 (442)
..+...+.++.+|+.+||+.||++|||+ +|+++
T Consensus 244 ------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 ------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1122345668889999999999999995 56653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=357.50 Aligned_cols=244 Identities=21% Similarity=0.382 Sum_probs=176.5
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--------
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA-------- 227 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-------- 227 (442)
++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|+++|++|+|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35889999999999999999964 5899999999643 3345567899999999999999999999987544
Q ss_pred ----eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEeccc
Q 047892 228 ----HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFG 290 (442)
Q Consensus 228 ----~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFG 290 (442)
.+|||||||++|+|.++++.... .....+..++.++.|++.||+|||+. ++.++.+||+|||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 37999999999999999976422 23456677889999999999999875 4456899999999
Q ss_pred CccccCCCcce-----------eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhh
Q 047892 291 LAKLLGAERSY-----------VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQV 359 (442)
Q Consensus 291 la~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~ 359 (442)
+|+.+...... ..++.+||+.|||||++.+..|+.++|||||||++|||++ ||... .
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~---------~ 231 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ---------M 231 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH---------H
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc---------c
Confidence 99876443211 1234689999999999999999999999999999999996 77421 1
Q ss_pred hHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH--HHhcCCC
Q 047892 360 NLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEAEEF 424 (442)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~--~L~~~~~ 424 (442)
+....+... ..... +......+..+.+|+.+||+.||++|||+.|+++ .++++..
T Consensus 232 ~~~~~~~~~-~~~~~---------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 232 ERVRTLTDV-RNLKF---------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HHHHHHHHH-HTTCC---------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred HHHHHHHHH-hcCCC---------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 111111111 11110 0111233455678999999999999999999987 4666543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=357.44 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=187.9
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEe------CCe
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE------GAH 228 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------~~~ 228 (442)
++|++++.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|+.|+|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5699999999999999999996 46999999999643 23445678899999999999999999999764 357
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCCCeEEecccCcccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKWNPKLSDFGLAKLL 295 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~~~kl~DFGla~~~ 295 (442)
+|||||||+ |+|.+++... ..+++..+..++.||+.||.|||+. + +.++.+||+|||+|+.+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 899999996 5899999764 5799999999999999999999875 3 45679999999999876
Q ss_pred CCCc---ceeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhc
Q 047892 296 GAER---SYVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTN 371 (442)
Q Consensus 296 ~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (442)
.... .....+.+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+..+. ...+......
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~-------l~~I~~~~g~ 281 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ-------LQLIMMVLGT 281 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-------HHHHHHHHCC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH-------HHHHHHhcCC
Confidence 4322 2234567999999999998775 468999999999999999999999976543211 1111111110
Q ss_pred CCcc-----------c---ccCcccCCCC---cHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH--Hhc
Q 047892 372 GNAE-----------G---VLDPRLQEKP---SSRALKRALLVALRCVDPNAHKRPKMGHVIHM--LEA 421 (442)
Q Consensus 372 ~~~~-----------~---~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~--L~~ 421 (442)
.... . .+.+...... ....+.++.+|+.+||+.||++|||+.|+++. +.+
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 0000 0 0000000000 01234568899999999999999999999863 544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=374.99 Aligned_cols=239 Identities=21% Similarity=0.343 Sum_probs=195.6
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
.++|++.+.||+|+||.||+|... +|+.||+|.+........+.+.+|+++|+.|+|||||+++++|.+.+.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 357999999999999999999964 5899999999776666667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC---------CCCeEEecccCccccCCCcc
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP---------KWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~---------~~~~kl~DFGla~~~~~~~~ 300 (442)
|+||+|.++|... ...+++..+..++.||+.||.|||+. +++ .+.+||+|||+|+.+.....
T Consensus 236 ~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 236 MSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp CCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred cCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 9999999999653 25689999999999999999999875 332 37899999999998754433
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
....+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+.. +.+... .....
T Consensus 313 --~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~----------~~~~~i-~~~~~------ 373 (573)
T 3uto_A 313 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD----------ETLRNV-KSCDW------ 373 (573)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----------HHHHHH-HTTCC------
T ss_pred --eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----------HHHHHH-HhCCC------
Confidence 34568999999999999999999999999999999999999999754321 111111 11111
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.+........+.++.+|+.+||+.||.+|||+.|+++
T Consensus 374 ~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 374 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111234566888999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=343.91 Aligned_cols=268 Identities=39% Similarity=0.694 Sum_probs=224.3
Q ss_pred hhHHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 151 RELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 151 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
.++....++|++.+.||+|+||.||+|.+.+++.||||++........+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 34455667899999999999999999998889999999987666566778999999999999999999999999999999
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+||||+++|+|.+++.........+++..++.++.|++.||.|||+. ++.++.+||+|||+++....
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999999976544445689999999999999999999875 34567899999999986543
Q ss_pred Cc-ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 298 ER-SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 298 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||....+... .....|............
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM----VNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC----CCHHHHTHHHHTTTCCCS
T ss_pred ccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHH----HHHHHHhhhccccccHHH
Confidence 22 2223345689999999999888999999999999999999999999987655433 234445444555556666
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.+++.+........+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 7777777777788899999999999999999999999999999865
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=346.77 Aligned_cols=277 Identities=39% Similarity=0.725 Sum_probs=229.4
Q ss_pred ceeehhhHHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcch-hhHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 047892 146 HWYTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLVGYCA 224 (442)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 224 (442)
..|++.++....++|.+.+.||+|+||.||+|...+++.||||++..... .....+.+|+++++.++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 34788999999999999999999999999999987899999999865432 22236889999999999999999999999
Q ss_pred eCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC----------------CCCCCCeEEec
Q 047892 225 EGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG----------------LEPKWNPKLSD 288 (442)
Q Consensus 225 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~----------------l~~~~~~kl~D 288 (442)
+.+..++||||+++|+|.++++........+++..+..++.|++.||.|||+. ++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 99999999999999999999987655556799999999999999999999974 34567899999
Q ss_pred ccCccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHH
Q 047892 289 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTM 368 (442)
Q Consensus 289 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 368 (442)
||+++..............||+.|+|||++.+..++.++|||||||++|||++|..||........ .......|+...
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~ 255 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND--DDVMLLDWVKGL 255 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT--SCSBHHHHHTTT
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccc--cchhHHHHHHHH
Confidence 999988765554445566799999999999888899999999999999999999999963211100 112344555555
Q ss_pred hhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCC
Q 047892 369 VTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 424 (442)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 424 (442)
..........+..+........+..+.+++.+||+.||.+|||+.||++.|+....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 55555666667777777788889999999999999999999999999999987543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=365.73 Aligned_cols=238 Identities=18% Similarity=0.252 Sum_probs=187.5
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHH---HHHHHHHHhcCCCCcceEEEEEEeCC
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEF---KVEVEAIGRVRHKNLVRLVGYCAEGA 227 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~hpnIv~l~~~~~~~~ 227 (442)
+..++|++.++||+|+||+||+|+.. +|+.||||++.... ......+ ..++.+++.++|||||+++++|.+.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 45678999999999999999999964 59999999995321 1112223 33466777889999999999999999
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKL 294 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~ 294 (442)
.+|||||||+||+|.++|.+. ..+++..+..++.||+.||+|||+. ++.+|++||+|||+|+.
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999999865 5799999999999999999999876 45678999999999987
Q ss_pred cCCCcceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (442)
+.... ..+.+||+.|||||++.+ ..|+.++|||||||+||||++|.+||.+....+. ........ ...
T Consensus 342 ~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-------~~i~~~i~-~~~ 410 (689)
T 3v5w_A 342 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-------HEIDRMTL-TMA 410 (689)
T ss_dssp CSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-------HHHHHHHH-HCC
T ss_pred cCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHHhhc-CCC
Confidence 65432 345799999999999965 5799999999999999999999999975433221 11111111 111
Q ss_pred cccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCC-----HHHHHH
Q 047892 374 AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPK-----MGHVIH 417 (442)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~ 417 (442)
...+...+.++.+|+.+||+.||.+|++ +.||++
T Consensus 411 ----------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 ----------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ----------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1112234566888999999999999998 677764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=343.71 Aligned_cols=186 Identities=23% Similarity=0.361 Sum_probs=154.7
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC----CCCeEEEEEecCcchhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeee
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE----DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~ 230 (442)
..+.|++.+.||+|+||+||+|+.+ +++.||+|.+.... ....+.+|+++|+.+ +|||||++++++.+.+++|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 3467999999999999999999853 46789999986543 335678899999998 6999999999999999999
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC-------C-CCeEEecccCccccC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP-------K-WNPKLSDFGLAKLLG 296 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-------~-~~~kl~DFGla~~~~ 296 (442)
||||||++|+|.++++ .+++..+..++.|++.||+|||+. ++| + +.+||+|||+|+...
T Consensus 97 lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 9999999999999984 478999999999999999999765 554 2 689999999998653
Q ss_pred CCcc---------------------------eeecccccccCCCCcccccCCC-CCCcCCchhhHHHHHHHHhCCCCCCC
Q 047892 297 AERS---------------------------YVTTRVMGTFGYVAPEYASTGM-LNETSDVYSFGILIMEVISGRNPVDY 348 (442)
Q Consensus 297 ~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~Pf~~ 348 (442)
.... ...+..+||+.|||||++.+.. |+.++||||+||++|||++|+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 3211 1123458999999999997764 89999999999999999999999965
Q ss_pred CC
Q 047892 349 SR 350 (442)
Q Consensus 349 ~~ 350 (442)
..
T Consensus 250 ~~ 251 (361)
T 4f9c_A 250 AS 251 (361)
T ss_dssp CS
T ss_pred CC
Confidence 43
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=329.18 Aligned_cols=246 Identities=24% Similarity=0.421 Sum_probs=196.4
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
.++|.+.+.||+|+||.||+|.+. +++.||+|.+........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 456888999999999999999964 5899999998776667778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++|+|.++++.. ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++.........
T Consensus 89 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999999999864 25689999999999999999999875 3456789999999998764332211
Q ss_pred -------------ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHh
Q 047892 303 -------------TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMV 369 (442)
Q Consensus 303 -------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 369 (442)
.....||+.|+|||++.+..++.++|||||||++|||++|..||......... ...........
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~-~~~~~~~~~~~-- 242 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD-FGLNVRGFLDR-- 242 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT-SSBCHHHHHHH--
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH-Hhhhhhccccc--
Confidence 11457999999999999999999999999999999999999998754332111 11111111110
Q ss_pred hcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 370 TNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
. .+..++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 243 -----------~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 243 -----------Y----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp -----------T----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----------c----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 01122345778999999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=320.09 Aligned_cols=238 Identities=21% Similarity=0.321 Sum_probs=193.9
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
.++|++.+.||+|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 45799999999999999999995 56899999999655555567789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++|+|.+++... .+++..+..++.|++.||.|||+. ++.++.+||+|||++........ .
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 172 (297)
T 3fxz_A 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (297)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-c
Confidence 9999999999764 588999999999999999999876 44578999999999987654332 2
Q ss_pred ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCccc
Q 047892 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (442)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...... ............
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----------~~~~~~~~~~~~-------- 234 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----------RALYLIATNGTP-------- 234 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------HHHHHHHHHCSC--------
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----------HHHHHHHhCCCC--------
Confidence 34567999999999999999999999999999999999999999653321 111111111110
Q ss_pred CCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 383 QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 383 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
....+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111123345668889999999999999999999863
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=326.98 Aligned_cols=252 Identities=26% Similarity=0.424 Sum_probs=189.1
Q ss_pred hhhHHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 047892 150 LRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA 227 (442)
Q Consensus 150 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 227 (442)
...+++..++|++.+.||+|+||.||+|.+ +++.||||.+.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 344556677899999999999999999987 67889999986543 344567899999999999999999999999999
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC---------------CCCCCCeEEecccCc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---------------LEPKWNPKLSDFGLA 292 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---------------l~~~~~~kl~DFGla 292 (442)
..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+. ++.++.+||+|||++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred ceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 9999999999999999997641 112389999999999999999999875 234678999999999
Q ss_pred cccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC
Q 047892 293 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372 (442)
Q Consensus 293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (442)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|..||...... +.........
T Consensus 187 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~----------~~~~~~~~~~ 255 (309)
T 3p86_A 187 RLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA----------QVVAAVGFKC 255 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH----------HHHHHHHHSC
T ss_pred ccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------HHHHHHHhcC
Confidence 8653322 2234467999999999999999999999999999999999999999753321 1111111111
Q ss_pred CcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
. ....+...+..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 256 ~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 256 K---------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp C---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 11122234456888999999999999999999999998764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=333.43 Aligned_cols=249 Identities=24% Similarity=0.410 Sum_probs=197.3
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEEC--------CCCeEEEEEecCc-chhhHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLE--------DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCA 224 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 224 (442)
+..++|.+.+.||+|+||.||+|.+. ++..||||.+... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 44567899999999999999999852 3457999999654 334456789999999999 8999999999999
Q ss_pred eCCeeeeEEecCCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CC
Q 047892 225 EGAHRMLVNEYVDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEG-------------LE 279 (442)
Q Consensus 225 ~~~~~~lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~ 279 (442)
..+..|+||||+++|+|.+++..... ....+++..++.++.|++.||.|||+. ++
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 237 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence 99999999999999999999976421 124588999999999999999999876 45
Q ss_pred CCCCeEEecccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccch
Q 047892 280 PKWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQF 357 (442)
Q Consensus 280 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~ 357 (442)
.++.+||+|||+++.+...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---- 313 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---- 313 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH----
Confidence 6789999999999876443321 2233467889999999999999999999999999999999 999997543211
Q ss_pred hhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 358 QVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
+... ...+. ....+..++..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 314 ---~~~~----~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 314 ---LFKL----LKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp ---HHHH----HHTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHH----HhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111 11111 11122334566888999999999999999999999998753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=324.63 Aligned_cols=260 Identities=23% Similarity=0.329 Sum_probs=196.2
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----ee
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA----HR 229 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~ 229 (442)
.+..++|++.+.||+|+||.||+|++. ++.||||++.... .....+.+|+.++++++||||+++++++.... .+
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 345667999999999999999999974 7899999985432 33345567899999999999999999998744 46
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-----------------------CCCCCCeEE
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-----------------------LEPKWNPKL 286 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-----------------------l~~~~~~kl 286 (442)
|+||||+++|+|.++++.. .+++..++.++.|++.||.|||+. ++.++.+||
T Consensus 98 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 9999999999999999764 589999999999999999999964 345678999
Q ss_pred ecccCccccCCCcce-eecccccccCCCCcccccCC-----CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhh
Q 047892 287 SDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTG-----MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVN 360 (442)
Q Consensus 287 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~ 360 (442)
+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..........+...
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 999999876543322 23346799999999999763 466789999999999999999999987554333222111
Q ss_pred -----HHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 361 -----LFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 361 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....+............+...+ .....+..+.+|+.+||+.||++|||+.|+++.|+.+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111112222221111111111 12345677899999999999999999999999998753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=321.52 Aligned_cols=245 Identities=25% Similarity=0.424 Sum_probs=196.9
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
+..++|++.+.||+|+||.||+|.+.+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred eChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 4456789999999999999999998888899999996543 234678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
|+++|+|.+++... ...+++..++.++.|++.||.|||+. + +.++.+||+|||+++........
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp CCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred eCCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999999999754 24689999999999999999999875 3 34568999999999876543333
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
......+|+.|+|||++.+..++.++|||||||++|||++ |..||...... ....... ..
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~----------~~~~~~~-~~-------- 223 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----------EVVEDIS-TG-------- 223 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------HHHHHHH-TT--------
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH----------HHHHHHh-cC--------
Confidence 3344567888999999998999999999999999999999 99999753221 1111111 11
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
.....+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 224 -FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 011111223456888999999999999999999999998754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=319.09 Aligned_cols=248 Identities=23% Similarity=0.374 Sum_probs=199.5
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++..++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 34566789999999999999999998888899999986543 23466889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++|+|.+++... ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++.......
T Consensus 83 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 83 EYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp ECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred EccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 999999999999764 23589999999999999999999876 45678999999999987755544
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
.......+|+.|+|||++.+..++.++|||||||++|||++ |..||...... ....... ...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----------~~~~~~~-~~~------ 222 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS----------EVVLKVS-QGH------ 222 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH----------HHHHHHH-TTC------
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH----------HHHHHHH-cCC------
Confidence 44444567788999999998889999999999999999999 99999653221 1111111 111
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCC
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 425 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 425 (442)
....+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 223 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 223 ---RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp ---CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ---CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 0011112235688899999999999999999999999988643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=329.11 Aligned_cols=250 Identities=26% Similarity=0.456 Sum_probs=194.9
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC----CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE----DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
..++|.+.+.||+|+||.||+|.+. .+..||||.+... .....+.+.+|+.++++++||||+++++++.+.+..|
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3456889999999999999999974 3445999999654 3445567999999999999999999999999999999
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+||||+++|+|.++++.. ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++....
T Consensus 127 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999999754 24689999999999999999999875 44577999999999987644
Q ss_pred Ccc--eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 298 ERS--YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 298 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||...... .. .... ...
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-------~~---~~~~-~~~-- 270 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-------DV---ISSV-EEG-- 270 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-------HH---HHHH-HTT--
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-------HH---HHHH-HcC--
Confidence 322 12233456788999999998899999999999999999999 99999653221 11 1111 111
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCCChh
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRD 428 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 428 (442)
.....+...+..+.+|+.+||+.||++|||+.+|++.|+.+....+.
T Consensus 271 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 271 -------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred -------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 11112223456688899999999999999999999999987544333
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=321.23 Aligned_cols=235 Identities=20% Similarity=0.257 Sum_probs=191.1
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++|+.++||||+++++++.+.+..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45799999999999999999996 56999999998543 3345567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++......
T Consensus 94 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp CCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred ECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence 999999999999764 4689999999999999999999876 4457799999999998764332
Q ss_pred eeecccccccCCCCcccccCCCCC-CcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLN-ETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
.....+||+.|+|||++.+..++ .++|||||||++|||++|+.||...+. .... .....+..
T Consensus 169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----------~~~~-~~i~~~~~----- 231 (328)
T 3fe3_A 169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL----------KELR-ERVLRGKY----- 231 (328)
T ss_dssp -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH----------HHHH-HHHHHCCC-----
T ss_pred -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH----------HHHH-HHHHhCCC-----
Confidence 23456899999999999888875 789999999999999999999975432 1111 11111111
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
..+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 232 -----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 -----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111234567889999999999999999999863
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=345.09 Aligned_cols=251 Identities=22% Similarity=0.373 Sum_probs=200.5
Q ss_pred hhHHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 151 RELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 151 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
..+++..++|.+.+.||+|+||.||+|.+.++..||||.+.... ...+.+.+|+.+|++++||||+++++++. .+..|
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 44567778899999999999999999999888899999996543 34678999999999999999999999986 56789
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+||||+++|+|.++++... ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++....
T Consensus 259 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp EEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 9999999999999997531 12578889999999999999999875 44567899999999987644
Q ss_pred CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
..........+|+.|+|||++....++.++|||||||++|||++ |+.||..... ..+... .. .+
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-------~~~~~~---i~-~~---- 401 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-------PEVIRA---LE-RG---- 401 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHH---HH-HT----
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-------HHHHHH---HH-cC----
Confidence 32222233456789999999998999999999999999999999 9999975322 111111 11 11
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCC
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 425 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 425 (442)
.....+..++..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 402 -----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 402 -----YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -----CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 11112233456788999999999999999999999999988644
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=337.92 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=197.1
Q ss_pred hHHHhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 047892 152 ELEVSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 152 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 229 (442)
.+.+..++|.+.+.||+|+||.||+|.+. +++.||||.+.... ......+.+|+++|++++||||+++++++...+..
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 34556678999999999999999999975 68999999986542 33445688999999999999999999999999999
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~ 296 (442)
|+||||+++|+|.++++.. ...+++..++.++.|++.||+|||+. ++.++.+||+|||+++...
T Consensus 188 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999999999753 23589999999999999999999875 4557899999999998754
Q ss_pred CCcceee-cccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 297 AERSYVT-TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 297 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
....... ....+++.|+|||++.++.++.++|||||||++|||++ |..||...... .. ......+.
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-------~~----~~~~~~~~- 332 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-------QT----REFVEKGG- 332 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-------HH----HHHHHTTC-
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HH----HHHHHcCC-
Confidence 3322111 12245778999999998899999999999999999998 99999653211 11 11111111
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....+..++..+.+|+.+||+.||++|||+.++++.|+++.
T Consensus 333 --------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 333 --------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 11122234456888999999999999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=317.70 Aligned_cols=249 Identities=22% Similarity=0.359 Sum_probs=191.8
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 232 (442)
.++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 456899999999999999999964 5889999998432 334456789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
|||+++|+|.+++... ..+++..++.++.|++.||.|||+. ++.++.+||+|||+++......
T Consensus 90 ~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 9999999999999764 4689999999999999999999875 4457789999999998765443
Q ss_pred ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... ..
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~----------~~~~~~~~~~-~~---- 230 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV----------SIAIKHIQDS-VP---- 230 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH----------HHHHHHHSSC-CC----
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH----------HHHHHHhhcc-CC----
Confidence 33344567999999999999999999999999999999999999999754321 1111111111 00
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCC-CHHHHHHHHhcCCCC
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRP-KMGHVIHMLEAEEFP 425 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~ 425 (442)
..........+..+.+++.+||+.||.+|| ++.++.+.|+.....
T Consensus 231 -~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 231 -NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp -CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred -CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 000011122345688899999999999998 899999999987543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=309.49 Aligned_cols=267 Identities=33% Similarity=0.616 Sum_probs=209.5
Q ss_pred eeehhhHHHhhCCCCcc------CeeccCCcEEEEEEEECCCCeEEEEEecCc----chhhHHHHHHHHHHHHhcCCCCc
Q 047892 147 WYTLRELEVSTNGFADE------NVIGEGGYGIVYRGVLEDNTNVAVKNLLNN----RGQAEKEFKVEVEAIGRVRHKNL 216 (442)
Q Consensus 147 ~~~~~~~~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~hpnI 216 (442)
.|+..++...+++|... +.||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++||||
T Consensus 14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 92 (307)
T 2nru_A 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92 (307)
T ss_dssp ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence 46777888888887776 8999999999999987 6789999998542 23445778999999999999999
Q ss_pred ceEEEEEEeCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCC
Q 047892 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWN 283 (442)
Q Consensus 217 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~ 283 (442)
+++++++.+.+..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+. ++.++.
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~ 171 (307)
T 2nru_A 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT 171 (307)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC
T ss_pred EEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc
Confidence 999999999999999999999999999997431 124689999999999999999999876 445679
Q ss_pred eEEecccCccccCCCcc-eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHH
Q 047892 284 PKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF 362 (442)
Q Consensus 284 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 362 (442)
+||+|||+++....... .......||+.|+|||++.+ .++.++|||||||++|||++|..||..........
T Consensus 172 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------ 244 (307)
T 2nru_A 172 AKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL------ 244 (307)
T ss_dssp EEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT------
T ss_pred EEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH------
Confidence 99999999987644322 22344679999999998854 58999999999999999999999998654433211
Q ss_pred HHHHHHhh-cCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 363 EWLKTMVT-NGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 363 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
.+...... .......++..+. ......+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11111111 1122233333332 345667788999999999999999999999999998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=344.13 Aligned_cols=251 Identities=22% Similarity=0.392 Sum_probs=202.4
Q ss_pred hHHHhhCCCCccCeeccCCcEEEEEEEECC-CCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 152 ELEVSTNGFADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 152 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
.+++..++|.+.+.||+|+||.||+|.+.. +..||||.+.... ...+.|.+|+.+|++++||||+++++++...+..|
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 345667788999999999999999999765 8899999986543 34567999999999999999999999999999999
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+||||+++|+|.++++... ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++....
T Consensus 293 lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 9999999999999997532 24689999999999999999999875 34467899999999997754
Q ss_pred CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
..........+|+.|+|||++.+..++.++|||||||++|||++ |..||...... .+...+ ..
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-------~~~~~~----~~----- 434 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELL----EK----- 434 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-------GHHHHH----HT-----
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-------HHHHHH----Hc-----
Confidence 43333344556789999999998899999999999999999999 99999754321 111111 11
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCC
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 425 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 425 (442)
......+..++..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 435 ----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 435 ----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 111122234456788899999999999999999999999987543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=318.92 Aligned_cols=246 Identities=21% Similarity=0.357 Sum_probs=194.3
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++..++|++.+.||+|+||.||+|.+.++..||+|.+.... ...+.+.+|++++.+++||||+++++++.+.+..|+||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 45566799999999999999999999888899999996543 23467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++|+|.+++... ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++.......
T Consensus 99 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 99 EYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred eccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 999999999999763 24689999999999999999999876 34567899999999987644333
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ...... ....
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~----------~~~~~~-~~~~------ 238 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----------ETAEHI-AQGL------ 238 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----------HHHHHH-HTTC------
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh----------HHHHHH-hccc------
Confidence 33334467888999999998899999999999999999998 99999653321 111111 1110
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 239 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 239 ---RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp ---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 11111222356888999999999999999999999998653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=311.36 Aligned_cols=247 Identities=24% Similarity=0.346 Sum_probs=188.0
Q ss_pred hCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHh--cCCCCcceEEEEEEe----CCeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR--VRHKNLVRLVGYCAE----GAHRM 230 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~----~~~~~ 230 (442)
.++|++.+.||+|+||.||+|.+ +++.||||++.. .....+.+|.+++.. ++||||+++++++.. ....|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 45799999999999999999998 688999999854 234556667777666 799999999998654 35689
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhh--------cC-------------CCCCCCeEEecc
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH--------EG-------------LEPKWNPKLSDF 289 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH--------~~-------------l~~~~~~kl~DF 289 (442)
+||||+++|+|.++++. ..+++..++.++.|++.||.||| +. ++.++.+||+||
T Consensus 83 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 99999999999999964 36899999999999999999999 54 445789999999
Q ss_pred cCccccCCCccee---ecccccccCCCCcccccCC------CCCCcCCchhhHHHHHHHHhC----------CCCCCCCC
Q 047892 290 GLAKLLGAERSYV---TTRVMGTFGYVAPEYASTG------MLNETSDVYSFGILIMEVISG----------RNPVDYSR 350 (442)
Q Consensus 290 Gla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvil~elltg----------~~Pf~~~~ 350 (442)
|+++......... .....||+.|+|||++.+. .++.++|||||||++|||++| ..||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9998764433221 2335799999999999776 455799999999999999999 78886543
Q ss_pred CCCccchhhhHHHHHHHHhhcCCcccccCcccC-CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 351 PPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ-EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
..... ............. .+.+. .......+..+.+|+.+||+.||++|||+.+|++.|+++
T Consensus 238 ~~~~~------~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PNDPS------FEDMRKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSSCC------HHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcc------hhhhhHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 32221 1111121111111 11111 112345677899999999999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=331.23 Aligned_cols=245 Identities=26% Similarity=0.463 Sum_probs=183.6
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC----CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE----DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
..++|.+.+.||+|+||.||+|++. ++..||||.+... .....+.+.+|+.++++++||||+++++++.+.+..|
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 4457999999999999999999864 4778999999654 3445567999999999999999999999999999999
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+||||+++|+|.++++.. ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++....
T Consensus 123 lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999999764 24689999999999999999999875 44567899999999987644
Q ss_pred Ccce--eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 298 ERSY--VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 298 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
.... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..... ....+
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-------~~~~~----~i~~~-- 266 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-------QDVIK----AVDEG-- 266 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-------HHHHH----HHHTT--
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHH----HHHcC--
Confidence 3221 1222345788999999999999999999999999999998 9999965322 11111 11111
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
.....+...+..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 267 -------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 267 -------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp -------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 111122234566888999999999999999999999998763
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=321.05 Aligned_cols=235 Identities=21% Similarity=0.239 Sum_probs=189.8
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 232 (442)
.++|++.+.||+|+||.||+|+.. +++.||+|.+... .......+.+|+.+|+.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 457889999999999999999965 5899999999543 223446688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
|||+++|+|.+++.+. ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++.....
T Consensus 84 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp EECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence 9999999999999764 4689999999999999999999875 445789999999999864322
Q ss_pred ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||...+.. .+ ...... ...
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~---~~~i~~-~~~----- 222 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RL---FELILM-EEI----- 222 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HH---HHHHHH-CCC-----
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH-------HH---HHHHHc-CCC-----
Confidence 22244568999999999999999999999999999999999999999653221 11 111111 111
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCC-----CHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRP-----KMGHVIH 417 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 417 (442)
..+...+.++.+|+.+||+.||++|| ++.|+++
T Consensus 223 -----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 11123345688899999999999999 8999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=324.28 Aligned_cols=238 Identities=24% Similarity=0.296 Sum_probs=189.4
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcch------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRG------QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 229 (442)
.+.|.+.+.||+|+||.||+|... +|+.||+|.+..... ...+.+.+|+.+|+.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 356889999999999999999965 589999999964322 1356789999999999999999999999999999
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCC----CeEEecccCc
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKW----NPKLSDFGLA 292 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~----~~kl~DFGla 292 (442)
|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+. ++ .++ .+||+|||++
T Consensus 91 ~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999999754 5689999999999999999999875 33 333 7999999999
Q ss_pred cccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC
Q 047892 293 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372 (442)
Q Consensus 293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (442)
+.+.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...... +..... ...
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~----------~~~~~i-~~~ 233 (361)
T 2yab_A 167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----------ETLANI-TAV 233 (361)
T ss_dssp EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----------HHHHHH-HTT
T ss_pred eEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----------HHHHHH-Hhc
Confidence 8765432 234567999999999999889999999999999999999999999754321 111111 111
Q ss_pred CcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.. ..++. .....+..+.+|+.+||..||.+|||+.|+++
T Consensus 234 ~~--~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 SY--DFDEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CC--CCCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CC--CCCch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 10 00100 01123456888999999999999999999985
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=329.03 Aligned_cols=257 Identities=23% Similarity=0.358 Sum_probs=200.1
Q ss_pred eehhhHHHhhCCCCccCeeccCCcEEEEEEEE------CCCCeEEEEEecCcc-hhhHHHHHHHHHHHHhc-CCCCcceE
Q 047892 148 YTLRELEVSTNGFADENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRL 219 (442)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l 219 (442)
+....+++..++|.+.+.||+|+||.||+|.+ .+++.||||.+.... ....+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 45567788889999999999999999999984 235789999996543 34456789999999999 88999999
Q ss_pred EEEEEeCC-eeeeEEecCCCCCHHHHHccCCCC-----------------------------------------------
Q 047892 220 VGYCAEGA-HRMLVNEYVDNGNLEQWLHGDVGP----------------------------------------------- 251 (442)
Q Consensus 220 ~~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~~----------------------------------------------- 251 (442)
++++.+.+ ..++|||||++|+|.++++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998755 489999999999999999764321
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCCCeEEecccCccccCCCcc-ee
Q 047892 252 ---------------HSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKWNPKLSDFGLAKLLGAERS-YV 302 (442)
Q Consensus 252 ---------------~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~~~kl~DFGla~~~~~~~~-~~ 302 (442)
...+++..++.++.|++.||.|||+. + +.++.+||+|||+++.+..... ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 251 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 251 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEE
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchh
Confidence 12289999999999999999999876 3 3467899999999987644322 23
Q ss_pred ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcc
Q 047892 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (442)
.....||+.|+|||++.+..++.++|||||||++|||++ |..||........ ... ......
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~----~~~~~~-------- 313 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCR----RLKEGT-------- 313 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHH----HHHHTC--------
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHH----HHHcCC--------
Confidence 345678999999999999999999999999999999998 9999976543211 111 111111
Q ss_pred cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 382 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....+...+..+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus 314 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 314 -RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 01111223456888999999999999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=318.65 Aligned_cols=257 Identities=21% Similarity=0.339 Sum_probs=191.9
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEE-----CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--C
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVL-----EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG--A 227 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~ 227 (442)
+..++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++... .
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 3456788999999999999999984 35789999999776666677899999999999999999999998653 4
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCccc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKL 294 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~ 294 (442)
..++||||+++|+|.+++... ...+++..++.++.|++.||.|||+. ++ .++.+||+|||+++.
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred ceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 589999999999999999765 23589999999999999999999875 33 357899999999987
Q ss_pred cCCCcce--eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCC-----CccchhhhHHHHHHH
Q 047892 295 LGAERSY--VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPP-----GEFQFQVNLFEWLKT 367 (442)
Q Consensus 295 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~-----~~~~~~~~~~~~~~~ 367 (442)
....... ......+|..|+|||++.+..++.++|||||||++|||++|..||...... ...............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6443221 223345788899999999999999999999999999999999998532100 000000000111111
Q ss_pred HhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 368 MVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
..... .....+..++..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 244 ~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 244 LLKNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcc---------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11111 111223344567889999999999999999999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=324.47 Aligned_cols=257 Identities=24% Similarity=0.331 Sum_probs=199.9
Q ss_pred hhHHHhhCCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEE
Q 047892 151 RELEVSTNGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYC 223 (442)
Q Consensus 151 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 223 (442)
..+.+..++|.+.+.||+|+||.||+|... +++.||||.+... .....+.+.+|+.++++++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345566788999999999999999999964 3478999999654 334456799999999999999999999999
Q ss_pred EeCCeeeeEEecCCCCCHHHHHccCCCC--------------------CCCCCHHHHHHHHHHHHHhhhhhhcC------
Q 047892 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGP--------------------HSPLTWEIRMNIILGTAKGLTYLHEG------ 277 (442)
Q Consensus 224 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi~~~l~yLH~~------ 277 (442)
.+.+..|+||||+++|+|.+++...... ...+++..++.++.|++.||.|||+.
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 9999999999999999999999764211 15689999999999999999999876
Q ss_pred -------CCCCCCeEEecccCccccCCCcc-eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCC
Q 047892 278 -------LEPKWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDY 348 (442)
Q Consensus 278 -------l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~ 348 (442)
++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 34467899999999987643322 12234568899999999998899999999999999999999 9999965
Q ss_pred CCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCCCh
Q 047892 349 SRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFR 427 (442)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 427 (442)
... .+.. .....+... ..+...+..+.+++.+||+.||++|||+.++++.|+++.....
T Consensus 280 ~~~----------~~~~-~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 280 MAH----------EEVI-YYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp SCH----------HHHH-HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCh----------HHHH-HHHhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 321 1111 111111110 1122334568889999999999999999999999999875543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=313.46 Aligned_cols=235 Identities=23% Similarity=0.317 Sum_probs=190.3
Q ss_pred CCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 160 FADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
|...+.||+|+||.||+|... +|+.||||.+........+.+.+|+.++++++||||+++++++...+..|+||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 666779999999999999975 6999999999765555567789999999999999999999999999999999999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeecc
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTR 305 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~~ 305 (442)
|+|.+++.. ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++....... ....
T Consensus 127 ~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 200 (321)
T 2c30_A 127 GALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKS 200 (321)
T ss_dssp CBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCC
T ss_pred CCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-cccc
Confidence 999999864 3589999999999999999999875 44578999999999987654322 2345
Q ss_pred cccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCC
Q 047892 306 VMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEK 385 (442)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (442)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... .+.+ .
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~----------~~~~~~~~~~~------~~~~--~ 262 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP----------VQAMKRLRDSP------PPKL--K 262 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----------HHHHHHHHHSS------CCCC--T
T ss_pred ccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----------HHHHHHHhcCC------CCCc--C
Confidence 6799999999999999999999999999999999999999965322 11111111110 0111 1
Q ss_pred CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 386 PSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 386 ~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.....+..+.+++.+||+.||++|||+.|+++.
T Consensus 263 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 263 NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122334568889999999999999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=330.86 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=197.7
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEEC--------CCCeEEEEEecCc-chhhHHHHHHHHHHHHhc-CCCCcceEEEEE
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLE--------DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYC 223 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 223 (442)
++..++|.+.+.||+|+||.||+|... .+..||||++... .......+.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 455677899999999999999999852 2357999999654 334457789999999999 999999999999
Q ss_pred EeCCeeeeEEecCCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------C
Q 047892 224 AEGAHRMLVNEYVDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEG-------------L 278 (442)
Q Consensus 224 ~~~~~~~lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l 278 (442)
...+..|+||||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 999999999999999999999976431 124589999999999999999999876 4
Q ss_pred CCCCCeEEecccCccccCCCcc-eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccc
Q 047892 279 EPKWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQ 356 (442)
Q Consensus 279 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~ 356 (442)
+.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~----- 299 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 299 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence 4578999999999987644322 22334567899999999999999999999999999999999 9999965321
Q ss_pred hhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 357 FQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
.+.. ....... ....+...+.++.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 300 -----~~~~-~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 300 -----EELF-KLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp -----HHHH-HHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHHH-HHHHcCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111 1111111 11112233456888999999999999999999999998764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=320.36 Aligned_cols=239 Identities=25% Similarity=0.327 Sum_probs=187.7
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
++|++.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57899999999999999999965 68999999985432 23345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc-ce
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER-SY 301 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~-~~ 301 (442)
|++|+|.+++... ..+++..++.++.|++.||.|||+. ++.++.+||+|||+++.+.... ..
T Consensus 87 ~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 87 CSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp CTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 9999999998754 5689999999999999999999875 4456899999999998653322 22
Q ss_pred eecccccccCCCCcccccCCCC-CCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 302 VTTRVMGTFGYVAPEYASTGML-NETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
.....+||+.|+|||++.+..+ +.++|||||||++|||++|..||........ .... .....
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----~~~~----~~~~~-------- 225 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----EYSD----WKEKK-------- 225 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-----HHHH----HHTTC--------
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-----HHHH----Hhccc--------
Confidence 2345689999999999987775 7789999999999999999999975443211 0111 11110
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 226 -~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 226 -TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0111122344567889999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=339.96 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=193.1
Q ss_pred hhHHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 151 RELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 151 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
..+++..++|.+.+.||+|+||.||+|.+.++..||||.+.... ...+.+.+|+.+|++++||||+++++++.+ +..|
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 34456677899999999999999999999877889999986543 235678999999999999999999999876 6789
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+||||+++|+|.++++... ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++....
T Consensus 255 iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp EEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 9999999999999997421 13588999999999999999999875 33457899999999987654
Q ss_pred CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
..........+|+.|+|||++.+..++.++|||||||++|||++ |..||...... ... .. ...+
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-------~~~---~~-i~~~---- 397 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVL---DQ-VERG---- 397 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHH---HH-HHTT----
T ss_pred CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-------HHH---HH-HHcC----
Confidence 33222334457889999999999999999999999999999999 99999653221 111 11 1111
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCC
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 425 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 425 (442)
.+...+..++..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 398 -----~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 398 -----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 11112234456788899999999999999999999999987643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=333.78 Aligned_cols=242 Identities=26% Similarity=0.368 Sum_probs=193.4
Q ss_pred HHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-eeee
Q 047892 153 LEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA-HRML 231 (442)
Q Consensus 153 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~l 231 (442)
+++..++|.+.+.||+|+||.||+|.+. ++.||||.+.... ..+.+.+|+.+|++++||||+++++++.... ..|+
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 3456678999999999999999999984 7799999996543 4567899999999999999999999987665 7899
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
|||||++|+|.++++... ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++.....
T Consensus 265 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp EEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 999999999999997642 23478999999999999999999875 445789999999999864322
Q ss_pred cceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 299 RSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
.....+++.|+|||++.+..++.++|||||||++|||++ |..||......+. ... ...+
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-------~~~----i~~~----- 402 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPR----VEKG----- 402 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH-------HHH----HHTT-----
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHH----HHcC-----
Confidence 122367889999999999999999999999999999998 9999976543221 111 1111
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
.+...+..++..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 403 ----~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 403 ----YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111223344567889999999999999999999999998653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=313.15 Aligned_cols=245 Identities=25% Similarity=0.411 Sum_probs=196.1
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
+..++|++.+.||+|+||.||+|.+.+++.||+|.+..... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred EchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 34567889999999999999999988888999999965432 34678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
|+++|+|.+++... ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++........
T Consensus 84 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp CCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999999764 24688999999999999999999876 345678999999999876443222
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
......+|+.|+|||++.+..++.++||||||+++|||++ |..||..... ........ .+.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----------~~~~~~i~-~~~------- 222 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----------SEVVEDIS-TGF------- 222 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------HHHHHHHH-TTC-------
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH----------HHHHHHHh-cCC-------
Confidence 2334567889999999998899999999999999999999 8999965321 11111111 110
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 223 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 223 --RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01111223456888999999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=311.04 Aligned_cols=255 Identities=18% Similarity=0.261 Sum_probs=190.9
Q ss_pred hCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
.++|++.+.||+|+||.||+|...+++.||+|++.... ......+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 35688999999999999999999889999999986432 2334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
|+++ +|.+++... ...+++..+..++.|++.||.|||+. ++.++.+||+|||+++.......
T Consensus 100 ~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 174 (311)
T 3niz_A 100 FMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR- 174 (311)
T ss_dssp CCSE-EHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred CCCC-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence 9986 888888754 24589999999999999999999875 44578999999999987643322
Q ss_pred eecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc---cc
Q 047892 302 VTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE---GV 377 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 377 (442)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.. ..+.......... ..
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL-------PKIFSILGTPNPREWPQV 247 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH-------HHHHHHHCCCCTTTSGGG
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH-------HHHHHHHCCCChHHhhhh
Confidence 2334578999999999876 56899999999999999999999999865543321 1111111110000 00
Q ss_pred c------C---cccCCC----CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH--HHhcCC
Q 047892 378 L------D---PRLQEK----PSSRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEAEE 423 (442)
Q Consensus 378 ~------~---~~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~--~L~~~~ 423 (442)
. . ...... .....+.++.+|+.+||+.||++|||+.|+++ .++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 0 0 000000 01123456788999999999999999999997 455544
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=314.45 Aligned_cols=247 Identities=20% Similarity=0.329 Sum_probs=183.2
Q ss_pred HHHhhCCCCccCeeccCCcEEEEEEEECC----CCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 047892 153 LEVSTNGFADENVIGEGGYGIVYRGVLED----NTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA 227 (442)
Q Consensus 153 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 227 (442)
+++..++|++.+.||+|+||.||+|.+.. +..||+|.+... .....+.+.+|+.++++++||||+++++++. .+
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 88 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence 34556779999999999999999999643 456999998653 3344567899999999999999999999984 56
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCccc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKL 294 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~ 294 (442)
..|+||||+++|+|.+++... ...+++..++.++.|++.||.|||+. ++ .++.+||+|||+++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred ccEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 789999999999999999754 24689999999999999999999875 33 457899999999987
Q ss_pred cCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCC
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (442)
.............+|+.|+|||++.+..++.++|||||||++|||++ |..||......+ ....+ ....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-------~~~~i----~~~~ 234 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRI----ENGE 234 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHH----HTTC
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-------HHHHH----HcCC
Confidence 65443333344567889999999998899999999999999999997 999997543221 11111 1111
Q ss_pred cccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 374 AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 235 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 235 ---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01112234456888999999999999999999999998764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=316.42 Aligned_cols=237 Identities=17% Similarity=0.270 Sum_probs=189.5
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
++|.+.+.||+|+||.||+|... +++.||+|.+... ......+.+|+.+++.++||||+++++++.+.+..|+|||||
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 56889999999999999999965 4888999988643 334566889999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CC--CCCeEEecccCccccCCCcce
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EP--KWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~--~~~~kl~DFGla~~~~~~~~~ 301 (442)
++|+|.+++... ...+++..++.++.|++.||.|||+. + +. ++.+||+|||+++.......
T Consensus 84 ~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~- 159 (321)
T 1tki_A 84 SGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN- 159 (321)
T ss_dssp CCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE-
T ss_pred CCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc-
Confidence 999999999754 24689999999999999999999875 2 22 67899999999988754332
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (442)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...... ........ .... ...
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----------~~~~~i~~-~~~~--~~~- 224 (321)
T 1tki_A 160 -FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ----------QIIENIMN-AEYT--FDE- 224 (321)
T ss_dssp -EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH----------HHHHHHHH-TCCC--CCH-
T ss_pred -cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH----------HHHHHHHc-CCCC--CCh-
Confidence 33457999999999998888999999999999999999999999753321 11111111 1100 000
Q ss_pred cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 382 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
......+.++.+|+.+||+.||.+|||+.|+++
T Consensus 225 ---~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 225 ---EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ---HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001123456888999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=318.85 Aligned_cols=252 Identities=26% Similarity=0.415 Sum_probs=198.9
Q ss_pred hHHHhhCCCCccCeeccCCcEEEEEEEE------CCCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 047892 152 ELEVSTNGFADENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCA 224 (442)
Q Consensus 152 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 224 (442)
++++..++|.+.+.||+|+||.||+|.. .++..||||.+... .....+.+.+|++++++++||||+++++++.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 4455677899999999999999999985 23578999999654 3345577899999999999999999999999
Q ss_pred eCCeeeeEEecCCCCCHHHHHccCCC--------------------CCCCCCHHHHHHHHHHHHHhhhhhhcC------C
Q 047892 225 EGAHRMLVNEYVDNGNLEQWLHGDVG--------------------PHSPLTWEIRMNIILGTAKGLTYLHEG------L 278 (442)
Q Consensus 225 ~~~~~~lv~E~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~l~yLH~~------l 278 (442)
+.+..|+||||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di 176 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL 176 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence 99999999999999999999976422 123488999999999999999999876 3
Q ss_pred -------CCCCCeEEecccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCC
Q 047892 279 -------EPKWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYS 349 (442)
Q Consensus 279 -------~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~ 349 (442)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 34678999999999876543322 2234467889999999998889999999999999999999 99999754
Q ss_pred CCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 350 RPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
.... .... ..... ....+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 257 ~~~~-------~~~~----~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 257 PPER-------LFNL----LKTGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp CGGG-------HHHH----HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHH-------HHHH----hhcCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 3311 1111 11111 11112234456888999999999999999999999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=323.09 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=196.7
Q ss_pred hHHHhhCCCCccCeeccCCcEEEEEEEE------CCCCeEEEEEecCc-chhhHHHHHHHHHHHHhc-CCCCcceEEEEE
Q 047892 152 ELEVSTNGFADENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYC 223 (442)
Q Consensus 152 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 223 (442)
++++..++|.+.+.||+|+||.||+|.+ .++..||||.+... .....+.+.+|+.+++++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3456677899999999999999999995 23567999999643 233446789999999999 999999999999
Q ss_pred EeCCeeeeEEecCCCCCHHHHHccCCCC-------------------CCCCCHHHHHHHHHHHHHhhhhhhcC------C
Q 047892 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGP-------------------HSPLTWEIRMNIILGTAKGLTYLHEG------L 278 (442)
Q Consensus 224 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~~l~yLH~~------l 278 (442)
...+..|+||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 9999999999999999999999764221 13478999999999999999999875 3
Q ss_pred -------CCCCCeEEecccCccccCCCcc-eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCC
Q 047892 279 -------EPKWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYS 349 (442)
Q Consensus 279 -------~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~ 349 (442)
+.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |..||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 4467899999999987643332 22344567889999999999999999999999999999998 99999765
Q ss_pred CCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCCCh
Q 047892 350 RPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFR 427 (442)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 427 (442)
..... .. ...... .....+...+..+.+|+.+||+.||.+|||+.++++.|+.+....+
T Consensus 279 ~~~~~------~~----~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 279 PVDAN------FY----KLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CCSHH------HH----HHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CcHHH------HH----HHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 33211 11 111111 1111122334668889999999999999999999999998765433
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=310.66 Aligned_cols=239 Identities=27% Similarity=0.460 Sum_probs=180.3
Q ss_pred hhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcch----hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRG----QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
..++|++.+.||+|+||.||+|.+. ++.||||.+..... ...+.+.+|+++++.++||||+++++++.+.+..|+
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 4567889999999999999999974 78999999854322 234678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC---------CCC---------------CCCeEEe
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---------LEP---------------KWNPKLS 287 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---------l~~---------------~~~~kl~ 287 (442)
||||+++|+|.+++.. ..+++..++.++.|++.||.|||+. +++ ++.+||+
T Consensus 84 v~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 9999999999999964 3689999999999999999999874 221 5679999
Q ss_pred cccCccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHH
Q 047892 288 DFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKT 367 (442)
Q Consensus 288 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 367 (442)
|||+++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....
T Consensus 159 Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------~~~~~ 225 (271)
T 3dtc_A 159 DFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL----------AVAYG 225 (271)
T ss_dssp CCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH----------HHHHH
T ss_pred cCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------HHHHh
Confidence 999998654332 22457899999999999999999999999999999999999999653211 11111
Q ss_pred HhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 368 MVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.... ......+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 226 ~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 226 VAMN---------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHTS---------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hhcC---------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111 111112233445688899999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=315.03 Aligned_cols=249 Identities=23% Similarity=0.399 Sum_probs=201.3
Q ss_pred hHHHhhCCCCccCeeccCCcEEEEEEEECC-CCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 152 ELEVSTNGFADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 152 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
++++..++|++.+.||+|+||.||+|.+.. +..||+|.+... ....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 445667789999999999999999999754 788999998653 334567889999999999999999999999999999
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~~~kl~DFGla~~~~~ 297 (442)
+||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. + +.++.+||+|||++.....
T Consensus 86 ~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 9999999999999997642 24689999999999999999999864 3 3456899999999988765
Q ss_pred CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
..........+|+.|+|||++.+..++.++|||||||++|+|++ |..||....... ....+ ...
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-------~~~~~----~~~---- 228 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELL----EKD---- 228 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHHH----HTT----
T ss_pred CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH----hcc----
Confidence 54444455567889999999998999999999999999999999 999997543211 11111 110
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
.....+...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 229 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 229 -----YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 111122234466888999999999999999999999998764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=317.15 Aligned_cols=238 Identities=21% Similarity=0.299 Sum_probs=188.3
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcch------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRG------QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
+.|.+.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.+|+.++||||+++++++.+.+..|
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45888999999999999999965 589999999854321 23567899999999999999999999999999999
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCC----CeEEecccCcc
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKW----NPKLSDFGLAK 293 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~----~~kl~DFGla~ 293 (442)
+||||+++|+|.+++... ..+++..++.++.|++.||.|||+. ++ .++ .+||+|||+++
T Consensus 91 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 999999999999999754 5689999999999999999999875 33 334 79999999998
Q ss_pred ccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC
Q 047892 294 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373 (442)
Q Consensus 294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (442)
....... .....||+.|+|||++.+..++.++|||||||++|||++|..||...... .... .... ..
T Consensus 167 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~---~~~~-~~ 233 (326)
T 2y0a_A 167 KIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLA---NVSA-VN 233 (326)
T ss_dssp ECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHH---HHHH-TC
T ss_pred ECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-------HHHH---HHHh-cC
Confidence 7643322 23457999999999999899999999999999999999999999653221 1111 1111 00
Q ss_pred cccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 374 AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
. ..........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 234 ~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 Y------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp C------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred C------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 00000011234567889999999999999999999873
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=321.30 Aligned_cols=239 Identities=19% Similarity=0.264 Sum_probs=192.1
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
++|.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+|+.++||||+++++++.+.+..|+||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 46889999999999999999964 58899999997655555667899999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC---------CCCCeEEecccCccccCCCcce
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE---------PKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~---------~~~~~kl~DFGla~~~~~~~~~ 301 (442)
++|+|.+++... ...+++..++.++.|++.||.|||+. ++ .++.+||+|||+++.......
T Consensus 131 ~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~- 206 (387)
T 1kob_A 131 SGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI- 206 (387)
T ss_dssp CCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc-
Confidence 999999998754 24689999999999999999999875 32 246799999999987754332
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (442)
....+||+.|+|||++.+..++.++|||||||++|||++|..||..... ...+...... .. .
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----------~~~~~~i~~~-~~------~ 268 (387)
T 1kob_A 207 -VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----------LETLQNVKRC-DW------E 268 (387)
T ss_dssp -EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----------HHHHHHHHHC-CC------C
T ss_pred -eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH----------HHHHHHHHhC-CC------C
Confidence 2334799999999999999999999999999999999999999975422 1111111111 10 0
Q ss_pred cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 382 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.........+.++.+|+.+||+.||++|||+.|+++.
T Consensus 269 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 269 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1111112334568889999999999999999999874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=318.90 Aligned_cols=232 Identities=20% Similarity=0.300 Sum_probs=186.5
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5689999999999999999996 568999999985431 122356889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+ +|+|.+++... ..+++..+..++.|++.||.|||+. + +.++.+||+|||++........
T Consensus 89 E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp CCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred ECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 999 67999998764 4689999999999999999999864 4 4457899999999987644322
Q ss_pred eeecccccccCCCCcccccCCCC-CCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 301 YVTTRVMGTFGYVAPEYASTGML-NETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
....+||+.|+|||++.+..+ ++++|||||||++|||++|..||.......... ....
T Consensus 164 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-------------------~i~~ 222 (336)
T 3h4j_B 164 --LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-------------------KVNS 222 (336)
T ss_dssp --TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-------------------CCCS
T ss_pred --cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-------------------HHHc
Confidence 344689999999999988776 689999999999999999999997654332211 0000
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
. ....+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 223 ~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 223 C--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp S--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred C--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0 01112234456788999999999999999999985
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=316.01 Aligned_cols=253 Identities=24% Similarity=0.408 Sum_probs=198.8
Q ss_pred hHHHhhCCCCccCeeccCCcEEEEEEEE------CCCCeEEEEEecCcc-hhhHHHHHHHHHHHHhc-CCCCcceEEEEE
Q 047892 152 ELEVSTNGFADENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLVGYC 223 (442)
Q Consensus 152 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 223 (442)
++++..++|.+.+.||+|+||.||+|.+ .+++.||||.+.... ....+.+.+|+.+++++ +||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 3455667899999999999999999984 246789999996543 34457789999999999 999999999999
Q ss_pred EeCCeeeeEEecCCCCCHHHHHccCCCC--------------CCCCCHHHHHHHHHHHHHhhhhhhcC------------
Q 047892 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGP--------------HSPLTWEIRMNIILGTAKGLTYLHEG------------ 277 (442)
Q Consensus 224 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~--------------~~~l~~~~~~~i~~qi~~~l~yLH~~------------ 277 (442)
...+..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+.
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 9999999999999999999999764211 22589999999999999999999875
Q ss_pred -CCCCCCeEEecccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCc
Q 047892 278 -LEPKWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGE 354 (442)
Q Consensus 278 -l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~ 354 (442)
++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 335678999999999876544322 2334567889999999999999999999999999999999 9999975433211
Q ss_pred cchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 355 FQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
..... ... .....+...+..+.+++.+||+.||.+|||+.|+++.|++..
T Consensus 257 ------~~~~~----~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 257 ------FYKMI----KEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp ------HHHHH----HHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HHHHh----ccC---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 11111 111 011112233456888999999999999999999999998653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=322.78 Aligned_cols=237 Identities=19% Similarity=0.270 Sum_probs=184.3
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc---chhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCee
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 229 (442)
+..++|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|..++..+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 44578999999999999999999964 5899999999643 223345678899999988 799999999999999999
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~ 296 (442)
|+|||||++|+|.+++.+. ..+++..++.++.|++.||.|||+. ++.++.+||+|||+++...
T Consensus 100 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 9999999999999999764 4689999999999999999999875 4457899999999998643
Q ss_pred CCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 297 AERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
.. .......+||+.|+|||++.+..|+.++|||||||++|||++|..||...+.. +....... ...
T Consensus 176 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----------~~~~~i~~-~~~-- 241 (353)
T 3txo_A 176 CN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED----------DLFEAILN-DEV-- 241 (353)
T ss_dssp C----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------HHHHHHHH-CCC--
T ss_pred cC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH----------HHHHHHHc-CCC--
Confidence 22 22345578999999999999888999999999999999999999999754321 11111111 111
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCH------HHHHH
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKM------GHVIH 417 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~------~evl~ 417 (442)
..+...+..+.+|+.+||+.||.+||++ .|+++
T Consensus 242 --------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 --------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1112234567889999999999999998 67764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=319.99 Aligned_cols=239 Identities=20% Similarity=0.297 Sum_probs=190.4
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
.++|.+.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456999999999999999999964 5899999999643 2344567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC----------CCCeEEecccCccccCC
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP----------KWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~----------~~~~kl~DFGla~~~~~ 297 (442)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++ ++.+||+|||+++....
T Consensus 108 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp CCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 999999999999754 4689999999999999999999875 332 24599999999987653
Q ss_pred CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
.. .....+||+.|+|||++.+..|+.++|||||||++|||++|..||..... ..+.. . ...+...
T Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-------~~~~~---~-i~~~~~~-- 248 (362)
T 2bdw_A 184 SE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYA---Q-IKAGAYD-- 248 (362)
T ss_dssp CC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH---H-HHHTCCC--
T ss_pred Cc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHH---H-HHhCCCC--
Confidence 32 23446899999999999998999999999999999999999999965321 11111 1 1111110
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 249 ----~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 ----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ----CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ----CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0111112334668889999999999999999999853
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=328.65 Aligned_cols=247 Identities=19% Similarity=0.229 Sum_probs=195.1
Q ss_pred hhhHHHhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 047892 150 LRELEVSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE 225 (442)
Q Consensus 150 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 225 (442)
+.++.+..++|.+.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4556677889999999999999999999975 48899999985421 1122347789999999999999999999999
Q ss_pred CCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCc
Q 047892 226 GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLA 292 (442)
Q Consensus 226 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla 292 (442)
.+..|+|||||++|+|.+++++. .+++..+..++.|++.||.|||+. ++.++.+||+|||++
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEecccee
Confidence 99999999999999999999753 589999999999999999999875 456789999999999
Q ss_pred cccCCCcceeecccccccCCCCcccccCCC----CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHH
Q 047892 293 KLLGAERSYVTTRVMGTFGYVAPEYASTGM----LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTM 368 (442)
Q Consensus 293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 368 (442)
+.............+||+.|+|||++.+.. |+.++|||||||++|||++|+.||...+... ... ..
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~---~i 285 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYS---KI 285 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHH---HH
T ss_pred EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh-------HHH---HH
Confidence 887655444455678999999999997665 8899999999999999999999997543211 111 11
Q ss_pred hhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCC--CCCHHHHHHH
Q 047892 369 VTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHK--RPKMGHVIHM 418 (442)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~evl~~ 418 (442)
..... .+........+.++.+|+.+||+.+|.+ ||++.||++.
T Consensus 286 ~~~~~-------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 286 MNHKN-------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HTHHH-------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred Hhccc-------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 10000 0000111123456888999999999988 9999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=313.72 Aligned_cols=232 Identities=22% Similarity=0.292 Sum_probs=189.2
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 232 (442)
.++|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 456889999999999999999964 58999999985432 22345678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp ECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 9999999999999764 4689999999999999999999876 456789999999999876432
Q ss_pred ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
....+||+.|+|||++.+..++.++|||||||++|||++|..||...+. .......... ..
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----------~~~~~~i~~~-~~----- 220 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----------MKTYEKILNA-EL----- 220 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----------HHHHHHHHHC-CC-----
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----------HHHHHHHHhC-CC-----
Confidence 3356899999999999999999999999999999999999999965322 1111111111 11
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCC-----CHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRP-----KMGHVIH 417 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 417 (442)
..+...+.++.+++.+||+.||++|| ++.++++
T Consensus 221 -----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 -----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11122345688899999999999999 8888874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=319.08 Aligned_cols=240 Identities=22% Similarity=0.277 Sum_probs=185.1
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeee
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~ 230 (442)
..++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|..++.++ +||||+++++++.+.+..|
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3457899999999999999999965 47889999996532 22234578899999887 8999999999999999999
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++....
T Consensus 130 lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999999764 4689999999999999999999875 45578999999999986322
Q ss_pred CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
. .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||......+... ......+.........
T Consensus 206 ~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~--~~~~~~~~~~i~~~~~--- 279 (396)
T 4dc2_A 206 P-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD--QNTEDYLFQVILEKQI--- 279 (396)
T ss_dssp T-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------CCHHHHHHHHHHCCC---
T ss_pred C-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc--hhhHHHHHHHHhcccc---
Confidence 2 223456789999999999999999999999999999999999999997543221110 0111111122111111
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCH
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKM 412 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~ 412 (442)
..+...+.++.+|+.+||+.||.+||++
T Consensus 280 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 -------RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1122234568889999999999999996
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=327.09 Aligned_cols=249 Identities=24% Similarity=0.401 Sum_probs=193.9
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA 227 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 227 (442)
+..++|.+.+.||+|+||.||+|.+. +++.||||.+... .......+.+|+.++++++||||+++++++.+..
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 44567889999999999999999953 3568999998644 3445567889999999999999999999999999
Q ss_pred eeeeEEecCCCCCHHHHHccCC---CCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC----------CCCeEEec
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDV---GPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP----------KWNPKLSD 288 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~---~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~----------~~~~kl~D 288 (442)
..|+|||||++|+|.+++.... .....+++..++.++.|++.||.|||+. +++ +..+||+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999999997532 1224589999999999999999999875 332 23599999
Q ss_pred ccCccccCCCcc-eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHH
Q 047892 289 FGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLK 366 (442)
Q Consensus 289 FGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 366 (442)
||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++ |..||...... .+ .
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~-------~~---~- 296 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-------EV---L- 296 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HH---H-
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HH---H-
Confidence 999986522211 12234568999999999999999999999999999999998 99999754321 11 1
Q ss_pred HHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 367 TMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
.....+. ....+...+..+.+|+.+||+.||++|||+.+|++.|+...
T Consensus 297 ~~i~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 297 EFVTSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHcCC---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1111111 11122233456888999999999999999999999998653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=326.96 Aligned_cols=240 Identities=20% Similarity=0.265 Sum_probs=189.4
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
.++|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 35689999999999999999996 458899999986543 334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC----------CCCeEEecccCccccCC
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP----------KWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~----------~~~~kl~DFGla~~~~~ 297 (442)
|||.+|+|.+++... ..+++..+..++.|++.||.|||+. +++ ++.+||+|||+++....
T Consensus 90 E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 90 DLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp CCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 999999999999765 5689999999999999999999865 433 46799999999987654
Q ss_pred CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||..... ..... . ...+... .
T Consensus 166 ~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-------~~~~~---~-i~~~~~~-~ 232 (444)
T 3soa_A 166 EQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-------HRLYQ---Q-IKAGAYD-F 232 (444)
T ss_dssp TCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHH---H-HHHTCCC-C
T ss_pred CCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-------HHHHH---H-HHhCCCC-C
Confidence 322 23456899999999999998999999999999999999999999965322 11111 1 1111110 0
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 233 -----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 -----PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 111112334568889999999999999999999873
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=331.08 Aligned_cols=251 Identities=18% Similarity=0.223 Sum_probs=196.0
Q ss_pred ehhhHHHhhCCCCccCeeccCCcEEEEEEEECC-CCeEEEEEecCcch---hhHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 047892 149 TLRELEVSTNGFADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLVGYCA 224 (442)
Q Consensus 149 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 224 (442)
.+.++.+..++|++.++||+|+||+||+|+... ++.||+|++..... .....+.+|..++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 345667778899999999999999999999754 78899999854221 12233788999999999999999999999
Q ss_pred eCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccC
Q 047892 225 EGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGL 291 (442)
Q Consensus 225 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGl 291 (442)
+.+..|+|||||++|+|.+++.+. ...+++..+..++.|++.||.|||+. ++.++.+||+|||+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhh
Confidence 999999999999999999999763 25689999999999999999999865 44578999999999
Q ss_pred ccccCCCcceeecccccccCCCCccccc-----CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHH
Q 047892 292 AKLLGAERSYVTTRVMGTFGYVAPEYAS-----TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLK 366 (442)
Q Consensus 292 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 366 (442)
++.............+||+.|+|||++. ...|+.++|||||||++|||++|+.||...+..+ ....+.
T Consensus 222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-------~~~~i~ 294 (437)
T 4aw2_A 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-------TYGKIM 294 (437)
T ss_dssp CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHH
T ss_pred hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH-------HHHhhh
Confidence 9877555444445578999999999986 5679999999999999999999999997543211 111111
Q ss_pred HHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCC--CCCHHHHHHH
Q 047892 367 TMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHK--RPKMGHVIHM 418 (442)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~evl~~ 418 (442)
....... + +.. ....+..+.+|+.+||..+|++ ||++.|+++.
T Consensus 295 ~~~~~~~----~-p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 295 NHKERFQ----F-PTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp THHHHCC----C-CSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hcccccc----C-Ccc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0000000 0 100 1123456788999999988888 9999999863
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=310.94 Aligned_cols=249 Identities=25% Similarity=0.413 Sum_probs=198.0
Q ss_pred hhHHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 151 RELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 151 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
.++++..++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|++++++++||||+++++++.+ +..+
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 83 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcE
Confidence 34566677899999999999999999998888899999986533 235678999999999999999999999864 5689
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++....
T Consensus 84 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 9999999999999996431 12589999999999999999999876 44567899999999988755
Q ss_pred CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
..........++..|+|||++.+..++.++|||||||++|||++ |..||...... ... ... ..+.
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~---~~~-~~~~--- 227 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-------EVI---QNL-ERGY--- 227 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHH---HHH-HTTC---
T ss_pred cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-------HHH---HHH-hccc---
Confidence 44333344567889999999988889999999999999999999 99999653221 111 111 1110
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 228 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 228 ------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 11112233456888999999999999999999999998764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=317.73 Aligned_cols=238 Identities=21% Similarity=0.275 Sum_probs=189.4
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
..++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+|+.++||||+++++++.+.+..|+
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3456899999999999999999964 48899999985432 2334678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
||||+.+|+|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++.+...
T Consensus 93 v~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EECCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999999864 5689999999999999999999875 456789999999999876433
Q ss_pred cceeecccccccCCCCcccccC---CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 299 RSYVTTRVMGTFGYVAPEYAST---GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
. .....+||+.|+|||++.+ ..|+.++|||||||++|||++|..||........ .......... .
T Consensus 169 ~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-------~~~~~~~~~~-~-- 236 (384)
T 4fr4_A 169 T--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-------KEIVHTFETT-V-- 236 (384)
T ss_dssp C--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH-------HHHHHHHHHC-C--
T ss_pred C--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH-------HHHHHHHhhc-c--
Confidence 2 2355789999999999864 4589999999999999999999999975433221 1111111111 0
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCC-HHHHHH
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPK-MGHVIH 417 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-~~evl~ 417 (442)
...+...+..+.+|+.+||+.||.+||+ +.++++
T Consensus 237 --------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 --------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0112233456888999999999999998 777764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=343.54 Aligned_cols=251 Identities=25% Similarity=0.383 Sum_probs=198.6
Q ss_pred hhHHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 151 RELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 151 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
..+++..++|++.+.||+|+||.||+|.+.++..||||++.... ...+.|.+|+++|++++||||+++++++.+ +..|
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 34556677888999999999999999999888889999996543 234678999999999999999999999876 6789
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
|||||+.+|+|.++++... ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++.+..
T Consensus 338 lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp EEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred EeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 9999999999999997421 13588999999999999999999875 33457899999999987643
Q ss_pred CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
..........++..|+|||++.+..++.++|||||||+||||++ |..||..... ..+.. . +..+
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-------~~~~~---~-i~~~---- 480 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLD---Q-VERG---- 480 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-------HHHHH---H-HHTT----
T ss_pred CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHH---H-HHcC----
Confidence 32222233457789999999999999999999999999999999 9999965321 11111 1 1111
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCC
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 425 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 425 (442)
.+...+..++..+.+||.+||+.||++|||+.+|++.|+.+...
T Consensus 481 -----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 481 -----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 11112233456788899999999999999999999999987644
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=306.89 Aligned_cols=258 Identities=20% Similarity=0.237 Sum_probs=196.2
Q ss_pred hCCCCccCeeccCCcEEEEEEEECC-CCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--eeeeE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA--HRMLV 232 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~lv 232 (442)
.++|.+.+.||+|+||.||+|.... ++.||||.+.... ....+.+.+|++++++++||||+++++++...+ ..|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 3458889999999999999999754 8999999986432 234567789999999999999999999998765 77999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-----------CCCCCeEEecccCcccc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-----------EPKWNPKLSDFGLAKLL 295 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-----------~~~~~~kl~DFGla~~~ 295 (442)
|||+++|+|.+++..... ...+++..++.++.|++.||.|||+. + +.++.+||+|||+++..
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 999999999999976421 23489999999999999999999875 3 33456899999999876
Q ss_pred CCCcceeecccccccCCCCccccc--------CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHH
Q 047892 296 GAERSYVTTRVMGTFGYVAPEYAS--------TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKT 367 (442)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 367 (442)
..... .....||+.|+|||++. +..++.++|||||||++|||++|..||......... ...+..
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------~~~~~~ 238 (319)
T 4euu_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN------KEVMYK 238 (319)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC------HHHHHH
T ss_pred CCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh------HHHHHH
Confidence 54332 23457999999999986 577999999999999999999999999754332211 111111
Q ss_pred HhhcCC---cccc---c--------CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 368 MVTNGN---AEGV---L--------DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 368 ~~~~~~---~~~~---~--------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
...... .... . ...............+.+++.+||+.||++|||+.|+++...+..
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 111110 0000 0 001112344677888999999999999999999999999876543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=317.82 Aligned_cols=242 Identities=22% Similarity=0.323 Sum_probs=188.3
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc-----hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR-----GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
.+.|++.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 345889999999999999999964 58999999985321 123567899999999999999999999999999999
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC-------C---CCeEEecccCccc
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP-------K---WNPKLSDFGLAKL 294 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-------~---~~~kl~DFGla~~ 294 (442)
+|||||++|+|.+++.........+++..+..++.|++.||.|||+. +++ + +.+||+|||+++.
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 99999999999988865322234689999999999999999999875 333 2 3499999999987
Q ss_pred cCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.... ..... ... .+..
T Consensus 183 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~---~i~-~~~~ 249 (351)
T 3c0i_A 183 LGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--------ERLFE---GII-KGKY 249 (351)
T ss_dssp CCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--------HHHHH---HHH-HTCC
T ss_pred ecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--------HHHHH---HHH-cCCC
Confidence 654322 2345679999999999999999999999999999999999999996521 11111 111 1111
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
. ..+.. ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 250 ~--~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 K--MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp C--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 00000 0123456888999999999999999999985
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=319.89 Aligned_cols=237 Identities=22% Similarity=0.309 Sum_probs=188.1
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCe
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAH 228 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 228 (442)
.+..++|.+.+.||+|+||.||+|+.. +++.||||.+.... ......+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 455678999999999999999999975 58899999996432 23345677899999876 99999999999999999
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLL 295 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~ 295 (442)
.|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999999999764 4689999999999999999999876 445789999999999864
Q ss_pred CCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 296 GAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...+.. .+.. .... ..
T Consensus 169 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~---~i~~-~~-- 234 (345)
T 1xjd_A 169 MLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFH---SIRM-DN-- 234 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHH---HHHH-CC--
T ss_pred ccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-------HHHH---HHHh-CC--
Confidence 3222 2245578999999999999999999999999999999999999999754321 1111 1111 11
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHH-HHH
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMG-HVI 416 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~-evl 416 (442)
.. .+...+..+.+|+.+||+.||++||++. +++
T Consensus 235 ----~~----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 ----PF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ----CC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ----CC----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11 1122345688899999999999999997 665
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=318.23 Aligned_cols=240 Identities=18% Similarity=0.266 Sum_probs=178.2
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
.++|.+.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 356889999999999999999965 68999999986532 2235688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC-------CC--CeEEecccCccccCCCcc
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP-------KW--NPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-------~~--~~kl~DFGla~~~~~~~~ 300 (442)
+++|+|.+++... ..+++..+..++.|++.||.|||+. +++ ++ .+||+|||+++......
T Consensus 98 ~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~- 172 (361)
T 3uc3_A 98 ASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 172 (361)
T ss_dssp CCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence 9999999999754 4689999999999999999999875 333 33 49999999997542221
Q ss_pred eeecccccccCCCCcccccCCCCCCc-CCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNET-SDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
.....+||+.|+|||++.+..++.+ +|||||||++|||++|+.||........+ ...+......
T Consensus 173 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------~~~~~~~~~~-------- 237 (361)
T 3uc3_A 173 -QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY------RKTIQRILSV-------- 237 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH------HHHHHHHHTT--------
T ss_pred -CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH------HHHHHHHhcC--------
Confidence 2334579999999999988887765 89999999999999999999765443321 1111111111
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
..........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 238 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 238 -KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11111111234567889999999999999999999853
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=312.24 Aligned_cols=239 Identities=23% Similarity=0.279 Sum_probs=185.8
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc---chhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 231 (442)
.++|++.+.||+|+||.||+|+.. +++.||+|++... .......+.+|..++.++ +||||+++++++.+.+..|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 456889999999999999999975 5889999999643 233456688999999988 89999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
||||+++|+|.+++.+. ..+++..++.++.|++.||.|||+. ++.++.+||+|||+++.....
T Consensus 88 v~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999999764 4689999999999999999999875 445789999999999864222
Q ss_pred cceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 299 RSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
. ......+||+.|+|||++.+..++.++|||||||++|||++|..||.......... ......+.........
T Consensus 164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~~~i~~~~~---- 236 (345)
T 3a8x_A 164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD--QNTEDYLFQVILEKQI---- 236 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------CHHHHHHHHHHCCC----
T ss_pred C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc--cccHHHHHHHHHcCCC----
Confidence 2 22445689999999999999999999999999999999999999997532221100 0011111111111111
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCH
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKM 412 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~ 412 (442)
..+...+..+.+|+.+||+.||.+||++
T Consensus 237 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ------RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ------CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1112334568889999999999999996
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=304.00 Aligned_cols=248 Identities=19% Similarity=0.288 Sum_probs=184.5
Q ss_pred CCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcch--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 158 NGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
++|++.+.||+|+||.||+|...+++.||+|++..... .....+.+|+.++++++||||+++++++.+.+..|+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888999999999999999997799999999854322 2346688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++ +|.+++... ...+++..+..++.|++.||.|||+. ++.++.+||+|||+++....... .
T Consensus 82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (288)
T ss_dssp CSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-c
Confidence 986 999998754 24689999999999999999999876 44578999999999987643221 2
Q ss_pred ecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc------
Q 047892 303 TTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE------ 375 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 375 (442)
.....||+.|+|||++.+. .++.++|||||||++|||++|..||...... .....+..........
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-------DQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHHHCCCCTTTSTTGG
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHHHCCCChhhchhhh
Confidence 2345789999999998764 5899999999999999999999999754321 1111111111110000
Q ss_pred --cccCcccCC-------CCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 376 --GVLDPRLQE-------KPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 376 --~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
...++.+.. ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000 001123456788999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=315.42 Aligned_cols=253 Identities=20% Similarity=0.374 Sum_probs=182.1
Q ss_pred hhHHHhhCCCCccCeeccCCcEEEEEEEECC-C---CeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 047892 151 RELEVSTNGFADENVIGEGGYGIVYRGVLED-N---TNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCA 224 (442)
Q Consensus 151 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 224 (442)
+++.+..++|.+.+.||+|+||.||+|.+.. + ..||||.+... .....+.+.+|++++++++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 4455667789999999999999999999543 3 27999998654 3345677999999999999999999999998
Q ss_pred eCCee------eeEEecCCCCCHHHHHccCC--CCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCC
Q 047892 225 EGAHR------MLVNEYVDNGNLEQWLHGDV--GPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWN 283 (442)
Q Consensus 225 ~~~~~------~lv~E~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~ 283 (442)
..... ++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+. ++.++.
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC
Confidence 77655 99999999999999996431 1223689999999999999999999875 445679
Q ss_pred eEEecccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhH
Q 047892 284 PKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNL 361 (442)
Q Consensus 284 ~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~ 361 (442)
+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||....... .
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~ 248 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-------I 248 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------H
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-------H
Confidence 999999999876443322 2233456889999999999999999999999999999999 999997643321 1
Q ss_pred HHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 362 FEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
.. ... ... ....+...+..+.+|+.+||+.||++|||+.++++.|+++.
T Consensus 249 ~~---~~~-~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 249 YN---YLI-GGN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp HH---HHH-TTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH---HHh-cCC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11 111 111 01112233456888999999999999999999999998753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=305.61 Aligned_cols=240 Identities=18% Similarity=0.307 Sum_probs=189.9
Q ss_pred hhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--Ceeee
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG--AHRML 231 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~l 231 (442)
..++|.+.+.||+|+||.||+|.+. ++.||||.+... .....+.+.+|+.++++++||||+++++++.+. +..++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 4457899999999999999999984 888999998654 334456799999999999999999999999877 77899
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC---------------CCCCCCeEEecccCccccC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---------------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---------------l~~~~~~kl~DFGla~~~~ 296 (442)
||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. ++.++.+||+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred eecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999998642 23589999999999999999999974 3346788999998876532
Q ss_pred CCcceeecccccccCCCCcccccCCCCCC---cCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC
Q 047892 297 AERSYVTTRVMGTFGYVAPEYASTGMLNE---TSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373 (442)
Q Consensus 297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (442)
. ....||+.|+|||++.+..++. ++|||||||++|||++|+.||..... ............
T Consensus 165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------~~~~~~~~~~~~ 228 (271)
T 3kmu_A 165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN----------MEIGMKVALEGL 228 (271)
T ss_dssp C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH----------HHHHHHHHHSCC
T ss_pred c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh----------HHHHHHHHhcCC
Confidence 2 2346899999999998766554 79999999999999999999965322 111111111111
Q ss_pred cccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 374 AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 229 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 229 ---------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11122234456888999999999999999999999998765
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=316.20 Aligned_cols=250 Identities=24% Similarity=0.417 Sum_probs=196.2
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEEC--------CCCeEEEEEecCc-chhhHHHHHHHHHHHHhc-CCCCcceEEEEE
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLE--------DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYC 223 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 223 (442)
++..++|.+.+.||+|+||.||+|.+. ++..||||.+... .......+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 455678999999999999999999863 4678999999654 334456789999999999 999999999999
Q ss_pred EeCCeeeeEEecCCCCCHHHHHccCCCC------------CCCCCHHHHHHHHHHHHHhhhhhhcC-------------C
Q 047892 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGP------------HSPLTWEIRMNIILGTAKGLTYLHEG-------------L 278 (442)
Q Consensus 224 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l 278 (442)
...+..|+||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 9999999999999999999999764321 23489999999999999999999876 4
Q ss_pred CCCCCeEEecccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccc
Q 047892 279 EPKWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQ 356 (442)
Q Consensus 279 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~ 356 (442)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----- 265 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 265 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-----
Confidence 45789999999999876543322 2233467889999999988889999999999999999999 9999965321
Q ss_pred hhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 357 FQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
..+.. .. .... ....+...+..+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 266 --~~~~~---~~-~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 266 --EELFK---LL-KEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp --HHHHH---HH-HHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHH---HH-hcCC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111 11 1111 01112233456888999999999999999999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=310.63 Aligned_cols=236 Identities=22% Similarity=0.294 Sum_probs=180.5
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcch--------------------------hhHHHHHHHHHHHH
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRG--------------------------QAEKEFKVEVEAIG 209 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 209 (442)
.++|.+.+.||+|+||.||+|... +++.||||.+..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 457899999999999999999964 588999999854321 11245889999999
Q ss_pred hcCCCCcceEEEEEEe--CCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC----------
Q 047892 210 RVRHKNLVRLVGYCAE--GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---------- 277 (442)
Q Consensus 210 ~l~hpnIv~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---------- 277 (442)
+++||||+++++++.+ .+..|+||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 9999999999999986 5688999999999999886543 4689999999999999999999875
Q ss_pred ---CCCCCCeEEecccCccccCCCcceeecccccccCCCCcccccCCC---CCCcCCchhhHHHHHHHHhCCCCCCCCCC
Q 047892 278 ---LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM---LNETSDVYSFGILIMEVISGRNPVDYSRP 351 (442)
Q Consensus 278 ---l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvil~elltg~~Pf~~~~~ 351 (442)
++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||.....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 44578999999999987654332 234467999999999997665 47789999999999999999999964321
Q ss_pred CCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 352 PGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
........ .... ........+..+.+|+.+||+.||++|||+.|+++
T Consensus 246 ----------~~~~~~~~-~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 ----------MCLHSKIK-SQAL--------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ----------HHHHHHHH-HCCC--------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----------HHHHHHHh-cccC--------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 11111111 1111 00111123456888999999999999999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=311.91 Aligned_cols=257 Identities=24% Similarity=0.310 Sum_probs=194.9
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEE----eCCee
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCA----EGAHR 229 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~----~~~~~ 229 (442)
+..++|++.+.||+|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++||||+++++++. .....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 4456799999999999999999996 568999999987656666778999999999999999999999986 33578
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~ 296 (442)
|+||||+.+|+|.+++.........+++..++.++.|++.||.|||+. ++.++.+||+|||++....
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999999999999976333346789999999999999999999876 4457899999999987643
Q ss_pred CCcce--------eecccccccCCCCcccccCCC---CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHH
Q 047892 297 AERSY--------VTTRVMGTFGYVAPEYASTGM---LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWL 365 (442)
Q Consensus 297 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 365 (442)
..... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ ...
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~--- 257 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-----SVA--- 257 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-----CHH---
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-----hhh---
Confidence 21110 012345799999999987554 68899999999999999999999953110000 000
Q ss_pred HHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCCChhh
Q 047892 366 KTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDE 429 (442)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 429 (442)
..... ..........+..+.+++.+||+.||.+|||+.++++.|+.+..+.+.+
T Consensus 258 -~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 258 -LAVQN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp -HHHHC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred -HHhhc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 00111 0111111233456888999999999999999999999999987665543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=305.17 Aligned_cols=241 Identities=27% Similarity=0.498 Sum_probs=186.4
Q ss_pred hhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchh---h----HHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 047892 156 STNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQ---A----EKEFKVEVEAIGRVRHKNLVRLVGYCAEGA 227 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~----~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 227 (442)
..++|++.+.||+|+||.||+|.. .+++.||+|.+...... . .+.+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 346788999999999999999996 46899999998543221 1 167889999999999999999999986654
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC--------CCC-------CCC-----eEEe
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--------LEP-------KWN-----PKLS 287 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------l~~-------~~~-----~kl~ 287 (442)
++||||+++|+|.+++... ...+++..++.++.|++.||.|||+. +++ ++. +||+
T Consensus 97 --~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 7999999999999998654 34689999999999999999999875 222 333 9999
Q ss_pred cccCccccCCCcceeecccccccCCCCcccc--cCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHH
Q 047892 288 DFGLAKLLGAERSYVTTRVMGTFGYVAPEYA--STGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWL 365 (442)
Q Consensus 288 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 365 (442)
|||+++..... .....||+.|+|||++ ....++.++|||||||++|||++|+.||........ ...
T Consensus 172 Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------~~~ 239 (287)
T 4f0f_A 172 DFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI--------KFI 239 (287)
T ss_dssp CCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH--------HHH
T ss_pred CCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH--------HHH
Confidence 99999854332 3446799999999998 345578999999999999999999999975433211 111
Q ss_pred HHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 366 KTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
....... .....+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 240 ~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 240 NMIREEG---------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHSC---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHhccC---------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111111 11112223446688899999999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=311.32 Aligned_cols=238 Identities=22% Similarity=0.282 Sum_probs=174.4
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
.+.|++.+.||+|+||.||+|... +++.||||.+.... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 456889999999999999999975 47889999986532 345688899999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CC---CCCCeEEecccCccccCCCc
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LE---PKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~---~~~~~kl~DFGla~~~~~~~ 299 (442)
+++|+|.+++... ..+++..++.++.|++.||.|||+. ++ .++.+||+|||+++......
T Consensus 130 ~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 130 VTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp CCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 9999999999764 4689999999999999999999875 22 36789999999998764322
Q ss_pred ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
......||+.|+|||++.+..++.++|||||||++|||++|..||....... ........... ...
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----------~~~~~i~~~~~-~~~- 271 (349)
T 2w4o_A 206 --LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ----------FMFRRILNCEY-YFI- 271 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH----------HHHHHHHTTCC-CCC-
T ss_pred --ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH----------HHHHHHHhCCC-ccC-
Confidence 2344679999999999999899999999999999999999999996543211 01111111111 011
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 272 ----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 272 ----SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11112334568889999999999999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=316.59 Aligned_cols=243 Identities=25% Similarity=0.426 Sum_probs=185.1
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCC----eEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNT----NVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
.++|++.+.||+|+||.||+|.+. +++ +||+|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 456889999999999999999953 344 3688887543 2345577899999999999999999999998755 78
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~~~~ 297 (442)
+|+||+.+|+|.+++... ...+++..++.++.|++.||.|||+. ++ .++.+||+|||+++....
T Consensus 93 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 999999999999999764 25689999999999999999999875 33 357899999999987654
Q ss_pred Ccce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 298 ERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 298 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
.... ......||+.|+|||++.+..++.++|||||||++|||++ |..||....... +.. ......
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~----~~~~~~-- 236 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISS----ILEKGE-- 236 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHH----HHHTTC--
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-------HHH----HHHcCC--
Confidence 3322 2234467889999999999999999999999999999999 999997543211 111 111111
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 237 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 237 -------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11112234456888999999999999999999999998764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=307.74 Aligned_cols=238 Identities=19% Similarity=0.349 Sum_probs=183.4
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--------
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA-------- 227 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-------- 227 (442)
++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+|++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 45888999999999999999975 6899999999643 3345677999999999999999999999986543
Q ss_pred -------------------------------------------------eeeeEEecCCCCCHHHHHccCCCCCCCCCHH
Q 047892 228 -------------------------------------------------HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWE 258 (442)
Q Consensus 228 -------------------------------------------------~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~ 258 (442)
..++|||||++|+|.+++..... .....+.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~ 164 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREHG 164 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhhH
Confidence 37999999999999999986532 2346777
Q ss_pred HHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc-----------eeecccccccCCCC
Q 047892 259 IRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS-----------YVTTRVMGTFGYVA 314 (442)
Q Consensus 259 ~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~gt~~y~a 314 (442)
.++.++.|++.||.|||+. ++.++.+||+|||+++....... .......||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 8899999999999999876 44578999999999987754321 12234579999999
Q ss_pred cccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHH
Q 047892 315 PEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRA 394 (442)
Q Consensus 315 PE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (442)
||++.+..++.++|||||||++|||++|..|+. ......... .... ...........+
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~------------~~~~~~~~~-~~~~---------~~~~~~~~~~~~ 302 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM------------ERVRIITDV-RNLK---------FPLLFTQKYPQE 302 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH------------HHHHHHHHH-HTTC---------CCHHHHHHCHHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh------------HHHHHHHHh-hccC---------CCcccccCChhH
Confidence 999999999999999999999999999877642 111111111 1110 011123445667
Q ss_pred HHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 395 LLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 395 ~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.+|+.+||+.||++|||+.|+++.
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 889999999999999999999863
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=313.74 Aligned_cols=261 Identities=22% Similarity=0.380 Sum_probs=203.2
Q ss_pred eehhhHHHhhCCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEE
Q 047892 148 YTLRELEVSTNGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLV 220 (442)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~ 220 (442)
+...++++..++|.+.+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+.+++.++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344556677788999999999999999999853 36789999986543 34456788999999999999999999
Q ss_pred EEEEeCCeeeeEEecCCCCCHHHHHccCC------CCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCC
Q 047892 221 GYCAEGAHRMLVNEYVDNGNLEQWLHGDV------GPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPK 281 (442)
Q Consensus 221 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~ 281 (442)
+++.+.+..++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+. ++.+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 174 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC
Confidence 99999999999999999999999986421 1124578999999999999999999875 4456
Q ss_pred CCeEEecccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhh
Q 047892 282 WNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQV 359 (442)
Q Consensus 282 ~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~ 359 (442)
+.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------- 246 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------- 246 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH--------
Confidence 79999999999866433222 2233467889999999998899999999999999999999 8999965321
Q ss_pred hHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCCChh
Q 047892 360 NLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRD 428 (442)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 428 (442)
.... ........ ...+...+..+.+++.+||+.||.+|||+.|+++.|++...+...
T Consensus 247 --~~~~-~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~ 303 (322)
T 1p4o_A 247 --EQVL-RFVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 303 (322)
T ss_dssp --HHHH-HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred --HHHH-HHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCc
Confidence 1111 11111111 011223345688899999999999999999999999988665443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=302.00 Aligned_cols=250 Identities=27% Similarity=0.430 Sum_probs=182.8
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
++..++|++.+.||+|+||.||+|.+. ..||+|.+... .....+.+.+|+.++++++||||+++++++ .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 455678999999999999999999863 36999998643 334557789999999999999999999965 4566899
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
||||+++++|.+++... ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++.....
T Consensus 97 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EEEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 99999999999999654 35689999999999999999999875 334678999999999865432
Q ss_pred c-ceeecccccccCCCCccccc---CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 299 R-SYVTTRVMGTFGYVAPEYAS---TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 299 ~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
. ........||+.|+|||++. +..++.++|||||||++|||++|+.||....... .+.........
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----------~~~~~~~~~~~ 243 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----------QIIEMVGRGSL 243 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH----------HHHHHHHHTSC
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH----------HHHHHhccccc
Confidence 2 12233457999999999986 5678899999999999999999999997543211 11111111111
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCC
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 424 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 424 (442)
.... ......++..+.+|+.+||+.||++|||+.++++.|+++..
T Consensus 244 ~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 244 SPDL-----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCCT-----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred Ccch-----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1111 11122344668889999999999999999999999998753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=315.19 Aligned_cols=232 Identities=20% Similarity=0.235 Sum_probs=189.3
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 232 (442)
.++|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 457899999999999999999965 58999999985432 23346688899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
|||+++|+|.+++.+. ..+++..++.++.|++.||.|||+. ++.++.+||+|||+++.....
T Consensus 120 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999999764 4689999999999999999999875 455789999999999876432
Q ss_pred ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
....+||+.|+|||++.+..++.++|||||||++|||++|..||..... ......... +..
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----------~~~~~~i~~-~~~----- 255 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP----------IQIYEKIVS-GKV----- 255 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------HHHHHHHHH-CCC-----
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH----------HHHHHHHHc-CCC-----
Confidence 2346899999999999999999999999999999999999999975422 111111111 111
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCC-----HHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPK-----MGHVIH 417 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~ 417 (442)
..+...+..+.+|+.+||+.||.+||+ +.||++
T Consensus 256 -----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 111223456888999999999999998 888875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=326.74 Aligned_cols=250 Identities=18% Similarity=0.193 Sum_probs=194.2
Q ss_pred ehhhHHHhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcch---hhHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 047892 149 TLRELEVSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLVGYCA 224 (442)
Q Consensus 149 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 224 (442)
.+.+..+..++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 45566777889999999999999999999974 689999999854321 22234788999999999999999999999
Q ss_pred eCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccC
Q 047892 225 EGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGL 291 (442)
Q Consensus 225 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGl 291 (442)
+.+..|+||||+++|+|.+++.+. ...+++..++.++.|++.||+|||+. ++.++.+||+|||+
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechh
Confidence 999999999999999999999753 13689999999999999999999875 45578999999999
Q ss_pred ccccCCCcceeecccccccCCCCccccc-------CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHH
Q 047892 292 AKLLGAERSYVTTRVMGTFGYVAPEYAS-------TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEW 364 (442)
Q Consensus 292 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 364 (442)
++.............+||+.|+|||++. ...|+.++|||||||++|||++|+.||...+... ....
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~ 281 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-------TYGK 281 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHH
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH-------HHHH
Confidence 9877554443444578999999999987 3568999999999999999999999997543211 1111
Q ss_pred HHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCC---CCHHHHHHH
Q 047892 365 LKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKR---PKMGHVIHM 418 (442)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R---Ps~~evl~~ 418 (442)
+...... ...+. .....+.++.+|+.+||. +|.+| |++.|+++.
T Consensus 282 i~~~~~~-----~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 282 IVHYKEH-----LSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHTHHHH-----CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHhcccC-----cCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1000000 00011 112234568889999999 99998 589998753
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=303.00 Aligned_cols=249 Identities=18% Similarity=0.222 Sum_probs=184.5
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 232 (442)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467999999999999999999965 58899999986432 23346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
|||+++++|.+++... ..+++..++.++.|++.||.|||+. ++.++.+||+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 9999999999999764 4689999999999999999999876 4457889999999998765443
Q ss_pred ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+......... .
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------~~~~~~~~~~~~----~ 253 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-----------SVMGAHINQAIP----R 253 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-----------HHHHHHHHSCCC----C
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-----------HHHHHHhccCCC----C
Confidence 3333456789999999999998999999999999999999999999964321 111111111110 0
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCC-CHHHHHHHHhcCCCCCh
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRP-KMGHVIHMLEAEEFPFR 427 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~~ 427 (442)
+ .......+..+.+++.+||+.||++|| |+.++++.|+.......
T Consensus 254 ~---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 254 P---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp G---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred c---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 0 011122334577899999999999999 99999999998765443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=313.42 Aligned_cols=273 Identities=23% Similarity=0.335 Sum_probs=189.9
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHH--HHhcCCCCcceEEEEEEe-----CC
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEA--IGRVRHKNLVRLVGYCAE-----GA 227 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~hpnIv~l~~~~~~-----~~ 227 (442)
+..++|++.+.||+|+||.||+|.. +++.||||++... ....+..|.++ +..++||||+++++.+.. ..
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 4456799999999999999999987 6889999998543 23334444444 456899999999986542 23
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC----------------------CCCCCCeE
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG----------------------LEPKWNPK 285 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~----------------------l~~~~~~k 285 (442)
..|+||||+++|+|.++++.. ..++..++.++.|++.||.|||+. ++.++.+|
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred eEEEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 678999999999999999764 458889999999999999999964 33467899
Q ss_pred EecccCccccCCCcc-------eeecccccccCCCCcccccC-------CCCCCcCCchhhHHHHHHHHhCCCCCCCCCC
Q 047892 286 LSDFGLAKLLGAERS-------YVTTRVMGTFGYVAPEYAST-------GMLNETSDVYSFGILIMEVISGRNPVDYSRP 351 (442)
Q Consensus 286 l~DFGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvil~elltg~~Pf~~~~~ 351 (442)
|+|||+++.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987643221 12234579999999999976 3567789999999999999999777654433
Q ss_pred CCccchhh-------hHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCC
Q 047892 352 PGEFQFQV-------NLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 424 (442)
Q Consensus 352 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 424 (442)
........ ..................+...+ ......+..+.+|+.+||+.||++|||+.|+++.|+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 22221110 01111112222211111111111 1223467789999999999999999999999999999987
Q ss_pred CChhhhhhcccCCC
Q 047892 425 PFRDERRAGREHGR 438 (442)
Q Consensus 425 ~~~~~~~~~~~~~~ 438 (442)
.+..++.....+.+
T Consensus 319 ~~~~~~~~~~~~~~ 332 (336)
T 3g2f_A 319 IWERNKSVSPTAHH 332 (336)
T ss_dssp CCCC----------
T ss_pred HHHhcccCCCcccc
Confidence 77777665554443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=312.56 Aligned_cols=236 Identities=24% Similarity=0.302 Sum_probs=179.1
Q ss_pred hhCCCCccCeeccCCcEEEEEEEE----CCCCeEEEEEecCcc----hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 047892 156 STNGFADENVIGEGGYGIVYRGVL----EDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA 227 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 227 (442)
..++|++.+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|+.+|+.++||||+++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 345689999999999999999996 468999999986532 233456788999999999999999999999999
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKL 294 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~ 294 (442)
..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++.
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999999764 4688999999999999999999875 34567899999999976
Q ss_pred cCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... ......... ..
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------~~~~~i~~~-~~ 238 (327)
T 3a62_A 171 SIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK----------KTIDKILKC-KL 238 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----------HHHHHHHHT-CC
T ss_pred cccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH----------HHHHHHHhC-CC
Confidence 43222 2234568999999999999989999999999999999999999999754321 111111111 10
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCC-----CHHHHHH
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRP-----KMGHVIH 417 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 417 (442)
..+...+..+.+|+.+||+.||++|| ++.|+++
T Consensus 239 ----------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 ----------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ----------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ----------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11122345688899999999999999 7778775
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=315.31 Aligned_cols=237 Identities=21% Similarity=0.270 Sum_probs=188.2
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEECC-CCeEEEEEecCcc---hhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCee
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 229 (442)
+..++|++.+.||+|+||.||+|+... ++.||+|.+.... ......+.+|..++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 445789999999999999999999754 7889999985432 23345678899999988 899999999999999999
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~ 296 (442)
|+||||+++|+|.+++... ..+++..++.++.|++.||.|||+. ++.++.+||+|||+++...
T Consensus 97 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999999999764 4689999999999999999999875 4457899999999998643
Q ss_pred CCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 297 AERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+ ...... ...
T Consensus 173 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~---~~~i~~-~~~-- 238 (353)
T 2i0e_A 173 WD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------EL---FQSIME-HNV-- 238 (353)
T ss_dssp CT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HH---HHHHHH-CCC--
T ss_pred cC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH-------HH---HHHHHh-CCC--
Confidence 22 22244578999999999999999999999999999999999999999754321 11 111111 111
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCC-----HHHHHH
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPK-----MGHVIH 417 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~ 417 (442)
..+...+.++.+|+.+||+.||.+||+ +.++++
T Consensus 239 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 --------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred --------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 111234456888999999999999995 466654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=308.18 Aligned_cols=245 Identities=22% Similarity=0.379 Sum_probs=188.5
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEECC----CCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLED----NTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 229 (442)
+..++|.+.+.||+|+||.||+|.+.. +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+ +..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 87 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence 445678999999999999999998543 235999998654 33456778999999999999999999999865 457
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~~~ 296 (442)
|+||||+++|+|.+++... ...+++..++.++.|++.||.|||+. ++ .++.+||+|||+++...
T Consensus 88 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 8999999999999999754 24589999999999999999999875 33 45789999999998765
Q ss_pred CCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 297 AERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
...........+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... ....+. ...
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-------~~~~~~----~~~-- 231 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-------VIGVLE----KGD-- 231 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-------HHHHHH----HTC--
T ss_pred cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-------HHHHHh----cCC--
Confidence 443333344567889999999988899999999999999999998 999996543211 111111 110
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....+...+..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 232 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 232 -------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 00111223456888999999999999999999999998763
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=316.80 Aligned_cols=241 Identities=20% Similarity=0.315 Sum_probs=183.2
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCC--CCcceEEEEEEeCCeee
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRH--KNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~ 230 (442)
+..+.|++.+.||+|+||.||+|...+++.||||++... .....+.+.+|+.+|.+++| |||+++++++.+.+..|
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 345568999999999999999999888999999998543 33445778999999999987 99999999999999999
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC------CCCeEEecccCccccCCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP------KWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~------~~~~kl~DFGla~~~~~~ 298 (442)
+||| +.+|+|.+++... ..+++..+..++.|++.||.|||+. +++ ++.+||+|||+++.....
T Consensus 86 lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEC-CCSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCCC---
T ss_pred EEEe-CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEECCcEEEeecccccccCcc
Confidence 9999 5677999999865 5689999999999999999999865 443 467999999999876443
Q ss_pred cce-eecccccccCCCCcccccC-----------CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHH
Q 047892 299 RSY-VTTRVMGTFGYVAPEYAST-----------GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLK 366 (442)
Q Consensus 299 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 366 (442)
... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---------~~~~~~ 231 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---------QISKLH 231 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS---------HHHHHH
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh---------HHHHHH
Confidence 322 2345679999999999864 6789999999999999999999999964321 111111
Q ss_pred HHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 367 TMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.... +......+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 232 ~~~~---------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 232 AIID---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHC---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhc---------CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111 111111122223457889999999999999999999854
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=315.78 Aligned_cols=239 Identities=20% Similarity=0.235 Sum_probs=176.3
Q ss_pred CCCCcc-CeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHH-hcCCCCcceEEEEEEe----CCeee
Q 047892 158 NGFADE-NVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIG-RVRHKNLVRLVGYCAE----GAHRM 230 (442)
Q Consensus 158 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~----~~~~~ 230 (442)
++|.+. +.||+|+||.||+|... +++.||||++... ..+.+|+.++. ..+||||+++++++.. ...+|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 68999999999999964 5889999998532 34667888874 4589999999999875 56789
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CC---CCCeEEecccCccc
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EP---KWNPKLSDFGLAKL 294 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~---~~~~kl~DFGla~~ 294 (442)
||||||++|+|.+++.... ...+++..+..++.|++.||.|||+. + +. ++.+||+|||+++.
T Consensus 136 lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 9999999999999997642 24689999999999999999999875 2 23 57899999999987
Q ss_pred cCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
..... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||........... ....+ ..+..
T Consensus 214 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~~i----~~~~~ 284 (400)
T 1nxk_A 214 TTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRI----RMGQY 284 (400)
T ss_dssp CC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS---HHHHH----HHTCC
T ss_pred cCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH---HHHHH----HcCcc
Confidence 64322 23456899999999999999999999999999999999999999976544322110 11111 11111
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
. +........+.++.+|+.+||+.||++|||+.|+++.
T Consensus 285 ~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 E------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp C------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0111112344668889999999999999999999863
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=311.29 Aligned_cols=237 Identities=22% Similarity=0.322 Sum_probs=165.6
Q ss_pred cCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeeeEEecCCCCC
Q 047892 163 ENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLVGYCAEGAHRMLVNEYVDNGN 240 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~~g~ 240 (442)
.+.||+|+||.||+|... +++.||||.+.. .....+.+|+.+++.+. ||||+++++++.+....|+||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999974 589999999843 34466788999999997 9999999999999999999999999999
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC-------CC---CeEEecccCccccCCCcceeec
Q 047892 241 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP-------KW---NPKLSDFGLAKLLGAERSYVTT 304 (442)
Q Consensus 241 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-------~~---~~kl~DFGla~~~~~~~~~~~~ 304 (442)
|.+++... ..+++..+..++.|++.||.|||+. +++ ++ .+||+|||+++....... ...
T Consensus 93 L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~ 167 (325)
T 3kn6_A 93 LFERIKKK----KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLK 167 (325)
T ss_dssp HHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-ccc
Confidence 99999865 5689999999999999999999875 333 22 799999999987543322 234
Q ss_pred ccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCC
Q 047892 305 RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQE 384 (442)
Q Consensus 305 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (442)
..+||+.|+|||++.+..++.++|||||||++|||++|..||........... ..+.. .....+.. .+..
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---~~~~~-~~i~~~~~------~~~~ 237 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS---AVEIM-KKIKKGDF------SFEG 237 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCC---HHHHH-HHHTTTCC------CCCS
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccccc---HHHHH-HHHHcCCC------CCCc
Confidence 45789999999999999999999999999999999999999976543221111 11111 11111111 0111
Q ss_pred CCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 385 KPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 385 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
......+.++.+|+.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 111234567889999999999999999999984
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=323.92 Aligned_cols=238 Identities=21% Similarity=0.366 Sum_probs=191.5
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 232 (442)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 456889999999999999999975 68999999985432 12345788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
|||+++|+|.+++... ..+++..++.++.|++.||.|||+. ++.++.+||+|||+++......
T Consensus 95 ~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 95 MEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 9999999999999754 5689999999999999999999875 4557899999999998764432
Q ss_pred ceeecccccccCCCCcccccCCCC-CCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGML-NETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
.....+||+.|+|||++.+..+ +.++|||||||++|||++|..||...... .+ .... ..+..
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-------~~---~~~i-~~~~~---- 233 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-------TL---FKKI-CDGIF---- 233 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-------HH---HHHH-HTTCC----
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-------HH---HHHH-hcCCc----
Confidence 2345689999999999988776 68999999999999999999999754321 11 1111 11111
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH--HHhc
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEA 421 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~--~L~~ 421 (442)
..+...+..+.+|+.+||+.||.+|||+.|+++ .+..
T Consensus 234 ------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 234 ------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred ------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 011123356788999999999999999999996 4543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=317.71 Aligned_cols=259 Identities=21% Similarity=0.280 Sum_probs=196.4
Q ss_pred hhCCCCccCeeccCCcEEEEEEEE-----CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEE--eCCe
Q 047892 156 STNGFADENVIGEGGYGIVYRGVL-----EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCA--EGAH 228 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~~ 228 (442)
..++|++.+.||+|+||.||+|.+ .+++.||||++........+.+.+|++++++++||||+++++++. +...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 345688999999999999999984 357889999997766666778999999999999999999999987 4567
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCcccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKLL 295 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~~ 295 (442)
.|+||||+++|+|.+++... ...+++..++.++.|++.||.|||+. ++ .++.+||+|||+++..
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 89999999999999999753 13589999999999999999999875 33 4678999999999876
Q ss_pred CCCcce--eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCcc----chhhhHHHHHHHHh
Q 047892 296 GAERSY--VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEF----QFQVNLFEWLKTMV 369 (442)
Q Consensus 296 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~----~~~~~~~~~~~~~~ 369 (442)
...... ......||+.|+|||++.+..++.++|||||||++|||++|..||......... ..............
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 543322 223456888999999999888999999999999999999999998542110000 00000001111111
Q ss_pred hcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCCC
Q 047892 370 TNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPF 426 (442)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 426 (442)
.. ......+...+..+.+|+.+||+.||++|||+.|+++.|+.+....
T Consensus 258 ~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 258 EE---------GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hc---------ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 11 1111223344566888999999999999999999999999875443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=307.36 Aligned_cols=244 Identities=25% Similarity=0.421 Sum_probs=192.1
Q ss_pred hhCCCCccC-eeccCCcEEEEEEEEC---CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 156 STNGFADEN-VIGEGGYGIVYRGVLE---DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 156 ~~~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
..++|.+.+ .||+|+||.||+|.+. ++..||||.+... .....+.+.+|++++++++||||+++++++ ..+..+
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence 345566666 8999999999999853 5778999999654 334567789999999999999999999999 456689
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~~~~ 297 (442)
+||||+++|+|.+++... ...+++..++.++.|++.||.|||+. ++ .++.+||+|||+++....
T Consensus 86 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999999653 35689999999999999999999875 33 467899999999987754
Q ss_pred Cccee--ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 298 ERSYV--TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 298 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
..... .....||+.|+|||++.+..++.++|||||||++|||++ |..||...... .... ....+.
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~----~i~~~~- 230 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMA----FIEQGK- 230 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------HHHH----HHHTTC-
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-------HHHH----HHhcCC-
Confidence 33221 223456889999999988889999999999999999999 99999754321 1111 111111
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 231 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 231 --------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp --------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01122234467888999999999999999999999998764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=314.59 Aligned_cols=237 Identities=21% Similarity=0.280 Sum_probs=184.1
Q ss_pred cCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCCCCH
Q 047892 163 ENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNL 241 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~g~L 241 (442)
.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|++++++++||||+++++++.+.+..|+||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56899999999999996 45899999999776556667899999999999999999999999999999999999999999
Q ss_pred HHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C---------CCCCCeEEecccCccccCCCcceeeccc
Q 047892 242 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L---------EPKWNPKLSDFGLAKLLGAERSYVTTRV 306 (442)
Q Consensus 242 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l---------~~~~~~kl~DFGla~~~~~~~~~~~~~~ 306 (442)
.+++... ...+++..++.++.|++.||.|||+. + +.++.+||+|||+++....... ....
T Consensus 174 ~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~~ 248 (373)
T 2x4f_A 174 FDRIIDE---SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVN 248 (373)
T ss_dssp HHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCCC
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cccc
Confidence 9998653 24689999999999999999999875 2 3456799999999987644332 2345
Q ss_pred ccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCC
Q 047892 307 MGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKP 386 (442)
Q Consensus 307 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (442)
+||+.|+|||++.+..++.++|||||||++|||++|..||...... ..+....... . . +....
T Consensus 249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----------~~~~~i~~~~-~-~-----~~~~~ 311 (373)
T 2x4f_A 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA----------ETLNNILACR-W-D-----LEDEE 311 (373)
T ss_dssp CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH----------HHHHHHHHTC-C-C-----SCSGG
T ss_pred cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH----------HHHHHHHhcc-C-C-----CChhh
Confidence 7999999999998888999999999999999999999999754321 1111111111 0 0 01111
Q ss_pred cHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH--HHhc
Q 047892 387 SSRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEA 421 (442)
Q Consensus 387 ~~~~~~~~~~li~~cl~~dP~~RPs~~evl~--~L~~ 421 (442)
....+..+.+|+.+||+.||.+|||+.|+++ .+..
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 1223456888999999999999999999997 4554
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=311.49 Aligned_cols=257 Identities=23% Similarity=0.356 Sum_probs=199.3
Q ss_pred eehhhHHHhhCCCCccCeeccCCcEEEEEEEE------CCCCeEEEEEecCcc-hhhHHHHHHHHHHHHhc-CCCCcceE
Q 047892 148 YTLRELEVSTNGFADENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRL 219 (442)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l 219 (442)
+...++++..++|++.+.||+|+||.||+|.+ .+++.||||.+.... ....+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34456677788999999999999999999984 246789999996543 33456789999999999 79999999
Q ss_pred EEEEEeCC-eeeeEEecCCCCCHHHHHccCCCC------------CCCCCHHHHHHHHHHHHHhhhhhhcC---------
Q 047892 220 VGYCAEGA-HRMLVNEYVDNGNLEQWLHGDVGP------------HSPLTWEIRMNIILGTAKGLTYLHEG--------- 277 (442)
Q Consensus 220 ~~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~l~yLH~~--------- 277 (442)
++++...+ ..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+.
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp 176 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 176 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCcc
Confidence 99987654 589999999999999999765321 12388999999999999999999876
Q ss_pred ----CCCCCCeEEecccCccccCCCcc-eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCC
Q 047892 278 ----LEPKWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRP 351 (442)
Q Consensus 278 ----l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~ 351 (442)
++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 33467899999999987644332 23344568899999999999999999999999999999998 9999975433
Q ss_pred CCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 352 PGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
... ... ....+.. ...+...+..+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 257 ~~~------~~~----~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 257 DEE------FCR----RLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp SHH------HHH----HHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHH------HHH----HhccCcc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 211 111 1111110 0111223456888999999999999999999999998764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=316.37 Aligned_cols=245 Identities=23% Similarity=0.395 Sum_probs=186.5
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC-CCCe----EEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE-DNTN----VAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 229 (442)
..++|++.+.||+|+||.||+|.+. +++. ||+|.+.... ......+.+|+.++++++||||+++++++. .+..
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 89 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL 89 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence 3457889999999999999999964 3444 7888774332 223345778999999999999999999986 4568
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~~~kl~DFGla~~~~ 296 (442)
++||||+.+|+|.+++... ...+++..++.++.|++.||.|||+. + +.++.+||+|||+++...
T Consensus 90 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 9999999999999999764 24688889999999999999999875 3 346789999999998765
Q ss_pred CCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 297 AERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 297 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
..... ......||..|+|||++.+..++.++|||||||++|||++ |..||....... ... .......
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~----~~~~~~~ 235 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-------VPD----LLEKGER 235 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-------HHH----HHHTTCB
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-------HHH----HHHcCCC
Confidence 43322 2344567889999999998999999999999999999999 999997644321 111 1111110
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCC
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 424 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 424 (442)
...+...+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 236 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 236 ---------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ---------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ---------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 01111123346779999999999999999999999988753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=310.96 Aligned_cols=246 Identities=15% Similarity=0.145 Sum_probs=190.1
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeeeEEe
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
.++|++.+.||+|+||.||+|.. .+++.||||.+..... ...+.+|+.+++.+ +||||+++++++.+.+..|+|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 35689999999999999999996 5688999999854322 23578899999999 99999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC-------CCC-----eEEecccCccccC
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP-------KWN-----PKLSDFGLAKLLG 296 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-------~~~-----~kl~DFGla~~~~ 296 (442)
|+ +|+|.+++... ...+++..++.++.|++.||.|||+. +++ ++. +||+|||+++.+.
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99 89999999764 24789999999999999999999875 333 344 9999999998764
Q ss_pred CCcce------eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhh
Q 047892 297 AERSY------VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVT 370 (442)
Q Consensus 297 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 370 (442)
..... ......||+.|+|||++.+..++.++|||||||++|||++|..||......... .....+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~----~~~~~i~~~~~ 237 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK----ERYQKIGDTKR 237 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH----HHHHHHHHHHH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHH----HHHHHHHhhhc
Confidence 43221 124568999999999999999999999999999999999999999865433221 11111111100
Q ss_pred cCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 371 NGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.... ..+.. ..+ ++.+++.+||+.||.+||++.+|++.|+++
T Consensus 238 ~~~~-----~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 238 ATPI-----EVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HSCH-----HHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cCCH-----HHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 0000 00000 122 688899999999999999999999998754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=320.02 Aligned_cols=252 Identities=23% Similarity=0.382 Sum_probs=195.8
Q ss_pred HHHhhCCCCccCeeccCCcEEEEEEEECC-C-----CeEEEEEecCcc-hhhHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 047892 153 LEVSTNGFADENVIGEGGYGIVYRGVLED-N-----TNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLVGYCA 224 (442)
Q Consensus 153 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 224 (442)
+++..++|.+.+.||+|+||.||+|.... + ..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 45556789999999999999999999643 2 479999996543 34556789999999999 8999999999999
Q ss_pred eCCeeeeEEecCCCCCHHHHHccCCC----------CCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CC
Q 047892 225 EGAHRMLVNEYVDNGNLEQWLHGDVG----------PHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PK 281 (442)
Q Consensus 225 ~~~~~~lv~E~~~~g~L~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~ 281 (442)
..+..|+||||+++|+|.+++..... ....+++..++.++.|++.||.|||+. ++ .+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 99999999999999999999964210 124579999999999999999999875 44 35
Q ss_pred CCeEEecccCccccCCCcc-eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhh
Q 047892 282 WNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQV 359 (442)
Q Consensus 282 ~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~ 359 (442)
+.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~----- 275 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK----- 275 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-----
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-----
Confidence 6789999999986643322 22334567889999999998999999999999999999999 9999975433211
Q ss_pred hHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 360 NLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
..... .... ....+...+..+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus 276 -~~~~~----~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 276 -FYKLV----KDGY---------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp -HHHHH----HHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHH----hcCC---------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 11111 1110 11111223456888999999999999999999999998765
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=313.94 Aligned_cols=262 Identities=15% Similarity=0.171 Sum_probs=191.0
Q ss_pred hCCCCccCeeccC--CcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 157 TNGFADENVIGEG--GYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 157 ~~~~~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
.++|++.+.||+| +||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++|||||++++++.+.+..|+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4568999999999 99999999975 58999999996432 3445678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
|||||++|+|.+++.... ...+++..+..++.|++.||.|||+. ++.++.+||+|||++......
T Consensus 104 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 999999999999997642 24589999999999999999999875 445789999999998654221
Q ss_pred cc------eeecccccccCCCCcccccC--CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhh
Q 047892 299 RS------YVTTRVMGTFGYVAPEYAST--GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVT 370 (442)
Q Consensus 299 ~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 370 (442)
.. ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............. ........
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~ 259 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLD 259 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCcccc
Confidence 11 11223478999999999987 5799999999999999999999999976544322111000 00000000
Q ss_pred ------------------cCCcccccC---------cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH--Hhc
Q 047892 371 ------------------NGNAEGVLD---------PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM--LEA 421 (442)
Q Consensus 371 ------------------~~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~--L~~ 421 (442)
.......+. ...........+..+.+|+.+||+.||++|||+.|+++. ++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 000000000 000001122345678899999999999999999999854 554
Q ss_pred C
Q 047892 422 E 422 (442)
Q Consensus 422 ~ 422 (442)
+
T Consensus 340 ~ 340 (389)
T 3gni_B 340 I 340 (389)
T ss_dssp C
T ss_pred H
Confidence 4
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=311.29 Aligned_cols=244 Identities=21% Similarity=0.315 Sum_probs=187.2
Q ss_pred hhCCCCccCeeccCCcEEEEEEEECC-C-------CeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLED-N-------TNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA 227 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 227 (442)
..++|.+.+.||+|+||.||+|.... + ..||+|.+........+.+.+|+.++++++||||+++++++.+.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 34578899999999999999998543 3 469999997666666778999999999999999999999999999
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC-------CCC--------eEE
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP-------KWN--------PKL 286 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-------~~~--------~kl 286 (442)
..++||||+++|+|.+++... ...+++..++.++.|++.||.|||+. +++ ++. +||
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999999764 23489999999999999999999865 443 333 999
Q ss_pred ecccCccccCCCcceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHH
Q 047892 287 SDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWL 365 (442)
Q Consensus 287 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 365 (442)
+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|||++|..|+...... ....
T Consensus 163 ~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~---------~~~~ 228 (289)
T 4fvq_A 163 SDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS---------QRKL 228 (289)
T ss_dssp CCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---------HHHH
T ss_pred ccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch---------HHHH
Confidence 999999765322 23468899999999987 67999999999999999999955444322110 0111
Q ss_pred HHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCCChh
Q 047892 366 KTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRD 428 (442)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 428 (442)
........ + ... .+..+.+|+.+||+.||++|||+.++++.|+++..+...
T Consensus 229 ~~~~~~~~----~----~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 229 QFYEDRHQ----L----PAP----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp HHHHTTCC----C----CCC----SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred HHhhccCC----C----CCC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 11111110 1 111 123477899999999999999999999999999865433
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=305.90 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=196.1
Q ss_pred ehhhHHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHh--cCCCCcceEEEEEEeC
Q 047892 149 TLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR--VRHKNLVRLVGYCAEG 226 (442)
Q Consensus 149 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~ 226 (442)
.+.......++|.+.+.||+|+||.||+|.+ +++.||||.+.. .....+.+|.+++.. ++||||+++++++...
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 3344455667899999999999999999998 588999999843 334567788998887 7999999999999877
Q ss_pred C----eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhh--------cC-------------CCCC
Q 047892 227 A----HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH--------EG-------------LEPK 281 (442)
Q Consensus 227 ~----~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH--------~~-------------l~~~ 281 (442)
+ ..|+||||+++|+|.+++.+. .+++..++.++.|++.||.||| +. ++.+
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~ 183 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 183 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT
T ss_pred CCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC
Confidence 6 789999999999999999753 5899999999999999999999 43 4567
Q ss_pred CCeEEecccCccccCCCcce---eecccccccCCCCcccccCCC------CCCcCCchhhHHHHHHHHhC----------
Q 047892 282 WNPKLSDFGLAKLLGAERSY---VTTRVMGTFGYVAPEYASTGM------LNETSDVYSFGILIMEVISG---------- 342 (442)
Q Consensus 282 ~~~kl~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvil~elltg---------- 342 (442)
+.+||+|||+++........ ......||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 89999999999876443322 224457999999999997652 34689999999999999999
Q ss_pred CCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCC-CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 343 RNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEK-PSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 343 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
..||......... ...+......... .+.+... ........+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 264 ~~p~~~~~~~~~~------~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 264 QLPYYDLVPSDPS------VEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp CCTTTTTSCSSCC------HHHHHHHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccCccccCcCccc------HHHHHHHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 7787654332211 1111122211111 1111111 223667789999999999999999999999999987
Q ss_pred CC
Q 047892 422 EE 423 (442)
Q Consensus 422 ~~ 423 (442)
+.
T Consensus 334 i~ 335 (342)
T 1b6c_B 334 LS 335 (342)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=307.41 Aligned_cols=248 Identities=21% Similarity=0.322 Sum_probs=183.4
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|++.+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4588899999999999999996 46899999998642 3445567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++|+|.+++.........+++..++.++.|++.||.|||+. ++.++.+||+|||+++.......
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 191 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-----------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc
Confidence 99999999999865322235689999999999999999999876 45578999999999987643322
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
......||+.|+|||++.+..++.++|||||||++|||++|..||...... ........ .....
T Consensus 192 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~-~~~~~------ 255 (310)
T 2wqm_A 192 -AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--------LYSLCKKI-EQCDY------ 255 (310)
T ss_dssp --------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC--------HHHHHHHH-HTTCS------
T ss_pred -cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh--------HHHHHHHh-hcccC------
Confidence 223457899999999999999999999999999999999999999653221 11111111 11111
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
........+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 256 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 256 --PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp --CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11111233456888999999999999999999999998764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=299.62 Aligned_cols=249 Identities=19% Similarity=0.258 Sum_probs=185.9
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46889999999999999999964 5889999999643 23345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
|+++ +|.+++... ...+++..+..++.|++.||.|||+. ++.++.+||+|||+++.......
T Consensus 82 ~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred cCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence 9987 666666543 25689999999999999999999876 44578999999999987643322
Q ss_pred eecccccccCCCCcccccCCC-CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc---c
Q 047892 302 VTTRVMGTFGYVAPEYASTGM-LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG---V 377 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 377 (442)
......||+.|+|||++.+.. ++.++|||||||++|||++|..||...... ......+........... .
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~------~~~~~~i~~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV------DDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH------HHHHHHHHHHHCCCCTTTCTTG
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH------HHHHHHHHHHhCCCChhhhhhh
Confidence 234457899999999997766 899999999999999999988886433211 111111111111100000 0
Q ss_pred c------------CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 378 L------------DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 378 ~------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
. ............+..+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 000000111234566788999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=318.50 Aligned_cols=238 Identities=19% Similarity=0.299 Sum_probs=182.8
Q ss_pred CCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcC--CCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVR--HKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~lv~ 233 (442)
.+|.+.+.||+|+||.||+|...+++.||||.+... .....+.+.+|+.+|.+++ ||||+++++++...+..|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458899999999999999999877999999998543 3445577899999999996 599999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC------CCCeEEecccCccccCCCcce
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP------KWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~------~~~~kl~DFGla~~~~~~~~~ 301 (442)
| +.+|+|.+++... ..+++..+..++.|++.||.|||+. +++ ++.+||+|||+++.+......
T Consensus 136 E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp E-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESSSCEEECCCSSSCCC------
T ss_pred e-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEECCeEEEEecCccccccCCCcc
Confidence 9 5678999999865 4688889999999999999999875 443 578999999999876433221
Q ss_pred -eecccccccCCCCcccccC-----------CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHh
Q 047892 302 -VTTRVMGTFGYVAPEYAST-----------GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMV 369 (442)
Q Consensus 302 -~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 369 (442)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ....+....
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---------~~~~~~~~~ 281 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---------QISKLHAII 281 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC---------HHHHHHHHH
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH---------HHHHHHHHh
Confidence 2345689999999999865 3688999999999999999999999964321 111111111
Q ss_pred hcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 370 TNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.. ......+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 282 ~~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 DP---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CT---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Cc---------cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11 11111111123567889999999999999999999853
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=311.53 Aligned_cols=249 Identities=23% Similarity=0.342 Sum_probs=191.1
Q ss_pred CCccCeeccCCcEEEEEEEEC-----CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeeee
Q 047892 160 FADENVIGEGGYGIVYRGVLE-----DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE--GAHRML 231 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l 231 (442)
|++.+.||+|+||.||++.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478899999999999998752 57889999996543 3455678999999999999999999999987 467899
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
||||+++|+|.+++... .+++..++.++.|++.||.|||+. ++.++.+||+|||+++.....
T Consensus 113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 99999999999999764 489999999999999999999875 445678999999999877544
Q ss_pred cce--eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCC-----ccchhhhHHHHHHHHhhc
Q 047892 299 RSY--VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPG-----EFQFQVNLFEWLKTMVTN 371 (442)
Q Consensus 299 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~ 371 (442)
... ......||..|+|||++.+..++.++|||||||++|||++|..||....... ........ ..+......
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 266 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV-LRLTELLER 266 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHH-HHHHHHHHT
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhH-HHHHHHHhc
Confidence 322 2334568889999999998899999999999999999999999986421100 00000000 011111111
Q ss_pred CCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 372 GNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
......+...+..+.+|+.+||+.||++|||+.|+++.|+.+.
T Consensus 267 ---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 267 ---------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp ---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111222344567889999999999999999999999998764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=302.91 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=188.9
Q ss_pred hhHHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHh--cCCCCcceEEEEEEeC--
Q 047892 151 RELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR--VRHKNLVRLVGYCAEG-- 226 (442)
Q Consensus 151 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~-- 226 (442)
.......++|++.+.||+|+||.||+|.+. ++.||||.+... ....+.+|.+++.. ++||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 334455678999999999999999999984 889999998532 23444556666655 4999999999999887
Q ss_pred --CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC---------------------CCCCCC
Q 047892 227 --AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---------------------LEPKWN 283 (442)
Q Consensus 227 --~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---------------------l~~~~~ 283 (442)
...|+||||+++|+|.++++.. .+++..++.++.|++.||.|||.. ++.++.
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 7889999999999999999753 589999999999999999999953 335678
Q ss_pred eEEecccCccccCCCcce---eecccccccCCCCcccccCCCCCCc------CCchhhHHHHHHHHhC----------CC
Q 047892 284 PKLSDFGLAKLLGAERSY---VTTRVMGTFGYVAPEYASTGMLNET------SDVYSFGILIMEVISG----------RN 344 (442)
Q Consensus 284 ~kl~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~------sDvwSlGvil~elltg----------~~ 344 (442)
+||+|||+++........ ......||+.|+|||++.+..++.+ +|||||||++|||++| ..
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 999999999876433222 1234579999999999987776665 9999999999999999 56
Q ss_pred CCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCC-CCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 345 PVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQE-KPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 345 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
||......... ............. .+.+.. .....++..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 261 p~~~~~~~~~~------~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 261 PYHDLVPSDPS------YEDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp TTTTTSCSSCC------HHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cHhhhcCCCCc------hhhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 66543322211 1111122111111 111111 112367788999999999999999999999999998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=307.73 Aligned_cols=257 Identities=19% Similarity=0.314 Sum_probs=177.0
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 356899999999999999999954 58999999986432 2334668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCC--CCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc
Q 047892 235 YVDNGNLEQWLHGDV--GPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
|++ |+|.+++.... .....+++..+..++.|++.||.|||+. ++.++.+||+|||+++......
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 999 59999986431 1224589999999999999999999875 4457899999999998764332
Q ss_pred ceeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC--c-c
Q 047892 300 SYVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN--A-E 375 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~ 375 (442)
. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ ....+........ . .
T Consensus 163 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 163 N-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-------QLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp C-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHHHCSCCTTTCG
T ss_pred c-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHHHHhCCCChhHhh
Confidence 2 22345789999999999764 68999999999999999999999997543211 1111111111000 0 0
Q ss_pred c-----ccCccc------------CCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH--HhcC
Q 047892 376 G-----VLDPRL------------QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM--LEAE 422 (442)
Q Consensus 376 ~-----~~~~~~------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~--L~~~ 422 (442)
. ...+.. ........+..+.+|+.+||+.||++|||+.|+++. +.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 300 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcc
Confidence 0 000000 000011234568899999999999999999999863 4443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=309.95 Aligned_cols=242 Identities=30% Similarity=0.473 Sum_probs=182.2
Q ss_pred hCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
.++|++.+.||+|+||.||+|.+. ++.||||.+... ...+.+.+|++++++++||||+++++++.+ ..|+||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 356888999999999999999984 788999998543 345678999999999999999999998763 479999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc---C------C-------CCCCC-eEEecccCccccCCCc
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE---G------L-------EPKWN-PKLSDFGLAKLLGAER 299 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~---~------l-------~~~~~-~kl~DFGla~~~~~~~ 299 (442)
++|+|.+++.... ....+++..++.++.|++.||.|||+ . + +.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp TTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 9999999997642 12347888999999999999999998 3 2 23454 799999999765322
Q ss_pred ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... .....
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~-~~~~~----- 222 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--------FRIMWAV-HNGTR----- 222 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH--------HHHHHHH-HTTCC-----
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH--------HHHHHHH-hcCCC-----
Confidence 223468999999999999999999999999999999999999997533211 1111111 11110
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCCC
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPF 426 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 426 (442)
.......+..+.+++.+||+.||++|||+.++++.|+.+...+
T Consensus 223 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 223 ----PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp ----CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred ----CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111223456788999999999999999999999998765443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=315.05 Aligned_cols=253 Identities=15% Similarity=0.167 Sum_probs=186.7
Q ss_pred hhCCCCccCeeccCCcEEEEEEEECC------CCeEEEEEecCcchhhH-----------HHHHHHHHHHHhcCCCCcce
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLED------NTNVAVKNLLNNRGQAE-----------KEFKVEVEAIGRVRHKNLVR 218 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpnIv~ 218 (442)
..++|.+.+.||+|+||.||+|.+.. ++.||||.+........ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34568899999999999999999754 47899999865432211 12344666778889999999
Q ss_pred EEEEEEeC----CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CC--
Q 047892 219 LVGYCAEG----AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LE-- 279 (442)
Q Consensus 219 l~~~~~~~----~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~-- 279 (442)
+++++... ...||||||+ +|+|.+++... ...+++..++.++.|++.||.|||+. ++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC
Confidence 99998764 4589999999 99999999764 25689999999999999999999875 33
Q ss_pred CCCCeEEecccCccccCCCcce------eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCC
Q 047892 280 PKWNPKLSDFGLAKLLGAERSY------VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPG 353 (442)
Q Consensus 280 ~~~~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~ 353 (442)
.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 5678999999999876433211 1133469999999999999999999999999999999999999997533221
Q ss_pred ccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 354 EFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
. ......... .......+++.+.. ...+.++.+++..||+.||++||++.+|++.|+.+
T Consensus 269 ~------~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 269 K------YVRDSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp H------HHHHHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred H------HHHHHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 1 111111110 01111222222211 12235688899999999999999999999998754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=312.25 Aligned_cols=246 Identities=26% Similarity=0.461 Sum_probs=187.2
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEECC-----CCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLED-----NTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAH 228 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 228 (442)
+..++|.+.+.||+|+||.||+|.+.. +..||||.+... .......+.+|+.+++.++||||+++++++...+.
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 345568888999999999999998543 235999999654 33445678999999999999999999999999999
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLL 295 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~ 295 (442)
.++||||+++|+|.+++... ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++..
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred cEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999999764 24689999999999999999999875 445779999999999876
Q ss_pred CCCcce--eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcC
Q 047892 296 GAERSY--VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372 (442)
Q Consensus 296 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (442)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... ..+. . ....+
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~~~---~-~~~~~ 266 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVM---K-AINDG 266 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHH---H-HHHTT
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-------HHHH---H-HHHCC
Confidence 433221 1223356789999999999999999999999999999999 9999964321 1111 1 11111
Q ss_pred CcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
. ....+...+..+.+++.+||+.||++||++.++++.|+++.
T Consensus 267 ~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 267 F---------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp C---------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred C---------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 11112234456888999999999999999999999998764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=299.57 Aligned_cols=235 Identities=24% Similarity=0.364 Sum_probs=168.1
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|.+.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 4688999999999999999996 468999999985432 122467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++++|.+++... ...+++..++.++.|++.||.|||+. ++.++.+||+|||++........
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp ECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred ecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 999999999999764 24689999999999999999999876 44578999999999987643222
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .....
T Consensus 168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------------------~~~~~ 227 (278)
T 3cok_A 168 -KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN-------------------KVVLA 227 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------------CCSS
T ss_pred -cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-------------------HHhhc
Confidence 1234578999999999998889999999999999999999999997644322110 00000
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.. ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 228 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 DY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 01 112223456788999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=302.01 Aligned_cols=236 Identities=22% Similarity=0.287 Sum_probs=187.9
Q ss_pred CCCCccCeeccCCcEEEEEEEECC-CCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 158 NGFADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
++|++.+.||+|+||.||+|.... +..||+|++........+.+.+|++++++++||||+++++++.+.+..|+||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 458889999999999999999654 7789999997655555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------C---CCCCCeEEecccCccccCCCcc
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------L---EPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l---~~~~~~kl~DFGla~~~~~~~~ 300 (442)
++++|.+++... ..+++..++.++.|++.||.|||+. + +.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~- 163 (277)
T 3f3z_A 89 TGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK- 163 (277)
T ss_dssp CSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-
Confidence 999999998764 4689999999999999999999876 3 456789999999998764432
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
......||+.|+|||++.+ .++.++|||||||++|||++|..||...... ....... .+...
T Consensus 164 -~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------~~~~~~~-~~~~~----- 225 (277)
T 3f3z_A 164 -MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS----------EVMLKIR-EGTFT----- 225 (277)
T ss_dssp -CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----------HHHHHHH-HCCCC-----
T ss_pred -chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH----------HHHHHHH-hCCCC-----
Confidence 2344579999999998865 4999999999999999999999999653221 1111111 11100
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.........+..+.+|+.+||+.||++|||+.++++
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 226 -FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000123456888999999999999999999985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=303.56 Aligned_cols=249 Identities=14% Similarity=0.153 Sum_probs=193.0
Q ss_pred hhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeeeEE
Q 047892 156 STNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
..++|.+.+.||+|+||.||+|.. .+++.||||.+.... ....+.+|+.++..+ +|+||+++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 346789999999999999999995 568999999885432 234578899999999 8999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCC-----eEEecccCcccc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWN-----PKLSDFGLAKLL 295 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~-----~kl~DFGla~~~ 295 (442)
||+ +|+|.+++... ...+++..++.++.|++.||.|||+. ++.++. +||+|||+++..
T Consensus 86 e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999 88999999864 24589999999999999999999876 323333 999999999876
Q ss_pred CCCcce------eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHh
Q 047892 296 GAERSY------VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMV 369 (442)
Q Consensus 296 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 369 (442)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~----~~~~~~~~~~ 237 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK----QKYERIGEKK 237 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH----HHHHHHHHHH
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH----HHHHHHHhhc
Confidence 543221 234567999999999999999999999999999999999999999765433221 1111111111
Q ss_pred hcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 370 TNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
..... +.+. ...+..+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 238 ~~~~~-----~~~~----~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 238 QSTPL-----RELC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp HHSCH-----HHHT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred cCccH-----HHHH----hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 00000 0001 123456888999999999999999999999998753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=335.40 Aligned_cols=242 Identities=26% Similarity=0.428 Sum_probs=186.2
Q ss_pred hCCCCccC-eeccCCcEEEEEEEEC---CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 157 TNGFADEN-VIGEGGYGIVYRGVLE---DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 157 ~~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
.+++.+.+ .||+|+||.||+|.+. ++..||||.+.... ....+.+.+|+++|++++|||||++++++.. +..|+
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 34444445 7999999999999863 45679999996542 3456789999999999999999999999976 56899
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~~~~~ 298 (442)
|||||++|+|.+++... ...+++..++.++.|++.||.|||+. ++ .++.+||+|||+++.+...
T Consensus 413 v~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EEEeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999999999999754 35689999999999999999999875 33 4578999999999876543
Q ss_pred cceee--cccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 299 RSYVT--TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 299 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
..... ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+.. ....+.
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~~~----~i~~~~-- 556 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMA----FIEQGK-- 556 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-------HHHH----HHHTTC--
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-------HHHH----HHHcCC--
Confidence 32211 22345789999999998999999999999999999998 99999764331 1111 111111
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
....+..++..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 557 -------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 557 -------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp -------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1122234556788999999999999999999999999874
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=299.55 Aligned_cols=238 Identities=25% Similarity=0.348 Sum_probs=189.1
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 46889999999999999999975 5899999998543 234457789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc-e
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS-Y 301 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~-~ 301 (442)
+++|+|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||++........ .
T Consensus 87 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 87 CSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 9999999998754 5689999999999999999999875 45578999999999986533221 2
Q ss_pred eecccccccCCCCcccccCCCC-CCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 302 VTTRVMGTFGYVAPEYASTGML-NETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
......||+.|+|||++.+..+ +.++|||||||++|||++|..||........ ....+ .....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~----~~~~~------- 226 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----EYSDW----KEKKT------- 226 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-----HHHHH----HTTCT-------
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-----HHHHh----hhccc-------
Confidence 2345678999999999987765 7789999999999999999999976443211 01111 11100
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
........+..+.+|+.+||+.||++|||+.|+++
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 --YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00111233456788999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=307.74 Aligned_cols=239 Identities=23% Similarity=0.296 Sum_probs=189.1
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcch------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRG------QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 229 (442)
.++|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 345889999999999999999965 588999999854321 1357789999999999999999999999999999
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCC----CeEEecccCc
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKW----NPKLSDFGLA 292 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~----~~kl~DFGla 292 (442)
|+||||+++|+|.+++... ..+++..++.++.|++.||.|||+. + +.++ .+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999999764 5689999999999999999999875 3 3344 7999999999
Q ss_pred cccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC
Q 047892 293 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372 (442)
Q Consensus 293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (442)
+....... .....||+.|+|||++.+..++.++|||||||++|||++|..||...... ....... ..
T Consensus 167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----------~~~~~i~-~~ 233 (321)
T 2a2a_A 167 HEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----------ETLANIT-SV 233 (321)
T ss_dssp EECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----------HHHHHHH-TT
T ss_pred eecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH----------HHHHHHH-hc
Confidence 87654322 23457999999999999999999999999999999999999999653221 1111111 11
Q ss_pred CcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.. ...+.. ....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 234 ~~--~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 234 SY--DFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CC--CCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cc--ccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 001100 11234567889999999999999999999873
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=306.47 Aligned_cols=252 Identities=22% Similarity=0.350 Sum_probs=189.8
Q ss_pred CCCCccCeeccCCcEEEEEEEE-----CCCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--Cee
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-----EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG--AHR 229 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~ 229 (442)
..|++.+.||+|+||.||+|.+ .+++.||+|.+... .......+.+|+.+++.++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4478889999999999999984 35889999998643 233456789999999999999999999999876 668
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~~~ 296 (442)
++||||+++|+|.+++... ...+++..++.++.|++.||.|||+. ++ .++.+||+|||+++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 9999999999999999653 24689999999999999999999875 33 46789999999998775
Q ss_pred CCcc--eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCC-----CccchhhhHHHHHHHHh
Q 047892 297 AERS--YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPP-----GEFQFQVNLFEWLKTMV 369 (442)
Q Consensus 297 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~-----~~~~~~~~~~~~~~~~~ 369 (442)
.... .......||..|+|||++.+..++.++|||||||++|||++|..|+...... ........... .....
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 256 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR-LVNTL 256 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH-HHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH-HHHHH
Confidence 4432 2233456888999999999989999999999999999999999986421000 00000011111 11111
Q ss_pred hcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 370 TNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
... .....+...+..+.+|+.+||+.||.+|||+.++++.|+++
T Consensus 257 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 257 KEG---------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HTT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcc---------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 111 11112233456788999999999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=309.74 Aligned_cols=253 Identities=22% Similarity=0.390 Sum_probs=186.3
Q ss_pred hhHHHhhCCCCccCeeccCCcEEEEEEEEC----CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 047892 151 RELEVSTNGFADENVIGEGGYGIVYRGVLE----DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCA 224 (442)
Q Consensus 151 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 224 (442)
.++.+..++|.+.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 444566778999999999999999999853 2457999998643 3344567899999999999999999999997
Q ss_pred eCC-----eeeeEEecCCCCCHHHHHccCC--CCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCe
Q 047892 225 EGA-----HRMLVNEYVDNGNLEQWLHGDV--GPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNP 284 (442)
Q Consensus 225 ~~~-----~~~lv~E~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~ 284 (442)
..+ ..++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+. ++.++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCE
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcE
Confidence 654 3499999999999999985321 2235689999999999999999999876 4456799
Q ss_pred EEecccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHH
Q 047892 285 KLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLF 362 (442)
Q Consensus 285 kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~ 362 (442)
||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||....... ..
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~ 259 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-------MY 259 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HH
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-------HH
Confidence 99999999876433221 2233457889999999999999999999999999999999 899997543211 11
Q ss_pred HHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 363 EWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
.. .. .+. ....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 260 ~~---~~-~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 260 DY---LL-HGH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp HH---HH-TTC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH---HH-cCC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 11 110 11112234456888999999999999999999999998764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=301.50 Aligned_cols=256 Identities=21% Similarity=0.276 Sum_probs=184.0
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 56889999999999999999975 48999999985443 2345668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
|+++++|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++.......
T Consensus 83 ~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 157 (311)
T 4agu_A 83 YCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD- 157 (311)
T ss_dssp CCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred eCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence 99999999988754 4689999999999999999999875 44578999999999987643322
Q ss_pred eecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHH----HHHHHHhhcCCc-c
Q 047892 302 VTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF----EWLKTMVTNGNA-E 375 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~----~~~~~~~~~~~~-~ 375 (442)
......||+.|+|||++.+ ..++.++|||||||++|||++|..||......+......... ............ .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 2334578999999999876 568999999999999999999999997643321110000000 000000000000 0
Q ss_pred cccCcccCCCCc-----HHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 376 GVLDPRLQEKPS-----SRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 376 ~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
....+....... ...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000000 1234568889999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=314.13 Aligned_cols=256 Identities=16% Similarity=0.183 Sum_probs=185.9
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC----CCCeEEEEEecCcchhh-----------HHHHHHHHHHHHhcCCCCcceEEE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE----DNTNVAVKNLLNNRGQA-----------EKEFKVEVEAIGRVRHKNLVRLVG 221 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpnIv~l~~ 221 (442)
.++|.+.+.||+|+||.||+|... ++..||+|.+....... ...+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 456889999999999999999975 57889999986543211 123567889999999999999999
Q ss_pred EEEe----CCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCC--
Q 047892 222 YCAE----GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKW-- 282 (442)
Q Consensus 222 ~~~~----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~-- 282 (442)
++.. ....|+||||+ +++|.+++... ..+++..++.++.|++.||.|||+. ++ .++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence 9987 77899999999 89999999764 3789999999999999999999875 33 344
Q ss_pred CeEEecccCccccCCCcce------eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccc
Q 047892 283 NPKLSDFGLAKLLGAERSY------VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQ 356 (442)
Q Consensus 283 ~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~ 356 (442)
.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-- 268 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV-- 268 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH--
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH--
Confidence 8999999999876432211 11345799999999999999999999999999999999999999964221110
Q ss_pred hhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCCCh
Q 047892 357 FQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFR 427 (442)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 427 (442)
............ ....+..... ....+.++.+++.+||+.||++|||+.+|++.|+....+..
T Consensus 269 ----~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 331 (345)
T 2v62_A 269 ----AVQTAKTNLLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLG 331 (345)
T ss_dssp ----HHHHHHHHHHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCC
T ss_pred ----HHHHHHHhhccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCccc
Confidence 111111111000 0000000000 11234568889999999999999999999999998876543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=309.04 Aligned_cols=253 Identities=21% Similarity=0.236 Sum_probs=186.9
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc-----chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN-----RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA 227 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 227 (442)
....++|.+.+.||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 34456799999999999999999996 45889999998543 2344567899999999999999999999999999
Q ss_pred eeeeEEecCCCCCHHHHHccCCCC------------------------------------CCCCCHHHHHHHHHHHHHhh
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGP------------------------------------HSPLTWEIRMNIILGTAKGL 271 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~qi~~~l 271 (442)
..|+|||||++|+|.+++...... ...+++..+..++.|++.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999998521000 11235677888999999999
Q ss_pred hhhhcC------CC-------CCC--CeEEecccCccccCCCc---ceeecccccccCCCCcccccC--CCCCCcCCchh
Q 047892 272 TYLHEG------LE-------PKW--NPKLSDFGLAKLLGAER---SYVTTRVMGTFGYVAPEYAST--GMLNETSDVYS 331 (442)
Q Consensus 272 ~yLH~~------l~-------~~~--~~kl~DFGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwS 331 (442)
.|||+. ++ .++ .+||+|||+++.+.... ........||+.|+|||++.+ ..++.++||||
T Consensus 182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 999875 33 234 79999999998653321 122345679999999999865 67899999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCC
Q 047892 332 FGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPK 411 (442)
Q Consensus 332 lGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs 411 (442)
|||++|||++|+.||...... +.......... ..........+..+.+|+.+||+.||.+|||
T Consensus 262 lG~il~el~~g~~pf~~~~~~----------~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDA----------DTISQVLNKKL-------CFENPNYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHH----------HHHHHHHHCCC-------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHCCCCCCCCChH----------HHHHHHHhccc-------ccCCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence 999999999999999654321 11111111111 0011111223456888999999999999999
Q ss_pred HHHHHH--HHhcCC
Q 047892 412 MGHVIH--MLEAEE 423 (442)
Q Consensus 412 ~~evl~--~L~~~~ 423 (442)
+.|+++ .+....
T Consensus 325 ~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 325 AMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHSHHHHTTS
T ss_pred HHHHhcChhhccCh
Confidence 999986 355443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=311.31 Aligned_cols=195 Identities=22% Similarity=0.271 Sum_probs=164.7
Q ss_pred eehhhHHHhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcC-----CCCcceEEE
Q 047892 148 YTLRELEVSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-----HKNLVRLVG 221 (442)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~l~~ 221 (442)
+++.+..+..++|.+.+.||+|+||.||+|.. .+++.||||.+... ......+..|+.+++.+. ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 34455556678899999999999999999996 45889999998642 344556788999999986 999999999
Q ss_pred EEEeCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CC---------
Q 047892 222 YCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LE--------- 279 (442)
Q Consensus 222 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~--------- 279 (442)
++...+..|+||||+ +++|.+++.... ...+++..+..++.|++.||.|||+. ++
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccccc
Confidence 999999999999999 889999997642 23589999999999999999999875 22
Q ss_pred ----------------CCCCeEEecccCccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCC
Q 047892 280 ----------------PKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGR 343 (442)
Q Consensus 280 ----------------~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~ 343 (442)
.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence 2678999999999875432 23467899999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 047892 344 NPVDYSR 350 (442)
Q Consensus 344 ~Pf~~~~ 350 (442)
.||....
T Consensus 257 ~pf~~~~ 263 (360)
T 3llt_A 257 LLFRTHE 263 (360)
T ss_dssp CSCCCSS
T ss_pred CCCCCCc
Confidence 9997543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=316.21 Aligned_cols=234 Identities=23% Similarity=0.258 Sum_probs=177.6
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHH-HHhcCCCCcceEEEEEEeCCeeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEA-IGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 356889999999999999999975 48889999996432 2233456677776 577899999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
||||+++|+|.+++.+. ..+++..++.++.|++.||+|||+. ++.++.+||+|||+++.....
T Consensus 117 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999999764 4688999999999999999999875 445789999999999864322
Q ss_pred cceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 299 RSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||...+. .+........ ..
T Consensus 193 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----------~~~~~~i~~~-~~---- 256 (373)
T 2r5t_A 193 -NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT----------AEMYDNILNK-PL---- 256 (373)
T ss_dssp -CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH----------HHHHHHHHHS-CC----
T ss_pred -CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH----------HHHHHHHHhc-cc----
Confidence 2234557899999999999999999999999999999999999999975322 1111111111 10
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHH
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVI 416 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl 416 (442)
.+ +...+..+.+|+.+||+.||.+||++.+.+
T Consensus 257 --~~----~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 257 --QL----KPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp --CC----CSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred --CC----CCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 11 112345678899999999999999985433
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=298.88 Aligned_cols=238 Identities=20% Similarity=0.304 Sum_probs=188.5
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
.++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467899999999999999999964 4889999998543 3344567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC-------C---CCeEEecccCccccCC
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP-------K---WNPKLSDFGLAKLLGA 297 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-------~---~~~kl~DFGla~~~~~ 297 (442)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++ + +.+||+|||++.....
T Consensus 85 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999988764 4689999999999999999999875 332 2 3499999999987644
Q ss_pred CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... .... .. ..+...
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~---~~-~~~~~~-- 225 (284)
T 3kk8_A 161 SEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYA---QI-KAGAYD-- 225 (284)
T ss_dssp SCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHH---HH-HHTCCC--
T ss_pred Ccc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-------HHHH---HH-Hhcccc--
Confidence 322 23467999999999999999999999999999999999999999653221 1111 11 111110
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.........+..+.+|+.+||+.||++|||+.|+++
T Consensus 226 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 226 ----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 011111223456888999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=323.38 Aligned_cols=245 Identities=20% Similarity=0.250 Sum_probs=193.5
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
+..++|.+.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+|++++||||+++++++.+.+.+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 34577999999999999999999974 58999999995432 123456889999999999999999999999999999
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+||||++||+|.+++.........+++..++.++.||+.||.|||+. ++.++.+||+|||+++.+..
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999999976543345799999999999999999999875 45578999999999987644
Q ss_pred CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||........ .......... ...
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~------~~~~~~~i~~-~~~--- 410 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE------NKELKQRVLE-QAV--- 410 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC------HHHHHHHHHH-CCC---
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh------HHHHHHHHhh-ccc---
Confidence 322 23446899999999999999999999999999999999999999976543211 1111111111 110
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCH-----HHHHH
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKM-----GHVIH 417 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~-----~evl~ 417 (442)
..+...+..+.+|+.+||+.||++||++ .++++
T Consensus 411 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 -------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1122334568889999999999999975 56653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=309.02 Aligned_cols=238 Identities=23% Similarity=0.347 Sum_probs=185.2
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeeeEEe
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
.++|.+.+.||+|+||.||+|... +++.||||.+..... ...+|++++.++ +||||+++++++.+.+..|+|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 356889999999999999999965 588999999965432 234688888887 79999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCCC-----------CCeEEecccCccccCC
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEPK-----------WNPKLSDFGLAKLLGA 297 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~~-----------~~~kl~DFGla~~~~~ 297 (442)
||++|+|.+++... ..+++..+..++.|++.||.|||+. ++++ +.+||+|||+++....
T Consensus 97 ~~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 97 LMKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 99999999999764 4689999999999999999999875 3332 2499999999987644
Q ss_pred CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||........ .+.... ...+...
T Consensus 173 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-------~~~~~~-i~~~~~~-- 241 (342)
T 2qr7_A 173 ENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP-------EEILAR-IGSGKFS-- 241 (342)
T ss_dssp TTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH-------HHHHHH-HHHCCCC--
T ss_pred CCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH-------HHHHHH-HccCCcc--
Confidence 322 23456899999999999888899999999999999999999999975322111 111111 1111111
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
+........+..+.+|+.+||+.||++|||+.++++
T Consensus 242 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 ----LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ----CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111234456888999999999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=299.04 Aligned_cols=239 Identities=19% Similarity=0.297 Sum_probs=181.8
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
++|.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 45888999999999999999964 58899999986543 33457789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C----------CCCCCeEEecccCccccCCCc
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L----------EPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l----------~~~~~~kl~DFGla~~~~~~~ 299 (442)
+++|+|.+++.........+++..++.++.|++.||.|||+. + +.++.+||+|||+++......
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 999999999864322235689999999999999999999875 2 335679999999998764332
Q ss_pred ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
......||+.|+|||++. ..++.++|||||||++|||++|+.||...... ...........
T Consensus 182 --~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~----------~~~~~~~~~~~------ 242 (285)
T 3is5_A 182 --HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE----------EVQQKATYKEP------ 242 (285)
T ss_dssp -------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----------HHHHHHHHCCC------
T ss_pred --cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH----------HHHhhhccCCc------
Confidence 234457899999999885 57899999999999999999999999753211 11111111110
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.... .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 243 -~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 243 -NYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -CCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -cccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00012355778999999999999999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=308.67 Aligned_cols=243 Identities=23% Similarity=0.343 Sum_probs=179.4
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe----
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAH---- 228 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~---- 228 (442)
.++|++.+.||+|+||.||+|.. .+++.||||.+... .......+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 45689999999999999999996 56889999999654 23344678899999999999999999999876543
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLL 295 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~ 295 (442)
.|+||||+++|+|.++++.. ..+++..++.++.|++.||.|||+. ++.++.+||+|||+++.+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 49999999999999999764 4689999999999999999999875 335678999999999876
Q ss_pred CCCcc--eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC
Q 047892 296 GAERS--YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373 (442)
Q Consensus 296 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (442)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~----------~~~~~~~~~~~ 236 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV----------SVAYQHVREDP 236 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----------HHHHHHHHCCC
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH----------HHHHHHhcCCC
Confidence 44322 1223457999999999999999999999999999999999999999654321 11111111110
Q ss_pred cccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHH-HHHh
Q 047892 374 AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVI-HMLE 420 (442)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl-~~L~ 420 (442)
. .+. ......+..+.+++.+||+.||++||++.+++ ..|.
T Consensus 237 ~----~~~---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 237 I----PPS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp C----CHH---HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred C----Ccc---cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 0 000 00112345688899999999999999766655 4444
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=305.49 Aligned_cols=251 Identities=20% Similarity=0.252 Sum_probs=182.9
Q ss_pred CCCCcc-CeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeeeEEe
Q 047892 158 NGFADE-NVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 158 ~~~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
+.|.+. +.||+|+||.||+|.. .+++.||||.+..........+.+|++++.++ +||||+++++++.+.+..|+|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 457774 7899999999999995 46899999999765555567889999999885 79999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC-------CCC---eEEecccCccccCCC
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP-------KWN---PKLSDFGLAKLLGAE 298 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-------~~~---~kl~DFGla~~~~~~ 298 (442)
|+++|+|.+++... ..+++..+..++.|++.||.|||+. +++ ++. +||+|||+++.....
T Consensus 92 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 92 KMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred cCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999764 4689999999999999999999876 333 333 899999999865322
Q ss_pred cc------eeecccccccCCCCcccccC-----CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchh----hhHHH
Q 047892 299 RS------YVTTRVMGTFGYVAPEYAST-----GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQ----VNLFE 363 (442)
Q Consensus 299 ~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~----~~~~~ 363 (442)
.. ......+||+.|+|||++.+ ..++.++|||||||++|||++|..||......+..-.. .....
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 11 11223569999999999865 55889999999999999999999999765432210000 00001
Q ss_pred HHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 364 WLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.+.......... +........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~i~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 248 MLFESIQEGKYE------FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHCCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhccCcc------cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111111111110 0000001234568889999999999999999999873
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=300.60 Aligned_cols=235 Identities=26% Similarity=0.373 Sum_probs=185.7
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
..++|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3467899999999999999999965 47789999985432 2234568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
||||+++|+|.+++... ..+++..++.++.|++.||.|||+. ++.++.+||+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999999764 4689999999999999999999876 456789999999998654322
Q ss_pred cceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 299 RSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
. .....||+.|+|||++.+..++.++||||||+++|||++|..||...... ....... ...
T Consensus 163 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------~~~~~~~-~~~----- 223 (279)
T 3fdn_A 163 R---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----------ETYKRIS-RVE----- 223 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----------HHHHHHH-HTC-----
T ss_pred c---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH----------HHHHHHH-hCC-----
Confidence 2 23457899999999999999999999999999999999999999743211 1111111 110
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
...+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 224 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 -----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -----CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -----CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01112234567889999999999999999999964
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=313.11 Aligned_cols=233 Identities=25% Similarity=0.355 Sum_probs=184.1
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
+.|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3488889999999999999996 568899999986432 233467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+. |+|.+++... ...+++..+..++.|++.||.|||+. ++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp ECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9998 5888888643 24689999999999999999999875 344678999999999875432
Q ss_pred eeecccccccCCCCccccc---CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 301 YVTTRVMGTFGYVAPEYAS---TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
....||+.|+|||++. ...++.++|||||||++|||++|..||..... ...+........
T Consensus 208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~----------~~~~~~~~~~~~---- 270 (348)
T 1u5q_A 208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----------MSALYHIAQNES---- 270 (348)
T ss_dssp ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----------HHHHHHHHHSCC----
T ss_pred ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----------HHHHHHHHhcCC----
Confidence 3457999999999984 56799999999999999999999999964321 111122221111
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
+.. .....+..+.+|+.+||+.||++|||+.++++.
T Consensus 271 --~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 271 --PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp --CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --CCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111 112234567889999999999999999999853
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=305.98 Aligned_cols=245 Identities=26% Similarity=0.397 Sum_probs=190.4
Q ss_pred HHhhCCCCccC-eeccCCcEEEEEEEE---CCCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 047892 154 EVSTNGFADEN-VIGEGGYGIVYRGVL---EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA 227 (442)
Q Consensus 154 ~~~~~~~~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 227 (442)
.+..++|.+.+ .||+|+||.||+|.+ .+++.||||.+.... ....+.+.+|+.+++.++||||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 34456688887 999999999999964 236789999986442 33456799999999999999999999999 567
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCccc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKL 294 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~ 294 (442)
..++||||+++|+|.+++... ..+++..++.++.|++.||.|||+. ++ .++.+||+|||+++.
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CcEEEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 789999999999999999864 4689999999999999999999875 33 457899999999987
Q ss_pred cCCCccee--ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhc
Q 047892 295 LGAERSYV--TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTN 371 (442)
Q Consensus 295 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (442)
........ .....+|+.|+|||++.+..++.++|||||||++|||++ |..||...... ... .....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~----~~~~~ 235 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVT----AMLEK 235 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHH----HHHHT
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHH----HHHHc
Confidence 65443322 223356789999999988889999999999999999999 99999753221 111 11111
Q ss_pred CCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 372 GNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
.. ....+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 236 ~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 236 GE---------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp TC---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 11112234456888999999999999999999999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=306.03 Aligned_cols=232 Identities=24% Similarity=0.292 Sum_probs=177.2
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeeeE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 232 (442)
.++|++.+.||+|+||+||+|... +++.||||++... .......+..|+..+.++ +||||+++++++.+++..|+|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 356899999999999999999975 6899999998543 223334455566666555 999999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
|||+ +|+|.+++... ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++......
T Consensus 136 ~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred Eecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9999 56999998764 24689999999999999999999875 3456789999999998764332
Q ss_pred ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
......||+.|+|||++.+ .++.++|||||||++|||++|..||.... ... . ..... ..
T Consensus 212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~~---~-~~~~~----~~ 270 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GWQ---Q-LRQGY----LP 270 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HHH---H-HTTTC----CC
T ss_pred --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HHH---H-HhccC----CC
Confidence 2344579999999999875 79999999999999999999977664210 111 1 11111 11
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
+. .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 271 ~~----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 271 PE----FTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cc----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11 11223466888999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=325.46 Aligned_cols=242 Identities=22% Similarity=0.264 Sum_probs=193.1
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
+..++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++|+.++||||+++++++.+.+..|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 55678999999999999999999974 68999999985431 223456789999999999999999999999999999
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+||||+++|+|.+++.... ...+++..++.++.||+.||.|||+. ++.++.+||+|||+++.+..
T Consensus 261 lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EEECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999999997642 23589999999999999999999875 45578999999999987654
Q ss_pred CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
... ....+||+.|+|||++.+..|+.++|||||||++|||++|..||......... ..+. .......
T Consensus 339 ~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~---~~i~----~~i~~~~---- 405 (576)
T 2acx_A 339 GQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVE----RLVKEVP---- 405 (576)
T ss_dssp TCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH---HHHH----HHHHHCC----
T ss_pred Ccc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH---HHHH----HHhhccc----
Confidence 332 33458999999999999989999999999999999999999999765432211 1111 1111110
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCC-----CHHHHHH
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRP-----KMGHVIH 417 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 417 (442)
...+...+..+.+|+.+||+.||.+|| ++.|+++
T Consensus 406 ------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 ------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 111223445688899999999999999 7888874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=321.46 Aligned_cols=237 Identities=20% Similarity=0.232 Sum_probs=180.8
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
+..++|++.+.||+|+||.||+|.. .+++.||||.+... .......+.+|+.+++.++||||+++++++.+.+..|
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 3456799999999999999999996 45899999998543 2233456778999999999999999999999999999
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc-C-------------CCCCCCeEEecccCccccC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-G-------------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~-------------l~~~~~~kl~DFGla~~~~ 296 (442)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+ . ++.++.+||+|||+++...
T Consensus 225 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EEECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEEeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999999764 468999999999999999999996 4 3456899999999998643
Q ss_pred CCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 297 AERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...... .. ....... ..
T Consensus 301 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~---~~~i~~~-~~-- 366 (446)
T 4ejn_A 301 KDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KL---FELILME-EI-- 366 (446)
T ss_dssp C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HH---HHHHHHC-CC--
T ss_pred CCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------HH---HHHHHhC-CC--
Confidence 222 2234578999999999999999999999999999999999999999653221 11 1111111 10
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCC-----CHHHHHH
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRP-----KMGHVIH 417 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 417 (442)
..+...+..+.+|+.+||+.||.+|| |+.|+++
T Consensus 367 --------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 --------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11122345688899999999999999 9999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=315.80 Aligned_cols=243 Identities=26% Similarity=0.377 Sum_probs=179.6
Q ss_pred CCccCeeccCCcEEEEEEEEC--C--CCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEE-eCCeeeeEE
Q 047892 160 FADENVIGEGGYGIVYRGVLE--D--NTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCA-EGAHRMLVN 233 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~--~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~~lv~ 233 (442)
|.+.+.||+|+||.||+|.+. + +..||+|.+... .....+.+.+|+.++++++||||+++++++. ..+..|+||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 667789999999999999853 2 235899988643 3345677999999999999999999999875 456789999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++|+|.++++.. ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++.+.....
T Consensus 171 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp ECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred ECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 999999999999764 24578899999999999999999875 44567899999999986643321
Q ss_pred e---eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 301 Y---VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 301 ~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
. ......+|+.|+|||++.+..++.++|||||||++|||++ |.+||......+. ... ...+.
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~-------~~~----~~~~~--- 313 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-------TVY----LLQGR--- 313 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH-------HHH----HHTTC---
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH-------HHH----HHcCC---
Confidence 1 1233467889999999999999999999999999999999 7788865443221 111 11111
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCC
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 425 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 425 (442)
....+..++..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 314 ------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 314 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0011223345688899999999999999999999999876533
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=307.53 Aligned_cols=256 Identities=21% Similarity=0.346 Sum_probs=193.8
Q ss_pred hhCCCCccCeeccCCcEEEEEEEE-----CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--e
Q 047892 156 STNGFADENVIGEGGYGIVYRGVL-----EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA--H 228 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~ 228 (442)
..++|++.+.||+|+||.||+|.+ .+++.||||++........+.+.+|++++++++||||+++++++...+ .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 345688899999999999999984 358899999997766666778999999999999999999999986544 7
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCcccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKLL 295 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~~ 295 (442)
.++||||+++|+|.+++... ...+++..++.++.|++.||.|||+. ++ .++.+||+|||+++..
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 89999999999999999764 24689999999999999999999875 33 4678999999999877
Q ss_pred CCCcce--eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCC-----CccchhhhHHHHHHHH
Q 047892 296 GAERSY--VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPP-----GEFQFQVNLFEWLKTM 368 (442)
Q Consensus 296 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~-----~~~~~~~~~~~~~~~~ 368 (442)
...... ......++..|+|||++.+..++.++|||||||++|||++|..||...... ............+...
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 544322 122345778899999998888999999999999999999999998531000 0000000000111111
Q ss_pred hhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 369 VTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
.... .....+...+..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 276 ~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 276 LKNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcC---------CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111 111122334567888999999999999999999999998763
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=302.90 Aligned_cols=241 Identities=20% Similarity=0.310 Sum_probs=188.6
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
++|.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++++.+.+..|+||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 45888999999999999999964 68999999997654445567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------C---CCCCCeEEecccCccccCCCcc
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------L---EPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l---~~~~~~kl~DFGla~~~~~~~~ 300 (442)
++|+|.+++... ..+++..+..++.|++.||.|||+. + +.++.+||+|||+++.....
T Consensus 89 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-- 162 (304)
T 2jam_A 89 SGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162 (304)
T ss_dssp CSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred CCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence 999999998754 4689999999999999999999875 2 45678999999999764322
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... ..... .. ..+.. .
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~---~i-~~~~~-~---- 225 (304)
T 2jam_A 163 -IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-------SKLFE---KI-KEGYY-E---- 225 (304)
T ss_dssp -TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHH---HH-HHCCC-C----
T ss_pred -ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHH---HH-HcCCC-C----
Confidence 12335689999999999999999999999999999999999999965321 11111 11 11111 0
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH--HHhcC
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEAE 422 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~--~L~~~ 422 (442)
.........+..+.+++.+||+.||++|||+.|+++ .++..
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 226 -FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp -CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred -CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 011111233456888999999999999999999986 45543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=308.90 Aligned_cols=244 Identities=23% Similarity=0.392 Sum_probs=187.5
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCe--EEEEEecCc-chhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTN--VAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 231 (442)
.++|.+.+.||+|+||.||+|... ++.. ||+|.+... .....+.+.+|+++++++ +||||+++++++.+.+..|+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 457899999999999999999954 4554 499988643 233446688999999999 99999999999999999999
Q ss_pred EEecCCCCCHHHHHccCC------------CCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCCCeEE
Q 047892 232 VNEYVDNGNLEQWLHGDV------------GPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKWNPKL 286 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~~~kl 286 (442)
||||+++|+|.+++.... .....+++..++.++.|++.||.|||+. + +.++.+||
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEE
Confidence 999999999999997642 2234789999999999999999999875 3 44578999
Q ss_pred ecccCccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHH
Q 047892 287 SDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWL 365 (442)
Q Consensus 287 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 365 (442)
+|||+++.... ........+++.|+|||++.+..++.++|||||||++|||++ |..||...... ...
T Consensus 184 ~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~----------~~~ 251 (327)
T 1fvr_A 184 ADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----------ELY 251 (327)
T ss_dssp CCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------HHH
T ss_pred cccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH----------HHH
Confidence 99999975322 111233457889999999988889999999999999999998 99999654221 111
Q ss_pred HHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 366 KTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.. ...+ .....+...+..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus 252 ~~-~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 252 EK-LPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp HH-GGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH-hhcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 1111 11112223445688899999999999999999999998865
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=301.23 Aligned_cols=244 Identities=26% Similarity=0.385 Sum_probs=186.9
Q ss_pred CCCCccCeeccCCcEEEEEEEECC----CCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEE-eCCeeee
Q 047892 158 NGFADENVIGEGGYGIVYRGVLED----NTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCA-EGAHRML 231 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~~l 231 (442)
..|.+.+.||+|+||.||+|.+.+ ...||+|.+... .....+.+.+|+.++++++||||+++++++. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 347888999999999999998532 235899988653 3345577899999999999999999999864 5567899
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
||||+++|+|.++++.. ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++.....
T Consensus 105 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999999999764 24678999999999999999999876 445678999999999876443
Q ss_pred cce---eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 299 RSY---VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 299 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
... ......||+.|+|||.+.+..++.++|||||||++|||++ |.+||........ ... . ....
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~-------~~~---~-~~~~- 249 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-------TVY---L-LQGR- 249 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH-------HHH---H-HTTC-
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH-------HHH---H-hcCC-
Confidence 221 2234567889999999999999999999999999999999 6666654433221 111 1 1110
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCC
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 424 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 424 (442)
....+...+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 250 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 250 --------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 001112234568889999999999999999999999987643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=299.70 Aligned_cols=242 Identities=24% Similarity=0.337 Sum_probs=186.1
Q ss_pred CCccCeeccCCcEEEEEEEEC-CCC---eEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee-eeEE
Q 047892 160 FADENVIGEGGYGIVYRGVLE-DNT---NVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHR-MLVN 233 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~-~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~-~lv~ 233 (442)
|...+.||+|+||.||+|.+. ++. .||+|.+... .....+.+.+|+.++++++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 556689999999999999853 233 6999998653 334557789999999999999999999999876655 9999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+.+|+|.+++... ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++.......
T Consensus 103 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 103 PYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp CCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred ecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 999999999999763 35688999999999999999999876 44567999999999986643321
Q ss_pred ---eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 301 ---YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 301 ---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
.......+|+.|+|||.+.+..++.++|||||||++|||++|..|+....... .....+ ....
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~------~~~~~~----~~~~---- 245 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF------DLTHFL----AQGR---- 245 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG------GHHHHH----HTTC----
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH------HHHHHh----hcCC----
Confidence 12234567899999999999999999999999999999999555543322111 111111 1111
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....+...+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 246 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 246 -----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11112223456888999999999999999999999998764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=309.37 Aligned_cols=243 Identities=25% Similarity=0.423 Sum_probs=183.7
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCe----EEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTN----VAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
.++|++.+.||+|+||.||+|.+. +++. ||+|.+... .......+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467899999999999999999963 3444 577777433 3345677899999999999999999999998765 78
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~~~~ 297 (442)
+|+||+.+|+|.+++... ...+++..++.++.|++.||.|||+. ++ .++.+||+|||+++....
T Consensus 93 ~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999999764 24689999999999999999999875 43 357899999999987643
Q ss_pred Ccce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 298 ERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 298 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
.... ......||+.|+|||++.+..++.++|||||||++|||++ |..||....... ... ......
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~----~~~~~~-- 236 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISS----ILEKGE-- 236 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHH----HHHTTC--
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHH----HHHcCC--
Confidence 3221 2233457889999999999999999999999999999999 999997543221 111 111111
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....+...+..+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 237 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 237 -------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11112234456888999999999999999999999998764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=309.64 Aligned_cols=242 Identities=21% Similarity=0.269 Sum_probs=188.3
Q ss_pred hCCCCccCeeccCCcEEEEEEEE----CCCCeEEEEEecCcc----hhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL----EDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGA 227 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 227 (442)
.++|.+.+.||+|+||.||+|+. .+++.||||++.... ......+.+|++++..+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 45689999999999999999997 368999999985431 22334567899999999 6999999999999999
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKL 294 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~ 294 (442)
..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999999764 4689999999999999999999875 44567999999999987
Q ss_pred cCCCcceeecccccccCCCCcccccC--CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYAST--GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (442)
............+||+.|+|||++.+ ..++.++|||||||++|||++|..||......... ..........
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~------~~~~~~~~~~- 281 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ------AEISRRILKS- 281 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH------HHHHHHHHHC-
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH------HHHHHHHhcc-
Confidence 64443333445689999999999975 34789999999999999999999999754432221 1111111111
Q ss_pred CcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCC-----CHHHHHHHH
Q 047892 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRP-----KMGHVIHML 419 (442)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~~L 419 (442)
.+ ..+...+..+.+|+.+||+.||.+|| |+.|+++..
T Consensus 282 ------~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 ------EP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ------CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ------CC----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 01 11223345678899999999999999 999998653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=307.45 Aligned_cols=229 Identities=20% Similarity=0.331 Sum_probs=185.9
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcch--------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRG--------QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA 227 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 227 (442)
.++|++.+.||+|+||.||+|.. .+++.||||.+..... .....+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 35699999999999999999995 4588999999864321 12345678999999999999999999999999
Q ss_pred eeeeEEecCCCC-CHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcc
Q 047892 228 HRMLVNEYVDNG-NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAK 293 (442)
Q Consensus 228 ~~~lv~E~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~ 293 (442)
..++||||+.+| +|.+++... ..+++..+..++.|++.||.|||.. ++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 999999999777 999999765 4689999999999999999999875 4457799999999998
Q ss_pred ccCCCcceeecccccccCCCCcccccCCCC-CCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC
Q 047892 294 LLGAERSYVTTRVMGTFGYVAPEYASTGML-NETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372 (442)
Q Consensus 294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (442)
....... ....+||+.|+|||++.+..+ +.++|||||||++|||++|..||.....
T Consensus 179 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------------------- 235 (335)
T 3dls_A 179 YLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------------------- 235 (335)
T ss_dssp ECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------------------
T ss_pred ECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------------------
Confidence 7654332 234579999999999988876 7899999999999999999999964211
Q ss_pred CcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
...... ..+...+..+.+|+.+||+.||++|||+.++++.
T Consensus 236 ----~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ----TVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----GTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----HHhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 1111234568889999999999999999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=300.25 Aligned_cols=251 Identities=24% Similarity=0.290 Sum_probs=182.6
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc-----hhhHHHHHHHHHHHHhc---CCCCcceEEEEEEe
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR-----GQAEKEFKVEVEAIGRV---RHKNLVRLVGYCAE 225 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~ 225 (442)
+..++|++.+.||+|+||.||+|.. .+++.||||.+.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3456899999999999999999995 568999999985321 11234566777777666 59999999999987
Q ss_pred CC-----eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCCCeEEe
Q 047892 226 GA-----HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKWNPKLS 287 (442)
Q Consensus 226 ~~-----~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~~~kl~ 287 (442)
.. ..++||||+.+ +|.+++.... ...+++..++.++.|++.||.|||+. + +.++.+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CCSSSEEEEEEEEECCCC-BHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred cCCCCceeEEEEehhhhc-CHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEe
Confidence 55 57999999985 9999997652 23489999999999999999999875 3 346789999
Q ss_pred cccCccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHH
Q 047892 288 DFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKT 367 (442)
Q Consensus 288 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 367 (442)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..
T Consensus 163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------~~~~~i~~ 233 (308)
T 3g33_A 163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-------DQLGKIFD 233 (308)
T ss_dssp SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-------HHHHHHHH
T ss_pred eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHH
Confidence 999998764332 234568999999999999999999999999999999999999999754321 11111111
Q ss_pred HhhcCC---cccc---cCcccCCC-------CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 368 MVTNGN---AEGV---LDPRLQEK-------PSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 368 ~~~~~~---~~~~---~~~~~~~~-------~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
...... .... ....+... .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 111000 0000 00000000 00123456788999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=299.00 Aligned_cols=237 Identities=24% Similarity=0.334 Sum_probs=184.6
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc------hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR------GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 45888999999999999999975 58999999985432 123577899999999999999999999999999999
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCC----CeEEecccCcc
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKW----NPKLSDFGLAK 293 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~----~~kl~DFGla~ 293 (442)
+||||+++++|.+++... ..+++..++.++.|++.||.|||+. + +.++ .+||+|||++.
T Consensus 85 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 999999999999999754 4689999999999999999999875 2 2333 79999999998
Q ss_pred ccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC
Q 047892 294 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373 (442)
Q Consensus 294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (442)
....... .....||+.|+|||++.+..++.++||||||+++|||++|..||...... ....... ...
T Consensus 161 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------~~~~~~~-~~~ 227 (283)
T 3bhy_A 161 KIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ----------ETLTNIS-AVN 227 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----------HHHHHHH-TTC
T ss_pred eccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH----------HHHHHhH-hcc
Confidence 7643322 23457899999999999899999999999999999999999999653221 1111111 110
Q ss_pred cccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 374 AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
. ..... .....+..+.+++.+||+.||++|||+.|+++
T Consensus 228 ~--~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 228 Y--DFDEE----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp C--CCCHH----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c--CCcch----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 00000 01123456788999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=311.43 Aligned_cols=258 Identities=19% Similarity=0.225 Sum_probs=195.5
Q ss_pred hCCCCccCeeccCCcEEEEEEEECC-CCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--eeeeE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA--HRMLV 232 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~lv 232 (442)
.++|.+.+.||+|+||.||+|.+.. ++.||||.+.... ....+.+.+|++++++++||||+++++++...+ ..|+|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 3458889999999999999999754 8999999996432 234566789999999999999999999998765 77999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-----------CCCCCeEEecccCcccc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-----------EPKWNPKLSDFGLAKLL 295 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-----------~~~~~~kl~DFGla~~~ 295 (442)
||||++|+|.+++..... ...+++..++.++.|++.||.|||+. + +.++.+||+|||+++..
T Consensus 88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 999999999999975421 23489999999999999999999875 3 33445899999999876
Q ss_pred CCCcceeecccccccCCCCcccccC--------CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHH
Q 047892 296 GAERSYVTTRVMGTFGYVAPEYAST--------GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKT 367 (442)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 367 (442)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .+.+..
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~------~~~~~~ 238 (396)
T 4eut_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN------KEVMYK 238 (396)
T ss_dssp CCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC------HHHHHH
T ss_pred cCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch------HHHHHH
Confidence 44332 234579999999999864 56788999999999999999999999754332221 111122
Q ss_pred HhhcCCc---c---ccc--------CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 368 MVTNGNA---E---GVL--------DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 368 ~~~~~~~---~---~~~--------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....... . ... ...............+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 2211110 0 000 001112334677788899999999999999999999999887653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=302.12 Aligned_cols=241 Identities=27% Similarity=0.377 Sum_probs=183.7
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-CeeeeE
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG-AHRMLV 232 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~lv 232 (442)
.+..++|++.+.||+|+||.||+|.. +++.||||.+.... ..+.+.+|+.++++++||||+++++++... +..|+|
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred cCChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 34556799999999999999999987 47899999986532 456788999999999999999999997554 578999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
|||+++|+|.+++.... ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++.....
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp ECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 99999999999997531 12378899999999999999999876 345788999999999865332
Q ss_pred ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
.....+++.|+|||++.+..++.++|||||||++|||++ |..||....... ... ....+
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~----~~~~~------ 230 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVP----RVEKG------ 230 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-------HHH----HHTTT------
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHH----HHhcC------
Confidence 123467889999999998899999999999999999998 999997543211 111 11111
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
.....+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 231 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 231 ---YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 111122234466888999999999999999999999998753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=309.94 Aligned_cols=250 Identities=20% Similarity=0.316 Sum_probs=176.6
Q ss_pred hhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCC--ee
Q 047892 156 STNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVR-HKNLVRLVGYCAEGA--HR 229 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~--~~ 229 (442)
..++|++.+.||+|+||.||+|.. .+++.||||++... .......+.+|+.++..+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 356799999999999999999996 45899999998543 3445566889999999997 999999999997544 68
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~ 296 (442)
|+|||||++ +|.++++.. .+++..+..++.|++.||.|||+. ++.++.+||+|||+++.+.
T Consensus 87 ~lv~e~~~~-~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 87 YLVFDYMET-DLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEECCSE-EHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEecccCc-CHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 999999985 999999753 688999999999999999999875 4457789999999998653
Q ss_pred CC--------------------cceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCcc
Q 047892 297 AE--------------------RSYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEF 355 (442)
Q Consensus 297 ~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~ 355 (442)
.. .....+..+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~- 239 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ- 239 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 21 1112344689999999999976 6799999999999999999999999976432211
Q ss_pred chhhhHHHHHHHHhhcCCccc---------------------ccCcccCCC------------CcHHHHHHHHHHHhhhh
Q 047892 356 QFQVNLFEWLKTMVTNGNAEG---------------------VLDPRLQEK------------PSSRALKRALLVALRCV 402 (442)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~------------~~~~~~~~~~~li~~cl 402 (442)
...+........... ......... .....+..+.+|+.+||
T Consensus 240 ------~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 240 ------LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp ------HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred ------HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 111111000000000 000000000 00123456889999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 047892 403 DPNAHKRPKMGHVIHM 418 (442)
Q Consensus 403 ~~dP~~RPs~~evl~~ 418 (442)
+.||++|||+.|+++.
T Consensus 314 ~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 314 QFNPNKRISANDALKH 329 (388)
T ss_dssp CSSGGGSCCHHHHTTS
T ss_pred ccCcccCCCHHHHhCC
Confidence 9999999999999865
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=302.35 Aligned_cols=256 Identities=23% Similarity=0.352 Sum_probs=185.0
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 346889999999999999999975 48999999985432 334566889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++++|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++.+.....
T Consensus 104 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 104 EFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp ECCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred ecCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 999999999887654 4689999999999999999999876 44567999999999987643322
Q ss_pred eeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhH-----HHHHHHHhhcCCc
Q 047892 301 YVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNL-----FEWLKTMVTNGNA 374 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 374 (442)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||............... .............
T Consensus 180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 23345789999999999775 6899999999999999999999999764322111000000 0000000001001
Q ss_pred ccccCcccCCCCc-----HHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 375 EGVLDPRLQEKPS-----SRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 375 ~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.....+.+..... ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1111111111111 123567889999999999999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=314.08 Aligned_cols=253 Identities=21% Similarity=0.233 Sum_probs=180.8
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------C
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG------A 227 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~ 227 (442)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+|+.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467999999999999999999964 5889999999653 334456788999999999999999999999654 3
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKL 294 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~ 294 (442)
..|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||+. ++.++.+||+|||+++.
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 56999999987 57777753 388999999999999999999875 44567999999999987
Q ss_pred cCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhH------------H
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNL------------F 362 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~------------~ 362 (442)
.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+........ .
T Consensus 214 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 214 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ---C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred cCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 6432 2234568999999999999999999999999999999999999999764321111000000 0
Q ss_pred HHHHHHhhcC-Ccc-----cccCcccCCC---CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 363 EWLKTMVTNG-NAE-----GVLDPRLQEK---PSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 363 ~~~~~~~~~~-~~~-----~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.......... ... ......+... .....+.++.+|+.+||+.||++|||+.|+++.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 000 0000000000 011235678999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=302.18 Aligned_cols=239 Identities=18% Similarity=0.275 Sum_probs=190.9
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|.+.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 45888999999999999999975 4788999998543 2345567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+++++|.+++... ..+++..++.++.|++.||.|||+. ++.++.+||+|||+++.......
T Consensus 121 e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 121 ELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp CCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred ecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 999999999998764 4689999999999999999999876 44567899999999987643222
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....... ...
T Consensus 197 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------~~~~~~~~~-~~~------ 258 (335)
T 2owb_A 197 -RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL----------KETYLRIKK-NEY------ 258 (335)
T ss_dssp -CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH----------HHHHHHHHH-TCC------
T ss_pred -cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH----------HHHHHHHhc-CCC------
Confidence 23445799999999999998999999999999999999999999965321 111111111 110
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH--HHhcC
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEAE 422 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~--~L~~~ 422 (442)
. .+...+..+.+|+.+||+.||++|||+.|+++ .+...
T Consensus 259 ~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 259 S----IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp C----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred C----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 0 11123345778999999999999999999986 45543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=307.58 Aligned_cols=249 Identities=24% Similarity=0.405 Sum_probs=190.5
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEE------CCCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA 227 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 227 (442)
+..++|.+.+.||+|+||.||+|.+ .+++.||||.+... .......+.+|+.++++++||||+++++++...+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 4556799999999999999999983 24678999999643 3445567889999999999999999999999999
Q ss_pred eeeeEEecCCCCCHHHHHccCCC---CCCCCCHHHHHHHHHHHHHhhhhhhcC------CC----------CCCCeEEec
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEG------LE----------PKWNPKLSD 288 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~----------~~~~~kl~D 288 (442)
..|+||||+++|+|.+++..... ....+++..++.++.|++.||.|||+. ++ .+..+||+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECc
Confidence 99999999999999999976432 124589999999999999999999875 32 234699999
Q ss_pred ccCccccCCCcc-eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHH
Q 047892 289 FGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLK 366 (442)
Q Consensus 289 FGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 366 (442)
||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||..... ....
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~~~---- 255 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------QEVL---- 255 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHH----
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-------HHHH----
Confidence 999976533221 12234567899999999988999999999999999999998 9999965321 1111
Q ss_pred HHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 367 TMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....... ....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 256 ~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 256 EFVTSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcCC---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 1111111 01112233456888999999999999999999999998654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=295.31 Aligned_cols=236 Identities=18% Similarity=0.274 Sum_probs=189.4
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 232 (442)
.++|.+.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 345888999999999999999975 4788999998543 234556788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
|||+++++|.+++... ..+++..++.++.|++.||.|||+. ++.++.+||+|||+++......
T Consensus 94 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 94 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999998764 4689999999999999999999876 4557799999999998764322
Q ss_pred ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
. ......||+.|+|||++.+..++.++||||||+++|||++|..||...... +...... ....
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------~~~~~~~-~~~~----- 232 (294)
T 2rku_A 170 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK----------ETYLRIK-KNEY----- 232 (294)
T ss_dssp C-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----------HHHHHHH-TTCC-----
T ss_pred c-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------HHHHHHh-hccC-----
Confidence 2 233457899999999999888999999999999999999999999653211 1111111 1110
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 233 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 -----SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -----CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1111233567889999999999999999999863
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=295.99 Aligned_cols=247 Identities=17% Similarity=0.184 Sum_probs=189.2
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEE-EeCCeeeeEEe
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYC-AEGAHRMLVNE 234 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~~~~lv~E 234 (442)
.++|++.+.||+|+||.||+|.. .+++.||||.+..... ...+.+|+.+++.++|++++..+..+ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 35689999999999999999996 5689999998854332 23578899999999998876666554 66778899999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------C---CCCCCeEEecccCccccCCC
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------L---EPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l---~~~~~~kl~DFGla~~~~~~ 298 (442)
|+ +|+|.+++... ...+++..++.++.|++.||.|||+. + +.++.+||+|||+++.....
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred ec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99 88999999743 24689999999999999999999876 3 35678999999999876543
Q ss_pred cce------eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC
Q 047892 299 RSY------VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372 (442)
Q Consensus 299 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (442)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||................. .... .
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~~~-~ 237 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE---KKMS-T 237 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH---HHHH-S
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc---cccC-C
Confidence 321 12446799999999999999999999999999999999999999986543332211111111 1000 0
Q ss_pred CcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.. +.+. ...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 238 ~~-----~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 238 PI-----EVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp CH-----HHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred ch-----HHHH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 00 0000 12235688899999999999999999999999865
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=298.40 Aligned_cols=234 Identities=22% Similarity=0.328 Sum_probs=188.7
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
..++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+++++.++||||+++++++.+.+..|+
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 3467899999999999999999975 47789999985432 2234678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||++......
T Consensus 92 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999999764 4689999999999999999999876 446789999999999765432
Q ss_pred cceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 299 RSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
. .....||+.|+|||++.+..++.++||||||+++|||++|..||...... ....... ...
T Consensus 168 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----------~~~~~~~-~~~----- 228 (284)
T 2vgo_A 168 R---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT----------ETHRRIV-NVD----- 228 (284)
T ss_dssp C---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----------HHHHHHH-TTC-----
T ss_pred c---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh----------HHHHHHh-ccc-----
Confidence 2 23457899999999999999999999999999999999999999653211 1111111 111
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.. .+...+..+.+++.+||+.||.+|||+.++++
T Consensus 229 -~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 -LK----FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -CC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -cC----CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 01 11223456788999999999999999999985
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=300.99 Aligned_cols=235 Identities=23% Similarity=0.366 Sum_probs=189.2
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
+.|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 45888999999999999999964 58899999986432 34557789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++++|.+++.. ..+++..+..++.|++.||.|||+. ++.++.+||+|||++........ .
T Consensus 102 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 175 (303)
T 3a7i_A 102 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K 175 (303)
T ss_dssp CTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-C
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc-c
Confidence 999999999964 3689999999999999999999876 45678999999999987644322 2
Q ss_pred ecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCccc
Q 047892 303 TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (442)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...... .... ... ... .+.+
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~---~~~-~~~-----~~~~ 239 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-------KVLF---LIP-KNN-----PPTL 239 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHH---HHH-HSC-----CCCC
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH-------HHHH---Hhh-cCC-----CCCC
Confidence 34457899999999999999999999999999999999999999643211 1111 111 111 1111
Q ss_pred CCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 383 QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 383 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
....+..+.+|+.+||+.||++|||+.++++.
T Consensus 240 ----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 ----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11233558889999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=303.32 Aligned_cols=245 Identities=22% Similarity=0.302 Sum_probs=189.6
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE--GAHRML 231 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l 231 (442)
.++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+ ....|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 356889999999999999999975 5899999998643 33455678999999999999999999998854 568899
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------------------CCCCCCeEEecccCcc
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------------------LEPKWNPKLSDFGLAK 293 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------------------l~~~~~~kl~DFGla~ 293 (442)
||||+++|+|.+++.........+++..++.++.|++.||.|||+. ++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 9999999999999975432334689999999999999999999862 3346789999999998
Q ss_pred ccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC
Q 047892 294 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373 (442)
Q Consensus 294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (442)
....... ......||+.|+|||++.+..++.++|||||||++|||++|..||..... ..... ....+.
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~----~i~~~~ 232 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAG----KIREGK 232 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH----HHHHTC
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-------HHHHH----HHhhcc
Confidence 7643322 12345789999999999988999999999999999999999999975321 11111 111111
Q ss_pred cccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 374 AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.. ..+...+..+.+++.+||+.||++|||+.|+++.+...
T Consensus 233 ~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 233 FR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred cc---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 11 11123345688899999999999999999999876543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=308.01 Aligned_cols=247 Identities=21% Similarity=0.316 Sum_probs=189.2
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeE
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 232 (442)
+..++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 34567999999999999999999975 5889999998654 344557789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC--------------CCCCCCeEEecccCccccCCC
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++.....
T Consensus 110 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp ECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999999764 4689999999999999999999862 345788999999999765221
Q ss_pred cceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchh--------------------
Q 047892 299 RSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQ-------------------- 358 (442)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~-------------------- 358 (442)
......||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 223457999999999999999999999999999999999999999753321100000
Q ss_pred ------------hhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 359 ------------VNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 359 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
............ ...........+..+.+|+.+||+.||++|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVN---------EPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -----------CCCHHHHHHHHHH---------SCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccccCCCCcccchhhhhHHhc---------cCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000000000000 00011111223456889999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=297.45 Aligned_cols=247 Identities=17% Similarity=0.185 Sum_probs=186.5
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEE-EeCCeeeeEEe
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYC-AEGAHRMLVNE 234 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~~~~lv~E 234 (442)
.++|++.+.||+|+||.||+|.. .+++.||||.+.... ....+.+|+.+++.++|+|++..+..+ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 46799999999999999999996 568899999874432 223477899999999988877766655 67788899999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------C---CCCCCeEEecccCccccCCC
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------L---EPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l---~~~~~~kl~DFGla~~~~~~ 298 (442)
|+ +|+|.+++... ...+++..++.++.|++.||.|||+. + +.++.+||+|||+++.....
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 86 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred cc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99 88999999753 24689999999999999999999876 3 45678999999999876543
Q ss_pred cc------eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC
Q 047892 299 RS------YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372 (442)
Q Consensus 299 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (442)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||................. ... ..
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~~-~~ 237 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE---KKM-ST 237 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH---HHH-HS
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhc---ccc-cc
Confidence 32 122346799999999999999999999999999999999999999986544333221111111 100 00
Q ss_pred CcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.. +... ...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 238 ~~-----~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 238 PI-----EVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp CH-----HHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hh-----hhhh----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 00 0000 11235688899999999999999999999999865
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=319.45 Aligned_cols=241 Identities=20% Similarity=0.293 Sum_probs=188.8
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
++|++.+.||+|+||.||+|... +++.||||++... .......+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 45889999999999999999964 6899999998532 22345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC----------CCCCeEEecccCccccCCC
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE----------PKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~----------~~~~~kl~DFGla~~~~~~ 298 (442)
||.+|+|.+++... ..+++..+..++.|++.||.|||+. ++ .++.+||+|||+++.....
T Consensus 102 ~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 102 LYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 99999999998764 4689999999999999999999875 32 3457999999999876433
Q ss_pred cceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 299 RSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
. .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||..... .+...... .+...
T Consensus 178 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------~~~~~~i~-~~~~~--- 240 (486)
T 3mwu_A 178 T--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE----------YDILKRVE-TGKYA--- 240 (486)
T ss_dssp ------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----------HHHHHHHH-HTCCC---
T ss_pred C--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH----------HHHHHHHH-hCCCC---
Confidence 2 2344679999999999865 599999999999999999999999975432 11111111 11111
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH--HhcC
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM--LEAE 422 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~--L~~~ 422 (442)
.........+..+.+|+.+||+.||.+|||+.|+++. +...
T Consensus 241 ---~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 241 ---FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp ---SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred ---CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 0111112345668899999999999999999999963 5543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=305.82 Aligned_cols=244 Identities=21% Similarity=0.314 Sum_probs=173.1
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcC-CCCcceEEEEEE-------
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLVGYCA------- 224 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~------- 224 (442)
++...+|++.+.||+|+||.||+|.+. +++.||||.+..........+.+|+.++.++. ||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 344556899999999999999999964 68999999987666666678899999999996 999999999984
Q ss_pred -eCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC---------------CCCCCCeEEec
Q 047892 225 -EGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---------------LEPKWNPKLSD 288 (442)
Q Consensus 225 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---------------l~~~~~~kl~D 288 (442)
.....++||||+. |+|.+++.... ....+++..++.++.|++.||.|||+. ++.++.+||+|
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEec
Confidence 3445799999997 59999886421 124689999999999999999999864 23467899999
Q ss_pred ccCccccCCCcce-----------eecccccccCCCCcccc---cCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCc
Q 047892 289 FGLAKLLGAERSY-----------VTTRVMGTFGYVAPEYA---STGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGE 354 (442)
Q Consensus 289 FGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~ 354 (442)
||+++........ ......||+.|+|||++ .+..++.++|||||||++|||++|..||........
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 9999876443221 11134689999999998 566789999999999999999999999964322110
Q ss_pred cchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 355 FQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
+............+..+.+|+.+||+.||++|||+.|+++.|+.+
T Consensus 262 -----------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 262 -----------------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp ---------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred -----------------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000011111111223467799999999999999999999999865
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=317.05 Aligned_cols=260 Identities=19% Similarity=0.247 Sum_probs=172.5
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----Cee
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG-----AHR 229 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~ 229 (442)
++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+|+.++||||+++++++... ..+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 56899999999999999999964 5899999998543 334556789999999999999999999998443 568
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~ 296 (442)
|+||||+. |+|.+++... ..+++..+..++.||+.||.|||+. ++.++.+||+|||+++...
T Consensus 133 ~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEECCCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEeccc-cchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 99999986 5999999764 5689999999999999999999875 4456799999999998764
Q ss_pred CCcc--------------------------eeecccccccCCCCcccc-cCCCCCCcCCchhhHHHHHHHHh--------
Q 047892 297 AERS--------------------------YVTTRVMGTFGYVAPEYA-STGMLNETSDVYSFGILIMEVIS-------- 341 (442)
Q Consensus 297 ~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvil~ellt-------- 341 (442)
.... ...+..+||+.|+|||++ .+..|+.++|||||||++|||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 2211 122446789999999976 45679999999999999999999
Q ss_pred ---CCCCCCCCCCCCc---------cch----hhhHHHHHHHHhhcCCc--------------ccccCcccCC---CCcH
Q 047892 342 ---GRNPVDYSRPPGE---------FQF----QVNLFEWLKTMVTNGNA--------------EGVLDPRLQE---KPSS 388 (442)
Q Consensus 342 ---g~~Pf~~~~~~~~---------~~~----~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~---~~~~ 388 (442)
|+++|.+...... +.+ ..+....+......... ...+...... ....
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 6666654321100 000 00111111111100000 0000000000 0011
Q ss_pred HHHHHHHHHHhhhhCCCCCCCCCHHHHHHH--HhcC
Q 047892 389 RALKRALLVALRCVDPNAHKRPKMGHVIHM--LEAE 422 (442)
Q Consensus 389 ~~~~~~~~li~~cl~~dP~~RPs~~evl~~--L~~~ 422 (442)
..+..+.+|+.+||+.||++|||+.|+++. ++.+
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 235668899999999999999999999974 4443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=331.13 Aligned_cols=234 Identities=26% Similarity=0.420 Sum_probs=181.8
Q ss_pred CeeccCCcEEEEEEEEC---CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 164 NVIGEGGYGIVYRGVLE---DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
+.||+|+||.||+|.+. .++.||||++... .....+.+.+|+++|++++|||||++++++.. +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 4678999999653 23446789999999999999999999999965 558899999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCccccCCCcce--ee
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKLLGAERSY--VT 303 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~~~~~~~~--~~ 303 (442)
|+|.++++.. ..+++..++.++.||+.||.|||+. ++ .++.+||+|||+++.+...... ..
T Consensus 454 g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 9999999764 5689999999999999999999865 33 4568999999999876543321 22
Q ss_pred cccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCccc
Q 047892 304 TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (442)
....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+ ......+.
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~----~~~i~~~~--------- 589 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EV----TAMLEKGE--------- 589 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HH----HHHHHTTC---------
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HH----HHHHHcCC---------
Confidence 33457889999999999999999999999999999998 99999754321 11 11111111
Q ss_pred CCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 383 QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 383 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
....+..++.++.+|+.+||+.||++|||+.+|++.|++.
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1112233456788999999999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=295.25 Aligned_cols=232 Identities=24% Similarity=0.389 Sum_probs=181.5
Q ss_pred CCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeeeeE
Q 047892 160 FADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE----GAHRMLV 232 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~lv 232 (442)
|.+.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....|+|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 677889999999999999964 5788999998543 34455678999999999999999999999865 4568999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC---------------CC-CCCCeEEecccCccccC
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---------------LE-PKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---------------l~-~~~~~kl~DFGla~~~~ 296 (442)
|||+++|+|.+++... ..+++..++.++.|++.||.|||+. ++ .++.+||+|||++....
T Consensus 108 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 9999999999999764 4689999999999999999999975 22 46789999999997654
Q ss_pred CCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 297 AERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
... .....||+.|+|||++. +.++.++|||||||++|+|++|..||...... ....... .....
T Consensus 184 ~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---------~~~~~~~-~~~~~-- 247 (290)
T 1t4h_A 184 ASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA---------AQIYRRV-TSGVK-- 247 (290)
T ss_dssp TTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---------HHHHHHH-TTTCC--
T ss_pred ccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH---------HHHHHHH-hccCC--
Confidence 332 23457999999999886 56999999999999999999999999653221 1111111 11110
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.. ......+..+.+++.+||+.||.+|||+.|+++
T Consensus 248 --~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 --PA----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --CG----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --cc----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 01 111122345888999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=303.11 Aligned_cols=249 Identities=19% Similarity=0.297 Sum_probs=178.7
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcch--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
.++|++.+.||+|+||.||+|... +++.||||.+..... .....+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 456899999999999999999954 588999999964432 23456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC------------CCCeEEecccCcccc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP------------KWNPKLSDFGLAKLL 295 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~------------~~~~kl~DFGla~~~ 295 (442)
||+++ +|.+++... ..+++..+..++.|++.||.|||+. +++ ++.+||+|||+++..
T Consensus 113 e~~~~-~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 113 EYAEN-DLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp ECCSE-EHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred ecCCC-CHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 99985 999999865 4689999999999999999999875 332 334999999999876
Q ss_pred CCCcceeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC--
Q 047892 296 GAERSYVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG-- 372 (442)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-- 372 (442)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|..||......+ .+...........
T Consensus 188 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 188 GIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID------QLFKIFEVLGLPDDT 260 (329)
T ss_dssp C------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHHHCCCCTT
T ss_pred CCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH------HHHHHHHHhCCCchh
Confidence 43322 23345789999999999775 48999999999999999999999997543211 1111111110000
Q ss_pred Cccc------c--cCcccCCC-----CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 373 NAEG------V--LDPRLQEK-----PSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 373 ~~~~------~--~~~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.... . ..+..... .....+.++.+|+.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000 0 00000000 01113466889999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=314.05 Aligned_cols=241 Identities=20% Similarity=0.342 Sum_probs=177.9
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--------hhhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--------GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE 225 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 225 (442)
...++|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.+|++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34678999999999999999999964 58899999985431 1112347899999999999999999999854
Q ss_pred CCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC----------CCCeEEecc
Q 047892 226 GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP----------KWNPKLSDF 289 (442)
Q Consensus 226 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~----------~~~~kl~DF 289 (442)
+..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++ ++.+||+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred -CceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeec
Confidence 5589999999999999998754 5689999999999999999999875 332 235999999
Q ss_pred cCccccCCCcceeecccccccCCCCcccccC---CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHH
Q 047892 290 GLAKLLGAERSYVTTRVMGTFGYVAPEYAST---GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLK 366 (442)
Q Consensus 290 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 366 (442)
|+++..... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||......... ..
T Consensus 287 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~------~~--- 355 (419)
T 3i6u_A 287 GHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------KD--- 355 (419)
T ss_dssp STTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH------HH---
T ss_pred ccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH------HH---
Confidence 999876432 22345689999999999853 56889999999999999999999999764332221 11
Q ss_pred HHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 367 TMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
....+... .. +. .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 356 -~i~~~~~~-~~-~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 356 -QITSGKYN-FI-PE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp -HHHTTCCC-CC-HH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -HHhcCCCC-CC-ch----hhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11111110 00 00 001234568889999999999999999999863
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=321.52 Aligned_cols=237 Identities=21% Similarity=0.327 Sum_probs=189.5
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 232 (442)
.++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356889999999999999999965 6899999998543 234567789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C----------CCCCCeEEecccCccccC
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L----------EPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l----------~~~~~~kl~DFGla~~~~ 296 (442)
||||.+|+|.+++... ..+++..+..++.|++.||.|||+. + ..++.+||+|||+++...
T Consensus 105 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp ECCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999999999764 5689999999999999999999875 2 345789999999998764
Q ss_pred CCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 297 AERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
.... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||...... .. .... ..+...
T Consensus 181 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~---~~~i-~~~~~~- 245 (484)
T 3nyv_A 181 ASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-------DI---LKKV-EKGKYT- 245 (484)
T ss_dssp CCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HH---HHHH-HHCCCC-
T ss_pred cccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-------HH---HHHH-HcCCCC-
Confidence 4322 334579999999999865 6999999999999999999999999754321 11 1111 111111
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.........+..+.+|+.+||+.||.+|||+.|+++
T Consensus 246 -----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 -----FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -----CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 011111234566889999999999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=295.64 Aligned_cols=236 Identities=22% Similarity=0.412 Sum_probs=187.2
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEe----------
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE---------- 225 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~---------- 225 (442)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ..+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 345889999999999999999975 68999999986543 246689999999999999999998864
Q ss_pred ------CCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCCCeEE
Q 047892 226 ------GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKWNPKL 286 (442)
Q Consensus 226 ------~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~~~kl 286 (442)
....|+||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. + +.++.+||
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 455799999999999999997532 24689999999999999999999875 3 34578999
Q ss_pred ecccCccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHH
Q 047892 287 SDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLK 366 (442)
Q Consensus 287 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 366 (442)
+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|..||.. ......
T Consensus 164 ~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~------------~~~~~~ 229 (284)
T 2a19_B 164 GDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE------------TSKFFT 229 (284)
T ss_dssp CCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH------------HHHHHH
T ss_pred Ccchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh------------HHHHHH
Confidence 99999987644322 2345789999999999999999999999999999999999988631 111111
Q ss_pred HHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCC
Q 047892 367 TMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 425 (442)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 425 (442)
.. .... +.. ..+..+.+++.+||+.||.+|||+.|+++.|......
T Consensus 230 ~~-~~~~--------~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 230 DL-RDGI--------ISD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HH-HTTC--------CCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred Hh-hccc--------ccc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 11 1111 111 1234577899999999999999999999999887644
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=297.85 Aligned_cols=241 Identities=25% Similarity=0.406 Sum_probs=184.7
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
.++|.....||+|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 34566677999999999999996 45889999999766556667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCC-CCCeEEecccCccccCCCcce
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEP-KWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~-~~~~kl~DFGla~~~~~~~~~ 301 (442)
+++|+|.+++..... ...+++..+..++.|++.||.|||+. ++. ++.+||+|||+++.......
T Consensus 101 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~- 178 (295)
T 2clq_A 101 VPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP- 178 (295)
T ss_dssp CSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence 999999999976422 23567888999999999999999876 233 67899999999987643221
Q ss_pred eecccccccCCCCcccccCCC--CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 302 VTTRVMGTFGYVAPEYASTGM--LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
......||+.|+|||++.+.. ++.++|||||||++|||++|..||....... .......... ..
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~------~~ 244 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ--------AAMFKVGMFK------VH 244 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH--------HHHHHHHHHC------CC
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh--------HHHHhhcccc------cc
Confidence 233457899999999987654 8899999999999999999999996422110 0000000000 11
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
+ ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 245 ~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 245 P----EIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp C----CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred c----cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 112233456788999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.12 Aligned_cols=243 Identities=21% Similarity=0.311 Sum_probs=187.0
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcch-------------hhHHHHHHHHHHHHhcCCCCcceEEEE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRG-------------QAEKEFKVEVEAIGRVRHKNLVRLVGY 222 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpnIv~l~~~ 222 (442)
.++|.+.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.+|++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 456899999999999999999964 578999999864321 234678899999999999999999999
Q ss_pred EEeCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC-------CC---CeEE
Q 047892 223 CAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP-------KW---NPKL 286 (442)
Q Consensus 223 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-------~~---~~kl 286 (442)
+.+....|+|||||++|+|.+++... ..+++..+..++.|++.||.|||+. +++ ++ .+||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 99999999999999999999998764 4689999999999999999999875 333 22 6999
Q ss_pred ecccCccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHH
Q 047892 287 SDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLK 366 (442)
Q Consensus 287 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 366 (442)
+|||+++...... .....+||+.|+|||++. +.++.++|||||||++|+|++|..||...... +...
T Consensus 191 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----------~~~~ 257 (504)
T 3q5i_A 191 VDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ----------DIIK 257 (504)
T ss_dssp CCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------HHHH
T ss_pred EECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH----------HHHH
Confidence 9999998764432 234567999999999986 56999999999999999999999999754321 1111
Q ss_pred HHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH--HHhcCC
Q 047892 367 TMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEAEE 423 (442)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~--~L~~~~ 423 (442)
.. ..+... .. .......+..+.+|+.+||+.||.+|||+.|+++ ++....
T Consensus 258 ~i-~~~~~~--~~----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 258 KV-EKGKYY--FD----FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HH-HHCCCC--CC----HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred HH-HcCCCC--CC----ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 11 111110 00 0000123456888999999999999999999985 455443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=301.08 Aligned_cols=251 Identities=21% Similarity=0.244 Sum_probs=182.6
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchh-----hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQ-----AEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 229 (442)
..++|.+.+.||+|+||.||+|... +++.||||.+...... ....+.+|+.+++.++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3467999999999999999999964 5899999998543211 124578899999999999999999999999999
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~ 296 (442)
++||||+++ +|.+++... ...+++..+..++.|++.||.|||+. ++.++.+||+|||+++.+.
T Consensus 88 ~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred EEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 999999997 899998754 24678889999999999999999875 4456899999999998764
Q ss_pred CCcceeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc-
Q 047892 297 AERSYVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA- 374 (442)
Q Consensus 297 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 374 (442)
.... .....+||+.|+|||++.+. .++.++|||||||++|||++|.+||...... .....+.........
T Consensus 164 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-------~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 164 SPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-------DQLTRIFETLGTPTEE 235 (346)
T ss_dssp SCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHHHCCCCTT
T ss_pred CCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHHHcCCCChh
Confidence 3322 23446789999999998664 4899999999999999999999999754321 111111111111000
Q ss_pred --cc------ccCcccCCCCc-----HHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 375 --EG------VLDPRLQEKPS-----SRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 375 --~~------~~~~~~~~~~~-----~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.. .+........+ ...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 00000000001 2234678899999999999999999999964
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=318.95 Aligned_cols=236 Identities=21% Similarity=0.324 Sum_probs=182.6
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
+.|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 45888999999999999999975 58899999986432 2334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC----------CCCeEEecccCccccCCC
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP----------KWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~----------~~~~kl~DFGla~~~~~~ 298 (442)
||++|+|.+++... ..+++..+..++.|++.||.|||+. +++ ++.+||+|||+++.....
T Consensus 117 ~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 117 CYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 99999999988764 4689999999999999999999875 333 345999999999876543
Q ss_pred cceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 299 RSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
. .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||...... .. .... ..+... ..
T Consensus 193 ~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~---~~~i-~~~~~~-~~ 257 (494)
T 3lij_A 193 K--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-------EI---LRKV-EKGKYT-FD 257 (494)
T ss_dssp B--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HH---HHHH-HHTCCC-CC
T ss_pred c--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-------HH---HHHH-HhCCCC-CC
Confidence 2 234567999999999885 57999999999999999999999999754321 11 1111 111110 01
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.+.+ ...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 258 ~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 SPEW-----KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp SGGG-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhc-----ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 1111 123456888999999999999999999984
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=304.11 Aligned_cols=253 Identities=20% Similarity=0.295 Sum_probs=181.6
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchh-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
++|.+.+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46889999999999999999975 6889999998543221 112355799999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++ +|.+++... ...+++..+..++.|++.||.|||+. ++.++.+||+|||+++....... .
T Consensus 82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~ 156 (324)
T 3mtl_A 82 LDK-DLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T 156 (324)
T ss_dssp CSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ccc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-c
Confidence 985 999998764 24689999999999999999999875 45578999999999986543322 2
Q ss_pred ecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC---ccccc
Q 047892 303 TTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN---AEGVL 378 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 378 (442)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+........ .....
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-------EQLHFIFRILGTPTEETWPGIL 229 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHHHCCCCTTTSTTGG
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHHhCCCChHhchhhh
Confidence 234578999999999876 56899999999999999999999999764321 11111111111100 00000
Q ss_pred C---------cccCCC----CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH--HHhcC
Q 047892 379 D---------PRLQEK----PSSRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEAE 422 (442)
Q Consensus 379 ~---------~~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~--~L~~~ 422 (442)
. +..... .....+..+.+|+.+||+.||++|||+.|+++ .+.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 0 000000 00123456788999999999999999999986 35544
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=305.50 Aligned_cols=241 Identities=19% Similarity=0.325 Sum_probs=188.3
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--------hhhHHHHHHHHHHHHhc-CCCCcceEEEEE
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--------GQAEKEFKVEVEAIGRV-RHKNLVRLVGYC 223 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 223 (442)
....++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 334467999999999999999999975 69999999985432 11245678899999999 899999999999
Q ss_pred EeCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEeccc
Q 047892 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFG 290 (442)
Q Consensus 224 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFG 290 (442)
...+..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecC
Confidence 9999999999999999999999754 4689999999999999999999876 4567899999999
Q ss_pred CccccCCCcceeecccccccCCCCcccccC------CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHH
Q 047892 291 LAKLLGAERSYVTTRVMGTFGYVAPEYAST------GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEW 364 (442)
Q Consensus 291 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 364 (442)
++..+..... ....+||+.|+|||++.+ ..++.++|||||||++|||++|..||..... .....
T Consensus 246 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-------~~~~~- 315 (365)
T 2y7j_A 246 FSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-------ILMLR- 315 (365)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH-
T ss_pred cccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-------HHHHH-
Confidence 9987654322 345689999999999853 3588999999999999999999999965321 11111
Q ss_pred HHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 365 LKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.. ..+... ...+.+ ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 316 --~i-~~~~~~-~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 316 --MI-MEGQYQ-FSSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp --HH-HHTCCC-CCHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --HH-HhCCCC-CCCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 111110 000000 112355888999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=291.09 Aligned_cols=236 Identities=20% Similarity=0.336 Sum_probs=180.2
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
..++|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.+++.++||||+++++++...+..|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 4467899999999999999999975 68999999985432 2234578899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
||||+++++|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999999764 4689999999999999999999864 445778999999999876433
Q ss_pred cceeecccccccCCCCcccccCCCC-CCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 299 RSYVTTRVMGTFGYVAPEYASTGML-NETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
. ......||+.|+|||++.+..+ +.++||||||+++|||++|..||..... ..... .. .....
T Consensus 165 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~---~~-~~~~~--- 228 (276)
T 2h6d_A 165 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-------PTLFK---KI-RGGVF--- 228 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH---HH-HHCCC---
T ss_pred c--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------HHHHH---Hh-hcCcc---
Confidence 2 1234578999999999987765 6899999999999999999999965321 11111 11 11110
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 229 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 -------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0111223557889999999999999999999973
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=300.20 Aligned_cols=254 Identities=20% Similarity=0.299 Sum_probs=171.8
Q ss_pred HHHhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 153 LEVSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 153 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
+.+..++|.+.+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.++++++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 345677899999999999999999995 468899999885432 334566889999999999999999999999999999
Q ss_pred eEEecCCCCCHHHHHccC----CCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcc
Q 047892 231 LVNEYVDNGNLEQWLHGD----VGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAK 293 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~----~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~ 293 (442)
+||||+++|+|.+++... ......+++..++.++.|++.||.|||+. ++.++.+||+|||++.
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999999998631 11235689999999999999999999876 4457899999999998
Q ss_pred ccCCCcc----eeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHH
Q 047892 294 LLGAERS----YVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTM 368 (442)
Q Consensus 294 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 368 (442)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||........ . ...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~---~~~ 239 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-------L---MLT 239 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-------H---HHH
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH-------H---HHH
Confidence 6643211 11234578999999999865 5689999999999999999999999975432111 0 011
Q ss_pred hhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 369 VTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
... ..................+..+.+++.+||+.||.+|||+.++++
T Consensus 240 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 240 LQN-DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HTS-SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hcc-CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111 100000000001111223456788999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=309.24 Aligned_cols=255 Identities=20% Similarity=0.239 Sum_probs=181.5
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEe-------
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE------- 225 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------- 225 (442)
+...++|.+.+.||+|+||.||+|.. .+++.||||++..... ...+|+++++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 44567899999999999999999996 5689999999864422 22369999999999999999999844
Q ss_pred -------------------------------CCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhh
Q 047892 226 -------------------------------GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 274 (442)
Q Consensus 226 -------------------------------~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yL 274 (442)
....++||||+++ +|.+++.........+++..+..++.|++.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3348899999995 88877764222335799999999999999999999
Q ss_pred hcC------CC--------CCCCeEEecccCccccCCCcceeecccccccCCCCcccccCCC-CCCcCCchhhHHHHHHH
Q 047892 275 HEG------LE--------PKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM-LNETSDVYSFGILIMEV 339 (442)
Q Consensus 275 H~~------l~--------~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~el 339 (442)
|+. ++ .++.+||+|||+++.+..... .....||+.|+|||++.+.. ++.++|||||||++|||
T Consensus 158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 875 32 467899999999987644332 33457899999999987654 89999999999999999
Q ss_pred HhCCCCCCCCCCCCccchhhhH-----HHHHHHHhhcCCcccccCcccCC-----CCcHHHHHHHHHHHhhhhCCCCCCC
Q 047892 340 ISGRNPVDYSRPPGEFQFQVNL-----FEWLKTMVTNGNAEGVLDPRLQE-----KPSSRALKRALLVALRCVDPNAHKR 409 (442)
Q Consensus 340 ltg~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dP~~R 409 (442)
++|+.||......+........ .+.+..+ ........-+.... ..+...+..+.+|+.+||+.||++|
T Consensus 236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRM--NPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH--CTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh--CcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 9999999764332111000000 0000000 01111111111111 1122345568899999999999999
Q ss_pred CCHHHHHH
Q 047892 410 PKMGHVIH 417 (442)
Q Consensus 410 Ps~~evl~ 417 (442)
||+.|+++
T Consensus 314 ~t~~e~l~ 321 (383)
T 3eb0_A 314 INPYEAMA 321 (383)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhc
Confidence 99999984
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=301.36 Aligned_cols=245 Identities=23% Similarity=0.352 Sum_probs=182.2
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC--CCC--eEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE--DNT--NVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 229 (442)
.++|++.+.||+|+||.||+|.+. +++ .||||.+... .....+.+.+|+.++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 456889999999999999999853 233 5899988543 2345577899999999999999999999998765 8
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~~~ 296 (442)
++||||+++|+|.+++... ...+++..+..++.|++.||.|||+. ++ .++.+||+|||+++...
T Consensus 96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 9999999999999999753 24589999999999999999999875 33 45789999999998765
Q ss_pred CCcce--eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCC
Q 047892 297 AERSY--VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373 (442)
Q Consensus 297 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (442)
..... ......+|..|+|||++.+..++.++|||||||++|||++ |..||..... ............
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----------~~~~~~~~~~~~ 242 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG----------SQILHKIDKEGE 242 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------HHHHHHHHTSCC
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH----------HHHHHHHHccCC
Confidence 43322 2233467889999999988889999999999999999999 9999965422 111111111111
Q ss_pred cccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCC
Q 047892 374 AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 424 (442)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 424 (442)
........+..+.+++.+||+.||++|||+.++++.|++...
T Consensus 243 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 243 ---------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ---------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 111122344668889999999999999999999999988764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=295.50 Aligned_cols=239 Identities=18% Similarity=0.257 Sum_probs=183.3
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
.+.|++.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 456889999999999999999975 4889999998765555667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+++|+|.+++... ...+++..+..++.|++.||.|||+. ++.++.+||+|||++...... ...
T Consensus 98 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 173 (302)
T 2j7t_A 98 CPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQK 173 (302)
T ss_dssp CTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HHC
T ss_pred CCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-ccc
Confidence 9999999998653 24689999999999999999999876 445788999999997643211 111
Q ss_pred ecccccccCCCCcccc-----cCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 303 TTRVMGTFGYVAPEYA-----STGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
.....||+.|+|||++ .+..++.++|||||||++|||++|..||..... ............ .
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------~~~~~~~~~~~~-~-- 240 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP----------MRVLLKIAKSDP-P-- 240 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH----------HHHHHHHHHSCC-C--
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH----------HHHHHHHhccCC-c--
Confidence 2335789999999998 366789999999999999999999999965322 111111111111 0
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
....+...+..+.+++.+||+.||++|||+.++++
T Consensus 241 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 241 -----TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -----CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -----ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 01112334456888999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=300.75 Aligned_cols=242 Identities=21% Similarity=0.298 Sum_probs=173.2
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc-hhhH-HHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR-GQAE-KEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~-~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
+..++|++.+.||+|+||.||+|.. .+++.||+|.+.... .... +.+..+...++.++||||+++++++.+.+..|+
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 4556799999999999999999996 468899999996542 2222 334455556888999999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC--------------CCCCCCeEEecccCccccCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------------l~~~~~~kl~DFGla~~~~~ 297 (442)
||||+++ +|.+++.........+++..++.++.|++.||.|||+. ++.++.+||+|||+++....
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9999985 88888764222345799999999999999999999963 34567899999999987643
Q ss_pred CcceeecccccccCCCCcccc----cCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC
Q 047892 298 ERSYVTTRVMGTFGYVAPEYA----STGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (442)
... .....||+.|+|||++ .+..++.++|||||||++|||++|..||...... ............
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------~~~~~~~~~~~~ 231 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP---------FQQLKQVVEEPS 231 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH---------HHHHHHHHHSCC
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch---------HHHHHHHhccCC
Confidence 322 2334799999999996 4567899999999999999999999999643221 111111111111
Q ss_pred cccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 374 AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
........+..+.+++.+||+.||++|||+.|+++
T Consensus 232 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 ---------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11111233456888999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=296.17 Aligned_cols=234 Identities=20% Similarity=0.293 Sum_probs=183.8
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeeeE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 232 (442)
.++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 356889999999999999999975 6899999998643 234456788899999999 999999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC--------------------------C
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE--------------------------P 280 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~--------------------------~ 280 (442)
|||+++|+|.+++.........+++..++.++.|++.||.|||+. ++ .
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 999999999999975322224689999999999999999999875 22 2
Q ss_pred CCCeEEecccCccccCCCcceeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhh
Q 047892 281 KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQV 359 (442)
Q Consensus 281 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~ 359 (442)
...+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|||++|.+|+....
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------- 235 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--------- 235 (289)
T ss_dssp CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---------
T ss_pred ceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---------
Confidence 3368999999998764432 23589999999999766 56789999999999999999988764211
Q ss_pred hHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 360 NLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
... ....... +. .+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 236 -~~~----~~~~~~~-----~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 -QWH----EIRQGRL-----PR----IPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -HHH----HHHTTCC-----CC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -HHH----HHHcCCC-----CC----CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111 1111111 11 112234568889999999999999999999863
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=309.00 Aligned_cols=186 Identities=24% Similarity=0.333 Sum_probs=151.8
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----Ce
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG-----AH 228 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~ 228 (442)
.++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+|+.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 356899999999999999999964 5888999999643 334556789999999999999999999999766 56
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLL 295 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~ 295 (442)
.|+||||+++ +|.++++.. ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++..
T Consensus 105 ~~lv~e~~~~-~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIADS-DLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCSE-EHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCCc-CHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 8999999985 999999764 5689999999999999999999875 445679999999999876
Q ss_pred CCCcc---------------------eeecccccccCCCCcccc-cCCCCCCcCCchhhHHHHHHHHhCCCCCC
Q 047892 296 GAERS---------------------YVTTRVMGTFGYVAPEYA-STGMLNETSDVYSFGILIMEVISGRNPVD 347 (442)
Q Consensus 296 ~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvil~elltg~~Pf~ 347 (442)
..... ...+..+||+.|+|||++ ....|+.++|||||||++|||++|..||.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 43321 112556899999999986 55669999999999999999998655553
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=303.09 Aligned_cols=243 Identities=14% Similarity=0.138 Sum_probs=189.2
Q ss_pred hHHHhhCCCCccCeeccCCcEEEEEEE------ECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcC---CCCcceEEEE
Q 047892 152 ELEVSTNGFADENVIGEGGYGIVYRGV------LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR---HKNLVRLVGY 222 (442)
Q Consensus 152 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~ 222 (442)
++++..++|.+.+.||+|+||.||+|. ..+++.||||.+... ....+.+|++++..++ |+||++++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 344556779999999999999999994 446889999999654 3456777888888886 9999999999
Q ss_pred EEeCCeeeeEEecCCCCCHHHHHccCCC-CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCC--------
Q 047892 223 CAEGAHRMLVNEYVDNGNLEQWLHGDVG-PHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEP-------- 280 (442)
Q Consensus 223 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~-------- 280 (442)
+...+..|+|||||++|+|.++++.... ....+++..++.++.|++.||+|||+. ++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999999974211 235799999999999999999999875 334
Q ss_pred ---CCCeEEecccCccccCC-CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccc
Q 047892 281 ---KWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQ 356 (442)
Q Consensus 281 ---~~~~kl~DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~ 356 (442)
++.+||+|||+++.+.. .........+||+.|+|||++.+..|+.++|||||||++|||+||+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 68899999999976532 22233455789999999999999999999999999999999999999995432110
Q ss_pred hhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCC-CCHHHHHHHHhcC
Q 047892 357 FQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKR-PKMGHVIHMLEAE 422 (442)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R-Ps~~evl~~L~~~ 422 (442)
..+...+..... .+.+.+++..||+.+|.+| |++.++.+.|+..
T Consensus 293 -------------------~~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 293 -------------------CKPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp -------------------EEECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred -------------------eeechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 001111121122 3446678889999999999 6788888777764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=330.03 Aligned_cols=249 Identities=20% Similarity=0.338 Sum_probs=191.6
Q ss_pred hhHHHhhCCCCccCeeccCCcEEEEEEEECC----CCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 047892 151 RELEVSTNGFADENVIGEGGYGIVYRGVLED----NTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE 225 (442)
Q Consensus 151 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 225 (442)
.++++..++|.+.+.||+|+||.||+|.+.. +..||+|.+... .....+.+.+|+.++++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 3445566789999999999999999999642 456999998653 3344567899999999999999999999985
Q ss_pred CCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCc
Q 047892 226 GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLA 292 (442)
Q Consensus 226 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla 292 (442)
.+..|+||||+++|+|.++++.. ...+++..++.++.|++.||.|||+. ++ .++.+||+|||++
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred cCceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCC
Confidence 46689999999999999999754 24689999999999999999999875 33 4678999999999
Q ss_pred cccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhc
Q 047892 293 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTN 371 (442)
Q Consensus 293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (442)
+..............+|+.|+|||++.+..++.++|||||||++|||++ |..||...... .... ... .
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-------~~~~---~i~-~ 607 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-------DVIG---RIE-N 607 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHH---HHH-H
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-------HHHH---HHH-c
Confidence 8775444333344567889999999998899999999999999999997 99999754321 1111 111 1
Q ss_pred CCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 372 GNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
+. ....+...+..+.+|+.+||+.||++|||+.++++.|+++.
T Consensus 608 ~~---------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 608 GE---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC---------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11 01112234456888999999999999999999999998764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=292.83 Aligned_cols=238 Identities=24% Similarity=0.349 Sum_probs=184.3
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
..++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567889999999999999999975 48999999986532 34568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
|+++|+|.+++... ...+++..++.++.|++.||.|||+. ++.++.+||+|||++........
T Consensus 105 ~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (314)
T 3com_A 105 YCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA- 180 (314)
T ss_dssp CCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence 99999999999632 24689999999999999999999875 44678999999999987643322
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (442)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... ............ +.
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------~~~~~~~~~~~~------~~ 244 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP----------MRAIFMIPTNPP------PT 244 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH----------HHHHHHHHHSCC------CC
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh----------HHHHHHHhcCCC------cc
Confidence 23345789999999999998999999999999999999999999964321 111111111110 00
Q ss_pred cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 382 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
+ ..+...+..+.+|+.+||+.||.+|||+.++++
T Consensus 245 ~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 245 F--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp C--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred c--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0 112223456888999999999999999999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=314.01 Aligned_cols=230 Identities=14% Similarity=0.172 Sum_probs=174.9
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecC---cchhhHHHHHHHH---HHHHhcCCCCcceEE-------EE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLN---NRGQAEKEFKVEV---EAIGRVRHKNLVRLV-------GY 222 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~hpnIv~l~-------~~ 222 (442)
.++|.+.+.||+|+||.||+|.. .+++.||||.+.. ......+.+.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45688899999999999999995 5699999999863 2344567789999 555666899999998 77
Q ss_pred EEeCCe-----------------eeeEEecCCCCCHHHHHccCCC---CCCCCCHHHHHHHHHHHHHhhhhhhcC-----
Q 047892 223 CAEGAH-----------------RMLVNEYVDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEG----- 277 (442)
Q Consensus 223 ~~~~~~-----------------~~lv~E~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~----- 277 (442)
+.+.+. .|+||||+ +|+|.+++..... ....+++..++.++.|++.||+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 665532 78999999 5799999975311 012344578889999999999999875
Q ss_pred --------CCCCCCeEEecccCccccCCCcceeecccccccCCCCcccccCC-----------CCCCcCCchhhHHHHHH
Q 047892 278 --------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-----------MLNETSDVYSFGILIME 338 (442)
Q Consensus 278 --------l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlGvil~e 338 (442)
++.++.+||+|||+++.... .....+| +.|+|||++.+. .++.++|||||||++||
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 44578999999999986432 2345578 999999999887 89999999999999999
Q ss_pred HHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 339 VISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 339 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
|++|+.||.......... .... .. ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 306 lltg~~Pf~~~~~~~~~~-------------------~~~~-~~-----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 306 IWCADLPITKDAALGGSE-------------------WIFR-SC-----KNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHSSCCC------CCSG-------------------GGGS-SC-----CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHCCCCCcccccccchh-------------------hhhh-hc-----cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999997543322211 0111 00 122356888999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=302.38 Aligned_cols=253 Identities=23% Similarity=0.241 Sum_probs=177.9
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA------ 227 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------ 227 (442)
.++|.+.+.||+|+||.||+|... +++.||||++... .......+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 357999999999999999999964 5889999998643 3344567889999999999999999999997654
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKL 294 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~ 294 (442)
..|+||||+++ +|.+++.. .+++..+..++.|++.||.|||+. ++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 78999999986 89888863 478999999999999999999875 34567999999999987
Q ss_pred cCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhh------------hHH
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQV------------NLF 362 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~------------~~~ 362 (442)
..... ......||+.|+|||++.+..++.++|||||||++|||++|..||...+......... .+.
T Consensus 177 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 177 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred ccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 54322 2344679999999999999999999999999999999999999997643211100000 000
Q ss_pred HHHHHHhhcC-Ccc-----cccCcccCCC---CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 363 EWLKTMVTNG-NAE-----GVLDPRLQEK---PSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 363 ~~~~~~~~~~-~~~-----~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.......... ... .......... .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000000000 000 0000000000 112346778999999999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=304.03 Aligned_cols=249 Identities=15% Similarity=0.151 Sum_probs=187.3
Q ss_pred hCCCCccCeeccCCcEEEEEEEECC---------CCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcce---------
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLED---------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR--------- 218 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~--------- 218 (442)
.++|.+.+.||+|+||.||+|.... ++.||+|.+... ..+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3568899999999999999999753 789999998543 35778999999999999998
Q ss_pred ------EEEEEEe-CCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC------
Q 047892 219 ------LVGYCAE-GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE------ 279 (442)
Q Consensus 219 ------l~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~------ 279 (442)
+++++.. .+..|+||||+ +|+|.+++.... ...+++..++.++.|++.||.|||+. ++
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 6777765 67889999999 899999997531 24689999999999999999999875 33
Q ss_pred -CCC--CeEEecccCccccCCCcce------eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCC
Q 047892 280 -PKW--NPKLSDFGLAKLLGAERSY------VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSR 350 (442)
Q Consensus 280 -~~~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~ 350 (442)
.++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 345 8999999999876433211 1133579999999999999899999999999999999999999997543
Q ss_pred CCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 351 PPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
... ..+........... ........ .....+..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 273 ~~~-----~~~~~~~~~~~~~~--~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 273 PNT-----EDIMKQKQKFVDKP--GPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp TCH-----HHHHHHHHHHHHSC--CCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cCH-----HHHHHHHHhccCCh--hhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 211 11111111111111 11111110 01122356888999999999999999999999998753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=300.97 Aligned_cols=246 Identities=19% Similarity=0.269 Sum_probs=187.6
Q ss_pred hHHHhhCCCCcc-CeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--hhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 047892 152 ELEVSTNGFADE-NVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEG 226 (442)
Q Consensus 152 ~~~~~~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 226 (442)
..+...+.|.+. +.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++..+ +||||+++++++.+.
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 334455567777 88999999999999965 58999999986432 33456788999999999 569999999999999
Q ss_pred CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------C---CCCeEEeccc
Q 047892 227 AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------P---KWNPKLSDFG 290 (442)
Q Consensus 227 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~---~~~~kl~DFG 290 (442)
+..|+||||+.+|+|.+++... ....+++..++.++.|++.||.|||+. ++ . ++.+||+|||
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred CeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 9999999999999999998653 235689999999999999999999875 32 2 5789999999
Q ss_pred CccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhh
Q 047892 291 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVT 370 (442)
Q Consensus 291 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 370 (442)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||...... .... ....
T Consensus 180 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~---~i~~ 247 (327)
T 3lm5_A 180 MSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ-------ETYL---NISQ 247 (327)
T ss_dssp GCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHH---HHHH
T ss_pred cccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------HHHH---HHHh
Confidence 998764332 223457999999999999999999999999999999999999999653321 1111 1111
Q ss_pred cCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 371 NGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
. . ...........+..+.+|+.+||+.||++|||+.++++.
T Consensus 248 ~-~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 248 V-N------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp T-C------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred c-c------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 0 011111122344568889999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=300.95 Aligned_cols=248 Identities=19% Similarity=0.300 Sum_probs=185.5
Q ss_pred eehhhHHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcC--CCCcceEEEEE
Q 047892 148 YTLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVR--HKNLVRLVGYC 223 (442)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~ 223 (442)
+.+..+.+..++|++.+.||+|+||.||+|...+++.||||.+... .......+.+|+.++.+++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3344555667779999999999999999999888999999998543 3445577899999999997 59999999999
Q ss_pred EeCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC------CCCeEEecccC
Q 047892 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP------KWNPKLSDFGL 291 (442)
Q Consensus 224 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~------~~~~kl~DFGl 291 (442)
...+..|+||| +.+++|.+++... ..+++..++.++.|++.||.|||+. +++ ++.+||+|||+
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~kL~Dfg~ 172 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGI 172 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSS
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEECCeEEEeeccc
Confidence 99999999999 5677999999865 4689999999999999999999876 333 46799999999
Q ss_pred ccccCCCcce-eecccccccCCCCcccccC-----------CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhh
Q 047892 292 AKLLGAERSY-VTTRVMGTFGYVAPEYAST-----------GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQV 359 (442)
Q Consensus 292 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~ 359 (442)
++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------- 244 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------- 244 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS--------
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH--------
Confidence 9876433221 2234578999999999865 4688899999999999999999999964321
Q ss_pred hHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 360 NLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
........... ......+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 245 -~~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 245 -QISKLHAIIDP---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp -HHHHHHHHHCT---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHHHHHHhc---------ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11111111111 11111111223567889999999999999999999853
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=303.03 Aligned_cols=262 Identities=21% Similarity=0.245 Sum_probs=186.6
Q ss_pred ehhhHHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcc-----------hhhHHHHHHHHHHHHhcCCCCcc
Q 047892 149 TLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNR-----------GQAEKEFKVEVEAIGRVRHKNLV 217 (442)
Q Consensus 149 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~hpnIv 217 (442)
.+.++....++|.+.+.||+|+||.||+|...+++.||||++.... ....+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 3467778889999999999999999999998789999999984321 12236789999999999999999
Q ss_pred eEEEEEEe-----CCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CC
Q 047892 218 RLVGYCAE-----GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LE 279 (442)
Q Consensus 218 ~l~~~~~~-----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~ 279 (442)
++++++.. ....|+||||+. |+|.+++... ...+++..+..++.|++.||.|||+. ++
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA 168 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEc
Confidence 99999854 336799999998 5898888754 34689999999999999999999876 34
Q ss_pred CCCCeEEecccCccccCCCcceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchh
Q 047892 280 PKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQ 358 (442)
Q Consensus 280 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~ 358 (442)
.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---- 242 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ---- 242 (362)
T ss_dssp TTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----
T ss_pred CCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH----
Confidence 57889999999998643322 2334578999999999876 6799999999999999999999999976432111
Q ss_pred hhHHHHHHHHhhcCC-----------cccccCcccCC---C----CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH--
Q 047892 359 VNLFEWLKTMVTNGN-----------AEGVLDPRLQE---K----PSSRALKRALLVALRCVDPNAHKRPKMGHVIHM-- 418 (442)
Q Consensus 359 ~~~~~~~~~~~~~~~-----------~~~~~~~~~~~---~----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~-- 418 (442)
...+........ ....+...... . .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 243 ---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 319 (362)
T 3pg1_A 243 ---LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319 (362)
T ss_dssp ---HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred ---HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence 111111100000 00000000000 0 011224568889999999999999999999864
Q ss_pred HhcCC
Q 047892 419 LEAEE 423 (442)
Q Consensus 419 L~~~~ 423 (442)
++...
T Consensus 320 f~~~~ 324 (362)
T 3pg1_A 320 FESLF 324 (362)
T ss_dssp GTTTC
T ss_pred hhhcc
Confidence 55443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=301.26 Aligned_cols=247 Identities=21% Similarity=0.288 Sum_probs=181.1
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------e
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA------H 228 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~ 228 (442)
++|.+.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 5688999999999999999996 45899999998543 3344567889999999999999999999997653 4
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLL 295 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~ 295 (442)
.|+||||+ +++|.++++.. .+++..+..++.|++.||.|||+. ++.++.+||+|||+++..
T Consensus 105 ~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 59999999 77999999753 588999999999999999999875 445789999999999875
Q ss_pred CCCcceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC-
Q 047892 296 GAERSYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN- 373 (442)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~- 373 (442)
... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+. ...+........
T Consensus 179 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 179 DSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-------LKEIMKVTGTPPA 247 (367)
T ss_dssp CSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHHHCCCCH
T ss_pred ccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHHhcCCCCH
Confidence 432 334678999999999877 6799999999999999999999999976432111 111100000000
Q ss_pred -----------------cccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH--HhcC
Q 047892 374 -----------------AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM--LEAE 422 (442)
Q Consensus 374 -----------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~--L~~~ 422 (442)
........+. ......+..+.+|+.+||+.||++|||+.|+++. ++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 0000000000 0111234568889999999999999999999973 5544
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=327.97 Aligned_cols=238 Identities=21% Similarity=0.272 Sum_probs=189.0
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc---chhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCe
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAH 228 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 228 (442)
.+..++|++.+.||+|+||.||+|... +++.||||++... .......+..|..++..+ +||||+++++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 345678999999999999999999964 5888999998643 123345677899999887 79999999999999999
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCCCeEEecccCcccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKWNPKLSDFGLAKLL 295 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~~~kl~DFGla~~~ 295 (442)
+||||||+++|+|.++++.. ..+++..++.++.||+.||.|||+. | +.++.+||+|||+++..
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999999864 4689999999999999999999875 3 45678999999999864
Q ss_pred CCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 296 GAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
.... ......+||+.|+|||++.+..|+.++|||||||+||||++|..||...+.. +...... ....
T Consensus 493 ~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~----------~~~~~i~-~~~~- 559 (674)
T 3pfq_A 493 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----------ELFQSIM-EHNV- 559 (674)
T ss_dssp CCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------HHHHHHH-SSCC-
T ss_pred ccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH----------HHHHHHH-hCCC-
Confidence 3222 2345678999999999999999999999999999999999999999754321 1111111 1111
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCH-----HHHHH
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKM-----GHVIH 417 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~-----~evl~ 417 (442)
..+...+.++.+|+.+||+.||++||++ .||++
T Consensus 560 ---------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 ---------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ---------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ---------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1122345668889999999999999997 66653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=289.63 Aligned_cols=238 Identities=20% Similarity=0.286 Sum_probs=187.8
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---------hhhHHHHHHHHHHHHhcC-CCCcceEEEEEEe
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---------GQAEKEFKVEVEAIGRVR-HKNLVRLVGYCAE 225 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~ 225 (442)
.++|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 457889999999999999999975 58899999985432 123456789999999995 9999999999999
Q ss_pred CCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCc
Q 047892 226 GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLA 292 (442)
Q Consensus 226 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla 292 (442)
.+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999999764 4689999999999999999999876 456789999999999
Q ss_pred cccCCCcceeecccccccCCCCccccc------CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHH
Q 047892 293 KLLGAERSYVTTRVMGTFGYVAPEYAS------TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLK 366 (442)
Q Consensus 293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 366 (442)
........ .....||+.|+|||++. ...++.++|||||||++|||++|..||..... .....
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----------~~~~~ 239 (298)
T 1phk_A 172 CQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----------MLMLR 239 (298)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------HHHHH
T ss_pred hhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH----------HHHHH
Confidence 87643322 33457899999999885 45688999999999999999999999965321 11111
Q ss_pred HHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 367 TMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
... ..... .........+..+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~-~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIM-SGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHH-HTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHh-cCCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111 11110 111111234566888999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=302.15 Aligned_cols=247 Identities=25% Similarity=0.356 Sum_probs=183.2
Q ss_pred HHHhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhc-CCCCcceEEEEEEe-----
Q 047892 153 LEVSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAE----- 225 (442)
Q Consensus 153 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~----- 225 (442)
+....++|++.+.||+|+||.||+|.. .+++.||||.+.... .....+.+|+.+++++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 344567799999999999999999996 468999999986432 2346788999999999 89999999999976
Q ss_pred -CCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccC
Q 047892 226 -GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGL 291 (442)
Q Consensus 226 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGl 291 (442)
.+..|+||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. ++.++.+||+|||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 467899999999999999997542 24688999999999999999999876 44578899999999
Q ss_pred ccccCCCcceeecccccccCCCCccccc-----CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHH
Q 047892 292 AKLLGAERSYVTTRVMGTFGYVAPEYAS-----TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLK 366 (442)
Q Consensus 292 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 366 (442)
+........ ......||+.|+|||++. +..++.++|||||||++|||++|..||...... ....
T Consensus 176 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------~~~~ 244 (326)
T 2x7f_A 176 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----------RALF 244 (326)
T ss_dssp TC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----------HHHH
T ss_pred ceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH----------HHHH
Confidence 987543221 223457899999999986 566899999999999999999999999643211 1111
Q ss_pred HHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH--HHhcC
Q 047892 367 TMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEAE 422 (442)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~--~L~~~ 422 (442)
...... .. .. .....+..+.+|+.+||+.||.+|||+.++++ .+...
T Consensus 245 ~~~~~~-~~-----~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 245 LIPRNP-AP-----RL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp HHHHSC-CC-----CC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred HhhcCc-cc-----cC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 111111 10 01 11122356788999999999999999999986 45543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=303.85 Aligned_cols=245 Identities=18% Similarity=0.256 Sum_probs=189.1
Q ss_pred hCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchh-----------------hHHHHHHHHHHHHhcCCCCcceE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQ-----------------AEKEFKVEVEAIGRVRHKNLVRL 219 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~hpnIv~l 219 (442)
.++|.+.+.||+|+||.||+|.. +++.||||.+...... ..+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46799999999999999999999 8999999998533211 11778999999999999999999
Q ss_pred EEEEEeCCeeeeEEecCCCCCHHHH------HccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc-C-------------CC
Q 047892 220 VGYCAEGAHRMLVNEYVDNGNLEQW------LHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-G-------------LE 279 (442)
Q Consensus 220 ~~~~~~~~~~~lv~E~~~~g~L~~~------l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~-------------l~ 279 (442)
++++.+.+..|+||||+++|+|.++ +... ....+++..++.++.|++.||.|||+ . ++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 9999999999999999999999998 5432 13578999999999999999999997 4 45
Q ss_pred CCCCeEEecccCccccCCCcceeecccccccCCCCcccccCC-CCCC-cCCchhhHHHHHHHHhCCCCCCCCCCCCccch
Q 047892 280 PKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNE-TSDVYSFGILIMEVISGRNPVDYSRPPGEFQF 357 (442)
Q Consensus 280 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~ 357 (442)
.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|||++|..||.......
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---- 259 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV---- 259 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH----
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH----
Confidence 6789999999999876433 23456799999999999877 6776 9999999999999999999997543311
Q ss_pred hhhHHHHHHHHhhcCCcccc------cCcccC---CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 358 QVNLFEWLKTMVTNGNAEGV------LDPRLQ---EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~------~~~~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.. ... ......... ..+... .......+..+.+|+.+||+.||.+|||+.|+++
T Consensus 260 --~~---~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 --EL---FNN-IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --HH---HHH-HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HH---HHH-HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 111 111111000 000000 0001234567888999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=306.43 Aligned_cols=186 Identities=18% Similarity=0.235 Sum_probs=156.1
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhc------CCCCcceEEEEEEeCCee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV------RHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~l~~~~~~~~~~ 229 (442)
..+|++.+.||+|+||.||+|... +++.||||++... ......+.+|+.++..+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 456899999999999999999864 4889999998653 33445677888888877 678999999999999999
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCC--eEEecccCccc
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWN--PKLSDFGLAKL 294 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~--~kl~DFGla~~ 294 (442)
|+||||+. |+|.+++.... ...+++..++.++.|++.||.|||+. ++ .++. +||+|||+++.
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 99999997 59999997642 23589999999999999999999764 43 3445 99999999976
Q ss_pred cCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCC
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSR 350 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~ 350 (442)
.... ....+||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 252 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 252 EHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 5332 234679999999999999999999999999999999999999997653
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=297.54 Aligned_cols=250 Identities=18% Similarity=0.253 Sum_probs=183.8
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEe--------C
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE--------G 226 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--------~ 226 (442)
++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++.++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 4688999999999999999997 568999999985432 2234567889999999999999999999977 4
Q ss_pred CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcc
Q 047892 227 AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAK 293 (442)
Q Consensus 227 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~ 293 (442)
+..|+||||+++ +|.+.+... ...+++..+..++.|++.||.|||+. ++.++.+||+|||+++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 468999999986 888877654 24689999999999999999999875 4457899999999998
Q ss_pred ccCCCc---ceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHh
Q 047892 294 LLGAER---SYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMV 369 (442)
Q Consensus 294 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 369 (442)
.+.... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||...... .....+....
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~~~ 245 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-------HQLALISQLC 245 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHHH
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHHHh
Confidence 764322 122344578999999999876 45899999999999999999999999764321 1111111111
Q ss_pred hcCCc---ccc--------cCc--ccCCCCcHH-----HHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 370 TNGNA---EGV--------LDP--RLQEKPSSR-----ALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 370 ~~~~~---~~~--------~~~--~~~~~~~~~-----~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
..... ... +.. ......... .+..+.+|+.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 11000 000 000 000000001 13457889999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=298.20 Aligned_cols=238 Identities=21% Similarity=0.349 Sum_probs=180.7
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc--------hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR--------GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA 227 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 227 (442)
.++|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|++++++++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 356899999999999999999964 47899999985432 112235789999999999999999999987655
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC-------CC---CeEEecccC
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP-------KW---NPKLSDFGL 291 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-------~~---~~kl~DFGl 291 (442)
.|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++ ++ .+||+|||+
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred -eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 89999999999999999754 5689999999999999999999875 332 23 499999999
Q ss_pred ccccCCCcceeecccccccCCCCccccc---CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHH
Q 047892 292 AKLLGAERSYVTTRVMGTFGYVAPEYAS---TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTM 368 (442)
Q Consensus 292 a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 368 (442)
++...... ......||+.|+|||++. ...++.++|||||||++|||++|..||........ +...+
T Consensus 164 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~--- 232 (322)
T 2ycf_A 164 SKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------LKDQI--- 232 (322)
T ss_dssp CEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC------HHHHH---
T ss_pred ceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH------HHHHH---
Confidence 98764332 123457899999999874 56789999999999999999999999976543322 11111
Q ss_pred hhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 369 VTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
..+... ..+.. ....+..+.+|+.+||+.||++|||+.++++
T Consensus 233 -~~~~~~--~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 -TSGKYN--FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -HHTCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HhCccc--cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111100 00000 0123456888999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=304.76 Aligned_cols=253 Identities=24% Similarity=0.322 Sum_probs=189.3
Q ss_pred ehhhHHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 047892 149 TLRELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG 226 (442)
Q Consensus 149 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 226 (442)
.+.++++..++|++.+.||+|+||.||+|.+.+ .||+|.+.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 345667778889999999999999999999753 59999985432 22334577899999999999999999999999
Q ss_pred CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC------CCCeEEecccCccc
Q 047892 227 AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP------KWNPKLSDFGLAKL 294 (442)
Q Consensus 227 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~------~~~~kl~DFGla~~ 294 (442)
+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+. +++ ++.+||+|||+++.
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSI 178 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC--CCEECCCSCCC-
T ss_pred CceEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeCCCEEEeecCCccc
Confidence 9999999999999999999764 24688999999999999999999875 443 46899999999876
Q ss_pred cCCCc----ceeecccccccCCCCcccccC---------CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhH
Q 047892 295 LGAER----SYVTTRVMGTFGYVAPEYAST---------GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNL 361 (442)
Q Consensus 295 ~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~ 361 (442)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||......
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------- 249 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--------- 249 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---------
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------
Confidence 53211 111233468999999999864 45788999999999999999999999653211
Q ss_pred HHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCC
Q 047892 362 FEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 425 (442)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 425 (442)
...... ...... ... ....+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 250 -~~~~~~-~~~~~~-----~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 250 -AIIWQM-GTGMKP-----NLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp -HHHHHH-HTTCCC-----CCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred -HHHHHh-ccCCCC-----CCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 111111 111111 111 111233477899999999999999999999999998744
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=296.85 Aligned_cols=248 Identities=18% Similarity=0.251 Sum_probs=184.1
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcC-CCCcceEEEEEEe--CCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLVGYCAE--GAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~--~~~~~lv~ 233 (442)
++|++.+.||+|+||.||+|.. .+++.||||.+... ..+.+.+|+.++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5688999999999999999995 56899999998543 3467889999999997 9999999999987 66789999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC-------CC-CeEEecccCccccCCCc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP-------KW-NPKLSDFGLAKLLGAER 299 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-------~~-~~kl~DFGla~~~~~~~ 299 (442)
||+++++|.++++ .+++..+..++.|++.||.|||+. +++ ++ .+||+|||+++......
T Consensus 113 e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp ECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred eccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 9999999999984 378889999999999999999875 333 44 79999999998764433
Q ss_pred ceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCcc-chh------hhHHHHHHHHhh-
Q 047892 300 SYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEF-QFQ------VNLFEWLKTMVT- 370 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~-~~~------~~~~~~~~~~~~- 370 (442)
. .....||..|+|||++.+ ..++.++|||||||++|||++|..||......... ... .....++.....
T Consensus 186 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 186 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred c--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 2 334578999999999877 66999999999999999999999999543221100 000 000011100000
Q ss_pred ---------cCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 371 ---------NGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 371 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
....................+..+.+|+.+||+.||++|||+.|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000111111222234567889999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=305.32 Aligned_cols=239 Identities=11% Similarity=0.020 Sum_probs=164.9
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhc--CCCCcceEE-------EEEEe
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV--RHKNLVRLV-------GYCAE 225 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~hpnIv~l~-------~~~~~ 225 (442)
+|.+.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++..| +||||++++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 4788899999999999999964 68899999996543 23445677785544444 699988755 55543
Q ss_pred C-----------------CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHH------HHHHHHHHHhhhhhhcC-----
Q 047892 226 G-----------------AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIR------MNIILGTAKGLTYLHEG----- 277 (442)
Q Consensus 226 ~-----------------~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~------~~i~~qi~~~l~yLH~~----- 277 (442)
. ...|+|||||+ |+|.+++.... ..+.+..+ +.++.|++.||+|||+.
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr 218 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG 218 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence 3 33799999999 79999997531 12344444 67789999999999875
Q ss_pred --------CCCCCCeEEecccCccccCCCcceeecccccccCCCCcccccC--CCCCCcCCchhhHHHHHHHHhCCCCCC
Q 047892 278 --------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST--GMLNETSDVYSFGILIMEVISGRNPVD 347 (442)
Q Consensus 278 --------l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~Pf~ 347 (442)
++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 455789999999999876422 223457799999999987 679999999999999999999999997
Q ss_pred CCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 348 YSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.......... .....................+..+.+|+.+||+.||++|||+.++++
T Consensus 295 ~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 295 LVTPGIKGSW------------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp BCCTTCTTCC------------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CcCcccccch------------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 6543211000 000000001111111111234567888999999999999999999974
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=309.26 Aligned_cols=252 Identities=22% Similarity=0.277 Sum_probs=178.5
Q ss_pred CCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------eeee
Q 047892 158 NGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA------HRML 231 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~~~l 231 (442)
.+|.+.+.||+|+||.||+|....+..||+|++...... ..+|+++++.++||||+++++++...+ ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 358889999999999999999877777999988543221 236999999999999999999986543 3789
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CC-CCCCeEEecccCccccCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LE-PKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~-~~~~~kl~DFGla~~~~~ 297 (442)
||||++++ +...+.........+++..+..++.|++.||.|||+. ++ .++.+||+|||+++.+..
T Consensus 116 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 116 VLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp EEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 99999984 4443332111235789999999999999999999875 33 467899999999987643
Q ss_pred CcceeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhH-----HHHHHHHhhc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNL-----FEWLKTMVTN 371 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~ 371 (442)
... .....||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+....+........ ...+..+ .
T Consensus 195 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~--~ 270 (394)
T 4e7w_A 195 GEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM--N 270 (394)
T ss_dssp TCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH--C
T ss_pred CCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh--C
Confidence 322 2345789999999998765 5899999999999999999999999764322111000000 0000000 0
Q ss_pred CCcccccCcccCCC-----CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 372 GNAEGVLDPRLQEK-----PSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 372 ~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.......-+..... .....+.++.+|+.+||+.||.+|||+.|+++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000001111111 111244578899999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=286.07 Aligned_cols=241 Identities=21% Similarity=0.268 Sum_probs=184.1
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc----hhhHHHHHHHHHHHHhcCCCCcceEEEEEE--eCCeee
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVRHKNLVRLVGYCA--EGAHRM 230 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~~~~ 230 (442)
++|.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++. +....|
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 5799999999999999999996 458899999985432 234567899999999999999999999984 456789
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+||||+++| |.+++.... ...+++..+..++.|++.||.|||+. ++.++.+||+|||++.....
T Consensus 85 lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 999999986 777776532 34689999999999999999999876 44678999999999987643
Q ss_pred Cc-ceeecccccccCCCCcccccCCC--CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 298 ER-SYVTTRVMGTFGYVAPEYASTGM--LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 298 ~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
.. ........||+.|+|||++.+.. ++.++|||||||++|||++|..||..... ........ ....
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------~~~~~~i~-~~~~ 230 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI----------YKLFENIG-KGSY 230 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH----------HHHHHHHH-HCCC
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH----------HHHHHHHh-cCCC
Confidence 22 22234457999999999987644 47799999999999999999999975321 11111111 1111
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH--HHhcC
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEAE 422 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~--~L~~~ 422 (442)
..+...+..+.+++.+||+.||.+|||+.|+++ .+.+.
T Consensus 231 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 231 ----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp ----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred ----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 111123456788999999999999999999995 35544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=301.38 Aligned_cols=256 Identities=16% Similarity=0.253 Sum_probs=167.4
Q ss_pred CCc-cCeeccCCcEEEEEEEEC---CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeeeeEE
Q 047892 160 FAD-ENVIGEGGYGIVYRGVLE---DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE--GAHRMLVN 233 (442)
Q Consensus 160 ~~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~ 233 (442)
|.+ .++||+|+||.||+|.+. +++.||||.+.... ....+.+|+.+|++++||||+++++++.. ....|+||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 554 458999999999999965 47889999986432 23467889999999999999999999954 67899999
Q ss_pred ecCCCCCHHHHHccC-----CCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------C----CCCCCeEEecccC
Q 047892 234 EYVDNGNLEQWLHGD-----VGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------L----EPKWNPKLSDFGL 291 (442)
Q Consensus 234 E~~~~g~L~~~l~~~-----~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l----~~~~~~kl~DFGl 291 (442)
||+.+ +|.+++... ......+++..++.++.|++.||.|||+. + +.++.+||+|||+
T Consensus 100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 178 (405)
T 3rgf_A 100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178 (405)
T ss_dssp ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence 99986 888887532 11123589999999999999999999875 2 3457899999999
Q ss_pred ccccCCCcc--eeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCcc--chhhhHHHHHH
Q 047892 292 AKLLGAERS--YVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEF--QFQVNLFEWLK 366 (442)
Q Consensus 292 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~--~~~~~~~~~~~ 366 (442)
++....... ......+||+.|+|||++.+. .++.++|||||||++|||++|..||......... .........+.
T Consensus 179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~ 258 (405)
T 3rgf_A 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 258 (405)
T ss_dssp CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHH
T ss_pred ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHH
Confidence 987643221 223446899999999999874 4899999999999999999999999765432100 00111111111
Q ss_pred HHhhcCCc---ccc-------------cCcccCCCCc--------HHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 367 TMVTNGNA---EGV-------------LDPRLQEKPS--------SRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 367 ~~~~~~~~---~~~-------------~~~~~~~~~~--------~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
........ ... .......... ...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 259 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11110000 000 0000000000 0013457889999999999999999999964
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=304.87 Aligned_cols=247 Identities=17% Similarity=0.188 Sum_probs=189.1
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCC-CCcceEEEEEEeCCeeeeEEe
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH-KNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~E 234 (442)
.++|.+.+.||+|+||.||+|.+ .+++.||||.+..... ...+.+|+++++.|+| ++|..+..++...+..|||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 35799999999999999999996 5689999998754322 2347789999999987 566667777788889999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------C---CCCCCeEEecccCccccCCC
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------L---EPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l---~~~~~~kl~DFGla~~~~~~ 298 (442)
|+ +++|.+++... ...+++..++.++.||+.||.|||.. + +.++.+||+|||+++.+...
T Consensus 84 ~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99 88999999753 24689999999999999999999875 2 35678999999999876543
Q ss_pred cce------eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC
Q 047892 299 RSY------VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372 (442)
Q Consensus 299 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (442)
... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.......... ....+.......
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~----~~~~i~~~~~~~ 235 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ----KYEKISEKKVAT 235 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH----HHHHHHHHHHHS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHH----HHHHHhhccccc
Confidence 321 1235679999999999999999999999999999999999999998654432211 111111111100
Q ss_pred CcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
... .+. ...+.++.+|+.+||+.||++||++.+|++.|+.+
T Consensus 236 ~~~-----~l~----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 236 SIE-----ALC----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp CHH-----HHH----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cHH-----HHh----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 000 000 12235688899999999999999999999988765
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=295.62 Aligned_cols=248 Identities=21% Similarity=0.296 Sum_probs=185.1
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----Ceee
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG-----AHRM 230 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~ 230 (442)
++|++.+.||+|+||.||+|... +++.||||++... .......+.+|++++++++||||+++++++... ...|
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 46899999999999999999964 5788999999643 334456788999999999999999999999765 3689
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+||||+.+ +|.++++.. .+++..+..++.|++.||.|||+. ++.++.+||+|||+++....
T Consensus 107 iv~e~~~~-~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 107 IVQDLMET-DLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEECCSE-EHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEcccCc-CHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 99999985 999999753 589999999999999999999875 44567899999999987643
Q ss_pred Ccce--eecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 298 ERSY--VTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 298 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
.... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+... .+.........
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-------~i~~~~~~~~~ 253 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN-------HILGILGSPSQ 253 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHH-------HHHHHHCSCCH
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHH-------HHHHHhCCCCH
Confidence 3221 1234589999999998754 458999999999999999999999997654332211 11110000000
Q ss_pred c--------------cccCcccCCC---CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 375 E--------------GVLDPRLQEK---PSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 375 ~--------------~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
. .......... .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000000000 001234568889999999999999999999863
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=299.10 Aligned_cols=252 Identities=17% Similarity=0.181 Sum_probs=187.3
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcC--------CCCcceEEEEEE---
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR--------HKNLVRLVGYCA--- 224 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------hpnIv~l~~~~~--- 224 (442)
.++|++.+.||+|+||.||+|.. .+++.||||.+... ....+.+.+|+.+++.++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46799999999999999999996 45889999998643 344567889999999985 788999999987
Q ss_pred -eCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------CC-------CCC-------
Q 047892 225 -EGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------LE-------PKW------- 282 (442)
Q Consensus 225 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------l~-------~~~------- 282 (442)
+....|+||||+ +|+|.+++.... ...+++..++.++.|++.||.|||+. ++ .++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 556889999999 457777765431 24689999999999999999999964 22 222
Q ss_pred ------------------------------------------CeEEecccCccccCCCcceeecccccccCCCCcccccC
Q 047892 283 ------------------------------------------NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 320 (442)
Q Consensus 283 ------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (442)
.+||+|||+++..... .....||+.|+|||++.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence 7999999999876432 234578999999999999
Q ss_pred CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhc--------CCc-ccccCc--------c--
Q 047892 321 GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTN--------GNA-EGVLDP--------R-- 381 (442)
Q Consensus 321 ~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~-~~~~~~--------~-- 381 (442)
..++.++|||||||++|||++|+.||............. ....+...... ... ...... .
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDED-HIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHH-HHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHH-HHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 999999999999999999999999998655433221111 11111111100 000 000000 0
Q ss_pred ---------cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 382 ---------LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 382 ---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
-........+..+.+|+.+||+.||++|||+.|+++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 001234566778999999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=309.67 Aligned_cols=246 Identities=23% Similarity=0.280 Sum_probs=178.7
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------Ceeee
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG------AHRML 231 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~~~l 231 (442)
+|.+.+.||+|+||.||+|.+. +++.||||++..... ...+|+++|+.++||||+++++++... ..+++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 4788899999999999999975 589999999854321 234699999999999999999998542 23679
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC-------C-CCeEEecccCccccCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP-------K-WNPKLSDFGLAKLLGA 297 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-------~-~~~kl~DFGla~~~~~ 297 (442)
||||+++ +|.+++.........+++..+..++.|++.||.|||+. +++ + +.+||+|||+++.+..
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 9999997 67766643222235789999999999999999999875 333 3 4689999999987643
Q ss_pred CcceeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHh-------
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMV------- 369 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~------- 369 (442)
... ....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+....+. +...+....
T Consensus 210 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~------l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 210 GEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ------LVEIIKVLGTPTREQI 281 (420)
T ss_dssp TCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHHHCSCCHHHH
T ss_pred CCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHHHhCCCCHHHH
Confidence 322 2345789999999998765 699999999999999999999999976432111 111111100
Q ss_pred --hcCCcccccCcccCCC-----CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 370 --TNGNAEGVLDPRLQEK-----PSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 370 --~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
..........+.+... .....+.++.+|+.+||+.||++|||+.|+++
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0111111111111111 11223467889999999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=286.82 Aligned_cols=238 Identities=24% Similarity=0.357 Sum_probs=177.0
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEe-----------
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE----------- 225 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----------- 225 (442)
++|++.+.||+|+||.||+|... +++.||||.+.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 45888999999999999999964 689999999854 33445678899999999999999999998865
Q ss_pred --CCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEeccc
Q 047892 226 --GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFG 290 (442)
Q Consensus 226 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFG 290 (442)
.+..|+||||+++|+|.+++... ...+++..++.++.|++.||.|||+. ++.++.+||+|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 45679999999999999999754 24678889999999999999999876 4457889999999
Q ss_pred CccccCCCc-------------ceeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccc
Q 047892 291 LAKLLGAER-------------SYVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQ 356 (442)
Q Consensus 291 la~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~ 356 (442)
+++...... ........||+.|+|||++.+. .++.++|||||||++|||++ ||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~------- 231 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG------- 231 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH-------
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc-------
Confidence 998654221 1122345789999999999764 68999999999999999998 55321
Q ss_pred hhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 357 FQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
........... .. ...+........+..+.+++.+||+.||.+|||+.++++.
T Consensus 232 --~~~~~~~~~~~-~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 --MERVNILKKLR-SV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp --HHHHHHHHHHH-ST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --hhHHHHHHhcc-cc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 11111111111 11 1111222233344567889999999999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=289.42 Aligned_cols=255 Identities=23% Similarity=0.290 Sum_probs=186.2
Q ss_pred hCCCCccCeeccCCcEEEEEEEE--CCCCeEEEEEecCcc--hhhHHHHHHHHHHHHhc---CCCCcceEEEEEE-----
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL--EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRV---RHKNLVRLVGYCA----- 224 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~----- 224 (442)
.++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 46799999999999999999997 357889999985432 11223456777777666 8999999999987
Q ss_pred eCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccC
Q 047892 225 EGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGL 291 (442)
Q Consensus 225 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGl 291 (442)
.....++||||+. |+|.+++.... ...+++..+..++.|++.||.|||+. ++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 5567899999998 59999997642 23589999999999999999999876 34578899999999
Q ss_pred ccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhc
Q 047892 292 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTN 371 (442)
Q Consensus 292 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (442)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+......
T Consensus 167 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~~~ 237 (326)
T 1blx_A 167 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-------DQLGKILDVIGL 237 (326)
T ss_dssp CCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHHHCC
T ss_pred cccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHHHcCC
Confidence 98764322 233457899999999999999999999999999999999999999754321 111111111110
Q ss_pred CCccc----------ccCccc---CCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH--HHhcCC
Q 047892 372 GNAEG----------VLDPRL---QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEAEE 423 (442)
Q Consensus 372 ~~~~~----------~~~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~--~L~~~~ 423 (442)
..... ...... ........+..+.+|+.+||+.||++|||+.|+++ .+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 00000 000000 00011223456788999999999999999999994 355554
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=287.89 Aligned_cols=247 Identities=16% Similarity=0.240 Sum_probs=187.0
Q ss_pred hCCCCccCeeccCCcEEEEEEEE--CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCC------cceEEEEEEeCCe
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL--EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN------LVRLVGYCAEGAH 228 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~l~~~~~~~~~ 228 (442)
.++|++.+.||+|+||.||+|.. .+++.||||.+... ....+.+.+|+.+++.++|+| |+++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 45799999999999999999986 35788999998643 344567888999999887654 9999999999999
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------C---------------
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------P--------------- 280 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~--------------- 280 (442)
.|+||||+ +++|.+++.... ...+++..+..++.|++.||.|||+. ++ .
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 99999999 789999997642 23688999999999999999999875 32 2
Q ss_pred ----CCCeEEecccCccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccc
Q 047892 281 ----KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQ 356 (442)
Q Consensus 281 ----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~ 356 (442)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||......+.
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-- 242 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH-- 242 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH--
T ss_pred ccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH--
Confidence 456999999999875332 2345789999999999998999999999999999999999999975432111
Q ss_pred hhhhHHHHHHHHhhcC--------Ccccc---------------------cCc-ccCCCCcHHHHHHHHHHHhhhhCCCC
Q 047892 357 FQVNLFEWLKTMVTNG--------NAEGV---------------------LDP-RLQEKPSSRALKRALLVALRCVDPNA 406 (442)
Q Consensus 357 ~~~~~~~~~~~~~~~~--------~~~~~---------------------~~~-~~~~~~~~~~~~~~~~li~~cl~~dP 406 (442)
...+....... ..... ..+ .-........+..+.+|+.+||+.||
T Consensus 243 -----~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 243 -----LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp -----HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred -----HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 11111110000 00000 000 00011223456788999999999999
Q ss_pred CCCCCHHHHHHH
Q 047892 407 HKRPKMGHVIHM 418 (442)
Q Consensus 407 ~~RPs~~evl~~ 418 (442)
.+|||+.|+++.
T Consensus 318 ~~Rpt~~ell~h 329 (339)
T 1z57_A 318 AKRITLREALKH 329 (339)
T ss_dssp TTSCCHHHHTTS
T ss_pred ccccCHHHHhcC
Confidence 999999999853
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=299.08 Aligned_cols=244 Identities=22% Similarity=0.274 Sum_probs=166.6
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------Ce
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG------AH 228 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~ 228 (442)
++|.+.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 5789999999999999999995 45889999998543 334456788999999999999999999998754 56
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLL 295 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~ 295 (442)
.|+||||+ +++|.++++. ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++..
T Consensus 109 ~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred EEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 79999999 5799998864 3689999999999999999999875 445679999999999875
Q ss_pred CCCcceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC-
Q 047892 296 GAERSYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN- 373 (442)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~- 373 (442)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+ ....+........
T Consensus 183 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 183 ADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-------QLKLILRLVGTPGA 251 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHHHCSCCH
T ss_pred ccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHHHhCCCCH
Confidence 332 334679999999999877 679999999999999999999999997643211 1111111110000
Q ss_pred ----------cccc---cCcccCCCC---cHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 374 ----------AEGV---LDPRLQEKP---SSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 374 ----------~~~~---~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.... +........ ....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000 000000000 01124567889999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=284.38 Aligned_cols=239 Identities=21% Similarity=0.298 Sum_probs=186.9
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
...++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++||||+++++++.+.+..|+
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34467999999999999999999975 5889999998543 23345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC----------CCCeEEecccCcccc
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP----------KWNPKLSDFGLAKLL 295 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~----------~~~~kl~DFGla~~~ 295 (442)
||||+++++|.+++... ..+++..++.++.|++.||.|||+. +++ ++.+||+|||++...
T Consensus 99 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999999998754 4689999999999999999999876 222 346999999999876
Q ss_pred CCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 296 GAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
..... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||..... ....... ..+...
T Consensus 175 ~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----------~~~~~~~-~~~~~~ 240 (287)
T 2wei_A 175 QQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE----------YDILKRV-ETGKYA 240 (287)
T ss_dssp CCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------HHHHHHH-HHCCCC
T ss_pred cCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH----------HHHHHHH-HcCCCC
Confidence 43322 233468999999998865 589999999999999999999999975321 1111111 111110
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
. ........+..+.+++.+||+.||++|||+.|+++
T Consensus 241 ~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 F------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp C------CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C------CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 00011123456888999999999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=300.33 Aligned_cols=267 Identities=18% Similarity=0.216 Sum_probs=176.5
Q ss_pred hHHHhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe--
Q 047892 152 ELEVSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAH-- 228 (442)
Q Consensus 152 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-- 228 (442)
......++|.+.+.||+|+||.||+|... +++.||||++.... .....+.+|++.+..++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 44566788999999999999999999974 58999999885432 222345678888899999999999999865433
Q ss_pred -----eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhh--cC-------------CCC-CCCeEEe
Q 047892 229 -----RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH--EG-------------LEP-KWNPKLS 287 (442)
Q Consensus 229 -----~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH--~~-------------l~~-~~~~kl~ 287 (442)
.++||||+++ +|...+.........+++..+..++.|++.||.||| +. ++. ++.+||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 7899999997 565554432222357899999999999999999999 53 233 6789999
Q ss_pred cccCccccCCCcceeecccccccCCCCcccccCCC-CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhH-----
Q 047892 288 DFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM-LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNL----- 361 (442)
Q Consensus 288 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~----- 361 (442)
|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...............
T Consensus 175 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 175 DFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp CCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence 9999987654332 33457899999999986654 899999999999999999999999764322111000000
Q ss_pred HHHHHHHhhcCCcccccC-c-----ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH--HhcC
Q 047892 362 FEWLKTMVTNGNAEGVLD-P-----RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM--LEAE 422 (442)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~--L~~~ 422 (442)
..+............... . ..........+..+.+|+.+||+.||.+|||+.|+++. +++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 000000000000000000 0 00011112245678999999999999999999999863 4443
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=293.12 Aligned_cols=246 Identities=24% Similarity=0.308 Sum_probs=165.2
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc-hhhHHHHHHHHH-HHHhcCCCCcceEEEEEEeCCeee
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVE-AIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
.+..++|.+.+.||+|+||.||+|... +++.||||.+.... ......+..|+. +++.++||||+++++++...+..+
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 345678999999999999999999974 58899999996542 334445666666 677889999999999999999999
Q ss_pred eEEecCCCCCHHHHHccC-CCCCCCCCHHHHHHHHHHHHHhhhhhhcC--------------CCCCCCeEEecccCcccc
Q 047892 231 LVNEYVDNGNLEQWLHGD-VGPHSPLTWEIRMNIILGTAKGLTYLHEG--------------LEPKWNPKLSDFGLAKLL 295 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------------l~~~~~~kl~DFGla~~~ 295 (442)
+||||+++ +|.+++... ......+++..+..++.|++.||.|||+. ++.++.+||+|||+++..
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99999996 888877531 01125689999999999999999999863 235678999999999876
Q ss_pred CCCcceeecccccccCCCCcccc----cCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhc
Q 047892 296 GAERSYVTTRVMGTFGYVAPEYA----STGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTN 371 (442)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (442)
.... ......||+.|+|||++ .+..++.++|||||||++|||++|..||........ .. .
T Consensus 177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------~~----~- 240 (327)
T 3aln_A 177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---------QL----T- 240 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------------C-
T ss_pred cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---------HH----H-
Confidence 4332 12334789999999998 456789999999999999999999999975322100 00 0
Q ss_pred CCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 372 GNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.......+.+........+..+.+|+.+||+.||++|||+.++++
T Consensus 241 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 241 -QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000001111111112234456888999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=295.51 Aligned_cols=243 Identities=21% Similarity=0.282 Sum_probs=179.8
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee-----
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHR----- 229 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~----- 229 (442)
++|.+.+.||+|+||.||+|... +++.||||++... .......+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 56889999999999999999964 5889999999653 333456788999999999999999999999877655
Q ss_pred -eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcccc
Q 047892 230 -MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLL 295 (442)
Q Consensus 230 -~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~ 295 (442)
|+||||+. |+|.+++.. .+++..+..++.|++.||.|||+. ++.++.+||+|||+++..
T Consensus 122 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred EEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999998 499888743 489999999999999999999875 445678999999999865
Q ss_pred CCCcceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 296 GAERSYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. ...+.........
T Consensus 195 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------~~~i~~~~~~~~~ 263 (371)
T 4exu_A 195 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-------LTQILKVTGVPGT 263 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHHHCCCCH
T ss_pred ccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHHHHhCCCcH
Confidence 332 334678999999999877 6799999999999999999999999975432111 1111000000000
Q ss_pred --------------ccccCcccCCC---CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 375 --------------EGVLDPRLQEK---PSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 375 --------------~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
...+....... .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000000 011234678899999999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=289.02 Aligned_cols=261 Identities=20% Similarity=0.298 Sum_probs=181.8
Q ss_pred hCCCCccCeeccCCcEEEEEEEECC-CCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEE-----------
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCA----------- 224 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~----------- 224 (442)
.++|.+.+.||+|+||.||+|.... ++.||+|.+........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 3568899999999999999999754 8899999997666666778999999999999999999999873
Q ss_pred ---eCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC--------CCCCeEEe
Q 047892 225 ---EGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE--------PKWNPKLS 287 (442)
Q Consensus 225 ---~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~--------~~~~~kl~ 287 (442)
+.+..|+||||++ |+|.+++.. ..+++..++.++.|++.||.|||+. ++ .++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 3467899999998 599999964 3688999999999999999999875 32 34689999
Q ss_pred cccCccccCCCcc--eeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhH---
Q 047892 288 DFGLAKLLGAERS--YVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNL--- 361 (442)
Q Consensus 288 DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~--- 361 (442)
|||+++....... .......+|..|+|||++.+ ..++.++|||||||++|||++|+.||...............
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999987643211 11234467999999998865 67899999999999999999999999764321110000000
Q ss_pred --HHHHHHHhhcCCcccccCcccC-CC-----CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH--HHhcCCCC
Q 047892 362 --FEWLKTMVTNGNAEGVLDPRLQ-EK-----PSSRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEAEEFP 425 (442)
Q Consensus 362 --~~~~~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~ 425 (442)
......... .....+..... .. .....+..+.+|+.+||+.||++|||+.|+++ .+.....+
T Consensus 244 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 244 VHEEDRQELLS--VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp CCHHHHHHHHT--TSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred Cchhhhhhhhh--cCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 000000000 00000000000 00 00123466888999999999999999999986 46555433
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=292.40 Aligned_cols=254 Identities=17% Similarity=0.263 Sum_probs=185.7
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----Cee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG-----AHR 229 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~ 229 (442)
.++|.+.+.||+|+||.||+|... +++.||||.+... .......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 356889999999999999999965 5889999999643 334456788999999999999999999988654 678
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~ 296 (442)
|+||||+.+ +|.+++... .+++..+..++.|++.||.|||+. ++.++.+||+|||+++...
T Consensus 90 ~lv~e~~~~-~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 90 YIIQELMQT-DLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEECCCSE-EHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeccCc-cHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 999999984 999998753 589999999999999999999875 4457789999999998764
Q ss_pred CCcce---------eecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHH
Q 047892 297 AERSY---------VTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLK 366 (442)
Q Consensus 297 ~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 366 (442)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||....... ....+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~ 236 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-------QLLLIF 236 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHH
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-------HHHHHH
Confidence 32211 1223578999999998764 678999999999999999999999997543211 011111
Q ss_pred HHhhcCCccc----c--------cC--cccCCC----CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH--HHhcCC
Q 047892 367 TMVTNGNAEG----V--------LD--PRLQEK----PSSRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEAEE 423 (442)
Q Consensus 367 ~~~~~~~~~~----~--------~~--~~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~--~L~~~~ 423 (442)
.......... . +. +..... .....+..+.+|+.+||+.||++|||+.|+++ .++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 1100000000 0 00 000000 00123456788999999999999999999986 355543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=294.01 Aligned_cols=189 Identities=21% Similarity=0.265 Sum_probs=157.4
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcC-CC-----CcceEEEEEEeC
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HK-----NLVRLVGYCAEG 226 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----nIv~l~~~~~~~ 226 (442)
+...++|.+.+.||+|+||.||+|... +++.||||++... ......+.+|+.++..++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 344578999999999999999999965 5788999998643 334566778898888875 55 499999999999
Q ss_pred CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC--------C---------CCCCCeEEecc
Q 047892 227 AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--------L---------EPKWNPKLSDF 289 (442)
Q Consensus 227 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~--------l---------~~~~~~kl~DF 289 (442)
+..|+||||+++ +|.+++.... ...+++..+..++.|++.||.|||.. + +.++.+||+||
T Consensus 129 ~~~~lv~e~~~~-~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 129 NHLCLVFEMLSY-NLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp TEEEEEEECCCC-BHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred CceEEEEecCCC-CHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 999999999975 9999997642 24589999999999999999999842 2 23567999999
Q ss_pred cCccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCC
Q 047892 290 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSR 350 (442)
Q Consensus 290 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~ 350 (442)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 206 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 206 GSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999876432 234678999999999999999999999999999999999999997643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=300.84 Aligned_cols=238 Identities=21% Similarity=0.255 Sum_probs=171.8
Q ss_pred CCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 160 FADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+.+..|+|||||.
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 4456889999999998776667999999998543 335678899999876 89999999999999999999999996
Q ss_pred CCHHHHHccCCCCCCC---CCHHHHHHHHHHHHHhhhhhhcC------CCC--------------------CCCeEEecc
Q 047892 239 GNLEQWLHGDVGPHSP---LTWEIRMNIILGTAKGLTYLHEG------LEP--------------------KWNPKLSDF 289 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~---l~~~~~~~i~~qi~~~l~yLH~~------l~~--------------------~~~~kl~DF 289 (442)
|+|.+++......... ..+..++.++.|++.||.|||+. +++ ++.+||+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 5999999764322111 12334578999999999999875 332 347899999
Q ss_pred cCccccCCCcce---eecccccccCCCCcccccC-------CCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchh
Q 047892 290 GLAKLLGAERSY---VTTRVMGTFGYVAPEYAST-------GMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQ 358 (442)
Q Consensus 290 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~ 358 (442)
|+++.+...... .....+||+.|+|||++.+ ..++.++|||||||++|||++ |..||.......
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~----- 247 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE----- 247 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-----
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-----
Confidence 999887543321 1234579999999999965 568999999999999999999 999996432210
Q ss_pred hhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 359 VNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.. .... .. ..+..........+.++.+|+.+||+.||.+|||+.++++
T Consensus 248 ---~~----i~~~-~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 ---SN----IIRG-IF---SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---HH----HHHT-CC---CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HH----HhcC-CC---CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 01 1111 00 0111122234566788999999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=293.46 Aligned_cols=257 Identities=18% Similarity=0.201 Sum_probs=187.3
Q ss_pred hhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcC-----------CCCcceEEEEE
Q 047892 156 STNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-----------HKNLVRLVGYC 223 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~l~~~~ 223 (442)
..++|.+.+.||+|+||.||+|.. .+++.||||.+... ......+.+|+.++++++ ||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 346799999999999999999996 46889999998643 334566888999998886 89999999998
Q ss_pred EeCC----eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------CCC------------
Q 047892 224 AEGA----HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------LEP------------ 280 (442)
Q Consensus 224 ~~~~----~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------l~~------------ 280 (442)
...+ ..++||||+ +++|.+++.... ...+++..+..++.|++.||.|||+. +++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence 7654 789999999 789999997642 24589999999999999999999974 332
Q ss_pred -CCCeEEecccCccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhh
Q 047892 281 -KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQV 359 (442)
Q Consensus 281 -~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~ 359 (442)
.+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.............
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 236899999999876432 234578999999999999999999999999999999999999997654322111111
Q ss_pred hHHHHHHHHhhc------------------C-CcccccCc---------ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCC
Q 047892 360 NLFEWLKTMVTN------------------G-NAEGVLDP---------RLQEKPSSRALKRALLVALRCVDPNAHKRPK 411 (442)
Q Consensus 360 ~~~~~~~~~~~~------------------~-~~~~~~~~---------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs 411 (442)
.+.... ..... . ........ .-....+...+..+.+|+.+||+.||++|||
T Consensus 249 ~~~~~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 249 HIAQII-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHH-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHH-HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 111111 11000 0 00000000 0011234567788999999999999999999
Q ss_pred HHHHHH--HHhc
Q 047892 412 MGHVIH--MLEA 421 (442)
Q Consensus 412 ~~evl~--~L~~ 421 (442)
+.|+++ .+.+
T Consensus 328 ~~ell~hp~f~~ 339 (373)
T 1q8y_A 328 AGGLVNHPWLKD 339 (373)
T ss_dssp HHHHHTCGGGTT
T ss_pred HHHHhhChhhhc
Confidence 999987 3544
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=289.96 Aligned_cols=239 Identities=18% Similarity=0.222 Sum_probs=157.2
Q ss_pred hCCCCcc-CeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeee
Q 047892 157 TNGFADE-NVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE----GAHRM 230 (442)
Q Consensus 157 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~ 230 (442)
.++|.+. +.||+|+||.||+|... +++.||||++.... ... ......++.++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 3457775 46999999999999975 58999999985532 111 222334567799999999999876 45689
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC----------CCCeEEecccCccc
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP----------KWNPKLSDFGLAKL 294 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~----------~~~~kl~DFGla~~ 294 (442)
+||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +++ ++.+||+|||+++.
T Consensus 103 lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 9999999999999997642 24689999999999999999999875 322 45599999999986
Q ss_pred cCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.......... .........
T Consensus 181 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------~~~~~~~~~-- 248 (336)
T 3fhr_A 181 TTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP-------GMKRRIRLG-- 248 (336)
T ss_dssp C-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------
T ss_pred ccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh-------hHHHhhhcc--
Confidence 54322 234578999999999988889999999999999999999999996543321100 000000000
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
............+..+.+|+.+||+.||.+|||+.|+++
T Consensus 249 ----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 249 ----QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 001111111234566888999999999999999999997
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=288.67 Aligned_cols=242 Identities=20% Similarity=0.280 Sum_probs=179.7
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe------
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAH------ 228 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~------ 228 (442)
++|.+.+.||+|+||.||+|... +|+.||||.+... .......+.+|+.+++.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 56889999999999999999964 5889999998643 23345678899999999999999999999987654
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLL 295 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~ 295 (442)
.|+||||+.+ +|.+++.. .+++..+..++.|++.||.|||+. ++.++.+||+|||+++..
T Consensus 104 ~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 104 FYLVMPFMQT-DLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CEEEEECCSE-EGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred EEEEeccccC-CHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 4999999984 88887743 489999999999999999999876 445688999999999865
Q ss_pred CCCcceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC--
Q 047892 296 GAERSYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG-- 372 (442)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-- 372 (442)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||......+. ...+.......
T Consensus 177 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-------~~~i~~~~~~~~~ 245 (353)
T 3coi_A 177 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-------LTQILKVTGVPGT 245 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH-------HHHHHHHHCBCCH
T ss_pred CCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHHHhCCCCH
Confidence 332 234578999999999876 6789999999999999999999999975432111 11110000000
Q ss_pred ----------------CcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 373 ----------------NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 373 ----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.........+. ......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000010 1112345678889999999999999999999853
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=284.77 Aligned_cols=251 Identities=16% Similarity=0.224 Sum_probs=187.1
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CC-CeEEEEEecCcchhhHHHHHHHHHHHHhcCCCC------cceEEEEEEeCCe
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DN-TNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN------LVRLVGYCAEGAH 228 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~l~~~~~~~~~ 228 (442)
.++|++.+.||+|+||.||+|... ++ +.||+|.+... ......+.+|+.+++.++|+| ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 467999999999999999999964 34 68999998643 344567888999999987766 9999999999999
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------C-----------------
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------L----------------- 278 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l----------------- 278 (442)
.|+||||+ +|+|.+++.... ...+++..++.++.|++.||.|||+. +
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence 99999999 567877776542 24689999999999999999999976 2
Q ss_pred --CCCCCeEEecccCccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccc
Q 047892 279 --EPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQ 356 (442)
Q Consensus 279 --~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~ 356 (442)
..++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--- 246 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE--- 246 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---
T ss_pred cccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence 34578999999999875332 234579999999999999999999999999999999999999997543211
Q ss_pred hhhhHHHHHHHHhhcC--------Cc-ccccCc---------------------ccCCCCcHHHHHHHHHHHhhhhCCCC
Q 047892 357 FQVNLFEWLKTMVTNG--------NA-EGVLDP---------------------RLQEKPSSRALKRALLVALRCVDPNA 406 (442)
Q Consensus 357 ~~~~~~~~~~~~~~~~--------~~-~~~~~~---------------------~~~~~~~~~~~~~~~~li~~cl~~dP 406 (442)
....+....... .. ...... ..........+..+.+|+.+||+.||
T Consensus 247 ----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 247 ----HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp ----HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred ----HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 111111110000 00 000000 00011223445678899999999999
Q ss_pred CCCCCHHHHHH--HHhcC
Q 047892 407 HKRPKMGHVIH--MLEAE 422 (442)
Q Consensus 407 ~~RPs~~evl~--~L~~~ 422 (442)
++|||+.|+++ .+.++
T Consensus 323 ~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 323 AQRITLAEALLHPFFAGL 340 (355)
T ss_dssp TTSCCHHHHTTSGGGGGC
T ss_pred hhCcCHHHHhcChhhcCC
Confidence 99999999984 34443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=290.19 Aligned_cols=230 Identities=23% Similarity=0.370 Sum_probs=175.6
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchh------hHHHHHHHHHHHHhc----CCCCcceEEEEE
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQ------AEKEFKVEVEAIGRV----RHKNLVRLVGYC 223 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~hpnIv~l~~~~ 223 (442)
...++|++.+.||+|+||.||+|.. .+++.||||.+...... ....+.+|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3456799999999999999999985 46889999998644221 223356799999988 899999999999
Q ss_pred EeCCeeeeEEec-CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CC-CCCCeEEec
Q 047892 224 AEGAHRMLVNEY-VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LE-PKWNPKLSD 288 (442)
Q Consensus 224 ~~~~~~~lv~E~-~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~-~~~~~kl~D 288 (442)
...+..++|||| +.+++|.+++... ..+++..++.++.|++.||.|||+. ++ .++.+||+|
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEE
Confidence 999999999999 7899999999764 4689999999999999999999865 33 567899999
Q ss_pred ccCccccCCCcceeecccccccCCCCcccccCCCCC-CcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHH
Q 047892 289 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN-ETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKT 367 (442)
Q Consensus 289 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 367 (442)
||+++...... .....||..|+|||++.+..+. .++|||||||++|||++|+.||.... .
T Consensus 184 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~---- 244 (312)
T 2iwi_A 184 FGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------E---- 244 (312)
T ss_dssp CSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------H----
T ss_pred cchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------H----
Confidence 99998765432 2345789999999999777764 58999999999999999999995310 0
Q ss_pred HhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 368 MVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
... ... ..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~-~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 ILE-AEL----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHH-TCC----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred Hhh-hcc----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 000 1112234567889999999999999999999973
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=293.08 Aligned_cols=238 Identities=21% Similarity=0.361 Sum_probs=186.0
Q ss_pred hHHHhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcch------hhHHHHHHHHHHHHhcC--CCCcceEEEE
Q 047892 152 ELEVSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRG------QAEKEFKVEVEAIGRVR--HKNLVRLVGY 222 (442)
Q Consensus 152 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--hpnIv~l~~~ 222 (442)
+.+...++|++.+.||+|+||.||+|.. .+++.||||.+..... .....+.+|+.++++++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3344567799999999999999999995 4588999999854321 12244677999999996 5999999999
Q ss_pred EEeCCeeeeEEecCCC-CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------C-CCCCeEEe
Q 047892 223 CAEGAHRMLVNEYVDN-GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------E-PKWNPKLS 287 (442)
Q Consensus 223 ~~~~~~~~lv~E~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~-~~~~~kl~ 287 (442)
+...+..++||||+.+ ++|.+++... ..+++..++.++.|++.||.|||+. + + .++.+||+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence 9999999999999986 8999999764 4689999999999999999999875 3 3 46789999
Q ss_pred cccCccccCCCcceeecccccccCCCCcccccCCCC-CCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHH
Q 047892 288 DFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML-NETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLK 366 (442)
Q Consensus 288 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 366 (442)
|||+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .
T Consensus 193 Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~--- 254 (320)
T 3a99_A 193 DFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------E--- 254 (320)
T ss_dssp CCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------H---
T ss_pred eCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------h---
Confidence 999998765332 234579999999999987775 678999999999999999999995311 0
Q ss_pred HHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH--HhcCC
Q 047892 367 TMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM--LEAEE 423 (442)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 423 (442)
.... .. ... ...+..+.+|+.+||+.||++|||+.|+++. ++...
T Consensus 255 -~~~~-~~------~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 255 -IIRG-QV------FFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp -HHHC-CC------CCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred -hhcc-cc------ccc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 0000 00 011 1223567889999999999999999999974 55443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=279.56 Aligned_cols=240 Identities=21% Similarity=0.326 Sum_probs=164.9
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcch-hh-HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRG-QA-EKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
...++|++.+.||+|+||.||+|... +++.||||.+..... .. .+.+..+..+++.++||||+++++++.+.+..|+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 34567889999999999999999975 689999999965432 22 2334455567888899999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc--C------------CCCCCCeEEecccCccccCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE--G------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~--~------------l~~~~~~kl~DFGla~~~~~ 297 (442)
||||+ ++.+..+.... ...+++..+..++.|++.||.|||+ . ++.++.+||+|||++.....
T Consensus 102 v~e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EECCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99999 45666665432 2468999999999999999999996 2 34568999999999976543
Q ss_pred CcceeecccccccCCCCccccc-----CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC
Q 047892 298 ERSYVTTRVMGTFGYVAPEYAS-----TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (442)
.. ......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ...........
T Consensus 178 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---------~~~~~~~~~~~ 246 (318)
T 2dyl_A 178 DK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD---------FEVLTKVLQEE 246 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH---------HHHHHHHHHSC
T ss_pred Cc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---------HHHHHHHhccC
Confidence 22 223457899999999984 456889999999999999999999999643211 11111121111
Q ss_pred CcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
. +.+. .....+..+.+++.+||+.||.+|||+.++++
T Consensus 247 ~------~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 P------PLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp C------CCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C------CCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 0011 01123356788999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=296.18 Aligned_cols=236 Identities=25% Similarity=0.313 Sum_probs=171.2
Q ss_pred hCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeeeEEec
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
..+|...+.||+|+||.||.....+++.||||++..... ..+.+|+++|+.+ +|||||++++++.+....|+||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 345788899999999997655556789999999854322 2356799999999 899999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCCC------------CCeEEecccCccccCC
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEPK------------WNPKLSDFGLAKLLGA 297 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~~------------~~~kl~DFGla~~~~~ 297 (442)
|.+ +|.+++.... .......++.++.|++.||.|||+. ++++ ..+||+|||+++.+..
T Consensus 100 ~~g-~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 100 CAA-TLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp CSE-EHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred CCC-CHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 975 9999997652 2233445678999999999999865 4443 2477999999987643
Q ss_pred Ccc--eeecccccccCCCCccccc---CCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhc
Q 047892 298 ERS--YVTTRVMGTFGYVAPEYAS---TGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTN 371 (442)
Q Consensus 298 ~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (442)
... ......+||+.|+|||++. ...++.++|||||||++|||++ |..||...... ........
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-----------~~~~~~~~ 244 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-----------QANILLGA 244 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-----------HHHHHTTC
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-----------HHHHHhcc
Confidence 321 2234567999999999997 4567889999999999999999 99999542210 01111111
Q ss_pred CCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 372 GNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
... . ...........+.+|+.+||+.||.+|||+.|+++
T Consensus 245 ~~~-----~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 CSL-----D--CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCC-----T--TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCc-----c--ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 100 0 11122344566788999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=306.85 Aligned_cols=254 Identities=22% Similarity=0.300 Sum_probs=182.3
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEe------CCee
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE------GAHR 229 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------~~~~ 229 (442)
++|++.+.||+|+||.||+|.. .+++.||||.+... .....+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6799999999999999999996 45899999998654 34456678999999999999999999998765 6778
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCCC-------C---CeEEecccCcc
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEPK-------W---NPKLSDFGLAK 293 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~~-------~---~~kl~DFGla~ 293 (442)
|+|||||++|+|.+++.... ....+++..++.++.|++.||.|||+. ++++ + .+||+|||+++
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 99999999999999997642 223588889999999999999999875 4443 2 38999999998
Q ss_pred ccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC
Q 047892 294 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373 (442)
Q Consensus 294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (442)
...... ......||+.|+|||++.+..++.++|||||||++|||++|..||............... ...........
T Consensus 173 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~-~~~~~~~~~~~ 249 (676)
T 3qa8_A 173 ELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE-KSNEHIVVYDD 249 (676)
T ss_dssp BTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-------CCSCCC
T ss_pred cccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhc-ccchhhhhhhh
Confidence 764432 234467999999999999999999999999999999999999999653111000000000 00000000000
Q ss_pred cccc--cCc--ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHH
Q 047892 374 AEGV--LDP--RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHV 415 (442)
Q Consensus 374 ~~~~--~~~--~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ev 415 (442)
.... ... ..........+..+.+++.+||+.||++|||+.|+
T Consensus 250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 0000 000 11122334567789999999999999999999774
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-35 Score=307.76 Aligned_cols=228 Identities=21% Similarity=0.319 Sum_probs=179.0
Q ss_pred hhCCCCccCeeccCCcEEEEEEEEC--CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe----
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLE--DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAH---- 228 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~---- 228 (442)
..++|++.+.||+|+||.||+|.+. +++.||||.+... .......+.+|+.++++++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3478999999999999999999975 5889999998643 33455678899999999999999999999987655
Q ss_pred -eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC------CCCeEEecccCcccc
Q 047892 229 -RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP------KWNPKLSDFGLAKLL 295 (442)
Q Consensus 229 -~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~------~~~~kl~DFGla~~~ 295 (442)
.||||||+++++|.+++.. .+++..++.++.|++.||.|||+. +++ .+.+||+|||+++..
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSCEEECCCTTCEET
T ss_pred eeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCCcEEEEecccchhc
Confidence 6999999999999987753 589999999999999999999875 443 348999999999876
Q ss_pred CCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 296 GAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
... ....||+.|+|||++.+. ++.++|||||||++|||++|..||........
T Consensus 232 ~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------------------- 284 (681)
T 2pzi_A 232 NSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------------------- 284 (681)
T ss_dssp TCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------------------
T ss_pred ccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc---------------------
Confidence 432 345799999999998765 48899999999999999999988854211100
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCC-HHHHHHHHhcC
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPK-MGHVIHMLEAE 422 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-~~evl~~L~~~ 422 (442)
.........+..+.+|+.+||+.||++||+ ++++...|..+
T Consensus 285 ------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 ------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 011112233456888999999999999995 56666666543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=265.82 Aligned_cols=224 Identities=13% Similarity=0.093 Sum_probs=167.0
Q ss_pred hCCCCccCeeccCCcEEEEEEEECC-CCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 232 (442)
.++|++.+.||+|+||.||+|.... ++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 3568899999999999999999754 8999999996542 33446789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCCCCCeEEecccCccccCCCcceeeccc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEPKWNPKLSDFGLAKLLGAERSYVTTRV 306 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~~~~~kl~DFGla~~~~~~~~~~~~~~ 306 (442)
|||+++++|.+++++. .....+..++.|++.||.|||+. +++++ +.|.+.|..+
T Consensus 110 ~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~N-Ill~~~g~~k------------- 169 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSR-VRVSIDGDVV------------- 169 (286)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGG-EEEETTSCEE-------------
T ss_pred EEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHCCCccCCCCccc-EEEcCCCCEE-------------
Confidence 9999999999999542 34556888999999999999876 33322 2233333222
Q ss_pred ccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCC--
Q 047892 307 MGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQE-- 384 (442)
Q Consensus 307 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 384 (442)
.+++.|++| ++.++|||||||++|||++|+.||............ ...+......
T Consensus 170 l~~~~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~----------------~~~~~~~~~~~~ 226 (286)
T 3uqc_A 170 LAYPATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA----------------ERDTAGQPIEPA 226 (286)
T ss_dssp ECSCCCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC----------------CBCTTSCBCCHH
T ss_pred EEeccccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH----------------HHHhccCCCChh
Confidence 124456654 689999999999999999999999875443221000 0000000000
Q ss_pred CCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCC
Q 047892 385 KPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 424 (442)
Q Consensus 385 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 424 (442)
......+..+.+|+.+||+.||++| |+.|+++.|+.+..
T Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 0111234568889999999999999 99999999998653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-33 Score=264.26 Aligned_cols=215 Identities=18% Similarity=0.239 Sum_probs=161.9
Q ss_pred CCCCcc-CeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHH-HhcCCCCcceEEEEEEe----CCeee
Q 047892 158 NGFADE-NVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAI-GRVRHKNLVRLVGYCAE----GAHRM 230 (442)
Q Consensus 158 ~~~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~l~~~~~~----~~~~~ 230 (442)
++|.+. +.||+|+||.||+|.. .+++.||+|.+... ..+.+|+.++ +.++||||+++++++.. ....|
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 346666 7899999999999996 45889999998542 3466788887 56699999999999877 67889
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CC---CCCeEEecccCccc
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EP---KWNPKLSDFGLAKL 294 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~---~~~~kl~DFGla~~ 294 (442)
+||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. + +. ++.+||+|||++..
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 9999999999999998642 24689999999999999999999875 2 23 67899999999865
Q ss_pred cCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
.. +..++.++|||||||++|||++|..||......... ....
T Consensus 170 ~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~---------------~~~~ 211 (299)
T 3m2w_A 170 TT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---------------PGMK 211 (299)
T ss_dssp CT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------------------CCSC
T ss_pred cc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh---------------HHHH
Confidence 32 245778999999999999999999999654322110 0000
Q ss_pred ccccCcccCCCCc--HHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 375 EGVLDPRLQEKPS--SRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 375 ~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
............. ...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 212 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0111111110000 224567889999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=275.13 Aligned_cols=227 Identities=17% Similarity=0.166 Sum_probs=162.0
Q ss_pred CCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcch---hhHHHHHHHHHHHHhcCC-CCcc----------------
Q 047892 159 GFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRH-KNLV---------------- 217 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-pnIv---------------- 217 (442)
.|...+.||+|+||.||+|.+ .+++.||||++..... ...+.+.+|+.+++.++| +|..
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 466778999999999999995 4589999999863322 234678899999999987 2211
Q ss_pred -----eEEEEEEe-----CCeeeeEEecCCCCCHHHHHccC---CCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------
Q 047892 218 -----RLVGYCAE-----GAHRMLVNEYVDNGNLEQWLHGD---VGPHSPLTWEIRMNIILGTAKGLTYLHEG------- 277 (442)
Q Consensus 218 -----~l~~~~~~-----~~~~~lv~E~~~~g~L~~~l~~~---~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------- 277 (442)
.+..++.. ....+++|+++. ++|.++++.. ......+++..++.++.|++.||+|||+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp CCC---------------CCSEEEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred cCCCCccccccCCCccccccceEEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 11111111 123567777664 6999988411 11234678889999999999999999865
Q ss_pred ------CCCCCCeEEecccCccccCCCcceeecccccccCCCCcccc----------cCCCCCCcCCchhhHHHHHHHHh
Q 047892 278 ------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA----------STGMLNETSDVYSFGILIMEVIS 341 (442)
Q Consensus 278 ------l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwSlGvil~ellt 341 (442)
++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++|||++
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 445678999999999875332 345678 999999999 55568889999999999999999
Q ss_pred CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHH
Q 047892 342 GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVI 416 (442)
Q Consensus 342 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl 416 (442)
|+.||......... ...+... . ..+..+.+|+.+||+.||++|||+.+++
T Consensus 313 g~~Pf~~~~~~~~~-------------------~~~~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 313 ADLPNTDDAALGGS-------------------EWIFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp SSCCCCTTGGGSCS-------------------GGGGSSC--C----CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCCCCCCcchhhhH-------------------HHHHhhc--c----cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999754332211 1111100 0 1235688899999999999999977764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-33 Score=273.54 Aligned_cols=230 Identities=13% Similarity=0.107 Sum_probs=170.3
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcc--------hhhHHHHHHHHHHHHhcC---------CCCcc
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNR--------GQAEKEFKVEVEAIGRVR---------HKNLV 217 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------hpnIv 217 (442)
+..++|++.+.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.+++.++ ||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 3346688999999999999999998 68999999996432 223467888999998885 88888
Q ss_pred eEEEEEE------------------------------eCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHH
Q 047892 218 RLVGYCA------------------------------EGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 267 (442)
Q Consensus 218 ~l~~~~~------------------------------~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi 267 (442)
++.+++. ..+..|||||||++|++.+.+.+ ..+++..++.++.|+
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQL 170 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHH
Confidence 8877653 26789999999999977766643 357999999999999
Q ss_pred HHhhhhhh-cC------CCC-------CC--------------------CeEEecccCccccCCCcceeecccccccCCC
Q 047892 268 AKGLTYLH-EG------LEP-------KW--------------------NPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 313 (442)
Q Consensus 268 ~~~l~yLH-~~------l~~-------~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~ 313 (442)
+.||.||| +. +++ ++ .+||+|||+|+..... ..+||+.||
T Consensus 171 ~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~ 244 (336)
T 2vuw_A 171 TASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM 244 (336)
T ss_dssp HHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred HHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence 99999999 43 433 34 8999999999876432 347999999
Q ss_pred CcccccCCCCCCcCCchhhHHH-HHHHHhCCCCCCCCCCCCccchhhhHHHHHH-HHhhcCCcccccCcccCCCCcHHHH
Q 047892 314 APEYASTGMLNETSDVYSFGIL-IMEVISGRNPVDYSRPPGEFQFQVNLFEWLK-TMVTNGNAEGVLDPRLQEKPSSRAL 391 (442)
Q Consensus 314 aPE~~~~~~~~~~sDvwSlGvi-l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (442)
|||++.+.. +.++||||||++ .+++++|..||... ....... ........ ............+
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~----------~~~~~~~~~~~~~~~~----~~~~~~~~~~~~s 309 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV----------LWLHYLTDKMLKQMTF----KTKCNTPAMKQIK 309 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH----------HHHHHHHHHHHHTCCC----SSCCCSHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch----------hhhhHHHHhhhhhhcc----CcccchhhhhhcC
Confidence 999998666 889999998877 77888899998310 0001111 11111111 1111112234678
Q ss_pred HHHHHHHhhhhCCCCCCCCCHHHHH
Q 047892 392 KRALLVALRCVDPNAHKRPKMGHVI 416 (442)
Q Consensus 392 ~~~~~li~~cl~~dP~~RPs~~evl 416 (442)
.++.+|+.+||+.| |+.|++
T Consensus 310 ~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 310 RKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHHhccC-----CHHHHH
Confidence 88999999999976 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-25 Score=231.77 Aligned_cols=172 Identities=13% Similarity=0.042 Sum_probs=115.2
Q ss_pred eeccCCcEEEEEEE-ECCCCeEEEEEecCc----------chhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeeeE
Q 047892 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLLNN----------RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 165 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 232 (442)
..+.|++|.+..++ +-.|+.+++|.+... .....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777666655 335889999998543 122345699999999999 799999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCCCeEEecccCccccCCCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~~~kl~DFGla~~~~~~~ 299 (442)
|||++||+|.++|... .+++.. .|+.||+.||+|||++ | +.+|.+||+|||+|+......
T Consensus 321 MEyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 9999999999999865 456654 4889999999999865 4 457899999999998764432
Q ss_pred ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCC
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNP 345 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~P 345 (442)
....+.+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 394 -~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 -SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred -ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 23445789999999999865 567789999999998887665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.1e-22 Score=209.00 Aligned_cols=172 Identities=15% Similarity=0.174 Sum_probs=131.0
Q ss_pred ccCeeccCCcEEEEEEEECCCCeEEEEEecCcc---h-----hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 162 DENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNR---G-----QAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 162 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
..+.||+|+||.||+|.. .++.+++|+..... . ...+.+.+|++++++++||||+++..++...+..||||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 356899999999999954 57889999874321 1 12345889999999999999996655556777889999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCCCC-----CeEEecccCccccCCCccee
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEPKW-----NPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~~~-----~~kl~DFGla~~~~~~~~~~ 302 (442)
||+++|+|.++++. +..++.|++.||.|||+. ++++| .+||+|||+++.........
T Consensus 419 E~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 419 SYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDKDLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp ECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESSSEEECCCTTCEECCCHHHHH
T ss_pred ECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECCeEEEEECccCEECCCccccc
Confidence 99999999999864 457899999999999764 66544 78999999999875432211
Q ss_pred ------ecccccccCCCCcccccC--CCCCCcCCchhhHHHHHHHHhCCCCC
Q 047892 303 ------TTRVMGTFGYVAPEYAST--GMLNETSDVYSFGILIMEVISGRNPV 346 (442)
Q Consensus 303 ------~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~Pf 346 (442)
....+||+.|||||++.. ..|+..+|+||..+-..+.+.++.+|
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 235689999999999976 56888999999999998888877766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.5e-18 Score=163.64 Aligned_cols=152 Identities=16% Similarity=0.043 Sum_probs=112.5
Q ss_pred hHHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcch------------------hhHHHHHHHHHHHHhcCC
Q 047892 152 ELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRG------------------QAEKEFKVEVEAIGRVRH 213 (442)
Q Consensus 152 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h 213 (442)
.+......|.+.+.||+|+||.||+|.+.+|+.||+|.+..... .....+.+|+++|++++|
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~ 163 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 163 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence 34444556778899999999999999997799999999853221 134568899999999994
Q ss_pred CCcceEEEEEEeCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC------C
Q 047892 214 KNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP------K 281 (442)
Q Consensus 214 pnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~------~ 281 (442)
+++.+++.. +..|+||||+++|+|.+ +.. .....++.|++.||.|||+. +++ +
T Consensus 164 ---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~~ 228 (282)
T 1zar_A 164 ---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE 228 (282)
T ss_dssp ---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET
T ss_pred ---CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEEC
Confidence 555554433 56799999999999988 422 12346899999999999765 444 6
Q ss_pred CCeEEecccCccccCCCcceeecccccccCCCCcccccC----------CCCCCcCCchhh
Q 047892 282 WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST----------GMLNETSDVYSF 332 (442)
Q Consensus 282 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~sDvwSl 332 (442)
+.+||+|||+++. +..++|||.+.. ..|+..+|+|.+
T Consensus 229 ~~vkl~DFG~a~~--------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 229 EGIWIIDFPQSVE--------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp TEEEECCCTTCEE--------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred CcEEEEECCCCeE--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 7899999999864 345789998753 345666676643
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=1.1e-13 Score=128.46 Aligned_cols=125 Identities=19% Similarity=0.114 Sum_probs=91.9
Q ss_pred CCccCeeccCCcEEEEEEEE-CCCCe--EEEEEecCcch------------------------hhHHHHHHHHHHHHhcC
Q 047892 160 FADENVIGEGGYGIVYRGVL-EDNTN--VAVKNLLNNRG------------------------QAEKEFKVEVEAIGRVR 212 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l~ 212 (442)
|.+.+.||+|+||.||+|.. .+|+. ||||.+..... .....+.+|+.+|..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56788999999999999997 67888 99998743211 11235788999999998
Q ss_pred CCCc--ceEEEEEEeCCeeeeEEecCCC-C----CHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhh-cC------C
Q 047892 213 HKNL--VRLVGYCAEGAHRMLVNEYVDN-G----NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-EG------L 278 (442)
Q Consensus 213 hpnI--v~l~~~~~~~~~~~lv~E~~~~-g----~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH-~~------l 278 (442)
|+|| ..++++ +..+|||||+.+ | +|.++... .++..+..++.|++.||.||| +. +
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~givHrDl 197 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAELVHADL 197 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSCEECSSC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 8764 444442 356899999943 4 77776532 123456789999999999999 54 4
Q ss_pred CCCC-----CeEEecccCcccc
Q 047892 279 EPKW-----NPKLSDFGLAKLL 295 (442)
Q Consensus 279 ~~~~-----~~kl~DFGla~~~ 295 (442)
+|.+ .++|+|||+|...
T Consensus 198 kp~NILl~~~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYIDKVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESSSEEECCCTTCEET
T ss_pred CHHHEEEcCcEEEEECcccccC
Confidence 4433 7899999999765
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.00 E-value=4.8e-10 Score=108.85 Aligned_cols=127 Identities=11% Similarity=-0.014 Sum_probs=84.9
Q ss_pred hCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcch--------------hhH--------HHHHHHHHHHHhcCCC
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRG--------------QAE--------KEFKVEVEAIGRVRHK 214 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~--------~~~~~E~~~l~~l~hp 214 (442)
..-|.+...||+|+||.||+|...+|+.||||+++.... ... ....+|...|.++.+.
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 334899999999999999999988899999998742100 000 1123577777777555
Q ss_pred CcceEEEEEEeCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCCCC------
Q 047892 215 NLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEPKW------ 282 (442)
Q Consensus 215 nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~~~------ 282 (442)
++....-+... ..+|||||++|++|.++... .....++.|++.+|.|||+. +++.|
T Consensus 174 gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 174 GFPVPEPIAQS--RHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE 241 (397)
T ss_dssp TCSCCCEEEEE--TTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE
T ss_pred CCCCCeeeecc--CceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC
Confidence 44322112122 24799999999988765321 12346788999999998654 55543
Q ss_pred -----------CeEEecccCcccc
Q 047892 283 -----------NPKLSDFGLAKLL 295 (442)
Q Consensus 283 -----------~~kl~DFGla~~~ 295 (442)
.+.|+||+-+...
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCcccccccccceEEEEeCCcccC
Confidence 2679999877654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=1.2e-06 Score=80.76 Aligned_cols=111 Identities=13% Similarity=0.016 Sum_probs=86.6
Q ss_pred hhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeeeEEe
Q 047892 156 STNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 156 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E 234 (442)
..++|++...++.|+.+.||++... ++.+++|............+.+|+++++.+. |..+.++++++.+.+..|+|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3456888888899999999999854 6889999885422122345888999999884 6788899999998899999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~ 276 (442)
|++|.+|.+.+.. ......++.+++.+|..||+
T Consensus 91 ~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~ 123 (263)
T 3tm0_A 91 EADGVLCSEEYED---------EQSPEKIIELYAECIRLFHS 123 (263)
T ss_dssp CCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHH
T ss_pred ecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhC
Confidence 9999999876321 11234678899999999997
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.82 E-value=2.7e-05 Score=71.09 Aligned_cols=103 Identities=16% Similarity=0.090 Sum_probs=74.7
Q ss_pred CCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCC--cceEEEEEEeCCeeeeEEecCC
Q 047892 160 FADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN--LVRLVGYCAEGAHRMLVNEYVD 237 (442)
Q Consensus 160 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~~~~~lv~E~~~ 237 (442)
+.+....+.|..+.||++...+|..+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++||||++
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred CceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 4443333456679999998767788999987543 2245778999998885544 5678998888888999999999
Q ss_pred CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC
Q 047892 238 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277 (442)
Q Consensus 238 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 277 (442)
|.+|. ... .. ...++.+++..|..||+.
T Consensus 99 G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~ 126 (264)
T 1nd4_A 99 GQDLL--SSH-------LA---PAEKVSIMADAMRRLHTL 126 (264)
T ss_dssp SEETT--TSC-------CC---HHHHHHHHHHHHHHHTTS
T ss_pred CcccC--cCc-------CC---HhHHHHHHHHHHHHHhCC
Confidence 98884 211 11 236778889999999974
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.0001 Score=71.08 Aligned_cols=110 Identities=9% Similarity=0.115 Sum_probs=80.0
Q ss_pred CccCeeccCCcEEEEEEEECCCCeEEEEEec--Ccc-hhhHHHHHHHHHHHHhcC--CCCcceEEEEEEeC---CeeeeE
Q 047892 161 ADENVIGEGGYGIVYRGVLEDNTNVAVKNLL--NNR-GQAEKEFKVEVEAIGRVR--HKNLVRLVGYCAEG---AHRMLV 232 (442)
Q Consensus 161 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~---~~~~lv 232 (442)
...+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.|. +..+.+++.++.+. +..|+|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 34567899999999999875 4678888765 221 122346788999999987 45688999988776 457999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 277 (442)
|||++|..+.+.. ...++......++.+++..|..||..
T Consensus 120 me~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~ 158 (359)
T 3dxp_A 120 MEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTV 158 (359)
T ss_dssp EECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHS
T ss_pred EEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCC
Confidence 9999997774311 12467788889999999999999974
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0081 Score=56.27 Aligned_cols=103 Identities=15% Similarity=0.028 Sum_probs=77.7
Q ss_pred cCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCC---CcceEEEEEE-eCCeeeeEEecCCC
Q 047892 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK---NLVRLVGYCA-EGAHRMLVNEYVDN 238 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~l~~~~~-~~~~~~lv~E~~~~ 238 (442)
.+.++.|....||+. +..+++|.-. .......+.+|.++|..|.+. .+.+++.+.. ..+..|+||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888999999987 5678888752 233456788999999999653 3566677664 44567899999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 277 (442)
.+|.+..- ..++......++.+++..|.-||+.
T Consensus 98 ~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~ 130 (306)
T 3tdw_A 98 QILGEDGM------AVLPDDAKDRLALQLAEFMNELSAF 130 (306)
T ss_dssp EECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHS
T ss_pred eECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcC
Confidence 88876432 2356778888999999999999974
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0065 Score=53.40 Aligned_cols=93 Identities=19% Similarity=0.130 Sum_probs=53.7
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhh------hcCCCCCCCeEEecccCccccCCCcceeecccccccCC
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL------HEGLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 312 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yL------H~~l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y 312 (442)
-+|.+.|+.. ..++++.+++.++.|.+.+|.-+ |..+..-..+.|.--|...+..... ......+
T Consensus 33 vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~~~s------~~~~~~~ 103 (229)
T 2yle_A 33 LSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAPAAD------DAGEPPP 103 (229)
T ss_dssp EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECCC---------------
T ss_pred ccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceecccccc------cccccCC
Confidence 3788888764 47899999999999999988765 2222222233333333322221110 0123346
Q ss_pred CCcccccCCCCCCcCCchhhHHHHHHHHh
Q 047892 313 VAPEYASTGMLNETSDVYSFGILIMEVIS 341 (442)
Q Consensus 313 ~aPE~~~~~~~~~~sDvwSlGvil~ellt 341 (442)
.|||... ...+.+.=|||||+++|.-+-
T Consensus 104 ~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 104 VAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred CChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 7888763 344577889999999999886
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=96.41 E-value=0.018 Score=52.42 Aligned_cols=101 Identities=16% Similarity=0.083 Sum_probs=72.9
Q ss_pred eccCCcE-EEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeeeEEecCCCCCHH
Q 047892 166 IGEGGYG-IVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLVGYCAEGAHRMLVNEYVDNGNLE 242 (442)
Q Consensus 166 lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~~g~L~ 242 (442)
+..|..| .||+.... ++..+++|.-.. .....+.+|...|+.|. +--+.++++++.+.+..|+|||+++|.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 4445444 68987754 466788997632 33456788999998874 334678899999999999999999999888
Q ss_pred HHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC
Q 047892 243 QWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277 (442)
Q Consensus 243 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 277 (442)
+..... ......++.+++..|.-||..
T Consensus 109 ~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~ 135 (272)
T 4gkh_A 109 QVLEEY--------PDSGENIVDALAVFLRRLHSI 135 (272)
T ss_dssp HHHHHC--------GGGHHHHHHHHHHHHHHHHTS
T ss_pred ccccCC--------HHHHHHHHHHHHHHHHHhcCC
Confidence 765432 122345778888999999963
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=96.32 E-value=0.0073 Score=56.37 Aligned_cols=102 Identities=17% Similarity=0.106 Sum_probs=73.6
Q ss_pred cCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcC-CCC--cceEEEEEEeCC---eeeeEEecC
Q 047892 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKN--LVRLVGYCAEGA---HRMLVNEYV 236 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpn--Iv~l~~~~~~~~---~~~lv~E~~ 236 (442)
.+.++.|....||+.. ..+++|..... .....+.+|.++|+.+. +.. +.+++......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 56888876432 34567889999998883 333 445555443333 348999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~ 276 (442)
+|.+|.+... ..++......++.+++..|..||+
T Consensus 99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~ 132 (304)
T 3sg8_A 99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHS 132 (304)
T ss_dssp CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHc
Confidence 9988865432 236777888999999999999996
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.11 E-value=0.023 Score=53.35 Aligned_cols=95 Identities=15% Similarity=0.124 Sum_probs=72.3
Q ss_pred CccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcC---CCCcceEEEEEEeCCeeeeEEecCC
Q 047892 161 ADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR---HKNLVRLVGYCAEGAHRMLVNEYVD 237 (442)
Q Consensus 161 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~E~~~ 237 (442)
...+.|+.|....+|+... ++..+++|.... .....+..|.+.|+.|. ...+.+++.+....+..|+||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3456789999999999886 467888897643 23566888999888873 3668889998888888999999999
Q ss_pred CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC
Q 047892 238 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277 (442)
Q Consensus 238 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 277 (442)
+..+. . ..+.++...|+-||..
T Consensus 115 G~~~~-----------~-------~~~~~lG~~LA~LH~~ 136 (312)
T 3jr1_A 115 KSKNK-----------Q-------SSFTIFAEKIAQLHQI 136 (312)
T ss_dssp CCCCC-----------T-------THHHHHHHHHHHHHHC
T ss_pred CCCCC-----------c-------hhHHHHHHHHHHHHcC
Confidence 86531 0 2456777888999975
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.39 E-value=0.0099 Score=37.50 Aligned_cols=27 Identities=15% Similarity=0.283 Sum_probs=10.9
Q ss_pred HHHHHHHHHHHHHHHHHHHhhheeeee
Q 047892 17 VVLGICVGAGIVLVLFLISLWFTSKRN 43 (442)
Q Consensus 17 ~~i~i~~~~~~~~~~~~~~~~~~~~~~ 43 (442)
+..|++.|+.++++++++.+++.|||+
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr 38 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKS 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhh
Confidence 333444334443444444344444433
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=95.23 E-value=0.015 Score=55.58 Aligned_cols=115 Identities=12% Similarity=0.007 Sum_probs=76.2
Q ss_pred cCee-ccCCcEEEEEEEEC-------CCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcC-C--CCcceEEEEEEeC--
Q 047892 163 ENVI-GEGGYGIVYRGVLE-------DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVR-H--KNLVRLVGYCAEG-- 226 (442)
Q Consensus 163 ~~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--pnIv~l~~~~~~~-- 226 (442)
.+.| +.|....+|+.... ++..+++|...... ......+.+|+.+++.|. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999998754 25678888764322 001235677888888774 2 3577888887655
Q ss_pred -CeeeeEEecCCCCCHHHHHccCC--CCCCCCCHHHHHHHHHHHHHhhhhhhcC
Q 047892 227 -AHRMLVNEYVDNGNLEQWLHGDV--GPHSPLTWEIRMNIILGTAKGLTYLHEG 277 (442)
Q Consensus 227 -~~~~lv~E~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 277 (442)
+..|+||||++|..+.+.+.... .....++......++.+++..|.-||+.
T Consensus 105 ~g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~ 158 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSI 158 (357)
T ss_dssp TSSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTC
T ss_pred cCCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCC
Confidence 35689999999977654321000 0001355666677889999999999974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=95.17 E-value=0.026 Score=52.15 Aligned_cols=78 Identities=23% Similarity=0.279 Sum_probs=56.8
Q ss_pred CCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCC---CCcceEEEEEEeCCeeeeEEec
Q 047892 159 GFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH---KNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pnIv~l~~~~~~~~~~~lv~E~ 235 (442)
.....+.+|.|..+.||+.+..+|+.|.+|+-..........|..|...|+.|.- --+.+++++. .-++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 3455678999999999999999999999998754443334567889999988842 2345555542 34789999
Q ss_pred CCCCC
Q 047892 236 VDNGN 240 (442)
Q Consensus 236 ~~~g~ 240 (442)
++++.
T Consensus 92 l~~~~ 96 (288)
T 3f7w_A 92 VDERP 96 (288)
T ss_dssp CCCCC
T ss_pred ecccC
Confidence 98743
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.02 E-value=0.0082 Score=37.96 Aligned_cols=25 Identities=24% Similarity=0.231 Sum_probs=10.1
Q ss_pred HHHHHHHHHHHHHHHHHHhhheeee
Q 047892 18 VLGICVGAGIVLVLFLISLWFTSKR 42 (442)
Q Consensus 18 ~i~i~~~~~~~~~~~~~~~~~~~~~ 42 (442)
++|++.|++++++++++.+++.|||
T Consensus 14 A~gVVgGv~~~~ii~~~~~~~~RRr 38 (44)
T 2ks1_B 14 ATGMVGALLLLLVVALGIGLFMRRR 38 (44)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EeehhHHHHHHHHHHHHHHHHhhhh
Confidence 3444444434334444433443333
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=94.93 E-value=0.058 Score=52.24 Aligned_cols=75 Identities=15% Similarity=0.130 Sum_probs=49.7
Q ss_pred cCeeccCCcEEEEEEEEC-CCCeEEEEEecCcch-------hhHHHHHHHHHHHHhcCC--C-CcceEEEEEEeCCeeee
Q 047892 163 ENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRG-------QAEKEFKVEVEAIGRVRH--K-NLVRLVGYCAEGAHRML 231 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--p-nIv~l~~~~~~~~~~~l 231 (442)
.+.||.|.++.||++... +++.++||....... .....+..|.++|+.+.. | .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 567999999999999753 467899997643211 122346778888887732 3 34466654 4455689
Q ss_pred EEecCCCC
Q 047892 232 VNEYVDNG 239 (442)
Q Consensus 232 v~E~~~~g 239 (442)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=94.86 E-value=0.018 Score=36.25 Aligned_cols=12 Identities=17% Similarity=0.241 Sum_probs=5.9
Q ss_pred HHHHHHHHHHHH
Q 047892 16 WVVLGICVGAGI 27 (442)
Q Consensus 16 ~~~i~i~~~~~~ 27 (442)
..++++++|+.+
T Consensus 12 ~~Ia~~vVGvll 23 (44)
T 2jwa_A 12 TSIISAVVGILL 23 (44)
T ss_dssp HHHHHHHHHHHH
T ss_pred cchHHHHHHHHH
Confidence 344555556333
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=94.79 E-value=0.027 Score=34.48 Aligned_cols=16 Identities=19% Similarity=0.237 Sum_probs=10.6
Q ss_pred chhHHHHHHHHHHHHH
Q 047892 12 GLRIWVVLGICVGAGI 27 (442)
Q Consensus 12 ~~~~~~~i~i~~~~~~ 27 (442)
+++-..++|+++|.++
T Consensus 7 ~ls~GaIAGiVvG~v~ 22 (38)
T 2k1k_A 7 GLTGGEIVAVIFGLLL 22 (38)
T ss_dssp TCCHHHHHHHHHHHHH
T ss_pred CCCCCceeeeehHHHH
Confidence 4556677787777544
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.41 E-value=0.063 Score=33.53 Aligned_cols=25 Identities=28% Similarity=0.460 Sum_probs=10.0
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhhee
Q 047892 16 WVVLGICVGAGIVLVLFLISLWFTS 40 (442)
Q Consensus 16 ~~~i~i~~~~~~~~~~~~~~~~~~~ 40 (442)
++++++++|+++++++++++++++|
T Consensus 14 ~I~~~vv~Gv~ll~~iv~~~~~~~r 38 (41)
T 2k9y_A 14 AVIGGVAVGVVLLLVLAGVGFFIHR 38 (41)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHSSSS
T ss_pred EEEeehhHHHHHHHHHHHHheeEee
Confidence 3444444444333323333344443
|
| >2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.05 E-value=0.19 Score=33.12 Aligned_cols=28 Identities=25% Similarity=0.654 Sum_probs=19.7
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHHhhhe
Q 047892 12 GLRIWVVLGICVGAGIVLVLFLISLWFT 39 (442)
Q Consensus 12 ~~~~~~~i~i~~~~~~~~~~~~~~~~~~ 39 (442)
+..+|++++.++++.++++++++++|.+
T Consensus 9 ~vp~wiIi~svl~GLllL~li~~~LwK~ 36 (54)
T 2knc_A 9 AIPIWWVLVGVLGGLLLLTILVLAMWKV 36 (54)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcchHHHHHHHHHHHHHHHHHHHHHHHc
Confidence 4668888888777776666666666643
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.87 E-value=0.11 Score=34.08 Aligned_cols=27 Identities=26% Similarity=0.694 Sum_probs=19.3
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHHhhh
Q 047892 12 GLRIWVVLGICVGAGIVLVLFLISLWF 38 (442)
Q Consensus 12 ~~~~~~~i~i~~~~~~~~~~~~~~~~~ 38 (442)
+..+|++++.++|+.++++++++++|.
T Consensus 6 ~vp~WiIi~svl~GLLLL~Lii~~LwK 32 (54)
T 2l8s_A 6 RVPLWVILLSAFAGLLLLMLLILALWK 32 (54)
T ss_dssp CCCTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cCchHHHHHHHHHHHHHHHHHHHHHHH
Confidence 456888888877777666666666664
|
| >2k1a_A Integrin alpha-IIB; single-PASS transmembrane segment, alternative splicing, calcium, cell adhesion, cleavage on PAIR of basic residues; NMR {Homo sapiens} PDB: 2k9j_A | Back alignment and structure |
|---|
Probab=91.47 E-value=0.21 Score=31.12 Aligned_cols=27 Identities=26% Similarity=0.678 Sum_probs=19.0
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHHhhh
Q 047892 12 GLRIWVVLGICVGAGIVLVLFLISLWF 38 (442)
Q Consensus 12 ~~~~~~~i~i~~~~~~~~~~~~~~~~~ 38 (442)
+...|++++.++++.+++++++.++|.
T Consensus 7 ~vp~wiIi~s~l~GLllL~li~~~LwK 33 (42)
T 2k1a_A 7 AIPIWWVLVGVLGGLLLLTILVLAMWK 33 (42)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcchHHHHHHHHHHHHHHHHHHHHHHH
Confidence 466888888777776666666666663
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=88.32 E-value=0.051 Score=53.96 Aligned_cols=62 Identities=6% Similarity=0.004 Sum_probs=18.9
Q ss_pred CccCeeccCCcEEEEEEEECC-CCeEEE------EEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 047892 161 ADENVIGEGGYGIVYRGVLED-NTNVAV------KNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE 225 (442)
Q Consensus 161 ~~~~~lG~G~~g~Vy~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 225 (442)
.+.+.|| ||.||+|.+.. ..+||| |...... ......+.+|..++..++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 4456676 99999999754 467888 7664322 2223457889999999999999999887643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=87.20 E-value=1.5 Score=40.84 Aligned_cols=94 Identities=18% Similarity=0.262 Sum_probs=53.3
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhc-----CCCCcceEE-E--EEEeCCeeeeEEec
Q 047892 164 NVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-----RHKNLVRLV-G--YCAEGAHRMLVNEY 235 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~-~--~~~~~~~~~lv~E~ 235 (442)
+.|+.|..+.||++...++ .+++|..... ...+..|..++..| ..|.++... | +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999987554 5889988542 12333455555444 234444310 0 12346678999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 277 (442)
++|.++.. .+. ..+.+++..|+-||..
T Consensus 113 i~G~~~~~-----------~~~----~~~~~~g~~La~lH~~ 139 (346)
T 2q83_A 113 IEGRPFEL-----------TVK----QDLEFIMKGLADFHTA 139 (346)
T ss_dssp CCCBCCCT-----------TSH----HHHHHHHHHHHHHHHH
T ss_pred ecCccCCC-----------CCH----HHHHHHHHHHHHHHHh
Confidence 99865420 111 2346677788888864
|
| >2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B | Back alignment and structure |
|---|
Probab=86.63 E-value=0.56 Score=27.52 Aligned_cols=27 Identities=30% Similarity=0.509 Sum_probs=15.6
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHhhhe
Q 047892 13 LRIWVVLGICVGAGIVLVLFLISLWFT 39 (442)
Q Consensus 13 ~~~~~~i~i~~~~~~~~~~~~~~~~~~ 39 (442)
++.+.++||++|-++..+++++..|++
T Consensus 4 L~~gaIaGIVvgdi~~t~~i~~~vy~~ 30 (33)
T 2l34_A 4 VSPGVLAGIVVGDLVLTVLIALAVYFL 30 (33)
T ss_dssp CCTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cCcceEEeEeHHHHHHHHHHHHHHhhe
Confidence 445677888888555444444444443
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=86.15 E-value=1.1 Score=43.74 Aligned_cols=97 Identities=15% Similarity=0.188 Sum_probs=62.6
Q ss_pred cCeeccCCcEEEEEEEECC--------CCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCC-cceEEEEEEeCCeeeeEE
Q 047892 163 ENVIGEGGYGIVYRGVLED--------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN-LVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~ 233 (442)
.+.|+.|....||++...+ +..+++|+..... ....+.+|..++..|...+ ..++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4568888889999998753 4788898773311 1134557888888874333 3567776542 3899
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 277 (442)
||++|.+|... .+. ...++.+++..|+-||..
T Consensus 152 e~l~G~~l~~~---------~l~---~~~~~~~ia~~La~LH~~ 183 (429)
T 1nw1_A 152 EYIPSRPLSCH---------EIS---LAHMSTKIAKRVAKVHQL 183 (429)
T ss_dssp CCCCEEECCTT---------GGG---SHHHHHHHHHHHHHHTTC
T ss_pred EEeCCcccChh---------hcC---CHHHHHHHHHHHHHHhCC
Confidence 99987444210 110 123567788888999973
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=84.79 E-value=1.2 Score=42.69 Aligned_cols=98 Identities=14% Similarity=0.098 Sum_probs=57.8
Q ss_pred cCeeccCCcEEEEEEEEC--------CCCeEEEEEecCcchhhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeeeeEE
Q 047892 163 ENVIGEGGYGIVYRGVLE--------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~ 233 (442)
.+.|..|-...+|++... +++.+++|+.-. .......+.+|..+++.|. +.-..++++++.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 346777888889999864 246788887522 1123345668999888773 3333567766543 2999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 277 (442)
||++|.+|..- .+.. -.+..+++..|+-||..
T Consensus 130 e~i~G~~l~~~---------~l~~---p~~~~~ia~~La~LH~~ 161 (379)
T 3feg_A 130 QYIPSRPLKTQ---------ELRE---PVLSAAIATKMAQFHGM 161 (379)
T ss_dssp ECCSEEECCGG---------GGGC---HHHHHHHHHHHHHHHTC
T ss_pred EEecCccCChh---------HhCC---HHHHHHHHHHHHHHhCC
Confidence 99998554311 1110 23556778888889974
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=83.48 E-value=2.1 Score=39.83 Aligned_cols=101 Identities=12% Similarity=0.103 Sum_probs=55.9
Q ss_pred CeeccCCcEE-EEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCC--CCcceEEEEEEeCCeeeeEEecCCCCC
Q 047892 164 NVIGEGGYGI-VYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH--KNLVRLVGYCAEGAHRMLVNEYVDNGN 240 (442)
Q Consensus 164 ~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~lv~E~~~~g~ 240 (442)
+.|+.|.... +|+....++..+++|....... ..+..|+.++..+.. -.+.+++.+..+.+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4565554444 6677654467777776533210 233456666666532 23556676643333 78999998888
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC
Q 047892 241 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277 (442)
Q Consensus 241 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 277 (442)
+.+++... .... ...+.+++..|.-||..
T Consensus 99 l~~~l~~~-----~~~~---~~~~~~~~~~La~lH~~ 127 (333)
T 3csv_A 99 FTEVINND-----PAQE---MPLYRAAVDLLIHLHDA 127 (333)
T ss_dssp HHHHHHHC-----GGGH---HHHHHHHHHHHHHHHTS
T ss_pred hHHHhcCC-----CccH---HHHHHHHHHHHHHHhcC
Confidence 88887542 1111 34566777888888864
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=82.23 E-value=3.4 Score=40.01 Aligned_cols=81 Identities=12% Similarity=0.151 Sum_probs=48.8
Q ss_pred ccCeeccCCcEEEEEEEECCCCeEEEEEecCc-----ch----hhHHHHHHHHHHHH-hcCCCCcceEEEEEEeCCeeee
Q 047892 162 DENVIGEGGYGIVYRGVLEDNTNVAVKNLLNN-----RG----QAEKEFKVEVEAIG-RVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 162 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-----~~----~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~~~~l 231 (442)
..+.||.|..+.||++.. +++.++||..... .. .....+..|+..+. ......+.+++.+. .+..++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 356789999999999964 4678999943211 10 12223333433222 22334567777665 566799
Q ss_pred EEecC-CC-CCHHHHH
Q 047892 232 VNEYV-DN-GNLEQWL 245 (442)
Q Consensus 232 v~E~~-~~-g~L~~~l 245 (442)
||||+ ++ -.+.+.+
T Consensus 115 v~e~l~~g~~~l~~~l 130 (420)
T 2pyw_A 115 GMRYLEPPHIILRKGL 130 (420)
T ss_dssp EECCCCTTCEEHHHHH
T ss_pred EEeecCCcchhHHHHH
Confidence 99999 77 3444443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.01 E-value=1.5 Score=27.52 Aligned_cols=31 Identities=19% Similarity=0.022 Sum_probs=18.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhhheeeeecc
Q 047892 15 IWVVLGICVGAGIVLVLFLISLWFTSKRNSN 45 (442)
Q Consensus 15 ~~~~i~i~~~~~~~~~~~~~~~~~~~~~~~~ 45 (442)
..-++|.+++++++++++++++=.+++++++
T Consensus 13 A~gVVgGv~~v~ii~~~~~~~~RRRr~~~kr 43 (44)
T 2l2t_A 13 AAGVIGGLFILVIVGLTFAVYVRRKSIKKKR 43 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHTTCSSCCC
T ss_pred EEeehHHHHHHHHHHHHHHHHhhhhhhhhcc
Confidence 3334444445555667777777777776654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=81.45 E-value=2 Score=42.33 Aligned_cols=98 Identities=14% Similarity=0.113 Sum_probs=60.9
Q ss_pred cCeeccCCcEEEEEEEECC-CCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeeeeEEecCCCCC
Q 047892 163 ENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL-VRLVGYCAEGAHRMLVNEYVDNGN 240 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~~g~ 240 (442)
.+.|+.|-...+|++...+ +..+++|......... -...+|..++..|...++ .++++++. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4568888889999998765 4678888763321111 112478888888865444 56777763 2 25999999854
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC
Q 047892 241 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277 (442)
Q Consensus 241 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 277 (442)
|.. ..+. ...++.+++..|+-||..
T Consensus 188 l~~---------~~l~---~~~~~~~ia~~La~LH~~ 212 (458)
T 2qg7_A 188 LSR---------EDIK---NPKFQKLIAKNLKLLHDI 212 (458)
T ss_dssp CCT---------TTTT---SHHHHHHHHHHHHHHHTC
T ss_pred CCh---------hhcC---CHHHHHHHHHHHHHHhcC
Confidence 421 0111 124567788889999964
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 442 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-57 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-52 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-51 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-49 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-48 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-47 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-43 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-43 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-41 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-40 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-36 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-36 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-35 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-33 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-31 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-31 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-31 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-30 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-30 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-28 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-28 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-27 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-25 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-25 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-22 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-22 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-21 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-20 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-20 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-16 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-13 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 3e-57
Identities = 67/288 (23%), Positives = 116/288 (40%), Gaps = 40/288 (13%)
Query: 152 ELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 211
+ E+ IG G +G VY+G + V + N+ Q + FK EV + +
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 212 RHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 271
RH N++ +GY +V ++ + +L LH + ++I TA+G+
Sbjct: 62 RHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGM 117
Query: 272 TYLHEG-------------LEPKWNPKLSDFGLAKLLG-AERSYVTTRVMGTFGYVAPEY 317
YLH L K+ DFGLA + S+ ++ G+ ++APE
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 318 AST---GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374
+ SDVY+FGI++ E+++G+ P + F V
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-------------- 223
Query: 375 EGVLDPRLQEKPS--SRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
G L P L + S +A+KR + C+ +RP ++ +E
Sbjct: 224 RGYLSPDLSKVRSNCPKAMKR---LMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 4e-54
Identities = 64/282 (22%), Positives = 109/282 (38%), Gaps = 36/282 (12%)
Query: 152 ELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 211
E EV +G G +G V+ G +T VAVK L + F E + ++
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVK-SLKQGSMSPDAFLAEANLMKQL 65
Query: 212 RHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 271
+H+ LVRL + ++ EY++NG+L +L G LT +++ A+G+
Sbjct: 66 QHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEGM 122
Query: 272 TYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 318
++ E + + K++DFGLA+L+ + APE
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 319 STGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378
+ G SDV+SFGIL+ E+++ R P + + L+ G
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHG------RIPYPGMTNPEVIQNLE--------RGYR 228
Query: 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
R P + + C RP ++ +LE
Sbjct: 229 MVRPDNCP-----EELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-52
Identities = 54/293 (18%), Positives = 107/293 (36%), Gaps = 42/293 (14%)
Query: 163 ENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGY 222
+ IG+G +G V+RG VAVK + ++R + + E+ +RH+N++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 223 CAEG----AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG- 277
+ LV++Y ++G+L +L+ +T E + + L TA GL +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 278 --------------------LEPKWNPKLSDFGLAKLLGAERSYV---TTRVMGTFGYVA 314
++ ++D GLA + + +GT Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 315 PEYASTGM------LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTM 368
PE + + +D+Y+ G++ E+ + + + +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 369 VTNGNAEGVLDPRLQEKPSSRALKRALL-VALRCVDPNAHKRPKMGHVIHMLE 420
+ E L P + + S R + + C N R + L
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 3e-51
Identities = 49/270 (18%), Positives = 98/270 (36%), Gaps = 36/270 (13%)
Query: 164 NVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYC 223
+G G +G+V G +VA+K ++ +E EF E + + + H+ LV+L G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------ 277
+ ++ EY+ NG L +L + + + + + YL
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 125
Query: 278 -------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVY 330
+ + K+SDFGL++ + + + + PE + SD++
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185
Query: 331 SFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRA 390
+FG+L+ E+ S E + A+G+ R
Sbjct: 186 AFGVLMWEIYSLGKMPYERFTNSETAEHI--------------AQGLRLYRPHLAS---- 227
Query: 391 LKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
++ + C A +RP ++ +
Sbjct: 228 -EKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 4e-51
Identities = 63/270 (23%), Positives = 108/270 (40%), Gaps = 36/270 (13%)
Query: 164 NVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYC 223
IG G +G+V+ G + VA+K + +E++F E E + ++ H LV+L G C
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIK-TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------ 277
E A LV E++++G L +L G + E + + L +G+ YL E
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYLEEACVIHRD 126
Query: 278 -------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVY 330
+ K+SDFG+ + + ++ +T + +PE S + SDV+
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186
Query: 331 SFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRA 390
SFG+L+ EV S + P E + + E + + PRL
Sbjct: 187 SFGVLMWEVFSEG------KIPYENRSNSEVVEDIS------TGFRLYKPRLAS------ 228
Query: 391 LKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
+ C RP ++ L
Sbjct: 229 -THVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (426), Expect = 2e-49
Identities = 65/304 (21%), Positives = 116/304 (38%), Gaps = 53/304 (17%)
Query: 148 YTLRELEVSTNGFADE---------NVIGEGGYGIVYRGVLEDNTN----VAVKNL-LNN 193
+T + + FA E VIG G +G V G L+ VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 194 RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHS 253
+ ++F E +G+ H N++ L G + M++ E+++NG+L+ +L + G
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 254 PLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300
T + ++ G A G+ YL + + K+SDFGL++ L + S
Sbjct: 126 --TVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 301 YVTTR----VMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQ 356
T + APE SDV+S+GI++ EV+S + +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 243
Query: 357 FQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVI 416
+ + + P + L C + + RPK G ++
Sbjct: 244 NAI-------------------EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 417 HMLE 420
+ L+
Sbjct: 285 NTLD 288
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 7e-49
Identities = 56/299 (18%), Positives = 103/299 (34%), Gaps = 46/299 (15%)
Query: 153 LEVSTNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGR 210
+E+ + F + +G G G+V++ +A K + L + + E++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 211 VRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 270
+V G + E++D G+L+Q L + +I + + KG
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKG 116
Query: 271 LTYLHEG--------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 316
LTYL E + + KL DFG++ L +GT Y++PE
Sbjct: 117 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPE 173
Query: 317 YASTGMLNETSDVYSFGILIMEVISGRNPVD-------------------YSRPPGEFQF 357
+ SD++S G+ ++E+ GR P+ PP
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 358 QVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVAL----RCVDPNAHKRPKM 412
L + +LD + E P L +C+ N +R +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 2e-48
Identities = 60/282 (21%), Positives = 104/282 (36%), Gaps = 36/282 (12%)
Query: 152 ELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 211
E+ E +G+G +G V+ G T VA+K L + + F E + + ++
Sbjct: 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK-TLKPGTMSPEAFLQEAQVMKKL 69
Query: 212 RHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 271
RH+ LV+L +E +V EY+ G+L +L G+ G + +++ A G+
Sbjct: 70 RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLR--LPQLVDMAAQIASGM 126
Query: 272 TYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 318
Y+ + K++DFGLA+L+ + APE A
Sbjct: 127 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 319 STGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378
G SDV+SFGIL+ E+ + E QV
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV------------------- 227
Query: 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
+ + + + +C +RP ++ LE
Sbjct: 228 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 3e-47
Identities = 68/312 (21%), Positives = 120/312 (38%), Gaps = 48/312 (15%)
Query: 151 RELEVSTNGFA-DENVIGEGGYGIVYRGVL---EDNTNVAVKNLLNNRGQAE-KEFKVEV 205
++L + + + +G G +G V +GV + +VA+K L +A+ +E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 206 EAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIIL 265
+ + ++ + +VRL+G C + MLV E G L ++L G + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 116
Query: 266 GTAKGLTYLHE-------------GLEPKWNPKLSDFGLAKLLGAERSYVTTR--VMGTF 310
+ G+ YL E L + K+SDFGL+K LGA+ SY T R
Sbjct: 117 QVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 311 GYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVT 370
+ APE + + SDV+S+G+ + E +S Y + P + + +++
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALS------YGQKPYKKMKGPEVMAFIEQ--- 227
Query: 371 NGNAEGVLDPRLQEKPS-SRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDE 429
R++ P L + C RP V + A +
Sbjct: 228 --------GKRMECPPECPPELYA---LMSDCWIYKWEDRPDFLTVEQRMRA---CYYSL 273
Query: 430 RRAGREHGRSPH 441
H H
Sbjct: 274 ASKVEGHHHHHH 285
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 4e-47
Identities = 63/288 (21%), Positives = 120/288 (41%), Gaps = 43/288 (14%)
Query: 154 EVSTNGFADENVIGEGGYGIVYRGVLEDNTN-----VAVKNLLNNRGQAEK-EFKVEVEA 207
E+ + + VIG G +G VY+G+L+ ++ VA+K L + ++ +F E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 208 IGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 267
+G+ H N++RL G ++ M++ EY++NG L+++L + + ++ G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGI 119
Query: 268 AKGLTYLHEG-------------LEPKWNPKLSDFGLAKLL--GAERSYVTTRVMGTFGY 312
A G+ YL + K+SDFGL+++L E +Y T+ +
Sbjct: 120 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 313 VAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372
APE S SDV+SFGI++ EV++ + E +
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI------------- 226
Query: 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
+ + + ++C +RPK ++ +L+
Sbjct: 227 ------NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (407), Expect = 8e-47
Identities = 55/283 (19%), Positives = 109/283 (38%), Gaps = 36/283 (12%)
Query: 152 ELEVSTNGFADENVIGEGGYGIVYRGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGR 210
+ E+ ++ +G G YG VY GV + + VAVK L + + E EF E +
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE 69
Query: 211 VRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 270
++H NLV+L+G C ++ E++ GNL +L ++ + + + +
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSA 127
Query: 271 LTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 317
+ YL + + K++DFGL++L+ + + APE
Sbjct: 128 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187
Query: 318 ASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377
+ + SDV++FG+L+ E+ + + ++E +
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYE-------------L 228
Query: 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
L+ + + ++ + C N RP + E
Sbjct: 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (407), Expect = 1e-46
Identities = 63/312 (20%), Positives = 106/312 (33%), Gaps = 60/312 (19%)
Query: 150 LRELEVSTNGFADENVIGEGGYGIVYRGVL------EDNTNVAVKNL-LNNRGQAEKEFK 202
L LE N IGEG +G V++ E T VAVK L + +F+
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 203 VEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHG--------------- 247
E + + N+V+L+G CA G L+ EY+ G+L ++L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 248 -----DVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDF 289
PL+ ++ I A G+ YL E + K++DF
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 184
Query: 290 GLAKLL-GAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDY 348
GL++ + A+ ++ PE SDV+++G+++ E+ S Y
Sbjct: 185 GLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244
Query: 349 SRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHK 408
E + V D + P + + C
Sbjct: 245 GMAHEEVIYY------------------VRDGNILACPEN-CPLELYNLMRLCWSKLPAD 285
Query: 409 RPKMGHVIHMLE 420
RP + +L+
Sbjct: 286 RPSFCSIHRILQ 297
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 5e-46
Identities = 59/279 (21%), Positives = 103/279 (36%), Gaps = 44/279 (15%)
Query: 162 DENVIGEGGYGIVYRGVLEDNTN---VAVKNLLN--NRGQAEKEFKVEVEAIGRVRHKNL 216
++ +G G +G V +G + VAVK L N N + E E + ++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276
VR++G C E MLV E + G L ++L + + + + ++ + G+ YL E
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 277 -------------GLEPKWNPKLSDFGLAKLLGAERSYVTTR--VMGTFGYVAPEYASTG 321
L + K+SDFGL+K L A+ +Y + + APE +
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 322 MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381
+ SDV+SFG+L+ E S E + +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------------------EKG 226
Query: 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
+ + + + C + RP V L
Sbjct: 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-45
Identities = 63/281 (22%), Positives = 95/281 (33%), Gaps = 42/281 (14%)
Query: 154 EVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 213
++ IG+G +G V G VAVK + + F E + ++RH
Sbjct: 3 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRH 59
Query: 214 KNLVRLVGYCAEGAHRM-LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 272
NLV+L+G E + +V EY+ G+L +L S L + + L + +
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAME 117
Query: 273 YLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 319
YL + K+SDFGL K S + APE
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALR 173
Query: 320 TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379
+ SDV+SFGIL+ E+ S P + +V +G
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE--------------KGYKM 219
Query: 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
P V C +A RP + LE
Sbjct: 220 DAPDGCP-----PAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-44
Identities = 68/281 (24%), Positives = 111/281 (39%), Gaps = 44/281 (15%)
Query: 163 ENVIGEGGYGIVYRGVLEDNTN----VAVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNLV 217
VIG G +G VY G L DN AVK+L E +F E + H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 218 RLVGYCAEG-AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276
L+G C ++V Y+ +G+L ++ + T + + L AKG+ +L
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLAS 148
Query: 277 -------------GLEPKWNPKLSDFGLAKLL---GAERSYVTTRVMGTFGYVAPEYAST 320
L+ K+ K++DFGLA+ + + + T ++A E T
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 321 GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380
SDV+SFG+L+ E+++ P VN F+ ++
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP---------PYPDVNTFDITVYLLQG-------RR 252
Query: 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421
LQ + L V L+C P A RP ++ + A
Sbjct: 253 LLQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 3e-44
Identities = 60/306 (19%), Positives = 106/306 (34%), Gaps = 54/306 (17%)
Query: 151 RELEVSTNGFADENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNNRGQAEKE-FKV 203
+ E N + +G G +G V + VAVK L + E+E
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75
Query: 204 EVEAIGRV-RHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHG--------------D 248
E++ + + H N+V L+G C G +++ EY G+L +L
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 249 VGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLL 295
L E ++ AKG+ +L L K+ DFGLA+ +
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 296 GAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGE 354
+ +Y V ++APE + SDV+S+GI + E+ S + P
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 355 FQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGH 414
++ ++ + A + C D + KRP
Sbjct: 256 KFYK------------------MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 297
Query: 415 VIHMLE 420
++ ++E
Sbjct: 298 IVQLIE 303
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (388), Expect = 9e-44
Identities = 60/273 (21%), Positives = 93/273 (34%), Gaps = 48/273 (17%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKN 215
F+D IG G +G VY + ++ VA+K + + ++ EV + ++RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 275
++ G LV EY + PL + G +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLH 132
Query: 276 EG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-- 320
L KL DFG A ++ +GT ++APE
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAMD 187
Query: 321 -GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379
G + DV+S GI +E+ + P+ F +N L + N
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPL----------FNMNAMSALYHIAQNE------S 231
Query: 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKM 412
P LQ S + C+ RP
Sbjct: 232 PALQSGHWSEYFRN---FVDSCLQKIPQDRPTS 261
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 2e-43
Identities = 62/310 (20%), Positives = 109/310 (35%), Gaps = 59/310 (19%)
Query: 154 EVSTNGFADENVIGEGGYGIVYRGVLEDNTN------VAVKNLLNNRGQAEKE-FKVEVE 206
E V+G G +G V + VAVK L +E+E E++
Sbjct: 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 92
Query: 207 AIGRV-RHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHS------------ 253
+ ++ H+N+V L+G C L+ EY G+L +L S
Sbjct: 93 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 254 -------PLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAK 293
LT+E + AKG+ +L + K+ DFGLA+
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212
Query: 294 LLGAERSYVT-TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPP 352
+ ++ +YV ++APE G+ SDV+S+GIL+ E+ S P
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 353 GEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKM 412
++ ++ + A + ++ C ++ KRP
Sbjct: 273 DANFYK------------------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF 314
Query: 413 GHVIHMLEAE 422
++ L +
Sbjct: 315 PNLTSFLGCQ 324
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-43
Identities = 60/278 (21%), Positives = 109/278 (39%), Gaps = 49/278 (17%)
Query: 163 ENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRL 219
+ IG G + VY+G+ E VA L + + + FK E E + ++H N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 220 VGYCAEGA----HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 275
+LV E + +G L+ +L + ++ + KGL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH 129
Query: 276 EG----------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 319
P + K+ D GLA L A V+GT ++APE
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMYE 186
Query: 320 TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379
+E+ DVY+FG+ ++E+ + P E Q ++ + + V + + V
Sbjct: 187 -EKYDESVDVYAFGMCMLEMATSE------YPYSECQNAAQIYRRVTSGVKPASFDKVAI 239
Query: 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417
P ++E + C+ N +R + +++
Sbjct: 240 PEVKE------------IIEGCIRQNKDERYSIKDLLN 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 3e-43
Identities = 61/286 (21%), Positives = 107/286 (37%), Gaps = 52/286 (18%)
Query: 148 YTLRELEVSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLN---NRGQAEKEFKV 203
+ L + E+ +G+G +G VY + +A+K L + E + +
Sbjct: 3 WALEDFEI-------GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 55
Query: 204 EVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNI 263
EVE +RH N++RL GY + L+ EY G + + L S +
Sbjct: 56 EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATY 111
Query: 264 ILGTAKGLTYLHE-------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTF 310
I A L+Y H L K++DFG + + R T + GT
Sbjct: 112 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTL 168
Query: 311 GYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVT 370
Y+ PE M +E D++S G+L E + G+ P F+ N ++ ++
Sbjct: 169 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP-----------FEANTYQETYKRIS 217
Query: 371 NGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVI 416
+ + + A + R + N +RP + V+
Sbjct: 218 RV------EFTFPDFVTEGARD----LISRLLKHNPSQRPMLREVL 253
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 4e-43
Identities = 57/276 (20%), Positives = 101/276 (36%), Gaps = 44/276 (15%)
Query: 164 NVIGEGGYGIVYRGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLV 220
IG G YG + D + K + + ++ EV + ++H N+VR
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 221 GYCAEGAHRML--VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG- 277
+ + L V EY + G+L + L E + ++ L H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 278 -----------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 320
L+ K N KL DFGLA++L + S+ +GT Y++PE +
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQMNR 188
Query: 321 GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380
NE SD++S G L+ E+ + P F + L + G
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPP-----------FTAFSQKELAGKIREGK-----FR 232
Query: 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVI 416
R+ + S + + R ++ + RP + ++
Sbjct: 233 RIPYRYSDELNE----IITRMLNLKDYHRPSVEEIL 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-42
Identities = 62/282 (21%), Positives = 105/282 (37%), Gaps = 45/282 (15%)
Query: 164 NVIGEGGYGIVYRGVLEDNTN----VAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNL 216
+G+G +G+V RG + + VAVK L + ++ +A +F EV A+ + H+NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276
+RL G +M V E G+L L G + A+G+ YL
Sbjct: 74 IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLES 129
Query: 277 -------------GLEPKWNPKLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEYASTG 321
L + K+ DFGL + L + + F + APE T
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 322 MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381
+ SD + FG+ + E+ + + ++ + EG PR
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI-------------DKEGERLPR 236
Query: 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHML-EAE 422
++ P + V ++C RP + L EA+
Sbjct: 237 PEDCP-----QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-41
Identities = 55/297 (18%), Positives = 108/297 (36%), Gaps = 51/297 (17%)
Query: 154 EVSTNGFADENVIGEGGYGIVYRGVLEDN---TNVAVKNL-LNNRGQAEKEFKVEVEAIG 209
+ N ++VIGEG +G V + ++ + + A+K + ++F E+E +
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65
Query: 210 RV-RHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHG------------DVGPHSPLT 256
++ H N++ L+G C + L EY +GNL +L S L+
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 257 WEIRMNIILGTAKGLTYLHE-------------GLEPKWNPKLSDFGLAKLLGAERSYVT 303
+ ++ A+G+ YL + + + K++DFGL++
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--K 183
Query: 304 TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFE 363
T ++A E + + SDV+S+G+L+ E++S P L+E
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG------GTPYCGMTCAELYE 237
Query: 364 WLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
L + +C ++RP ++ L
Sbjct: 238 KLPQG---------YRLEKPLNCDDEVYD----LMRQCWREKPYERPSFAQILVSLN 281
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-41
Identities = 56/300 (18%), Positives = 104/300 (34%), Gaps = 47/300 (15%)
Query: 152 ELEVSTNGFADENVIGEGGYGIVYRGVLEDNTN----VAVKNLLNNRGQAEKE-FKVEVE 206
+ E+ IGEG +G V++G+ N VA+K N + +E F E
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 207 AIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 266
+ + H ++V+L+G E ++ E G L +L L +
Sbjct: 61 TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQ 116
Query: 267 TAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 313
+ L YL + KL DFGL++ + Y ++ ++
Sbjct: 117 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 176
Query: 314 APEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373
APE + SDV+ FG+ + E++ P + ++ ++
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHG------VKPFQGVKNNDVIGRIEN------ 224
Query: 374 AEGVLDPRLQEKPS-SRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDERRA 432
RL P+ L + +C + +RP+ + L +E +A
Sbjct: 225 -----GERLPMPPNCPPTLYS---LMTKCWAYDPSRRPRFTELKAQLST----ILEEEKA 272
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 6e-41
Identities = 60/309 (19%), Positives = 115/309 (37%), Gaps = 46/309 (14%)
Query: 148 YTLRELEVSTNGFADENVIGEGGYGIVYRGVL------EDNTNVAVKNL-LNNRGQAEKE 200
Y E EV+ +G+G +G+VY GV E T VA+K + + E
Sbjct: 10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 69
Query: 201 FKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLH------GDVGPHSP 254
F E + ++VRL+G ++G +++ E + G+L+ +L + +P
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 255 LTWEIRMNIILGTAKGLTYLHE-------------GLEPKWNPKLSDFGLAKLLGAERSY 301
+ + + A G+ YL+ + + K+ DFG+ + + Y
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 189
Query: 302 -VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVN 360
+ + +++PE G+ SDV+SFG+++ E+ + +
Sbjct: 190 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF-- 247
Query: 361 LFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
V++ L +KP + + C N RP +I ++
Sbjct: 248 ----------------VMEGGLLDKPDN-CPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
Query: 421 AEEFPFRDE 429
E P E
Sbjct: 291 EEMEPGFRE 299
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 7e-41
Identities = 60/281 (21%), Positives = 109/281 (38%), Gaps = 43/281 (15%)
Query: 160 FADENVIGEGGYGIVYRGVLEDN-----TNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRH 213
F V+G G +G VY+G+ VA+K L +A KE E + V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 214 KNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 273
++ RL+G C +++ + + G L ++ + +N + AKG+ Y
Sbjct: 71 PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIG---SQYLLNWCVQIAKGMNY 126
Query: 274 LHEG-------------LEPKWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYAS 319
L + ++ + K++DFGLAKLLGA E+ Y ++A E
Sbjct: 127 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 320 TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379
+ SDV+S+G+ + E+++ + P E + +G
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE--------------KGERL 232
Query: 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
P+ ++ ++C +A RPK +I
Sbjct: 233 PQPPICT-----IDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-40
Identities = 59/263 (22%), Positives = 100/263 (38%), Gaps = 38/263 (14%)
Query: 164 NVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGY 222
IG+G G VY + + VA++ + + ++ E+ + ++ N+V +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 223 CAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE------ 276
G +V EY+ G+L + + + + + L +LH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 277 -------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDV 329
L + KL+DFG + E+S +T V GT ++APE + D+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 199
Query: 330 YSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSR 389
+S GI+ +E+I G P P L + TNG P LQ
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENP----------LRALYLIATNGT------PELQNPEKLS 243
Query: 390 ALKRALLVALRCVDPNAHKRPKM 412
A+ R L RC+D + KR
Sbjct: 244 AIFRDFL--NRCLDMDVEKRGSA 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 3e-40
Identities = 59/269 (21%), Positives = 96/269 (35%), Gaps = 39/269 (14%)
Query: 164 NVIGEGGYGIVYRGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLVG 221
+GEG YG V V VAVK + + + K E+ + H+N+V+ G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 222 YCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE----- 276
+ EG + L EY G L + P + G+ YLH
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 126
Query: 277 --------GLEPKWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLN-ET 326
L+ + N K+SDFGLA + R + ++ GT YVAPE + E
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 327 SDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKP 386
DV+S GI++ +++G P D + + + P
Sbjct: 187 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK------------------EKKTYLNP 228
Query: 387 SSRALKRALLVALRCVDPNAHKRPKMGHV 415
+ L + + + N R + +
Sbjct: 229 WKKIDSAPLALLHKILVENPSARITIPDI 257
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-39
Identities = 49/268 (18%), Positives = 93/268 (34%), Gaps = 41/268 (15%)
Query: 164 NVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGY 222
+G+G +G VY+ E + A K + + +++ VE++ + H N+V+L+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 223 CAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG----- 277
+ ++ E+ G ++ + PLT + T L YLH+
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLHDNKIIHR 134
Query: 278 --------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML-----N 324
+ KL+DFG++ + + GT ++APE +
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYD 193
Query: 325 ETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQE 384
+DV+S GI ++E+ P P + + P
Sbjct: 194 YKADVWSLGITLIEMAEIEPPHHELNPMRVLL-----------KIAKSEPPTLAQP---- 238
Query: 385 KPSSRALKRALLVALRCVDPNAHKRPKM 412
S K L +C++ N R
Sbjct: 239 SRWSSNFKDFL---KKCLEKNVDARWTT 263
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-37
Identities = 65/308 (21%), Positives = 103/308 (33%), Gaps = 53/308 (17%)
Query: 148 YTLRELEVSTNGFADENVIGEGGYGIVYRGV------LEDNTNVAVKNLLNNRGQAE-KE 200
Y + E + +G G +G V VAVK L +E +
Sbjct: 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 62
Query: 201 FKVEVEAIGR-VRHKNLVRLVGYCAE-GAHRMLVNEYVDNGNLEQWLHGDVGPHSP---- 254
E++ + H N+V L+G C + G M++ E+ GNL +L P
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 255 --------LTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAK 293
LT E + AKG+ +L L K K+ DFGLA+
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 182
Query: 294 LLGAERSYV-TTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPP 352
+ + YV ++APE + SDV+SFG+L+ E+ S
Sbjct: 183 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG--- 239
Query: 353 GEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKM 412
V + E + G R + + + L C +RP
Sbjct: 240 ------VKIDEEFCRRLKEGT-----RMRAPDYTTPEMYQ----TMLDCWHGEPSQRPTF 284
Query: 413 GHVIHMLE 420
++ L
Sbjct: 285 SELVEHLG 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 137 bits (347), Expect = 1e-37
Identities = 48/264 (18%), Positives = 100/264 (37%), Gaps = 38/264 (14%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYC 223
+G G +G+V+R N A K ++ ++ + E++ + +RH LV L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE------- 276
+ +++ E++ G L + + + H+ ++ + + + KGL ++HE
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLD 149
Query: 277 --------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSD 328
+ KL DFGL L ++S T GT + APE A + +D
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYTD 207
Query: 329 VYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSS 388
++S G+L ++SG +P + + D + + S
Sbjct: 208 MWSVGVLSYILLSGLSPFGGENDDETLRNVKS-----------------CDWNMDDSAFS 250
Query: 389 RALKRALLVALRCVDPNAHKRPKM 412
+ + + + + R +
Sbjct: 251 GISEDGKDFIRKLLLADPNTRMTI 274
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-37
Identities = 60/303 (19%), Positives = 111/303 (36%), Gaps = 55/303 (18%)
Query: 154 EVSTNGFADENVIGEGGYGIVYRGVL--------EDNTNVAVKNLLNNRGQAE-KEFKVE 204
E+ + +GEG +G V T VAVK L ++ + + + E
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68
Query: 205 VEAIGRV-RHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLH------------GDVGP 251
+E + + +HKN++ L+G C + ++ EY GNL ++L P
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 252 HSPLTWEIRMNIILGTAKGLTYLHE-------------GLEPKWNPKLSDFGLAKLLGAE 298
L+ + ++ A+G+ YL + K++DFGLA+ +
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 299 RSYVTTRVM-GTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQF 357
Y T ++APE + SDV+SFG+L+ E+ + P +
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG------GSP----Y 238
Query: 358 QVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417
E L ++ G+ + S ++ C +RP ++
Sbjct: 239 PGVPVEELFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289
Query: 418 MLE 420
L+
Sbjct: 290 DLD 292
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (336), Expect = 2e-36
Identities = 57/280 (20%), Positives = 102/280 (36%), Gaps = 41/280 (14%)
Query: 151 RELEVSTNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQ-AEKEFKVEVEAI 208
++ E + + +V+G G + V VA+K + + E + E+ +
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 209 GRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 268
+++H N+V L G H L+ + V G L + T +I
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVL 117
Query: 269 KGLTYLHE----------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 312
+ YLH+ L+ +SDFGL+K+ + V + GT GY
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGY 175
Query: 313 VAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372
VAPE + ++ D +S G++ ++ G PP + LFE +
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCG-------YPPFYDENDAKLFEQIL------ 222
Query: 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKM 412
AE D + S A + + ++ + KR
Sbjct: 223 KAEYEFDSPYWDDISDSA--KDFI--RHLMEKDPEKRFTC 258
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 5e-36
Identities = 45/264 (17%), Positives = 92/264 (34%), Gaps = 39/264 (14%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYC 223
+G G +GIV+R V K + +G + K E+ + RH+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE------- 276
+++ E++ ++ + ++ L ++ + + L +LH
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLHSHNIGHFD 127
Query: 277 --------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSD 328
K+ +FG A+ L ++ Y APE +++ +D
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVSTATD 185
Query: 329 VYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSS 388
++S G L+ ++SG NP F + + + N E D ++ S
Sbjct: 186 MWSLGTLVYVLLSGINP-----------FLAETNQQIIENIMNA--EYTFDEEAFKEISI 232
Query: 389 RALKRALLVALRCVDPNAHKRPKM 412
A + R + R
Sbjct: 233 EA--MDFV--DRLLVKERKSRMTA 252
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 133 bits (336), Expect = 5e-36
Identities = 47/264 (17%), Positives = 94/264 (35%), Gaps = 38/264 (14%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYC 223
+G G +G+V+R V K + + K E+ + ++ H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 224 AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE------- 276
+ +L+ E++ G L + ++ +N + +GL ++HE
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLD 152
Query: 277 --------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSD 328
+ + K+ DFGLA L + + T + APE + +D
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGFYTD 210
Query: 329 VYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSS 388
+++ G+L ++SG +P GE + L+T+ + D S
Sbjct: 211 MWAIGVLGYVLLSGLSPF-----AGE--------DDLETLQNVKRCDWEFDEDAFSSVSP 257
Query: 389 RALKRALLVALRCVDPNAHKRPKM 412
A + + + KR +
Sbjct: 258 EA--KDFI--KNLLQKEPRKRLTV 277
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 131 bits (329), Expect = 1e-35
Identities = 62/282 (21%), Positives = 104/282 (36%), Gaps = 45/282 (15%)
Query: 163 ENVIGEGGYGIVYRGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVR 218
++G GG V+ L + +VAVK L L F+ E + + H +V
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 219 LVGYCAE----GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 274
+ G +V EYVD L +H P+T + + +I + L +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFS 127
Query: 275 HE-------------GLEPKWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPEYAS 319
H+ + K+ DFG+A+ + + V T V+GT Y++PE A
Sbjct: 128 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187
Query: 320 TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379
++ SDVYS G ++ EV++G P P V E +
Sbjct: 188 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--------------EDPIP 233
Query: 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPK-MGHVIHMLE 420
P + + S L + L+ + N R + + L
Sbjct: 234 PSARHEGLSADLDAVV---LKALAKNPENRYQTAAEMRADLV 272
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 4e-35
Identities = 53/282 (18%), Positives = 96/282 (34%), Gaps = 43/282 (15%)
Query: 163 ENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAE---KEFKVEVEAIGRVRHKNLVR 218
++GEG + V L + A+K L E E + + R+ H V+
Sbjct: 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72
Query: 219 LVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG- 277
L + Y NG L +++ L YLH
Sbjct: 73 LYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 278 ------------LEPKWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYASTGMLN 324
L + +++DFG AK+L E + +GT YV+PE +
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188
Query: 325 ETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQE 384
++SD+++ G +I ++++G P F+ + + + E
Sbjct: 189 KSSDLWALGCIIYQLVAGLPP-----------FRAGNEYLIFQKIIKL------EYDFPE 231
Query: 385 KPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPF 426
K +A R L+ + + +A KR + + PF
Sbjct: 232 KFFPKA--RDLV--EKLLVLDATKRLGCEEMEGYGPLKAHPF 269
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 124 bits (313), Expect = 2e-33
Identities = 43/272 (15%), Positives = 89/272 (32%), Gaps = 27/272 (9%)
Query: 164 NVIGEGGYGIVYRGVLEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVG 221
IGEG YG+VY+ A+K L E+ + ++H N+V+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 222 YCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE----- 276
+LV E++D + L + +L G+ Y H+
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 277 --------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSD 328
+ + K++DFGLA+ G T ++ + + + T D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 329 VYSFGILIMEVISGRNPVDYSRPPGEFQ--------FQVNLFEWLKTMVTNGNAEGVLDP 380
++S G + E+++G + + + + V +P
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKM 412
E + + + + + + ++R
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 125 bits (314), Expect = 9e-33
Identities = 53/280 (18%), Positives = 95/280 (33%), Gaps = 46/280 (16%)
Query: 156 STNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV 211
+ N F+ +IG GG+G VY + A+K L R Q E E + V
Sbjct: 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61
Query: 212 R---HKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 268
+V + + + ++ G+L L H +
Sbjct: 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEII 117
Query: 269 KGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 315
GL ++H L+ + ++SD GLA ++ +GT GY+AP
Sbjct: 118 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAP 174
Query: 316 EYASTGM-LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374
E G+ + ++D +S G ++ +++ G +P + + +
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---------- 224
Query: 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGH 414
L + S R+LL L D N +R
Sbjct: 225 ----AVELPDSFSPEL--RSLLEGLLQRDVN--RRLGCLG 256
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 6e-32
Identities = 52/282 (18%), Positives = 102/282 (36%), Gaps = 39/282 (13%)
Query: 160 FADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 218
+ D VIG G +G+VY+ L + VA+K +L + ++ E++ + ++ H N+VR
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVR 77
Query: 219 LVGYCAEGAHRM------LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 272
L + + LV +YV H L + + L
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPVIYVKLYMYQLFRSLA 136
Query: 273 YLHEG------LEPKWNP--------KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 318
Y+H ++P+ KL DFG AK L + + +
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICSRYYRAPELIF 195
Query: 319 STGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF-----EWLKTMVTNGN 373
+ DV+S G ++ E++ G+ + + + E ++ M N N
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM--NPN 253
Query: 374 AEGVLDPRLQEKPSSRALKR-----ALLVALRCVDPNAHKRP 410
P+++ P ++ + A+ + R ++ R
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 120 bits (302), Expect = 1e-31
Identities = 41/282 (14%), Positives = 85/282 (30%), Gaps = 43/282 (15%)
Query: 163 ENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVG 221
IG G +G +Y G + VA+K + +E + ++ + +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIPTIR 69
Query: 222 YC-AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE---- 276
+C AEG + ++V E + + + + + + + + Y+H
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKNFI 125
Query: 277 --GLEPK----------WNPKLSDFGLAKLLGAERSYV------TTRVMGTFGYVAPEYA 318
++P + DFGLAK R++ + GT Y +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 319 STGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378
+ D+ S G ++M G P + + Q + E + +G
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY- 244
Query: 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
L C +P ++ +
Sbjct: 245 ---------PSEFATYL---NFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 119 bits (300), Expect = 1e-31
Identities = 51/280 (18%), Positives = 98/280 (35%), Gaps = 53/280 (18%)
Query: 163 ENVIGEGGYGIVYRGV-LEDNTNVAVKNL---------LNNRGQAEKEFKVEVEAIGRVR 212
+ ++G G +V R + AVK + + + EV+ + +V
Sbjct: 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 67
Query: 213 -HKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 271
H N+++L LV + + G L +L L+ + I+ + +
Sbjct: 68 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVI 123
Query: 272 TYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 318
LH+ L+ N KL+DFG + L + V GT Y+APE
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAPEII 181
Query: 319 STGMLNET------SDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372
M + D++S G+++ +++G P + + + M+ +G
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR-----------MIMSG 230
Query: 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKM 412
N + + S +K + R + KR
Sbjct: 231 NYQ---FGSPEWDDYSDTVKDLV---SRFLVVQPQKRYTA 264
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-31
Identities = 51/272 (18%), Positives = 94/272 (34%), Gaps = 47/272 (17%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNL------LNNRGQAEKEFKVEVEAIGRVRHKNLV 217
+G G + +V + A K + + RG + ++ + EV + ++H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE- 276
L +L+ E V G L +L LT E + G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL 132
Query: 277 ----------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 320
PK K+ DFGLA + + + GT +VAPE +
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIVNY 190
Query: 321 GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380
L +D++S G++ ++SG +P +
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA---------------VNYEF 235
Query: 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKM 412
+ ++ AL + + R + + KR +
Sbjct: 236 EDEYFSNTSALAKDFI--RRLLVKDPKKRMTI 265
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-31
Identities = 51/266 (19%), Positives = 90/266 (33%), Gaps = 44/266 (16%)
Query: 163 ENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKE---FKVEVEAIGRV-RHKNLV 217
++G+G +G V+ + N A+K L + + + VE + H L
Sbjct: 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277
+ + V EY++ G+L + GL +LH
Sbjct: 67 HMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 278 -------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 324
L+ + K++DFG+ K + T GT Y+APE N
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQKYN 181
Query: 325 ETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQE 384
+ D +SFG+L+ E++ G++P LF ++ +P
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPFHGQDE-------EELFHSIRMD----------NPFYPR 224
Query: 385 KPSSRALKRALLVALRCVDPNAHKRP 410
A + LL ++ KR
Sbjct: 225 WLEKEA--KDLL--VKLFVREPEKRL 246
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-30
Identities = 53/284 (18%), Positives = 104/284 (36%), Gaps = 29/284 (10%)
Query: 157 TNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAE-KEFKVEVEAIGRVRHK 214
+ + + IGEG YG+V + VA+K + Q + E++ + R RH+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 215 NLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 274
N++ + + + Y+ + L+ + L+ + + +GL Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 275 HEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT--TRVMGTFGYVAPEYAS 319
H L + K+ DFGLA++ + + T + T Y APE
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 320 TGMLNETS-DVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF------EWLKTMVTNG 372
S D++S G ++ E++S R + + + + +
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245
Query: 373 NAEGVLDPRLQEKPSSRALKRALLVAL----RCVDPNAHKRPKM 412
+ P + P +R A AL + + N HKR ++
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 289
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 4e-30
Identities = 58/286 (20%), Positives = 102/286 (35%), Gaps = 47/286 (16%)
Query: 153 LEVSTNGFAD-----ENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVE 206
L++ N D V+G G G V + A+K +L + +A +E ++
Sbjct: 2 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWR 60
Query: 207 AIGRVRHKNLVRLVGYC----AEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMN 262
A + ++VR+V A ++V E +D G L + T
Sbjct: 61 AS---QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASE 115
Query: 263 IILGTAKGLTYLHE----------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRV 306
I+ + + YLH P KL+DFG AK + S T
Sbjct: 116 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--P 173
Query: 307 MGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLK 366
T YVAPE +++ D++S G+++ ++ G PP + + +K
Sbjct: 174 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG-------YPPFYSNHGLAISPGMK 226
Query: 367 TMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKM 412
T + G E P + S +K + + +R +
Sbjct: 227 TRIRMGQYE---FPNPEWSEVSEEVKMLI---RNLLKTEPTQRMTI 266
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 9e-30
Identities = 51/276 (18%), Positives = 92/276 (33%), Gaps = 32/276 (11%)
Query: 164 NVIGEGGYGIVYRGV-LEDNTNVAVK-----NLLNNRGQAEKEFKVEVEAIGRVRHKNLV 217
+ +GEG + VY+ N VA+K + + + E++ + + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 218 RLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277
L+ ++ LV ++++ LT +L T +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 278 -------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML- 323
L+ KL+DFGLAK G+ T +V T Y APE +
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARMY 178
Query: 324 NETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF------EWLKTMVTNGNAEGV 377
D+++ G ++ E++ + + +W
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 378 LDPRLQ-EKPSSRALKRALLVALRCVDPNAHKRPKM 412
P + S A L + N R
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA 274
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-29
Identities = 46/277 (16%), Positives = 88/277 (31%), Gaps = 27/277 (9%)
Query: 160 FADENVIGEGGYGIVYRGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNL 216
F IGEG YG+VY+ VA+K L E+ + + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 276
V+L+ LV E++ + D + + + + + +GL + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 277 G-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 323
+ + KL+DFGLA+ G T V+ +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 324 NETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE----GVLD 379
+ D++S G + E+++ R + +V G
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 380 PRLQEKPSSRALKRALLVAL----RCVDPNAHKRPKM 412
P+ + S+ + + + + +KR
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 2e-28
Identities = 55/277 (19%), Positives = 98/277 (35%), Gaps = 30/277 (10%)
Query: 164 NVIGEGGYGIVYRGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEA-----IGRVRHKNL 216
IGEG YG V++ N VA+K + G+ E + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 217 VRLVGYCAEGAHRMLVNEYVDNGNLEQW--LHGDVGPHSPLTWEIRMNIILGTAKGLTYL 274
VRL C + +++Q + D P + E +++ +GL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 275 HEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 321
H + KL+DFGLA++ + + T V+ T Y APE
Sbjct: 133 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEVLLQS 190
Query: 322 MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF------EWLKTMVTNGNAE 375
D++S G + E+ + S + +++ +W + + A
Sbjct: 191 SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 250
Query: 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKM 412
+ EK + + + L+C+ N KR
Sbjct: 251 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 4e-28
Identities = 50/255 (19%), Positives = 100/255 (39%), Gaps = 37/255 (14%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKE------FKVEVEAIGRVR--HKN 215
++G GG+G VY G+ + DN VA+K++ +R E +EV + +V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 216 LVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL- 274
++RL+ + +L+ E + + L E+ + + + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCH 127
Query: 275 -----HEGLEP--------KWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 321
H ++ + KL DFG LL + V T GT Y PE+
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYH 184
Query: 322 ML-NETSDVYSFGILIMEVISGRNPVDYSRPP--GEFQFQVNLFEWLKTMVTNGNAEGVL 378
++ V+S GIL+ +++ G P ++ G+ F+ + + ++ L
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI-----RWCL 239
Query: 379 DPRLQEKPSSRALKR 393
R ++P+ ++
Sbjct: 240 ALRPSDRPTFEEIQN 254
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (276), Expect = 6e-28
Identities = 49/215 (22%), Positives = 86/215 (40%), Gaps = 32/215 (14%)
Query: 148 YTLRELEVSTNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNL---LNNRGQAEKEFKV 203
Y+L++ ++ +G G +G V+ + A+K L + R + +
Sbjct: 1 YSLQDFQI-------LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 53
Query: 204 EVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNI 263
E + V H ++R+ G + ++ +Y++ G L L +
Sbjct: 54 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFY 109
Query: 264 ILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTF 310
L YLH L+ + K++DFG AK + + GT
Sbjct: 110 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTP 165
Query: 311 GYVAPEYASTGMLNETSDVYSFGILIMEVISGRNP 345
Y+APE ST N++ D +SFGILI E+++G P
Sbjct: 166 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 9e-28
Identities = 49/295 (16%), Positives = 98/295 (33%), Gaps = 33/295 (11%)
Query: 148 YTLRELEVSTNGFAD----ENVIGEGGYGIVYRGV-LEDNTNVAVK--NLLNNRGQAEKE 200
+ +E+ + +G G YG V V VA+K K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 201 FKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIR 260
E+ + +RH+N++ L+ ++ G + H L +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 261 MNIILGTAKGLTYLHE-------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVM 307
++ KGL Y+H + K+ DFGLA+ +E T V+
Sbjct: 124 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVV 180
Query: 308 GTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF----- 362
+ + +T D++S G ++ E+I+G+ S + + + +
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240
Query: 363 -EWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVAL----RCVDPNAHKRPKM 412
+ P L++K + L A +A+ + + +A +R
Sbjct: 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 109 bits (273), Expect = 1e-27
Identities = 37/284 (13%), Positives = 79/284 (27%), Gaps = 45/284 (15%)
Query: 163 ENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH-KNLVRLV 220
IGEG +G+++ G L +N VA+K R + + E + + +
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVY 67
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE---- 276
+ EG H +LV + + + + + + +HE
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123
Query: 277 --GLEPK------------WNPKLSDFGLAKLLGAERS------YVTTRVMGTFGYVAPE 316
++P + DFG+ K + + GT Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 317 YASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376
+ D+ + G + M + G P + Q + E ++
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST-------- 235
Query: 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420
R + + P ++ +
Sbjct: 236 --PLRELCAGFPEEFYK---YMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 2e-27
Identities = 48/274 (17%), Positives = 93/274 (33%), Gaps = 29/274 (10%)
Query: 164 NVIGEGGYGIVYRGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLV 220
IGEG YG V++ E + VA+K L ++ E+ + ++HKN+VRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--- 277
LV E+ D + + + L EI + + KGL + H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123
Query: 278 ----------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETS 327
+ KL++FGLA+ G + V+ + + + +
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 328 DVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPS 387
D++S G + E+ + P+ + ++ T + + D +
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243
Query: 388 SRALKRALLVAL---------RCVDPNAHKRPKM 412
+ ++ L + N +R
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA 277
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 1e-25
Identities = 48/208 (23%), Positives = 71/208 (34%), Gaps = 22/208 (10%)
Query: 155 VSTNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKE---FKVEVEAIGR 210
V+ N F ++G+G +G V A+K L A+ E E +
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 211 VRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 270
RH L L V EY + G L L T E
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSA 117
Query: 271 LTYLHE-------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 317
L YLH L+ + K++DFGL K ++ + GT Y+APE
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEV 176
Query: 318 ASTGMLNETSDVYSFGILIMEVISGRNP 345
D + G+++ E++ GR P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 9e-25
Identities = 45/291 (15%), Positives = 95/291 (32%), Gaps = 49/291 (16%)
Query: 164 NVIGEGGYGIVYRGV-LEDNTNVAVKNLL--NNRGQAEKEFKVEVEAIGRVRHKNLVRLV 220
IG+G +G V++ + VA+K +L N + E++ + ++H+N+V L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 221 GYCAEGAHRM--------LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 272
C A LV ++ ++ + T ++ GL
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLY 131
Query: 273 YLHEG-------------LEPKWNPKLSDFGLAKLLGAERS---YVTTRVMGTFGYVAPE 316
Y+H + KL+DFGLA+ ++ T + T Y PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 317 YASTGML-NETSDVYSFGILIMEVISGRNPVDYSR--------------PPGEFQFQVNL 361
D++ G ++ E+ + + + E V+
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 362 FEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKM 412
+E + + + + RL+ + + + + +R
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLI---DKLLVLDPAQRIDS 299
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 94.5 bits (234), Expect = 5e-22
Identities = 51/260 (19%), Positives = 93/260 (35%), Gaps = 26/260 (10%)
Query: 147 WYTLRELEVSTNGFADENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKE---FK 202
W T + + F +G G +G V E + A+K L + K+
Sbjct: 30 WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL 89
Query: 203 VEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMN 262
E + V LV+L + ++ +V EYV G + L +
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARF 145
Query: 263 IILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTTRVMGT 309
YLH ++ + +++DFG AK T + GT
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGT 201
Query: 310 FGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMV 369
+APE + N+ D ++ G+LI E+ +G P +P ++ V+ +
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261
Query: 370 TNGNAEGVLDPRLQEKPSSR 389
++ + + +L LQ + R
Sbjct: 262 SS-DLKDLLRNLLQVDLTKR 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 94.1 bits (233), Expect = 6e-22
Identities = 58/307 (18%), Positives = 104/307 (33%), Gaps = 55/307 (17%)
Query: 147 WYTLRELEVSTNGFAD---ENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFK 202
++ V D +G G Y V+ + + +N V VK L + +K+ K
Sbjct: 21 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIK 77
Query: 203 VEVEAIGRVR-HKNLVRLVGYCAEGAHRM--LVNEYVDNGNLEQWLHGDVGPHSPLTWEI 259
E++ + +R N++ L + R LV E+V+N + +Q LT
Sbjct: 78 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYD 130
Query: 260 RMNIILGTAKGLTYLHEG--------------LEPKWNPKLSDFGLAKLLGAERSYVTTR 305
+ K L Y H +L D+GLA+ + Y
Sbjct: 131 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NV 188
Query: 306 VMGTFGYVAPE-YASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEF---QFQVNL 361
+ + + PE M + + D++S G ++ +I + P + + +V
Sbjct: 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248
Query: 362 FEWLKTMVTNGNAEGVLDPRLQEKPSSRALKR----------------ALLVALRCVDPN 405
E L + N E LDPR + + KR AL + + +
Sbjct: 249 TEDLYDYIDKYNIE--LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306
Query: 406 AHKRPKM 412
R
Sbjct: 307 HQSRLTA 313
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.0 bits (230), Expect = 1e-21
Identities = 56/284 (19%), Positives = 106/284 (37%), Gaps = 45/284 (15%)
Query: 155 VSTNGFADENVIGEGGYGIVYRGVL----EDNTNVAVKNL----LNNRGQAEKEFKVEVE 206
V F V+G G YG V+ + A+K L + + + + + E +
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 207 AIGRVRHK-NLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIIL 265
+ +R LV L L+ +Y++ G L L T +
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVG 136
Query: 266 GTAKGLTYLHE-------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 312
L +LH+ L+ + L+DFGL+K A+ + GT Y
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 313 VAPEYASTGM--LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVT 370
+AP+ G ++ D +S G+L+ E+++G +P F V+ + + ++
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP-----------FTVDGEKNSQAEIS 245
Query: 371 NGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGH 414
+ +P ++ S+ A + L+ R + + KR G
Sbjct: 246 RRILKS--EPPYPQEMSALA--KDLI--QRLLMKDPKKRLGCGP 283
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.6 bits (221), Expect = 2e-20
Identities = 40/198 (20%), Positives = 73/198 (36%), Gaps = 19/198 (9%)
Query: 164 NVIGEGGYGIVYRGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLV 220
+ +G G YG V + VAVK + K E+ + ++H+N++ L+
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 221 GYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE---- 276
N+ +L ++ LT + +I +GL Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADII 143
Query: 277 ---------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETS 327
+ K+ DFGLA+ E T V + + N+T
Sbjct: 144 HRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQTV 200
Query: 328 DVYSFGILIMEVISGRNP 345
D++S G ++ E+++GR
Sbjct: 201 DIWSVGCIMAELLTGRTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.2 bits (220), Expect = 3e-20
Identities = 45/214 (21%), Positives = 75/214 (35%), Gaps = 31/214 (14%)
Query: 165 VIGEGGYGIVYRGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVG 221
IG G GIV + NVA+K + K E+ + V HKN++ L+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 222 YCA------EGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 275
E LV E +D + E ++ G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQMLCGIKHLH 136
Query: 276 E-------------GLEPKWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 322
++ K+ DFGLA+ G S++ T + T Y APE
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMG 194
Query: 323 LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQ 356
E D++S G ++ E++ + ++
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 76.2 bits (186), Expect = 8e-16
Identities = 41/260 (15%), Positives = 83/260 (31%), Gaps = 30/260 (11%)
Query: 163 ENVIGEGGYGIVYRGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVG 221
+G G + V+ + +NT+VA+K ++ + + E++ + RV + +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 222 YCAEGAHRMLVNEYVDNGNLEQW------------LHGDVGPHSPLTWEIRMNIILGTAK 269
A ++L + N H + I
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 270 GLTYL-------HEGLEP--------KWNPKLSDFGLAKLLGAERSYVT-TRVMGTFGYV 313
GL Y+ H ++P L +A L A T + T Y
Sbjct: 137 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 314 APEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373
+PE +D++S LI E+I+G + + ++ + ++ + +
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256
Query: 374 AEGVLDPRLQEKPSSRALKR 393
+ +SR L R
Sbjct: 257 YLLRNGKYTRTFFNSRGLLR 276
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 65.6 bits (159), Expect = 4e-13
Identities = 21/159 (13%), Positives = 42/159 (26%), Gaps = 29/159 (18%)
Query: 164 NVIGEGGYGIVYRGVLEDNTNVAVK----------NLLNNRGQAEKEFKVEVEAIGRVRH 213
++GEG V+ E VK + R + F V R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 214 KNLVRLVGYCAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 273
+ L +L G + + N L + + + ++ + +
Sbjct: 66 RALQKLQGLAVPKVY-----AWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118
Query: 274 LHEG------------LEPKWNPKLSDFGLAKLLGAERS 300
+ L + + DF + +G E
Sbjct: 119 FYHRGIVHGDLSQYNVLVSEEGIWIIDFPQSVEVGEEGW 157
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 442 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.67 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 96.94 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 94.47 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 84.7 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=378.27 Aligned_cols=241 Identities=25% Similarity=0.401 Sum_probs=184.0
Q ss_pred CCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCC
Q 047892 158 NGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVD 237 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 237 (442)
++|++.+.||+|+||.||+|.+.+++.||||++... ....+.|.+|++++++++|||||+++|++...+..|+|||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 468889999999999999999988889999998653 3345679999999999999999999999999999999999999
Q ss_pred CCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceeec
Q 047892 238 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVTT 304 (442)
Q Consensus 238 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~~ 304 (442)
+|+|.+++... ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++...........
T Consensus 84 ~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 84 HGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp TCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 99999998754 35689999999999999999999875 344678999999999887554444444
Q ss_pred ccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhC-CCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccC
Q 047892 305 RVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISG-RNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ 383 (442)
Q Consensus 305 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (442)
...||+.|||||++.+..|+.++|||||||++|||+|+ .+||..... ..+.. ...... +
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-------~~~~~---~i~~~~----------~ 220 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVVE---DISTGF----------R 220 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-------HHHHH---HHHHTC----------C
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-------HHHHH---HHHhcC----------C
Confidence 56799999999999999999999999999999999995 555543211 11111 111111 1
Q ss_pred CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 384 EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 384 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
...+..++.++.+|+.+||+.||++||||+||++.|+++
T Consensus 221 ~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 112223346688999999999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-50 Score=381.85 Aligned_cols=250 Identities=21% Similarity=0.358 Sum_probs=202.6
Q ss_pred hHHHhhCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 152 ELEVSTNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 152 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
++++..++|++.+.||+|+||+||+|.+. +++.||||++.... ...+.|.+|+++|++++|||||+++++|.+++..|
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 45667778999999999999999999975 48899999986543 34567999999999999999999999999999999
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+|||||++|+|.+++.... ...+++..++.++.|++.||+|||+. ++.++.+||+|||+|+....
T Consensus 90 iv~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp EEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred EEeecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 9999999999999997532 35789999999999999999999875 34567899999999998765
Q ss_pred CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
..........||+.|||||++.++.|+.++|||||||++|||++|..||...... ..+. .....+
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~------~~~~----~~i~~~----- 232 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVY----ELLEKD----- 232 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHH----HHHHTT-----
T ss_pred CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH------HHHH----HHHhcC-----
Confidence 5554455567899999999999999999999999999999999977766432221 1111 111111
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
.....+...+.++.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 233 ----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 233 ----YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ----CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111222344567889999999999999999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-50 Score=372.12 Aligned_cols=242 Identities=20% Similarity=0.353 Sum_probs=199.8
Q ss_pred hCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
.++|++.+.||+|+||+||+|++++++.||||.+.... ...+.|.+|+.++++++||||++++|+|.+++.+++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 35799999999999999999999888899999987543 34567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceee
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT 303 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~ 303 (442)
++|+|.+++... ...+++..++.++.|+++||.|||+. ++.++.+||+|||+++.+........
T Consensus 82 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 82 ANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 999999997654 24688999999999999999999876 45678999999999988765544444
Q ss_pred cccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCccc
Q 047892 304 TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (442)
....||+.|+|||++.+..|+.++|||||||++|||+| |+.||...... .+ . ..+..+.
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-------~~---~-~~i~~~~--------- 218 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------ET---A-EHIAQGL--------- 218 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-------HH---H-HHHHTTC---------
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-------HH---H-HHHHhCC---------
Confidence 55679999999999999999999999999999999998 89999754321 11 1 1111211
Q ss_pred CCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 383 QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 383 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
+...+...+.++.+|+.+||+.||++|||+++|++.|.++
T Consensus 219 ~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1122233446788999999999999999999999998753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=372.37 Aligned_cols=250 Identities=27% Similarity=0.427 Sum_probs=191.1
Q ss_pred HHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 153 LEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 153 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
+++..++|.+.+.||+|+||+||+|+++ ..||||++... .....+.|.+|+.+|++++|||||++++++.+ +.++
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~ 79 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA 79 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence 4566788999999999999999999864 36999998543 34556789999999999999999999998754 5689
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
||||||++|+|.++++.. ...+++..++.++.|++.||+|||+. ++.++.+||+|||+|+....
T Consensus 80 lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EEEECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EEEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 999999999999999754 24689999999999999999999875 34567999999999987644
Q ss_pred Ccc-eeecccccccCCCCcccccC---CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC
Q 047892 298 ERS-YVTTRVMGTFGYVAPEYAST---GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373 (442)
Q Consensus 298 ~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (442)
... .......||+.|||||++.+ ..|+.++|||||||+||||+||+.||....... .+......+.
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~----------~~~~~~~~~~ 226 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----------QIIFMVGRGY 226 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----------HHHHHHHHTS
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH----------HHHHHHhcCC
Confidence 322 23345689999999999864 358999999999999999999999997543211 1111111111
Q ss_pred cccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 374 AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
..+.+. .....++.++.+|+.+||+.||++||||+||++.|+.+.
T Consensus 227 ----~~p~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 227 ----LSPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp ----CCCCGG-GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCcch-hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111110 112234567888999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=378.25 Aligned_cols=249 Identities=23% Similarity=0.378 Sum_probs=197.9
Q ss_pred hhHHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 151 RELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 151 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
+++++..++|++.+.||+|+||.||+|.+++++.||||++.... ...+.|.+|+++|++++|||||++++++.+ +..|
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence 34566778899999999999999999999888899999986533 345679999999999999999999998754 5679
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+|||||++|+|.+++.... ...+++..++.++.||+.||.|||+. ++.++.+||+|||+|+.+..
T Consensus 84 iv~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp EEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccC
Confidence 9999999999999886431 23589999999999999999999875 45678999999999998866
Q ss_pred CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
..........||+.|||||++.++.|+.++|||||||++|||+||..|+...... ..+.. .. ..+
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~------~~~~~---~i-~~~----- 226 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQ---NL-ERG----- 226 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHH---HH-HTT-----
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH------HHHHH---HH-Hhc-----
Confidence 5554455668999999999999899999999999999999999965554322111 11111 11 111
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.+...+...+.++.+|+.+||+.||++||||+||++.|+..
T Consensus 227 ----~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 227 ----YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 11112223456688999999999999999999999998853
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-50 Score=372.40 Aligned_cols=238 Identities=25% Similarity=0.327 Sum_probs=189.0
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
++|++.+.||+|+||+||+|+.. +|+.||||.+.... ....+.+.+|+++|++++|||||++++++.+++..||||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 56889999999999999999964 58999999986443 23445689999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc-e
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS-Y 301 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~-~ 301 (442)
|++|+|.+++... ..+++..++.++.|++.||+|||+. ++.++.+||+|||+|+.+..... .
T Consensus 85 ~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 85 CSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 9999999999754 5799999999999999999999875 44568999999999997644332 2
Q ss_pred eecccccccCCCCcccccCCCC-CCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 302 VTTRVMGTFGYVAPEYASTGML-NETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
.....+||+.|||||++.+..+ +.++|||||||++|||+||+.||........ . ........
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~------~---~~~~~~~~-------- 223 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------E---YSDWKEKK-------- 223 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH------H---HHHHHTTC--------
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH------H---HHHHhcCC--------
Confidence 3345789999999999988876 5789999999999999999999976443211 0 00111111
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.........+.++.+|+.+||+.||++|||++|+++
T Consensus 224 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 224 -TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011122234566788999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=368.63 Aligned_cols=236 Identities=22% Similarity=0.334 Sum_probs=194.3
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
++|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+++|++++|||||++++++.+.+.+|||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4699999999999999999995 469999999996555455677999999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceee
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT 303 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~ 303 (442)
++|+|.+++.+. .+++..+..++.|++.||.|||+. ++.++.+||+|||+|+.+..... ..
T Consensus 100 ~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~ 173 (293)
T d1yhwa1 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 173 (293)
T ss_dssp TTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred CCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-cc
Confidence 999999998753 589999999999999999999876 45578999999999998754332 23
Q ss_pred cccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcccC
Q 047892 304 TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQ 383 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (442)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ...+......... .
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----------~~~~~~~~~~~~~--------~ 235 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----------LRALYLIATNGTP--------E 235 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----------HHHHHHHHHHCSC--------C
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH----------HHHHHHHHhCCCC--------C
Confidence 456899999999999999999999999999999999999999965332 1111112111111 1
Q ss_pred CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 384 EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 384 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
...+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122344567889999999999999999999985
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=367.59 Aligned_cols=232 Identities=26% Similarity=0.389 Sum_probs=190.9
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|++.+.||+|+||+||+|+.. +++.||+|.+... .......+.+|++++++++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46899999999999999999974 5889999998532 2234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
|||++|+|.+++.+. ..+++..+..++.|++.||+|||+. ++.++.+||+|||+|+......
T Consensus 86 Ey~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred eecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 999999999999764 5689999999999999999999875 4456899999999998764332
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+.. +.... ......
T Consensus 161 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----------~~~~~-i~~~~~------ 221 (263)
T d2j4za1 161 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----------ETYKR-ISRVEF------ 221 (263)
T ss_dssp --CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----------HHHHH-HHTTCC------
T ss_pred --ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH----------HHHHH-HHcCCC------
Confidence 33468999999999999999999999999999999999999999754321 11111 111111
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
..+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 222 ----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 ----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 112234466888999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-49 Score=374.96 Aligned_cols=243 Identities=26% Similarity=0.446 Sum_probs=184.7
Q ss_pred hCCCCccCeeccCCcEEEEEEEECC-C---CeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLED-N---TNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
.++|++.+.||+|+||+||+|.+.. + ..||||.+... .....+.|.+|+++|++++|||||+++|++.+.+..|+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 4568888999999999999999643 3 25899988654 34455679999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
|||||++|+|.+++... ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++.+...
T Consensus 105 v~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999998764 34689999999999999999999875 456789999999999876543
Q ss_pred cce----eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCC
Q 047892 299 RSY----VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373 (442)
Q Consensus 299 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (442)
... ......||+.|||||++.++.|+.++|||||||++|||+| |+.||...... .+.. .. ..+
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-------~~~~---~i-~~~- 249 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-------DVIN---AI-EQD- 249 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHH---HH-HTT-
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-------HHHH---HH-HcC-
Confidence 221 1123467999999999999999999999999999999998 89999754321 1111 11 111
Q ss_pred cccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 374 AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.+...+..++..+.+|+.+||+.||++||||.||++.|+.+
T Consensus 250 --------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 250 --------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11122334556788999999999999999999999999865
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=370.91 Aligned_cols=243 Identities=25% Similarity=0.429 Sum_probs=192.6
Q ss_pred hhCCCCccCe-eccCCcEEEEEEEEC---CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 156 STNGFADENV-IGEGGYGIVYRGVLE---DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 156 ~~~~~~~~~~-lG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
..++|.+.+. ||+|+||+||+|.+. ++..||||.+... .....+.|.+|+++|++++|||||++++++.+ +.+|
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 3455666674 999999999999863 3457999999654 34456789999999999999999999999875 4689
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~~~kl~DFGla~~~~~ 297 (442)
||||||++|+|.+++... ...+++..++.++.|++.||+|||+. + +.++.+||+|||+++.+..
T Consensus 85 lvmE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999999998654 35789999999999999999999875 3 4467899999999998755
Q ss_pred Ccce--eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 298 ERSY--VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 298 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
.... ......||+.|||||++.++.++.++|||||||++|||+| |+.||...... .+.. .+..+.
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-------~~~~----~i~~~~- 229 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMA----FIEQGK- 229 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------HHHH----HHHTTC-
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-------HHHH----HHHcCC-
Confidence 4332 2234578999999999999999999999999999999998 99999754321 1111 111211
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
+...+..++.++.+|+.+||+.||++||||.+|++.|+..
T Consensus 230 --------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 230 --------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp --------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1122234456788999999999999999999999998764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-50 Score=372.58 Aligned_cols=240 Identities=23% Similarity=0.324 Sum_probs=184.9
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE--GAHRML 231 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l 231 (442)
.++|++.+.||+|+||+||+|+. .+|+.||||.+... .....+.+.+|+++|++++|||||++++++.+ .+.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 35689999999999999999996 45899999998543 33445678999999999999999999999865 456899
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc-----------C-------CCCCCCeEEecccCcc
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-----------G-------LEPKWNPKLSDFGLAK 293 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-----------~-------l~~~~~~kl~DFGla~ 293 (442)
|||||++|+|.+++.+.......+++..++.++.|++.||.|||+ + ++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999986533234579999999999999999999975 2 4456899999999999
Q ss_pred ccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC
Q 047892 294 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373 (442)
Q Consensus 294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (442)
.+..... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||...+.. .+. .....+.
T Consensus 163 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-------~~~----~~i~~~~ 230 (269)
T d2java1 163 ILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-------ELA----GKIREGK 230 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHH----HHHHHTC
T ss_pred ecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH-------HHH----HHHHcCC
Confidence 8754322 234578999999999999999999999999999999999999999753221 111 1111221
Q ss_pred cccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 374 AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.. ..+...++++.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~---------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 231 FR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11 112234456888999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-49 Score=369.43 Aligned_cols=238 Identities=19% Similarity=0.273 Sum_probs=191.8
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
+.|++.+.||+|+||+||+|++. +++.||||++........+.+.+|+++|++++|||||++++++.+.+..|||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 45888999999999999999964 58899999997665566677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceee
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT 303 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~ 303 (442)
++|+|.+++.+. ...+++..+..++.|++.||.|||+. ++.++.+||+|||+|+...... ...
T Consensus 92 ~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~ 167 (288)
T d2jfla1 92 AGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 167 (288)
T ss_dssp TTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHH
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-ccc
Confidence 999999998653 24699999999999999999999865 4457899999999998653221 123
Q ss_pred cccccccCCCCccccc-----CCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 304 TRVMGTFGYVAPEYAS-----TGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
...+||+.|||||++. +..|+.++|||||||++|||+||+.||...+..+. . ....... ..
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-------~---~~i~~~~-~~--- 233 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-------L---LKIAKSE-PP--- 233 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-------H---HHHHHSC-CC---
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-------H---HHHHcCC-CC---
Confidence 4568999999999984 45689999999999999999999999976543211 1 1111111 00
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
....+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 234 ----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 ----TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122344567889999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=375.96 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=194.9
Q ss_pred HHHhhCCCCccCeeccCCcEEEEEEEECC-C-----CeEEEEEecCc-chhhHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 047892 153 LEVSTNGFADENVIGEGGYGIVYRGVLED-N-----TNVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCA 224 (442)
Q Consensus 153 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 224 (442)
+++..++|++.+.||+|+||+||+|++.. + ..||+|.+... .......+.+|+.+|.++ +|||||++++++.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 45677889999999999999999999643 2 26999988543 333446788999999998 8999999999999
Q ss_pred eCCeeeeEEecCCCCCHHHHHccCCC-------------------CCCCCCHHHHHHHHHHHHHhhhhhhcC------CC
Q 047892 225 EGAHRMLVNEYVDNGNLEQWLHGDVG-------------------PHSPLTWEIRMNIILGTAKGLTYLHEG------LE 279 (442)
Q Consensus 225 ~~~~~~lv~E~~~~g~L~~~l~~~~~-------------------~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~ 279 (442)
+.+..|+|||||++|+|.++|+.... ....+++..++.++.|++.||+|||+. ++
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK 191 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 191 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence 99999999999999999999976421 123589999999999999999999765 44
Q ss_pred -------CCCCeEEecccCccccCCCcc-eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCC
Q 047892 280 -------PKWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSR 350 (442)
Q Consensus 280 -------~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~ 350 (442)
.++.+||+|||+|+....... .......||+.|||||++.++.|+.++|||||||++|||+| |..||.+..
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 467899999999987644332 23345678999999999999999999999999999999998 899997644
Q ss_pred CCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHh
Q 047892 351 PPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 420 (442)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 420 (442)
.... + ......+ .+...+..++.++.+|+.+||+.||++|||++||++.|.
T Consensus 272 ~~~~------~----~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VDAN------F----YKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSHH------H----HHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHH------H----HHHHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 3211 1 1111111 112223344567889999999999999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-48 Score=368.95 Aligned_cols=238 Identities=21% Similarity=0.309 Sum_probs=176.4
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
.+.|++.+.||+|+||+||+|+.. +++.||||.+.... ......+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 356899999999999999999964 58999999986432 2334568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C----------CCCCCeEEecccCccccCCC
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L----------EPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l----------~~~~~~kl~DFGla~~~~~~ 298 (442)
||+||+|.+++... ..+++..+..++.|++.||+|||+. + +.++.+||+|||+|+.....
T Consensus 88 ~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 88 LVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred ccCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 99999999999764 5799999999999999999999875 3 34678999999999876433
Q ss_pred cceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 299 RSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.... .+. ........
T Consensus 164 ~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~----~~i~~~~~---- 226 (307)
T d1a06a_ 164 S--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-------KLF----EQILKAEY---- 226 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHH----HHHHTTCC----
T ss_pred C--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-------HHH----HHHhccCC----
Confidence 2 234568999999999999999999999999999999999999999753221 111 11111111
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
..........+.++.+|+.+||+.||++|||+.|+++
T Consensus 227 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 227 --EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp --CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1111112234566888999999999999999999997
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-49 Score=369.45 Aligned_cols=250 Identities=23% Similarity=0.351 Sum_probs=191.2
Q ss_pred HHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeE
Q 047892 153 LEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 153 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 232 (442)
+++..++|++.+.||+|+||.||+|.+++++.||||++.... ...+.|.+|+.+|++++|||||++++++.+ +..|+|
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence 345567899999999999999999999888889999986533 345679999999999999999999999854 568999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
||||++|+|..++.... ...+++..++.++.||+.||+|||.. ++.++.+||+|||+++.+....
T Consensus 90 ~Ey~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp ECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 99999999999987531 24589999999999999999999876 4456789999999998775444
Q ss_pred ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
........||+.|+|||++.++.++.++|||||||++|||++|..||...... ..+.. .. ..+.
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~------~~~~~---~i-~~~~------ 231 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLD---QV-ERGY------ 231 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHH---HH-HTTC------
T ss_pred ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH------HHHHH---HH-HhcC------
Confidence 44444567999999999999999999999999999999999966665432211 11111 11 1111
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCC
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 425 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 425 (442)
....+..+++++.+|+.+||+.||++|||+++|+++|+.....
T Consensus 232 ---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 232 ---RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ---CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 1122233456788999999999999999999999999986543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=374.94 Aligned_cols=256 Identities=19% Similarity=0.259 Sum_probs=191.5
Q ss_pred HhhCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeE
Q 047892 155 VSTNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 155 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 232 (442)
+..++|++.+.||+|+||+||+|+. .+|+.||+|++... .......+.+|+.+|++++|||||+++++|.+.+.+|||
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4567899999999999999999996 45899999998643 344456789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhc-C-------------CCCCCCeEEecccCccccCCC
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-G-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
||||++|+|.+++.+. ..+++..+..++.|++.||.|||+ + ++.++.+||+|||+|+.+...
T Consensus 83 mEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 9999999999999764 468999999999999999999984 2 345789999999999875322
Q ss_pred cceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchh-hhHHHHHH----HHhh---
Q 047892 299 RSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQ-VNLFEWLK----TMVT--- 370 (442)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~-~~~~~~~~----~~~~--- 370 (442)
...+.+||+.|||||++.+..|+.++||||+||++|||++|+.||...+........ ........ ....
T Consensus 159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred ---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 234568999999999999999999999999999999999999999765432110000 00000000 0000
Q ss_pred -------cC----Ccc----cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 371 -------NG----NAE----GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 371 -------~~----~~~----~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.. ... ..........+....+.++.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00 000 000000001111123456888999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=357.30 Aligned_cols=231 Identities=25% Similarity=0.389 Sum_probs=181.6
Q ss_pred CccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeeeeEE
Q 047892 161 ADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE----GAHRMLVN 233 (442)
Q Consensus 161 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~lv~ 233 (442)
++.+.||+|+||+||+|.+. +++.||+|.+... .....+.+.+|+++|++++|||||++++++.+ ...+|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45678999999999999964 5889999998543 33445678999999999999999999999865 35689999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC---------------CC-CCCCeEEecccCccccCC
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---------------LE-PKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---------------l~-~~~~~kl~DFGla~~~~~ 297 (442)
|||++|+|.+++++. ..+++..++.++.|++.||+|||++ ++ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 999999999999764 5789999999999999999999864 22 357899999999987543
Q ss_pred CcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGV 377 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (442)
.. ....+||+.|||||++.+ .|+.++|||||||++|||++|+.||...... .. +......+..
T Consensus 168 ~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~---------~~-~~~~i~~~~~--- 230 (270)
T d1t4ha_ 168 SF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA---------AQ-IYRRVTSGVK--- 230 (270)
T ss_dssp TS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---------HH-HHHHHTTTCC---
T ss_pred Cc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH---------HH-HHHHHHcCCC---
Confidence 32 345689999999999865 6999999999999999999999999643221 11 1111111111
Q ss_pred cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 378 LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
... .+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 231 -~~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 -PAS----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -CGG----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -Ccc----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111 11223345788999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=363.54 Aligned_cols=245 Identities=25% Similarity=0.462 Sum_probs=186.2
Q ss_pred hCCCCccCeeccCCcEEEEEEEECCC-----CeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLEDN-----TNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
.+.|+..++||+|+||.||+|.++.. ..||||++... .......|.+|+++|++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 45678889999999999999996432 36999998644 3344567899999999999999999999999999999
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGA 297 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~ 297 (442)
+|||||.+|+|.+++... ...+++..++.++.|++.||+|||+. ++.++.+||+|||+++.+..
T Consensus 86 ~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999988654 35689999999999999999999875 45578999999999987644
Q ss_pred Ccc--eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 298 ERS--YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 298 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
... .......||+.|||||++.++.++.++|||||||++|||++|..||...... ..+.. ....+
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~------~~~~~----~i~~~--- 229 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HEVMK----AINDG--- 229 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHH----HHHTT---
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH------HHHHH----HHhcc---
Confidence 322 2233456899999999999999999999999999999999966665432211 11111 11111
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
.+...+..++..+.+|+.+||+.||++||||.||++.|+.+.
T Consensus 230 ------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 230 ------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp ------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 112223334567889999999999999999999999998754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2e-47 Score=369.60 Aligned_cols=239 Identities=21% Similarity=0.329 Sum_probs=195.3
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+.+|||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4799999999999999999996 458999999997766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC---------CCCCeEEecccCccccCCCcce
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE---------PKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~---------~~~~~kl~DFGla~~~~~~~~~ 301 (442)
++|+|.+++... ...+++..+..++.||+.||.|||+. ++ .++.+||+|||+++.+.....
T Consensus 106 ~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~- 181 (350)
T d1koaa2 106 SGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS- 181 (350)
T ss_dssp CSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC-
T ss_pred CCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc-
Confidence 999999999653 24699999999999999999999875 33 346899999999998754433
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (442)
.....||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+.. +.+..... ... .
T Consensus 182 -~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----------~~~~~i~~-~~~------~ 243 (350)
T d1koaa2 182 -VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD----------ETLRNVKS-CDW------N 243 (350)
T ss_dssp -EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----------HHHHHHHH-TCC------C
T ss_pred -cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH----------HHHHHHHh-CCC------C
Confidence 34468999999999999999999999999999999999999999754321 11111111 110 1
Q ss_pred cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 382 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.........++++.+|+.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111122345678899999999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=367.33 Aligned_cols=235 Identities=19% Similarity=0.269 Sum_probs=188.4
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|++.+.||+|+||+||+|+. .+++.||||++... .....+.+.+|+++|++++|||||++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4689999999999999999996 46899999998542 2234467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc-
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER- 299 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~- 299 (442)
|||++|+|.+++... ..+++..++.++.|++.||+|||+. ++.++.+||+|||+|+.+....
T Consensus 88 Ey~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 999999999998765 5799999999999999999999875 4557899999999999875432
Q ss_pred ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
.......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.. .+ ... ......
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~---~~~-i~~~~~----- 227 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-------LI---FQK-IIKLEY----- 227 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HH---HHH-HHTTCC-----
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH-------HH---HHH-HHcCCC-----
Confidence 22334568999999999999999999999999999999999999999754321 11 111 111111
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
..+...+.++.+|+.+||+.||++|||++|+++
T Consensus 228 -----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 112234456888999999999999999999753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=361.69 Aligned_cols=234 Identities=26% Similarity=0.415 Sum_probs=183.9
Q ss_pred CeeccCCcEEEEEEEECC---CCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecCCC
Q 047892 164 NVIGEGGYGIVYRGVLED---NTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYVDN 238 (442)
Q Consensus 164 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~ 238 (442)
+.||+|+||+||+|.+.+ ++.||||++... .....+.|.+|+++|++++|||||+++++|.+ +..|||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998643 467999998643 23445679999999999999999999999865 457899999999
Q ss_pred CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCccccCCCcce--ee
Q 047892 239 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKLLGAERSY--VT 303 (442)
Q Consensus 239 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~~~~~~~~--~~ 303 (442)
|+|.+++++. ..+++..++.++.||+.||+|||+. ++ .++.+||+|||+++.+...... ..
T Consensus 92 g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 9999999865 5699999999999999999999765 44 4578999999999876544332 22
Q ss_pred cccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCccc
Q 047892 304 TRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRL 382 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (442)
....||+.|||||++.+..++.++|||||||++|||+| |+.||.+... ..+. ..+..+.
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-------~~~~----~~i~~~~--------- 227 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SEVT----AMLEKGE--------- 227 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHH----HHHHTTC---------
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-------HHHH----HHHHcCC---------
Confidence 34578999999999999999999999999999999998 8999975322 1111 1222211
Q ss_pred CCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 383 QEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 383 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
+...+..++.++.+|+.+||+.||++|||+++|++.|+..
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 1122234456788999999999999999999999988753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=363.03 Aligned_cols=246 Identities=20% Similarity=0.331 Sum_probs=184.6
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEECC----CCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLED----NTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAH 228 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 228 (442)
++..++|++.+.||+|+||.||+|.+.. +..||||.+... .....+.+.+|+++|++++|||||++++++. .+.
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 81 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence 4566789999999999999999998643 346889988543 3444567999999999999999999999986 467
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCcccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKLL 295 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~~ 295 (442)
.|+|||||++|+|.+++... ...+++..++.++.|++.||.|||+. ++ .++.+||+|||+++.+
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 89999999999999988654 35689999999999999999999875 33 4578999999999987
Q ss_pred CCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 296 GAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
............||+.|+|||++.+..|+.++|||||||++|||+| |.+||......+ +... ...+.
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-------~~~~----i~~~~- 226 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGR----IENGE- 226 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHH----HHTTC-
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-------HHHH----HHcCC-
Confidence 6554444556678999999999999999999999999999999998 899997654321 1111 11111
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
....+..++..+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 227 --------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 227 --------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11122334567889999999999999999999999998753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=360.47 Aligned_cols=237 Identities=23% Similarity=0.329 Sum_probs=189.9
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc------hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeee
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR------GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 230 (442)
+.|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5689999999999999999996 468999999985321 223577999999999999999999999999999999
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC-------CC----CeEEecccCcc
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP-------KW----NPKLSDFGLAK 293 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-------~~----~~kl~DFGla~ 293 (442)
||||||++|+|.+++... ..+++..++.++.|++.||+|||+. +++ ++ .+||+|||+++
T Consensus 90 iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999999999764 4799999999999999999999865 333 22 58999999998
Q ss_pred ccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC
Q 047892 294 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373 (442)
Q Consensus 294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (442)
....... .....||+.|||||++.+..++.++|||||||++|||++|+.||.+.+.. +..... ....
T Consensus 166 ~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----------~~~~~i-~~~~ 232 (293)
T d1jksa_ 166 KIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----------ETLANV-SAVN 232 (293)
T ss_dssp ECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------HHHHHH-HTTC
T ss_pred hcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH----------HHHHHH-HhcC
Confidence 7644332 34567999999999999999999999999999999999999999754321 111111 1111
Q ss_pred cccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 374 AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
. ..........+..+.+|+.+||+.||++|||++|+++
T Consensus 233 ~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 Y------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0010111223456888999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.9e-47 Score=366.05 Aligned_cols=238 Identities=18% Similarity=0.259 Sum_probs=194.0
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
++|++.+.||+|+||.||+|.. .+|+.||||++..........+.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4689999999999999999996 469999999997665556677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC---------CCCCeEEecccCccccCCCcce
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE---------PKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~---------~~~~~kl~DFGla~~~~~~~~~ 301 (442)
++|+|.+++... ...+++..++.++.||+.||.|||+. ++ .++.+||+|||+|+.+.....
T Consensus 109 ~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~- 184 (352)
T d1koba_ 109 SGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI- 184 (352)
T ss_dssp CCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred CCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc-
Confidence 999999987654 34699999999999999999999865 33 357899999999998754432
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (442)
.....||+.|||||++.+..|+.++|||||||++|||+||+.||.+.... .. +.... .... .
T Consensus 185 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~---~~~i~-~~~~------~ 246 (352)
T d1koba_ 185 -VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ET---LQNVK-RCDW------E 246 (352)
T ss_dssp -EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HH---HHHHH-HCCC------C
T ss_pred -eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HH---HHHHH-hCCC------C
Confidence 34457999999999999999999999999999999999999999754321 11 11111 1111 1
Q ss_pred cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 382 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
+........+.++.+|+.+||+.||.+|||+.|+++
T Consensus 247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122234566888999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-48 Score=358.05 Aligned_cols=240 Identities=26% Similarity=0.378 Sum_probs=184.5
Q ss_pred HHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeeeeE
Q 047892 154 EVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE-GAHRMLV 232 (442)
Q Consensus 154 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv 232 (442)
++..++|++.+.||+|+||.||+|.+ .|..||||+++.. ...+.+.+|++++++++||||++++|++.+ .+.+|+|
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 34556788899999999999999998 4778999999653 344678999999999999999999999865 4668999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
|||+++|+|.+++.... ...+++..++.++.||+.||.|||+. ++.++.+||+|||+++.....
T Consensus 80 ~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp ECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC-
Confidence 99999999999996531 13589999999999999999999876 456789999999999875332
Q ss_pred ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
.....+|..|+|||++.++.+++++|||||||++|||+| |++||...... .+...+ .++
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-------~~~~~i----~~~------ 216 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPRV----EKG------ 216 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-------GHHHHH----TTT------
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH-------HHHHHH----HcC------
Confidence 233468999999999999999999999999999999998 78888654321 122211 111
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.+...+...+.++.+|+.+||+.||++||||.+|++.|+.+
T Consensus 217 ---~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 217 ---YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 11122233446788999999999999999999999999865
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-47 Score=363.08 Aligned_cols=231 Identities=24% Similarity=0.326 Sum_probs=185.6
Q ss_pred CCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc---hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 159 GFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
.|+.++.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 388899999999999999996 458899999986432 2344678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
||.+|+|..++... ..+++..++.++.||+.||.|||+. + +.++.+||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp CCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred ecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 99999998777654 5789999999999999999999875 3 3467899999999987543
Q ss_pred eecccccccCCCCcccccC---CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccccc
Q 047892 302 VTTRVMGTFGYVAPEYAST---GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVL 378 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (442)
....+||+.|||||++.+ +.|+.++|||||||++|||++|..||..... .+.+........
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~----------~~~~~~i~~~~~----- 231 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----------MSALYHIAQNES----- 231 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----------HHHHHHHHHSCC-----
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH----------HHHHHHHHhCCC-----
Confidence 234579999999999854 4689999999999999999999999965322 111112211111
Q ss_pred CcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 379 DPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
+. ......++.+.+|+.+||+.||++|||+.|+++
T Consensus 232 -~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 -PA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -CC---CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CC---CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 01 111233456888999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-47 Score=362.16 Aligned_cols=254 Identities=24% Similarity=0.337 Sum_probs=199.3
Q ss_pred hhhHHHhhCCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCcc-hhhHHHHHHHHHHHHhcCCCCcceEEEE
Q 047892 150 LRELEVSTNGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLVGY 222 (442)
Q Consensus 150 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 222 (442)
+.+++++.++|++.+.||+|+||+||+|++. +++.||||++.... ....+.|.+|+++|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 4567788899999999999999999999963 35689999986543 3445779999999999999999999999
Q ss_pred EEeCCeeeeEEecCCCCCHHHHHccCC--------------------CCCCCCCHHHHHHHHHHHHHhhhhhhcC-----
Q 047892 223 CAEGAHRMLVNEYVDNGNLEQWLHGDV--------------------GPHSPLTWEIRMNIILGTAKGLTYLHEG----- 277 (442)
Q Consensus 223 ~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------------~~~~~l~~~~~~~i~~qi~~~l~yLH~~----- 277 (442)
+...+..++||||+++|+|.++++... .....+++..++.++.|++.||+|||+.
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr 164 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 164 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee
Confidence 999999999999999999999996431 1123588999999999999999999875
Q ss_pred --------CCCCCCeEEecccCccccCCCcc-eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCC-CCCC
Q 047892 278 --------LEPKWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGR-NPVD 347 (442)
Q Consensus 278 --------l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~-~Pf~ 347 (442)
++.++.+||+|||+|+.+..... ...+...||+.|+|||.+.+..|+.++|||||||++|||++|. +||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 34467899999999987644332 2334567899999999999999999999999999999999985 5675
Q ss_pred CCCCCCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 348 YSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
..... +.... +..+.. ...+...+.++.+|+.+||+.||++||||.||++.|+++-
T Consensus 245 ~~~~~----------e~~~~-v~~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 245 GMAHE----------EVIYY-VRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TSCHH----------HHHHH-HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCHH----------HHHHH-HHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 43221 11111 122211 1122234456889999999999999999999999998763
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=359.51 Aligned_cols=235 Identities=21% Similarity=0.227 Sum_probs=192.3
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeE
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 232 (442)
.++|++++.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+.+|++++|||||++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 46799999999999999999996 46999999999543 223456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
||||++|+|.+++.+. ..+++..++.++.|++.||+|||+. ++.+|.+||+|||+|+......
T Consensus 84 ~ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eeccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 9999999999999865 5689999999999999999999875 4567899999999998764332
Q ss_pred ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+.. .+ .... .....
T Consensus 160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-------~~---~~~i-~~~~~----- 222 (337)
T d1o6la_ 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RL---FELI-LMEEI----- 222 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HH---HHHH-HHCCC-----
T ss_pred -cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH-------HH---HHHH-hcCCC-----
Confidence 2345578999999999999999999999999999999999999999764321 11 1111 11111
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCC-----HHHHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPK-----MGHVIH 417 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~ 417 (442)
..+...+.++.+|+.+||+.||.+||+ +.|+++
T Consensus 223 -----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 112234456888999999999999995 788875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=356.43 Aligned_cols=241 Identities=26% Similarity=0.425 Sum_probs=186.5
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCC----eEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeee
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNT----NVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 231 (442)
++|+++++||+|+||+||+|.+. +|+ .||+|++... .....+.+.+|+.+|++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999964 343 5899988543 334567899999999999999999999999865 5678
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~~~~~ 298 (442)
++||+.+|+|.+++... ...+++..++.++.||+.||.|||+. ++ .++.+||+|||+++.+...
T Consensus 88 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 89999999999988764 35789999999999999999999875 33 4578999999999987544
Q ss_pred cce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCCccc
Q 047892 299 RSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEG 376 (442)
Q Consensus 299 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (442)
... ......||+.|||||++.++.|+.++|||||||++|||+| |..||....... +...+ ..+.
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-------~~~~i----~~~~--- 230 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSIL----EKGE--- 230 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-------HHHHH----HHTC---
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-------HHHHH----HcCC---
Confidence 332 2334578999999999999999999999999999999999 899987543211 11111 1111
Q ss_pred ccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 377 VLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
+...+..++..+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 231 ------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 231 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 1122233456788999999999999999999999988764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-47 Score=352.93 Aligned_cols=243 Identities=23% Similarity=0.353 Sum_probs=181.9
Q ss_pred hCCCCccCeeccCCcEEEEEEEECC--C--CeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLED--N--TNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 229 (442)
.++|++.+.||+|+||.||+|++.. + ..||||++... .....+.|.+|+.+|++++|||||+++|++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3568899999999999999998532 2 36899988543 23445679999999999999999999999976 467
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~~~ 296 (442)
++|||||++|+|.+++... ...+++..++.++.|++.||.|||+. ++ .++.+||+|||+++.+.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 8999999999999988654 24689999999999999999999875 33 45789999999999875
Q ss_pred CCcce--eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCccchhhhHHHHHHHHhhcCC
Q 047892 297 AERSY--VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373 (442)
Q Consensus 297 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (442)
..... ......||..|+|||++.+..++.++|||||||++|||+| |+.||.+.+. .+........+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~----------~~~~~~i~~~~- 231 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG----------SQILHKIDKEG- 231 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------HHHHHHHHTSC-
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH----------HHHHHHHHhCC-
Confidence 44322 2234567889999999999999999999999999999998 8999965332 11122222221
Q ss_pred cccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 374 AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
.....+...+..+.+|+.+||+.||++||||.||++.|.+.
T Consensus 232 --------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 --------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11112233445688999999999999999999999998753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-45 Score=352.29 Aligned_cols=231 Identities=23% Similarity=0.300 Sum_probs=189.7
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+.+|+.++|||||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5689999999999999999996 45899999998543 2234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
|||+||+|..++... ..+++..+..++.|++.||+|||+. ++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eecCCcccccccccc----ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 999999999999865 5678889999999999999999876 455789999999999986443
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.. +....... +..
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~----------~~~~~i~~-~~~------ 218 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM----------KTYEKILN-AEL------ 218 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----------HHHHHHHH-CCC------
T ss_pred --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH----------HHHHHHHc-CCC------
Confidence 23568999999999999999999999999999999999999999754321 11111111 111
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCC-----CHHHHHH
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRP-----KMGHVIH 417 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 417 (442)
..+...+.++.+++.+||+.||.+|+ |++++++
T Consensus 219 ----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 ----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11122345678899999999999996 8999975
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-46 Score=353.22 Aligned_cols=256 Identities=23% Similarity=0.352 Sum_probs=189.6
Q ss_pred eehhhHHHhhCCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCc-chhhHHHHHHHHHHHHhc-CCCCcceE
Q 047892 148 YTLRELEVSTNGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRL 219 (442)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l 219 (442)
|...++++..++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|..++.++ +|+||+.+
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 455677888899999999999999999999953 2457999998643 334456688888888777 68999999
Q ss_pred EEEEEeC-CeeeeEEecCCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-
Q 047892 220 VGYCAEG-AHRMLVNEYVDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEG------LE- 279 (442)
Q Consensus 220 ~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~- 279 (442)
++++... +.+++|||||++|+|.++++.... ....+++..++.++.|++.||.|||+. ++
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp 162 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 162 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCc
Confidence 9998654 468999999999999999975321 124589999999999999999999865 44
Q ss_pred ------CCCCeEEecccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhC-CCCCCCCCC
Q 047892 280 ------PKWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISG-RNPVDYSRP 351 (442)
Q Consensus 280 ------~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg-~~Pf~~~~~ 351 (442)
.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+|| .+||.....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 4578999999999876443322 33456799999999999999999999999999999999996 567764432
Q ss_pred CCccchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 352 PGEFQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
... +. .....+. ....+...+.++.+|+.+||+.||++|||+.||++.|+.+
T Consensus 243 ~~~------~~----~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 243 DEE------FC----RRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp SHH------HH----HHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH------HH----HHHhcCC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 211 11 1111111 1112223445688999999999999999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-46 Score=354.03 Aligned_cols=252 Identities=24% Similarity=0.407 Sum_probs=198.5
Q ss_pred hHHHhhCCCCccCeeccCCcEEEEEEEE------CCCCeEEEEEecCc-chhhHHHHHHHHHHHHhc-CCCCcceEEEEE
Q 047892 152 ELEVSTNGFADENVIGEGGYGIVYRGVL------EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYC 223 (442)
Q Consensus 152 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 223 (442)
.+++..++|++.+.||+|+||.||+|++ .+++.||||++... .......+.+|+.+++++ +|||||++++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 3456678899999999999999999985 23568999999654 334556789999999999 799999999999
Q ss_pred EeCCeeeeEEecCCCCCHHHHHccCCC--------------CCCCCCHHHHHHHHHHHHHhhhhhhcC------C-----
Q 047892 224 AEGAHRMLVNEYVDNGNLEQWLHGDVG--------------PHSPLTWEIRMNIILGTAKGLTYLHEG------L----- 278 (442)
Q Consensus 224 ~~~~~~~lv~E~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~~l~yLH~~------l----- 278 (442)
.+.+..|+|||||++|+|.++++.... ....+++..++.++.||+.||+|||++ +
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NI 176 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccc
Confidence 999999999999999999999975421 123689999999999999999999876 3
Q ss_pred --CCCCCeEEecccCccccCCCcc-eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCc
Q 047892 279 --EPKWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGE 354 (442)
Q Consensus 279 --~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~ 354 (442)
+.++.+||+|||+++....... ......+||+.|+|||++.++.++.++|||||||++|||+| |.+||......+.
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 3467899999999998754433 33445689999999999999999999999999999999999 5555644332211
Q ss_pred cchhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 355 FQFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
+. .....+ .+...+...+..+.+|+.+||+.||++||||.||+++|++.
T Consensus 257 ------~~----~~i~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 257 ------FY----KMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp ------HH----HHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HH----HHHhcC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11 111111 11122233456688999999999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=354.68 Aligned_cols=260 Identities=22% Similarity=0.375 Sum_probs=204.9
Q ss_pred eehhhHHHhhCCCCccCeeccCCcEEEEEEEEC------CCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEE
Q 047892 148 YTLRELEVSTNGFADENVIGEGGYGIVYRGVLE------DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLV 220 (442)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~ 220 (442)
|..+++++..++|.+.+.||+|+||.||+|.+. +++.||||++... .......|.+|+.++++++|||||+++
T Consensus 10 ~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence 344566777889999999999999999999863 2578999999643 334445689999999999999999999
Q ss_pred EEEEeCCeeeeEEecCCCCCHHHHHccC------CCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCC
Q 047892 221 GYCAEGAHRMLVNEYVDNGNLEQWLHGD------VGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPK 281 (442)
Q Consensus 221 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~------~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~ 281 (442)
+++...+..++|||||++|+|.+++... ......+++..+..++.|+++||.|||+. ++.+
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 169 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCC
Confidence 9999999999999999999999998642 11224578999999999999999999875 4557
Q ss_pred CCeEEecccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhC-CCCCCCCCCCCccchhh
Q 047892 282 WNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISG-RNPVDYSRPPGEFQFQV 359 (442)
Q Consensus 282 ~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg-~~Pf~~~~~~~~~~~~~ 359 (442)
+.+||+|||+++.+...... ......||+.|+|||.+.++.++.++|||||||++|||+|| .+||...+.
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-------- 241 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------- 241 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH--------
Confidence 79999999999876443332 23445789999999999999999999999999999999997 577754321
Q ss_pred hHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCCCh
Q 047892 360 NLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFR 427 (442)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 427 (442)
.+...... ++. ....+..++..+.+|+.+||+.||++|||+.+|++.|++...+..
T Consensus 242 --~~~~~~i~-~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~ 297 (308)
T d1p4oa_ 242 --EQVLRFVM-EGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297 (308)
T ss_dssp --HHHHHHHH-TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred --HHHHHHHH-hCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 12222221 211 111222344678899999999999999999999999998866654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-46 Score=353.65 Aligned_cols=245 Identities=22% Similarity=0.359 Sum_probs=188.0
Q ss_pred hCCCCccCeeccCCcEEEEEEEECC-CC--eEEEEEecCc-chhhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeeee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLED-NT--NVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 231 (442)
.++|++.+.||+|+||.||+|.+.+ +. .||||++... .....+.+.+|+++|+++ +|||||++++++.+++..|+
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 3578889999999999999999643 43 4788887543 333456799999999999 79999999999999999999
Q ss_pred EEecCCCCCHHHHHccCC------------CCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCCCeEE
Q 047892 232 VNEYVDNGNLEQWLHGDV------------GPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKWNPKL 286 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~~~kl 286 (442)
|||||++|+|.++|+... .....+++..+..++.||+.||.|||+. + +.++.+||
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEE
Confidence 999999999999997541 2345799999999999999999999875 3 44568999
Q ss_pred ecccCccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCC-CCCCCCCCCCccchhhhHHHHH
Q 047892 287 SDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGR-NPVDYSRPPGEFQFQVNLFEWL 365 (442)
Q Consensus 287 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~-~Pf~~~~~~~~~~~~~~~~~~~ 365 (442)
+|||+++...... ......||..|+|||.+.++.|+.++|||||||++|||++|. +||...+. .+..
T Consensus 169 ~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~----------~~~~ 236 (309)
T d1fvra_ 169 ADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----------AELY 236 (309)
T ss_dssp CCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------HHHH
T ss_pred ccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH----------HHHH
Confidence 9999998653222 223456899999999999999999999999999999999965 56654321 1111
Q ss_pred HHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 366 KTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
..+..+ .+...+...+.++.+|+.+||+.||++||||.||++.|+++.
T Consensus 237 -~~i~~~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 237 -EKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp -HHGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHhc---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111111 111222334567889999999999999999999999988753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.5e-45 Score=343.74 Aligned_cols=237 Identities=20% Similarity=0.276 Sum_probs=190.4
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc---------hhhHHHHHHHHHHHHhcC-CCCcceEEEEEEeC
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR---------GQAEKEFKVEVEAIGRVR-HKNLVRLVGYCAEG 226 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~ 226 (442)
++|++.+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+.+|++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5789999999999999999996 468899999985432 112345889999999997 99999999999999
Q ss_pred CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcc
Q 047892 227 AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAK 293 (442)
Q Consensus 227 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~ 293 (442)
+.+|||||||++|+|.++|+.. ..+++..++.++.||+.||+|||+. ++.++.+||+|||+++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhee
Confidence 9999999999999999999764 5799999999999999999999876 4567899999999999
Q ss_pred ccCCCcceeecccccccCCCCcccccC------CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHH
Q 047892 294 LLGAERSYVTTRVMGTFGYVAPEYAST------GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKT 367 (442)
Q Consensus 294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 367 (442)
.+.... .....+||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.+.. .. ..
T Consensus 159 ~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-------~~----~~ 225 (277)
T d1phka_ 159 QLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------LM----LR 225 (277)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HH----HH
T ss_pred EccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH-------HH----HH
Confidence 875432 2345689999999999853 35788999999999999999999999754321 11 11
Q ss_pred HhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 368 MVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
....+.. .+........++++.+|+.+||+.||++|||+.|+++
T Consensus 226 ~i~~~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 226 MIMSGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111111 1112222345567889999999999999999999975
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=348.79 Aligned_cols=254 Identities=22% Similarity=0.293 Sum_probs=185.4
Q ss_pred CCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----eeeeEEe
Q 047892 159 GFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA----HRMLVNE 234 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~lv~E 234 (442)
+|.+.+.||+|+||.||+|++ +|+.||||++.... ........|+..+..++|||||++++++.+.+ .+|+|||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 467788999999999999997 68899999985432 11222334555556789999999999997654 5799999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC---------------------CCCCCCeEEecccCcc
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG---------------------LEPKWNPKLSDFGLAK 293 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---------------------l~~~~~~kl~DFGla~ 293 (442)
||++|+|.++|++. .+++..++.++.|++.||.|||.. ++.++.+||+|||+++
T Consensus 82 y~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999864 589999999999999999999852 4567899999999998
Q ss_pred ccCCCcce---eecccccccCCCCcccccCCC------CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccch----hhh
Q 047892 294 LLGAERSY---VTTRVMGTFGYVAPEYASTGM------LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQF----QVN 360 (442)
Q Consensus 294 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~----~~~ 360 (442)
........ ......||+.|||||++.+.. ++.++|||||||+||||+||..||........... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 77443322 234568999999999986543 67789999999999999999988854332211100 011
Q ss_pred HHHHHHHHhhcCCcccccCcccCCC-CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCC
Q 047892 361 LFEWLKTMVTNGNAEGVLDPRLQEK-PSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 423 (442)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~ 423 (442)
............. .++.+... ........+.+|+.+||+.||++|||+.||++.|+++.
T Consensus 237 ~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 237 SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1222222222222 12222111 12345667889999999999999999999999998653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=349.72 Aligned_cols=250 Identities=25% Similarity=0.411 Sum_probs=192.8
Q ss_pred HHHhhCCCCccCeeccCCcEEEEEEEECC--------CCeEEEEEecCcc-hhhHHHHHHHHHHHHhc-CCCCcceEEEE
Q 047892 153 LEVSTNGFADENVIGEGGYGIVYRGVLED--------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLVGY 222 (442)
Q Consensus 153 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 222 (442)
+++..++|++.+.||+|+||.||+|+... +..||||++.... ......+.+|...+.++ +|||||+++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 45667789999999999999999998532 2469999996543 34456788899999888 89999999999
Q ss_pred EEeCCeeeeEEecCCCCCHHHHHccCCC------------CCCCCCHHHHHHHHHHHHHhhhhhhcC-------------
Q 047892 223 CAEGAHRMLVNEYVDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEG------------- 277 (442)
Q Consensus 223 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~yLH~~------------- 277 (442)
|.+++..|+|||||++|+|.++|..... ....+++..++.++.|++.||+|||+.
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence 9999999999999999999999975421 234689999999999999999999875
Q ss_pred CCCCCCeEEecccCccccCCCcce-eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHh-CCCCCCCCCCCCcc
Q 047892 278 LEPKWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVIS-GRNPVDYSRPPGEF 355 (442)
Q Consensus 278 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~Pf~~~~~~~~~ 355 (442)
++.++.+||+|||+++........ ......||+.|+|||.+.++.|+.++|||||||++|||++ |.+||.....
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---- 243 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 243 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH----
Confidence 445678999999999876443322 2345678999999999999999999999999999999998 7888864322
Q ss_pred chhhhHHHHHHHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 356 QFQVNLFEWLKTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
..+. .....+. ....+...+.++.+|+.+||+.||.+||||.||++.|+++
T Consensus 244 ---~~~~----~~i~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 244 ---EELF----KLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ---HHHH----HHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHH----HHHHcCC---------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1111 1222211 1112223445688999999999999999999999999865
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-45 Score=348.27 Aligned_cols=237 Identities=17% Similarity=0.273 Sum_probs=189.9
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
++|++.+.||+|+||+||+|... +++.||||.+.... .....+.+|+++|+.++|||||++++++.+.+.+|||||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 56899999999999999999964 58899999996543 33456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC---------CCCeEEecccCccccCCCcce
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP---------KWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~---------~~~~kl~DFGla~~~~~~~~~ 301 (442)
+||+|.++++.. ...+++..+..++.||+.||+|||+. ++| .+.+||+|||+++.......
T Consensus 84 ~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~- 159 (321)
T d1tkia_ 84 SGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN- 159 (321)
T ss_dssp CCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE-
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCc-
Confidence 999999999764 24689999999999999999999865 443 34799999999987644332
Q ss_pred eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCcc
Q 047892 302 VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDPR 381 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (442)
.....||+.|+|||.+.+..|+.++|||||||++|||++|..||...... .+ ...... .... .+.
T Consensus 160 -~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-------~~---~~~i~~-~~~~--~~~- 224 (321)
T d1tkia_ 160 -FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------QI---IENIMN-AEYT--FDE- 224 (321)
T ss_dssp -EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HH---HHHHHH-TCCC--CCH-
T ss_pred -ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-------HH---HHHHHh-CCCC--CCh-
Confidence 34457899999999999999999999999999999999999999754321 11 111111 1100 000
Q ss_pred cCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 382 LQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 382 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
......+.++.+|+.+||+.||++|||+.|+++
T Consensus 225 ---~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 225 ---EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ---HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---hhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001123456888999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=351.87 Aligned_cols=234 Identities=22% Similarity=0.310 Sum_probs=186.9
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHHHHHHHHH-hcCCCCcceEEEEEEeCCeeeeE
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIG-RVRHKNLVRLVGYCAEGAHRMLV 232 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~~~~lv 232 (442)
++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|..++. .++|||||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57899999999999999999964 58999999995431 223345667777665 68999999999999999999999
Q ss_pred EecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCc
Q 047892 233 NEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 233 ~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~ 299 (442)
||||++|+|.++++.. ..+++..++.++.||+.||.|||+. ++.++.+||+|||+++......
T Consensus 82 mEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 9999999999999765 5689999999999999999999876 4456899999999998764332
Q ss_pred ceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccC
Q 047892 300 SYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLD 379 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (442)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.. .+.. .. ..+.
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-------~~~~---~i-~~~~------ 219 (320)
T d1xjda_ 158 -AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFH---SI-RMDN------ 219 (320)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHH---HH-HHCC------
T ss_pred -ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-------HHHH---HH-HcCC------
Confidence 2334568999999999999999999999999999999999999999754321 1111 11 1111
Q ss_pred cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHH-HHHH
Q 047892 380 PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMG-HVIH 417 (442)
Q Consensus 380 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~-evl~ 417 (442)
+ ..+...+.++.+|+.+||+.||++|||+. |+++
T Consensus 220 ~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 P----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp C----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1 11223345688999999999999999995 6753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=344.38 Aligned_cols=241 Identities=26% Similarity=0.377 Sum_probs=187.1
Q ss_pred cCeeccCCcEEEEEEEECCC----CeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeeeeEEecC
Q 047892 163 ENVIGEGGYGIVYRGVLEDN----TNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE-GAHRMLVNEYV 236 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~E~~ 236 (442)
.++||+|+||+||+|.+..+ ..||||++... .....+.|.+|+++|++++|||||+++|++.. ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999996432 25899998643 44556789999999999999999999999865 56889999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce--
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY-- 301 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~-- 301 (442)
++|+|.+++... ...+++..++.++.|++.||.|||+. ++.++.+||+|||+++.+......
T Consensus 112 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999998764 34678888999999999999999875 455688999999999876543322
Q ss_pred -eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 302 -VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 302 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
......||+.|+|||.+.+..++.++|||||||++|||+||..||........ ... .. ..+.
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~------~~~---~i-~~g~------- 251 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITV---YL-LQGR------- 251 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHH---HH-HTTC-------
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH------HHH---HH-HcCC-------
Confidence 22345789999999999999999999999999999999998888754322111 111 11 1111
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcCCCC
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 425 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 425 (442)
+...+..++..+.+|+.+||+.||++||||.||++.|+++...
T Consensus 252 --~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 252 --RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1111223445688999999999999999999999999887543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-44 Score=352.26 Aligned_cols=236 Identities=19% Similarity=0.255 Sum_probs=185.0
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcc---hhhHHHHH---HHHHHHHhcCCCCcceEEEEEEeCCee
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNR---GQAEKEFK---VEVEAIGRVRHKNLVRLVGYCAEGAHR 229 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~hpnIv~l~~~~~~~~~~ 229 (442)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+. +|+.+++.++|||||++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 467999999999999999999964 58999999985321 11222333 446777888999999999999999999
Q ss_pred eeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccC
Q 047892 230 MLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLG 296 (442)
Q Consensus 230 ~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~ 296 (442)
|+|||||++|+|.++|.+. ..+++..++.++.||+.||.|||+. ++.++.+||+|||+|+.+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999999765 5688999999999999999999875 4556899999999999765
Q ss_pred CCcceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc
Q 047892 297 AERSYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE 375 (442)
Q Consensus 297 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (442)
... ....+||+.|||||++.. ..|+.++|||||||+||||+||+.||........ .. +.......
T Consensus 159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------~~-~~~~~~~~--- 224 (364)
T d1omwa3 159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-------HE-IDRMTLTM--- 224 (364)
T ss_dssp SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-------HH-HHHHSSSC---
T ss_pred CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-------HH-HHHhcccC---
Confidence 432 345689999999999965 5689999999999999999999999976543221 11 11111110
Q ss_pred cccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCC-----HHHHHH
Q 047892 376 GVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPK-----MGHVIH 417 (442)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~ 417 (442)
....+...+.++.+|+.+||+.||++||| ++|+++
T Consensus 225 -------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 -------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 01112234456888999999999999999 688874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-44 Score=340.21 Aligned_cols=245 Identities=23% Similarity=0.322 Sum_probs=185.2
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----e
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA----H 228 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~ 228 (442)
.++|++.+.||+|+||.||+|+. .+++.||||.+... +......+.+|+++|+.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 35699999999999999999996 46899999999643 2344567899999999999999999999987654 3
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCcccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKLL 295 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~~ 295 (442)
.|||||||+||+|.+++... ..+++..++.++.|++.||+|||+. ++ .++.++|+|||.++..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence 79999999999999998764 5799999999999999999999875 44 4568899999998765
Q ss_pred CCCcc--eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC
Q 047892 296 GAERS--YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373 (442)
Q Consensus 296 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (442)
..... ......+||+.|||||++.+..|++++|||||||++|||+||+.||...+.. +..........
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----------~~~~~~~~~~~ 231 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV----------SVAYQHVREDP 231 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----------HHHHHHHHCCC
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH----------HHHHHHHhcCC
Confidence 43322 2334568999999999999999999999999999999999999999754321 11122222211
Q ss_pred cccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCC-CHHHHHHHHhcC
Q 047892 374 AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRP-KMGHVIHMLEAE 422 (442)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-s~~evl~~L~~~ 422 (442)
. .+. ......+.++.+|+.+||+.||++|| |++++++.|..+
T Consensus 232 ~----~~~---~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 232 I----PPS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp C----CGG---GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred C----CCc---hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 1 000 11112345688899999999999999 899998887654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=347.00 Aligned_cols=238 Identities=21% Similarity=0.256 Sum_probs=184.3
Q ss_pred CCCCccC-eeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhc-CCCCcceEEEEEEe----CCeee
Q 047892 158 NGFADEN-VIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLVGYCAE----GAHRM 230 (442)
Q Consensus 158 ~~~~~~~-~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~----~~~~~ 230 (442)
++|.+.. .||+|+||.||+|+. .+++.||||++... ..+.+|+.++.++ +|||||+++++|.+ ...+|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5687764 699999999999996 56899999998542 3567899987654 89999999999875 46789
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC----------CCCeEEecccCccc
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP----------KWNPKLSDFGLAKL 294 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~----------~~~~kl~DFGla~~ 294 (442)
||||||+||+|.++|.+.. ...+++..+..++.|++.||+|||+. +++ .+.+||+|||+|+.
T Consensus 86 ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence 9999999999999997542 24699999999999999999999875 333 45799999999987
Q ss_pred cCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
...... ....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+...... .+......
T Consensus 164 ~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~-------~~~~~i~~--- 231 (335)
T d2ozaa1 164 TTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------GMKTRIRM--- 231 (335)
T ss_dssp CCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------CCCS---
T ss_pred ccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH-------HHHHHHhc---
Confidence 654332 345689999999999999999999999999999999999999997654322110 00000000
Q ss_pred ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 375 EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
....+........+.++.+|+.+||+.||++|||+.|+++
T Consensus 232 ---~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 232 ---GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ---CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0011111222345678999999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.7e-45 Score=351.51 Aligned_cols=231 Identities=21% Similarity=0.240 Sum_probs=189.5
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc---chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 233 (442)
++|++++.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+++|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5699999999999999999996 46999999998532 2233467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERS 300 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~ 300 (442)
||+.+|+|.+++.+. ..+++..++.++.||+.||.|||+. ++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred ccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 999999999999765 4689999999999999999999865 445789999999999987433
Q ss_pred eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcccccCc
Q 047892 301 YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAEGVLDP 380 (442)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (442)
....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+. ........ ....
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----------~~~~~~i~-~~~~------ 255 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP----------IQIYEKIV-SGKV------ 255 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------HHHHHHHH-HCCC------
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH----------HHHHHHHh-cCCC------
Confidence 2346899999999999999999999999999999999999999975432 11111111 1111
Q ss_pred ccCCCCcHHHHHHHHHHHhhhhCCCCCCCC-----CHHHHHH
Q 047892 381 RLQEKPSSRALKRALLVALRCVDPNAHKRP-----KMGHVIH 417 (442)
Q Consensus 381 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 417 (442)
..+...+.++.+|+.+||+.||.+|+ |++|+++
T Consensus 256 ----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 ----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11223445688899999999999994 8999985
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-44 Score=337.95 Aligned_cols=248 Identities=21% Similarity=0.224 Sum_probs=182.2
Q ss_pred cCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchh-----hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEecC
Q 047892 163 ENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQ-----AEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEYV 236 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 236 (442)
+++||+|+||+||+|+. .+|+.||||++...... ..+.+.+|+.+|++++|||||++++++.+++..|||||||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57899999999999996 45899999998543211 1246889999999999999999999999999999999999
Q ss_pred CCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcceee
Q 047892 237 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYVT 303 (442)
Q Consensus 237 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~~ 303 (442)
.++++..+.... ..+++..+..++.|++.||+|||+. ++.++.+||+|||+++....... ..
T Consensus 83 ~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~ 157 (299)
T d1ua2a_ 83 ETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AY 157 (299)
T ss_dssp SEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CC
T ss_pred cchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc-cc
Confidence 998777665433 5688889999999999999999875 34567999999999987654332 23
Q ss_pred cccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCcc---cc--
Q 047892 304 TRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNAE---GV-- 377 (442)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-- 377 (442)
...+||+.|||||++.+. .|+.++|||||||++|||++|..||...... +....+.......... ..
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-------~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-------DQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHHHCCCCTTTSSSTTS
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-------HHHHHHHHhcCCCChhhccchhc
Confidence 346899999999998654 5899999999999999999999999754321 1111111111110000 00
Q ss_pred ----c-CcccCCCCc----HHHHHHHHHHHhhhhCCCCCCCCCHHHHHH--HHhcC
Q 047892 378 ----L-DPRLQEKPS----SRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEAE 422 (442)
Q Consensus 378 ----~-~~~~~~~~~----~~~~~~~~~li~~cl~~dP~~RPs~~evl~--~L~~~ 422 (442)
. ......... ...++++.+|+.+||+.||++|||++|+++ .+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0 000000000 123467889999999999999999999986 35543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-43 Score=330.96 Aligned_cols=260 Identities=19% Similarity=0.287 Sum_probs=190.4
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
++|++++.||+|+||+||+|.. .+++.||||++.... ......+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5799999999999999999996 568999999995432 2234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
||.++ +.+++... ....+++..+..++.|++.||.|||+. ++.++.+||+|||+|+.......
T Consensus 82 ~~~~~-~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~- 157 (298)
T d1gz8a_ 82 FLHQD-LKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 157 (298)
T ss_dssp CCSEE-HHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred ecCCc-hhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence 99874 54454332 135689999999999999999999875 34567899999999987644332
Q ss_pred eecccccccCCCCcccccCCC-CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC-------
Q 047892 302 VTTRVMGTFGYVAPEYASTGM-LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN------- 373 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 373 (442)
......||+.|+|||++.... ++.++|||||||++|||++|+.||...+..+. +............
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~------~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ------LFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHHHCCCCTTTSTTGG
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH------HHHHHHhcCCCchhhccccc
Confidence 234457999999999887766 57899999999999999999999975432111 1111111100000
Q ss_pred ----cccccCcccCCCC---cHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH--HhcCCCCCh
Q 047892 374 ----AEGVLDPRLQEKP---SSRALKRALLVALRCVDPNAHKRPKMGHVIHM--LEAEEFPFR 427 (442)
Q Consensus 374 ----~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~ 427 (442)
............. ....+.++.+|+.+||+.||++|||+.|+++. ++++..|.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p 294 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCCC
Confidence 0000000000000 01234568889999999999999999999974 777766654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.4e-42 Score=324.62 Aligned_cols=248 Identities=19% Similarity=0.249 Sum_probs=185.3
Q ss_pred CCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcc--hhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEec
Q 047892 158 NGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 235 (442)
++|++.+.||+|+||+||+|++++++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788999999999999999999889999999995432 23356789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCCccee
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAERSYV 302 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~~~~~ 302 (442)
+.++.+..+.+.. ..+++..+..++.|++.||+|||+. ++.++.+||+|||++........ .
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~ 156 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (286)
T ss_dssp CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc-c
Confidence 9987777776543 5799999999999999999999875 44578999999999987644322 2
Q ss_pred ecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC--------
Q 047892 303 TTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN-------- 373 (442)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 373 (442)
.....|++.|+|||.+.+. .++.++|||||||++|||++|+.||...+..+ .............
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-------~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-------QLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHHHCCCCTTTSTTGG
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-------HHHHHHHhhCCCChhhccchh
Confidence 3445789999999998754 57899999999999999999999997543211 1111111110000
Q ss_pred ----cccccC---cccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 374 ----AEGVLD---PRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 374 ----~~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
...... +..........+..+.+|+.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 00000111223456889999999999999999999984
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=332.60 Aligned_cols=232 Identities=22% Similarity=0.378 Sum_probs=183.9
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcch------hhHHHHHHHHHHHHhcC--CCCcceEEEEEEeCCe
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRG------QAEKEFKVEVEAIGRVR--HKNLVRLVGYCAEGAH 228 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~ 228 (442)
++|++.+.||+|+||+||+|+. .+++.||||++..... .....+.+|+.+|++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 4689999999999999999996 4689999999854211 11234668999999996 8999999999999999
Q ss_pred eeeEEecCCC-CCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC--------CCCeEEecccCcc
Q 047892 229 RMLVNEYVDN-GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP--------KWNPKLSDFGLAK 293 (442)
Q Consensus 229 ~~lv~E~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~--------~~~~kl~DFGla~ 293 (442)
.|+||||+.+ +++.+++... ..+++..++.++.|++.||+|||+. +++ ++.+||+|||+|+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccce
Confidence 9999999976 6888888754 5789999999999999999999875 332 3689999999998
Q ss_pred ccCCCcceeecccccccCCCCcccccCCCC-CCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC
Q 047892 294 LLGAERSYVTTRVMGTFGYVAPEYASTGML-NETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372 (442)
Q Consensus 294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (442)
..... ..+..+||+.|||||++.+..+ +.++|||||||++|||++|+.||...+ .... .
T Consensus 160 ~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------------~i~~-~ 219 (273)
T d1xwsa_ 160 LLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------------EIIR-G 219 (273)
T ss_dssp ECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------------HHHH-C
T ss_pred ecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------------HHhh-c
Confidence 75433 2345689999999999987775 567899999999999999999996321 0111 1
Q ss_pred CcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH--HHhcCC
Q 047892 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEAEE 423 (442)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~--~L~~~~ 423 (442)
.. .++ ...+.++.+|+.+||+.||++|||++|+++ .++++.
T Consensus 220 ~~------~~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 220 QV------FFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp CC------CCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred cc------CCC----CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 00 111 123456888999999999999999999987 465543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-42 Score=325.50 Aligned_cols=255 Identities=22% Similarity=0.258 Sum_probs=183.5
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CC-CCeEEEEEecCcc--hhhHHHHHHHHHHHHhc---CCCCcceEEEEEEe----
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-ED-NTNVAVKNLLNNR--GQAEKEFKVEVEAIGRV---RHKNLVRLVGYCAE---- 225 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~---- 225 (442)
.++|++++.||+|+||+||+|+. .+ ++.||||++.... ......+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46799999999999999999996 34 5679999985432 22223456777777665 89999999999853
Q ss_pred -CCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCCCeEEecccC
Q 047892 226 -GAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKWNPKLSDFGL 291 (442)
Q Consensus 226 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~~~kl~DFGl 291 (442)
....+++|||+.+|++....... ...+++..+..++.|++.||+|||+. + +.++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhh
Confidence 35679999999997776554433 35689999999999999999999875 3 4467899999999
Q ss_pred ccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhc
Q 047892 292 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTN 371 (442)
Q Consensus 292 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (442)
++...... ......||+.|||||++.+..|+.++||||+||++|||++|+.||...+..+ ....+......
T Consensus 163 ~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~~~ 233 (305)
T d1blxa_ 163 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-------QLGKILDVIGL 233 (305)
T ss_dssp CCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHHHCC
T ss_pred hhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-------HHHHHHHhhCC
Confidence 98653322 2345689999999999999999999999999999999999999997643211 11111111100
Q ss_pred CCc----------ccccCcccC---CCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH--HhcCC
Q 047892 372 GNA----------EGVLDPRLQ---EKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM--LEAEE 423 (442)
Q Consensus 372 ~~~----------~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 423 (442)
... ......... .......+..+.+|+.+||+.||++|||+.|+++. ++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 000 000000000 00112234567889999999999999999999863 55543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=325.47 Aligned_cols=240 Identities=20% Similarity=0.273 Sum_probs=188.9
Q ss_pred hCCCCccCeeccCCcEEEEEEEE----CCCCeEEEEEecCc----chhhHHHHHHHHHHHHhcCC-CCcceEEEEEEeCC
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL----EDNTNVAVKNLLNN----RGQAEKEFKVEVEAIGRVRH-KNLVRLVGYCAEGA 227 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~ 227 (442)
.++|++.+.||+|+||+||+|.. .+|+.||||.+... .....+.+.+|+++|++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 35699999999999999999985 24789999998532 22334567889999999977 89999999999999
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKL 294 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~ 294 (442)
..+++|||+.+|+|.+++... ..+++..+..++.|++.||.|||+. ++.++.+||+|||+++.
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ceeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999999765 4678889999999999999999875 44578999999999987
Q ss_pred cCCCcceeecccccccCCCCcccccCC--CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcC
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYASTG--MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNG 372 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (442)
+............|++.|+|||.+.+. .++.++|||||||+||||++|+.||........... + ..... ..
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~---i---~~~~~-~~ 251 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE---I---SRRIL-KS 251 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH---H---HHHHH-HC
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---H---HHhcc-cC
Confidence 755444444567899999999999765 477899999999999999999999987655433211 1 11111 10
Q ss_pred CcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCC-----CHHHHHH
Q 047892 373 NAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRP-----KMGHVIH 417 (442)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 417 (442)
....+...+.++.+|+.+||+.||++|| |++|+++
T Consensus 252 ----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1111223456788899999999999999 4788875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-40 Score=316.93 Aligned_cols=250 Identities=17% Similarity=0.209 Sum_probs=180.0
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEe--------C
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE--------G 226 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--------~ 226 (442)
++|++.+.||+|+||+||+|++ .+|+.||||++... .......+.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 5689999999999999999996 46899999998533 23344678899999999999999999999855 3
Q ss_pred CeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcc
Q 047892 227 AHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAK 293 (442)
Q Consensus 227 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~ 293 (442)
+..|+|||||.++.+..+... ...+++..+..++.|++.||.|||+. ++.++.+||+|||+++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 467999999998766655433 25688999999999999999999875 4557899999999998
Q ss_pred ccCCCcce---eecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHh
Q 047892 294 LLGAERSY---VTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMV 369 (442)
Q Consensus 294 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 369 (442)
.+...... .....+||+.|+|||++.+. .|++++|||||||++|||++|+.||...... .....+....
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~-------~~~~~i~~~~ 238 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-------HQLALISQLC 238 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHHH
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH-------HHHHHHHHhc
Confidence 76543221 22345799999999998765 6899999999999999999999999754321 1111111111
Q ss_pred hcCCc-----------ccccCcccCCCCcH-------HHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 370 TNGNA-----------EGVLDPRLQEKPSS-------RALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 370 ~~~~~-----------~~~~~~~~~~~~~~-------~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
..... ...+.......... .....+.+|+.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 11000 00000000000110 123456789999999999999999999964
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-41 Score=325.88 Aligned_cols=257 Identities=21% Similarity=0.228 Sum_probs=179.5
Q ss_pred CCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------Ceeee
Q 047892 159 GFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG------AHRML 231 (442)
Q Consensus 159 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~~~l 231 (442)
+|+..++||+|+||+||+|++. +|+.||||++..... ...+|+++|++++||||++++++|... .++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 3777899999999999999974 589999999965432 234699999999999999999998543 35789
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCC-CCeEEecccCccccCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPK-WNPKLSDFGLAKLLGA 297 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~-~~~kl~DFGla~~~~~ 297 (442)
|||||++|. .+.+.........+++..+..++.|++.||+|||+. + +.+ ..+||+|||+++.+..
T Consensus 97 v~Ey~~~~~-~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 97 VLDYVPETV-YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp EEECCSEEH-HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred EEeccCCcc-HHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 999998754 333322111235799999999999999999999876 3 334 3799999999987654
Q ss_pred CcceeecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhh-----HHHHHHHHhhc
Q 047892 298 ERSYVTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVN-----LFEWLKTMVTN 371 (442)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~ 371 (442)
... ....+||+.|+|||.+.+ ..|+.++||||+||++|||++|+.||......+.+..... ..++.......
T Consensus 176 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 176 GEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp TSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred Ccc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence 332 334689999999998865 4689999999999999999999999975432211100000 00011111000
Q ss_pred ---CCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH--HhcC
Q 047892 372 ---GNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM--LEAE 422 (442)
Q Consensus 372 ---~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~--L~~~ 422 (442)
..........+........+.++.+|+.+||+.||++|||+.|+++. ++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 00000000011111122345568889999999999999999999853 4443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-40 Score=319.55 Aligned_cols=254 Identities=22% Similarity=0.297 Sum_probs=181.1
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA------ 227 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------ 227 (442)
.++|++++.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 45799999999999999999996 45999999999643 3344567889999999999999999999997654
Q ss_pred eeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccc
Q 047892 228 HRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKL 294 (442)
Q Consensus 228 ~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~ 294 (442)
.+|+||||| +++|..+++. ..+++..++.++.|++.||.|||+. ++.++.+||+|||+|+.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceec
Confidence 469999999 4588888765 3699999999999999999999875 44578999999999987
Q ss_pred cCCCcceeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHH-----HHH---
Q 047892 295 LGAERSYVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF-----EWL--- 365 (442)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~-----~~~--- 365 (442)
.... .+...||+.|+|||++.+. .++.++||||+||++|||++|+.||...+............ .+.
T Consensus 171 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 171 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 6433 2446799999999998764 57899999999999999999999997643211100000000 000
Q ss_pred -----HHHhhcCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH--HhcCC
Q 047892 366 -----KTMVTNGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM--LEAEE 423 (442)
Q Consensus 366 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 423 (442)
...... ........+. ......+..+.+|+.+||..||++|||+.|+++. |+.+.
T Consensus 247 ~~~~~~~~~~~--~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 247 QSDEAKNYMKG--LPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp SCHHHHHHHHH--SCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred cchhhhhhhcc--CCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 000000 0000000000 0111234567889999999999999999999974 66544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-40 Score=313.91 Aligned_cols=245 Identities=17% Similarity=0.162 Sum_probs=181.1
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCCCCcc-eEEEEEEeCCeeeeEEec
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV-RLVGYCAEGAHRMLVNEY 235 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~l~~~~~~~~~~~lv~E~ 235 (442)
++|++.+.||+|+||+||+|++ .+++.||||.+..... ...+.+|+++++.++|+|++ .+.+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4589999999999999999996 4588999998754322 23578899999999877655 555666788889999999
Q ss_pred CCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCCC----------CCeEEecccCccccCCCc
Q 047892 236 VDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEPK----------WNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 236 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~~----------~~~kl~DFGla~~~~~~~ 299 (442)
+.+ +|.+.+... ...+++..+..++.|++.||+|||+. ++|+ ..+||+|||+|+.+....
T Consensus 85 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 85 LGP-SLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp CCC-BHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred cCC-chhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 965 676666543 25689999999999999999999765 5543 369999999999775432
Q ss_pred ce------eecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC
Q 047892 300 SY------VTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN 373 (442)
Q Consensus 300 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (442)
.. ......||+.|||||++.+..++.++|||||||++|||+||+.||............ ......... ..
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~---~~~~~~~~~-~~ 236 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY---ERISEKKMS-TP 236 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H---HHHHHHHHH-SC
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH---HHhhcccCC-CC
Confidence 21 234568999999999999999999999999999999999999999765443322111 111100000 00
Q ss_pred cccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhc
Q 047892 374 AEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 421 (442)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 421 (442)
.+.+ ....+.++.+++.+||+.||++||++.++.+.|+.
T Consensus 237 -----~~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 237 -----IEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp -----HHHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred -----hhHh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 0001 11234568889999999999999999998887775
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=308.30 Aligned_cols=254 Identities=19% Similarity=0.215 Sum_probs=191.1
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeeeeEEe
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 234 (442)
++|++++.||+|+||+||+|++ .+++.||||+++.. .......+.+|+.+|+.++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4689999999999999999996 46889999998543 33456788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------C-------CCCCCeEEecccCccccCCCcce
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------L-------EPKWNPKLSDFGLAKLLGAERSY 301 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l-------~~~~~~kl~DFGla~~~~~~~~~ 301 (442)
++.+++|..++... ..+++..+..++.|++.||+|||+. + +.++.+||+|||.++........
T Consensus 82 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 82 FCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp CCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eccccccccccccc----cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 99999998888654 5788999999999999999999875 3 44678999999999886543322
Q ss_pred eecccccccCCCCcccccCCC-CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCC---c---
Q 047892 302 VTTRVMGTFGYVAPEYASTGM-LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGN---A--- 374 (442)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~--- 374 (442)
.....+++.|+|||.+.+.. ++.++|||||||++|||++|+.||....... .....+........ .
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD------DQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp -CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH------HHHHHHHHHHCCCCTTTCTTG
T ss_pred -ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH------HHHHHHHhhcCCCChhhhhhh
Confidence 23346788999999987665 6899999999999999999999975432211 11111111111100 0
Q ss_pred ---------ccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH--HHhcC
Q 047892 375 ---------EGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEAE 422 (442)
Q Consensus 375 ---------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~--~L~~~ 422 (442)
................+..+.+|+.+||+.||.+||||+|+++ .|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 0000000011112234456888999999999999999999986 45543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-40 Score=316.38 Aligned_cols=249 Identities=20% Similarity=0.266 Sum_probs=179.9
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc-chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----eeee
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEGA----HRML 231 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~l 231 (442)
++|++++.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+++|++++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 4588999999999999999995 56999999999643 3445567889999999999999999999987653 2345
Q ss_pred EEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCccccCCC
Q 047892 232 VNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLLGAE 298 (442)
Q Consensus 232 v~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~~~~ 298 (442)
+++|+.+|+|.+++... .+++..++.++.|++.||+|||+. ++.++.+||+|||+++.....
T Consensus 88 l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 55667789999999753 589999999999999999999875 445679999999999876443
Q ss_pred cce--eecccccccCCCCcccccC-CCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc-
Q 047892 299 RSY--VTTRVMGTFGYVAPEYAST-GMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA- 374 (442)
Q Consensus 299 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 374 (442)
... .....+||+.|+|||++.. ..++.++||||+||++|||++|+.||......+.. ............
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~-------~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL-------NHILGILGSPSQE 235 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-------HHHHHHHCSCCHH
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH-------HHHhhhccCCChh
Confidence 221 2345679999999999854 56789999999999999999999999765321111 000000000000
Q ss_pred -------------ccccCcccCCC---CcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 375 -------------EGVLDPRLQEK---PSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 375 -------------~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
........... .....+.++.+|+.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000000 001123467889999999999999999999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-39 Score=313.53 Aligned_cols=246 Identities=18% Similarity=0.245 Sum_probs=182.5
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcC-CCCcceEEEEEEeC--CeeeeEE
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLVGYCAEG--AHRMLVN 233 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~--~~~~lv~ 233 (442)
++|++++.||+|+||+||+|+. .+++.||||++... ..+.+.+|+++|+.++ ||||+++++++... ..+++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5699999999999999999996 46899999998543 3456889999999995 99999999999743 5689999
Q ss_pred ecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC-------C-CCeEEecccCccccCCCc
Q 047892 234 EYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP-------K-WNPKLSDFGLAKLLGAER 299 (442)
Q Consensus 234 E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~-------~-~~~kl~DFGla~~~~~~~ 299 (442)
|||.+|+|..+. ..+++..++.++.||+.||.|||+. +++ + +.+||+|||+|+......
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999999997764 3589999999999999999999765 443 2 358999999998765433
Q ss_pred ceeecccccccCCCCcccccCC-CCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHH---------HHHHHHh
Q 047892 300 SYVTTRVMGTFGYVAPEYASTG-MLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF---------EWLKTMV 369 (442)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~---------~~~~~~~ 369 (442)
. ....+||+.|+|||.+.+. .++.++||||+||++|||++|+.||......... ...+. .+.....
T Consensus 185 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~--~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 185 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ--LVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH--HHHHHHHHCHHHHHHHHHHTT
T ss_pred c--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHH--HHHHHHHHCCchhhhhhhhcc
Confidence 2 3456799999999998765 4799999999999999999999999754332110 00000 0110000
Q ss_pred hcCC--cccc--------cCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH
Q 047892 370 TNGN--AEGV--------LDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIH 417 (442)
Q Consensus 370 ~~~~--~~~~--------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 417 (442)
.... .... .............+.++.+|+.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0000 0011111122334567889999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-39 Score=307.63 Aligned_cols=247 Identities=15% Similarity=0.174 Sum_probs=188.9
Q ss_pred hCCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCcchhhHHHHHHHHHHHHhcCC-CCcceEEEEEEeCCeeeeEEe
Q 047892 157 TNGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH-KNLVRLVGYCAEGAHRMLVNE 234 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~E 234 (442)
.++|++.+.||+|+||+||+|++. +|+.||||.+.... ....+.+|+++++.|+| +||+.+++++..+...|+|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 357899999999999999999964 58899999875432 22346778999999976 899999999999999999999
Q ss_pred cCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCC------------CCCeEEecccCccccC
Q 047892 235 YVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEP------------KWNPKLSDFGLAKLLG 296 (442)
Q Consensus 235 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~------------~~~~kl~DFGla~~~~ 296 (442)
|+ +|+|.++++.. ...++...+..++.|++.||+|||+. ++| ++.+||+|||+|+...
T Consensus 82 ~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 82 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99 57999998764 24689999999999999999999875 333 4579999999998764
Q ss_pred CCcc------eeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhh
Q 047892 297 AERS------YVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVT 370 (442)
Q Consensus 297 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 370 (442)
.... ......+||+.|||||++.+..++.++|||||||++|||+||+.||.......... ....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~----~~~~i~~~~~ 233 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ----KYERIGEKKQ 233 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH----HHHHHHHHHH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH----HHHHHHhccC
Confidence 3321 12334689999999999999999999999999999999999999997654433211 1111111111
Q ss_pred cCCcccccCcccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHHHhcC
Q 047892 371 NGNAEGVLDPRLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 422 (442)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~~ 422 (442)
..... .+.. ..++++.+++..||+.+|++||+++.+.+.|+++
T Consensus 234 ~~~~~-----~l~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 234 STPLR-----ELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HSCHH-----HHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCChH-----HhcC----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 00000 1111 1235678899999999999999999988887764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-39 Score=312.38 Aligned_cols=252 Identities=22% Similarity=0.226 Sum_probs=175.2
Q ss_pred CCCCccCeeccCCcEEEEEEEEC-CCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEe------CCe
Q 047892 158 NGFADENVIGEGGYGIVYRGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAE------GAH 228 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------~~~ 228 (442)
++|+++++||+|+||+||+|++. +|+.||||++... .......+.+|+.+|++++|||||+++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 56999999999999999999965 5999999999643 33445678899999999999999999999964 367
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CC-------CCCCeEEecccCcccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LE-------PKWNPKLSDFGLAKLL 295 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~-------~~~~~kl~DFGla~~~ 295 (442)
+|+|||||.++ +.+.+. ..+++..++.++.|++.||.|||+. ++ .++.+|++|||+++..
T Consensus 97 ~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence 89999999875 555554 3478999999999999999999875 43 4678999999999876
Q ss_pred CCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhh------------hHHH
Q 047892 296 GAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQV------------NLFE 363 (442)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~------------~~~~ 363 (442)
.... .....+||+.|+|||++.+..+++++||||+||++|||++|+.||.+.+......... ....
T Consensus 170 ~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 170 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred cccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 4332 2345679999999999999999999999999999999999999997543211100000 0000
Q ss_pred HHHHHhhcCC-c-----ccccCcccCC---CCcHHHHHHHHHHHhhhhCCCCCCCCCHHHHHHH
Q 047892 364 WLKTMVTNGN-A-----EGVLDPRLQE---KPSSRALKRALLVALRCVDPNAHKRPKMGHVIHM 418 (442)
Q Consensus 364 ~~~~~~~~~~-~-----~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 418 (442)
.......... . .......... ......+..+.+|+.+||+.||++||||+|+|+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0111111110 0 0001111111 1123456788999999999999999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=314.67 Aligned_cols=250 Identities=21% Similarity=0.258 Sum_probs=181.3
Q ss_pred hCCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCc--chhhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----Ce
Q 047892 157 TNGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLVGYCAEG-----AH 228 (442)
Q Consensus 157 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~ 228 (442)
.++|++++.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 35799999999999999999996 46999999999643 234456788999999999999999999998643 34
Q ss_pred eeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------------CCCCCCeEEecccCcccc
Q 047892 229 RMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------------LEPKWNPKLSDFGLAKLL 295 (442)
Q Consensus 229 ~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------l~~~~~~kl~DFGla~~~ 295 (442)
.+++|+|+.+|+|.+++.. ..+++..+..++.|++.||+|||+. ++.++.+|++|||++...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc
Confidence 4777888899999999964 3699999999999999999999875 345678999999999765
Q ss_pred CCCcceeecccccccCCCCcccccCCC-CCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHHHHHHHHhhcCCc
Q 047892 296 GAERSYVTTRVMGTFGYVAPEYASTGM-LNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLFEWLKTMVTNGNA 374 (442)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (442)
... .....||+.|+|||.+.+.. ++.++|||||||++|||++|+.||.+.+.... ...+.........
T Consensus 172 ~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-------~~~i~~~~~~~~~ 240 (348)
T d2gfsa1 172 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-------LKLILRLVGTPGA 240 (348)
T ss_dssp TGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHHHCCCCH
T ss_pred Ccc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH-------HHHHHHhcCCCCh
Confidence 322 34467899999999876654 68899999999999999999999975432111 1111000000000
Q ss_pred --------------ccccCcccCCCC---cHHHHHHHHHHHhhhhCCCCCCCCCHHHHHH--HHhcC
Q 047892 375 --------------EGVLDPRLQEKP---SSRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEAE 422 (442)
Q Consensus 375 --------------~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~evl~--~L~~~ 422 (442)
...+........ ....+..+.+|+.+||+.||.+|||+.|+++ .+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 000000000000 0123456788999999999999999999997 46554
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-33 Score=273.94 Aligned_cols=257 Identities=18% Similarity=0.177 Sum_probs=177.0
Q ss_pred CCCCccCeeccCCcEEEEEEEE-CCCCeEEEEEecCcchhhHHHHHHHHHHHHhcC-----------CCCcceEEEEEEe
Q 047892 158 NGFADENVIGEGGYGIVYRGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-----------HKNLVRLVGYCAE 225 (442)
Q Consensus 158 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~l~~~~~~ 225 (442)
++|+++++||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3589999999999999999996 468999999996532 33456788998888775 5789999998764
Q ss_pred --CCeeeeEEecCCCCCH-HHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC-------CCCCC-------------
Q 047892 226 --GAHRMLVNEYVDNGNL-EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-------LEPKW------------- 282 (442)
Q Consensus 226 --~~~~~lv~E~~~~g~L-~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------l~~~~------------- 282 (442)
....+++|+++..+.. ....... ....+++..+..++.|++.||.|||+. +++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 3456677776655433 3322222 235688899999999999999999863 45432
Q ss_pred CeEEecccCccccCCCcceeecccccccCCCCcccccCCCCCCcCCchhhHHHHHHHHhCCCCCCCCCCCCccchhhhHH
Q 047892 283 NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNETSDVYSFGILIMEVISGRNPVDYSRPPGEFQFQVNLF 362 (442)
Q Consensus 283 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 362 (442)
.+|++|||.+...... ....+||+.|+|||++.+..|+.++||||+||+++||++|+.||..............+.
T Consensus 170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 3899999999865332 244679999999999999999999999999999999999999997543322211111111
Q ss_pred HHHHHHhh-------c----------CCcccccCc----------ccCCCCcHHHHHHHHHHHhhhhCCCCCCCCCHHHH
Q 047892 363 EWLKTMVT-------N----------GNAEGVLDP----------RLQEKPSSRALKRALLVALRCVDPNAHKRPKMGHV 415 (442)
Q Consensus 363 ~~~~~~~~-------~----------~~~~~~~~~----------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ev 415 (442)
..+..... . ......+.. ..........+..+.+|+.+||+.||.+|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 11111000 0 000000000 01122345677889999999999999999999999
Q ss_pred HHH--Hhc
Q 047892 416 IHM--LEA 421 (442)
Q Consensus 416 l~~--L~~ 421 (442)
|+. +++
T Consensus 326 L~Hp~f~~ 333 (362)
T d1q8ya_ 326 VNHPWLKD 333 (362)
T ss_dssp HTCGGGTT
T ss_pred hcCcccCC
Confidence 874 553
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.67 E-value=3.3e-17 Score=143.06 Aligned_cols=155 Identities=15% Similarity=0.082 Sum_probs=105.6
Q ss_pred CccCeeccCCcEEEEEEEECCCCeEEEEEecCcch------------------hhHHHHHHHHHHHHhcCCCCcceEEEE
Q 047892 161 ADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRG------------------QAEKEFKVEVEAIGRVRHKNLVRLVGY 222 (442)
Q Consensus 161 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~hpnIv~l~~~ 222 (442)
.+.+.||+|+||.||+|...+|+.||||.++.... .......+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45689999999999999988899999998642110 112234568899999999999998865
Q ss_pred EEeCCeeeeEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC------CCCCC------CeEEeccc
Q 047892 223 CAEGAHRMLVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEPKW------NPKLSDFG 290 (442)
Q Consensus 223 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------l~~~~------~~kl~DFG 290 (442)
. ..+++|||++++.+.++ +......++.|++.+|.|||+. ++|.| .++|+|||
T Consensus 83 ~----~~~lvme~~~~~~~~~l-----------~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~~~liDFG 147 (191)
T d1zara2 83 E----GNAVLMELIDAKELYRV-----------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFP 147 (191)
T ss_dssp E----TTEEEEECCCCEEGGGC-----------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEECCCT
T ss_pred c----CCEEEEEeeccccccch-----------hhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCCEEEEECC
Confidence 3 23799999998665432 2233567889999999999764 66643 58999999
Q ss_pred CccccCCCcceee-cccccccCCCCcccccCCCCCCcCCchhhHHH
Q 047892 291 LAKLLGAERSYVT-TRVMGTFGYVAPEYASTGMLNETSDVYSFGIL 335 (442)
Q Consensus 291 la~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvi 335 (442)
+|+....+..... ...+.. -.+.+ ...|+.++|+||..--
T Consensus 148 ~a~~~~~~~~~~~l~rd~~~----~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 148 QSVEVGEEGWREILERDVRN----IITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp TCEETTSTTHHHHHHHHHHH----HHHHH-HHHHCCCCCHHHHHHH
T ss_pred CcccCCCCCcHHHHHHHHHH----HHHHH-cCCCCCcccHHHHHHH
Confidence 9987643321100 000000 00111 3568899999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=96.94 E-value=0.001 Score=58.52 Aligned_cols=116 Identities=13% Similarity=0.031 Sum_probs=79.2
Q ss_pred hHHHhhCCCCccCeeccCCcEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeee
Q 047892 152 ELEVSTNGFADENVIGEGGYGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLVGYCAEGAHRM 230 (442)
Q Consensus 152 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~ 230 (442)
++....+.|++.+..+-++.+.||+... +++.+.+|............+.+|...+..+. +--+.+++.+..+++..|
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4444456677666555555678998864 56678888875443333344677888877763 434677888888889999
Q ss_pred eEEecCCCCCHHHHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC
Q 047892 231 LVNEYVDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277 (442)
Q Consensus 231 lv~E~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 277 (442)
+||++++|.++.+..... . ....++.+++..+.-||+.
T Consensus 87 lv~~~l~G~~~~~~~~~~------~---~~~~~~~~l~~~l~~lH~~ 124 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE------Q---SPEKIIELYAECIRLFHSI 124 (263)
T ss_dssp EEEECCSSEEHHHHTTTC------S---CHHHHHHHHHHHHHHHHTS
T ss_pred EEEEeccccccccccccc------c---cHHHHHHHHHHHHHHHhcc
Confidence 999999999887654321 1 1334567778888999974
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=94.47 E-value=0.023 Score=48.94 Aligned_cols=97 Identities=16% Similarity=0.084 Sum_probs=64.9
Q ss_pred eccCC-cEEEEEEEECCCCeEEEEEecCcchhhHHHHHHHHHHHHhcCC--CCcceEEEEEEeCCeeeeEEecCCCCCHH
Q 047892 166 IGEGG-YGIVYRGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH--KNLVRLVGYCAEGAHRMLVNEYVDNGNLE 242 (442)
Q Consensus 166 lG~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~lv~E~~~~g~L~ 242 (442)
+..|. .+.||+....++..+++|...... ...+..|...++.+.. -.+.+++.+..+.+..++||++++|.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 34443 467999988778888889764432 2346677777776632 33677888888888899999999986653
Q ss_pred HHHccCCCCCCCCCHHHHHHHHHHHHHhhhhhhcC
Q 047892 243 QWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 277 (442)
Q Consensus 243 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~ 277 (442)
+. .... ..++.++...|.-||+.
T Consensus 95 ~~---------~~~~---~~~~~~l~~~la~LH~~ 117 (255)
T d1nd4a_ 95 SS---------HLAP---AEKVSIMADAMRRLHTL 117 (255)
T ss_dssp TS---------CCCH---HHHHHHHHHHHHHHTTS
T ss_pred cc---------cccH---HHHHHHHHHHHHHHccC
Confidence 31 1222 23445677778888863
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=84.70 E-value=0.82 Score=41.74 Aligned_cols=77 Identities=16% Similarity=0.175 Sum_probs=48.9
Q ss_pred cCeeccCCcEEEEEEEECC-CCeEEEEEecCc-------chhhHHHHHHHHHHHHhcC-C--CCcceEEEEEEeCCeeee
Q 047892 163 ENVIGEGGYGIVYRGVLED-NTNVAVKNLLNN-------RGQAEKEFKVEVEAIGRVR-H--KNLVRLVGYCAEGAHRML 231 (442)
Q Consensus 163 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--pnIv~l~~~~~~~~~~~l 231 (442)
.+.||.|....||++...+ ++.++||.-... -.....+...|.+.|+.+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4568999999999998544 678999965321 0112233456787777652 2 346666654 4556689
Q ss_pred EEecCCCCCH
Q 047892 232 VNEYVDNGNL 241 (442)
Q Consensus 232 v~E~~~~g~L 241 (442)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|